data_2mmc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mmc _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.3 t . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.472 -1.677 . . . . 100.0 106.472 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.74 138.89 53.44 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.904 -1.953 . . . . 100.0 108.102 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.66 146.06 50.33 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.753 -0.832 . . . . 100.0 108.753 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -94.67 120.54 35.06 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 104.731 -2.322 . . . . 100.0 104.731 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.3 tp -112.12 126.25 54.99 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.964 -1.926 . . . . 100.0 106.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 79' ' ' TYR . 43.0 t -101.82 123.19 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.097 -1.446 . . . . 100.0 107.097 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD12 ' SD ' ' A' ' 89' ' ' MET . 36.5 tp -110.89 116.51 31.36 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.094 -2.558 . . . . 100.0 104.094 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -128.8 163.4 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 120.765 0.317 . . . . 100.0 111.797 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.54 173.47 22.76 Favored Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 107.848 -2.101 . . . . 100.0 107.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -68.12 154.91 40.71 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.964 0.888 . . . . 100.0 112.574 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.85 140.0 41.64 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.606 -2.198 . . . . 100.0 107.606 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 -4.34 82.11 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.469 -1.184 . . . . 100.0 113.868 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.597 ' HB ' HD22 ' A' ' 122' ' ' ASN . 19.6 p -62.87 -39.01 93.13 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 119.055 1.428 . . . . 100.0 111.372 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 22.82 4.53 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 110.322 -1.111 . . . . 100.0 110.322 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -59.52 -46.56 88.48 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 124.554 1.142 . . . . 100.0 112.889 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -63.23 -44.29 95.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.411 1.084 . . . . 100.0 110.087 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -62.47 -42.01 99.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.294 1.037 . . . . 100.0 109.178 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -60.75 -48.73 80.47 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.06 0.944 . . . . 100.0 113.285 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.9 -40.89 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.064 0.459 . . . . 100.0 110.523 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.27 99.6 mttt -69.35 -6.85 32.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.174 1.916 . . . . 100.0 116.174 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 49.1 mtt180 -60.7 -37.89 83.17 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.03 -1.1 . . . . 100.0 108.03 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.709 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 54.0 t-80 -80.87 112.92 18.7 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.48 -43.59 98.44 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.854 1.798 . . . . 100.0 115.854 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 78.8 m -63.75 -40.95 97.96 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.904 -0.776 . . . . 100.0 108.904 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.709 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -60.96 -41.78 99.5 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.388 -1.085 . . . . 100.0 110.388 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.274 81.0 mt-10 -63.77 -45.15 91.09 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 117.38 0.59 . . . . 100.0 111.649 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.81 -40.32 97.02 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.256 1.022 . . . . 100.0 111.857 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -93.23 8.91 38.34 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 114.841 1.422 . . . . 100.0 114.841 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -60.87 142.57 56.12 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 113.743 1.016 . . . . 100.0 113.743 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -124.01 131.05 53.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.994 -1.003 . . . . 100.0 108.378 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -101.05 123.64 45.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.541 -2.022 . . . . 100.0 105.541 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.64 112.19 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 102.809 -3.034 . . . . 100.0 102.809 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.86 94.98 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 116.471 2.026 . . . . 100.0 116.471 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -61.9 -48.44 80.47 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 122.895 0.478 . . . . 100.0 110.578 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.64 -38.62 70.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.67 1.359 . . . . 100.0 114.67 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.77 44.04 21.26 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 106.312 -2.715 . . . . 100.0 106.312 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.86 144.61 37.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.726 1.21 . . . . 100.0 109.271 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -106.1 118.96 37.97 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.077 -3.305 . . . . 100.0 102.077 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.46 120.88 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.267 -1.753 . . . . 100.0 106.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -113.16 119.5 42.23 Favored Pre-proline 0 N--CA 1.434 -1.234 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.55 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -80.32 104.25 1.61 Allowed 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.654 2.236 . . . . 100.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.4 113.97 26.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.31 -0.996 . . . . 100.0 108.31 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.85 127.19 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.272 -1.381 . . . . 100.0 107.272 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.56 135.09 55.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.461 -2.052 . . . . 100.0 105.461 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -102.52 117.6 35.05 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.32 -0.622 . . . . 100.0 109.32 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.413 ' HG1' ' H ' ' A' ' 56' ' ' ARG . 17.5 p -107.09 175.92 5.34 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.816 0.817 . . . . 100.0 110.288 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.26 -35.0 74.52 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.314 1.445 . . . . 100.0 109.502 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.413 ' H ' ' HG1' ' A' ' 54' ' ' THR . 96.9 mtt180 -87.59 -2.33 58.54 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 113.499 0.926 . . . . 100.0 113.499 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.6 -179.72 16.2 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.593 -1.003 . . . . 100.0 110.593 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.74 140.13 54.94 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.869 2.379 . . . . 100.0 115.833 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.13 130.06 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 102.304 -3.221 . . . . 100.0 102.304 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.45 128.35 56.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -110.19 116.31 31.28 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -87.67 106.8 18.28 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.812 -4.144 . . . . 100.0 99.812 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -93.36 123.76 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.396 0 N-CA-C 106.412 -1.699 . . . . 100.0 106.412 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -97.8 114.5 26.55 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 105.838 -1.912 . . . . 100.0 105.838 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -109.33 135.2 50.78 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.5 p -72.28 163.45 27.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.874 0.845 . . . . 100.0 112.559 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.14 20.55 12.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.206 -0.906 . . . . 100.0 108.586 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.85 12.21 58.16 Favored Glycine 0 C--N 1.359 1.847 0 CA-C-O 119.341 -0.699 . . . . 100.0 114.128 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 90.7 mt-30 -60.29 -31.37 70.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.259 1.824 . . . . 100.0 112.591 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -57.54 -32.38 67.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.924 2.49 . . . . 100.0 111.813 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.88 -39.62 95.03 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 123.527 0.731 . . . . 100.0 111.565 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 22.9 p90 -94.87 -14.14 24.83 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.774 1.398 . . . . 100.0 114.774 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.58 -160.36 26.96 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 119.933 -1.127 . . . . 100.0 112.422 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.02 176.95 54.54 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 109.874 -1.29 . . . . 100.0 109.874 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.31 143.5 33.4 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.49 -0.929 . . . . 100.0 108.49 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -70.5 160.11 33.04 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.02 -0.991 . . . . 100.0 113.175 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -59.48 -37.99 79.66 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 125.443 1.497 . . . . 100.0 110.237 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.37 91.8 Favored Glycine 0 C--N 1.358 1.797 0 C-N-CA 124.77 1.176 . . . . 100.0 111.29 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.407 ' CE2' HG11 ' A' ' 14' ' ' VAL . 76.0 t80 -62.98 -47.0 85.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.33 0.565 . . . . 100.0 111.218 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -70.51 -36.73 73.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 116.976 2.213 . . . . 100.0 116.976 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.5 mt -50.86 134.64 11.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-O 123.189 1.471 . . . . 100.0 114.796 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 61.19 29.26 18.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 128.023 2.529 . . . . 100.0 113.877 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB1' ' HG ' ' A' ' 112' ' ' CYS . . . -74.11 133.12 42.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -96.39 -26.26 15.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 110.103 -0.332 . . . . 100.0 110.103 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.22 162.61 41.11 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.852 0.358 . . . . 100.0 110.839 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.6 152.84 38.6 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 114.413 1.264 . . . . 100.0 114.413 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.6 mt -126.17 125.89 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 103.41 -2.811 . . . . 100.0 103.41 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 119' ' ' LEU . 48.6 mt -109.74 125.31 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 102.87 -3.011 . . . . 100.0 102.87 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.471 ' SD ' HD12 ' A' ' 15' ' ' LEU . 89.3 mtp -110.46 135.91 50.41 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.923 1.083 . . . . 100.0 113.923 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.76 162.43 28.45 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 112.686 -2.052 . . . . 100.0 107.14 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.53 124.37 49.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.962 -1.496 . . . . 100.0 106.962 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.18 -18.86 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 114.211 1.189 . . . . 100.0 114.211 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.5 p -89.44 -7.5 54.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 118.378 0.535 . . . . 100.0 111.18 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 m -124.98 116.78 22.71 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.596 1.189 . . . . 100.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -63.32 -38.51 91.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.459 1.503 . . . . 100.0 111.872 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.59 -40.88 83.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 125.872 1.669 . . . . 100.0 110.72 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.2 p -62.19 -41.53 98.43 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 118.192 0.451 . . . . 100.0 111.77 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -65.02 -40.95 95.61 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.559 0.743 . . . . 100.0 110.251 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.1 mttt -61.38 -36.45 80.29 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.531 1.132 . . . . 100.0 111.142 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.18 -3.85 53.53 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 115.272 1.582 . . . . 100.0 115.272 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.55 -41.94 85.73 Favored Pre-proline 0 C--N 1.362 1.128 0 CA-C-O 116.572 -1.68 . . . . 100.0 111.182 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 63.0 Cg_exo -56.86 -38.3 96.17 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.292 1.995 . . . . 100.0 112.864 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.61 -45.25 91.19 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.59 1.156 . . . . 100.0 110.873 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -64.46 -41.36 96.57 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.122 0.264 . . . . 100.0 111.356 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.21 -44.32 96.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.619 0.767 . . . . 100.0 110.14 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -61.99 -45.26 94.42 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 119.015 -0.517 . . . . 100.0 112.179 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.53 -42.43 98.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 O-C-N 123.24 0.337 . . . . 100.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.9 -48.16 80.17 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.783 0.833 . . . . 100.0 112.469 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.279 22.9 m -67.2 -29.23 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -60.62 -47.28 86.93 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.778 -0.823 . . . . 100.0 108.778 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.85 -45.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 112.598 0.592 . . . . 100.0 112.598 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.478 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 76.7 m -124.61 107.79 11.39 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.985 0.898 . . . . 100.0 110.077 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.89 140.05 30.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.358 -0.837 . . . . 100.0 111.59 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.13 39.57 31.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.981 2.113 . . . . 100.0 116.701 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.1 144.99 29.24 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 106.635 -1.617 . . . . 100.0 106.635 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -62.59 132.08 36.39 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.21 2.606 . . . . 100.0 109.691 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HB ' HD21 ' A' ' 144' ' ' LEU . 73.0 mt -134.18 137.57 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.198 0.999 . . . . 100.0 108.364 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.13 132.1 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 105.593 -2.002 . . . . 100.0 105.593 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 139' ' ' HIS 0.294 23.2 mt -105.95 131.04 53.74 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 103.725 -2.694 . . . . 100.0 103.725 175.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.49 131.21 55.54 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.052 -1.431 . . . . 100.0 112.48 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.3 104.97 2.89 Favored Glycine 0 CA--C 1.486 -1.757 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.597 HD22 ' HB ' ' A' ' 21' ' ' THR . 24.6 p30 -86.73 173.21 9.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.185 1.179 . . . . 100.0 114.185 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 mttp 60.26 40.39 17.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.141 2.576 . . . . 100.0 113.725 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.339 28.5 m -71.76 -7.79 10.02 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 120.33 -0.548 . . . . 100.0 111.495 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.71 -38.21 89.55 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.464 1.906 . . . . 100.0 110.334 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -69.74 130.18 34.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 N-CA-C 108.514 -0.921 . . . . 100.0 108.514 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.14 -41.82 98.64 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 117.223 2.305 . . . . 100.0 117.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -85.49 94.57 9.04 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.146 -1.798 . . . . 100.0 106.146 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -92.66 123.96 36.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 104.921 -2.251 . . . . 100.0 104.921 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.69 -36.62 10.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 113.301 0.852 . . . . 100.0 113.301 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.93 104.07 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 103.752 -2.684 . . . . 100.0 103.752 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.25 172.77 7.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.905 -1.043 . . . . 100.0 111.513 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.08 -31.9 65.71 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.267 1.827 . . . . 100.0 109.401 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.847 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 96.5 mttt -57.11 -39.08 74.39 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 130.092 3.357 . . . . 100.0 111.391 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.2 p -105.06 2.27 29.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 117.047 2.24 . . . . 100.0 117.047 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 60.3 mt -89.43 84.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.361 1.088 0 C-N-CA 118.062 -1.455 . . . . 100.0 110.576 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 2.3 p -100.81 -6.09 9.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -59.37 -37.37 77.73 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 116.09 1.885 . . . . 100.0 116.09 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.275 78.6 m-70 -59.5 -37.97 79.69 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 116.718 2.118 . . . . 100.0 116.718 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.708 ' CB ' ' HA ' ' A' ' 215' ' ' ASP . 43.6 ttp85 -59.01 -49.28 78.48 Favored 'General case' 0 CA--C 1.471 -2.092 0 O-C-N 124.178 0.924 . . . . 100.0 112.964 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.63 -41.19 98.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 125.456 1.723 . . . . 100.0 111.074 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.04 0.32 54.4 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.206 2.298 . . . . 100.0 117.206 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 58.32 40.04 24.9 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.155 1.382 . . . . 100.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 117' ' ' ILE . 24.6 mt -101.9 152.52 20.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.754 -1.943 . . . . 100.0 105.754 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.29 143.24 30.71 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.206 -0.665 . . . . 100.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.507 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 84.4 t80 -110.32 136.53 49.36 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.299 1.222 . . . . 100.0 114.299 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -134.42 137.61 44.15 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.432 -1.258 . . . . 100.0 111.18 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.276 72.6 m-20 -84.72 128.64 34.7 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 102.688 -3.078 . . . . 100.0 102.688 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.491 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.8 pt -134.22 157.84 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.702 1.239 . . . . 100.0 111.303 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 70.4 m -139.04 108.49 6.15 Favored 'General case' 0 CA--C 1.48 -1.714 0 N-CA-C 104.861 -2.274 . . . . 100.0 104.861 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.8 -44.18 97.38 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.712 -1.131 . . . . 100.0 112.529 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -61.47 -39.24 90.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 124.853 1.261 . . . . 100.0 112.734 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.567 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 92.3 p -100.31 2.09 42.23 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 115.868 1.803 . . . . 100.0 115.868 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.436 ' HA ' HH11 ' A' ' 29' ' ' ARG . 68.0 m-80 65.19 20.68 12.0 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.94 1.296 . . . . 100.0 110.99 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 83.4 t80 -72.94 125.7 28.21 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.473 -0.936 . . . . 100.0 108.473 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 54.05 36.68 25.2 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 128.185 2.594 . . . . 100.0 114.584 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 64.3 t80 -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.359 0.99 0 O-C-N 121.881 -0.512 . . . . 100.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -63.67 -38.49 91.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.499 2.037 . . . . 100.0 116.499 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.12 -47.97 98.19 Favored Pre-proline 0 C--N 1.358 0.938 0 N-CA-C 120.097 3.369 . . . . 100.0 120.097 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.15 -41.08 45.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 CA-C-N 123.475 2.277 . . . . 100.0 112.592 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.21 -42.45 96.59 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.712 1.205 . . . . 100.0 110.814 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.23 -44.29 92.32 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 118.795 -0.621 . . . . 100.0 111.628 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -64.88 -42.26 94.96 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 123.499 0.499 . . . . 100.0 110.389 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.54 -43.82 98.16 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.453 0.47 . . . . 100.0 110.594 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.52 -44.18 97.52 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.076 0.951 . . . . 100.0 110.656 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.58 -45.6 93.42 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 122.672 0.389 . . . . 100.0 111.783 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -66.17 -44.54 83.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.858 0.688 . . . . 100.0 112.858 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.26 -45.19 89.18 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 113.451 0.908 . . . . 100.0 113.451 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 50.9 mm -74.52 -30.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.902 0.881 . . . . 100.0 110.11 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.79 13.82 66.28 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 118.635 -1.091 . . . . 100.0 111.447 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -116.39 112.31 41.55 Favored Pre-proline 0 C--N 1.363 1.168 0 CA-C-N 118.439 1.119 . . . . 100.0 108.044 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.99 -14.1 31.98 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.749 2.966 . . . . 100.0 113.255 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -85.63 -3.18 58.81 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.125 0.97 . . . . 100.0 113.026 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.84 134.21 56.86 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 113.226 0.825 . . . . 100.0 113.226 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.14 149.29 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.525 -1.216 . . . . 100.0 108.235 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -90.03 114.62 26.53 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 103.525 -2.769 . . . . 100.0 103.525 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.24 -40.04 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.53 146.8 52.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.8 mtt -88.27 129.61 48.99 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.336 -1.727 . . . . 100.0 106.336 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.27 158.48 52.14 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.276 1.984 . . . . 100.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.43 124.88 23.98 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.722 -1.214 . . . . 100.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.54 145.85 45.02 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 114.263 -1.335 . . . . 100.0 110.403 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.38 136.28 96.63 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.796 -1.927 . . . . 100.0 105.796 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 138.88 77.58 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 123.55 2.833 . . . . 100.0 112.553 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -57.81 129.09 31.71 Favored 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.23 1.954 . . . . 100.0 113.509 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.86 -43.8 82.65 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 124.701 1.251 . . . . 100.0 108.085 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 158.24 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.58 -1.637 . . . . 100.0 106.58 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.42 131.89 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.567 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -87.47 123.91 32.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.654 -2.721 . . . . 100.0 103.654 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 34.0 t70 -62.85 128.65 92.29 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 114.779 -1.101 . . . . 100.0 110.565 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.0 Cg_exo -58.7 -37.65 93.09 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.725 2.95 . . . . 100.0 113.546 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.06 95.23 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 123.979 0.8 . . . . 100.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.3 -42.22 99.03 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 122.769 0.428 . . . . 100.0 111.147 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.2 97.73 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 123.703 0.801 . . . . 100.0 110.625 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.03 97.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.508 0.723 . . . . 100.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.26 -44.75 95.83 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.758 0.823 . . . . 100.0 112.075 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -63.49 -43.51 97.04 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 122.918 0.487 . . . . 100.0 111.793 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.19 -39.83 94.83 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.707 -0.224 . . . . 100.0 111.19 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.78 -42.67 99.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.158 0.983 . . . . 100.0 110.007 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -61.51 -42.35 98.68 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.838 0.855 . . . . 100.0 110.645 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.481 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 81.9 mt -61.03 -48.43 81.84 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.391 -0.822 . . . . 100.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.48 -41.84 98.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.66 -47.14 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.968 0 CA-C-O 118.221 -0.895 . . . . 100.0 109.124 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.715 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.705 . . -88.87 -8.67 53.85 Favored 'General case' 1 N--CA 1.379 -4.008 1 C-N-CA 104.543 -6.863 . . . . 100.0 116.647 179.881 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 55.1 mt-30 -53.48 -34.89 59.7 Favored 'General case' 0 CA--C 1.444 -3.108 0 C-N-CA 128.179 2.591 . . . . 100.0 107.507 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -82.73 41.47 0.73 Allowed 'General case' 0 N--CA 1.416 -2.133 0 O-C-N 124.825 1.328 . . . . 100.0 109.766 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.6 m 57.96 30.24 18.86 Favored 'General case' 0 CA--C 1.473 -1.988 0 C-N-CA 127.13 2.172 . . . . 100.0 112.578 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.443 ' HB1' ' CB ' ' A' ' 204' ' ' ALA 0.275 . . -73.61 175.51 7.05 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 101.155 -3.646 . . . . 100.0 101.155 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.03 -36.7 49.04 Favored Pre-proline 0 CA--C 1.489 -1.393 0 CA-C-O 116.359 -1.781 . . . . 100.0 114.024 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.847 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.457 0.3 OUTLIER -53.58 137.79 66.35 Favored 'Trans proline' 0 N--CA 1.433 -2.088 0 O-C-N 123.814 1.428 . . . . 100.0 112.634 176.602 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.507 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.305 99.3 m-20 -64.01 -43.03 96.86 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 121.499 3.888 . . . . 100.0 121.499 -172.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.1 tm-20 -71.42 -16.03 62.37 Favored 'General case' 0 CA--C 1.463 -2.394 1 CA-C-O 130.799 5.095 . . . . 100.0 112.989 177.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.785 66.3 m-20 -86.07 -50.04 7.33 Favored 'General case' 1 N--CA 1.257 -10.116 1 CA-C-N 105.781 -5.19 . . . . 100.0 104.025 -172.932 . . . . . . . . 5 3 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.05 -28.96 69.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.255 -2.153 . . . . 100.0 106.528 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.708 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 73.0 m-20 -61.77 -40.29 94.64 Favored 'General case' 0 CA--C 1.476 -1.889 0 C-N-CA 126.925 2.09 . . . . 100.0 112.591 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.283 0.6 OUTLIER . . . . . 0 N--CA 1.428 -1.558 0 CA-C-O 115.334 -2.27 . . . . 100.0 114.301 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.435 -1.194 0 N-CA-C 101.759 -3.422 . . . . 100.0 101.759 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -128.58 138.13 52.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.534 -0.757 . . . . 100.0 109.876 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.75 144.09 51.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 82' ' ' GLN . 99.5 mttt -91.4 122.54 34.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.596 -2.001 . . . . 100.0 105.596 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.21 126.53 55.16 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.7 t -104.27 124.36 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.773 -1.195 . . . . 100.0 107.773 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.419 HD12 ' SD ' ' A' ' 89' ' ' MET . 38.1 tp -108.7 118.83 37.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.039 -1.837 . . . . 100.0 106.039 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.81 162.36 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.802 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.24 172.78 22.52 Favored Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.015 -2.034 . . . . 100.0 108.015 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -66.74 153.45 43.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.958 0.885 . . . . 100.0 111.973 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.24 140.89 43.89 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.471 -2.252 . . . . 100.0 107.471 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.57 -3.08 85.12 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-O 118.568 -1.129 . . . . 100.0 114.37 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -62.77 -38.53 90.97 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.868 1.334 . . . . 100.0 112.248 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 23.55 3.79 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 110.247 -1.141 . . . . 100.0 110.247 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -59.98 -47.78 84.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.382 1.073 . . . . 100.0 113.163 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -64.17 -42.76 96.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 123.906 0.882 . . . . 100.0 110.42 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -62.53 -42.04 99.26 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.209 1.004 . . . . 100.0 109.309 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -60.29 -49.59 77.01 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.663 1.185 . . . . 100.0 112.646 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.37 -41.63 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 123.547 0.529 . . . . 100.0 111.168 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.302 99.4 mttt -69.45 -6.63 31.61 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 115.775 1.769 . . . . 100.0 115.775 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.605 HH11 ' HA ' ' A' ' 154' ' ' ASN . 43.2 mtm180 -60.23 -38.22 82.75 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 109.013 -0.736 . . . . 100.0 109.013 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.642 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 47.3 t-80 -81.32 112.22 18.41 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.637 -1.616 . . . . 100.0 106.637 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.92 -45.12 95.11 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.191 1.923 . . . . 100.0 116.191 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.8 m -63.73 -41.15 98.1 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.252 0.621 . . . . 100.0 109.63 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.642 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.46 -41.66 99.59 Favored Glycine 0 C--N 1.358 1.799 0 N-CA-C 110.841 -0.904 . . . . 100.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.76 -46.52 84.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.824 0.85 . . . . 100.0 111.14 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -63.96 -39.63 94.57 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 113.003 0.742 . . . . 100.0 113.003 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -93.27 11.65 27.32 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 115.4 1.63 . . . . 100.0 115.4 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.85 144.84 51.95 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 113.896 1.073 . . . . 100.0 113.896 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -122.23 130.74 53.47 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.219 -1.03 . . . . 100.0 108.219 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -101.06 125.46 47.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.876 -1.157 . . . . 100.0 107.876 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -99.32 109.18 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.47 98.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 116.649 2.092 . . . . 100.0 116.649 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.4 m -61.92 -44.29 97.08 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.004 0.922 . . . . 100.0 110.925 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.76 -21.39 23.83 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 114.303 1.223 . . . . 100.0 114.303 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.7 45.72 51.01 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 109.296 -1.522 . . . . 100.0 109.296 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.84 144.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 109.147 -0.686 . . . . 100.0 109.147 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -108.26 118.33 36.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 101.598 -3.482 . . . . 100.0 101.598 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.21 120.09 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.71 -1.959 . . . . 100.0 105.71 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -111.52 119.43 45.08 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.825 -0.625 . . . . 100.0 110.076 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.46 103.31 1.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.604 2.203 . . . . 100.0 111.062 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.35 116.03 28.81 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.21 128.46 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.278 -1.378 . . . . 100.0 107.278 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.38 135.6 54.73 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -102.08 117.49 34.9 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -108.56 175.59 5.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.761 0.791 . . . . 100.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.52 -32.97 71.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.39 1.476 . . . . 100.0 109.919 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -92.37 3.81 54.68 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.401 0.889 . . . . 100.0 113.401 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.92 177.93 17.26 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 121.274 -0.891 . . . . 100.0 111.67 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.11 140.45 59.66 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.16 2.573 . . . . 100.0 114.751 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.3 131.12 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 103.057 -2.942 . . . . 100.0 103.057 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -114.4 128.77 56.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.569 -0.53 . . . . 100.0 109.569 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.47 115.7 29.65 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 104.946 -2.242 . . . . 100.0 104.946 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -88.32 105.81 17.81 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 101.051 -3.685 . . . . 100.0 101.051 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.53 123.3 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 107.87 -1.159 . . . . 100.0 107.87 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -95.03 115.73 27.8 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.041 -1.466 . . . . 100.0 107.041 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -111.13 137.62 48.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.625 -1.62 . . . . 100.0 106.625 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -72.77 164.59 26.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.252 1.025 . . . . 100.0 112.38 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.53 22.88 10.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.77 15.63 59.39 Favored Glycine 0 C--N 1.362 1.98 0 O-C-N 121.612 -0.68 . . . . 100.0 113.122 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.456 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 60.3 mt-30 -59.64 -35.1 73.73 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 127.077 2.151 . . . . 100.0 112.364 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.47 -33.1 69.38 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 128.064 2.545 . . . . 100.0 112.011 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.42 -39.37 94.31 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.173 0.589 . . . . 100.0 111.569 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 12.6 p90 -94.66 -7.85 39.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.12 -163.38 35.0 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 119.405 1.002 . . . . 100.0 112.382 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.67 -179.59 53.0 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 108.639 -1.784 . . . . 100.0 108.639 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 79' ' ' TYR . 92.8 mt -107.52 142.22 37.76 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.603 0.716 . . . . 100.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -70.16 157.31 37.85 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.586 -1.188 . . . . 100.0 112.455 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -59.96 -37.57 79.96 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 124.993 1.317 . . . . 100.0 110.623 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.3 -37.45 87.29 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 125.193 1.378 . . . . 100.0 111.102 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.438 ' CE2' HD11 ' A' ' 75' ' ' LEU . 90.0 t80 -62.59 -45.8 91.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.417 0.687 . . . . 100.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -75.58 -28.7 59.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.401 2.0 . . . . 100.0 116.401 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.7 mt -51.31 131.63 12.35 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 123.269 1.509 . . . . 100.0 114.824 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . 0.476 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS 0.263 52.9 mt-30 59.87 29.9 19.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 128.899 2.88 . . . . 100.0 114.006 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 112' ' ' CYS . . . -69.36 132.06 45.8 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.015 -1.846 . . . . 100.0 106.015 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.09 -31.53 13.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.473 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 p -151.81 163.51 39.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.457 -0.572 . . . . 100.0 109.457 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.67 41.98 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 114.64 1.348 . . . . 100.0 114.64 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.3 mt -127.56 126.38 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 104.072 -2.566 . . . . 100.0 104.072 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.449 ' HB ' HD21 ' A' ' 119' ' ' LEU . 33.3 mt -110.51 124.49 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 102.898 -3.001 . . . . 100.0 102.898 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.419 ' SD ' HD12 ' A' ' 15' ' ' LEU . 88.5 mtp -111.94 137.08 50.42 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -130.73 163.69 26.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.537 -2.119 . . . . 100.0 107.706 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -106.67 127.25 53.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.076 -1.824 . . . . 100.0 106.076 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.21 -15.93 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.428 0.899 . . . . 100.0 113.428 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.8 p -90.25 -6.85 54.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.072 0.396 . . . . 100.0 110.543 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -125.75 116.04 20.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.449 1.119 . . . . 100.0 110.561 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.0 -37.7 88.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.591 1.156 . . . . 100.0 112.217 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.59 -40.16 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.983 1.713 . . . . 100.0 110.322 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -62.34 -41.68 98.77 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 118.344 0.52 . . . . 100.0 111.28 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.63 -40.92 96.32 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.268 0.627 . . . . 100.0 110.423 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -60.57 -36.95 79.75 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 123.941 0.896 . . . . 100.0 111.091 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -79.11 -5.91 55.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.94 -42.79 92.46 Favored Pre-proline 0 C--N 1.364 1.215 0 CA-C-O 116.466 -1.73 . . . . 100.0 111.368 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 72.9 Cg_exo -57.8 -37.51 96.18 Favored 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 122.25 1.839 . . . . 100.0 112.69 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -64.14 -44.38 92.35 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.873 1.269 . . . . 100.0 111.076 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -64.64 -40.91 96.28 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 122.877 0.471 . . . . 100.0 110.915 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.73 -44.01 97.73 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 124.09 0.956 . . . . 100.0 109.395 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.46 -45.56 93.77 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 123.71 0.804 . . . . 100.0 111.66 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.0 -45.81 91.95 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.375 0.67 . . . . 100.0 110.699 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.67 -47.27 81.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.665 1.186 . . . . 100.0 113.259 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.321 25.9 m -65.84 -33.8 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 N-CA-C 113.597 0.962 . . . . 100.0 113.597 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 110' ' ' ARG . 55.6 mtt85 -60.14 -46.71 88.75 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 123.813 0.696 . . . . 100.0 109.227 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.07 -44.37 50.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 112.16 0.43 . . . . 100.0 112.16 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.444 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 74.2 m -125.88 107.7 10.74 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.997 0.903 . . . . 100.0 110.715 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.71 138.93 32.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.025 -0.988 . . . . 100.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 53.52 42.02 32.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 117.547 2.425 . . . . 100.0 117.547 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.0 pt -94.99 144.64 28.15 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 106.353 -1.721 . . . . 100.0 106.353 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.61 133.45 42.54 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.36 2.04 . . . . 100.0 110.43 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.445 ' HB ' HD21 ' A' ' 144' ' ' LEU . 70.8 mt -133.98 137.45 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.343 -0.984 . . . . 100.0 108.343 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.37 131.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 105.04 -2.207 . . . . 100.0 105.04 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 24.6 mt -106.63 128.93 54.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.198 -2.519 . . . . 100.0 104.198 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.6 m -120.23 130.6 54.59 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.465 -1.243 . . . . 100.0 113.363 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.3 107.4 3.23 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 105.4 -3.08 . . . . 100.0 105.4 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.353 9.0 p-10 -95.88 177.93 5.6 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 114.501 1.297 . . . . 100.0 114.501 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.1 mttt 62.0 40.4 12.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 128.761 2.824 . . . . 100.0 112.863 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.6 m -71.75 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 114.882 -1.054 . . . . 100.0 111.713 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -66.0 -29.14 69.47 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.981 0.912 . . . . 100.0 110.524 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.6 128.43 34.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 107.158 -1.423 . . . . 100.0 107.158 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.23 -41.81 98.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 115.779 1.77 . . . . 100.0 115.779 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.25 97.08 11.0 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.774 -1.935 . . . . 100.0 105.774 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -96.79 125.11 41.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 113.845 -1.525 . . . . 100.0 106.885 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.27 -39.14 12.23 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.585 0.958 . . . . 100.0 113.585 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -103.5 102.93 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.66 -1.607 . . . . 100.0 106.66 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 168.06 12.41 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.481 1.512 . . . . 100.0 114.022 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.46 67.57 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.989 2.116 . . . . 100.0 108.696 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.827 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 93.8 mttt -57.61 -38.62 75.25 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 129.19 2.996 . . . . 100.0 112.835 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.8 p -105.29 3.04 29.52 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 116.493 2.035 . . . . 100.0 116.493 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 66.8 mt -91.09 89.79 3.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 117.792 -1.563 . . . . 100.0 109.324 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.459 ' CA ' ' HB3' ' A' ' 211' ' ' ASP 0.361 0.0 OUTLIER -101.46 -12.81 8.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 115.636 1.717 . . . . 100.0 115.636 -175.842 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.55 -35.95 73.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 118.235 2.68 . . . . 100.0 118.235 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.548 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.263 60.6 m-70 -59.6 -37.11 77.68 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.396 1.878 . . . . 100.0 113.927 -176.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.688 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.273 55.2 ttp85 -59.15 -50.09 75.38 Favored 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 113.926 1.084 . . . . 100.0 113.926 -175.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.68 -41.23 98.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 125.033 1.458 . . . . 100.0 111.769 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.23 2.74 53.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 116.396 1.999 . . . . 100.0 116.396 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 55.69 43.78 27.46 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-O 123.116 1.436 . . . . 100.0 113.37 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 26.2 mt -101.88 146.48 27.77 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.573 -2.38 . . . . 100.0 104.573 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -94.14 142.39 27.45 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.945 -1.131 . . . . 100.0 107.945 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.458 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 88.3 t80 -113.67 139.04 49.39 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 113.222 0.823 . . . . 100.0 113.222 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.69 139.85 42.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.202 -1.363 . . . . 100.0 111.578 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.26 85.2 m-20 -86.59 128.34 34.98 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 102.743 -3.058 . . . . 100.0 102.743 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 43.3 pt -135.33 157.59 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 122.049 0.928 . . . . 100.0 111.732 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -137.11 109.52 7.38 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 103.376 -2.824 . . . . 100.0 103.376 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.75 -41.38 99.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.885 -1.052 . . . . 100.0 110.825 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.64 -40.85 93.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.208 1.403 . . . . 100.0 112.353 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.487 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 95.8 p -100.85 3.57 42.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.305 1.965 . . . . 100.0 116.305 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.605 ' HA ' HH11 ' A' ' 29' ' ' ARG . 72.5 m-80 63.85 22.83 13.18 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.03 1.332 . . . . 100.0 110.677 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -72.61 124.11 24.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.458 -1.312 . . . . 100.0 107.458 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 53.53 37.83 26.71 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.657 2.383 . . . . 100.0 113.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.26 -44.54 95.21 Favored 'General case' 0 C--N 1.362 1.141 0 O-C-N 121.903 -0.498 . . . . 100.0 111.324 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -63.08 -38.69 92.2 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.636 1.974 . . . . 100.0 115.628 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -57.7 -47.4 99.01 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 120.531 3.53 . . . . 100.0 120.531 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.06 -42.39 36.82 Favored 'Trans proline' 0 C--N 1.373 1.834 0 CA-C-N 123.403 2.251 . . . . 100.0 112.066 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -65.08 -42.55 94.01 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 124.852 1.261 . . . . 100.0 111.74 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -44.27 91.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.518 0.727 . . . . 100.0 110.241 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -63.7 -44.51 93.46 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-N 117.949 0.34 . . . . 100.0 110.345 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.34 -43.25 99.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 119.112 -0.471 . . . . 100.0 111.363 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.62 98.56 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.065 0.946 . . . . 100.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.88 -45.35 94.13 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 119.021 -0.514 . . . . 100.0 112.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.0 -42.53 76.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 112.734 0.642 . . . . 100.0 112.734 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.65 -38.83 74.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.692 1.197 . . . . 100.0 109.937 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.73 10.76 56.29 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-O 118.489 -1.173 . . . . 100.0 111.025 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -112.47 111.48 52.2 Favored Pre-proline 0 C--N 1.365 1.258 0 CA-C-N 118.485 1.142 . . . . 100.0 108.262 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -15.99 40.26 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.961 3.108 . . . . 100.0 113.256 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -96.17 8.37 44.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 114.349 1.24 . . . . 100.0 114.349 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.11 136.7 58.06 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-O 121.307 0.575 . . . . 100.0 110.705 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -133.16 150.57 52.01 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.53 -0.915 . . . . 100.0 108.53 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -91.06 113.19 25.39 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 103.65 -2.722 . . . . 100.0 103.65 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.24 -39.51 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 114.061 1.134 . . . . 100.0 114.061 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.0 146.07 51.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.506 -0.924 . . . . 100.0 108.506 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.91 130.48 48.3 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 108.031 -1.1 . . . . 100.0 108.031 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.54 155.62 67.96 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.223 1.949 . . . . 100.0 109.847 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.07 123.73 21.84 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.8 -1.555 . . . . 100.0 106.8 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -119.02 145.85 45.52 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.239 -1.346 . . . . 100.0 109.665 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.64 96.33 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 105.965 -1.865 . . . . 100.0 105.965 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 72.0 Cg_exo -55.65 142.35 82.38 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 123.453 2.769 . . . . 100.0 113.563 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.513 ' HG3' HD21 ' A' ' 154' ' ' ASN . 51.0 Cg_exo -56.7 127.63 26.68 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 122.848 2.366 . . . . 100.0 113.281 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -70.14 -42.44 72.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 124.714 1.259 . . . . 100.0 107.867 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.15 158.83 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.411 -1.7 . . . . 100.0 106.411 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.64 128.37 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.408 -2.071 . . . . 100.0 105.408 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.487 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -89.58 125.02 35.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.7 -2.333 . . . . 100.0 104.7 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.6 t70 -62.66 129.27 92.72 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 114.568 -1.196 . . . . 100.0 111.613 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 59.8 Cg_exo -59.1 -37.53 92.03 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.654 2.903 . . . . 100.0 113.481 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.55 93.73 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.146 0.904 . . . . 100.0 110.179 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.07 -41.84 99.52 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.135 0.574 . . . . 100.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.02 96.35 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.803 0.841 . . . . 100.0 110.672 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.26 99.27 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.699 0.799 . . . . 100.0 110.84 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.32 -45.12 94.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.829 0.851 . . . . 100.0 111.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -63.68 -43.63 96.11 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 112.392 0.515 . . . . 100.0 112.392 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -64.51 -39.86 94.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 123.248 0.343 . . . . 100.0 111.287 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -63.09 -42.45 99.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.952 0.901 . . . . 100.0 110.303 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.4 -42.46 98.77 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.975 0.91 . . . . 100.0 110.609 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.46 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.8 mt -61.26 -47.23 86.97 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.431 -0.804 . . . . 100.0 109.262 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.46 -42.04 98.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.3 1.222 . . . . 100.0 114.3 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.34 -47.4 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.047 0 CA-C-O 117.504 -1.236 . . . . 100.0 108.517 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.719 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.714 . . -89.72 -8.15 52.93 Favored 'General case' 0 N--CA 1.382 -3.849 1 C-N-CA 103.86 -7.136 . . . . 100.0 117.204 178.721 . . . . . . . . 4 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.75 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 54.3 mt-30 -53.69 -34.07 57.53 Favored 'General case' 0 CA--C 1.447 -2.994 0 C-N-CA 127.813 2.445 . . . . 100.0 106.801 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -80.87 36.57 0.4 Allowed 'General case' 0 N--CA 1.416 -2.142 0 O-C-N 124.933 1.395 . . . . 100.0 109.5 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.8 m 58.5 31.9 21.52 Favored 'General case' 0 CA--C 1.472 -2.052 0 C-N-CA 126.871 2.068 . . . . 100.0 112.525 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.46 ' C ' ' HB2' ' A' ' 204' ' ' ALA . . . -75.63 -178.19 4.04 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 101.642 -3.466 . . . . 100.0 101.642 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 81.3 mt -57.68 -38.24 65.07 Favored Pre-proline 0 CA--C 1.492 -1.263 0 CA-C-O 116.274 -1.822 . . . . 100.0 113.154 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.827 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.422 5.7 Cg_exo -53.1 136.45 61.46 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 CA-C-O 123.64 1.433 . . . . 100.0 112.7 177.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.459 ' HB3' ' CA ' ' A' ' 137' ' ' VAL 0.331 84.8 m-20 -65.18 -42.22 93.85 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 120.956 3.687 . . . . 100.0 120.956 -172.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.5 tm-20 -72.44 -14.72 61.76 Favored 'General case' 0 CA--C 1.459 -2.52 1 CA-C-O 130.685 5.04 . . . . 100.0 112.922 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.807 64.0 m-20 -87.55 -48.71 7.7 Favored 'General case' 1 N--CA 1.256 -10.162 1 CA-C-N 106.111 -5.04 . . . . 100.0 103.127 -172.786 . . . . . . . . 5 3 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.5 -27.57 69.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 118.901 -2.375 . . . . 100.0 106.211 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.688 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 51.5 m-20 -62.39 -39.96 94.94 Favored 'General case' 0 CA--C 1.478 -1.825 0 C-N-CA 127.137 2.175 . . . . 100.0 112.604 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.303 3.8 mm? . . . . . 0 N--CA 1.427 -1.624 0 CA-C-O 114.15 -2.833 . . . . 100.0 112.828 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 N--CA 1.439 -1.021 0 N-CA-C 102.844 -3.021 . . . . 100.0 102.844 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -127.89 140.48 51.98 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.839 -1.073 . . . . 100.0 110.431 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -129.07 144.08 51.08 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.074 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.18 120.49 34.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 105.577 -2.009 . . . . 100.0 105.577 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -113.4 127.03 55.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 100.0 107.473 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.6 124.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 114.844 -1.071 . . . . 100.0 110.317 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 HG11 ' A' ' 63' ' ' VAL . 6.4 mp -107.38 119.17 38.66 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-O 121.477 0.656 . . . . 100.0 109.471 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.31 160.56 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.819 -1.082 . . . . 100.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.23 174.31 24.98 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.047 -2.021 . . . . 100.0 108.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.61 155.02 40.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.744 0.783 . . . . 100.0 112.229 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.46 140.76 41.53 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 106.519 -2.632 . . . . 100.0 106.519 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.76 -5.27 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.533 -1.148 . . . . 100.0 114.458 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.0 p -62.28 -37.24 84.77 Favored 'General case' 0 C--N 1.362 1.109 0 CA-C-N 118.929 1.364 . . . . 100.0 112.2 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.25 21.86 6.08 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.179 -0.769 . . . . 100.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.95 -44.76 96.81 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 118.112 0.956 . . . . 100.0 112.559 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.2 m -62.25 -44.19 97.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.311 1.044 . . . . 100.0 109.846 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -63.03 -41.82 99.63 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.889 0.876 . . . . 100.0 109.362 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.46 -47.73 84.39 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.028 0.931 . . . . 100.0 112.559 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.16 -41.03 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 123.284 0.634 . . . . 100.0 110.066 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.38 -7.84 41.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 116.373 1.99 . . . . 100.0 116.373 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.575 HH11 ' HB2' ' A' ' 157' ' ' PHE . 62.0 mtt180 -60.31 -37.97 82.24 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.731 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 58.3 t-80 -80.07 112.3 17.25 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 106.977 -1.49 . . . . 100.0 106.977 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.79 -44.93 95.9 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 115.817 1.784 . . . . 100.0 115.817 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.426 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 90.4 m -63.77 -42.48 97.79 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.52 0.728 . . . . 100.0 109.7 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.731 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.57 -41.67 99.61 Favored Glycine 0 C--N 1.357 1.732 0 C-N-CA 123.807 0.718 . . . . 100.0 111.437 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.43 -45.55 87.07 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.916 0.886 . . . . 100.0 111.359 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -64.28 -39.77 94.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.501 1.12 . . . . 100.0 111.953 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -93.8 9.67 36.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 115.637 1.717 . . . . 100.0 115.637 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -61.12 141.85 57.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 114.225 1.194 . . . . 100.0 114.225 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -121.74 130.78 53.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.922 -1.035 . . . . 100.0 108.915 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.57 126.87 45.62 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.92 112.28 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 102.166 -3.272 . . . . 100.0 102.166 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.11 90.29 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 118.381 2.734 . . . . 100.0 118.381 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.6 m -63.08 -47.15 84.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 118.381 0.537 . . . . 100.0 110.329 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.88 -37.55 73.04 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 114.054 1.131 . . . . 100.0 114.054 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.01 44.4 30.24 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 106.895 -2.482 . . . . 100.0 106.895 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.57 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.076 0.95 . . . . 100.0 108.622 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -108.57 118.7 37.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.623 -3.473 . . . . 100.0 101.623 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.44 119.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 105.628 -1.99 . . . . 100.0 105.628 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -109.46 120.32 45.64 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.483 -0.781 . . . . 100.0 109.074 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -80.93 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.682 2.254 . . . . 100.0 109.491 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.56 112.83 24.99 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.329 -0.989 . . . . 100.0 108.329 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.35 128.33 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.526 -1.287 . . . . 100.0 107.526 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.24 135.66 54.79 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.437 -2.06 . . . . 100.0 105.437 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -102.59 119.17 38.36 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.55 -0.907 . . . . 100.0 108.55 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 p -108.63 175.87 5.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.99 0.9 . . . . 100.0 110.176 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -61.7 -26.43 68.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.317 1.447 . . . . 100.0 110.356 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -97.88 6.52 47.68 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.868 0.867 . . . . 100.0 112.633 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.65 179.36 20.03 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 121.298 -0.876 . . . . 100.0 111.208 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.72 139.94 59.82 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.182 2.588 . . . . 100.0 116.009 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.52 131.4 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 103.155 -2.905 . . . . 100.0 103.155 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -113.58 128.48 56.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.164 0.507 . . . . 100.0 109.833 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -110.74 114.77 28.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.957 -2.608 . . . . 100.0 103.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -89.74 103.95 16.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 100.87 -3.752 . . . . 100.0 100.87 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 15' ' ' LEU . 32.8 t -87.91 124.39 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.404 -1.271 . . . . 100.0 107.95 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -98.36 115.74 29.1 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.024 -2.213 . . . . 100.0 105.024 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.26 137.77 49.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.517 -1.66 . . . . 100.0 106.517 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.1 p -71.56 162.17 29.86 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.845 0.831 . . . . 100.0 112.926 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.3 14.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.939 -1.028 . . . . 100.0 108.538 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.22 57.99 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 121.703 -0.623 . . . . 100.0 113.194 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 63.6 mt-30 -59.68 -34.15 72.49 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.544 1.938 . . . . 100.0 112.101 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.22 -30.49 66.54 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.224 2.21 . . . . 100.0 113.131 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.09 -46.54 88.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 69' ' ' GLN 0.41 15.1 p90 -74.22 -40.45 62.43 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 116.912 2.19 . . . . 100.0 116.912 176.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.5 -154.18 9.31 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 120.303 -0.951 . . . . 100.0 111.918 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.46 53.06 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 122.337 0.965 . . . . 100.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 79' ' ' TYR . 93.5 mt -105.13 143.16 33.69 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 123.851 0.86 . . . . 100.0 109.993 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -68.18 156.4 37.62 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.417 -1.265 . . . . 100.0 112.949 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.77 -37.69 79.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 125.312 1.445 . . . . 100.0 110.077 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.62 89.27 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 124.867 1.222 . . . . 100.0 111.479 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CE2' HD11 ' A' ' 75' ' ' LEU . 85.8 t80 -62.76 -46.82 86.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.057 0.543 . . . . 100.0 111.032 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -70.59 -36.96 73.83 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 115.917 1.821 . . . . 100.0 115.917 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.2 mt -51.96 135.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 114.747 1.388 . . . . 100.0 114.747 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 68.85 14.41 8.91 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.204 2.202 . . . . 100.0 114.694 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 131.02 45.36 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.398 -0.964 . . . . 100.0 108.398 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.81 -31.15 13.87 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.305 -0.861 . . . . 100.0 108.726 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.04 163.8 37.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 120.824 0.345 . . . . 100.0 110.227 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.1 154.17 40.82 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.7 mt -126.51 125.38 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.231 -2.507 . . . . 100.0 104.231 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.485 ' HB ' ' CD2' ' A' ' 119' ' ' LEU . 45.4 mt -110.57 124.61 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 102.675 -3.083 . . . . 100.0 102.675 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.8 mtp -112.35 136.54 51.69 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 114.914 1.45 . . . . 100.0 114.914 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -129.47 164.2 24.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 112.501 -2.136 . . . . 100.0 107.976 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -109.69 125.43 52.63 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.041 -1.837 . . . . 100.0 106.041 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 m -64.8 -19.71 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 114.042 1.127 . . . . 100.0 114.042 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -86.75 -9.53 55.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 119.243 -0.408 . . . . 100.0 111.323 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -125.21 117.81 24.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 122.195 0.998 . . . . 100.0 110.547 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.67 -38.1 89.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.915 1.286 . . . . 100.0 111.838 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.92 -40.76 81.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.222 1.809 . . . . 100.0 110.601 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -62.97 -41.28 99.49 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.32 0.509 . . . . 100.0 111.307 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.87 -41.41 95.69 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.863 0.865 . . . . 100.0 110.604 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.6 mttt -60.91 -37.8 83.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.792 1.237 . . . . 100.0 110.777 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.83 -8.43 58.03 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.273 1.583 . . . . 100.0 115.273 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.11 -42.75 91.59 Favored Pre-proline 0 C--N 1.364 1.224 0 CA-C-O 116.419 -1.753 . . . . 100.0 112.077 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 73.8 Cg_exo -57.49 -37.47 97.16 Favored 'Trans proline' 0 C--N 1.375 1.955 0 CA-C-N 122.153 1.805 . . . . 100.0 112.657 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.93 -45.43 89.27 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.05 1.34 . . . . 100.0 110.894 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -64.16 -41.84 96.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 122.936 0.494 . . . . 100.0 110.917 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -62.65 -43.87 97.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 123.898 0.879 . . . . 100.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -63.0 -43.81 97.76 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 123.042 0.537 . . . . 100.0 111.769 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.5 -44.25 96.84 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.916 0.486 . . . . 100.0 110.425 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.1 tp -63.46 -48.34 78.1 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 124.314 1.046 . . . . 100.0 113.177 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.298 32.7 m -63.86 -35.53 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 C-N-CA 124.16 0.984 . . . . 100.0 113.08 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -59.65 -38.53 81.67 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 118.688 -0.672 . . . . 100.0 111.093 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.14 -43.9 17.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 C-N-CA 119.87 -0.732 . . . . 100.0 110.233 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.1 m -124.75 104.65 8.77 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.454 -0.943 . . . . 100.0 108.454 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.14 145.05 25.0 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.983 0.897 . . . . 100.0 110.389 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 57.79 38.04 27.24 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.447 2.017 . . . . 100.0 116.447 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 pt -96.81 143.59 26.38 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 106.185 -1.783 . . . . 100.0 106.185 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.59 131.14 32.35 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.782 2.322 . . . . 100.0 110.483 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.435 ' HB ' HD21 ' A' ' 144' ' ' LEU . 73.9 mt -132.84 138.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 122.369 1.08 . . . . 100.0 109.421 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.98 131.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.193 -1.78 . . . . 100.0 106.193 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 22.5 mt -105.84 128.96 54.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.852 -2.277 . . . . 100.0 104.852 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.36 130.77 56.19 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.126 -1.397 . . . . 100.0 113.398 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.576 ' HA3' ' HH ' ' A' ' 146' ' ' TYR . . . -100.48 104.36 2.77 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 106.222 -2.751 . . . . 100.0 106.222 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -83.24 166.09 18.85 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.555 1.142 . . . . 100.0 112.973 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 61.03 42.97 11.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.57 3.148 . . . . 100.0 114.933 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.327 24.5 m -72.07 -7.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 C-N-CA 120.527 -0.469 . . . . 100.0 111.64 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.93 -36.71 82.17 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.718 2.007 . . . . 100.0 109.958 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.95 128.42 33.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 106.915 -1.513 . . . . 100.0 106.915 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.77 -42.35 99.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 114.919 1.452 . . . . 100.0 114.919 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.21 98.04 11.54 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.843 -1.91 . . . . 100.0 105.843 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -95.57 122.2 38.08 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.771 -1.559 . . . . 100.0 106.911 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.94 -39.91 15.3 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.3 0.852 . . . . 100.0 113.3 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.07 104.86 17.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.552 -2.018 . . . . 100.0 105.552 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.57 174.3 6.51 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.209 -0.905 . . . . 100.0 113.109 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.28 65.69 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 127.045 2.138 . . . . 100.0 109.496 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.871 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 96.2 mttt -57.52 -39.12 75.86 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 129.128 2.971 . . . . 100.0 112.043 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.3 p -104.82 4.18 31.91 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 116.403 2.001 . . . . 100.0 116.403 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 56.5 mt -90.06 80.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 117.197 -1.801 . . . . 100.0 112.035 -176.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.255 58.9 t -71.53 -39.44 70.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 1 C-N-CA 133.757 4.823 . . . . 100.0 118.807 -178.279 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -55.79 -36.34 67.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 121.539 3.903 . . . . 100.0 121.539 -168.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.258 67.8 m-70 -59.73 -38.8 82.69 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 116.924 -1.512 . . . . 100.0 113.493 -176.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.786 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.255 0.9 OUTLIER -59.93 -46.83 88.11 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 116.6 2.074 . . . . 100.0 116.6 -176.887 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.93 -40.42 97.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 125.525 1.766 . . . . 100.0 110.2 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.63 3.89 47.94 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 117.279 2.326 . . . . 100.0 117.279 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 55.38 43.47 28.8 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 122.958 1.361 . . . . 100.0 113.311 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.2 mt -103.52 150.4 23.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.643 -1.984 . . . . 100.0 105.643 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -97.28 141.02 30.89 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 109.784 -0.451 . . . . 100.0 109.784 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.576 ' HH ' ' HA3' ' A' ' 121' ' ' GLY . 81.5 t80 -108.27 136.88 47.18 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 113.188 0.81 . . . . 100.0 113.188 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -134.11 136.47 43.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.221 -1.354 . . . . 100.0 110.743 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.322 66.0 m-20 -83.47 130.06 35.01 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 101.996 -3.335 . . . . 100.0 101.996 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.519 ' HB ' HH22 ' A' ' 29' ' ' ARG . 43.2 pt -134.72 156.73 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.525 1.155 . . . . 100.0 111.674 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 71.3 m -138.2 107.98 6.28 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.941 -2.244 . . . . 100.0 104.941 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.32 -44.63 96.88 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 115.214 -0.903 . . . . 100.0 112.854 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.92 -39.36 91.79 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 125.071 1.348 . . . . 100.0 113.372 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.539 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 93.5 p -99.97 1.57 42.73 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 115.669 1.729 . . . . 100.0 115.669 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.533 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.1 m-80 64.65 21.58 12.44 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.296 1.438 . . . . 100.0 111.263 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 78.1 t80 -70.98 125.61 27.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.906 -1.146 . . . . 100.0 107.906 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 54.45 36.5 25.73 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.102 2.561 . . . . 100.0 114.429 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.575 ' HB2' HH11 ' A' ' 29' ' ' ARG . 64.4 t80 -60.99 -45.49 94.62 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 121.644 -0.66 . . . . 100.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -35.63 81.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.799 2.148 . . . . 100.0 116.799 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.26 -46.98 99.73 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.166 3.025 . . . . 100.0 119.166 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -60.98 -42.51 36.45 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.116 2.149 . . . . 100.0 111.815 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -64.53 -42.29 95.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 125.23 1.412 . . . . 100.0 111.496 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.61 -45.01 92.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.839 0.856 . . . . 100.0 111.116 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.82 -43.77 95.24 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 123.372 0.42 . . . . 100.0 110.399 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -44.42 97.19 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 123.097 0.559 . . . . 100.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.8 98.18 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.445 1.098 . . . . 100.0 111.1 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.99 -45.04 95.36 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 122.851 0.46 . . . . 100.0 111.565 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -65.25 -46.31 81.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 122.893 0.477 . . . . 100.0 111.633 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.41 -46.99 80.85 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.397 1.258 . . . . 100.0 114.397 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.45 -38.23 73.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 C-N-CA 124.917 1.287 . . . . 100.0 109.623 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.71 10.53 57.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-O 118.515 -1.158 . . . . 100.0 111.14 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -114.17 113.1 46.49 Favored Pre-proline 0 C--N 1.364 1.224 0 N-CA-C 107.648 -1.241 . . . . 100.0 107.648 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.68 -14.15 32.95 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 123.894 3.063 . . . . 100.0 113.254 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -91.4 2.4 56.43 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.25 135.01 57.59 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 118.74 0.7 . . . . 100.0 112.108 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -133.99 148.78 51.17 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.029 -1.1 . . . . 100.0 108.029 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -90.25 112.3 23.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.674 -2.713 . . . . 100.0 103.674 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.81 -40.43 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 114.602 1.334 . . . . 100.0 114.602 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.39 145.8 50.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.34 -0.985 . . . . 100.0 108.34 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.4 ttm -85.73 129.58 54.15 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.129 -1.434 . . . . 100.0 107.129 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.95 155.93 65.25 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.366 2.044 . . . . 100.0 109.964 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.12 122.73 18.9 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.632 -1.618 . . . . 100.0 106.632 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.89 148.04 43.34 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-N 114.257 -1.338 . . . . 100.0 109.373 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.14 96.02 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 105.228 -2.138 . . . . 100.0 105.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.26 142.04 87.93 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 123.236 2.624 . . . . 100.0 112.866 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 154' ' ' ASN . 50.0 Cg_exo -56.5 125.94 20.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.638 2.226 . . . . 100.0 112.543 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.02 -42.66 72.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 124.938 1.399 . . . . 100.0 108.671 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.62 158.11 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 106.292 -1.744 . . . . 100.0 106.292 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.82 129.77 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.56 -1.644 . . . . 100.0 106.56 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.539 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -91.72 123.64 35.26 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 103.229 -2.878 . . . . 100.0 103.229 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.4 t70 -62.16 129.12 91.86 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.992 -1.004 . . . . 100.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 63.4 Cg_exo -58.9 -38.5 88.0 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.712 2.941 . . . . 100.0 113.552 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.92 94.78 Favored 'General case' 0 C--N 1.36 1.051 0 O-C-N 123.94 0.775 . . . . 100.0 110.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.36 -41.71 98.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 122.979 0.511 . . . . 100.0 111.114 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.14 97.6 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.745 0.818 . . . . 100.0 110.331 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.03 99.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.989 0.916 . . . . 100.0 110.547 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -62.33 -45.61 92.44 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.714 0.806 . . . . 100.0 111.754 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -63.6 -43.38 97.1 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 112.197 0.443 . . . . 100.0 112.197 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.34 -40.54 96.09 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.294 0.371 . . . . 100.0 111.455 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.57 -42.33 98.34 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.866 0.866 . . . . 100.0 110.197 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.33 -42.42 98.65 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 123.68 0.792 . . . . 100.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 85.2 mt -61.12 -48.1 83.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 123.735 0.647 . . . . 100.0 109.453 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.51 -43.64 98.33 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 114.084 1.142 . . . . 100.0 114.084 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.46 -47.02 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.072 0 CA-C-O 117.988 -1.006 . . . . 100.0 108.822 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.753 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.739 . . -88.66 -9.61 51.48 Favored 'General case' 1 N--CA 1.375 -4.202 1 C-N-CA 104.142 -7.023 . . . . 100.0 116.806 179.79 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 60.6 mt-30 -54.57 -36.03 63.93 Favored 'General case' 0 CA--C 1.445 -3.066 0 C-N-CA 128.86 2.864 . . . . 100.0 106.232 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.2 p -81.61 40.18 0.57 Allowed 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 123.07 1.414 . . . . 100.0 110.061 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.289 5.0 m 57.45 29.73 17.49 Favored 'General case' 0 CA--C 1.468 -2.206 0 C-N-CA 128.579 2.752 . . . . 100.0 112.918 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 204' ' ' ALA 0.257 . . -72.51 172.94 9.59 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 100.989 -3.708 . . . . 100.0 100.989 171.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.77 -35.9 34.01 Favored Pre-proline 0 CA--C 1.493 -1.22 0 CA-C-O 116.971 -1.49 . . . . 100.0 114.812 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.871 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.414 4.9 Cg_exo -53.97 137.95 69.47 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 CA-C-O 122.948 1.145 . . . . 100.0 113.124 176.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.545 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.375 45.8 m-20 -63.87 -43.91 94.66 Favored 'General case' 0 N--CA 1.408 -2.526 1 N-CA-C 122.783 4.364 . . . . 100.0 122.783 -174.245 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 16.0 tm-20 -66.34 -24.54 66.53 Favored 'General case' 0 CA--C 1.468 -2.208 1 CA-C-O 131.487 5.422 . . . . 100.0 111.598 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.749 55.2 m-20 -74.62 -51.47 14.38 Favored 'General case' 1 N--CA 1.267 -9.576 1 CA-C-N 105.454 -5.339 . . . . 100.0 105.406 -176.566 . . . . . . . . 5 3 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -63.66 -26.17 68.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 118.065 -2.897 . . . . 100.0 107.933 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.786 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 48.3 m-20 -62.89 -41.96 99.6 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 126.134 1.774 . . . . 100.0 112.754 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.552 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.383 1.0 OUTLIER . . . . . 0 C--O 1.261 1.67 0 CA-C-O 115.082 -2.389 . . . . 100.0 115.74 -178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.432 -1.33 0 CA-C-O 122.114 0.959 . . . . 100.0 109.627 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 43.1 mt-30 -127.48 135.75 50.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.399 -1.728 . . . . 100.0 107.73 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -124.43 144.24 50.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.46 -0.791 . . . . 100.0 109.134 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.1 121.64 33.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.32 128.16 56.22 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.419 -1.697 . . . . 100.0 106.419 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.29 125.6 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.621 -1.251 . . . . 100.0 107.621 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.436 HD12 ' SD ' ' A' ' 89' ' ' MET . 39.3 tp -110.06 117.47 33.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.86 -1.904 . . . . 100.0 105.86 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.88 160.45 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 112.165 0.432 . . . . 100.0 112.165 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.95 172.71 24.5 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 108.559 -1.816 . . . . 100.0 108.559 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -67.33 154.41 41.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.946 0.879 . . . . 100.0 112.478 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 139.9 42.49 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 107.263 -2.335 . . . . 100.0 107.263 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.0 -4.2 83.03 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 118.634 -1.092 . . . . 100.0 114.258 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 p -62.74 -38.36 90.22 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 118.784 1.292 . . . . 100.0 111.914 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.32 4.78 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.508 -1.037 . . . . 100.0 110.508 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HE3' ' HG ' ' A' ' 15' ' ' LEU . 50.0 mtpt -59.53 -47.11 86.81 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.38 1.072 . . . . 100.0 113.254 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.6 m -64.59 -42.75 95.38 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.254 0.622 . . . . 100.0 110.598 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.6 m -62.24 -42.14 99.05 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 124.126 0.97 . . . . 100.0 108.971 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.75 -48.37 82.11 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.215 1.006 . . . . 100.0 112.968 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.85 -39.94 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 123.133 0.271 . . . . 100.0 110.91 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -65.5 -12.14 49.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 115.249 1.574 . . . . 100.0 115.249 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 41.0 mtt180 -60.02 -38.35 82.43 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.491 -0.929 . . . . 100.0 108.491 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.758 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 62.1 t-80 -80.63 111.5 17.12 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 106.799 -1.556 . . . . 100.0 106.799 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.59 -44.37 97.14 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.227 1.566 . . . . 100.0 115.227 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.1 m -62.85 -42.67 99.84 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.333 1.053 . . . . 100.0 109.35 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.758 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.38 -42.07 99.68 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 111.15 -0.78 . . . . 100.0 111.15 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.15 -43.54 91.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 122.783 0.433 . . . . 100.0 111.502 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -62.89 -40.85 98.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.211 1.004 . . . . 100.0 111.85 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -94.07 10.08 35.12 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 115.211 1.56 . . . . 100.0 115.211 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -59.6 142.76 52.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 114.16 1.17 . . . . 100.0 114.16 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.22 132.89 51.65 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.296 -1.002 . . . . 100.0 108.296 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -100.44 127.49 46.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.855 -1.165 . . . . 100.0 107.855 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 109.32 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.352 -3.203 . . . . 100.0 102.352 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.23 99.35 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 p -61.73 -43.67 98.41 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 123.63 0.772 . . . . 100.0 112.718 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.9 mt -93.68 -18.15 22.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 114.393 1.257 . . . . 100.0 114.393 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.96 43.68 64.5 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.268 -1.533 . . . . 100.0 109.268 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.63 143.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.352 -0.981 . . . . 100.0 108.352 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.89 115.4 28.92 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 101.052 -3.685 . . . . 100.0 101.052 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 120.69 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.072 -1.455 . . . . 100.0 107.072 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -113.41 119.15 42.5 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 115.864 -0.607 . . . . 100.0 109.807 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.77 106.22 1.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.3 2.0 . . . . 100.0 111.468 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.79 115.88 29.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.827 -1.175 . . . . 100.0 107.827 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 t -102.39 129.11 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.053 -1.462 . . . . 100.0 107.053 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.91 136.61 53.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.666 -1.975 . . . . 100.0 105.666 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . 0.492 ' HD1' ' HB ' ' A' ' 177' ' ' VAL . 60.2 t-80 -101.83 119.17 38.36 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.601 -0.888 . . . . 100.0 108.601 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -106.45 -178.46 3.66 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.033 -0.985 . . . . 100.0 111.489 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.0 -37.99 78.16 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.581 1.952 . . . . 100.0 108.583 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -89.98 0.65 56.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 113.741 1.015 . . . . 100.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -175.37 15.86 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.199 -1.16 . . . . 100.0 110.199 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.25 138.95 58.09 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.979 2.452 . . . . 100.0 116.944 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -129.02 130.97 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 102.885 -3.006 . . . . 100.0 102.885 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 88.7 mttt -114.63 127.58 55.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.422 -0.585 . . . . 100.0 109.422 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -110.96 116.02 30.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -88.11 105.83 17.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 101.465 -3.531 . . . . 100.0 101.465 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.24 122.57 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.708 -1.219 . . . . 100.0 107.708 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -93.6 115.25 27.72 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.886 -1.894 . . . . 100.0 105.886 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -111.37 141.69 44.6 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.642 -1.985 . . . . 100.0 105.642 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -75.04 164.23 26.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.978 0.894 . . . . 100.0 112.882 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.39 16.15 20.95 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.756 -1.111 . . . . 100.0 108.318 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.77 59.2 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 121.728 -0.608 . . . . 100.0 113.422 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -62.24 -23.72 66.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.987 1.715 . . . . 100.0 112.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.31 -33.79 72.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.167 2.187 . . . . 100.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.4 -43.3 99.15 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.044 0.938 . . . . 100.0 109.684 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -70.14 -42.64 72.29 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.919 1.288 . . . . 100.0 113.09 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.93 -149.38 9.17 Favored Glycine 0 C--N 1.358 1.774 0 N-CA-C 110.99 -0.844 . . . . 100.0 110.99 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.87 50.28 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 122.185 0.881 . . . . 100.0 112.664 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.58 142.49 37.42 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 121.939 0.876 . . . . 100.0 109.651 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -64.03 151.75 42.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.403 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.01 -37.22 79.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.428 1.491 . . . . 100.0 110.003 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.76 89.34 Favored Glycine 0 C--N 1.356 1.652 0 C-N-CA 125.237 1.399 . . . . 100.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -62.85 -46.19 89.06 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 123.458 0.703 . . . . 100.0 111.081 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -70.9 -35.59 72.37 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.955 1.835 . . . . 100.0 115.955 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -51.87 134.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 122.987 1.375 . . . . 100.0 114.429 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 65.74 19.27 11.36 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 128.132 2.573 . . . . 100.0 114.635 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 132.32 48.57 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.052 -1.092 . . . . 100.0 108.052 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -95.19 -33.14 12.73 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.544 -0.753 . . . . 100.0 109.075 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.38 163.68 39.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.888 -0.412 . . . . 100.0 109.888 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.28 154.36 40.88 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 114.54 1.311 . . . . 100.0 114.54 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.5 mt -125.43 125.93 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.057 -2.571 . . . . 100.0 104.057 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.8 mt -110.55 123.89 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.941 -2.985 . . . . 100.0 102.941 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.436 ' SD ' HD12 ' A' ' 15' ' ' LEU . 87.3 mtp -111.41 136.82 50.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -129.53 164.23 24.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.295 -2.23 . . . . 100.0 108.187 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -106.39 125.41 50.96 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.476 -2.046 . . . . 100.0 105.476 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.75 -17.15 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -91.69 -4.57 54.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.215 0.462 . . . . 100.0 111.306 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 t -124.38 116.08 22.01 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.472 1.129 . . . . 100.0 109.213 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -65.4 -37.73 87.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.402 1.081 . . . . 100.0 111.087 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.41 -41.22 83.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.258 1.823 . . . . 100.0 110.333 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 p -62.41 -40.97 98.27 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.366 0.53 . . . . 100.0 111.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -64.13 -41.63 97.13 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 123.895 0.878 . . . . 100.0 109.789 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -61.17 -36.85 80.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.095 0.958 . . . . 100.0 111.495 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.27 -6.56 56.95 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.133 1.531 . . . . 100.0 115.133 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.69 -42.4 91.22 Favored Pre-proline 0 C--N 1.364 1.219 0 CA-C-O 116.316 -1.802 . . . . 100.0 111.285 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 75.9 Cg_exo -57.85 -36.82 98.04 Favored 'Trans proline' 0 C--N 1.377 2.071 0 CA-C-N 122.234 1.834 . . . . 100.0 112.597 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.11 -44.41 92.37 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 119.438 1.017 . . . . 100.0 111.385 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -63.98 -42.25 97.28 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 122.817 0.447 . . . . 100.0 110.394 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -62.67 -43.03 99.84 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.082 0.953 . . . . 100.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -62.35 -45.19 94.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 122.892 0.477 . . . . 100.0 112.2 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -63.69 -43.36 96.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.596 0.56 . . . . 100.0 111.397 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.11 -48.36 78.89 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.011 0.924 . . . . 100.0 113.093 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 27.5 m -65.69 -36.4 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 123.668 0.787 . . . . 100.0 112.97 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.13 -45.97 91.24 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 118.916 -0.564 . . . . 100.0 109.675 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.03 -45.15 55.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-N 118.154 0.433 . . . . 100.0 111.79 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 24.1 t -130.07 112.68 13.68 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 118.714 -1.195 . . . . 100.0 108.523 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.54 144.56 27.16 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.788 -1.097 . . . . 100.0 113.671 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.08 40.97 32.17 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 117.338 2.347 . . . . 100.0 117.338 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.0 pt -98.36 143.82 26.98 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 107.998 -1.112 . . . . 100.0 107.998 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.02 131.75 36.24 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.473 2.115 . . . . 100.0 111.017 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.451 ' HB ' HD21 ' A' ' 144' ' ' LEU . 74.3 mt -133.13 137.32 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 122.406 1.098 . . . . 100.0 108.794 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -115.98 130.88 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 106.767 -1.568 . . . . 100.0 106.767 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 14.4 mt -105.41 128.5 53.55 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.764 -2.31 . . . . 100.0 104.764 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.1 m -118.75 129.69 55.39 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.458 . . . . 100.0 112.399 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.607 ' HA3' ' HH ' ' A' ' 146' ' ' TYR . . . -102.09 109.07 3.48 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 105.261 -3.136 . . . . 100.0 105.261 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.378 9.4 p-10 -95.57 178.54 5.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 62.41 40.51 10.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 127.816 2.446 . . . . 100.0 112.511 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.3 28.1 m -72.21 -8.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 115.993 -0.549 . . . . 100.0 111.24 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.85 -36.79 84.42 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.47 1.908 . . . . 100.0 109.998 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.42 130.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 108.145 -1.057 . . . . 100.0 108.145 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -43.24 99.22 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.915 1.82 . . . . 100.0 115.915 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -88.68 97.85 11.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.607 -1.998 . . . . 100.0 105.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -96.5 112.79 24.4 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.42 -1.326 . . . . 100.0 107.42 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -75.2 -45.05 42.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.102 1.519 . . . . 100.0 115.102 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.23 106.73 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 105.985 -1.857 . . . . 100.0 105.985 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.07 174.08 6.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.854 -1.066 . . . . 100.0 112.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.63 66.93 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 127.367 2.267 . . . . 100.0 109.09 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.855 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 95.2 mttt -56.91 -39.33 74.24 Favored 'General case' 0 N--CA 1.42 -1.931 0 C-N-CA 128.723 2.809 . . . . 100.0 112.547 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 89.9 p -104.65 5.1 33.35 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 115.907 1.817 . . . . 100.0 115.907 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 65.6 mt -88.76 77.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.112 0 C-N-CA 117.548 -1.661 . . . . 100.0 111.788 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.253 59.0 t -70.86 -38.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 1 C-N-CA 133.81 4.844 . . . . 100.0 118.869 -178.387 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.04 -35.82 67.32 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 121.427 3.862 . . . . 100.0 121.427 -168.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.719 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.274 81.0 m-70 -59.58 -38.58 81.58 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 116.783 -1.579 . . . . 100.0 114.264 -176.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.758 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.254 0.4 OUTLIER -59.42 -46.61 88.23 Favored 'General case' 0 CA--C 1.452 -2.819 0 N-CA-C 116.194 1.924 . . . . 100.0 116.194 -176.661 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.87 -41.08 97.43 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 125.756 1.91 . . . . 100.0 110.832 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -101.49 6.46 42.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 117.15 2.278 . . . . 100.0 117.15 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 56.32 42.36 27.89 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-O 123.026 1.393 . . . . 100.0 113.646 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.451 HD21 ' HB ' ' A' ' 117' ' ' ILE . 25.2 mt -99.97 149.17 23.71 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.523 -2.029 . . . . 100.0 105.523 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.77 143.87 28.63 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.482 -0.933 . . . . 100.0 108.482 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.719 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.5 t80 -110.25 137.27 48.21 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.938 0.718 . . . . 100.0 112.938 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -133.78 137.01 44.9 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.543 -1.208 . . . . 100.0 110.575 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.362 69.9 m-20 -85.59 130.09 34.66 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 101.464 -3.532 . . . . 100.0 101.464 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 44.1 pt -137.27 158.29 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 122.248 1.023 . . . . 100.0 111.462 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.8 m -139.06 110.58 7.04 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 106.137 -1.801 . . . . 100.0 106.137 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.72 -44.47 96.86 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.625 -1.171 . . . . 100.0 112.71 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.79 -39.7 92.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.324 1.449 . . . . 100.0 113.012 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.519 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 99.0 p -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 115.676 1.732 . . . . 100.0 115.676 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.52 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.3 m-80 63.6 24.08 13.83 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 125.158 1.383 . . . . 100.0 110.919 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -74.12 125.14 27.69 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.504 -1.295 . . . . 100.0 107.504 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 53.43 36.73 23.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.095 2.558 . . . . 100.0 114.652 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.499 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 70.6 t80 -60.82 -43.39 98.3 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.726 -0.609 . . . . 100.0 111.94 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -63.53 -37.28 86.7 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.398 1.999 . . . . 100.0 116.398 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.47 -46.66 99.77 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.897 3.295 . . . . 100.0 119.897 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.62 -41.95 43.52 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.139 2.157 . . . . 100.0 111.919 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.92 -41.43 95.56 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.729 1.212 . . . . 100.0 110.969 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.3 -46.81 87.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.206 1.002 . . . . 100.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -65.63 -42.17 91.81 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 120.28 -0.568 . . . . 100.0 110.494 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.92 -42.87 99.59 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 119.208 -0.425 . . . . 100.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.73 98.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 124.018 0.927 . . . . 100.0 110.564 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.79 -45.72 92.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 119.188 -0.435 . . . . 100.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.55 -44.93 85.3 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.518 0.511 . . . . 100.0 112.105 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.46 -46.37 83.37 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 114.279 1.215 . . . . 100.0 114.279 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.7 -37.85 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.225 1.01 . . . . 100.0 109.479 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.43 57.13 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.27 -1.132 . . . . 100.0 110.27 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.57 110.53 52.58 Favored Pre-proline 0 C--N 1.364 1.218 0 N-CA-C 108.041 -1.096 . . . . 100.0 108.041 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.97 -14.15 32.08 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.748 2.965 . . . . 100.0 113.285 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -90.36 -0.47 57.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.499 1.12 . . . . 100.0 112.987 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.94 136.16 57.85 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.739 1.014 . . . . 100.0 113.739 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -134.89 154.86 51.5 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.908 -1.145 . . . . 100.0 107.908 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -90.49 116.24 28.25 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 103.872 -2.64 . . . . 100.0 103.872 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . 0.492 ' HB ' ' HD1' ' A' ' 53' ' ' HIS . 64.1 t -65.7 -44.73 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 123.971 0.908 . . . . 100.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.08 150.5 52.14 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.561 -0.903 . . . . 100.0 108.561 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -95.02 130.86 31.5 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.493 -1.299 . . . . 100.0 107.493 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -64.58 158.27 50.85 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.466 2.11 . . . . 100.0 111.51 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.8 125.43 25.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.37 1.081 . . . . 100.0 108.585 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.35 147.21 45.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.863 -1.517 . . . . 100.0 108.804 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.27 135.84 95.31 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 105.777 -1.934 . . . . 100.0 105.777 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.97 142.33 85.11 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 123.549 2.833 . . . . 100.0 113.197 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HG3' HD21 ' A' ' 154' ' ' ASN . 50.2 Cg_exo -56.8 128.67 30.91 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.634 2.223 . . . . 100.0 112.94 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.8 -43.37 72.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.892 -1.151 . . . . 100.0 107.892 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 157.78 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 106.538 -1.653 . . . . 100.0 106.538 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.05 130.41 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.87 -1.53 . . . . 100.0 106.87 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.519 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -87.64 125.86 34.62 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 103.664 -2.717 . . . . 100.0 103.664 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.22 126.93 90.26 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.122 -0.945 . . . . 100.0 110.327 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.92 -38.14 89.8 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 123.631 2.887 . . . . 100.0 113.68 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.71 94.07 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.146 0.904 . . . . 100.0 110.049 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -40.81 97.72 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 123.127 0.571 . . . . 100.0 111.251 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.54 98.67 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.659 0.784 . . . . 100.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.45 99.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.935 0.894 . . . . 100.0 110.533 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -61.71 -46.06 91.29 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.349 1.059 . . . . 100.0 111.363 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -63.91 -43.35 96.22 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 112.275 0.472 . . . . 100.0 112.275 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -64.33 -39.66 94.35 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.333 0.396 . . . . 100.0 111.633 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.76 -44.27 96.64 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.223 1.009 . . . . 100.0 110.209 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -61.61 -42.76 99.34 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.459 0.704 . . . . 100.0 110.894 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 79.5 mt -61.15 -48.49 81.37 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 115.784 -0.643 . . . . 100.0 110.271 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.26 -43.95 96.53 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 113.709 1.003 . . . . 100.0 113.709 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -45.81 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.945 0 CA-C-O 118.372 -0.823 . . . . 100.0 109.443 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.714 ' CB ' ' HB3' ' A' ' 213' ' ' ASP 0.746 . . -86.45 -10.78 53.51 Favored 'General case' 1 N--CA 1.376 -4.174 1 C-N-CA 104.526 -6.87 . . . . 100.0 115.747 179.945 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 52.6 mt-30 -54.68 -35.27 63.39 Favored 'General case' 0 CA--C 1.443 -3.158 0 C-N-CA 128.703 2.801 . . . . 100.0 107.148 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.2 p -81.36 40.58 0.57 Allowed 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.857 1.313 . . . . 100.0 109.572 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.266 6.4 m 59.13 27.17 16.07 Favored 'General case' 0 CA--C 1.471 -2.086 0 C-N-CA 127.277 2.231 . . . . 100.0 112.984 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 204' ' ' ALA 0.266 . . -72.09 170.5 13.78 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.316 -3.587 . . . . 100.0 101.316 171.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.95 -35.4 29.03 Favored Pre-proline 0 CA--C 1.486 -1.515 0 CA-C-O 116.499 -1.715 . . . . 100.0 114.911 -174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.855 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.445 0.0 OUTLIER -54.38 139.48 73.98 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 O-C-N 123.741 1.39 . . . . 100.0 111.898 176.403 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.608 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.453 39.5 m-20 -65.73 -43.21 89.75 Favored 'General case' 0 N--CA 1.408 -2.53 1 N-CA-C 125.03 5.196 . . . . 100.0 125.03 -173.577 . . . . . . . . 4 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.7 tm-20 -62.58 -35.81 80.71 Favored 'General case' 0 CA--C 1.469 -2.16 1 CA-C-O 132.292 5.806 . . . . 100.0 108.734 176.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.76 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.629 17.5 m-20 -62.34 -51.9 65.8 Favored 'General case' 1 N--CA 1.282 -8.842 2 CA-C-N 104.098 -5.955 . . . . 100.0 107.554 178.719 . . . . . . . . 5 3 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.28 -25.33 66.0 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 117.261 -3.399 . . . . 100.0 107.579 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.758 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 57.9 m-20 -63.78 -40.4 96.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 126.979 2.112 . . . . 100.0 112.395 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.274 3.2 mm? . . . . . 0 N--CA 1.426 -1.654 0 CA-C-O 114.157 -2.83 . . . . 100.0 112.781 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 102.009 -3.33 . . . . 100.0 102.009 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.41 138.74 52.47 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.813 -0.63 . . . . 100.0 110.828 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.83 144.37 51.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.605 -0.725 . . . . 100.0 110.017 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.64 120.3 32.93 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.217 -1.401 . . . . 100.0 107.217 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.6 125.87 53.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.131 -1.849 . . . . 100.0 107.23 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -103.05 124.69 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.694 -1.224 . . . . 100.0 107.694 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 ' SD ' ' A' ' 89' ' ' MET . 42.5 tp -109.29 117.33 33.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.124 -1.806 . . . . 100.0 106.124 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -128.79 161.47 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 112.129 0.418 . . . . 100.0 112.129 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.69 173.96 24.14 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 108.403 -1.879 . . . . 100.0 108.403 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.4 154.35 41.55 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.061 0.934 . . . . 100.0 112.938 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.84 141.18 43.31 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.07 -2.412 . . . . 100.0 107.07 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.78 -1.53 86.99 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-O 118.084 -1.398 . . . . 100.0 113.288 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 p -63.91 -38.39 90.91 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 119.261 1.531 . . . . 100.0 111.649 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.47 21.78 4.63 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.487 -1.045 . . . . 100.0 110.487 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -59.98 -46.86 88.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.759 1.224 . . . . 100.0 113.237 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -63.68 -43.73 95.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.986 0.914 . . . . 100.0 110.03 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -41.13 99.1 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.939 0.896 . . . . 100.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -60.44 -48.72 80.51 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.945 0.898 . . . . 100.0 112.772 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.89 -40.94 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 123.103 0.252 . . . . 100.0 111.114 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.265 99.3 mttt -69.13 -7.08 32.85 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 116.302 1.964 . . . . 100.0 116.302 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 43.6 mtt180 -61.01 -37.84 83.95 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 107.49 -1.3 . . . . 100.0 107.49 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.73 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 60.8 t-80 -80.71 112.71 18.33 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 106.831 -1.544 . . . . 100.0 106.831 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.92 -44.46 96.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.983 1.845 . . . . 100.0 115.983 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 84.8 m -63.72 -42.12 97.97 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.869 0.868 . . . . 100.0 109.479 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.73 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.63 -41.5 99.59 Favored Glycine 0 C--N 1.357 1.744 0 N-CA-C 110.977 -0.849 . . . . 100.0 110.977 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -64.6 -44.25 91.22 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.721 0.808 . . . . 100.0 110.866 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -63.42 -40.32 96.88 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.428 1.091 . . . . 100.0 111.484 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.12 8.6 34.81 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 114.887 1.44 . . . . 100.0 114.887 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -58.84 142.92 49.13 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 114.538 1.311 . . . . 100.0 114.538 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.61 139.98 52.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.354 -1.351 . . . . 100.0 107.354 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -111.89 125.97 54.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.34 -2.467 . . . . 100.0 104.34 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.28 108.15 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.448 -3.167 . . . . 100.0 102.448 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.66 99.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 114.591 1.33 . . . . 100.0 114.591 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -61.47 -42.5 98.86 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 123.699 0.8 . . . . 100.0 112.914 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.58 -20.97 19.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.356 1.243 . . . . 100.0 114.356 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.05 43.24 49.25 Favored Glycine 0 C--N 1.36 1.889 0 N-CA-C 108.504 -1.839 . . . . 100.0 108.504 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.7 145.39 34.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.337 -0.986 . . . . 100.0 108.337 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 117.82 34.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 102.44 -3.17 . . . . 100.0 102.44 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.63 123.12 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.094 -1.447 . . . . 100.0 107.094 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -115.15 121.59 34.78 Favored Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 115.365 -0.834 . . . . 100.0 110.519 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -80.45 103.38 1.51 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 122.226 1.951 . . . . 100.0 110.36 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.92 113.0 24.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.595 0.758 . . . . 100.0 109.323 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 t -98.48 130.26 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.689 0.796 . . . . 100.0 108.854 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.92 135.44 51.89 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.529 -2.026 . . . . 100.0 105.529 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -102.12 118.48 36.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.651 -0.819 . . . . 100.0 109.34 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p -103.86 176.12 5.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.077 -0.965 . . . . 100.0 109.768 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -60.13 -35.24 74.83 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.789 1.635 . . . . 100.0 109.582 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -90.5 -0.46 57.67 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 113.767 1.025 . . . . 100.0 113.767 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.07 178.07 15.26 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 119.493 1.042 . . . . 100.0 111.763 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.59 139.84 60.1 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 123.099 2.533 . . . . 100.0 114.323 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 mm -127.42 130.62 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 102.359 -3.2 . . . . 100.0 102.359 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -116.25 130.12 56.62 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 121.681 -0.637 . . . . 100.0 109.978 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.33 115.65 29.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 104.922 -2.251 . . . . 100.0 104.922 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.84 107.33 18.93 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 100.63 -3.841 . . . . 100.0 100.63 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.56 122.65 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.183 -1.043 . . . . 100.0 108.183 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -94.24 111.77 23.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.155 -2.165 . . . . 100.0 105.155 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -115.02 137.46 51.98 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 106.95 -1.5 . . . . 100.0 106.95 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.5 p -70.85 163.7 26.81 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.04 0.924 . . . . 100.0 113.078 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.88 25.9 7.49 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.229 -1.026 . . . . 100.0 108.229 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.76 13.73 60.59 Favored Glycine 0 C--N 1.361 1.92 0 O-C-N 121.613 -0.679 . . . . 100.0 114.147 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.467 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 73.9 mt-30 -59.55 -35.04 73.47 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.795 2.038 . . . . 100.0 112.296 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.96 -32.84 68.23 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.416 2.686 . . . . 100.0 112.128 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.54 -40.07 95.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.12 0.968 . . . . 100.0 111.159 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 17.3 p90 -94.56 -18.08 21.75 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 115.578 1.696 . . . . 100.0 115.578 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.44 -162.83 27.86 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 119.836 -1.173 . . . . 100.0 112.518 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.25 178.46 53.86 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.601 -1.4 . . . . 100.0 109.601 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 79' ' ' TYR . 95.6 mt -102.89 145.48 29.74 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 122.568 1.175 . . . . 100.0 111.09 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.15 150.12 49.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.082 -1.872 . . . . 100.0 111.433 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.39 -36.7 83.14 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.874 1.27 . . . . 100.0 108.859 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.67 -38.02 93.18 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 125.81 1.671 . . . . 100.0 110.587 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CE2' HD11 ' A' ' 75' ' ' LEU . 73.9 t80 -63.66 -46.96 83.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.251 0.526 . . . . 100.0 111.5 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -70.27 -37.01 74.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 116.871 2.174 . . . . 100.0 116.871 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.18 139.89 13.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 CA-C-O 122.375 1.083 . . . . 100.0 113.75 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 70.8 11.5 7.15 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.92 2.088 . . . . 100.0 113.582 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.97 131.55 46.49 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.827 -0.805 . . . . 100.0 108.827 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -98.65 -27.82 13.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.149 -0.932 . . . . 100.0 109.513 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.4 p -152.21 163.05 40.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 122.284 0.234 . . . . 100.0 110.392 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.74 153.43 38.19 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 95.6 mt -126.55 126.5 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 103.856 -2.646 . . . . 100.0 103.856 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.47 ' HB ' HD21 ' A' ' 119' ' ' LEU . 39.8 mt -111.37 125.09 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 102.934 -2.988 . . . . 100.0 102.934 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.454 ' SD ' HD12 ' A' ' 15' ' ' LEU . 88.8 mtp -112.5 137.1 51.2 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 114.596 1.332 . . . . 100.0 114.596 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -129.94 161.48 30.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.051 -2.34 . . . . 100.0 108.265 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.95 125.77 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.061 -1.829 . . . . 100.0 106.061 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.72 -16.95 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 113.355 0.872 . . . . 100.0 113.355 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -90.21 -7.44 53.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 119.146 -0.454 . . . . 100.0 111.109 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.4 t -123.66 116.9 23.83 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-O 122.214 1.007 . . . . 100.0 110.318 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -65.45 -36.85 85.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.146 0.978 . . . . 100.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.77 -40.22 81.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.571 1.549 . . . . 100.0 110.288 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.9 p -62.36 -41.04 98.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 118.439 0.563 . . . . 100.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -64.3 -41.67 96.74 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 123.734 0.814 . . . . 100.0 110.438 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.488 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.6 mttt -60.36 -37.76 81.72 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 124.336 1.054 . . . . 100.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -76.27 -9.79 58.91 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 115.631 1.715 . . . . 100.0 115.631 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -42.19 88.99 Favored Pre-proline 0 C--N 1.362 1.14 0 CA-C-O 116.32 -1.8 . . . . 100.0 112.087 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 76.5 Cg_exo -57.53 -37.91 95.61 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.351 2.034 . . . . 100.0 112.74 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.71 -44.59 89.75 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.631 1.172 . . . . 100.0 110.683 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -63.53 -42.43 98.44 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.267 0.627 . . . . 100.0 110.674 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.78 -44.91 94.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 124.339 1.055 . . . . 100.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -63.12 -42.28 99.51 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 112.636 0.606 . . . . 100.0 112.636 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -61.82 -46.11 90.93 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.02 0.528 . . . . 100.0 109.798 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.84 -48.25 79.85 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.588 0.959 . . . . 100.0 113.588 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.32 -38.37 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 125.069 1.348 . . . . 100.0 111.473 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -60.37 -39.38 87.01 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.554 0.616 . . . . 100.0 111.439 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.17 -44.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 118.279 0.49 . . . . 100.0 110.61 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.2 m -127.59 106.78 9.4 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.521 0.601 . . . . 100.0 109.944 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.37 144.96 26.52 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.957 0.884 . . . . 100.0 112.615 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . 0.255 72.2 m-20 54.06 41.18 32.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 116.926 2.195 . . . . 100.0 116.926 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -96.48 144.17 27.37 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.998 -2.223 . . . . 100.0 104.998 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 132.26 36.14 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.354 2.036 . . . . 100.0 110.148 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.433 ' HB ' HD21 ' A' ' 144' ' ' LEU . 73.3 mt -132.24 136.59 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 122.309 1.052 . . . . 100.0 108.57 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.55 131.95 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.989 -1.856 . . . . 100.0 105.989 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 25.9 mt -106.59 127.86 53.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.601 -2.0 . . . . 100.0 105.601 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 70.8 m -119.23 130.16 55.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.398 -1.274 . . . . 100.0 113.406 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.21 107.24 3.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 104.797 -3.321 . . . . 100.0 104.797 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.333 0.6 OUTLIER -95.64 177.9 5.65 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.668 1.358 . . . . 100.0 114.668 -178.266 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 61.82 40.14 13.13 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.742 2.417 . . . . 100.0 112.729 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.303 24.7 m -72.15 -8.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 CA-C-N 116.187 -0.461 . . . . 100.0 111.366 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.09 -37.3 86.64 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.6 1.96 . . . . 100.0 109.977 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.9 129.61 31.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 N-CA-C 107.743 -1.206 . . . . 100.0 107.743 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.54 -44.31 97.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.891 1.441 . . . . 100.0 114.891 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -87.74 95.29 10.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.773 -1.566 . . . . 100.0 106.773 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -94.99 125.31 39.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.229 -1.767 . . . . 100.0 106.229 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.32 -36.28 11.46 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 113.982 1.104 . . . . 100.0 113.982 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.52 106.34 20.35 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 104.395 -2.446 . . . . 100.0 104.395 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -100.8 173.6 6.43 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.115 -0.948 . . . . 100.0 112.045 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.14 67.46 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.496 1.919 . . . . 100.0 109.477 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.861 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 96.3 mttt -57.31 -38.91 74.74 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 129.674 3.189 . . . . 100.0 112.094 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.7 p -104.95 2.75 30.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.796 2.147 . . . . 100.0 116.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.468 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 61.9 mt -92.95 89.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 116.589 -2.045 . . . . 100.0 110.624 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.4 p -100.64 -8.61 9.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -60.47 -36.63 78.75 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 117.819 2.525 . . . . 100.0 117.819 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.262 63.6 m-70 -58.94 -39.14 80.74 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 126.489 1.916 . . . . 100.0 115.265 -176.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.695 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.314 24.1 ttp-105 -59.25 -49.6 77.23 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 113.963 1.098 . . . . 100.0 113.963 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.25 -40.81 97.43 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 125.275 1.61 . . . . 100.0 111.318 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.32 -0.65 52.57 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.576 1.695 . . . . 100.0 115.576 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.268 2.0 m-80 55.28 44.54 27.29 Favored 'General case' 0 C--N 1.362 1.134 0 CA-C-O 123.367 1.556 . . . . 100.0 114.146 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 27.5 mt -106.03 143.33 34.32 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.212 -2.514 . . . . 100.0 104.212 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.257 99.8 mm-40 -92.25 145.51 24.44 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 118.625 -1.23 . . . . 100.0 110.247 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.6 t80 -110.6 137.49 48.21 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 113.063 0.764 . . . . 100.0 113.063 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.79 137.21 43.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.35 -1.296 . . . . 100.0 110.652 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.27 78.7 m-20 -83.35 129.22 34.98 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.894 -3.002 . . . . 100.0 102.894 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 41.5 pt -135.32 158.5 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-O 122.295 1.045 . . . . 100.0 111.71 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 59.4 m -139.48 110.73 6.97 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 105.42 -2.067 . . . . 100.0 105.42 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -62.28 -44.83 95.62 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.559 -1.201 . . . . 100.0 113.107 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.7 -39.55 94.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 124.735 1.214 . . . . 100.0 112.98 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.524 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 91.8 p -97.27 -0.02 47.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 115.314 1.598 . . . . 100.0 115.314 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.508 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.8 m-80 65.45 20.1 11.68 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.918 1.287 . . . . 100.0 111.648 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.419 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -69.84 125.88 28.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.404 -0.962 . . . . 100.0 108.404 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 53.1 37.6 25.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 128.103 2.561 . . . . 100.0 114.566 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 71.1 t80 -60.48 -43.63 96.75 Favored 'General case' 0 C--N 1.362 1.113 0 O-C-N 121.885 -0.509 . . . . 100.0 111.457 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -64.8 -36.81 85.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 118.013 2.597 . . . . 100.0 118.013 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -56.38 -47.97 97.89 Favored Pre-proline 0 C--N 1.358 0.97 0 N-CA-C 118.863 2.912 . . . . 100.0 118.863 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.62 -40.55 54.84 Favored 'Trans proline' 0 C--N 1.373 1.835 0 CA-C-N 122.879 2.064 . . . . 100.0 112.29 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.97 -41.62 95.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 124.5 1.125 . . . . 100.0 111.164 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.45 -46.37 90.34 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 123.726 0.641 . . . . 100.0 112.024 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.78 -43.22 93.95 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.631 0.582 . . . . 100.0 110.646 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -44.83 96.17 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.243 0.617 . . . . 100.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.66 98.46 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 124.306 1.042 . . . . 100.0 110.793 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -61.65 -45.32 94.56 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 119.052 -0.499 . . . . 100.0 111.343 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.03 -43.72 86.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.985 1.106 . . . . 100.0 113.985 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.9 -46.59 84.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.699 0.8 . . . . 100.0 112.998 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 48.7 mm -70.77 -38.05 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.211 1.004 . . . . 100.0 110.469 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.67 10.53 58.95 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.498 -1.041 . . . . 100.0 110.498 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -114.98 114.02 43.93 Favored Pre-proline 0 C--N 1.365 1.242 0 N-CA-C 108.382 -0.97 . . . . 100.0 108.382 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.98 -12.6 30.8 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.931 3.087 . . . . 100.0 113.208 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -90.67 1.2 57.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.396 1.258 . . . . 100.0 114.396 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.95 135.85 57.52 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 118.734 0.697 . . . . 100.0 112.119 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.9 148.25 51.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.166 -0.924 . . . . 100.0 108.625 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -91.09 116.29 28.69 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 103.808 -2.664 . . . . 100.0 103.808 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.97 -44.08 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.776 0.83 . . . . 100.0 111.828 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.52 152.52 51.54 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.57 0.7 . . . . 100.0 110.508 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.06 133.79 47.52 Favored Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.797 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -66.12 156.92 62.32 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.623 2.215 . . . . 100.0 109.437 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.0 121.77 18.8 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.29 -1.745 . . . . 100.0 106.29 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.84 149.01 42.25 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.33 -1.304 . . . . 100.0 109.955 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.4 136.58 95.83 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 105.289 -2.115 . . . . 100.0 105.289 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -56.59 142.2 90.53 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.197 2.598 . . . . 100.0 112.602 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.508 ' HG3' HD21 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -56.13 126.25 21.76 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.834 2.356 . . . . 100.0 112.073 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -70.55 -42.98 70.45 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 124.693 1.245 . . . . 100.0 108.483 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.96 156.59 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 106.074 -1.824 . . . . 100.0 106.074 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.37 131.0 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 106.49 -1.67 . . . . 100.0 106.49 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.524 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.1 ttt -86.71 126.15 34.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.986 -2.598 . . . . 100.0 103.986 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.5 t70 -61.17 127.54 88.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 100.0 110.863 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 68.1 Cg_exo -59.31 -38.6 83.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.759 2.973 . . . . 100.0 113.699 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.66 -44.35 90.68 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.186 0.929 . . . . 100.0 110.59 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.69 -42.16 98.04 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.004 0.522 . . . . 100.0 111.419 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.8 96.28 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.321 0.648 . . . . 100.0 110.803 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.73 98.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.796 0.838 . . . . 100.0 110.753 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.0 -42.07 97.28 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.016 0.526 . . . . 100.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -62.94 -43.1 99.7 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 122.82 0.448 . . . . 100.0 111.816 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -62.15 -43.17 99.43 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.529 0.731 . . . . 100.0 109.097 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.03 -44.16 97.29 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.123 1.369 . . . . 100.0 111.976 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.95 -42.14 98.78 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.606 0.762 . . . . 100.0 110.65 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.46 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.4 mt -60.93 -48.53 81.38 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.101 0.875 . . . . 100.0 109.308 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.28 -43.64 97.34 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.462 1.282 . . . . 100.0 114.462 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.55 -45.96 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.447 -3.017 0 CA-C-O 117.72 -1.133 . . . . 100.0 109.434 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.722 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.749 . . -86.38 -10.89 53.45 Favored 'General case' 0 N--CA 1.381 -3.878 1 C-N-CA 104.503 -6.879 . . . . 100.0 116.547 179.445 . . . . . . . . 4 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.782 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 47.3 mt-30 -53.92 -33.83 57.84 Favored 'General case' 0 CA--C 1.445 -3.085 0 C-N-CA 128.534 2.734 . . . . 100.0 107.07 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 38.92 0.51 Allowed 'General case' 0 N--CA 1.415 -2.222 0 O-C-N 124.988 1.43 . . . . 100.0 109.533 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.8 m 60.41 25.42 14.98 Favored 'General case' 0 CA--C 1.473 -2.007 0 C-N-CA 126.135 1.774 . . . . 100.0 112.409 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 204' ' ' ALA 0.268 . . -71.51 172.98 8.57 Favored 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.776 -3.416 . . . . 100.0 101.776 172.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 79.1 mt -54.5 -36.65 45.63 Favored Pre-proline 0 CA--C 1.49 -1.337 0 CA-C-O 116.323 -1.799 . . . . 100.0 113.711 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.861 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.448 0.3 OUTLIER -53.42 137.73 65.11 Favored 'Trans proline' 0 N--CA 1.432 -2.143 0 CA-C-O 123.528 1.387 . . . . 100.0 112.991 176.738 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.297 98.1 m-20 -63.65 -43.89 95.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 121.215 3.783 . . . . 100.0 121.215 -172.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.9 tm-20 -69.25 -19.0 63.93 Favored 'General case' 0 CA--C 1.465 -2.306 1 CA-C-O 130.946 5.165 . . . . 100.0 112.771 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.782 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.777 68.3 m-20 -83.89 -49.73 8.74 Favored 'General case' 1 N--CA 1.262 -9.825 1 CA-C-N 105.623 -5.262 . . . . 100.0 104.915 -173.383 . . . . . . . . 5 3 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.96 -26.86 68.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.038 -2.289 . . . . 100.0 106.56 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.695 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 59.5 m-20 -62.8 -40.0 96.0 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 127.044 2.138 . . . . 100.0 112.952 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.26 3.9 mm? . . . . . 0 N--CA 1.426 -1.649 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.793 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.431 -1.381 0 N-CA-C 107.19 -1.411 . . . . 100.0 107.19 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -120.26 135.22 55.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.803 -1.999 . . . . 100.0 107.612 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.74 143.67 48.66 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.933 -1.136 . . . . 100.0 107.933 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.33 120.21 34.23 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.382 -1.71 . . . . 100.0 106.382 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.76 127.42 53.99 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.036 -1.893 . . . . 100.0 106.782 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.52 120.87 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.632 -1.622 . . . . 100.0 106.687 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.425 HD12 ' SD ' ' A' ' 89' ' ' MET . 36.6 tp -109.27 117.24 33.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.218 -2.141 . . . . 100.0 105.218 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 m -128.31 161.78 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 120.931 0.396 . . . . 100.0 111.667 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.36 175.45 27.34 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 108.38 -1.888 . . . . 100.0 108.38 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -71.78 155.72 40.12 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.935 -0.744 . . . . 100.0 112.18 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.74 141.7 40.69 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 107.321 -2.311 . . . . 100.0 107.321 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.2 81.46 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-O 118.823 -0.987 . . . . 100.0 113.436 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 80.0 m -62.67 -40.37 96.86 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-N 118.608 1.204 . . . . 100.0 110.777 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.08 25.02 4.61 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.823 -1.311 . . . . 100.0 109.823 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 10.1 mtpm? -60.17 -45.22 93.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.966 1.706 . . . . 100.0 112.554 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -62.89 -44.34 96.38 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.538 1.135 . . . . 100.0 109.486 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.7 m -63.8 -40.21 96.09 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.529 1.132 . . . . 100.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.482 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 47.6 t80 -59.4 -49.32 78.25 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 124.935 1.294 . . . . 100.0 111.534 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.19 -41.64 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 123.371 0.419 . . . . 100.0 111.258 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.277 99.2 mttt -69.83 -6.87 35.38 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 115.933 1.827 . . . . 100.0 115.933 -176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.712 HH21 ' HA ' ' A' ' 157' ' ' PHE . 83.7 mtm-85 -60.78 -37.68 82.71 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.129 -1.063 . . . . 100.0 108.129 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.735 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 60.8 t-80 -80.84 112.54 18.32 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 107.054 -1.461 . . . . 100.0 107.054 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.3 -43.78 98.02 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 115.207 1.558 . . . . 100.0 115.207 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.2 m -62.73 -42.48 99.68 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.884 -0.784 . . . . 100.0 108.884 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.735 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.46 -42.16 99.71 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 111.061 -0.816 . . . . 100.0 111.061 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.75 -44.95 91.99 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.873 0.869 . . . . 100.0 110.883 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -63.63 -39.72 95.06 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 123.601 0.76 . . . . 100.0 113.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -89.91 5.92 44.25 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -57.32 138.35 54.95 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 114.546 1.313 . . . . 100.0 114.546 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -124.61 130.35 52.28 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.702 -1.222 . . . . 100.0 107.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -100.77 123.27 44.73 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.233 -2.136 . . . . 100.0 105.233 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -102.85 114.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 103.37 -2.826 . . . . 100.0 103.37 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.03 94.94 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 115.393 1.627 . . . . 100.0 115.393 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.1 p -61.93 -48.36 80.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.665 0.386 . . . . 100.0 111.965 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.18 -38.41 75.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.307 1.443 . . . . 100.0 112.982 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.95 32.23 50.26 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 108.112 -1.995 . . . . 100.0 108.112 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 79' ' ' TYR . 22.9 m -129.01 153.17 38.22 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 121.629 0.728 . . . . 100.0 109.672 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.45 120.22 41.84 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 103.074 -2.935 . . . . 100.0 103.074 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.6 123.04 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 106.567 -1.642 . . . . 100.0 106.567 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -117.78 119.43 33.94 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.78 106.51 1.82 Allowed 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.123 1.882 . . . . 100.0 110.229 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.69 117.29 31.65 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.685 -1.598 . . . . 100.0 106.685 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 t -102.86 126.68 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.66 -1.237 . . . . 100.0 107.66 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -121.33 133.49 55.12 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.639 -1.985 . . . . 100.0 105.639 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -101.28 120.28 40.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.715 -1.217 . . . . 100.0 107.715 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.6 p -110.54 -179.26 3.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.05 -0.977 . . . . 100.0 110.894 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.77 -44.25 93.97 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.334 1.454 . . . . 100.0 108.294 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -67.04 -39.26 86.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 124.062 0.945 . . . . 100.0 113.052 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.69 28.83 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 107.381 -2.288 . . . . 100.0 107.381 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.08 137.92 50.1 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.117 1.878 . . . . 100.0 114.647 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.05 130.29 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.26 -3.237 . . . . 100.0 102.26 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.01 128.13 55.75 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.749 -0.834 . . . . 100.0 108.749 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.44 116.41 31.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.172 -2.529 . . . . 100.0 104.172 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -87.8 106.05 17.81 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.25 -4.352 . . . . 100.0 99.25 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.29 122.76 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.05 115.89 29.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.339 -2.097 . . . . 100.0 105.339 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -112.46 136.32 52.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.605 -1.998 . . . . 100.0 105.605 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 p -71.96 162.29 29.67 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.76 0.824 . . . . 100.0 112.86 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.74 17.29 16.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.694 -0.684 . . . . 100.0 109.687 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.08 11.64 52.04 Favored Glycine 0 C--N 1.357 1.732 0 O-C-N 121.804 -0.56 . . . . 100.0 112.328 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.27 -29.32 70.34 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.836 1.654 . . . . 100.0 111.385 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.66 -37.23 78.18 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 127.794 2.438 . . . . 100.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.93 -43.12 99.66 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.326 0.65 . . . . 100.0 110.025 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.18 -41.35 77.3 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 125.458 1.503 . . . . 100.0 111.972 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.34 -152.12 12.32 Favored Glycine 0 C--N 1.356 1.665 0 C-N-CA 120.996 -0.621 . . . . 100.0 111.57 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.26 169.58 52.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 122.069 0.816 . . . . 100.0 112.931 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.68 143.49 33.76 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.708 -0.746 . . . . 100.0 109.767 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -67.67 155.48 39.12 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.735 -1.12 . . . . 100.0 113.616 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -60.47 -37.68 81.78 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.827 -1.533 . . . . 100.0 110.328 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.78 -39.21 93.43 Favored Glycine 0 C--N 1.358 1.778 0 C-N-CA 124.846 1.213 . . . . 100.0 111.316 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 45' ' ' VAL . 60.8 t80 -62.53 -45.99 90.46 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.422 0.689 . . . . 100.0 110.895 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -68.94 -36.67 78.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.3 mt -50.85 135.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 C-N-CA 125.57 1.548 . . . . 100.0 114.297 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.62 30.29 18.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.104 2.562 . . . . 100.0 114.015 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.66 128.66 36.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.26 -1.756 . . . . 100.0 106.26 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -96.47 -35.35 11.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.428 ' HB3' HD12 ' A' ' 168' ' ' LEU . 22.3 p -143.76 159.27 42.81 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 120.899 0.381 . . . . 100.0 111.133 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.8 149.57 34.59 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 114.37 1.248 . . . . 100.0 114.37 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.9 mt -125.5 125.75 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.66 123.71 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 102.419 -3.178 . . . . 100.0 102.419 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.425 ' SD ' HD12 ' A' ' 15' ' ' LEU . 81.3 mtp -109.68 134.08 52.39 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 114.144 -1.389 . . . . 100.0 113.602 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -128.18 158.82 37.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 112.555 -2.112 . . . . 100.0 108.433 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.51 125.75 50.97 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.41 -21.6 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 113.797 1.036 . . . . 100.0 113.797 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.7 p -86.65 -10.16 54.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 119.241 -0.409 . . . . 100.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.6 t -118.49 116.39 26.57 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.136 0.969 . . . . 100.0 111.401 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -66.5 -38.38 87.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.892 -1.049 . . . . 100.0 111.079 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.56 -41.75 88.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 125.661 1.584 . . . . 100.0 110.55 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -62.36 -42.8 99.69 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 109.792 -0.448 . . . . 100.0 109.792 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' ' 136' ' ' ILE . 44.5 t80 -64.11 -41.04 97.41 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 123.714 0.805 . . . . 100.0 110.703 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -61.14 -37.86 84.34 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.958 0.903 . . . . 100.0 111.311 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.65 -9.0 58.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.12 -43.26 93.52 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 115.997 -1.954 . . . . 100.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.4 Cg_exo -57.57 -38.57 93.31 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.158 1.905 . . . . 100.0 112.742 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -64.25 -44.45 91.74 Favored 'General case' 0 C--N 1.358 0.978 0 O-C-N 124.186 0.929 . . . . 100.0 111.443 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -63.88 -41.22 97.79 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 122.744 0.418 . . . . 100.0 110.995 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.43 -43.83 97.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.43 1.092 . . . . 100.0 109.932 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.8 -45.34 94.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 123.577 0.751 . . . . 100.0 111.351 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -62.89 -44.82 95.07 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.06 0.544 . . . . 100.0 111.774 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.23 -46.03 88.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.548 1.139 . . . . 100.0 112.31 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.36 -37.69 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 125.593 1.557 . . . . 100.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.5 -49.14 78.45 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.649 -0.691 . . . . 100.0 110.183 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.5 t -73.07 -46.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 119.227 -0.989 . . . . 100.0 111.956 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -124.78 113.8 18.41 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 121.641 0.734 . . . . 100.0 110.177 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.64 146.6 23.54 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.466 -0.788 . . . . 100.0 112.142 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 54.72 44.44 28.54 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 126.463 1.905 . . . . 100.0 115.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.89 133.21 22.5 Favored Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 126.42 1.888 . . . . 100.0 107.376 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -62.96 129.02 24.59 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.86 2.373 . . . . 100.0 108.457 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.401 ' HB ' HD21 ' A' ' 144' ' ' LEU . 68.7 mt -131.05 137.58 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 122.292 1.044 . . . . 100.0 108.287 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.74 131.83 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.145 -2.168 . . . . 100.0 105.145 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 139' ' ' HIS . 28.8 mt -105.61 125.54 51.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.869 -2.641 . . . . 100.0 103.869 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -113.86 126.74 55.52 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.85 -1.523 . . . . 100.0 112.203 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.01 103.42 2.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 105.162 -3.175 . . . . 100.0 105.162 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.58 165.76 19.8 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.789 1.636 . . . . 100.0 112.53 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 21' ' ' THR . 85.0 mttt 59.42 43.38 16.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 128.541 2.736 . . . . 100.0 114.541 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.313 30.9 m -72.23 -8.8 12.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 C-N-CA 120.526 -0.47 . . . . 100.0 111.231 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.58 -38.3 87.05 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.968 2.107 . . . . 100.0 110.117 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.59 130.79 33.85 Favored 'Isoleucine or valine' 0 C--N 1.363 1.168 0 N-CA-C 107.221 -1.4 . . . . 100.0 107.221 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.14 -40.95 99.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 125.32 1.448 . . . . 100.0 114.357 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.74 91.07 8.2 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.262 -1.385 . . . . 100.0 107.262 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -94.85 120.6 35.34 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.087 -2.561 . . . . 100.0 104.087 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -96.15 -37.22 10.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.324 -0.853 . . . . 100.0 112.876 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -104.01 105.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 102.573 -3.121 . . . . 100.0 102.573 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -104.68 178.83 4.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 113.665 0.987 . . . . 100.0 113.665 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.4 -35.33 71.87 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.308 2.243 . . . . 100.0 109.402 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.721 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.7 mttt -59.42 -37.81 79.03 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.989 2.516 . . . . 100.0 112.32 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.5 p -104.73 -1.29 26.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 120.106 3.373 . . . . 100.0 120.106 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.595 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 49.8 mt -96.6 91.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 115.779 -2.368 . . . . 100.0 111.736 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.401 ' CA ' ' HB3' ' A' ' 211' ' ' ASP . 4.9 p -97.54 -7.98 9.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 115.767 1.766 . . . . 100.0 115.767 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.91 -36.2 72.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.01 1.485 . . . . 100.0 115.01 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 83.9 m-70 -59.87 -40.65 89.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 116.946 -1.502 . . . . 100.0 114.123 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 25.9 ttt180 -61.32 -45.42 94.51 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 119.971 1.259 . . . . 100.0 112.629 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.56 -41.9 98.05 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.387 1.075 . . . . 100.0 110.862 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.23 2.28 48.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 115.875 1.806 . . . . 100.0 115.875 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.67 44.5 26.32 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.777 1.631 . . . . 100.0 113.305 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.401 HD21 ' HB ' ' A' ' 117' ' ' ILE . 28.5 mt -106.96 152.19 24.29 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.781 -1.563 . . . . 100.0 106.781 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.336 90.6 mm-40 -101.43 145.71 28.59 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 113.474 0.916 . . . . 100.0 113.474 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.469 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.8 t80 -105.09 133.91 49.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 113.921 1.082 . . . . 100.0 113.921 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.12 133.35 46.58 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.048 -1.433 . . . . 100.0 111.172 173.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.279 36.9 m-20 -84.76 121.54 27.83 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.176 -3.268 . . . . 100.0 102.176 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.42 155.42 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 122.381 1.086 . . . . 100.0 110.613 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.2 m -137.31 111.36 8.35 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 105.908 -1.886 . . . . 100.0 105.908 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.564 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.44 -43.91 97.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.187 -1.369 . . . . 100.0 112.664 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.79 -42.31 98.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.377 1.071 . . . . 100.0 112.508 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.54 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 97.4 p -97.04 1.41 50.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.597 2.073 . . . . 100.0 116.597 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.589 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.0 m-80 64.03 24.58 13.59 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.223 1.409 . . . . 100.0 110.524 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 75.7 t80 -75.01 125.71 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.133 -1.062 . . . . 100.0 108.133 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 53.55 40.04 30.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.232 2.613 . . . . 100.0 115.404 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.712 ' HA ' HH21 ' A' ' 29' ' ' ARG . 67.3 t80 -61.77 -44.0 97.75 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.827 -0.546 . . . . 100.0 111.248 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 -39.65 95.04 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 116.374 1.99 . . . . 100.0 116.374 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.57 -47.94 97.83 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 121.035 3.717 . . . . 100.0 121.035 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.35 -41.9 38.26 Favored 'Trans proline' 0 C--N 1.371 1.733 0 CA-C-N 123.586 2.316 . . . . 100.0 112.437 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -64.52 -42.52 95.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.922 1.289 . . . . 100.0 110.799 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.8 tp -63.1 -45.19 93.21 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.241 1.017 . . . . 100.0 111.327 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.36 -44.65 94.2 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.684 -0.488 . . . . 100.0 109.684 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.9 mt -61.79 -44.49 96.76 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.062 0.545 . . . . 100.0 111.474 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.67 98.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.966 0.907 . . . . 100.0 111.228 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.13 -45.99 91.02 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 123.341 0.656 . . . . 100.0 111.542 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.38 -42.92 87.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.293 0.849 . . . . 100.0 113.293 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 85' ' ' CYS . 85.8 mt -63.72 -45.65 88.96 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.632 0.773 . . . . 100.0 112.032 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.97 -39.16 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.11 0.564 . . . . 100.0 109.552 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.07 10.64 58.38 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 110.411 -1.076 . . . . 100.0 110.411 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -114.07 112.82 46.92 Favored Pre-proline 0 C--N 1.361 1.107 0 N-CA-C 107.57 -1.27 . . . . 100.0 107.57 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.061 3.174 . . . . 100.0 113.992 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -87.96 2.12 52.44 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 123.979 0.912 . . . . 100.0 113.114 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.07 132.16 47.88 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.324 0.65 . . . . 100.0 109.355 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -134.44 151.36 51.12 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.15 113.61 23.94 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 104.195 -2.52 . . . . 100.0 104.195 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.02 -43.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 123.594 0.758 . . . . 100.0 110.293 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.48 149.02 51.43 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.451 0.643 . . . . 100.0 109.839 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -92.61 125.95 53.88 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.093 -2.188 . . . . 100.0 105.093 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.17 158.16 53.58 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.076 2.517 . . . . 100.0 111.458 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.77 126.9 29.11 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.146 0.974 . . . . 100.0 108.884 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.25 145.9 46.59 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-N 114.014 -1.448 . . . . 100.0 109.971 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.29 138.02 97.3 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 64.9 Cg_exo -55.95 139.71 84.91 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 123.67 2.913 . . . . 100.0 113.021 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.589 ' HG3' HD21 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -57.68 129.44 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 123.206 2.604 . . . . 100.0 113.028 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -68.36 -43.18 77.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 124.742 1.276 . . . . 100.0 108.122 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.9 158.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.351 -1.722 . . . . 100.0 106.351 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.68 130.6 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 106.208 -1.775 . . . . 100.0 106.208 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.54 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -87.24 127.54 35.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.749 -2.315 . . . . 100.0 104.749 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.73 128.14 91.39 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 114.493 -1.231 . . . . 100.0 110.295 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.6 -37.4 88.56 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.772 2.981 . . . . 100.0 113.001 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.18 94.14 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 124.257 0.973 . . . . 100.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.38 -42.28 98.83 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 122.817 0.447 . . . . 100.0 111.633 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.25 97.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.125 0.57 . . . . 100.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.54 98.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.943 0.897 . . . . 100.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -44.27 96.55 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.183 0.993 . . . . 100.0 112.405 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -63.4 -44.1 95.64 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 122.71 0.404 . . . . 100.0 111.073 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -64.5 -39.89 94.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.107 -0.497 . . . . 100.0 110.57 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.31 -43.85 97.88 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.95 1.3 . . . . 100.0 110.524 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.93 -42.89 99.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 123.955 0.902 . . . . 100.0 110.144 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.531 ' HG ' HE21 ' A' ' 205' ' ' GLN . 22.6 tp -59.9 -48.65 80.82 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.222 0.951 . . . . 100.0 109.951 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -43.36 99.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.999 1.481 . . . . 100.0 114.999 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.0 -47.09 91.04 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.217 0 CA-C-O 118.245 -0.883 . . . . 100.0 109.544 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.65 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.406 . . -95.66 0.91 53.25 Favored 'General case' 0 N--CA 1.402 -2.847 1 C-N-CA 109.729 -4.789 . . . . 100.0 114.685 179.573 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.531 HE21 ' HG ' ' A' ' 201' ' ' LEU 0.329 67.1 mt-30 -56.78 -36.35 69.74 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 106.246 -1.761 . . . . 100.0 106.246 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 64.9 p -82.25 52.04 1.93 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.091 0.948 . . . . 100.0 108.779 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.296 73.9 p 49.25 37.69 11.85 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 129.002 2.921 . . . . 100.0 116.157 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.466 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -82.86 -179.78 7.54 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.286 -2.486 . . . . 100.0 104.286 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.435 ' HG ' ' HD3' ' A' ' 210' ' ' PRO 0.439 3.7 pp -57.44 -38.73 70.99 Favored Pre-proline 0 CA--C 1.501 -0.941 0 CA-C-O 115.523 -2.18 . . . . 100.0 115.886 -175.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.721 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.312 79.0 Cg_exo -54.88 136.47 72.35 Favored 'Trans proline' 0 C--N 1.375 1.971 0 CA-C-N 121.839 1.692 . . . . 100.0 111.417 176.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . 0.401 ' HB3' ' CA ' ' A' ' 137' ' ' VAL . 96.0 m-20 -63.46 -47.86 80.1 Favored 'General case' 0 N--CA 1.424 -1.771 1 N-CA-C 124.784 5.105 . . . . 100.0 124.784 -173.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.595 ' CG ' ' HB ' ' A' ' 136' ' ' ILE 0.251 99.3 mt-10 -62.88 -35.56 80.42 Favored 'General case' 0 CA--C 1.48 -1.732 1 CA-C-O 128.621 4.057 . . . . 100.0 107.84 177.889 . . . . . . . . 4 3 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.65 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.49 39.2 m-20 -64.93 -49.03 71.97 Favored 'General case' 1 N--CA 1.354 -5.251 1 CA-C-N 107.796 -4.274 . . . . 100.0 106.297 -178.903 . . . . . . . . 5 3 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.12 -31.23 71.67 Favored 'General case' 0 C--N 1.36 1.033 0 O-C-N 120.535 -1.353 . . . . 100.0 107.682 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.8 t70 -57.63 -42.77 84.06 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 116.926 -1.512 . . . . 100.0 113.295 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.261 1.701 0 CA-C-O 115.558 -2.163 . . . . 100.0 112.6 -176.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 105.682 -1.97 . . . . 100.0 105.682 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -123.58 136.16 54.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.762 -1.563 . . . . 100.0 108.752 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.34 144.32 50.08 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.243 -1.021 . . . . 100.0 108.243 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.28 121.03 35.38 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.433 -1.692 . . . . 100.0 106.433 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -109.52 127.73 54.67 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 113.062 -1.881 . . . . 100.0 106.326 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 ' CE2' ' A' ' 79' ' ' TYR . 49.9 t -102.96 121.09 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 106.572 -1.64 . . . . 100.0 106.572 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 ' SD ' ' A' ' 89' ' ' MET . 29.9 tp -109.88 117.08 32.87 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.618 -2.364 . . . . 100.0 104.618 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -127.93 161.98 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 120.718 0.294 . . . . 100.0 111.528 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.22 175.0 26.7 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 108.875 -1.69 . . . . 100.0 108.875 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.03 156.27 39.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 O-C-N 121.832 -0.804 . . . . 100.0 112.092 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.93 141.38 39.77 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 106.984 -2.446 . . . . 100.0 106.984 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.66 -5.96 79.94 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-O 118.773 -1.015 . . . . 100.0 113.404 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -62.68 -39.87 95.29 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 118.804 1.302 . . . . 100.0 111.307 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.87 25.72 4.4 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.743 -1.343 . . . . 100.0 109.743 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -60.01 -46.79 88.32 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.362 1.465 . . . . 100.0 112.883 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.7 m -63.82 -43.06 97.36 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.408 1.083 . . . . 100.0 109.644 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 m -63.3 -41.4 98.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.483 1.113 . . . . 100.0 109.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.561 ' HA ' HH11 ' A' ' 29' ' ' ARG . 45.1 t80 -60.09 -49.11 78.93 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 123.626 0.77 . . . . 100.0 112.749 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.77 -41.05 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 123.739 0.649 . . . . 100.0 110.958 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.266 99.0 mttt -69.06 -7.57 36.99 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 115.826 1.787 . . . . 100.0 115.826 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.571 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.6 mtm-85 -61.04 -36.91 80.82 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 108.691 -0.855 . . . . 100.0 108.691 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.706 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 55.1 t-80 -80.34 112.23 17.47 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.4 -43.9 97.72 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 115.361 1.615 . . . . 100.0 115.361 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.9 m -63.09 -42.22 99.55 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.888 -0.782 . . . . 100.0 108.888 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.706 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.38 -42.47 99.78 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 111.383 -0.687 . . . . 100.0 111.383 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.64 -44.19 94.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.29 0.636 . . . . 100.0 110.836 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -63.83 -40.58 96.94 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 124.463 1.105 . . . . 100.0 112.295 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -91.14 8.56 35.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -59.18 140.36 55.99 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 114.649 1.352 . . . . 100.0 114.649 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.24 130.6 52.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.169 -1.419 . . . . 100.0 107.169 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -104.47 125.13 50.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 106.766 -1.568 . . . . 100.0 106.766 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.16 113.54 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 102.199 -3.26 . . . . 100.0 102.199 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.51 92.42 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 116.228 1.936 . . . . 100.0 116.228 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.2 p -62.58 -47.42 83.89 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.916 0.486 . . . . 100.0 111.784 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.06 -37.74 75.6 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.899 1.28 . . . . 100.0 112.912 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.36 53.91 Favored Glycine 0 C--N 1.359 1.837 0 N-CA-C 106.71 -2.556 . . . . 100.0 106.71 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.9 t -124.43 139.59 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 124.733 1.213 . . . . 100.0 108.754 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.74 117.02 32.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 102.387 -3.19 . . . . 100.0 102.387 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.06 122.1 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.065 -1.458 . . . . 100.0 107.065 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -115.17 121.05 35.66 Favored Pre-proline 0 N--CA 1.432 -1.337 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.105 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -80.13 104.57 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.426 2.084 . . . . 100.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.7 117.07 30.24 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.931 -1.507 . . . . 100.0 106.931 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.52 125.77 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.406 -1.331 . . . . 100.0 107.406 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.45 133.12 55.46 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.851 -1.907 . . . . 100.0 105.851 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -99.67 116.42 31.73 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -108.49 178.63 4.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.434 -0.803 . . . . 100.0 110.846 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -59.87 -43.6 94.62 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.99 1.316 . . . . 100.0 108.427 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -68.99 -38.37 79.26 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 112.839 0.681 . . . . 100.0 112.839 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.96 -172.38 30.61 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.642 -1.783 . . . . 100.0 108.642 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -65.52 136.87 48.26 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.518 2.145 . . . . 100.0 114.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -126.15 130.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 102.111 -3.292 . . . . 100.0 102.111 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.85 128.44 55.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.617 -0.883 . . . . 100.0 108.617 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.37 114.79 28.18 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.557 -2.757 . . . . 100.0 103.557 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -87.75 105.7 17.56 Favored 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 99.862 -4.125 . . . . 100.0 99.862 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.76 123.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.448 -1.686 . . . . 100.0 106.448 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -96.84 114.7 26.35 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.878 -1.897 . . . . 100.0 105.878 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.61 137.25 49.72 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.328 -1.731 . . . . 100.0 106.328 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -72.97 161.94 30.09 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.731 0.777 . . . . 100.0 112.487 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.1 19.47 14.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.668 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.47 13.19 52.29 Favored Glycine 0 C--N 1.356 1.681 0 O-C-N 121.818 -0.552 . . . . 100.0 112.277 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 65.3 mt-30 -60.44 -35.8 76.71 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.52 1.928 . . . . 100.0 111.583 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -58.26 -36.01 72.61 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.13 2.572 . . . . 100.0 111.869 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.84 -42.4 98.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.604 0.762 . . . . 100.0 111.041 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 26.7 p90 -95.37 -5.85 42.36 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.85 -166.69 38.08 Favored Glycine 0 C--N 1.358 1.756 0 C-N-CA 119.7 -1.238 . . . . 100.0 113.251 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.68 175.27 54.9 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.97 -1.252 . . . . 100.0 109.97 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.14 140.65 37.99 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 122.18 0.99 . . . . 100.0 110.465 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -68.7 154.64 41.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.676 -1.602 . . . . 100.0 113.602 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.95 -38.31 85.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.531 1.533 . . . . 100.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.04 93.85 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.854 1.216 . . . . 100.0 111.063 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.402 ' CE2' HG11 ' A' ' 14' ' ' VAL . 63.0 t80 -62.23 -46.98 86.45 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.697 0.799 . . . . 100.0 110.866 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 116.298 1.962 . . . . 100.0 116.298 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.3 mt -51.84 136.58 11.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 C-N-CA 125.04 1.336 . . . . 100.0 113.973 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 61.89 31.78 18.13 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.749 2.42 . . . . 100.0 114.706 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.87 128.44 35.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 105.595 -2.002 . . . . 100.0 105.595 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.4 ' O ' HG21 ' A' ' 115' ' ' ILE . 95.9 mm-40 -96.78 -36.82 10.51 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.6 p -143.52 159.97 41.45 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.776 0.431 . . . . 100.0 110.842 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB1' HG12 ' A' ' 117' ' ' ILE . . . -146.23 149.17 33.41 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.65 126.15 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 103.678 -2.712 . . . . 100.0 103.678 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.98 124.26 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 101.762 -3.422 . . . . 100.0 101.762 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.525 ' SD ' HD12 ' A' ' 15' ' ' LEU . 95.1 mtp -109.16 131.64 54.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.005 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.4 ' HA ' ' CG2' ' A' ' 97' ' ' THR . 54.5 p90 -129.25 159.43 36.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.155 -1.838 . . . . 100.0 108.434 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -106.4 126.95 52.89 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.46 -1.681 . . . . 100.0 106.46 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.65 -21.41 29.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 113.849 1.055 . . . . 100.0 113.849 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.0 p -85.12 -12.19 53.46 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 119.239 -0.41 . . . . 100.0 110.579 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -118.76 117.29 28.5 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.337 1.065 . . . . 100.0 111.427 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -66.51 -38.87 88.16 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.424 -1.262 . . . . 100.0 110.434 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.66 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 126.071 1.749 . . . . 100.0 110.856 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.4 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 74.8 m -62.71 -42.67 99.77 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.655 -0.498 . . . . 100.0 109.655 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.467 ' CE1' HG21 ' A' ' 136' ' ' ILE . 43.6 t80 -64.15 -40.28 95.81 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 123.452 0.701 . . . . 100.0 110.884 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -60.79 -38.77 86.44 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.546 1.139 . . . . 100.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.38 -9.38 58.6 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 115.182 1.549 . . . . 100.0 115.182 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.3 t -60.06 -42.98 92.99 Favored Pre-proline 0 C--N 1.363 1.194 0 CA-C-O 115.884 -2.007 . . . . 100.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 82.0 Cg_exo -57.78 -36.83 98.16 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.309 2.006 . . . . 100.0 112.852 177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.44 -46.93 84.05 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 124.355 1.062 . . . . 100.0 110.28 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -64.24 -42.08 96.69 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.162 0.585 . . . . 100.0 111.271 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.58 -44.25 96.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 124.326 1.05 . . . . 100.0 110.39 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -62.76 -44.38 96.35 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.759 -0.639 . . . . 100.0 112.031 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.34 -44.28 96.85 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 123.526 0.516 . . . . 100.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.45 -46.8 86.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.684 1.193 . . . . 100.0 112.577 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.32 -38.97 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 125.364 1.465 . . . . 100.0 111.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.37 -46.66 89.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 118.938 -0.553 . . . . 100.0 110.714 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.9 t -72.03 -45.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 120.254 -0.578 . . . . 100.0 111.534 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.81 115.65 18.97 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.249 -0.648 . . . . 100.0 109.249 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -93.29 147.3 23.04 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 115.771 -0.649 . . . . 100.0 112.492 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 54.55 44.55 28.55 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.436 1.895 . . . . 100.0 115.183 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 84' ' ' GLN . 33.9 mm -98.96 132.36 23.77 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 126.116 1.766 . . . . 100.0 107.066 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.49 129.25 25.99 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.536 2.158 . . . . 100.0 109.144 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.413 ' HB ' HD21 ' A' ' 144' ' ' LEU . 71.0 mt -130.71 136.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-O 122.257 1.027 . . . . 100.0 108.689 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.4 130.8 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 105.062 -2.199 . . . . 100.0 105.062 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 21.9 mt -105.25 127.07 52.76 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.136 -2.912 . . . . 100.0 103.136 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.83 127.21 54.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.642 -1.617 . . . . 100.0 112.061 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . 0.594 ' HA3' ' HH ' ' A' ' 146' ' ' TYR . . . -98.58 105.26 3.06 Favored Glycine 0 CA--C 1.489 -1.558 0 N-CA-C 106.427 -2.669 . . . . 100.0 106.427 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.14 164.25 23.48 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.2 2.6 . . . . 100.0 113.935 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.2 mttp 55.62 45.15 25.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 128.46 2.704 . . . . 100.0 114.367 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.296 32.8 m -71.82 -9.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 120.4 -0.52 . . . . 100.0 111.062 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.65 -39.1 90.15 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.658 1.983 . . . . 100.0 110.287 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.4 130.87 33.75 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.381 -0.97 . . . . 100.0 108.381 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -62.34 -40.54 96.7 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.937 1.458 . . . . 100.0 114.937 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -84.02 96.08 8.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 105.282 -2.118 . . . . 100.0 105.282 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -102.37 120.91 41.29 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 103.621 -2.733 . . . . 100.0 103.621 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.87 -36.51 10.57 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-N 115.612 -0.722 . . . . 100.0 112.528 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.32 104.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 103.534 -2.765 . . . . 100.0 103.534 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.23 179.95 4.13 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.472 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.21 -35.2 71.31 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.336 2.254 . . . . 100.0 109.539 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.712 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.4 mttt -59.29 -37.62 78.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 128.41 2.684 . . . . 100.0 112.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.6 p -104.99 -0.85 26.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 120.091 3.367 . . . . 100.0 120.091 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.599 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 53.8 mt -97.38 94.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 115.583 -2.447 . . . . 100.0 111.431 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 p -100.82 -5.32 9.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 115.338 1.606 . . . . 100.0 115.338 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.58 -36.55 74.15 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 115.199 1.555 . . . . 100.0 115.199 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.573 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.5 m-70 -59.54 -39.25 83.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.814 1.646 . . . . 100.0 113.344 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.548 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 57.3 ttp85 -58.69 -48.5 80.88 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 114.031 1.123 . . . . 100.0 114.031 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.52 -40.59 95.91 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.218 0.949 . . . . 100.0 111.812 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.01 -0.1 54.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 116.157 1.91 . . . . 100.0 116.157 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.258 73.2 m-20 54.55 47.13 23.39 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.378 1.471 . . . . 100.0 113.346 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 117' ' ' ILE . 27.7 mt -103.62 153.39 20.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.115 -1.809 . . . . 100.0 106.115 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -101.53 142.96 32.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.3 -0.63 . . . . 100.0 109.3 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.594 ' HH ' ' HA3' ' A' ' 121' ' ' GLY . 68.2 t80 -105.79 133.63 50.21 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.4 0.889 . . . . 100.0 113.4 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.82 133.4 45.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.575 -1.193 . . . . 100.0 111.491 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.297 37.1 m-20 -85.64 122.97 30.49 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 102.234 -3.247 . . . . 100.0 102.234 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.32 156.89 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 CA-C-O 122.364 1.078 . . . . 100.0 112.237 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.1 m -138.88 113.19 8.8 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.244 -1.761 . . . . 100.0 106.244 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.571 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.3 -43.06 98.91 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.836 -1.529 . . . . 100.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.22 -42.15 99.04 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.667 1.187 . . . . 100.0 112.375 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.456 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 96.8 p -97.25 2.12 50.45 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 117.3 2.333 . . . . 100.0 117.3 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.49 21.25 11.8 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.583 1.153 . . . . 100.0 110.113 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 85.8 t80 -73.58 124.48 26.0 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.038 -0.727 . . . . 100.0 109.038 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 53.32 40.1 30.8 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.12 2.568 . . . . 100.0 115.175 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.443 ' CA ' HH21 ' A' ' 29' ' ' ARG . 69.9 t80 -62.25 -44.46 96.51 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 121.638 -0.664 . . . . 100.0 111.529 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.33 -38.49 91.37 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.117 1.895 . . . . 100.0 116.117 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.53 -47.24 99.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 119.999 3.333 . . . . 100.0 119.999 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.07 -41.95 39.95 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.34 2.229 . . . . 100.0 111.334 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.45 -42.29 96.04 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 125.466 1.506 . . . . 100.0 110.884 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -61.14 -46.76 89.21 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 123.885 0.874 . . . . 100.0 112.002 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -63.67 -44.61 93.26 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.082 0.864 . . . . 100.0 110.421 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.92 -44.85 95.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 123.797 0.686 . . . . 100.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.7 98.26 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.174 0.99 . . . . 100.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.57 -45.71 91.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.564 0.745 . . . . 100.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -68.11 -42.4 80.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.543 0.527 . . . . 100.0 112.354 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.67 -46.96 85.74 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.469 0.708 . . . . 100.0 112.316 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.43 -38.59 74.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 123.546 0.738 . . . . 100.0 110.318 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.46 59.49 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-O 118.781 -1.01 . . . . 100.0 111.053 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -111.5 113.64 53.36 Favored Pre-proline 0 C--N 1.362 1.133 0 N-CA-C 107.492 -1.299 . . . . 100.0 107.492 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.57 -15.19 30.67 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.051 3.167 . . . . 100.0 114.282 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -89.73 2.82 54.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.993 0.917 . . . . 100.0 113.276 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.05 131.44 46.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.51 0.671 . . . . 100.0 109.663 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -133.83 152.94 52.02 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.358 -0.979 . . . . 100.0 108.358 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -90.35 114.29 26.34 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 104.314 -2.476 . . . . 100.0 104.314 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.54 -44.29 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.283 1.033 . . . . 100.0 110.55 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -127.86 148.01 50.46 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.373 0.606 . . . . 100.0 109.697 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 62.5 ttp -90.18 126.23 57.61 Favored Pre-proline 0 N--CA 1.432 -1.339 0 N-CA-C 104.772 -2.307 . . . . 100.0 104.772 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.68 158.1 55.23 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.869 2.379 . . . . 100.0 110.632 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.5 126.04 26.21 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.286 -1.005 . . . . 100.0 108.286 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.51 146.63 46.09 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 114.176 -1.375 . . . . 100.0 110.164 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 137.29 97.08 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 106.832 -1.544 . . . . 100.0 106.832 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -55.98 138.51 82.54 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.534 2.823 . . . . 100.0 112.569 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.68 130.25 32.53 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.738 2.292 . . . . 100.0 113.609 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.83 -44.36 81.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 124.858 1.349 . . . . 100.0 108.579 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.32 159.04 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.498 -1.667 . . . . 100.0 106.498 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.66 131.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.641 -1.985 . . . . 100.0 105.641 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.456 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.0 ttt -86.29 128.12 34.87 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 104.774 -2.306 . . . . 100.0 104.774 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -62.21 128.09 90.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 CA-C-N 114.911 -1.04 . . . . 100.0 109.738 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.53 -36.68 92.44 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.474 2.783 . . . . 100.0 112.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.37 92.22 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.33 1.019 . . . . 100.0 110.766 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.29 -41.89 96.66 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 122.971 0.508 . . . . 100.0 111.493 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.56 96.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 123.63 0.772 . . . . 100.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.8 97.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.293 1.037 . . . . 100.0 110.847 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.09 -43.98 97.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.632 0.773 . . . . 100.0 112.306 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -63.69 -43.7 95.85 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 122.534 0.333 . . . . 100.0 111.712 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -64.2 -39.93 95.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.601 0.36 . . . . 100.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.06 -42.83 99.78 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.625 1.17 . . . . 100.0 110.57 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.95 -42.41 99.09 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.968 0.907 . . . . 100.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.512 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 18.3 tp -59.69 -49.52 77.42 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 124.117 0.886 . . . . 100.0 110.089 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.22 -43.24 98.66 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 115.188 1.551 . . . . 100.0 115.188 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.61 -46.53 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.175 0 CA-C-O 118.425 -0.798 . . . . 100.0 109.984 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.403 . . -93.59 -0.63 56.13 Favored 'General case' 0 N--CA 1.403 -2.818 1 C-N-CA 109.854 -4.739 . . . . 100.0 114.006 179.76 . . . . . . . . 4 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.268 57.7 mt-30 -56.9 -35.77 69.36 Favored 'General case' 0 CA--C 1.458 -2.566 0 N-CA-C 107.523 -1.288 . . . . 100.0 107.523 178.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -82.74 53.87 2.51 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.403 1.097 . . . . 100.0 108.886 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.312 73.1 p 48.84 38.37 11.88 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 129.477 3.111 . . . . 100.0 116.281 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -83.13 -178.02 6.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.511 -2.404 . . . . 100.0 104.511 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.31 -41.53 91.56 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-O 115.885 -2.007 . . . . 100.0 114.788 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.325 32.4 Cg_exo -55.17 137.21 76.25 Favored 'Trans proline' 0 C--N 1.373 1.826 0 CA-C-N 121.406 1.538 . . . . 100.0 112.427 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -63.57 -47.45 81.49 Favored 'General case' 0 N--CA 1.427 -1.614 1 N-CA-C 124.764 5.098 . . . . 100.0 124.764 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.599 ' CG ' ' HB ' ' A' ' 136' ' ' ILE . 99.2 mt-10 -63.13 -35.36 80.02 Favored 'General case' 0 CA--C 1.48 -1.746 1 CA-C-O 128.51 4.005 . . . . 100.0 108.045 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.642 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.481 44.0 m-20 -65.74 -48.74 70.89 Favored 'General case' 1 N--CA 1.351 -5.385 2 CA-C-N 107.446 -4.434 . . . . 100.0 106.389 -179.093 . . . . . . . . 5 3 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.46 -29.43 70.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.499 -1.375 . . . . 100.0 107.889 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.0 OUTLIER -58.51 -43.74 89.24 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-O 117.021 -1.466 . . . . 100.0 113.442 176.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.26 1.632 0 CA-C-O 114.514 -2.66 . . . . 100.0 113.227 -176.679 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -124.4 138.0 54.4 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.884 -1.507 . . . . 100.0 108.261 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.59 144.15 50.31 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.099 -1.075 . . . . 100.0 108.099 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.24 120.34 35.29 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.73 128.36 54.8 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 113.442 -1.708 . . . . 100.0 106.83 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.4 t -104.51 121.05 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 N-CA-C 107.01 -1.478 . . . . 100.0 107.01 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.406 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 31.0 tp -110.48 115.59 29.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.54 161.96 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 115.379 -0.828 . . . . 100.0 111.881 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.68 176.7 30.02 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.008 -2.037 . . . . 100.0 108.008 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -72.1 156.4 39.23 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.831 0.824 . . . . 100.0 111.479 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.96 140.66 38.42 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.1 -5.49 78.57 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-O 118.453 -1.193 . . . . 100.0 113.696 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.1 m -62.2 -39.91 94.32 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 119.064 1.432 . . . . 100.0 111.06 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.69 26.88 4.29 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 109.464 -1.454 . . . . 100.0 109.464 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 89' ' ' MET . 32.7 mtmt -61.49 -44.81 96.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.493 0.717 . . . . 100.0 112.671 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -62.47 -43.08 99.68 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.267 1.027 . . . . 100.0 109.729 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 m -63.07 -41.7 99.49 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.786 1.234 . . . . 100.0 109.218 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.536 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 54.9 t80 -59.99 -48.48 81.52 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 124.141 0.976 . . . . 100.0 112.208 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.46 -41.68 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.691 0.619 . . . . 100.0 110.922 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.252 98.8 mttt -68.06 -8.09 34.89 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.919 1.822 . . . . 100.0 115.919 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.578 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 81.2 mtm-85 -60.91 -37.43 82.21 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 118.941 -0.552 . . . . 100.0 109.724 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.628 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 47.5 t-80 -80.53 113.17 18.53 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.78 -1.563 . . . . 100.0 106.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.52 -43.96 97.54 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 115.604 1.705 . . . . 100.0 115.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 63.7 m -63.33 -41.89 98.94 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.988 -0.745 . . . . 100.0 108.988 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.628 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.41 -42.45 99.77 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 123.671 0.653 . . . . 100.0 111.565 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.49 -45.36 91.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.368 0.667 . . . . 100.0 111.043 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.16 -40.65 98.16 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 124.685 1.194 . . . . 100.0 112.215 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -93.52 11.24 29.33 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 115.353 1.612 . . . . 100.0 115.353 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.55 140.01 56.66 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 113.875 1.065 . . . . 100.0 113.875 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -118.1 129.47 55.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -103.04 124.63 48.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.2 110.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 101.498 -3.519 . . . . 100.0 101.498 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.03 88.93 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 115.993 1.849 . . . . 100.0 115.993 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.6 p -62.86 -47.25 84.16 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 122.494 0.317 . . . . 100.0 111.568 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.79 -37.14 73.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.892 1.071 . . . . 100.0 113.892 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.77 30.84 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 107.261 -2.335 . . . . 100.0 107.261 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.25 141.99 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 124.246 1.018 . . . . 100.0 109.167 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.55 118.93 37.88 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 102.336 -3.209 . . . . 100.0 102.336 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.68 120.05 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.542 -2.021 . . . . 100.0 105.542 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -114.5 119.79 39.2 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 109.0 -0.741 . . . . 100.0 109.0 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.9 104.67 1.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.863 2.375 . . . . 100.0 110.934 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.33 119.05 34.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.93 126.59 58.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 107.191 -1.411 . . . . 100.0 107.191 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -122.49 133.1 54.6 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.102 -1.814 . . . . 100.0 106.102 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -100.35 118.3 36.32 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 121.73 0.776 . . . . 100.0 108.987 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.424 ' HG1' HD12 ' A' ' 174' ' ' LEU . 22.3 p -110.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.948 -1.023 . . . . 100.0 111.57 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.66 -44.21 93.66 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 125.497 1.519 . . . . 100.0 108.349 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.8 -38.42 76.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.188 0.995 . . . . 100.0 112.395 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.92 -173.05 29.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.889 -1.684 . . . . 100.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.93 138.43 57.43 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.521 2.147 . . . . 100.0 114.199 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.1 mt -127.4 129.93 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 102.801 -3.037 . . . . 100.0 102.801 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.81 128.99 55.97 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.048 -0.723 . . . . 100.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.85 116.76 31.19 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.653 -2.721 . . . . 100.0 103.653 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -87.81 106.65 18.22 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.616 -4.216 . . . . 100.0 99.616 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.28 122.3 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 106.368 -1.715 . . . . 100.0 106.368 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.25 117.0 30.48 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 106.631 -1.618 . . . . 100.0 106.631 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -116.45 141.28 48.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.005 -2.22 . . . . 100.0 105.005 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 p -75.08 165.88 24.53 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 113.558 0.947 . . . . 100.0 113.558 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.74 12.92 23.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.733 1.213 . . . . 100.0 109.788 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.49 51.14 Favored Glycine 0 C--N 1.358 1.803 0 O-C-N 121.693 -0.629 . . . . 100.0 112.209 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 85.0 mt-30 -61.96 -27.86 69.14 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.813 1.645 . . . . 100.0 112.166 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -59.05 -36.64 75.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.584 2.353 . . . . 100.0 111.826 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.59 -46.84 88.16 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 117.996 0.362 . . . . 100.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 69' ' ' GLN 0.371 13.9 p90 -71.99 -39.39 69.3 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 114.903 1.445 . . . . 100.0 114.903 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.5 -156.04 11.45 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 119.903 -1.142 . . . . 100.0 113.431 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.16 171.53 52.52 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.807 0.718 . . . . 100.0 111.731 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -106.3 142.99 35.06 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 121.822 0.82 . . . . 100.0 109.971 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -67.95 155.69 38.89 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.208 -1.36 . . . . 100.0 113.735 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -60.67 -38.36 84.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.776 -1.557 . . . . 100.0 110.372 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.76 -39.33 93.54 Favored Glycine 0 C--N 1.36 1.872 0 C-N-CA 124.38 0.99 . . . . 100.0 111.469 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -62.32 -46.96 86.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.516 0.726 . . . . 100.0 111.293 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.92 -37.11 78.73 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.0 mt -52.19 138.22 10.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 125.48 1.512 . . . . 100.0 113.739 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.86 24.65 12.78 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 127.853 2.461 . . . . 100.0 114.378 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.07 129.33 38.68 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.305 -1.368 . . . . 100.0 107.305 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -98.71 -34.93 10.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.143 -1.058 . . . . 100.0 108.143 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 168' ' ' LEU . 23.5 p -144.37 160.14 41.54 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 122.861 0.465 . . . . 100.0 110.527 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB1' HG12 ' A' ' 117' ' ' ILE . . . -146.17 149.3 33.72 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.404 1.261 . . . . 100.0 114.404 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.47 126.52 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 103.292 -2.855 . . . . 100.0 103.292 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.43 123.81 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 102.353 -3.203 . . . . 100.0 102.353 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 23' ' ' LYS . 41.0 mtm -115.45 140.55 49.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 118.738 -1.185 . . . . 100.0 113.692 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -127.08 159.59 33.73 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 110.423 -3.081 . . . . 100.0 108.751 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -102.87 126.59 50.08 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.802 -1.925 . . . . 100.0 105.802 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.52 -21.58 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.367 0.877 . . . . 100.0 113.367 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -87.59 -8.48 56.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 119.033 -0.508 . . . . 100.0 110.993 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 t -119.42 115.84 24.93 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 122.308 1.051 . . . . 100.0 110.576 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.77 -38.68 87.05 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.622 -1.172 . . . . 100.0 110.55 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.71 -41.86 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.217 1.807 . . . . 100.0 110.391 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.4 m -62.96 -42.06 99.71 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 118.111 0.414 . . . . 100.0 110.306 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.532 ' CE1' HG21 ' A' ' 136' ' ' ILE . 39.5 t80 -63.45 -41.22 98.65 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 123.259 0.624 . . . . 100.0 110.453 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.514 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.7 mttt -61.61 -37.53 84.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.691 0.796 . . . . 100.0 111.652 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.14 -10.3 59.34 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 114.471 1.286 . . . . 100.0 114.471 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.36 -43.04 95.73 Favored Pre-proline 0 C--N 1.363 1.191 0 CA-C-O 115.782 -2.056 . . . . 100.0 111.795 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 83.2 Cg_exo -57.41 -38.24 95.0 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 122.556 1.949 . . . . 100.0 112.725 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.02 -45.19 90.03 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 123.924 0.89 . . . . 100.0 111.401 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -63.15 -42.79 99.52 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 123.182 0.593 . . . . 100.0 110.347 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -62.15 -45.01 95.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.502 1.121 . . . . 100.0 110.517 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -63.0 -44.01 97.2 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 112.686 0.624 . . . . 100.0 112.686 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.68 -44.03 97.29 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.42 0.45 . . . . 100.0 111.357 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.79 -46.26 88.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.499 1.12 . . . . 100.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.43 -38.58 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 C-N-CA 125.082 1.353 . . . . 100.0 111.143 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -60.5 -46.07 91.45 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.463 0.574 . . . . 100.0 111.197 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.4 -45.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.352 -0.539 . . . . 100.0 111.159 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.1 m -127.39 115.33 18.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.48 0.657 . . . . 100.0 109.558 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.57 147.18 23.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.537 -0.756 . . . . 100.0 112.422 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.07 44.55 27.85 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 126.56 1.944 . . . . 100.0 114.457 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 32.0 mm -100.74 131.29 23.77 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 125.907 1.683 . . . . 100.0 107.193 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.19 130.33 28.45 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.601 2.201 . . . . 100.0 109.181 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.8 mt -130.82 136.73 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 O-C-N 124.317 1.011 . . . . 100.0 109.147 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.6 130.91 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 105.431 -2.062 . . . . 100.0 105.431 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 39.7 mt -105.85 125.14 50.64 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.465 -2.791 . . . . 100.0 103.465 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.4 m -116.82 129.99 56.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.199 -1.364 . . . . 100.0 112.509 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 103.51 2.83 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 105.347 -3.101 . . . . 100.0 105.347 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.36 167.44 16.52 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.082 1.353 . . . . 100.0 111.297 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 60.08 42.45 15.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 128.348 2.659 . . . . 100.0 115.199 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.307 20.4 m -73.18 -7.66 10.17 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 116.08 -0.509 . . . . 100.0 111.494 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.96 -38.09 87.21 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.759 2.023 . . . . 100.0 109.801 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.65 130.34 34.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.108 0 N-CA-C 106.694 -1.595 . . . . 100.0 106.694 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.36 -41.11 98.35 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 116.281 1.956 . . . . 100.0 116.281 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -86.23 99.4 11.52 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.201 -2.148 . . . . 100.0 105.201 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -99.01 118.77 36.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.351 -2.833 . . . . 100.0 103.351 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.3 -40.96 13.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.719 -0.673 . . . . 100.0 112.634 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.85 106.36 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 103.667 -2.716 . . . . 100.0 103.667 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -103.64 -179.49 3.97 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.247 -0.888 . . . . 100.0 113.209 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.43 -35.86 72.75 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 127.161 2.184 . . . . 100.0 109.276 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.715 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -59.73 -37.11 78.02 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 128.081 2.552 . . . . 100.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.8 p -103.96 -1.17 27.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 120.114 3.376 . . . . 100.0 120.114 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.591 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 56.2 mt -98.47 95.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.21 0 C-N-CA 115.487 -2.485 . . . . 100.0 111.324 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.6 -5.98 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 114.77 1.396 . . . . 100.0 114.77 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.89 -35.7 73.45 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.225 1.565 . . . . 100.0 115.225 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 87.0 m-70 -59.45 -40.5 87.05 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 125.587 1.555 . . . . 100.0 112.689 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.565 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 55.7 ttp85 -59.09 -47.69 84.33 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 124.567 1.147 . . . . 100.0 113.436 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -63.44 -41.44 98.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.277 0.986 . . . . 100.0 111.728 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.5 3.71 50.64 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 117.277 2.325 . . . . 100.0 117.277 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 57.42 42.84 24.07 Favored 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.526 1.531 . . . . 100.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 117' ' ' ILE . 27.3 mt -106.38 151.33 25.03 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.815 -1.55 . . . . 100.0 106.815 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 86.9 mm-40 -103.91 142.85 33.69 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 113.445 0.905 . . . . 100.0 113.445 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.464 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 79.7 t80 -98.83 132.18 44.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 113.633 0.975 . . . . 100.0 113.633 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.58 132.89 49.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 113.596 -1.638 . . . . 100.0 108.335 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.39 118.28 30.4 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.3 -3.593 . . . . 100.0 101.3 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.57 159.37 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.644 1.212 . . . . 100.0 114.05 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.1 m -140.02 111.43 7.18 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 106.418 -1.697 . . . . 100.0 106.418 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.578 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.58 -44.35 96.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.337 -1.301 . . . . 100.0 112.92 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.04 -40.12 96.78 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.715 0.806 . . . . 100.0 112.738 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.513 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 99.0 p -96.12 1.66 52.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.139 2.274 . . . . 100.0 117.139 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.42 11.92 Favored 'General case' 0 C--N 1.365 1.244 0 C-N-CA 125.277 1.431 . . . . 100.0 109.964 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 87.0 t80 -75.33 124.77 27.69 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.012 -0.736 . . . . 100.0 109.012 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 53.59 39.87 30.67 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.121 2.568 . . . . 100.0 115.399 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.565 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 69.8 t80 -62.61 -42.66 99.71 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 121.829 -0.544 . . . . 100.0 111.395 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.13 -39.43 94.67 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 115.746 1.758 . . . . 100.0 115.746 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.16 -48.53 96.87 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 120.932 3.679 . . . . 100.0 120.932 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.16 -41.79 40.47 Favored 'Trans proline' 0 C--N 1.373 1.853 0 CA-C-N 123.544 2.301 . . . . 100.0 112.681 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.7 -42.49 95.25 Favored 'General case' 0 CA--C 1.491 -1.325 0 O-C-N 124.656 1.223 . . . . 100.0 111.347 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.18 -45.05 93.6 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.457 0.703 . . . . 100.0 111.408 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -63.01 -44.53 95.74 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.523 0.514 . . . . 100.0 110.079 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.78 -44.15 97.44 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.121 0.568 . . . . 100.0 111.469 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.72 98.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.207 1.003 . . . . 100.0 111.315 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -62.22 -45.83 91.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 123.722 0.809 . . . . 100.0 111.022 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -64.56 -45.38 87.36 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 85' ' ' CYS . 82.0 mt -63.44 -46.74 84.91 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 123.826 0.85 . . . . 100.0 112.929 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 85.9 mt -70.54 -38.51 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 123.06 0.544 . . . . 100.0 109.989 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.98 9.74 59.31 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.477 -1.049 . . . . 100.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -108.97 112.63 59.97 Favored Pre-proline 0 C--N 1.362 1.121 0 N-CA-C 107.332 -1.358 . . . . 100.0 107.332 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.23 -16.7 28.16 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 123.412 2.741 . . . . 100.0 113.832 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.93 -0.12 56.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.827 0.851 . . . . 100.0 113.042 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.424 HD12 ' HG1' ' A' ' 54' ' ' THR . 19.1 tp -63.81 131.61 48.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.286 0.634 . . . . 100.0 110.337 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -136.65 153.77 50.82 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.987 -0.746 . . . . 100.0 108.987 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -88.21 113.21 23.6 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 106.257 -1.757 . . . . 100.0 106.257 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.7 t -67.02 -43.8 88.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.011 0.925 . . . . 100.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.91 150.7 49.19 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.522 0.677 . . . . 100.0 109.634 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 63.5 ttp -96.35 126.63 43.13 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 104.837 -2.283 . . . . 100.0 104.837 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.05 159.49 49.11 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.951 2.434 . . . . 100.0 111.541 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.72 125.06 23.6 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.283 -1.006 . . . . 100.0 108.283 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.1 144.56 46.54 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.335 -1.302 . . . . 100.0 109.972 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.65 137.85 97.27 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -56.08 138.33 82.36 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 123.516 2.811 . . . . 100.0 112.129 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.42 131.74 39.94 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.851 2.367 . . . . 100.0 114.264 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -66.06 -44.85 83.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 124.795 1.309 . . . . 100.0 108.503 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.03 158.42 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.787 -1.56 . . . . 100.0 106.787 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.7 t -99.78 130.64 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 105.651 -1.981 . . . . 100.0 105.651 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.513 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.1 ttt -85.83 126.7 34.24 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.345 -2.465 . . . . 100.0 104.345 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 77.6 m-20 -62.74 131.09 94.22 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 115.245 -0.889 . . . . 100.0 110.828 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.7 Cg_exo -58.67 -37.94 91.69 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.948 3.099 . . . . 100.0 112.828 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.05 93.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 124.449 1.093 . . . . 100.0 110.784 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.91 -42.49 97.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.067 0.547 . . . . 100.0 111.483 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 123.731 0.812 . . . . 100.0 110.512 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.88 97.72 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.126 0.97 . . . . 100.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.57 -44.42 96.37 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.614 0.765 . . . . 100.0 112.187 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -63.84 -43.83 95.0 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 112.397 0.518 . . . . 100.0 112.397 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.51 -41.37 98.52 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.55 -0.537 . . . . 100.0 109.55 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.14 -45.32 93.95 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.989 1.316 . . . . 100.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -42.75 99.4 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 123.366 0.667 . . . . 100.0 110.667 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.507 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 17.5 tp -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 124.122 0.889 . . . . 100.0 110.53 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.69 -41.77 95.8 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 115.664 1.727 . . . . 100.0 115.664 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.68 -46.36 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 CA-C-O 118.429 -0.796 . . . . 100.0 109.667 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.639 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.41 . . -93.35 -0.52 56.58 Favored 'General case' 0 N--CA 1.4 -2.931 1 C-N-CA 109.909 -4.717 . . . . 100.0 114.326 -179.886 . . . . . . . . 4 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.275 59.7 mt-30 -56.63 -36.51 69.56 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 106.535 -1.654 . . . . 100.0 106.535 178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.7 p -82.44 53.4 2.3 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.211 1.005 . . . . 100.0 108.969 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.291 78.7 p 49.11 37.74 11.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 129.123 2.969 . . . . 100.0 116.402 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -82.53 -179.32 7.38 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.443 -2.428 . . . . 100.0 104.443 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.6 -39.98 81.7 Favored Pre-proline 0 CA--C 1.499 -0.981 0 CA-C-O 115.851 -2.024 . . . . 100.0 114.904 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.715 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.332 45.4 Cg_exo -55.02 136.7 74.09 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 121.288 1.496 . . . . 100.0 111.991 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.55 -47.7 80.5 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 125.132 5.234 . . . . 100.0 125.132 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 136' ' ' ILE . 99.2 mt-10 -63.1 -35.26 79.67 Favored 'General case' 0 CA--C 1.482 -1.673 1 CA-C-O 128.626 4.06 . . . . 100.0 107.782 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.639 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.482 43.2 m-20 -65.49 -49.06 70.43 Favored 'General case' 1 N--CA 1.352 -5.352 1 CA-C-N 107.581 -4.372 . . . . 100.0 106.148 -179.058 . . . . . . . . 5 3 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.15 -27.64 69.21 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 120.412 -1.43 . . . . 100.0 108.217 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.1 t70 -58.33 -43.59 88.32 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-O 117.178 -1.391 . . . . 100.0 112.507 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.927 -177.23 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 N--CA 1.434 -1.248 0 N-CA-C 106.489 -1.671 . . . . 100.0 106.489 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.76 133.94 52.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.638 -1.619 . . . . 100.0 107.916 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.22 141.91 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.744 -1.206 . . . . 100.0 107.744 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.01 118.49 31.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp -106.92 125.66 51.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 113.008 -1.905 . . . . 100.0 106.955 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.3 t -102.39 121.86 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 106.23 -1.767 . . . . 100.0 106.23 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.68 117.95 33.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.628 -2.36 . . . . 100.0 104.628 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -127.58 162.87 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.847 -0.615 . . . . 100.0 112.307 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.78 175.26 28.5 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 108.569 -1.812 . . . . 100.0 108.569 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -71.71 156.1 39.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 121.777 -0.837 . . . . 100.0 111.786 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.0 141.07 40.98 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 107.423 -2.271 . . . . 100.0 107.423 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 -5.43 80.63 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.924 -0.931 . . . . 100.0 113.884 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -62.85 -40.03 96.2 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 118.618 1.209 . . . . 100.0 111.145 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.79 24.64 5.16 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.22 -1.152 . . . . 100.0 110.22 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -60.24 -46.22 90.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.363 1.465 . . . . 100.0 111.98 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.6 m -62.9 -43.76 97.92 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 124.864 1.265 . . . . 100.0 109.622 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.4 m -63.15 -41.64 99.3 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.421 1.088 . . . . 100.0 109.28 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.589 ' HA ' HH11 ' A' ' 29' ' ' ARG . 60.6 t80 -60.62 -48.77 80.32 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 122.868 0.467 . . . . 100.0 111.625 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.02 -42.64 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.672 0.789 . . . . 100.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.263 99.5 mttt -70.44 -6.39 35.46 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 115.718 1.747 . . . . 100.0 115.718 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' A' ' 26' ' ' PHE . 80.7 mtm-85 -61.32 -36.57 80.49 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 118.884 -0.579 . . . . 100.0 110.069 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.614 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 44.8 t-80 -79.98 113.79 18.41 Favored 'General case' 0 C--N 1.36 1.034 0 N-CA-C 107.128 -1.434 . . . . 100.0 107.128 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.23 -43.91 97.76 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.888 1.44 . . . . 100.0 114.888 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.448 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 79.8 m -64.11 -39.87 94.97 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.694 -0.854 . . . . 100.0 108.694 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.614 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.27 -42.44 99.78 Favored Glycine 0 C--N 1.361 1.938 0 N-CA-C 110.409 -1.076 . . . . 100.0 110.409 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.89 -45.33 93.06 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 117.56 0.68 . . . . 100.0 111.536 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.5 -40.92 98.26 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.996 0.919 . . . . 100.0 112.236 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -90.56 6.36 43.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 114.988 1.477 . . . . 100.0 114.988 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -61.06 140.61 57.82 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -121.07 133.59 55.24 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.108 -1.441 . . . . 100.0 107.108 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -103.32 124.63 49.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.331 -1.729 . . . . 100.0 106.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.56 109.73 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 100.641 -3.836 . . . . 100.0 100.641 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.55 92.22 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 116.669 2.1 . . . . 100.0 116.669 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.9 m -63.13 -48.55 78.02 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 123.37 0.419 . . . . 100.0 110.438 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.35 -36.1 74.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 113.957 1.095 . . . . 100.0 113.957 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.24 40.45 33.92 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 107.944 -2.062 . . . . 100.0 107.944 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.72 141.81 45.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.077 0.951 . . . . 100.0 109.141 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -103.96 119.52 39.1 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 102.839 -3.022 . . . . 100.0 102.839 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.23 120.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.696 -1.964 . . . . 100.0 105.696 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -113.22 119.21 42.73 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.023 -0.732 . . . . 100.0 109.023 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -80.09 106.54 1.93 Allowed 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.093 1.862 . . . . 100.0 109.62 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.32 117.42 32.68 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.196 -1.779 . . . . 100.0 106.196 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.17 125.98 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.41 133.25 54.63 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.782 -1.933 . . . . 100.0 105.782 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -100.66 119.19 38.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.176 -1.046 . . . . 100.0 108.176 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.875 -1.057 . . . . 100.0 110.874 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -59.83 -44.44 94.06 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.424 1.489 . . . . 100.0 108.255 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -67.23 -37.96 84.42 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.308 1.443 . . . . 100.0 112.792 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.25 -172.56 28.48 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 108.988 -1.645 . . . . 100.0 108.988 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.97 136.73 49.77 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.674 2.25 . . . . 100.0 113.953 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.58 129.75 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 102.659 -3.089 . . . . 100.0 102.659 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -110.32 129.66 55.7 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.646 -0.872 . . . . 100.0 108.646 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -109.82 116.61 31.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.177 -2.897 . . . . 100.0 103.177 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -87.42 107.7 18.66 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.338 -4.319 . . . . 100.0 99.338 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 t -93.2 121.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.069 -1.826 . . . . 100.0 106.069 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -93.57 109.88 21.49 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.797 -2.298 . . . . 100.0 104.797 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.22 136.6 52.77 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.035 -1.839 . . . . 100.0 106.035 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.2 p -72.95 162.2 29.78 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 113.378 0.881 . . . . 100.0 113.378 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.57 16.22 19.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.325 -0.852 . . . . 100.0 109.789 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.3 51.14 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 121.846 -0.534 . . . . 100.0 112.409 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -60.28 -33.78 72.82 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 126.871 2.069 . . . . 100.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -57.89 -36.68 72.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.566 2.346 . . . . 100.0 112.154 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.36 -43.53 98.6 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.13 0.572 . . . . 100.0 109.792 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -70.6 -41.68 72.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.216 1.406 . . . . 100.0 113.539 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.77 -155.2 13.51 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 121.363 -0.446 . . . . 100.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.0 171.66 52.16 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 123.764 0.697 . . . . 100.0 111.982 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.97 143.12 33.61 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 122.173 0.987 . . . . 100.0 111.128 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -65.16 150.48 48.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.441 -1.708 . . . . 100.0 113.14 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.43 -37.92 85.26 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 114.029 -1.441 . . . . 100.0 109.53 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.35 94.11 Favored Glycine 0 C--N 1.36 1.874 0 C-N-CA 124.728 1.156 . . . . 100.0 111.07 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.44 -46.83 86.77 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.899 0.88 . . . . 100.0 111.279 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -69.03 -37.21 78.49 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.671 1.73 . . . . 100.0 115.671 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.87 139.29 12.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 125.178 1.391 . . . . 100.0 113.232 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.93 22.17 10.18 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 127.544 2.338 . . . . 100.0 113.182 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.61 128.99 37.61 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.293 -1.373 . . . . 100.0 107.293 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.54 -37.68 10.77 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.471 -1.677 . . . . 100.0 106.471 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.442 ' HB2' HD21 ' A' ' 164' ' ' LEU . 24.3 p -144.6 161.57 38.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.681 0.277 . . . . 100.0 111.271 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.34 150.16 36.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.176 1.547 . . . . 100.0 115.176 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.4 mt -125.54 126.13 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 103.851 -2.648 . . . . 100.0 103.851 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.5 mt -111.03 124.17 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 102.944 -2.984 . . . . 100.0 102.944 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.507 ' HE2' ' CG ' ' A' ' 26' ' ' PHE . 38.9 mtt -110.89 135.51 51.32 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.268 -1.333 . . . . 100.0 114.549 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -129.23 159.41 36.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 111.583 -2.553 . . . . 100.0 108.33 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -103.78 126.61 51.03 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.291 -1.744 . . . . 100.0 106.291 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.68 -21.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.857 1.058 . . . . 100.0 113.857 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.6 p -88.33 -10.31 49.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 119.193 -0.432 . . . . 100.0 110.961 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -116.93 114.99 24.63 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.755 1.264 . . . . 100.0 110.193 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -65.93 -39.48 90.56 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.408 1.483 . . . . 100.0 109.815 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.97 -41.84 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.221 1.808 . . . . 100.0 110.777 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.1 m -62.74 -42.46 99.68 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 118.089 0.404 . . . . 100.0 109.93 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' A' ' 136' ' ' ILE . 45.7 t80 -63.93 -41.0 97.75 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.691 0.796 . . . . 100.0 110.767 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.501 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -60.83 -38.55 85.87 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.763 0.825 . . . . 100.0 110.515 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.36 -9.78 58.87 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 115.129 1.529 . . . . 100.0 115.129 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.71 -43.4 95.21 Favored Pre-proline 0 C--N 1.364 1.222 0 CA-C-O 115.93 -1.986 . . . . 100.0 111.529 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.2 Cg_exo -57.4 -36.23 98.84 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.242 1.961 . . . . 100.0 112.93 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.91 -47.08 84.82 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.951 1.3 . . . . 100.0 110.115 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -63.87 -42.64 97.47 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 123.837 0.855 . . . . 100.0 111.161 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CE1' HD12 ' A' ' 144' ' ' LEU . 85.7 t60 -62.45 -44.29 96.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.526 1.13 . . . . 100.0 110.265 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -62.62 -45.3 93.49 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 118.697 -0.668 . . . . 100.0 111.661 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -62.41 -43.98 97.53 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 123.481 0.488 . . . . 100.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.71 -46.54 87.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.466 1.106 . . . . 100.0 111.988 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.59 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 C-N-CA 125.376 1.47 . . . . 100.0 111.165 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.08 -46.32 89.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 119.017 -0.516 . . . . 100.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.86 -46.62 59.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.356 -0.538 . . . . 100.0 111.796 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.9 m -127.07 114.03 17.21 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -90.46 146.07 24.42 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.746 -0.661 . . . . 100.0 112.27 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.75 43.3 31.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 126.39 1.876 . . . . 100.0 115.36 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 pt -99.5 139.82 21.17 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 105.953 -1.869 . . . . 100.0 105.953 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.29 129.92 28.57 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.608 2.206 . . . . 100.0 109.525 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.413 ' HB ' HD21 ' A' ' 144' ' ' LEU . 72.3 mt -130.64 135.89 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.235 1.017 . . . . 100.0 108.777 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.67 131.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 105.594 -2.002 . . . . 100.0 105.594 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 20.5 mt -106.04 126.56 52.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.274 -2.861 . . . . 100.0 103.274 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 73.8 m -114.57 127.85 56.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.98 -1.464 . . . . 100.0 112.008 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.73 104.02 2.93 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 105.726 -2.95 . . . . 100.0 105.726 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 122' ' ' ASN . 1.1 m-80 -78.95 163.89 24.86 Favored 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 127.823 2.449 . . . . 100.0 112.069 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 55.58 45.48 24.77 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 127.921 2.488 . . . . 100.0 115.556 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.333 33.1 m -72.29 -7.5 9.64 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 120.069 -0.652 . . . . 100.0 111.109 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.46 -38.96 89.13 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.029 2.131 . . . . 100.0 109.932 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.96 130.64 34.05 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 N-CA-C 107.069 -1.456 . . . . 100.0 107.069 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.29 -41.19 98.3 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.323 1.972 . . . . 100.0 116.323 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.5 100.47 12.79 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -96.67 121.35 38.41 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 102.392 -3.188 . . . . 100.0 102.392 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.19 -36.02 11.09 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.744 -0.662 . . . . 100.0 112.363 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.73 105.23 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 101.707 -3.442 . . . . 100.0 101.707 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -101.87 177.71 4.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.951 1.093 . . . . 100.0 113.951 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.97 -35.51 73.31 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.082 2.153 . . . . 100.0 108.613 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.6 mttt -59.58 -37.05 77.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 128.395 2.678 . . . . 100.0 112.327 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.3 p -104.34 -3.13 24.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 120.061 3.356 . . . . 100.0 120.061 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.601 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 55.9 mt -95.75 94.34 4.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 116.394 -2.122 . . . . 100.0 112.317 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.29 -5.3 9.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -58.86 -36.73 75.08 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 115.418 1.636 . . . . 100.0 115.418 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.9 m-70 -59.87 -39.57 85.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.994 1.718 . . . . 100.0 114.371 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 47.1 ttp180 -58.95 -48.13 82.62 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 124.904 1.282 . . . . 100.0 112.442 -176.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.16 -41.3 99.23 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.039 1.336 . . . . 100.0 111.244 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -98.59 1.54 46.52 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 116.338 1.977 . . . . 100.0 116.338 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 54.9 45.82 25.71 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 125.079 1.351 . . . . 100.0 113.198 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.417 HD12 ' CE1' ' A' ' 105' ' ' HIS . 32.1 mt -106.38 150.05 26.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.863 -1.903 . . . . 100.0 105.863 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.315 89.2 mm-40 -100.97 143.9 30.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.588 -0.845 . . . . 100.0 112.518 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 69.5 t80 -102.03 132.94 47.58 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.591 0.96 . . . . 100.0 113.591 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.81 132.89 45.51 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -1.268 . . . . 100.0 111.038 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.278 38.0 m-20 -84.58 122.13 28.6 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 103.152 -2.907 . . . . 100.0 103.152 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.28 156.6 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 122.644 1.211 . . . . 100.0 110.999 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 74.5 m -138.6 110.63 7.27 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 105.698 -1.964 . . . . 100.0 105.698 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.554 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.76 -44.06 97.17 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.651 -1.613 . . . . 100.0 112.909 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.87 -41.46 99.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.955 0.902 . . . . 100.0 112.425 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.509 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 87.5 p -96.82 3.42 52.25 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 117.75 2.5 . . . . 100.0 117.75 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.617 HD21 ' HG3' ' A' ' 185' ' ' PRO . 71.6 m-80 65.45 21.17 11.83 Favored 'General case' 0 C--N 1.364 1.239 0 C-N-CA 124.451 1.101 . . . . 100.0 110.806 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.4 t80 -75.26 124.87 27.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.02 -0.733 . . . . 100.0 109.02 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.84 40.21 30.31 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 128.355 2.662 . . . . 100.0 115.364 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.43 ' HB2' HH21 ' A' ' 29' ' ' ARG . 78.9 t80 -62.65 -43.23 99.32 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.863 -0.523 . . . . 100.0 110.735 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -62.97 -39.19 93.94 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 115.996 1.85 . . . . 100.0 115.996 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.94 -47.45 98.86 Favored Pre-proline 0 C--N 1.356 0.862 0 N-CA-C 119.839 3.274 . . . . 100.0 119.839 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.94 -42.16 39.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 123.31 2.218 . . . . 100.0 111.222 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -64.05 -42.4 97.04 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 125.353 1.461 . . . . 100.0 111.614 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.19 -47.02 88.07 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 123.462 0.705 . . . . 100.0 111.722 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.25 -44.39 95.3 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 124.011 0.819 . . . . 100.0 110.46 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.69 -45.42 94.08 Favored 'General case' 0 CA--C 1.495 -1.171 0 O-C-N 123.752 0.657 . . . . 100.0 111.252 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.47 98.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 124.115 0.966 . . . . 100.0 111.555 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.05 -46.05 90.83 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 123.672 0.789 . . . . 100.0 111.402 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -65.52 -44.28 87.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 113.498 0.925 . . . . 100.0 113.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.63 -46.86 83.76 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.427 0.691 . . . . 100.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 87.8 mt -70.4 -38.74 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 123.309 0.644 . . . . 100.0 110.688 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.28 9.53 57.92 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-O 118.899 -0.945 . . . . 100.0 111.139 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -111.03 112.9 55.19 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.692 -1.225 . . . . 100.0 107.692 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.14 -14.93 28.94 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.72 2.946 . . . . 100.0 113.968 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.51 5.18 51.77 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.908 0.707 . . . . 100.0 112.908 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -65.75 131.8 47.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.362 0.665 . . . . 100.0 109.299 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -135.21 152.62 51.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.299 -0.63 . . . . 100.0 109.299 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -88.11 115.07 25.34 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 104.843 -2.281 . . . . 100.0 104.843 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.34 -45.04 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.071 0.948 . . . . 100.0 110.299 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.14 151.4 49.27 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.274 0.559 . . . . 100.0 109.734 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 64.2 ttp -96.63 127.42 39.67 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.322 -2.103 . . . . 100.0 105.322 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 179' ' ' MET . 34.9 Cg_exo -66.14 159.05 51.49 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.127 2.551 . . . . 100.0 111.571 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.56 126.37 27.67 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.02 0.914 . . . . 100.0 108.562 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.78 145.91 47.06 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.163 -1.38 . . . . 100.0 108.979 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.74 138.42 97.38 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.657 -1.238 . . . . 100.0 107.657 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 51.7 Cg_exo -56.97 140.4 92.26 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.36 2.707 . . . . 100.0 112.377 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 154' ' ' ASN . 39.3 Cg_exo -58.5 131.31 41.88 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.413 2.742 . . . . 100.0 114.079 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.94 -44.66 80.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.599 1.187 . . . . 100.0 107.961 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.19 158.4 43.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.458 -1.682 . . . . 100.0 106.458 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.6 130.72 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 105.919 -1.882 . . . . 100.0 105.919 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.509 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.1 ttt -87.36 127.4 35.2 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.382 -2.081 . . . . 100.0 105.382 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 55.4 m-20 -62.91 130.56 94.09 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 115.16 -0.927 . . . . 100.0 111.005 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 54.0 Cg_exo -58.68 -36.74 96.75 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.874 3.049 . . . . 100.0 112.579 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.36 96.35 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.42 1.075 . . . . 100.0 110.447 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.66 -42.78 98.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 123.115 0.566 . . . . 100.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.14 97.67 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 123.512 0.725 . . . . 100.0 110.634 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.5 98.61 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.87 0.868 . . . . 100.0 110.654 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -61.94 -45.83 91.96 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.3 1.04 . . . . 100.0 111.986 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -64.0 -44.63 92.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 112.209 0.448 . . . . 100.0 112.209 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.41 -39.91 94.76 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.353 0.408 . . . . 100.0 111.053 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.69 -43.77 97.96 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.883 1.273 . . . . 100.0 110.829 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.08 -42.53 99.3 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.158 0.983 . . . . 100.0 110.106 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.511 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.4 tp -59.8 -49.43 77.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 124.317 1.01 . . . . 100.0 109.861 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.48 -41.51 96.44 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 115.805 1.78 . . . . 100.0 115.805 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.41 -47.06 91.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 CA-C-O 118.305 -0.855 . . . . 100.0 109.423 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.65 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.409 . . -93.97 0.76 56.22 Favored 'General case' 0 N--CA 1.405 -2.71 1 C-N-CA 109.659 -4.816 . . . . 100.0 114.495 179.694 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 213' ' ' ASP 0.29 61.2 mt-30 -57.27 -35.86 70.28 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 106.94 -1.504 . . . . 100.0 106.94 178.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.8 p -82.82 53.88 2.53 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.487 1.137 . . . . 100.0 108.551 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.304 80.4 p 48.66 38.91 12.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 129.507 3.123 . . . . 100.0 115.741 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -83.31 -177.43 6.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.638 -2.356 . . . . 100.0 104.638 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 79.8 mt -56.39 -41.58 91.86 Favored Pre-proline 0 CA--C 1.502 -0.884 0 CA-C-O 116.105 -1.902 . . . . 100.0 114.882 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.307 41.8 Cg_exo -54.52 136.18 69.11 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.112 1.433 . . . . 100.0 112.389 177.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.63 -47.38 81.57 Favored 'General case' 0 N--CA 1.428 -1.572 1 N-CA-C 124.109 4.855 . . . . 100.0 124.109 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 136' ' ' ILE 0.256 99.5 mt-10 -63.17 -35.17 79.41 Favored 'General case' 0 CA--C 1.477 -1.86 1 CA-C-O 128.562 4.03 . . . . 100.0 108.064 177.753 . . . . . . . . 4 3 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.65 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.484 44.7 m-20 -66.57 -48.9 68.13 Favored 'General case' 1 N--CA 1.35 -5.473 1 CA-C-N 107.629 -4.351 . . . . 100.0 105.939 -178.624 . . . . . . . . 5 3 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.74 -25.43 67.93 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.574 -1.329 . . . . 100.0 108.524 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.583 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.84 -42.8 90.18 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-O 117.238 -1.363 . . . . 100.0 112.571 175.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.425 -1.71 0 CA-C-O 114.335 -2.745 . . . . 100.0 112.039 -176.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 105.532 -2.025 . . . . 100.0 105.532 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -121.29 134.77 55.16 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.238 -1.801 . . . . 100.0 108.155 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.15 143.11 49.28 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.598 -1.26 . . . . 100.0 107.598 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.64 120.81 35.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.793 -1.558 . . . . 100.0 106.793 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -109.21 127.65 54.41 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.913 -1.949 . . . . 100.0 107.107 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.8 t -103.02 120.78 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.714 -1.585 . . . . 100.0 106.892 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 48.5 tp -110.69 115.38 29.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.53 161.85 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 CA-C-N 115.741 -0.663 . . . . 100.0 111.992 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.14 176.61 30.38 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 108.341 -1.903 . . . . 100.0 108.341 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -72.67 157.27 37.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.621 0.724 . . . . 100.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.45 141.72 39.42 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 107.109 -2.396 . . . . 100.0 107.109 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.06 -5.62 81.66 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.079 -0.845 . . . . 100.0 113.62 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -63.04 -39.28 94.28 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 118.481 1.141 . . . . 100.0 111.204 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.49 23.9 5.53 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 111.076 -0.81 . . . . 100.0 111.076 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HD2' ' HG ' ' A' ' 15' ' ' LEU . 29.3 mtmt -61.71 -43.24 99.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.843 0.857 . . . . 100.0 111.902 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -62.16 -44.19 97.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.681 1.193 . . . . 100.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.2 m -63.08 -41.1 99.34 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.565 1.146 . . . . 100.0 108.826 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CD1' ' HE2' ' A' ' 89' ' ' MET . 50.0 t80 -59.75 -49.09 79.07 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.376 0.67 . . . . 100.0 112.676 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -41.95 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 123.869 0.731 . . . . 100.0 110.561 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.49 -8.43 40.93 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 115.757 1.762 . . . . 100.0 115.757 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.582 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.8 mtm-85 -61.36 -37.34 82.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.535 -0.542 . . . . 100.0 109.535 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' HIS . . . . . 0.694 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 53.8 t-80 -80.23 112.35 17.46 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.49 -43.85 97.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 115.222 1.564 . . . . 100.0 115.222 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 85.2 m -63.02 -41.96 99.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.621 0.768 . . . . 100.0 108.934 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.694 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.66 -42.43 99.75 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 123.855 0.741 . . . . 100.0 111.361 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.82 -43.75 95.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.023 0.529 . . . . 100.0 110.676 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.05 -40.04 95.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.31 1.044 . . . . 100.0 112.349 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -90.42 7.02 40.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 114.422 1.267 . . . . 100.0 114.422 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -58.81 140.23 55.35 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 115.215 1.561 . . . . 100.0 115.215 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.88 130.46 52.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -103.81 123.6 47.38 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.256 -2.127 . . . . 100.0 105.256 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.11 113.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 102.736 -3.061 . . . . 100.0 102.736 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.2 94.01 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.0 p -62.59 -47.41 83.91 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 122.679 0.392 . . . . 100.0 111.723 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.06 -38.22 75.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.718 1.207 . . . . 100.0 112.987 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 35.78 52.42 Favored Glycine 0 C--N 1.359 1.844 0 N-CA-C 106.625 -2.59 . . . . 100.0 106.625 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.45 141.45 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.766 1.227 . . . . 100.0 108.622 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -106.56 117.36 33.85 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 102.571 -3.122 . . . . 100.0 102.571 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.74 122.25 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 107.039 -1.467 . . . . 100.0 107.039 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -116.63 120.69 34.09 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.265 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -79.97 105.62 1.82 Allowed 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.298 1.999 . . . . 100.0 109.415 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.08 116.75 29.85 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.636 -1.616 . . . . 100.0 106.636 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.65 126.82 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.858 -1.164 . . . . 100.0 107.858 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.41 132.45 53.96 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -99.9 120.03 39.14 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.212 -1.033 . . . . 100.0 108.212 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.413 ' HG1' HD12 ' A' ' 174' ' ' LEU . 23.3 p -109.44 -179.77 3.92 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.817 -1.083 . . . . 100.0 110.754 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.81 -44.11 94.16 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 125.576 1.55 . . . . 100.0 107.837 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -67.32 -39.19 85.83 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.901 1.28 . . . . 100.0 112.846 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.83 -172.54 28.13 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.068 -2.013 . . . . 100.0 108.068 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.27 137.28 50.95 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.628 2.219 . . . . 100.0 114.552 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.34 130.42 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.325 -3.213 . . . . 100.0 102.325 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -110.94 129.65 55.82 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.412 -0.588 . . . . 100.0 109.412 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -111.31 115.27 29.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.174 -2.528 . . . . 100.0 104.174 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -86.82 106.38 17.68 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.653 -3.832 . . . . 100.0 100.653 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 122.4 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -98.04 114.78 27.03 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.116 -1.809 . . . . 100.0 106.116 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -112.63 135.68 53.08 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.531 -1.655 . . . . 100.0 106.531 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -72.25 162.66 29.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.199 0.814 . . . . 100.0 113.199 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.43 14.76 21.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.316 -0.857 . . . . 100.0 110.033 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.21 12.36 42.55 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 121.78 -0.575 . . . . 100.0 112.037 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.46 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 67.8 mt-30 -60.16 -34.43 73.57 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.557 1.943 . . . . 100.0 111.625 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.9 -35.39 70.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 127.624 2.37 . . . . 100.0 112.406 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.08 -40.9 97.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.474 0.71 . . . . 100.0 110.97 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 p90 -92.05 -14.0 30.01 Favored 'General case' 0 C--N 1.362 1.111 0 N-CA-C 114.908 1.447 . . . . 100.0 114.908 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.93 -163.9 33.04 Favored Glycine 0 C--N 1.357 1.745 0 C-N-CA 119.464 -1.35 . . . . 100.0 113.432 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.51 172.57 54.64 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 110.507 -1.037 . . . . 100.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.25 142.32 34.75 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.836 0.827 . . . . 100.0 110.186 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -68.1 155.6 39.24 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.192 -1.367 . . . . 100.0 113.323 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.56 -38.35 84.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 125.421 1.488 . . . . 100.0 110.415 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.91 -39.25 93.78 Favored Glycine 0 C--N 1.36 1.868 0 C-N-CA 124.673 1.13 . . . . 100.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.24 -46.65 87.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.605 0.762 . . . . 100.0 110.84 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -68.94 -37.02 78.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 115.86 1.8 . . . . 100.0 115.86 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.9 mt -52.15 137.09 11.79 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 125.396 1.478 . . . . 100.0 113.89 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 64.27 26.26 13.68 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 127.999 2.52 . . . . 100.0 113.753 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.76 36.76 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.993 -1.484 . . . . 100.0 106.993 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . 0.402 ' O ' HG21 ' A' ' 115' ' ' ILE . 96.1 mm-40 -97.25 -37.54 10.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.558 -1.275 . . . . 100.0 107.558 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' CYS . . . . . 0.428 ' HB3' HD12 ' A' ' 168' ' ' LEU . 22.8 p -142.54 160.14 40.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 122.701 0.4 . . . . 100.0 110.988 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.61 149.13 33.97 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 114.202 1.186 . . . . 100.0 114.202 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.5 mt -126.1 126.72 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.379 -2.823 . . . . 100.0 103.379 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.4 ' HB ' ' CD2' ' A' ' 119' ' ' LEU . 51.5 mt -111.78 124.17 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.947 -2.983 . . . . 100.0 102.947 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.554 ' HE2' ' CD1' ' A' ' 26' ' ' PHE . 42.8 mtt -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.183 -1.371 . . . . 100.0 114.603 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -127.74 158.35 37.87 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.763 -2.471 . . . . 100.0 108.088 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.93 126.56 51.14 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.879 -1.897 . . . . 100.0 105.879 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.54 -21.94 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.332 0.864 . . . . 100.0 113.332 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.8 p -86.99 -8.71 56.93 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 119.266 -0.397 . . . . 100.0 111.167 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.38 115.34 23.32 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.34 1.067 . . . . 100.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -66.84 -38.23 86.01 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 114.895 -1.048 . . . . 100.0 111.383 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.79 -41.0 86.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 125.787 1.635 . . . . 100.0 110.216 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.3 m -62.44 -42.59 99.57 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 118.147 0.43 . . . . 100.0 109.968 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . 0.525 ' CE1' HG21 ' A' ' 136' ' ' ILE . 35.8 t80 -63.12 -41.55 99.36 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.567 0.747 . . . . 100.0 110.801 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.1 mttt -61.25 -37.44 83.11 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 100.0 111.155 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.96 -8.44 57.38 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 115.003 1.483 . . . . 100.0 115.003 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.66 -42.97 94.43 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 116.013 -1.946 . . . . 100.0 111.49 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.1 Cg_exo -57.56 -37.23 97.76 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.074 1.849 . . . . 100.0 112.692 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -63.11 -46.33 87.82 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.366 1.067 . . . . 100.0 110.85 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -64.02 -41.82 97.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 123.25 0.62 . . . . 100.0 111.213 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -61.82 -44.92 95.88 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 124.239 1.016 . . . . 100.0 109.66 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.88 -43.74 97.98 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 118.805 -0.617 . . . . 100.0 112.462 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.15 -45.33 93.92 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 121.251 0.548 . . . . 100.0 110.626 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.81 -46.46 87.87 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.986 1.314 . . . . 100.0 112.647 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.19 -38.5 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 C-N-CA 125.237 1.415 . . . . 100.0 111.218 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -60.44 -46.38 90.27 Favored 'General case' 0 C--N 1.358 0.973 0 CA-C-O 118.833 -0.603 . . . . 100.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.75 -46.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 120.238 -0.585 . . . . 100.0 111.502 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.31 115.63 19.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -93.0 147.22 23.01 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.89 -0.596 . . . . 100.0 112.41 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 54.37 45.66 26.7 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.394 1.877 . . . . 100.0 114.871 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 84' ' ' GLN . 34.0 mm -99.35 131.45 25.04 Favored Pre-proline 0 N--CA 1.436 -1.139 0 C-N-CA 126.125 1.77 . . . . 100.0 106.802 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.89 130.02 27.94 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.601 2.2 . . . . 100.0 109.008 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.6 mt -130.47 137.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 122.369 1.081 . . . . 100.0 108.508 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -114.79 130.75 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.265 -2.124 . . . . 100.0 105.265 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.43 HD13 ' ND1' ' A' ' 139' ' ' HIS . 34.3 mt -104.97 125.24 50.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.079 -2.563 . . . . 100.0 104.079 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' CYS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.0 m -115.32 128.26 55.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.853 -1.521 . . . . 100.0 112.301 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.26 103.98 2.88 Favored Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.293 -3.123 . . . . 100.0 105.293 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -80.71 166.5 20.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 125.798 1.639 . . . . 100.0 111.725 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 56.58 44.66 23.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 128.29 2.636 . . . . 100.0 115.416 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.29 28.5 m -71.81 -9.33 12.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 120.416 -0.514 . . . . 100.0 110.724 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.91 -38.85 87.16 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 127.186 2.194 . . . . 100.0 110.279 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.55 129.88 34.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 107.414 -1.328 . . . . 100.0 107.414 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.98 -40.07 96.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 116.54 2.052 . . . . 100.0 116.54 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -85.63 98.69 10.81 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 104.426 -2.435 . . . . 100.0 104.426 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -100.72 109.36 21.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 105.384 -2.08 . . . . 100.0 105.384 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.18 -43.49 61.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.79 1.404 . . . . 100.0 114.79 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.49 108.54 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 104.73 -2.322 . . . . 100.0 104.73 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.01 179.73 4.19 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.189 -0.914 . . . . 100.0 113.422 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.51 -35.16 71.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.154 2.182 . . . . 100.0 109.318 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -59.45 -37.1 77.26 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 128.717 2.807 . . . . 100.0 112.017 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.3 p -105.01 -0.49 26.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 120.624 3.565 . . . . 100.0 120.624 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . 0.597 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 54.3 mt -99.46 96.01 4.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 115.372 -2.531 . . . . 100.0 111.346 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.06 -6.77 9.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 115.553 1.686 . . . . 100.0 115.553 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -58.79 -35.87 73.52 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.43 ' ND1' HD13 ' A' ' 119' ' ' LEU . 77.7 m-70 -59.63 -39.55 84.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.588 1.555 . . . . 100.0 112.578 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 42.3 ttp180 -59.29 -47.08 86.71 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.108 1.363 . . . . 100.0 112.382 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.04 -43.62 98.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.806 1.242 . . . . 100.0 111.469 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 116.213 1.931 . . . . 100.0 116.213 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 54.6 47.42 22.67 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.296 1.438 . . . . 100.0 113.126 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LEU . . . . . 0.402 HD21 ' HB ' ' A' ' 117' ' ' ILE . 30.4 mt -107.22 149.63 27.52 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.245 -1.761 . . . . 100.0 106.245 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -96.38 144.47 26.49 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 120.709 -0.397 . . . . 100.0 111.868 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.407 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 77.5 t80 -106.45 133.59 50.9 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 123.766 0.666 . . . . 100.0 112.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -130.01 132.41 46.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.184 -1.371 . . . . 100.0 110.416 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.314 35.2 m-20 -85.15 122.73 29.77 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 102.054 -3.313 . . . . 100.0 102.054 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 pt -135.88 157.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.574 1.178 . . . . 100.0 112.037 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 61.9 m -137.34 112.87 9.39 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.26 -43.88 96.71 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.735 -1.575 . . . . 100.0 112.772 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.83 -41.09 99.19 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.352 1.061 . . . . 100.0 112.098 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' SER . . . . . 0.627 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 96.1 p -97.48 2.37 50.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 117.563 2.431 . . . . 100.0 117.563 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 66.67 20.03 10.75 Favored 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.638 1.175 . . . . 100.0 110.846 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.46 -0.571 . . . . 100.0 109.46 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.11 39.79 30.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 128.709 2.804 . . . . 100.0 115.725 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . 0.491 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 76.8 t80 -61.82 -44.89 95.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 121.618 -0.676 . . . . 100.0 112.146 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.14 -37.27 86.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 116.87 2.174 . . . . 100.0 116.87 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.74 -46.82 99.71 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 119.166 3.024 . . . . 100.0 119.166 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -60.7 -42.2 40.92 Favored 'Trans proline' 0 C--N 1.372 1.813 0 CA-C-N 123.204 2.18 . . . . 100.0 111.544 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -64.24 -42.48 96.51 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 124.839 1.256 . . . . 100.0 111.76 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.81 -45.38 92.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 123.775 0.83 . . . . 100.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.18 -43.34 95.42 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 123.549 0.531 . . . . 100.0 110.424 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.6 -44.07 97.69 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 123.509 0.505 . . . . 100.0 111.508 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.04 97.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.126 0.97 . . . . 100.0 111.062 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -62.43 -45.67 92.03 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 123.242 0.617 . . . . 100.0 112.075 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -65.71 -44.73 85.21 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.76 0.663 . . . . 100.0 111.764 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 85' ' ' CYS . 85.0 mt -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 124.073 0.949 . . . . 100.0 113.141 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.16 -38.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.436 -0.579 . . . . 100.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.72 10.53 58.9 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 110.138 -1.185 . . . . 100.0 110.138 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.71 111.74 56.66 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 107.812 -1.181 . . . . 100.0 107.812 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.82 -15.85 29.75 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.776 2.984 . . . . 100.0 113.734 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -87.59 0.32 55.8 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.025 0.93 . . . . 100.0 113.133 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.413 HD12 ' HG1' ' A' ' 54' ' ' THR . 18.3 tp -64.78 132.03 48.43 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.178 0.591 . . . . 100.0 109.892 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -135.29 152.08 51.16 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 108.679 -0.859 . . . . 100.0 108.679 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -89.11 111.83 22.67 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 104.782 -2.303 . . . . 100.0 104.782 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.08 -43.91 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.243 1.017 . . . . 100.0 110.824 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.51 149.14 49.54 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 121.583 0.706 . . . . 100.0 110.559 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 59.5 ttm -91.39 125.45 57.99 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.433 -2.062 . . . . 100.0 105.433 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.28 157.4 60.23 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 123.039 2.493 . . . . 100.0 111.156 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.35 126.19 27.43 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.1 -1.074 . . . . 100.0 108.1 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.71 145.19 47.74 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 114.36 -1.291 . . . . 100.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.98 138.75 97.49 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.699 -1.223 . . . . 100.0 107.699 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -55.72 138.54 81.59 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.642 2.894 . . . . 100.0 112.3 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.36 129.59 30.42 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.753 2.302 . . . . 100.0 113.726 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -67.08 -43.67 82.03 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 124.774 1.296 . . . . 100.0 108.754 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.77 160.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.322 -1.733 . . . . 100.0 106.322 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.69 130.72 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 107.755 -1.202 . . . . 100.0 107.755 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' MET . . . . . 0.627 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 18.1 tpt -80.88 122.72 27.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.789 -2.3 . . . . 100.0 104.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.9 128.2 93.66 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.13 -0.941 . . . . 100.0 109.411 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.03 -39.06 83.98 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.54 2.827 . . . . 100.0 113.6 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.98 92.91 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 124.337 1.023 . . . . 100.0 110.832 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.8 -42.75 97.65 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 122.65 0.38 . . . . 100.0 111.653 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.16 97.4 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 123.546 0.738 . . . . 100.0 110.612 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.77 97.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.031 0.932 . . . . 100.0 110.672 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -63.76 -43.08 97.49 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.186 0.594 . . . . 100.0 112.077 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -63.03 -44.16 96.68 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 122.733 0.413 . . . . 100.0 111.273 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.89 -40.64 96.99 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 122.957 0.503 . . . . 100.0 110.477 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.55 -43.93 97.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.75 1.22 . . . . 100.0 110.78 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.06 -42.5 99.26 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.898 0.879 . . . . 100.0 110.169 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' LEU . . . . . 0.508 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.6 tp -59.9 -49.04 79.24 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.156 0.91 . . . . 100.0 110.033 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -43.44 98.12 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 115.203 1.557 . . . . 100.0 115.203 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.33 -46.74 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 CA-C-O 118.388 -0.815 . . . . 100.0 109.673 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ALA . . . . . 0.652 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.407 . . -94.61 0.54 55.24 Favored 'General case' 0 N--CA 1.404 -2.752 1 C-N-CA 109.655 -4.818 . . . . 100.0 114.332 179.711 . . . . . . . . 4 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 201' ' ' LEU 0.301 62.4 mt-30 -56.51 -37.01 69.84 Favored 'General case' 0 CA--C 1.465 -2.32 0 N-CA-C 106.354 -1.721 . . . . 100.0 106.354 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.9 p -82.03 52.82 2.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.247 1.022 . . . . 100.0 109.303 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.324 80.5 p 48.83 38.81 12.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.522 3.129 . . . . 100.0 116.111 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -83.12 -177.16 6.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.417 -2.438 . . . . 100.0 104.417 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LEU . . . . . 0.416 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 85.7 mt -56.46 -41.54 91.67 Favored Pre-proline 0 CA--C 1.502 -0.902 0 CA-C-O 116.014 -1.946 . . . . 100.0 114.545 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PRO . . . . . 0.713 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.309 23.3 Cg_exo -55.35 136.67 74.67 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 121.354 1.519 . . . . 100.0 112.382 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.71 -47.57 80.61 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 124.493 4.997 . . . . 100.0 124.493 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.597 ' CG ' ' HB ' ' A' ' 136' ' ' ILE . 99.4 mt-10 -62.88 -35.64 80.69 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 128.285 3.898 . . . . 100.0 107.918 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . 0.652 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.483 44.9 m-20 -65.49 -48.73 71.58 Favored 'General case' 1 N--CA 1.35 -5.426 1 CA-C-N 107.563 -4.381 . . . . 100.0 106.493 -179.017 . . . . . . . . 5 3 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.32 -29.85 71.09 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 120.448 -1.407 . . . . 100.0 108.168 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.35 -42.99 88.13 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-O 117.297 -1.335 . . . . 100.0 113.41 176.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.26 1.645 0 CA-C-O 115.478 -2.201 . . . . 100.0 113.968 -176.288 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.118 0 N-CA-C 113.416 0.895 . . . . 100.0 113.416 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.36 84.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.34 156.15 18.44 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.407 0.892 . . . . 100.0 113.407 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -80.22 160.53 25.57 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 123.843 0.857 . . . . 100.0 110.986 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.48 7.74 87.14 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.068 -0.515 . . . . 100.0 113.719 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -81.94 156.65 69.7 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 117.858 0.829 . . . . 100.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.71 155.23 64.59 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.422 2.748 . . . . 100.0 111.043 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.95 132.58 37.65 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.385 2.735 . . . . 100.0 118.385 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.3 t -92.29 116.07 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.094 -1.866 . . . . 100.0 106.472 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.74 138.89 53.44 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.904 -1.953 . . . . 100.0 108.102 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.66 146.06 50.33 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.753 -0.832 . . . . 100.0 108.753 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -94.67 120.54 35.06 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 104.731 -2.322 . . . . 100.0 104.731 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.3 tp -112.12 126.25 54.99 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.964 -1.926 . . . . 100.0 106.551 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.407 HG11 ' CE2' ' A' ' 79' ' ' TYR . 43.0 t -101.82 123.19 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.097 -1.446 . . . . 100.0 107.097 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD12 ' SD ' ' A' ' 89' ' ' MET . 36.5 tp -110.89 116.51 31.36 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.094 -2.558 . . . . 100.0 104.094 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -128.8 163.4 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 120.765 0.317 . . . . 100.0 111.797 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.54 173.47 22.76 Favored Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 107.848 -2.101 . . . . 100.0 107.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -68.12 154.91 40.71 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.964 0.888 . . . . 100.0 112.574 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.85 140.0 41.64 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.606 -2.198 . . . . 100.0 107.606 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 -4.34 82.11 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.469 -1.184 . . . . 100.0 113.868 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.597 ' HB ' HD22 ' A' ' 122' ' ' ASN . 19.6 p -62.87 -39.01 93.13 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 119.055 1.428 . . . . 100.0 111.372 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 22.82 4.53 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 110.322 -1.111 . . . . 100.0 110.322 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 50.0 mtpt -59.52 -46.56 88.48 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 124.554 1.142 . . . . 100.0 112.889 -179.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -63.23 -44.29 95.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.411 1.084 . . . . 100.0 110.087 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -62.47 -42.01 99.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.294 1.037 . . . . 100.0 109.178 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -60.75 -48.73 80.47 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.06 0.944 . . . . 100.0 113.285 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.9 -40.89 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.064 0.459 . . . . 100.0 110.523 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.27 99.6 mttt -69.35 -6.85 32.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.174 1.916 . . . . 100.0 116.174 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.557 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 49.1 mtt180 -60.7 -37.89 83.17 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.03 -1.1 . . . . 100.0 108.03 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.709 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 54.0 t-80 -80.87 112.92 18.7 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.48 -43.59 98.44 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.854 1.798 . . . . 100.0 115.854 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.434 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 78.8 m -63.75 -40.95 97.96 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.904 -0.776 . . . . 100.0 108.904 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.709 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -60.96 -41.78 99.5 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.388 -1.085 . . . . 100.0 110.388 179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.274 81.0 mt-10 -63.77 -45.15 91.09 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 117.38 0.59 . . . . 100.0 111.649 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.81 -40.32 97.02 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.256 1.022 . . . . 100.0 111.857 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -93.23 8.91 38.34 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 114.841 1.422 . . . . 100.0 114.841 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -60.87 142.57 56.12 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 113.743 1.016 . . . . 100.0 113.743 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -124.01 131.05 53.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.994 -1.003 . . . . 100.0 108.378 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -101.05 123.64 45.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.541 -2.022 . . . . 100.0 105.541 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.64 112.19 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 102.809 -3.034 . . . . 100.0 102.809 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.86 94.98 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 116.471 2.026 . . . . 100.0 116.471 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -61.9 -48.44 80.47 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 122.895 0.478 . . . . 100.0 110.578 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.64 -38.62 70.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.67 1.359 . . . . 100.0 114.67 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.77 44.04 21.26 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 106.312 -2.715 . . . . 100.0 106.312 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 94.5 t -129.86 144.61 37.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.726 1.21 . . . . 100.0 109.271 -178.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -106.1 118.96 37.97 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.077 -3.305 . . . . 100.0 102.077 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.46 120.88 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.267 -1.753 . . . . 100.0 106.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -113.16 119.5 42.23 Favored Pre-proline 0 N--CA 1.434 -1.234 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.55 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -80.32 104.25 1.61 Allowed 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.654 2.236 . . . . 100.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.4 113.97 26.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.31 -0.996 . . . . 100.0 108.31 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.85 127.19 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.272 -1.381 . . . . 100.0 107.272 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.56 135.09 55.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.461 -2.052 . . . . 100.0 105.461 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -102.52 117.6 35.05 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.32 -0.622 . . . . 100.0 109.32 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.413 ' HG1' ' H ' ' A' ' 56' ' ' ARG . 17.5 p -107.09 175.92 5.34 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.816 0.817 . . . . 100.0 110.288 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.26 -35.0 74.52 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.314 1.445 . . . . 100.0 109.502 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.413 ' H ' ' HG1' ' A' ' 54' ' ' THR . 96.9 mtt180 -87.59 -2.33 58.54 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 113.499 0.926 . . . . 100.0 113.499 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.6 -179.72 16.2 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.593 -1.003 . . . . 100.0 110.593 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.74 140.13 54.94 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.869 2.379 . . . . 100.0 115.833 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.13 130.06 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 102.304 -3.221 . . . . 100.0 102.304 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.45 128.35 56.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -110.19 116.31 31.28 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -87.67 106.8 18.28 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.812 -4.144 . . . . 100.0 99.812 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 22.6 t -93.36 123.76 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.396 0 N-CA-C 106.412 -1.699 . . . . 100.0 106.412 -176.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -97.8 114.5 26.55 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 105.838 -1.912 . . . . 100.0 105.838 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -109.33 135.2 50.78 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.5 p -72.28 163.45 27.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.874 0.845 . . . . 100.0 112.559 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.14 20.55 12.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.206 -0.906 . . . . 100.0 108.586 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.85 12.21 58.16 Favored Glycine 0 C--N 1.359 1.847 0 CA-C-O 119.341 -0.699 . . . . 100.0 114.128 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.443 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 90.7 mt-30 -60.29 -31.37 70.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.259 1.824 . . . . 100.0 112.591 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -57.54 -32.38 67.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.924 2.49 . . . . 100.0 111.813 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.88 -39.62 95.03 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 123.527 0.731 . . . . 100.0 111.565 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.443 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 22.9 p90 -94.87 -14.14 24.83 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.774 1.398 . . . . 100.0 114.774 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.58 -160.36 26.96 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 119.933 -1.127 . . . . 100.0 112.422 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.02 176.95 54.54 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 109.874 -1.29 . . . . 100.0 109.874 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 86.9 mt -105.31 143.5 33.4 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.49 -0.929 . . . . 100.0 108.49 -179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -70.5 160.11 33.04 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.02 -0.991 . . . . 100.0 113.175 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -59.48 -37.99 79.66 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 125.443 1.497 . . . . 100.0 110.237 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.37 91.8 Favored Glycine 0 C--N 1.358 1.797 0 C-N-CA 124.77 1.176 . . . . 100.0 111.29 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.407 ' CE2' HG11 ' A' ' 14' ' ' VAL . 76.0 t80 -62.98 -47.0 85.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.33 0.565 . . . . 100.0 111.218 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -70.51 -36.73 73.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 116.976 2.213 . . . . 100.0 116.976 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.5 mt -50.86 134.64 11.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-O 123.189 1.471 . . . . 100.0 114.796 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 61.19 29.26 18.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 128.023 2.529 . . . . 100.0 113.877 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.478 ' HB1' ' HG ' ' A' ' 112' ' ' CYS . . . -74.11 133.12 42.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 176.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -96.39 -26.26 15.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 110.103 -0.332 . . . . 100.0 110.103 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 18.7 p -153.22 162.61 41.11 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.852 0.358 . . . . 100.0 110.839 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.6 152.84 38.6 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 114.413 1.264 . . . . 100.0 114.413 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.6 mt -126.17 125.89 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 103.41 -2.811 . . . . 100.0 103.41 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.436 ' HB ' ' CD2' ' A' ' 119' ' ' LEU . 48.6 mt -109.74 125.31 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 102.87 -3.011 . . . . 100.0 102.87 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.471 ' SD ' HD12 ' A' ' 15' ' ' LEU . 89.3 mtp -110.46 135.91 50.41 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.923 1.083 . . . . 100.0 113.923 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.76 162.43 28.45 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 112.686 -2.052 . . . . 100.0 107.14 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.53 124.37 49.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.962 -1.496 . . . . 100.0 106.962 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.18 -18.86 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 114.211 1.189 . . . . 100.0 114.211 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.5 p -89.44 -7.5 54.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 118.378 0.535 . . . . 100.0 111.18 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 m -124.98 116.78 22.71 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.596 1.189 . . . . 100.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -63.32 -38.51 91.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.459 1.503 . . . . 100.0 111.872 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.59 -40.88 83.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 125.872 1.669 . . . . 100.0 110.72 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.2 p -62.19 -41.53 98.43 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 118.192 0.451 . . . . 100.0 111.77 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -65.02 -40.95 95.61 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.559 0.743 . . . . 100.0 110.251 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.447 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.1 mttt -61.38 -36.45 80.29 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.531 1.132 . . . . 100.0 111.142 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.18 -3.85 53.53 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 115.272 1.582 . . . . 100.0 115.272 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.2 t -60.55 -41.94 85.73 Favored Pre-proline 0 C--N 1.362 1.128 0 CA-C-O 116.572 -1.68 . . . . 100.0 111.182 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 63.0 Cg_exo -56.86 -38.3 96.17 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.292 1.995 . . . . 100.0 112.864 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.61 -45.25 91.19 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.59 1.156 . . . . 100.0 110.873 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -64.46 -41.36 96.57 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.122 0.264 . . . . 100.0 111.356 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.21 -44.32 96.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.619 0.767 . . . . 100.0 110.14 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -61.99 -45.26 94.42 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 119.015 -0.517 . . . . 100.0 112.179 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.53 -42.43 98.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 O-C-N 123.24 0.337 . . . . 100.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.6 tp -62.9 -48.16 80.17 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.783 0.833 . . . . 100.0 112.469 179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.279 22.9 m -67.2 -29.23 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -60.62 -47.28 86.93 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.778 -0.823 . . . . 100.0 108.778 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.85 -45.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 112.598 0.592 . . . . 100.0 112.598 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.478 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 76.7 m -124.61 107.79 11.39 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.985 0.898 . . . . 100.0 110.077 -178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.89 140.05 30.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.358 -0.837 . . . . 100.0 111.59 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.13 39.57 31.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.981 2.113 . . . . 100.0 116.701 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.1 144.99 29.24 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 106.635 -1.617 . . . . 100.0 106.635 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -62.59 132.08 36.39 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.21 2.606 . . . . 100.0 109.691 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.438 ' HB ' HD21 ' A' ' 144' ' ' LEU . 73.0 mt -134.18 137.57 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.198 0.999 . . . . 100.0 108.364 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.13 132.1 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 105.593 -2.002 . . . . 100.0 105.593 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.503 ' HB2' ' CE1' ' A' ' 139' ' ' HIS 0.294 23.2 mt -105.95 131.04 53.74 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 103.725 -2.694 . . . . 100.0 103.725 175.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.49 131.21 55.54 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.052 -1.431 . . . . 100.0 112.48 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.3 104.97 2.89 Favored Glycine 0 CA--C 1.486 -1.757 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.597 HD22 ' HB ' ' A' ' 21' ' ' THR . 24.6 p30 -86.73 173.21 9.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.185 1.179 . . . . 100.0 114.185 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 mttp 60.26 40.39 17.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.141 2.576 . . . . 100.0 113.725 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.339 28.5 m -71.76 -7.79 10.02 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 120.33 -0.548 . . . . 100.0 111.495 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.71 -38.21 89.55 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.464 1.906 . . . . 100.0 110.334 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -69.74 130.18 34.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 N-CA-C 108.514 -0.921 . . . . 100.0 108.514 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.14 -41.82 98.64 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 117.223 2.305 . . . . 100.0 117.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -85.49 94.57 9.04 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.146 -1.798 . . . . 100.0 106.146 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -92.66 123.96 36.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 104.921 -2.251 . . . . 100.0 104.921 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.69 -36.62 10.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 113.301 0.852 . . . . 100.0 113.301 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.93 104.07 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 103.752 -2.684 . . . . 100.0 103.752 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.25 172.77 7.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.905 -1.043 . . . . 100.0 111.513 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.08 -31.9 65.71 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.267 1.827 . . . . 100.0 109.401 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.847 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 96.5 mttt -57.11 -39.08 74.39 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 130.092 3.357 . . . . 100.0 111.391 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.2 p -105.06 2.27 29.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 117.047 2.24 . . . . 100.0 117.047 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.503 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 60.3 mt -89.43 84.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.361 1.088 0 C-N-CA 118.062 -1.455 . . . . 100.0 110.576 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.507 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 2.3 p -100.81 -6.09 9.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 65.8 t80 -59.37 -37.37 77.73 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 116.09 1.885 . . . . 100.0 116.09 -173.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.275 78.6 m-70 -59.5 -37.97 79.69 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 116.718 2.118 . . . . 100.0 116.718 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.708 ' CB ' ' HA ' ' A' ' 215' ' ' ASP . 43.6 ttp85 -59.01 -49.28 78.48 Favored 'General case' 0 CA--C 1.471 -2.092 0 O-C-N 124.178 0.924 . . . . 100.0 112.964 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.63 -41.19 98.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 125.456 1.723 . . . . 100.0 111.074 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.6 mmtt -95.04 0.32 54.4 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.206 2.298 . . . . 100.0 117.206 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 58.32 40.04 24.9 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.155 1.382 . . . . 100.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.438 HD21 ' HB ' ' A' ' 117' ' ' ILE . 24.6 mt -101.9 152.52 20.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.754 -1.943 . . . . 100.0 105.754 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.29 143.24 30.71 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.206 -0.665 . . . . 100.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.507 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 84.4 t80 -110.32 136.53 49.36 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.299 1.222 . . . . 100.0 114.299 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -134.42 137.61 44.15 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.432 -1.258 . . . . 100.0 111.18 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.276 72.6 m-20 -84.72 128.64 34.7 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 102.688 -3.078 . . . . 100.0 102.688 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.491 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.8 pt -134.22 157.84 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.702 1.239 . . . . 100.0 111.303 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.446 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 70.4 m -139.04 108.49 6.15 Favored 'General case' 0 CA--C 1.48 -1.714 0 N-CA-C 104.861 -2.274 . . . . 100.0 104.861 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.557 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.8 -44.18 97.38 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.712 -1.131 . . . . 100.0 112.529 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -61.47 -39.24 90.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 124.853 1.261 . . . . 100.0 112.734 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.567 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 92.3 p -100.31 2.09 42.23 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 115.868 1.803 . . . . 100.0 115.868 -178.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.436 ' HA ' HH11 ' A' ' 29' ' ' ARG . 68.0 m-80 65.19 20.68 12.0 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.94 1.296 . . . . 100.0 110.99 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.446 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 83.4 t80 -72.94 125.7 28.21 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.473 -0.936 . . . . 100.0 108.473 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 54.05 36.68 25.2 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 128.185 2.594 . . . . 100.0 114.584 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.531 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 64.3 t80 -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.359 0.99 0 O-C-N 121.881 -0.512 . . . . 100.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -63.67 -38.49 91.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.499 2.037 . . . . 100.0 116.499 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.12 -47.97 98.19 Favored Pre-proline 0 C--N 1.358 0.938 0 N-CA-C 120.097 3.369 . . . . 100.0 120.097 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.15 -41.08 45.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 CA-C-N 123.475 2.277 . . . . 100.0 112.592 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.21 -42.45 96.59 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.712 1.205 . . . . 100.0 110.814 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.23 -44.29 92.32 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 118.795 -0.621 . . . . 100.0 111.628 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -64.88 -42.26 94.96 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 123.499 0.499 . . . . 100.0 110.389 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 77.8 mt -61.54 -43.82 98.16 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.453 0.47 . . . . 100.0 110.594 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.52 -44.18 97.52 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.076 0.951 . . . . 100.0 110.656 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.58 -45.6 93.42 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 122.672 0.389 . . . . 100.0 111.783 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -66.17 -44.54 83.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.858 0.688 . . . . 100.0 112.858 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.26 -45.19 89.18 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 113.451 0.908 . . . . 100.0 113.451 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 50.9 mm -74.52 -30.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.902 0.881 . . . . 100.0 110.11 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.79 13.82 66.28 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 118.635 -1.091 . . . . 100.0 111.447 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -116.39 112.31 41.55 Favored Pre-proline 0 C--N 1.363 1.168 0 CA-C-N 118.439 1.119 . . . . 100.0 108.044 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.99 -14.1 31.98 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.749 2.966 . . . . 100.0 113.255 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -85.63 -3.18 58.81 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.125 0.97 . . . . 100.0 113.026 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.84 134.21 56.86 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 113.226 0.825 . . . . 100.0 113.226 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.14 149.29 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.525 -1.216 . . . . 100.0 108.235 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -90.03 114.62 26.53 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 103.525 -2.769 . . . . 100.0 103.525 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.24 -40.04 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.53 146.8 52.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.8 mtt -88.27 129.61 48.99 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.336 -1.727 . . . . 100.0 106.336 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.27 158.48 52.14 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.276 1.984 . . . . 100.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.43 124.88 23.98 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.722 -1.214 . . . . 100.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.54 145.85 45.02 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 114.263 -1.335 . . . . 100.0 110.403 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.38 136.28 96.63 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.796 -1.927 . . . . 100.0 105.796 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 138.88 77.58 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 123.55 2.833 . . . . 100.0 112.553 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -57.81 129.09 31.71 Favored 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.23 1.954 . . . . 100.0 113.509 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.86 -43.8 82.65 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 124.701 1.251 . . . . 100.0 108.085 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 158.24 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.58 -1.637 . . . . 100.0 106.58 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.42 131.89 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.567 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -87.47 123.91 32.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.654 -2.721 . . . . 100.0 103.654 178.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 34.0 t70 -62.85 128.65 92.29 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 114.779 -1.101 . . . . 100.0 110.565 -178.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.0 Cg_exo -58.7 -37.65 93.09 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.725 2.95 . . . . 100.0 113.546 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.06 95.23 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 123.979 0.8 . . . . 100.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.3 -42.22 99.03 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 122.769 0.428 . . . . 100.0 111.147 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.2 97.73 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 123.703 0.801 . . . . 100.0 110.625 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.03 97.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.508 0.723 . . . . 100.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.26 -44.75 95.83 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.758 0.823 . . . . 100.0 112.075 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -63.49 -43.51 97.04 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 122.918 0.487 . . . . 100.0 111.793 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.19 -39.83 94.83 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.707 -0.224 . . . . 100.0 111.19 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.78 -42.67 99.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.158 0.983 . . . . 100.0 110.007 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -61.51 -42.35 98.68 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.838 0.855 . . . . 100.0 110.645 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.481 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 81.9 mt -61.03 -48.43 81.84 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.391 -0.822 . . . . 100.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.48 -41.84 98.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.66 -47.14 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.968 0 CA-C-O 118.221 -0.895 . . . . 100.0 109.124 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.715 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.705 . . -88.87 -8.67 53.85 Favored 'General case' 1 N--CA 1.379 -4.008 1 C-N-CA 104.543 -6.863 . . . . 100.0 116.647 179.881 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 55.1 mt-30 -53.48 -34.89 59.7 Favored 'General case' 0 CA--C 1.444 -3.108 0 C-N-CA 128.179 2.591 . . . . 100.0 107.507 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -82.73 41.47 0.73 Allowed 'General case' 0 N--CA 1.416 -2.133 0 O-C-N 124.825 1.328 . . . . 100.0 109.766 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 4.6 m 57.96 30.24 18.86 Favored 'General case' 0 CA--C 1.473 -1.988 0 C-N-CA 127.13 2.172 . . . . 100.0 112.578 175.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.443 ' HB1' ' CB ' ' A' ' 204' ' ' ALA 0.275 . . -73.61 175.51 7.05 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 101.155 -3.646 . . . . 100.0 101.155 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.03 -36.7 49.04 Favored Pre-proline 0 CA--C 1.489 -1.393 0 CA-C-O 116.359 -1.781 . . . . 100.0 114.024 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.847 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.457 0.3 OUTLIER -53.58 137.79 66.35 Favored 'Trans proline' 0 N--CA 1.433 -2.088 0 O-C-N 123.814 1.428 . . . . 100.0 112.634 176.602 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.507 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.305 99.3 m-20 -64.01 -43.03 96.86 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 121.499 3.888 . . . . 100.0 121.499 -172.552 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.1 tm-20 -71.42 -16.03 62.37 Favored 'General case' 0 CA--C 1.463 -2.394 1 CA-C-O 130.799 5.095 . . . . 100.0 112.989 177.989 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.785 66.3 m-20 -86.07 -50.04 7.33 Favored 'General case' 1 N--CA 1.257 -10.116 1 CA-C-N 105.781 -5.19 . . . . 100.0 104.025 -172.932 . . . . . . . . 5 3 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -62.05 -28.96 69.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.255 -2.153 . . . . 100.0 106.528 176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.708 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 73.0 m-20 -61.77 -40.29 94.64 Favored 'General case' 0 CA--C 1.476 -1.889 0 C-N-CA 126.925 2.09 . . . . 100.0 112.591 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.51 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.283 0.6 OUTLIER . . . . . 0 N--CA 1.428 -1.558 0 CA-C-O 115.334 -2.27 . . . . 100.0 114.301 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.598 0.237 . . . . 100.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.17 68.51 9.93 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.081 -1.451 . . . . 100.0 107.081 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.13 158.67 43.26 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.468 -1.308 . . . . 100.0 107.468 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.99 156.58 21.08 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.489 -0.778 . . . . 100.0 109.058 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.83 8.26 84.58 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 119.377 -0.68 . . . . 100.0 113.796 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -71.92 138.57 82.43 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 117.911 0.855 . . . . 100.0 110.965 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.05 135.43 54.96 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.607 2.205 . . . . 100.0 109.841 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -76.02 150.89 37.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 124.555 1.16 . . . . 100.0 112.935 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.3 t -93.18 109.67 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 101.759 -3.422 . . . . 100.0 101.759 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -128.58 138.13 52.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.534 -0.757 . . . . 100.0 109.876 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.75 144.09 51.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.476 ' HZ2' ' HB2' ' A' ' 82' ' ' GLN . 99.5 mttt -91.4 122.54 34.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.596 -2.001 . . . . 100.0 105.596 177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.21 126.53 55.16 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 67.7 t -104.27 124.36 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.773 -1.195 . . . . 100.0 107.773 179.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.419 HD12 ' SD ' ' A' ' 89' ' ' MET . 38.1 tp -108.7 118.83 37.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.039 -1.837 . . . . 100.0 106.039 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.81 162.36 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.802 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.24 172.78 22.52 Favored Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.015 -2.034 . . . . 100.0 108.015 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -66.74 153.45 43.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.958 0.885 . . . . 100.0 111.973 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.24 140.89 43.89 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.471 -2.252 . . . . 100.0 107.471 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.57 -3.08 85.12 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-O 118.568 -1.129 . . . . 100.0 114.37 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -62.77 -38.53 90.97 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.868 1.334 . . . . 100.0 112.248 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 23.55 3.79 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 110.247 -1.141 . . . . 100.0 110.247 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -59.98 -47.78 84.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.382 1.073 . . . . 100.0 113.163 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -64.17 -42.76 96.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 123.906 0.882 . . . . 100.0 110.42 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -62.53 -42.04 99.26 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.209 1.004 . . . . 100.0 109.309 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -60.29 -49.59 77.01 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.663 1.185 . . . . 100.0 112.646 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.37 -41.63 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 123.547 0.529 . . . . 100.0 111.168 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.302 99.4 mttt -69.45 -6.63 31.61 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 115.775 1.769 . . . . 100.0 115.775 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.605 HH11 ' HA ' ' A' ' 154' ' ' ASN . 43.2 mtm180 -60.23 -38.22 82.75 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 109.013 -0.736 . . . . 100.0 109.013 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.642 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 47.3 t-80 -81.32 112.22 18.41 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.637 -1.616 . . . . 100.0 106.637 -179.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.92 -45.12 95.11 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.191 1.923 . . . . 100.0 116.191 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.8 m -63.73 -41.15 98.1 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.252 0.621 . . . . 100.0 109.63 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.642 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.46 -41.66 99.59 Favored Glycine 0 C--N 1.358 1.799 0 N-CA-C 110.841 -0.904 . . . . 100.0 110.841 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.76 -46.52 84.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.824 0.85 . . . . 100.0 111.14 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -63.96 -39.63 94.57 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 113.003 0.742 . . . . 100.0 113.003 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -93.27 11.65 27.32 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 115.4 1.63 . . . . 100.0 115.4 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.85 144.84 51.95 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 113.896 1.073 . . . . 100.0 113.896 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -122.23 130.74 53.47 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.219 -1.03 . . . . 100.0 108.219 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -101.06 125.46 47.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.876 -1.157 . . . . 100.0 107.876 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -99.32 109.18 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.47 98.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 116.649 2.092 . . . . 100.0 116.649 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.4 m -61.92 -44.29 97.08 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.004 0.922 . . . . 100.0 110.925 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.76 -21.39 23.83 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 114.303 1.223 . . . . 100.0 114.303 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.7 45.72 51.01 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 109.296 -1.522 . . . . 100.0 109.296 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.84 144.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 109.147 -0.686 . . . . 100.0 109.147 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -108.26 118.33 36.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 101.598 -3.482 . . . . 100.0 101.598 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.21 120.09 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.71 -1.959 . . . . 100.0 105.71 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -111.52 119.43 45.08 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.825 -0.625 . . . . 100.0 110.076 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.46 103.31 1.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.604 2.203 . . . . 100.0 111.062 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.35 116.03 28.81 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.21 128.46 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.278 -1.378 . . . . 100.0 107.278 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.38 135.6 54.73 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -102.08 117.49 34.9 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -108.56 175.59 5.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.761 0.791 . . . . 100.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.52 -32.97 71.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.39 1.476 . . . . 100.0 109.919 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -92.37 3.81 54.68 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.401 0.889 . . . . 100.0 113.401 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.92 177.93 17.26 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 121.274 -0.891 . . . . 100.0 111.67 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.11 140.45 59.66 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.16 2.573 . . . . 100.0 114.751 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.3 131.12 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 103.057 -2.942 . . . . 100.0 103.057 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -114.4 128.77 56.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.569 -0.53 . . . . 100.0 109.569 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.47 115.7 29.65 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 104.946 -2.242 . . . . 100.0 104.946 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -88.32 105.81 17.81 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 101.051 -3.685 . . . . 100.0 101.051 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.53 123.3 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 107.87 -1.159 . . . . 100.0 107.87 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -95.03 115.73 27.8 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.041 -1.466 . . . . 100.0 107.041 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -111.13 137.62 48.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.625 -1.62 . . . . 100.0 106.625 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -72.77 164.59 26.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.252 1.025 . . . . 100.0 112.38 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.53 22.88 10.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.77 15.63 59.39 Favored Glycine 0 C--N 1.362 1.98 0 O-C-N 121.612 -0.68 . . . . 100.0 113.122 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.456 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 60.3 mt-30 -59.64 -35.1 73.73 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 127.077 2.151 . . . . 100.0 112.364 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.47 -33.1 69.38 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 128.064 2.545 . . . . 100.0 112.011 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.42 -39.37 94.31 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.173 0.589 . . . . 100.0 111.569 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 12.6 p90 -94.66 -7.85 39.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.12 -163.38 35.0 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 119.405 1.002 . . . . 100.0 112.382 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.67 -179.59 53.0 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 108.639 -1.784 . . . . 100.0 108.639 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD11 ' CE2' ' A' ' 79' ' ' TYR . 92.8 mt -107.52 142.22 37.76 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.603 0.716 . . . . 100.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -70.16 157.31 37.85 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.586 -1.188 . . . . 100.0 112.455 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -59.96 -37.57 79.96 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 124.993 1.317 . . . . 100.0 110.623 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.3 -37.45 87.29 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 125.193 1.378 . . . . 100.0 111.102 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.438 ' CE2' HD11 ' A' ' 75' ' ' LEU . 90.0 t80 -62.59 -45.8 91.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.417 0.687 . . . . 100.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -75.58 -28.7 59.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.401 2.0 . . . . 100.0 116.401 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.7 mt -51.31 131.63 12.35 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 123.269 1.509 . . . . 100.0 114.824 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . 0.476 ' HB2' ' HZ2' ' A' ' 12' ' ' LYS 0.263 52.9 mt-30 59.87 29.9 19.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 128.899 2.88 . . . . 100.0 114.006 -178.572 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.444 ' HB1' ' HG ' ' A' ' 112' ' ' CYS . . . -69.36 132.06 45.8 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.015 -1.846 . . . . 100.0 106.015 177.331 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.09 -31.53 13.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.473 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 25.5 p -151.81 163.51 39.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.457 -0.572 . . . . 100.0 109.457 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.67 41.98 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 114.64 1.348 . . . . 100.0 114.64 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.3 mt -127.56 126.38 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 104.072 -2.566 . . . . 100.0 104.072 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.449 ' HB ' HD21 ' A' ' 119' ' ' LEU . 33.3 mt -110.51 124.49 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 102.898 -3.001 . . . . 100.0 102.898 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.419 ' SD ' HD12 ' A' ' 15' ' ' LEU . 88.5 mtp -111.94 137.08 50.42 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -130.73 163.69 26.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.537 -2.119 . . . . 100.0 107.706 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -106.67 127.25 53.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.076 -1.824 . . . . 100.0 106.076 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.21 -15.93 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.428 0.899 . . . . 100.0 113.428 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.8 p -90.25 -6.85 54.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.072 0.396 . . . . 100.0 110.543 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -125.75 116.04 20.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.449 1.119 . . . . 100.0 110.561 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.0 -37.7 88.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.591 1.156 . . . . 100.0 112.217 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.59 -40.16 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.983 1.713 . . . . 100.0 110.322 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -62.34 -41.68 98.77 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 118.344 0.52 . . . . 100.0 111.28 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.63 -40.92 96.32 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.268 0.627 . . . . 100.0 110.423 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.448 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -60.57 -36.95 79.75 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 123.941 0.896 . . . . 100.0 111.091 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -79.11 -5.91 55.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.8 t -59.94 -42.79 92.46 Favored Pre-proline 0 C--N 1.364 1.215 0 CA-C-O 116.466 -1.73 . . . . 100.0 111.368 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 72.9 Cg_exo -57.8 -37.51 96.18 Favored 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 122.25 1.839 . . . . 100.0 112.69 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -64.14 -44.38 92.35 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.873 1.269 . . . . 100.0 111.076 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -64.64 -40.91 96.28 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 122.877 0.471 . . . . 100.0 110.915 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.73 -44.01 97.73 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 124.09 0.956 . . . . 100.0 109.395 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.46 -45.56 93.77 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 123.71 0.804 . . . . 100.0 111.66 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.0 -45.81 91.95 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.375 0.67 . . . . 100.0 110.699 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.67 -47.27 81.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.665 1.186 . . . . 100.0 113.259 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.321 25.9 m -65.84 -33.8 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 N-CA-C 113.597 0.962 . . . . 100.0 113.597 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 110' ' ' ARG . 55.6 mtt85 -60.14 -46.71 88.75 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 123.813 0.696 . . . . 100.0 109.227 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.07 -44.37 50.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 112.16 0.43 . . . . 100.0 112.16 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.444 ' HG ' ' HB1' ' A' ' 83' ' ' ALA . 74.2 m -125.88 107.7 10.74 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.997 0.903 . . . . 100.0 110.715 -178.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.71 138.93 32.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.025 -0.988 . . . . 100.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 53.52 42.02 32.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 117.547 2.425 . . . . 100.0 117.547 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.0 pt -94.99 144.64 28.15 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 106.353 -1.721 . . . . 100.0 106.353 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.61 133.45 42.54 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.36 2.04 . . . . 100.0 110.43 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.445 ' HB ' HD21 ' A' ' 144' ' ' LEU . 70.8 mt -133.98 137.45 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.343 -0.984 . . . . 100.0 108.343 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.37 131.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 105.04 -2.207 . . . . 100.0 105.04 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.548 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 24.6 mt -106.63 128.93 54.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.198 -2.519 . . . . 100.0 104.198 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.6 m -120.23 130.6 54.59 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.465 -1.243 . . . . 100.0 113.363 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.3 107.4 3.23 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 105.4 -3.08 . . . . 100.0 105.4 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.353 9.0 p-10 -95.88 177.93 5.6 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 114.501 1.297 . . . . 100.0 114.501 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.1 mttt 62.0 40.4 12.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 128.761 2.824 . . . . 100.0 112.863 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.6 m -71.75 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 114.882 -1.054 . . . . 100.0 111.713 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -66.0 -29.14 69.47 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.981 0.912 . . . . 100.0 110.524 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.6 128.43 34.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 107.158 -1.423 . . . . 100.0 107.158 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.23 -41.81 98.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 115.779 1.77 . . . . 100.0 115.779 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.25 97.08 11.0 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.774 -1.935 . . . . 100.0 105.774 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -96.79 125.11 41.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 113.845 -1.525 . . . . 100.0 106.885 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.27 -39.14 12.23 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.585 0.958 . . . . 100.0 113.585 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -103.5 102.93 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.66 -1.607 . . . . 100.0 106.66 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -89.71 168.06 12.41 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.481 1.512 . . . . 100.0 114.022 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -57.22 -33.46 67.57 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.989 2.116 . . . . 100.0 108.696 179.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.827 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 93.8 mttt -57.61 -38.62 75.25 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 129.19 2.996 . . . . 100.0 112.835 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.8 p -105.29 3.04 29.52 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 116.493 2.035 . . . . 100.0 116.493 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 66.8 mt -91.09 89.79 3.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 117.792 -1.563 . . . . 100.0 109.324 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.459 ' CA ' ' HB3' ' A' ' 211' ' ' ASP 0.361 0.0 OUTLIER -101.46 -12.81 8.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 115.636 1.717 . . . . 100.0 115.636 -175.842 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.55 -35.95 73.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 118.235 2.68 . . . . 100.0 118.235 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.548 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.263 60.6 m-70 -59.6 -37.11 77.68 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.396 1.878 . . . . 100.0 113.927 -176.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.688 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.273 55.2 ttp85 -59.15 -50.09 75.38 Favored 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 113.926 1.084 . . . . 100.0 113.926 -175.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.68 -41.23 98.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 125.033 1.458 . . . . 100.0 111.769 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.23 2.74 53.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 116.396 1.999 . . . . 100.0 116.396 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 55.69 43.78 27.46 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-O 123.116 1.436 . . . . 100.0 113.37 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.456 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 26.2 mt -101.88 146.48 27.77 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.573 -2.38 . . . . 100.0 104.573 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -94.14 142.39 27.45 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.945 -1.131 . . . . 100.0 107.945 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.458 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 88.3 t80 -113.67 139.04 49.39 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 113.222 0.823 . . . . 100.0 113.222 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.69 139.85 42.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.202 -1.363 . . . . 100.0 111.578 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.26 85.2 m-20 -86.59 128.34 34.98 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 102.743 -3.058 . . . . 100.0 102.743 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.514 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 43.3 pt -135.33 157.59 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 122.049 0.928 . . . . 100.0 111.732 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -137.11 109.52 7.38 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 103.376 -2.824 . . . . 100.0 103.376 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.432 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.75 -41.38 99.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.885 -1.052 . . . . 100.0 110.825 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.64 -40.85 93.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.208 1.403 . . . . 100.0 112.353 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.487 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 95.8 p -100.85 3.57 42.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.305 1.965 . . . . 100.0 116.305 -178.059 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.605 ' HA ' HH11 ' A' ' 29' ' ' ARG . 72.5 m-80 63.85 22.83 13.18 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.03 1.332 . . . . 100.0 110.677 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -72.61 124.11 24.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.458 -1.312 . . . . 100.0 107.458 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 53.53 37.83 26.71 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.657 2.383 . . . . 100.0 113.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.26 -44.54 95.21 Favored 'General case' 0 C--N 1.362 1.141 0 O-C-N 121.903 -0.498 . . . . 100.0 111.324 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -63.08 -38.69 92.2 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.636 1.974 . . . . 100.0 115.628 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -57.7 -47.4 99.01 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 120.531 3.53 . . . . 100.0 120.531 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.06 -42.39 36.82 Favored 'Trans proline' 0 C--N 1.373 1.834 0 CA-C-N 123.403 2.251 . . . . 100.0 112.066 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -65.08 -42.55 94.01 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 124.852 1.261 . . . . 100.0 111.74 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -44.27 91.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.518 0.727 . . . . 100.0 110.241 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -63.7 -44.51 93.46 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-N 117.949 0.34 . . . . 100.0 110.345 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.34 -43.25 99.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 119.112 -0.471 . . . . 100.0 111.363 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.62 98.56 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.065 0.946 . . . . 100.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.88 -45.35 94.13 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 119.021 -0.514 . . . . 100.0 112.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.0 -42.53 76.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 112.734 0.642 . . . . 100.0 112.734 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.65 -38.83 74.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.692 1.197 . . . . 100.0 109.937 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.73 10.76 56.29 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-O 118.489 -1.173 . . . . 100.0 111.025 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 48.4 t0 -112.47 111.48 52.2 Favored Pre-proline 0 C--N 1.365 1.258 0 CA-C-N 118.485 1.142 . . . . 100.0 108.262 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -15.99 40.26 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.961 3.108 . . . . 100.0 113.256 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -96.17 8.37 44.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 114.349 1.24 . . . . 100.0 114.349 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 75.5 mt -62.11 136.7 58.06 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-O 121.307 0.575 . . . . 100.0 110.705 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -133.16 150.57 52.01 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.53 -0.915 . . . . 100.0 108.53 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -91.06 113.19 25.39 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 103.65 -2.722 . . . . 100.0 103.65 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.24 -39.51 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 114.061 1.134 . . . . 100.0 114.061 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.0 146.07 51.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.506 -0.924 . . . . 100.0 108.506 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.91 130.48 48.3 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 108.031 -1.1 . . . . 100.0 108.031 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.54 155.62 67.96 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.223 1.949 . . . . 100.0 109.847 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.07 123.73 21.84 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.8 -1.555 . . . . 100.0 106.8 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -119.02 145.85 45.52 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.239 -1.346 . . . . 100.0 109.665 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.64 96.33 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 105.965 -1.865 . . . . 100.0 105.965 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.403 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 72.0 Cg_exo -55.65 142.35 82.38 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 123.453 2.769 . . . . 100.0 113.563 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.513 ' HG3' HD21 ' A' ' 154' ' ' ASN . 51.0 Cg_exo -56.7 127.63 26.68 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 122.848 2.366 . . . . 100.0 113.281 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -70.14 -42.44 72.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 124.714 1.259 . . . . 100.0 107.867 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.15 158.83 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.411 -1.7 . . . . 100.0 106.411 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.64 128.37 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.408 -2.071 . . . . 100.0 105.408 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.487 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -89.58 125.02 35.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.7 -2.333 . . . . 100.0 104.7 178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.6 t70 -62.66 129.27 92.72 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 114.568 -1.196 . . . . 100.0 111.613 -178.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 59.8 Cg_exo -59.1 -37.53 92.03 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.654 2.903 . . . . 100.0 113.481 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.55 93.73 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.146 0.904 . . . . 100.0 110.179 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.07 -41.84 99.52 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.135 0.574 . . . . 100.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.02 96.35 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.803 0.841 . . . . 100.0 110.672 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.26 99.27 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.699 0.799 . . . . 100.0 110.84 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.32 -45.12 94.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.829 0.851 . . . . 100.0 111.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -63.68 -43.63 96.11 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 112.392 0.515 . . . . 100.0 112.392 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -64.51 -39.86 94.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 123.248 0.343 . . . . 100.0 111.287 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -63.09 -42.45 99.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.952 0.901 . . . . 100.0 110.303 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.4 -42.46 98.77 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.975 0.91 . . . . 100.0 110.609 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.46 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.8 mt -61.26 -47.23 86.97 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.431 -0.804 . . . . 100.0 109.262 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.46 -42.04 98.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.3 1.222 . . . . 100.0 114.3 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.34 -47.4 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.047 0 CA-C-O 117.504 -1.236 . . . . 100.0 108.517 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.719 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.714 . . -89.72 -8.15 52.93 Favored 'General case' 0 N--CA 1.382 -3.849 1 C-N-CA 103.86 -7.136 . . . . 100.0 117.204 178.721 . . . . . . . . 4 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.75 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 54.3 mt-30 -53.69 -34.07 57.53 Favored 'General case' 0 CA--C 1.447 -2.994 0 C-N-CA 127.813 2.445 . . . . 100.0 106.801 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -80.87 36.57 0.4 Allowed 'General case' 0 N--CA 1.416 -2.142 0 O-C-N 124.933 1.395 . . . . 100.0 109.5 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.8 m 58.5 31.9 21.52 Favored 'General case' 0 CA--C 1.472 -2.052 0 C-N-CA 126.871 2.068 . . . . 100.0 112.525 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.46 ' C ' ' HB2' ' A' ' 204' ' ' ALA . . . -75.63 -178.19 4.04 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 101.642 -3.466 . . . . 100.0 101.642 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.404 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 81.3 mt -57.68 -38.24 65.07 Favored Pre-proline 0 CA--C 1.492 -1.263 0 CA-C-O 116.274 -1.822 . . . . 100.0 113.154 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.827 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.422 5.7 Cg_exo -53.1 136.45 61.46 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 CA-C-O 123.64 1.433 . . . . 100.0 112.7 177.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.459 ' HB3' ' CA ' ' A' ' 137' ' ' VAL 0.331 84.8 m-20 -65.18 -42.22 93.85 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 120.956 3.687 . . . . 100.0 120.956 -172.836 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.5 tm-20 -72.44 -14.72 61.76 Favored 'General case' 0 CA--C 1.459 -2.52 1 CA-C-O 130.685 5.04 . . . . 100.0 112.922 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.807 64.0 m-20 -87.55 -48.71 7.7 Favored 'General case' 1 N--CA 1.256 -10.162 1 CA-C-N 106.111 -5.04 . . . . 100.0 103.127 -172.786 . . . . . . . . 5 3 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.5 -27.57 69.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 118.901 -2.375 . . . . 100.0 106.211 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.688 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 51.5 m-20 -62.39 -39.96 94.94 Favored 'General case' 0 CA--C 1.478 -1.825 0 C-N-CA 127.137 2.175 . . . . 100.0 112.604 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.458 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.303 3.8 mm? . . . . . 0 N--CA 1.427 -1.624 0 CA-C-O 114.15 -2.833 . . . . 100.0 112.828 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.631 0.253 . . . . 100.0 110.454 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.32 69.94 9.99 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.9 162.64 39.65 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.928 0.891 . . . . 100.0 109.028 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -80.32 157.99 26.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.491 0.716 . . . . 100.0 110.698 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.38 9.73 84.53 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.555 -0.748 . . . . 100.0 113.942 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.75 136.67 73.87 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 118.0 0.9 . . . . 100.0 112.113 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -63.29 136.51 55.85 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.985 2.457 . . . . 100.0 107.807 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.65 150.46 34.57 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 124.286 0.991 . . . . 100.0 111.641 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -88.74 111.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.844 -3.021 . . . . 100.0 102.844 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -127.89 140.48 51.98 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.839 -1.073 . . . . 100.0 110.431 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -129.07 144.08 51.08 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.074 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.18 120.49 34.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 105.577 -2.009 . . . . 100.0 105.577 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 47.7 tp -113.4 127.03 55.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 100.0 107.473 -179.043 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 74.8 t -106.6 124.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 114.844 -1.071 . . . . 100.0 110.317 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.406 HD11 HG11 ' A' ' 63' ' ' VAL . 6.4 mp -107.38 119.17 38.66 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-O 121.477 0.656 . . . . 100.0 109.471 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.31 160.56 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.819 -1.082 . . . . 100.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.23 174.31 24.98 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.047 -2.021 . . . . 100.0 108.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.61 155.02 40.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.744 0.783 . . . . 100.0 112.229 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.46 140.76 41.53 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 106.519 -2.632 . . . . 100.0 106.519 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.76 -5.27 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.533 -1.148 . . . . 100.0 114.458 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.0 p -62.28 -37.24 84.77 Favored 'General case' 0 C--N 1.362 1.109 0 CA-C-N 118.929 1.364 . . . . 100.0 112.2 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.25 21.86 6.08 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.179 -0.769 . . . . 100.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 41.5 mtmt -60.95 -44.76 96.81 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 118.112 0.956 . . . . 100.0 112.559 -178.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.2 m -62.25 -44.19 97.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.311 1.044 . . . . 100.0 109.846 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -63.03 -41.82 99.63 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.889 0.876 . . . . 100.0 109.362 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.46 -47.73 84.39 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.028 0.931 . . . . 100.0 112.559 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.9 t -64.16 -41.03 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 123.284 0.634 . . . . 100.0 110.066 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.38 -7.84 41.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 116.373 1.99 . . . . 100.0 116.373 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.575 HH11 ' HB2' ' A' ' 157' ' ' PHE . 62.0 mtt180 -60.31 -37.97 82.24 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.731 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 58.3 t-80 -80.07 112.3 17.25 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 106.977 -1.49 . . . . 100.0 106.977 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.79 -44.93 95.9 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 115.817 1.784 . . . . 100.0 115.817 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.426 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 90.4 m -63.77 -42.48 97.79 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.52 0.728 . . . . 100.0 109.7 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.731 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.57 -41.67 99.61 Favored Glycine 0 C--N 1.357 1.732 0 C-N-CA 123.807 0.718 . . . . 100.0 111.437 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.43 -45.55 87.07 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.916 0.886 . . . . 100.0 111.359 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -64.28 -39.77 94.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.501 1.12 . . . . 100.0 111.953 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -93.8 9.67 36.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 115.637 1.717 . . . . 100.0 115.637 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -61.12 141.85 57.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 114.225 1.194 . . . . 100.0 114.225 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -121.74 130.78 53.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.922 -1.035 . . . . 100.0 108.915 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.57 126.87 45.62 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.92 112.28 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 102.166 -3.272 . . . . 100.0 102.166 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.11 90.29 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 118.381 2.734 . . . . 100.0 118.381 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.6 m -63.08 -47.15 84.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 118.381 0.537 . . . . 100.0 110.329 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.88 -37.55 73.04 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 114.054 1.131 . . . . 100.0 114.054 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.01 44.4 30.24 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 106.895 -2.482 . . . . 100.0 106.895 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.9 t -127.57 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.076 0.95 . . . . 100.0 108.622 -178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -108.57 118.7 37.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.623 -3.473 . . . . 100.0 101.623 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.44 119.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 105.628 -1.99 . . . . 100.0 105.628 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -109.46 120.32 45.64 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.483 -0.781 . . . . 100.0 109.074 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -80.93 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.682 2.254 . . . . 100.0 109.491 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.56 112.83 24.99 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.329 -0.989 . . . . 100.0 108.329 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.35 128.33 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.526 -1.287 . . . . 100.0 107.526 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.24 135.66 54.79 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.437 -2.06 . . . . 100.0 105.437 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -102.59 119.17 38.36 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.55 -0.907 . . . . 100.0 108.55 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 p -108.63 175.87 5.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.99 0.9 . . . . 100.0 110.176 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -61.7 -26.43 68.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.317 1.447 . . . . 100.0 110.356 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -97.88 6.52 47.68 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.868 0.867 . . . . 100.0 112.633 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.65 179.36 20.03 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 121.298 -0.876 . . . . 100.0 111.208 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.72 139.94 59.82 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.182 2.588 . . . . 100.0 116.009 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.52 131.4 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 103.155 -2.905 . . . . 100.0 103.155 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -113.58 128.48 56.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.164 0.507 . . . . 100.0 109.833 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -110.74 114.77 28.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.957 -2.608 . . . . 100.0 103.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -89.74 103.95 16.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 100.87 -3.752 . . . . 100.0 100.87 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.406 HG11 HD11 ' A' ' 15' ' ' LEU . 32.8 t -87.91 124.39 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.404 -1.271 . . . . 100.0 107.95 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -98.36 115.74 29.1 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.024 -2.213 . . . . 100.0 105.024 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.26 137.77 49.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.517 -1.66 . . . . 100.0 106.517 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.1 p -71.56 162.17 29.86 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.845 0.831 . . . . 100.0 112.926 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.3 14.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.939 -1.028 . . . . 100.0 108.538 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.22 57.99 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 121.703 -0.623 . . . . 100.0 113.194 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.427 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 63.6 mt-30 -59.68 -34.15 72.49 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.544 1.938 . . . . 100.0 112.101 -179.534 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.22 -30.49 66.54 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.224 2.21 . . . . 100.0 113.131 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.09 -46.54 88.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.427 ' CE2' ' HA ' ' A' ' 69' ' ' GLN 0.41 15.1 p90 -74.22 -40.45 62.43 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 116.912 2.19 . . . . 100.0 116.912 176.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.5 -154.18 9.31 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 120.303 -0.951 . . . . 100.0 111.918 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.46 53.06 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 122.337 0.965 . . . . 100.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.443 HD11 ' CE2' ' A' ' 79' ' ' TYR . 93.5 mt -105.13 143.16 33.69 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 123.851 0.86 . . . . 100.0 109.993 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -68.18 156.4 37.62 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.417 -1.265 . . . . 100.0 112.949 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.77 -37.69 79.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 125.312 1.445 . . . . 100.0 110.077 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.62 89.27 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 124.867 1.222 . . . . 100.0 111.479 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.443 ' CE2' HD11 ' A' ' 75' ' ' LEU . 85.8 t80 -62.76 -46.82 86.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.057 0.543 . . . . 100.0 111.032 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -70.59 -36.96 73.83 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 115.917 1.821 . . . . 100.0 115.917 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.2 mt -51.96 135.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 114.747 1.388 . . . . 100.0 114.747 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 68.85 14.41 8.91 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.204 2.202 . . . . 100.0 114.694 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 131.02 45.36 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.398 -0.964 . . . . 100.0 108.398 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.81 -31.15 13.87 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.305 -0.861 . . . . 100.0 108.726 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 20.6 p -151.04 163.8 37.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 120.824 0.345 . . . . 100.0 110.227 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.1 154.17 40.82 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.7 mt -126.51 125.38 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.231 -2.507 . . . . 100.0 104.231 176.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.485 ' HB ' ' CD2' ' A' ' 119' ' ' LEU . 45.4 mt -110.57 124.61 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 102.675 -3.083 . . . . 100.0 102.675 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.8 mtp -112.35 136.54 51.69 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 114.914 1.45 . . . . 100.0 114.914 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -129.47 164.2 24.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 112.501 -2.136 . . . . 100.0 107.976 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -109.69 125.43 52.63 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.041 -1.837 . . . . 100.0 106.041 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 m -64.8 -19.71 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 114.042 1.127 . . . . 100.0 114.042 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -86.75 -9.53 55.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 119.243 -0.408 . . . . 100.0 111.323 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -125.21 117.81 24.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 122.195 0.998 . . . . 100.0 110.547 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.67 -38.1 89.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.915 1.286 . . . . 100.0 111.838 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.92 -40.76 81.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.222 1.809 . . . . 100.0 110.601 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -62.97 -41.28 99.49 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.32 0.509 . . . . 100.0 111.307 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.87 -41.41 95.69 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.863 0.865 . . . . 100.0 110.604 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.446 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.6 mttt -60.91 -37.8 83.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.792 1.237 . . . . 100.0 110.777 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.83 -8.43 58.03 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.273 1.583 . . . . 100.0 115.273 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.0 t -60.11 -42.75 91.59 Favored Pre-proline 0 C--N 1.364 1.224 0 CA-C-O 116.419 -1.753 . . . . 100.0 112.077 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.446 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 73.8 Cg_exo -57.49 -37.47 97.16 Favored 'Trans proline' 0 C--N 1.375 1.955 0 CA-C-N 122.153 1.805 . . . . 100.0 112.657 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.93 -45.43 89.27 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.05 1.34 . . . . 100.0 110.894 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -64.16 -41.84 96.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 122.936 0.494 . . . . 100.0 110.917 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -62.65 -43.87 97.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 123.898 0.879 . . . . 100.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -63.0 -43.81 97.76 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 123.042 0.537 . . . . 100.0 111.769 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.5 -44.25 96.84 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.916 0.486 . . . . 100.0 110.425 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.1 tp -63.46 -48.34 78.1 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 124.314 1.046 . . . . 100.0 113.177 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.298 32.7 m -63.86 -35.53 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 C-N-CA 124.16 0.984 . . . . 100.0 113.08 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -59.65 -38.53 81.67 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 118.688 -0.672 . . . . 100.0 111.093 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.14 -43.9 17.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 C-N-CA 119.87 -0.732 . . . . 100.0 110.233 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.1 m -124.75 104.65 8.77 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.454 -0.943 . . . . 100.0 108.454 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.14 145.05 25.0 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.983 0.897 . . . . 100.0 110.389 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 57.79 38.04 27.24 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.447 2.017 . . . . 100.0 116.447 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 pt -96.81 143.59 26.38 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 106.185 -1.783 . . . . 100.0 106.185 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -62.59 131.14 32.35 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.782 2.322 . . . . 100.0 110.483 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.435 ' HB ' HD21 ' A' ' 144' ' ' LEU . 73.9 mt -132.84 138.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 122.369 1.08 . . . . 100.0 109.421 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.98 131.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.193 -1.78 . . . . 100.0 106.193 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 22.5 mt -105.84 128.96 54.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.852 -2.277 . . . . 100.0 104.852 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.36 130.77 56.19 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.126 -1.397 . . . . 100.0 113.398 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.576 ' HA3' ' HH ' ' A' ' 146' ' ' TYR . . . -100.48 104.36 2.77 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 106.222 -2.751 . . . . 100.0 106.222 178.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -83.24 166.09 18.85 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.555 1.142 . . . . 100.0 112.973 -178.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 61.03 42.97 11.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.57 3.148 . . . . 100.0 114.933 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.327 24.5 m -72.07 -7.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 C-N-CA 120.527 -0.469 . . . . 100.0 111.64 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.93 -36.71 82.17 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.718 2.007 . . . . 100.0 109.958 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.95 128.42 33.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 106.915 -1.513 . . . . 100.0 106.915 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.77 -42.35 99.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 114.919 1.452 . . . . 100.0 114.919 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.21 98.04 11.54 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.843 -1.91 . . . . 100.0 105.843 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -95.57 122.2 38.08 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.771 -1.559 . . . . 100.0 106.911 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.94 -39.91 15.3 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.3 0.852 . . . . 100.0 113.3 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.07 104.86 17.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.552 -2.018 . . . . 100.0 105.552 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.57 174.3 6.51 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.209 -0.905 . . . . 100.0 113.109 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.28 65.69 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 127.045 2.138 . . . . 100.0 109.496 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.871 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 96.2 mttt -57.52 -39.12 75.86 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 129.128 2.971 . . . . 100.0 112.043 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.3 p -104.82 4.18 31.91 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 116.403 2.001 . . . . 100.0 116.403 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 56.5 mt -90.06 80.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 117.197 -1.801 . . . . 100.0 112.035 -176.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.545 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.255 58.9 t -71.53 -39.44 70.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 1 C-N-CA 133.757 4.823 . . . . 100.0 118.807 -178.279 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -55.79 -36.34 67.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 121.539 3.903 . . . . 100.0 121.539 -168.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.507 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.258 67.8 m-70 -59.73 -38.8 82.69 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 116.924 -1.512 . . . . 100.0 113.493 -176.586 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.786 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.255 0.9 OUTLIER -59.93 -46.83 88.11 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 116.6 2.074 . . . . 100.0 116.6 -176.887 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.93 -40.42 97.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 125.525 1.766 . . . . 100.0 110.2 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.63 3.89 47.94 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 117.279 2.326 . . . . 100.0 117.279 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 55.38 43.47 28.8 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 122.958 1.361 . . . . 100.0 113.311 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.469 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 24.2 mt -103.52 150.4 23.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.643 -1.984 . . . . 100.0 105.643 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -97.28 141.02 30.89 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 109.784 -0.451 . . . . 100.0 109.784 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.576 ' HH ' ' HA3' ' A' ' 121' ' ' GLY . 81.5 t80 -108.27 136.88 47.18 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 113.188 0.81 . . . . 100.0 113.188 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -134.11 136.47 43.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.221 -1.354 . . . . 100.0 110.743 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.322 66.0 m-20 -83.47 130.06 35.01 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 101.996 -3.335 . . . . 100.0 101.996 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.519 ' HB ' HH22 ' A' ' 29' ' ' ARG . 43.2 pt -134.72 156.73 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.525 1.155 . . . . 100.0 111.674 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.475 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 71.3 m -138.2 107.98 6.28 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.941 -2.244 . . . . 100.0 104.941 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.512 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.32 -44.63 96.88 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 115.214 -0.903 . . . . 100.0 112.854 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.92 -39.36 91.79 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 125.071 1.348 . . . . 100.0 113.372 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.539 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 93.5 p -99.97 1.57 42.73 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 115.669 1.729 . . . . 100.0 115.669 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.533 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.1 m-80 64.65 21.58 12.44 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.296 1.438 . . . . 100.0 111.263 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 78.1 t80 -70.98 125.61 27.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.906 -1.146 . . . . 100.0 107.906 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 54.45 36.5 25.73 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.102 2.561 . . . . 100.0 114.429 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.575 ' HB2' HH11 ' A' ' 29' ' ' ARG . 64.4 t80 -60.99 -45.49 94.62 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 121.644 -0.66 . . . . 100.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -35.63 81.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.799 2.148 . . . . 100.0 116.799 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.26 -46.98 99.73 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.166 3.025 . . . . 100.0 119.166 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -60.98 -42.51 36.45 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.116 2.149 . . . . 100.0 111.815 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -64.53 -42.29 95.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 125.23 1.412 . . . . 100.0 111.496 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.61 -45.01 92.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.839 0.856 . . . . 100.0 111.116 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.82 -43.77 95.24 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 123.372 0.42 . . . . 100.0 110.399 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 75.3 mt -61.36 -44.42 97.19 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 123.097 0.559 . . . . 100.0 110.91 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.8 98.18 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.445 1.098 . . . . 100.0 111.1 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.99 -45.04 95.36 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 122.851 0.46 . . . . 100.0 111.565 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 28.1 tptp -65.25 -46.31 81.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 122.893 0.477 . . . . 100.0 111.633 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.41 -46.99 80.85 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.397 1.258 . . . . 100.0 114.397 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.45 -38.23 73.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 C-N-CA 124.917 1.287 . . . . 100.0 109.623 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.71 10.53 57.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-O 118.515 -1.158 . . . . 100.0 111.14 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -114.17 113.1 46.49 Favored Pre-proline 0 C--N 1.364 1.224 0 N-CA-C 107.648 -1.241 . . . . 100.0 107.648 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.68 -14.15 32.95 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 123.894 3.063 . . . . 100.0 113.254 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -91.4 2.4 56.43 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.25 135.01 57.59 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 118.74 0.7 . . . . 100.0 112.108 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -133.99 148.78 51.17 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.029 -1.1 . . . . 100.0 108.029 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -90.25 112.3 23.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.674 -2.713 . . . . 100.0 103.674 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.81 -40.43 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 114.602 1.334 . . . . 100.0 114.602 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.39 145.8 50.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.34 -0.985 . . . . 100.0 108.34 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.4 ttm -85.73 129.58 54.15 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.129 -1.434 . . . . 100.0 107.129 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.95 155.93 65.25 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.366 2.044 . . . . 100.0 109.964 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.12 122.73 18.9 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.632 -1.618 . . . . 100.0 106.632 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.89 148.04 43.34 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-N 114.257 -1.338 . . . . 100.0 109.373 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.14 96.02 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 105.228 -2.138 . . . . 100.0 105.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_exo -56.26 142.04 87.93 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 123.236 2.624 . . . . 100.0 112.866 -178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 154' ' ' ASN . 50.0 Cg_exo -56.5 125.94 20.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.638 2.226 . . . . 100.0 112.543 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.02 -42.66 72.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 124.938 1.399 . . . . 100.0 108.671 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.62 158.11 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 106.292 -1.744 . . . . 100.0 106.292 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.82 129.77 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.56 -1.644 . . . . 100.0 106.56 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.539 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -91.72 123.64 35.26 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 103.229 -2.878 . . . . 100.0 103.229 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.421 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.4 t70 -62.16 129.12 91.86 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.992 -1.004 . . . . 100.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 63.4 Cg_exo -58.9 -38.5 88.0 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.712 2.941 . . . . 100.0 113.552 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.92 94.78 Favored 'General case' 0 C--N 1.36 1.051 0 O-C-N 123.94 0.775 . . . . 100.0 110.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.36 -41.71 98.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 122.979 0.511 . . . . 100.0 111.114 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.14 97.6 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.745 0.818 . . . . 100.0 110.331 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.03 99.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.989 0.916 . . . . 100.0 110.547 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -62.33 -45.61 92.44 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.714 0.806 . . . . 100.0 111.754 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -63.6 -43.38 97.1 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 112.197 0.443 . . . . 100.0 112.197 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.34 -40.54 96.09 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.294 0.371 . . . . 100.0 111.455 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.57 -42.33 98.34 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.866 0.866 . . . . 100.0 110.197 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.33 -42.42 98.65 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 123.68 0.792 . . . . 100.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.526 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 85.2 mt -61.12 -48.1 83.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 123.735 0.647 . . . . 100.0 109.453 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.51 -43.64 98.33 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 114.084 1.142 . . . . 100.0 114.084 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.46 -47.02 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.072 0 CA-C-O 117.988 -1.006 . . . . 100.0 108.822 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.753 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.739 . . -88.66 -9.61 51.48 Favored 'General case' 1 N--CA 1.375 -4.202 1 C-N-CA 104.142 -7.023 . . . . 100.0 116.806 179.79 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.772 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 60.6 mt-30 -54.57 -36.03 63.93 Favored 'General case' 0 CA--C 1.445 -3.066 0 C-N-CA 128.86 2.864 . . . . 100.0 106.232 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.2 p -81.61 40.18 0.57 Allowed 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 123.07 1.414 . . . . 100.0 110.061 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.289 5.0 m 57.45 29.73 17.49 Favored 'General case' 0 CA--C 1.468 -2.206 0 C-N-CA 128.579 2.752 . . . . 100.0 112.918 175.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.499 ' HB1' ' HA ' ' A' ' 204' ' ' ALA 0.257 . . -72.51 172.94 9.59 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 100.989 -3.708 . . . . 100.0 100.989 171.697 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.77 -35.9 34.01 Favored Pre-proline 0 CA--C 1.493 -1.22 0 CA-C-O 116.971 -1.49 . . . . 100.0 114.812 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.871 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.414 4.9 Cg_exo -53.97 137.95 69.47 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 CA-C-O 122.948 1.145 . . . . 100.0 113.124 176.569 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.545 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.375 45.8 m-20 -63.87 -43.91 94.66 Favored 'General case' 0 N--CA 1.408 -2.526 1 N-CA-C 122.783 4.364 . . . . 100.0 122.783 -174.245 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 16.0 tm-20 -66.34 -24.54 66.53 Favored 'General case' 0 CA--C 1.468 -2.208 1 CA-C-O 131.487 5.422 . . . . 100.0 111.598 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.749 55.2 m-20 -74.62 -51.47 14.38 Favored 'General case' 1 N--CA 1.267 -9.576 1 CA-C-N 105.454 -5.339 . . . . 100.0 105.406 -176.566 . . . . . . . . 5 3 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -63.66 -26.17 68.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 118.065 -2.897 . . . . 100.0 107.933 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.786 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 48.3 m-20 -62.89 -41.96 99.6 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 126.134 1.774 . . . . 100.0 112.754 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.552 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.383 1.0 OUTLIER . . . . . 0 C--O 1.261 1.67 0 CA-C-O 115.082 -2.389 . . . . 100.0 115.74 -178.47 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 CA--C 1.494 -1.183 0 CA-C-O 119.384 -0.341 . . . . 100.0 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.61 -41.64 90.83 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.01 158.69 17.92 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 115.291 1.589 . . . . 100.0 115.291 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -85.19 158.83 20.25 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.401 1.08 . . . . 100.0 109.412 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.3 9.63 86.79 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 119.475 -0.625 . . . . 100.0 114.463 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -81.37 150.27 67.04 Favored Pre-proline 0 N--CA 1.437 -1.102 0 CA-C-N 118.443 1.121 . . . . 100.0 109.886 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.8 152.6 81.5 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.98 2.453 . . . . 100.0 109.074 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.7 138.89 58.04 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.228 0.537 . . . . 100.0 111.492 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 115.27 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.585 -1.189 . . . . 100.0 109.627 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.431 ' HA ' ' O ' ' A' ' 60' ' ' LYS . 43.1 mt-30 -127.48 135.75 50.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.399 -1.728 . . . . 100.0 107.73 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -124.43 144.24 50.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.46 -0.791 . . . . 100.0 109.134 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.1 121.64 33.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.32 128.16 56.22 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.419 -1.697 . . . . 100.0 106.419 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.8 t -104.29 125.6 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.621 -1.251 . . . . 100.0 107.621 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.436 HD12 ' SD ' ' A' ' 89' ' ' MET . 39.3 tp -110.06 117.47 33.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.86 -1.904 . . . . 100.0 105.86 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.88 160.45 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 112.165 0.432 . . . . 100.0 112.165 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.95 172.71 24.5 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 108.559 -1.816 . . . . 100.0 108.559 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -67.33 154.41 41.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.946 0.879 . . . . 100.0 112.478 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 139.9 42.49 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 107.263 -2.335 . . . . 100.0 107.263 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.0 -4.2 83.03 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 118.634 -1.092 . . . . 100.0 114.258 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 p -62.74 -38.36 90.22 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 118.784 1.292 . . . . 100.0 111.914 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.32 4.78 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.508 -1.037 . . . . 100.0 110.508 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.432 ' HE3' ' HG ' ' A' ' 15' ' ' LEU . 50.0 mtpt -59.53 -47.11 86.81 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.38 1.072 . . . . 100.0 113.254 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.6 m -64.59 -42.75 95.38 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.254 0.622 . . . . 100.0 110.598 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.6 m -62.24 -42.14 99.05 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 124.126 0.97 . . . . 100.0 108.971 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.75 -48.37 82.11 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.215 1.006 . . . . 100.0 112.968 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.85 -39.94 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 123.133 0.271 . . . . 100.0 110.91 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -65.5 -12.14 49.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 115.249 1.574 . . . . 100.0 115.249 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.563 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 41.0 mtt180 -60.02 -38.35 82.43 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.491 -0.929 . . . . 100.0 108.491 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.758 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 62.1 t-80 -80.63 111.5 17.12 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 106.799 -1.556 . . . . 100.0 106.799 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.59 -44.37 97.14 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.227 1.566 . . . . 100.0 115.227 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.459 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.1 m -62.85 -42.67 99.84 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.333 1.053 . . . . 100.0 109.35 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.758 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.38 -42.07 99.68 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 111.15 -0.78 . . . . 100.0 111.15 -179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.15 -43.54 91.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 122.783 0.433 . . . . 100.0 111.502 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -62.89 -40.85 98.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.211 1.004 . . . . 100.0 111.85 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -94.07 10.08 35.12 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 115.211 1.56 . . . . 100.0 115.211 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -59.6 142.76 52.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 114.16 1.17 . . . . 100.0 114.16 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.22 132.89 51.65 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.296 -1.002 . . . . 100.0 108.296 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -100.44 127.49 46.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.855 -1.165 . . . . 100.0 107.855 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 109.32 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.352 -3.203 . . . . 100.0 102.352 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.23 99.35 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 p -61.73 -43.67 98.41 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 123.63 0.772 . . . . 100.0 112.718 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.9 mt -93.68 -18.15 22.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 114.393 1.257 . . . . 100.0 114.393 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.96 43.68 64.5 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.268 -1.533 . . . . 100.0 109.268 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.63 143.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.352 -0.981 . . . . 100.0 108.352 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.89 115.4 28.92 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 101.052 -3.685 . . . . 100.0 101.052 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 120.69 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.072 -1.455 . . . . 100.0 107.072 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -113.41 119.15 42.5 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 115.864 -0.607 . . . . 100.0 109.807 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.77 106.22 1.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.3 2.0 . . . . 100.0 111.468 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.79 115.88 29.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.827 -1.175 . . . . 100.0 107.827 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 t -102.39 129.11 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.053 -1.462 . . . . 100.0 107.053 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.91 136.61 53.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.666 -1.975 . . . . 100.0 105.666 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . 0.492 ' HD1' ' HB ' ' A' ' 177' ' ' VAL . 60.2 t-80 -101.83 119.17 38.36 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.601 -0.888 . . . . 100.0 108.601 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -106.45 -178.46 3.66 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.033 -0.985 . . . . 100.0 111.489 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.0 -37.99 78.16 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.581 1.952 . . . . 100.0 108.583 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -89.98 0.65 56.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 113.741 1.015 . . . . 100.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -175.37 15.86 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.199 -1.16 . . . . 100.0 110.199 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.25 138.95 58.09 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.979 2.452 . . . . 100.0 116.944 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -129.02 130.97 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 102.885 -3.006 . . . . 100.0 102.885 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' A' ' 10' ' ' GLN . 88.7 mttt -114.63 127.58 55.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.422 -0.585 . . . . 100.0 109.422 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -110.96 116.02 30.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -88.11 105.83 17.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 101.465 -3.531 . . . . 100.0 101.465 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.24 122.57 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.708 -1.219 . . . . 100.0 107.708 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -93.6 115.25 27.72 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.886 -1.894 . . . . 100.0 105.886 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -111.37 141.69 44.6 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.642 -1.985 . . . . 100.0 105.642 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -75.04 164.23 26.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.978 0.894 . . . . 100.0 112.882 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.39 16.15 20.95 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.756 -1.111 . . . . 100.0 108.318 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.77 59.2 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 121.728 -0.608 . . . . 100.0 113.422 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -62.24 -23.72 66.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.987 1.715 . . . . 100.0 112.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.31 -33.79 72.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.167 2.187 . . . . 100.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.4 -43.3 99.15 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.044 0.938 . . . . 100.0 109.684 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -70.14 -42.64 72.29 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.919 1.288 . . . . 100.0 113.09 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.93 -149.38 9.17 Favored Glycine 0 C--N 1.358 1.774 0 N-CA-C 110.99 -0.844 . . . . 100.0 110.99 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.87 50.28 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 122.185 0.881 . . . . 100.0 112.664 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.58 142.49 37.42 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 121.939 0.876 . . . . 100.0 109.651 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -64.03 151.75 42.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.403 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.01 -37.22 79.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.428 1.491 . . . . 100.0 110.003 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.76 89.34 Favored Glycine 0 C--N 1.356 1.652 0 C-N-CA 125.237 1.399 . . . . 100.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -62.85 -46.19 89.06 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 123.458 0.703 . . . . 100.0 111.081 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -70.9 -35.59 72.37 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.955 1.835 . . . . 100.0 115.955 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -51.87 134.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 122.987 1.375 . . . . 100.0 114.429 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 65.74 19.27 11.36 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 128.132 2.573 . . . . 100.0 114.635 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 132.32 48.57 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.052 -1.092 . . . . 100.0 108.052 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -95.19 -33.14 12.73 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.544 -0.753 . . . . 100.0 109.075 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 26.0 p -152.38 163.68 39.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.888 -0.412 . . . . 100.0 109.888 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.28 154.36 40.88 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 114.54 1.311 . . . . 100.0 114.54 179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.5 mt -125.43 125.93 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.057 -2.571 . . . . 100.0 104.057 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 50.8 mt -110.55 123.89 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.941 -2.985 . . . . 100.0 102.941 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.436 ' SD ' HD12 ' A' ' 15' ' ' LEU . 87.3 mtp -111.41 136.82 50.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -129.53 164.23 24.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.295 -2.23 . . . . 100.0 108.187 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -106.39 125.41 50.96 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.476 -2.046 . . . . 100.0 105.476 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.75 -17.15 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -91.69 -4.57 54.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.215 0.462 . . . . 100.0 111.306 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 t -124.38 116.08 22.01 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.472 1.129 . . . . 100.0 109.213 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -65.4 -37.73 87.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.402 1.081 . . . . 100.0 111.087 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.41 -41.22 83.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.258 1.823 . . . . 100.0 110.333 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 p -62.41 -40.97 98.27 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.366 0.53 . . . . 100.0 111.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -64.13 -41.63 97.13 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 123.895 0.878 . . . . 100.0 109.789 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -61.17 -36.85 80.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.095 0.958 . . . . 100.0 111.495 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.27 -6.56 56.95 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.133 1.531 . . . . 100.0 115.133 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.69 -42.4 91.22 Favored Pre-proline 0 C--N 1.364 1.219 0 CA-C-O 116.316 -1.802 . . . . 100.0 111.285 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.453 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 75.9 Cg_exo -57.85 -36.82 98.04 Favored 'Trans proline' 0 C--N 1.377 2.071 0 CA-C-N 122.234 1.834 . . . . 100.0 112.597 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.11 -44.41 92.37 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 119.438 1.017 . . . . 100.0 111.385 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -63.98 -42.25 97.28 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 122.817 0.447 . . . . 100.0 110.394 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -62.67 -43.03 99.84 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.082 0.953 . . . . 100.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -62.35 -45.19 94.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 122.892 0.477 . . . . 100.0 112.2 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -63.69 -43.36 96.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.596 0.56 . . . . 100.0 111.397 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 51.0 tp -63.11 -48.36 78.89 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.011 0.924 . . . . 100.0 113.093 -179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 27.5 m -65.69 -36.4 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 123.668 0.787 . . . . 100.0 112.97 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.13 -45.97 91.24 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 118.916 -0.564 . . . . 100.0 109.675 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.03 -45.15 55.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-N 118.154 0.433 . . . . 100.0 111.79 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 24.1 t -130.07 112.68 13.68 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 118.714 -1.195 . . . . 100.0 108.523 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.54 144.56 27.16 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.788 -1.097 . . . . 100.0 113.671 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.08 40.97 32.17 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 117.338 2.347 . . . . 100.0 117.338 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.0 pt -98.36 143.82 26.98 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 107.998 -1.112 . . . . 100.0 107.998 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -62.02 131.75 36.24 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.473 2.115 . . . . 100.0 111.017 178.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.451 ' HB ' HD21 ' A' ' 144' ' ' LEU . 74.3 mt -133.13 137.32 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 122.406 1.098 . . . . 100.0 108.794 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -115.98 130.88 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 106.767 -1.568 . . . . 100.0 106.767 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.626 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 14.4 mt -105.41 128.5 53.55 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.764 -2.31 . . . . 100.0 104.764 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.1 m -118.75 129.69 55.39 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.458 . . . . 100.0 112.399 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.607 ' HA3' ' HH ' ' A' ' 146' ' ' TYR . . . -102.09 109.07 3.48 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 105.261 -3.136 . . . . 100.0 105.261 178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.503 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.378 9.4 p-10 -95.57 178.54 5.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 62.41 40.51 10.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 127.816 2.446 . . . . 100.0 112.511 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.3 28.1 m -72.21 -8.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 115.993 -0.549 . . . . 100.0 111.24 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.85 -36.79 84.42 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.47 1.908 . . . . 100.0 109.998 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.42 130.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 108.145 -1.057 . . . . 100.0 108.145 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -43.24 99.22 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.915 1.82 . . . . 100.0 115.915 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -88.68 97.85 11.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.607 -1.998 . . . . 100.0 105.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -96.5 112.79 24.4 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.42 -1.326 . . . . 100.0 107.42 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -75.2 -45.05 42.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.102 1.519 . . . . 100.0 115.102 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.23 106.73 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 105.985 -1.857 . . . . 100.0 105.985 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.07 174.08 6.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.854 -1.066 . . . . 100.0 112.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.63 66.93 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 127.367 2.267 . . . . 100.0 109.09 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.855 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 95.2 mttt -56.91 -39.33 74.24 Favored 'General case' 0 N--CA 1.42 -1.931 0 C-N-CA 128.723 2.809 . . . . 100.0 112.547 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 89.9 p -104.65 5.1 33.35 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 115.907 1.817 . . . . 100.0 115.907 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.476 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 65.6 mt -88.76 77.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.112 0 C-N-CA 117.548 -1.661 . . . . 100.0 111.788 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.253 59.0 t -70.86 -38.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 1 C-N-CA 133.81 4.844 . . . . 100.0 118.869 -178.387 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.04 -35.82 67.32 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 121.427 3.862 . . . . 100.0 121.427 -168.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.719 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.274 81.0 m-70 -59.58 -38.58 81.58 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 116.783 -1.579 . . . . 100.0 114.264 -176.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.758 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.254 0.4 OUTLIER -59.42 -46.61 88.23 Favored 'General case' 0 CA--C 1.452 -2.819 0 N-CA-C 116.194 1.924 . . . . 100.0 116.194 -176.661 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.87 -41.08 97.43 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 125.756 1.91 . . . . 100.0 110.832 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -101.49 6.46 42.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 117.15 2.278 . . . . 100.0 117.15 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 56.32 42.36 27.89 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-O 123.026 1.393 . . . . 100.0 113.646 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.451 HD21 ' HB ' ' A' ' 117' ' ' ILE . 25.2 mt -99.97 149.17 23.71 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.523 -2.029 . . . . 100.0 105.523 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.77 143.87 28.63 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.482 -0.933 . . . . 100.0 108.482 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.719 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.5 t80 -110.25 137.27 48.21 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.938 0.718 . . . . 100.0 112.938 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -133.78 137.01 44.9 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.543 -1.208 . . . . 100.0 110.575 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.362 69.9 m-20 -85.59 130.09 34.66 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 101.464 -3.532 . . . . 100.0 101.464 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 44.1 pt -137.27 158.29 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 122.248 1.023 . . . . 100.0 111.462 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.8 m -139.06 110.58 7.04 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 106.137 -1.801 . . . . 100.0 106.137 175.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.563 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.72 -44.47 96.86 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.625 -1.171 . . . . 100.0 112.71 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.79 -39.7 92.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.324 1.449 . . . . 100.0 113.012 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.519 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 99.0 p -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 115.676 1.732 . . . . 100.0 115.676 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.52 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.3 m-80 63.6 24.08 13.83 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 125.158 1.383 . . . . 100.0 110.919 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -74.12 125.14 27.69 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.504 -1.295 . . . . 100.0 107.504 -178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 53.43 36.73 23.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.095 2.558 . . . . 100.0 114.652 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.499 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 70.6 t80 -60.82 -43.39 98.3 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.726 -0.609 . . . . 100.0 111.94 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -63.53 -37.28 86.7 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.398 1.999 . . . . 100.0 116.398 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.47 -46.66 99.77 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.897 3.295 . . . . 100.0 119.897 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.62 -41.95 43.52 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.139 2.157 . . . . 100.0 111.919 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.92 -41.43 95.56 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.729 1.212 . . . . 100.0 110.969 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.3 -46.81 87.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.206 1.002 . . . . 100.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -65.63 -42.17 91.81 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 120.28 -0.568 . . . . 100.0 110.494 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 85.0 mt -61.92 -42.87 99.59 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 119.208 -0.425 . . . . 100.0 111.415 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.73 98.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 124.018 0.927 . . . . 100.0 110.564 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.79 -45.72 92.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 119.188 -0.435 . . . . 100.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 52.6 tptt -65.55 -44.93 85.3 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.518 0.511 . . . . 100.0 112.105 -178.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.46 -46.37 83.37 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 114.279 1.215 . . . . 100.0 114.279 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.7 -37.85 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.225 1.01 . . . . 100.0 109.479 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.43 57.13 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.27 -1.132 . . . . 100.0 110.27 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -112.57 110.53 52.58 Favored Pre-proline 0 C--N 1.364 1.218 0 N-CA-C 108.041 -1.096 . . . . 100.0 108.041 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.97 -14.15 32.08 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.748 2.965 . . . . 100.0 113.285 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -90.36 -0.47 57.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.499 1.12 . . . . 100.0 112.987 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.3 mt -61.94 136.16 57.85 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.739 1.014 . . . . 100.0 113.739 -179.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -134.89 154.86 51.5 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.908 -1.145 . . . . 100.0 107.908 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -90.49 116.24 28.25 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 103.872 -2.64 . . . . 100.0 103.872 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . 0.492 ' HB ' ' HD1' ' A' ' 53' ' ' HIS . 64.1 t -65.7 -44.73 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 123.971 0.908 . . . . 100.0 111.188 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.08 150.5 52.14 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.561 -0.903 . . . . 100.0 108.561 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -95.02 130.86 31.5 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.493 -1.299 . . . . 100.0 107.493 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -64.58 158.27 50.85 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.466 2.11 . . . . 100.0 111.51 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.8 125.43 25.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.37 1.081 . . . . 100.0 108.585 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.35 147.21 45.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.863 -1.517 . . . . 100.0 108.804 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.27 135.84 95.31 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 105.777 -1.934 . . . . 100.0 105.777 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_exo -55.97 142.33 85.11 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 123.549 2.833 . . . . 100.0 113.197 -177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HG3' HD21 ' A' ' 154' ' ' ASN . 50.2 Cg_exo -56.8 128.67 30.91 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.634 2.223 . . . . 100.0 112.94 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.8 -43.37 72.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.892 -1.151 . . . . 100.0 107.892 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 157.78 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 106.538 -1.653 . . . . 100.0 106.538 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.05 130.41 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.87 -1.53 . . . . 100.0 106.87 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.519 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -87.64 125.86 34.62 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 103.664 -2.717 . . . . 100.0 103.664 178.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.22 126.93 90.26 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.122 -0.945 . . . . 100.0 110.327 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.92 -38.14 89.8 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 123.631 2.887 . . . . 100.0 113.68 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.71 94.07 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.146 0.904 . . . . 100.0 110.049 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -40.81 97.72 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 123.127 0.571 . . . . 100.0 111.251 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.54 98.67 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.659 0.784 . . . . 100.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.45 99.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.935 0.894 . . . . 100.0 110.533 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -61.71 -46.06 91.29 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.349 1.059 . . . . 100.0 111.363 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -63.91 -43.35 96.22 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 112.275 0.472 . . . . 100.0 112.275 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -64.33 -39.66 94.35 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.333 0.396 . . . . 100.0 111.633 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.76 -44.27 96.64 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.223 1.009 . . . . 100.0 110.209 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -61.61 -42.76 99.34 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.459 0.704 . . . . 100.0 110.894 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.474 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 79.5 mt -61.15 -48.49 81.37 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 115.784 -0.643 . . . . 100.0 110.271 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.26 -43.95 96.53 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 113.709 1.003 . . . . 100.0 113.709 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -45.81 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.945 0 CA-C-O 118.372 -0.823 . . . . 100.0 109.443 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.714 ' CB ' ' HB3' ' A' ' 213' ' ' ASP 0.746 . . -86.45 -10.78 53.51 Favored 'General case' 1 N--CA 1.376 -4.174 1 C-N-CA 104.526 -6.87 . . . . 100.0 115.747 179.945 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 52.6 mt-30 -54.68 -35.27 63.39 Favored 'General case' 0 CA--C 1.443 -3.158 0 C-N-CA 128.703 2.801 . . . . 100.0 107.148 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.2 p -81.36 40.58 0.57 Allowed 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.857 1.313 . . . . 100.0 109.572 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.266 6.4 m 59.13 27.17 16.07 Favored 'General case' 0 CA--C 1.471 -2.086 0 C-N-CA 127.277 2.231 . . . . 100.0 112.984 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.48 ' HB1' ' HA ' ' A' ' 204' ' ' ALA 0.266 . . -72.09 170.5 13.78 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.316 -3.587 . . . . 100.0 101.316 171.885 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.95 -35.4 29.03 Favored Pre-proline 0 CA--C 1.486 -1.515 0 CA-C-O 116.499 -1.715 . . . . 100.0 114.911 -174.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.855 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.445 0.0 OUTLIER -54.38 139.48 73.98 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 O-C-N 123.741 1.39 . . . . 100.0 111.898 176.403 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.608 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.453 39.5 m-20 -65.73 -43.21 89.75 Favored 'General case' 0 N--CA 1.408 -2.53 1 N-CA-C 125.03 5.196 . . . . 100.0 125.03 -173.577 . . . . . . . . 4 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.552 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.7 tm-20 -62.58 -35.81 80.71 Favored 'General case' 0 CA--C 1.469 -2.16 1 CA-C-O 132.292 5.806 . . . . 100.0 108.734 176.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.76 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.629 17.5 m-20 -62.34 -51.9 65.8 Favored 'General case' 1 N--CA 1.282 -8.842 2 CA-C-N 104.098 -5.955 . . . . 100.0 107.554 178.719 . . . . . . . . 5 3 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.28 -25.33 66.0 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 117.261 -3.399 . . . . 100.0 107.579 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.758 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 57.9 m-20 -63.78 -40.4 96.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 126.979 2.112 . . . . 100.0 112.395 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.441 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.274 3.2 mm? . . . . . 0 N--CA 1.426 -1.654 0 CA-C-O 114.157 -2.83 . . . . 100.0 112.781 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.046 0.45 . . . . 100.0 111.375 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.23 92.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.064 1.346 . . . . 100.0 114.33 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 162.67 27.82 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 116.849 2.166 . . . . 100.0 116.849 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -80.56 164.15 23.15 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.911 1.284 . . . . 100.0 110.126 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.55 -4.27 82.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.688 -0.507 . . . . 100.0 112.381 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.421 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 75.5 mm-40 -72.59 141.01 82.15 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 123.811 0.844 . . . . 100.0 111.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 6' ' ' GLU . 39.4 Cg_exo -62.92 137.88 65.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.859 2.373 . . . . 100.0 109.513 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.74 150.05 41.4 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.108 0.88 . . . . 100.0 111.051 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.09 106.92 16.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 102.009 -3.33 . . . . 100.0 102.009 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.41 138.74 52.47 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.813 -0.63 . . . . 100.0 110.828 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.83 144.37 51.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.605 -0.725 . . . . 100.0 110.017 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.64 120.3 32.93 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.217 -1.401 . . . . 100.0 107.217 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 57.1 tp -110.6 125.87 53.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.131 -1.849 . . . . 100.0 107.23 -179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 56.0 t -103.05 124.69 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.694 -1.224 . . . . 100.0 107.694 179.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.454 HD12 ' SD ' ' A' ' 89' ' ' MET . 42.5 tp -109.29 117.33 33.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.124 -1.806 . . . . 100.0 106.124 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -128.79 161.47 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 112.129 0.418 . . . . 100.0 112.129 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.69 173.96 24.14 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 108.403 -1.879 . . . . 100.0 108.403 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.4 154.35 41.55 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.061 0.934 . . . . 100.0 112.938 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.84 141.18 43.31 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.07 -2.412 . . . . 100.0 107.07 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.78 -1.53 86.99 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-O 118.084 -1.398 . . . . 100.0 113.288 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 p -63.91 -38.39 90.91 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 119.261 1.531 . . . . 100.0 111.649 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.47 21.78 4.63 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.487 -1.045 . . . . 100.0 110.487 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -59.98 -46.86 88.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.759 1.224 . . . . 100.0 113.237 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -63.68 -43.73 95.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.986 0.914 . . . . 100.0 110.03 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -41.13 99.1 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.939 0.896 . . . . 100.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -60.44 -48.72 80.51 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.945 0.898 . . . . 100.0 112.772 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.89 -40.94 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 123.103 0.252 . . . . 100.0 111.114 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.265 99.3 mttt -69.13 -7.08 32.85 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 116.302 1.964 . . . . 100.0 116.302 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.561 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 43.6 mtt180 -61.01 -37.84 83.95 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 107.49 -1.3 . . . . 100.0 107.49 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.73 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 60.8 t-80 -80.71 112.71 18.33 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 106.831 -1.544 . . . . 100.0 106.831 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.92 -44.46 96.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.983 1.845 . . . . 100.0 115.983 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 84.8 m -63.72 -42.12 97.97 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.869 0.868 . . . . 100.0 109.479 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.73 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.63 -41.5 99.59 Favored Glycine 0 C--N 1.357 1.744 0 N-CA-C 110.977 -0.849 . . . . 100.0 110.977 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -64.6 -44.25 91.22 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.721 0.808 . . . . 100.0 110.866 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -63.42 -40.32 96.88 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.428 1.091 . . . . 100.0 111.484 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.12 8.6 34.81 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 114.887 1.44 . . . . 100.0 114.887 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -58.84 142.92 49.13 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 114.538 1.311 . . . . 100.0 114.538 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.61 139.98 52.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.354 -1.351 . . . . 100.0 107.354 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -111.89 125.97 54.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.34 -2.467 . . . . 100.0 104.34 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.28 108.15 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.448 -3.167 . . . . 100.0 102.448 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.66 99.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 114.591 1.33 . . . . 100.0 114.591 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -61.47 -42.5 98.86 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 123.699 0.8 . . . . 100.0 112.914 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.58 -20.97 19.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.356 1.243 . . . . 100.0 114.356 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.05 43.24 49.25 Favored Glycine 0 C--N 1.36 1.889 0 N-CA-C 108.504 -1.839 . . . . 100.0 108.504 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.1 t -126.7 145.39 34.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.337 -0.986 . . . . 100.0 108.337 -178.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 117.82 34.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 102.44 -3.17 . . . . 100.0 102.44 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.63 123.12 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.094 -1.447 . . . . 100.0 107.094 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -115.15 121.59 34.78 Favored Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 115.365 -0.834 . . . . 100.0 110.519 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -80.45 103.38 1.51 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 122.226 1.951 . . . . 100.0 110.36 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.92 113.0 24.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.595 0.758 . . . . 100.0 109.323 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 t -98.48 130.26 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.689 0.796 . . . . 100.0 108.854 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.92 135.44 51.89 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.529 -2.026 . . . . 100.0 105.529 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -102.12 118.48 36.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.651 -0.819 . . . . 100.0 109.34 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p -103.86 176.12 5.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.077 -0.965 . . . . 100.0 109.768 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -60.13 -35.24 74.83 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.789 1.635 . . . . 100.0 109.582 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -90.5 -0.46 57.67 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 113.767 1.025 . . . . 100.0 113.767 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.07 178.07 15.26 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 119.493 1.042 . . . . 100.0 111.763 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.59 139.84 60.1 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 123.099 2.533 . . . . 100.0 114.323 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 mm -127.42 130.62 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 102.359 -3.2 . . . . 100.0 102.359 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -116.25 130.12 56.62 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 121.681 -0.637 . . . . 100.0 109.978 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.33 115.65 29.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 104.922 -2.251 . . . . 100.0 104.922 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.84 107.33 18.93 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 100.63 -3.841 . . . . 100.0 100.63 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 21.5 t -93.56 122.65 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.183 -1.043 . . . . 100.0 108.183 -175.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -94.24 111.77 23.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.155 -2.165 . . . . 100.0 105.155 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -115.02 137.46 51.98 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 106.95 -1.5 . . . . 100.0 106.95 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.5 p -70.85 163.7 26.81 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.04 0.924 . . . . 100.0 113.078 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.88 25.9 7.49 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.229 -1.026 . . . . 100.0 108.229 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.76 13.73 60.59 Favored Glycine 0 C--N 1.361 1.92 0 O-C-N 121.613 -0.679 . . . . 100.0 114.147 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.467 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 73.9 mt-30 -59.55 -35.04 73.47 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.795 2.038 . . . . 100.0 112.296 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.96 -32.84 68.23 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.416 2.686 . . . . 100.0 112.128 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.54 -40.07 95.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.12 0.968 . . . . 100.0 111.159 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.467 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 17.3 p90 -94.56 -18.08 21.75 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 115.578 1.696 . . . . 100.0 115.578 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.44 -162.83 27.86 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 119.836 -1.173 . . . . 100.0 112.518 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.25 178.46 53.86 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.601 -1.4 . . . . 100.0 109.601 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.457 HD11 ' CE2' ' A' ' 79' ' ' TYR . 95.6 mt -102.89 145.48 29.74 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 122.568 1.175 . . . . 100.0 111.09 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.15 150.12 49.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.082 -1.872 . . . . 100.0 111.433 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.39 -36.7 83.14 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.874 1.27 . . . . 100.0 108.859 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.67 -38.02 93.18 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 125.81 1.671 . . . . 100.0 110.587 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' CE2' HD11 ' A' ' 75' ' ' LEU . 73.9 t80 -63.66 -46.96 83.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.251 0.526 . . . . 100.0 111.5 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -70.27 -37.01 74.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 116.871 2.174 . . . . 100.0 116.871 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.18 139.89 13.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 CA-C-O 122.375 1.083 . . . . 100.0 113.75 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 70.8 11.5 7.15 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.92 2.088 . . . . 100.0 113.582 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.97 131.55 46.49 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.827 -0.805 . . . . 100.0 108.827 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -98.65 -27.82 13.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.149 -0.932 . . . . 100.0 109.513 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 22.4 p -152.21 163.05 40.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 122.284 0.234 . . . . 100.0 110.392 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -148.74 153.43 38.19 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 95.6 mt -126.55 126.5 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 103.856 -2.646 . . . . 100.0 103.856 176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.47 ' HB ' HD21 ' A' ' 119' ' ' LEU . 39.8 mt -111.37 125.09 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 102.934 -2.988 . . . . 100.0 102.934 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.454 ' SD ' HD12 ' A' ' 15' ' ' LEU . 88.8 mtp -112.5 137.1 51.2 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 114.596 1.332 . . . . 100.0 114.596 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -129.94 161.48 30.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.051 -2.34 . . . . 100.0 108.265 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.95 125.77 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.061 -1.829 . . . . 100.0 106.061 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.72 -16.95 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 113.355 0.872 . . . . 100.0 113.355 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -90.21 -7.44 53.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 119.146 -0.454 . . . . 100.0 111.109 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.4 t -123.66 116.9 23.83 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-O 122.214 1.007 . . . . 100.0 110.318 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -65.45 -36.85 85.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.146 0.978 . . . . 100.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.77 -40.22 81.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.571 1.549 . . . . 100.0 110.288 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.9 p -62.36 -41.04 98.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 118.439 0.563 . . . . 100.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -64.3 -41.67 96.74 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 123.734 0.814 . . . . 100.0 110.438 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.488 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.6 mttt -60.36 -37.76 81.72 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 124.336 1.054 . . . . 100.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -76.27 -9.79 58.91 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 115.631 1.715 . . . . 100.0 115.631 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -42.19 88.99 Favored Pre-proline 0 C--N 1.362 1.14 0 CA-C-O 116.32 -1.8 . . . . 100.0 112.087 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.488 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 76.5 Cg_exo -57.53 -37.91 95.61 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.351 2.034 . . . . 100.0 112.74 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.71 -44.59 89.75 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.631 1.172 . . . . 100.0 110.683 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -63.53 -42.43 98.44 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.267 0.627 . . . . 100.0 110.674 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -62.78 -44.91 94.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 124.339 1.055 . . . . 100.0 110.231 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -63.12 -42.28 99.51 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 112.636 0.606 . . . . 100.0 112.636 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -61.82 -46.11 90.93 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.02 0.528 . . . . 100.0 109.798 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.84 -48.25 79.85 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.588 0.959 . . . . 100.0 113.588 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.32 -38.37 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 125.069 1.348 . . . . 100.0 111.473 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -60.37 -39.38 87.01 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.554 0.616 . . . . 100.0 111.439 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.17 -44.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 118.279 0.49 . . . . 100.0 110.61 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.2 m -127.59 106.78 9.4 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.521 0.601 . . . . 100.0 109.944 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.37 144.96 26.52 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.957 0.884 . . . . 100.0 112.615 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . 0.255 72.2 m-20 54.06 41.18 32.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 116.926 2.195 . . . . 100.0 116.926 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -96.48 144.17 27.37 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.998 -2.223 . . . . 100.0 104.998 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 132.26 36.14 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.354 2.036 . . . . 100.0 110.148 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.433 ' HB ' HD21 ' A' ' 144' ' ' LEU . 73.3 mt -132.24 136.59 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 122.309 1.052 . . . . 100.0 108.57 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 60.7 t -115.55 131.95 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.989 -1.856 . . . . 100.0 105.989 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.49 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 25.9 mt -106.59 127.86 53.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.601 -2.0 . . . . 100.0 105.601 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 70.8 m -119.23 130.16 55.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.398 -1.274 . . . . 100.0 113.406 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.21 107.24 3.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 104.797 -3.321 . . . . 100.0 104.797 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.491 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.333 0.6 OUTLIER -95.64 177.9 5.65 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.668 1.358 . . . . 100.0 114.668 -178.266 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 61.82 40.14 13.13 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.742 2.417 . . . . 100.0 112.729 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.303 24.7 m -72.15 -8.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 CA-C-N 116.187 -0.461 . . . . 100.0 111.366 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.09 -37.3 86.64 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.6 1.96 . . . . 100.0 109.977 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.9 129.61 31.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 N-CA-C 107.743 -1.206 . . . . 100.0 107.743 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.54 -44.31 97.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.891 1.441 . . . . 100.0 114.891 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -87.74 95.29 10.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.773 -1.566 . . . . 100.0 106.773 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -94.99 125.31 39.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.229 -1.767 . . . . 100.0 106.229 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.32 -36.28 11.46 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 113.982 1.104 . . . . 100.0 113.982 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.52 106.34 20.35 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 104.395 -2.446 . . . . 100.0 104.395 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -100.8 173.6 6.43 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.115 -0.948 . . . . 100.0 112.045 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.84 -34.14 67.46 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.496 1.919 . . . . 100.0 109.477 -179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.861 ' HA ' ' CB ' ' A' ' 210' ' ' PRO . 96.3 mttt -57.31 -38.91 74.74 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 129.674 3.189 . . . . 100.0 112.094 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.7 p -104.95 2.75 30.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.796 2.147 . . . . 100.0 116.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.468 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 61.9 mt -92.95 89.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 116.589 -2.045 . . . . 100.0 110.624 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.495 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.4 p -100.64 -8.61 9.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -60.47 -36.63 78.75 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 117.819 2.525 . . . . 100.0 117.819 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.49 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.262 63.6 m-70 -58.94 -39.14 80.74 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 126.489 1.916 . . . . 100.0 115.265 -176.068 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.695 ' CB ' ' HA ' ' A' ' 215' ' ' ASP 0.314 24.1 ttp-105 -59.25 -49.6 77.23 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 113.963 1.098 . . . . 100.0 113.963 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.25 -40.81 97.43 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 125.275 1.61 . . . . 100.0 111.318 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -95.32 -0.65 52.57 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.576 1.695 . . . . 100.0 115.576 -176.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.268 2.0 m-80 55.28 44.54 27.29 Favored 'General case' 0 C--N 1.362 1.134 0 CA-C-O 123.367 1.556 . . . . 100.0 114.146 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.483 ' O ' ' HB3' ' A' ' 139' ' ' HIS . 27.5 mt -106.03 143.33 34.32 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.212 -2.514 . . . . 100.0 104.212 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.257 99.8 mm-40 -92.25 145.51 24.44 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 118.625 -1.23 . . . . 100.0 110.247 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.449 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.6 t80 -110.6 137.49 48.21 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 113.063 0.764 . . . . 100.0 113.063 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.79 137.21 43.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.35 -1.296 . . . . 100.0 110.652 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.27 78.7 m-20 -83.35 129.22 34.98 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.894 -3.002 . . . . 100.0 102.894 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . 0.491 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 41.5 pt -135.32 158.5 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-O 122.295 1.045 . . . . 100.0 111.71 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.419 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 59.4 m -139.48 110.73 6.97 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 105.42 -2.067 . . . . 100.0 105.42 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.561 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -62.28 -44.83 95.62 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.559 -1.201 . . . . 100.0 113.107 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.7 -39.55 94.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 124.735 1.214 . . . . 100.0 112.98 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.524 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 91.8 p -97.27 -0.02 47.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 115.314 1.598 . . . . 100.0 115.314 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.508 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.8 m-80 65.45 20.1 11.68 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.918 1.287 . . . . 100.0 111.648 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.419 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -69.84 125.88 28.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.404 -0.962 . . . . 100.0 108.404 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 53.1 37.6 25.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 128.103 2.561 . . . . 100.0 114.566 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.514 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 71.1 t80 -60.48 -43.63 96.75 Favored 'General case' 0 C--N 1.362 1.113 0 O-C-N 121.885 -0.509 . . . . 100.0 111.457 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -64.8 -36.81 85.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 118.013 2.597 . . . . 100.0 118.013 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -56.38 -47.97 97.89 Favored Pre-proline 0 C--N 1.358 0.97 0 N-CA-C 118.863 2.912 . . . . 100.0 118.863 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -60.62 -40.55 54.84 Favored 'Trans proline' 0 C--N 1.373 1.835 0 CA-C-N 122.879 2.064 . . . . 100.0 112.29 178.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.97 -41.62 95.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 124.5 1.125 . . . . 100.0 111.164 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.45 -46.37 90.34 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 123.726 0.641 . . . . 100.0 112.024 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.78 -43.22 93.95 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.631 0.582 . . . . 100.0 110.646 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 72.8 mt -61.72 -44.83 96.17 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.243 0.617 . . . . 100.0 110.885 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.66 98.46 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 124.306 1.042 . . . . 100.0 110.793 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -61.65 -45.32 94.56 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 119.052 -0.499 . . . . 100.0 111.343 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.03 -43.72 86.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.985 1.106 . . . . 100.0 113.985 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.9 -46.59 84.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.699 0.8 . . . . 100.0 112.998 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 48.7 mm -70.77 -38.05 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.211 1.004 . . . . 100.0 110.469 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.67 10.53 58.95 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.498 -1.041 . . . . 100.0 110.498 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -114.98 114.02 43.93 Favored Pre-proline 0 C--N 1.365 1.242 0 N-CA-C 108.382 -0.97 . . . . 100.0 108.382 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.98 -12.6 30.8 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.931 3.087 . . . . 100.0 113.208 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -90.67 1.2 57.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.396 1.258 . . . . 100.0 114.396 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.95 135.85 57.52 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 118.734 0.697 . . . . 100.0 112.119 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.9 148.25 51.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.166 -0.924 . . . . 100.0 108.625 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -91.09 116.29 28.69 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 103.808 -2.664 . . . . 100.0 103.808 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.97 -44.08 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.776 0.83 . . . . 100.0 111.828 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.52 152.52 51.54 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.57 0.7 . . . . 100.0 110.508 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.06 133.79 47.52 Favored Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.797 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -66.12 156.92 62.32 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.623 2.215 . . . . 100.0 109.437 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.0 121.77 18.8 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.29 -1.745 . . . . 100.0 106.29 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.84 149.01 42.25 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.33 -1.304 . . . . 100.0 109.955 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.4 136.58 95.83 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 105.289 -2.115 . . . . 100.0 105.289 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -56.59 142.2 90.53 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.197 2.598 . . . . 100.0 112.602 -178.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.508 ' HG3' HD21 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -56.13 126.25 21.76 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.834 2.356 . . . . 100.0 112.073 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -70.55 -42.98 70.45 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 124.693 1.245 . . . . 100.0 108.483 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.96 156.59 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 106.074 -1.824 . . . . 100.0 106.074 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.37 131.0 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 106.49 -1.67 . . . . 100.0 106.49 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.524 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.1 ttt -86.71 126.15 34.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.986 -2.598 . . . . 100.0 103.986 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.5 t70 -61.17 127.54 88.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 100.0 110.863 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 68.1 Cg_exo -59.31 -38.6 83.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.759 2.973 . . . . 100.0 113.699 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.66 -44.35 90.68 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.186 0.929 . . . . 100.0 110.59 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.69 -42.16 98.04 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.004 0.522 . . . . 100.0 111.419 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.8 96.28 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.321 0.648 . . . . 100.0 110.803 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.73 98.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.796 0.838 . . . . 100.0 110.753 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.0 -42.07 97.28 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.016 0.526 . . . . 100.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -62.94 -43.1 99.7 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 122.82 0.448 . . . . 100.0 111.816 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -62.15 -43.17 99.43 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.529 0.731 . . . . 100.0 109.097 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.03 -44.16 97.29 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.123 1.369 . . . . 100.0 111.976 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.95 -42.14 98.78 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.606 0.762 . . . . 100.0 110.65 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.46 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.4 mt -60.93 -48.53 81.38 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.101 0.875 . . . . 100.0 109.308 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.28 -43.64 97.34 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.462 1.282 . . . . 100.0 114.462 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.55 -45.96 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.447 -3.017 0 CA-C-O 117.72 -1.133 . . . . 100.0 109.434 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.722 ' CA ' ' HB3' ' A' ' 213' ' ' ASP 0.749 . . -86.38 -10.89 53.45 Favored 'General case' 0 N--CA 1.381 -3.878 1 C-N-CA 104.503 -6.879 . . . . 100.0 116.547 179.445 . . . . . . . . 4 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.782 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 47.3 mt-30 -53.92 -33.83 57.84 Favored 'General case' 0 CA--C 1.445 -3.085 0 C-N-CA 128.534 2.734 . . . . 100.0 107.07 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 38.92 0.51 Allowed 'General case' 0 N--CA 1.415 -2.222 0 O-C-N 124.988 1.43 . . . . 100.0 109.533 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . . 5.8 m 60.41 25.42 14.98 Favored 'General case' 0 CA--C 1.473 -2.007 0 C-N-CA 126.135 1.774 . . . . 100.0 112.409 175.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 204' ' ' ALA 0.268 . . -71.51 172.98 8.57 Favored 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.776 -3.416 . . . . 100.0 101.776 172.381 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 79.1 mt -54.5 -36.65 45.63 Favored Pre-proline 0 CA--C 1.49 -1.337 0 CA-C-O 116.323 -1.799 . . . . 100.0 113.711 -174.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.861 ' CB ' ' HA ' ' A' ' 134' ' ' LYS 0.448 0.3 OUTLIER -53.42 137.73 65.11 Favored 'Trans proline' 0 N--CA 1.432 -2.143 0 CA-C-O 123.528 1.387 . . . . 100.0 112.991 176.738 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.495 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.297 98.1 m-20 -63.65 -43.89 95.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 121.215 3.783 . . . . 100.0 121.215 -172.762 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.534 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.9 tm-20 -69.25 -19.0 63.93 Favored 'General case' 0 CA--C 1.465 -2.306 1 CA-C-O 130.946 5.165 . . . . 100.0 112.771 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.782 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.777 68.3 m-20 -83.89 -49.73 8.74 Favored 'General case' 1 N--CA 1.262 -9.825 1 CA-C-N 105.623 -5.262 . . . . 100.0 104.915 -173.383 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.96 -26.86 68.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.038 -2.289 . . . . 100.0 106.56 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.695 ' HA ' ' CB ' ' A' ' 140' ' ' ARG . 59.5 m-20 -62.8 -40.0 96.0 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 127.044 2.138 . . . . 100.0 112.952 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.26 3.9 mm? . . . . . 0 N--CA 1.426 -1.649 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.793 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.3 tpt . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 111.563 0.208 . . . . 100.0 111.563 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.691 1.197 . . . . 100.0 112.72 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.54 150.59 23.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 123.689 0.796 . . . . 100.0 111.99 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -89.5 157.9 17.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.514 0.725 . . . . 100.0 109.064 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.4 87.73 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-O 119.619 -0.545 . . . . 100.0 112.836 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -75.28 155.68 85.9 Favored Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.634 1.174 . . . . 100.0 111.349 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.87 154.64 65.11 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.576 2.85 . . . . 100.0 111.394 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -55.22 133.61 49.32 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 114.765 1.394 . . . . 100.0 114.765 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.4 t -96.79 119.43 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 114.009 -1.45 . . . . 100.0 107.19 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -120.26 135.22 55.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.803 -1.999 . . . . 100.0 107.612 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.74 143.67 48.66 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.933 -1.136 . . . . 100.0 107.933 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.33 120.21 34.23 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.382 -1.71 . . . . 100.0 106.382 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.76 127.42 53.99 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.036 -1.893 . . . . 100.0 106.782 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 53.6 t -103.52 120.87 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.632 -1.622 . . . . 100.0 106.687 179.124 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.425 HD12 ' SD ' ' A' ' 89' ' ' MET . 36.6 tp -109.27 117.24 33.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.218 -2.141 . . . . 100.0 105.218 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 m -128.31 161.78 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 120.931 0.396 . . . . 100.0 111.667 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.36 175.45 27.34 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 108.38 -1.888 . . . . 100.0 108.38 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -71.78 155.72 40.12 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.935 -0.744 . . . . 100.0 112.18 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.74 141.7 40.69 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 107.321 -2.311 . . . . 100.0 107.321 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.2 81.46 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-O 118.823 -0.987 . . . . 100.0 113.436 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.42 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 80.0 m -62.67 -40.37 96.86 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-N 118.608 1.204 . . . . 100.0 110.777 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.08 25.02 4.61 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.823 -1.311 . . . . 100.0 109.823 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 10.1 mtpm? -60.17 -45.22 93.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.966 1.706 . . . . 100.0 112.554 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -62.89 -44.34 96.38 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.538 1.135 . . . . 100.0 109.486 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.7 m -63.8 -40.21 96.09 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.529 1.132 . . . . 100.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.482 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 47.6 t80 -59.4 -49.32 78.25 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 124.935 1.294 . . . . 100.0 111.534 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.19 -41.64 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 123.371 0.419 . . . . 100.0 111.258 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.277 99.2 mttt -69.83 -6.87 35.38 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 115.933 1.827 . . . . 100.0 115.933 -176.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.712 HH21 ' HA ' ' A' ' 157' ' ' PHE . 83.7 mtm-85 -60.78 -37.68 82.71 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.129 -1.063 . . . . 100.0 108.129 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.735 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 60.8 t-80 -80.84 112.54 18.32 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 107.054 -1.461 . . . . 100.0 107.054 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.3 -43.78 98.02 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 115.207 1.558 . . . . 100.0 115.207 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.462 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.2 m -62.73 -42.48 99.68 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.884 -0.784 . . . . 100.0 108.884 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.735 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.46 -42.16 99.71 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 111.061 -0.816 . . . . 100.0 111.061 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.75 -44.95 91.99 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.873 0.869 . . . . 100.0 110.883 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -63.63 -39.72 95.06 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 123.601 0.76 . . . . 100.0 113.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -89.91 5.92 44.25 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -57.32 138.35 54.95 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 114.546 1.313 . . . . 100.0 114.546 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -124.61 130.35 52.28 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.702 -1.222 . . . . 100.0 107.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -100.77 123.27 44.73 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.233 -2.136 . . . . 100.0 105.233 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -102.85 114.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 103.37 -2.826 . . . . 100.0 103.37 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.03 94.94 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 115.393 1.627 . . . . 100.0 115.393 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.1 p -61.93 -48.36 80.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.665 0.386 . . . . 100.0 111.965 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.18 -38.41 75.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.307 1.443 . . . . 100.0 112.982 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.95 32.23 50.26 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 108.112 -1.995 . . . . 100.0 108.112 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.495 HG12 ' CD1' ' A' ' 79' ' ' TYR . 22.9 m -129.01 153.17 38.22 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 121.629 0.728 . . . . 100.0 109.672 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.45 120.22 41.84 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 103.074 -2.935 . . . . 100.0 103.074 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.6 123.04 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 106.567 -1.642 . . . . 100.0 106.567 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -117.78 119.43 33.94 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.78 106.51 1.82 Allowed 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.123 1.882 . . . . 100.0 110.229 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.69 117.29 31.65 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.685 -1.598 . . . . 100.0 106.685 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 t -102.86 126.68 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.66 -1.237 . . . . 100.0 107.66 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -121.33 133.49 55.12 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.639 -1.985 . . . . 100.0 105.639 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -101.28 120.28 40.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.715 -1.217 . . . . 100.0 107.715 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.6 p -110.54 -179.26 3.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.05 -0.977 . . . . 100.0 110.894 -178.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.77 -44.25 93.97 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.334 1.454 . . . . 100.0 108.294 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -67.04 -39.26 86.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 124.062 0.945 . . . . 100.0 113.052 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.69 28.83 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 107.381 -2.288 . . . . 100.0 107.381 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.08 137.92 50.1 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.117 1.878 . . . . 100.0 114.647 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -125.05 130.29 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.26 -3.237 . . . . 100.0 102.26 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.01 128.13 55.75 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.749 -0.834 . . . . 100.0 108.749 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.44 116.41 31.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.172 -2.529 . . . . 100.0 104.172 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -87.8 106.05 17.81 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.25 -4.352 . . . . 100.0 99.25 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.29 122.76 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.05 115.89 29.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.339 -2.097 . . . . 100.0 105.339 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -112.46 136.32 52.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.605 -1.998 . . . . 100.0 105.605 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 p -71.96 162.29 29.67 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.76 0.824 . . . . 100.0 112.86 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.74 17.29 16.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.694 -0.684 . . . . 100.0 109.687 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.08 11.64 52.04 Favored Glycine 0 C--N 1.357 1.732 0 O-C-N 121.804 -0.56 . . . . 100.0 112.328 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.27 -29.32 70.34 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.836 1.654 . . . . 100.0 111.385 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.66 -37.23 78.18 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 127.794 2.438 . . . . 100.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.93 -43.12 99.66 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.326 0.65 . . . . 100.0 110.025 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.18 -41.35 77.3 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 125.458 1.503 . . . . 100.0 111.972 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.34 -152.12 12.32 Favored Glycine 0 C--N 1.356 1.665 0 C-N-CA 120.996 -0.621 . . . . 100.0 111.57 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.26 169.58 52.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 122.069 0.816 . . . . 100.0 112.931 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 88.6 mt -105.68 143.49 33.76 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.708 -0.746 . . . . 100.0 109.767 -179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -67.67 155.48 39.12 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.735 -1.12 . . . . 100.0 113.616 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -60.47 -37.68 81.78 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.827 -1.533 . . . . 100.0 110.328 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.78 -39.21 93.43 Favored Glycine 0 C--N 1.358 1.778 0 C-N-CA 124.846 1.213 . . . . 100.0 111.316 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.495 ' CD1' HG12 ' A' ' 45' ' ' VAL . 60.8 t80 -62.53 -45.99 90.46 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.422 0.689 . . . . 100.0 110.895 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -68.94 -36.67 78.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.3 mt -50.85 135.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 C-N-CA 125.57 1.548 . . . . 100.0 114.297 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.62 30.29 18.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.104 2.562 . . . . 100.0 114.015 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.66 128.66 36.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.26 -1.756 . . . . 100.0 106.26 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -96.47 -35.35 11.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 179.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.428 ' HB3' HD12 ' A' ' 168' ' ' LEU . 22.3 p -143.76 159.27 42.81 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 120.899 0.381 . . . . 100.0 111.133 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.8 149.57 34.59 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 114.37 1.248 . . . . 100.0 114.37 179.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.9 mt -125.5 125.75 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 52.0 mt -110.66 123.71 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 102.419 -3.178 . . . . 100.0 102.419 178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.425 ' SD ' HD12 ' A' ' 15' ' ' LEU . 81.3 mtp -109.68 134.08 52.39 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 114.144 -1.389 . . . . 100.0 113.602 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -128.18 158.82 37.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 112.555 -2.112 . . . . 100.0 108.433 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.51 125.75 50.97 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.41 -21.6 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 113.797 1.036 . . . . 100.0 113.797 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.7 p -86.65 -10.16 54.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 119.241 -0.409 . . . . 100.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.6 t -118.49 116.39 26.57 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.136 0.969 . . . . 100.0 111.401 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -66.5 -38.38 87.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.892 -1.049 . . . . 100.0 111.079 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.56 -41.75 88.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 125.661 1.584 . . . . 100.0 110.55 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -62.36 -42.8 99.69 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 109.792 -0.448 . . . . 100.0 109.792 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.507 ' CE1' HG21 ' A' ' 136' ' ' ILE . 44.5 t80 -64.11 -41.04 97.41 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 123.714 0.805 . . . . 100.0 110.703 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.502 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -61.14 -37.86 84.34 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.958 0.903 . . . . 100.0 111.311 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.65 -9.0 58.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.12 -43.26 93.52 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 115.997 -1.954 . . . . 100.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.4 Cg_exo -57.57 -38.57 93.31 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.158 1.905 . . . . 100.0 112.742 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -64.25 -44.45 91.74 Favored 'General case' 0 C--N 1.358 0.978 0 O-C-N 124.186 0.929 . . . . 100.0 111.443 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -63.88 -41.22 97.79 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 122.744 0.418 . . . . 100.0 110.995 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.43 -43.83 97.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.43 1.092 . . . . 100.0 109.932 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.8 -45.34 94.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 123.577 0.751 . . . . 100.0 111.351 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -62.89 -44.82 95.07 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.06 0.544 . . . . 100.0 111.774 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 50.8 tp -63.23 -46.03 88.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.548 1.139 . . . . 100.0 112.31 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.36 -37.69 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 125.593 1.557 . . . . 100.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.5 -49.14 78.45 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.649 -0.691 . . . . 100.0 110.183 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.5 t -73.07 -46.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 119.227 -0.989 . . . . 100.0 111.956 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -124.78 113.8 18.41 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 121.641 0.734 . . . . 100.0 110.177 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.64 146.6 23.54 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.466 -0.788 . . . . 100.0 112.142 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 54.72 44.44 28.54 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 126.463 1.905 . . . . 100.0 115.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 27.9 mm -98.89 133.21 22.5 Favored Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 126.42 1.888 . . . . 100.0 107.376 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_exo -62.96 129.02 24.59 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.86 2.373 . . . . 100.0 108.457 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.401 ' HB ' HD21 ' A' ' 144' ' ' LEU . 68.7 mt -131.05 137.58 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 122.292 1.044 . . . . 100.0 108.287 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.74 131.83 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.145 -2.168 . . . . 100.0 105.145 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.427 HD13 ' CE1' ' A' ' 139' ' ' HIS . 28.8 mt -105.61 125.54 51.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.869 -2.641 . . . . 100.0 103.869 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -113.86 126.74 55.52 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.85 -1.523 . . . . 100.0 112.203 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.01 103.42 2.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 105.162 -3.175 . . . . 100.0 105.162 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.58 165.76 19.8 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.789 1.636 . . . . 100.0 112.53 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 21' ' ' THR . 85.0 mttt 59.42 43.38 16.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 128.541 2.736 . . . . 100.0 114.541 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.313 30.9 m -72.23 -8.8 12.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 C-N-CA 120.526 -0.47 . . . . 100.0 111.231 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.58 -38.3 87.05 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.968 2.107 . . . . 100.0 110.117 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.59 130.79 33.85 Favored 'Isoleucine or valine' 0 C--N 1.363 1.168 0 N-CA-C 107.221 -1.4 . . . . 100.0 107.221 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.14 -40.95 99.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 125.32 1.448 . . . . 100.0 114.357 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.74 91.07 8.2 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.262 -1.385 . . . . 100.0 107.262 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -94.85 120.6 35.34 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.087 -2.561 . . . . 100.0 104.087 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -96.15 -37.22 10.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.324 -0.853 . . . . 100.0 112.876 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.4 t -104.01 105.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 102.573 -3.121 . . . . 100.0 102.573 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -104.68 178.83 4.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 113.665 0.987 . . . . 100.0 113.665 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.4 -35.33 71.87 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.308 2.243 . . . . 100.0 109.402 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.721 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.7 mttt -59.42 -37.81 79.03 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.989 2.516 . . . . 100.0 112.32 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.5 p -104.73 -1.29 26.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 120.106 3.373 . . . . 100.0 120.106 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.595 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 49.8 mt -96.6 91.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 115.779 -2.368 . . . . 100.0 111.736 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.401 ' CA ' ' HB3' ' A' ' 211' ' ' ASP . 4.9 p -97.54 -7.98 9.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 115.767 1.766 . . . . 100.0 115.767 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.91 -36.2 72.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.01 1.485 . . . . 100.0 115.01 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 83.9 m-70 -59.87 -40.65 89.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 116.946 -1.502 . . . . 100.0 114.123 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.581 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 25.9 ttt180 -61.32 -45.42 94.51 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 119.971 1.259 . . . . 100.0 112.629 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.56 -41.9 98.05 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.387 1.075 . . . . 100.0 110.862 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.23 2.28 48.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 115.875 1.806 . . . . 100.0 115.875 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.67 44.5 26.32 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.777 1.631 . . . . 100.0 113.305 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.401 HD21 ' HB ' ' A' ' 117' ' ' ILE . 28.5 mt -106.96 152.19 24.29 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.781 -1.563 . . . . 100.0 106.781 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.336 90.6 mm-40 -101.43 145.71 28.59 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 113.474 0.916 . . . . 100.0 113.474 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.469 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.8 t80 -105.09 133.91 49.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 113.921 1.082 . . . . 100.0 113.921 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.12 133.35 46.58 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.048 -1.433 . . . . 100.0 111.172 173.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.279 36.9 m-20 -84.76 121.54 27.83 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.176 -3.268 . . . . 100.0 102.176 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.42 155.42 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 122.381 1.086 . . . . 100.0 110.613 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.2 m -137.31 111.36 8.35 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 105.908 -1.886 . . . . 100.0 105.908 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.564 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.44 -43.91 97.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.187 -1.369 . . . . 100.0 112.664 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.79 -42.31 98.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.377 1.071 . . . . 100.0 112.508 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.54 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 97.4 p -97.04 1.41 50.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.597 2.073 . . . . 100.0 116.597 -178.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.589 HD21 ' HG3' ' A' ' 185' ' ' PRO . 68.0 m-80 64.03 24.58 13.59 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.223 1.409 . . . . 100.0 110.524 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.454 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 75.7 t80 -75.01 125.71 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.133 -1.062 . . . . 100.0 108.133 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 53.55 40.04 30.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.232 2.613 . . . . 100.0 115.404 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.712 ' HA ' HH21 ' A' ' 29' ' ' ARG . 67.3 t80 -61.77 -44.0 97.75 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.827 -0.546 . . . . 100.0 111.248 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 -39.65 95.04 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 116.374 1.99 . . . . 100.0 116.374 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.57 -47.94 97.83 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 121.035 3.717 . . . . 100.0 121.035 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -61.35 -41.9 38.26 Favored 'Trans proline' 0 C--N 1.371 1.733 0 CA-C-N 123.586 2.316 . . . . 100.0 112.437 178.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -64.52 -42.52 95.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.922 1.289 . . . . 100.0 110.799 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.8 tp -63.1 -45.19 93.21 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.241 1.017 . . . . 100.0 111.327 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.36 -44.65 94.2 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.684 -0.488 . . . . 100.0 109.684 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.9 mt -61.79 -44.49 96.76 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.062 0.545 . . . . 100.0 111.474 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.67 98.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.966 0.907 . . . . 100.0 111.228 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.13 -45.99 91.02 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 123.341 0.656 . . . . 100.0 111.542 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.38 -42.92 87.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.293 0.849 . . . . 100.0 113.293 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 85' ' ' CYS . 85.8 mt -63.72 -45.65 88.96 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.632 0.773 . . . . 100.0 112.032 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 71.6 mt -69.97 -39.16 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.11 0.564 . . . . 100.0 109.552 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.07 10.64 58.38 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 110.411 -1.076 . . . . 100.0 110.411 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -114.07 112.82 46.92 Favored Pre-proline 0 C--N 1.361 1.107 0 N-CA-C 107.57 -1.27 . . . . 100.0 107.57 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.061 3.174 . . . . 100.0 113.992 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -87.96 2.12 52.44 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 123.979 0.912 . . . . 100.0 113.114 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 17.0 tp -66.07 132.16 47.88 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.324 0.65 . . . . 100.0 109.355 -179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -134.44 151.36 51.12 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.15 113.61 23.94 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 104.195 -2.52 . . . . 100.0 104.195 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.02 -43.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 123.594 0.758 . . . . 100.0 110.293 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.48 149.02 51.43 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.451 0.643 . . . . 100.0 109.839 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -92.61 125.95 53.88 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.093 -2.188 . . . . 100.0 105.093 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.17 158.16 53.58 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.076 2.517 . . . . 100.0 111.458 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.77 126.9 29.11 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.146 0.974 . . . . 100.0 108.884 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.25 145.9 46.59 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-N 114.014 -1.448 . . . . 100.0 109.971 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.29 138.02 97.3 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.411 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 64.9 Cg_exo -55.95 139.71 84.91 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 123.67 2.913 . . . . 100.0 113.021 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.589 ' HG3' HD21 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -57.68 129.44 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 123.206 2.604 . . . . 100.0 113.028 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -68.36 -43.18 77.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 124.742 1.276 . . . . 100.0 108.122 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.9 158.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.351 -1.722 . . . . 100.0 106.351 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.68 130.6 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 106.208 -1.775 . . . . 100.0 106.208 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.54 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.2 ttt -87.24 127.54 35.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.749 -2.315 . . . . 100.0 104.749 179.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.73 128.14 91.39 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 114.493 -1.231 . . . . 100.0 110.295 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.6 -37.4 88.56 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.772 2.981 . . . . 100.0 113.001 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.18 94.14 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 124.257 0.973 . . . . 100.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.38 -42.28 98.83 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 122.817 0.447 . . . . 100.0 111.633 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.25 97.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.125 0.57 . . . . 100.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.54 98.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.943 0.897 . . . . 100.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -44.27 96.55 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.183 0.993 . . . . 100.0 112.405 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -63.4 -44.1 95.64 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 122.71 0.404 . . . . 100.0 111.073 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -64.5 -39.89 94.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.107 -0.497 . . . . 100.0 110.57 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.31 -43.85 97.88 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.95 1.3 . . . . 100.0 110.524 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.93 -42.89 99.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 123.955 0.902 . . . . 100.0 110.144 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.531 ' HG ' HE21 ' A' ' 205' ' ' GLN . 22.6 tp -59.9 -48.65 80.82 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.222 0.951 . . . . 100.0 109.951 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -43.36 99.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.999 1.481 . . . . 100.0 114.999 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.0 -47.09 91.04 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.217 0 CA-C-O 118.245 -0.883 . . . . 100.0 109.544 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.65 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.406 . . -95.66 0.91 53.25 Favored 'General case' 0 N--CA 1.402 -2.847 1 C-N-CA 109.729 -4.789 . . . . 100.0 114.685 179.573 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.531 HE21 ' HG ' ' A' ' 201' ' ' LEU 0.329 67.1 mt-30 -56.78 -36.35 69.74 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 106.246 -1.761 . . . . 100.0 106.246 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 64.9 p -82.25 52.04 1.93 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.091 0.948 . . . . 100.0 108.779 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.296 73.9 p 49.25 37.69 11.85 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 129.002 2.921 . . . . 100.0 116.157 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.466 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -82.86 -179.78 7.54 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.286 -2.486 . . . . 100.0 104.286 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.435 ' HG ' ' HD3' ' A' ' 210' ' ' PRO 0.439 3.7 pp -57.44 -38.73 70.99 Favored Pre-proline 0 CA--C 1.501 -0.941 0 CA-C-O 115.523 -2.18 . . . . 100.0 115.886 -175.435 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.721 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.312 79.0 Cg_exo -54.88 136.47 72.35 Favored 'Trans proline' 0 C--N 1.375 1.971 0 CA-C-N 121.839 1.692 . . . . 100.0 111.417 176.43 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . 0.401 ' HB3' ' CA ' ' A' ' 137' ' ' VAL . 96.0 m-20 -63.46 -47.86 80.1 Favored 'General case' 0 N--CA 1.424 -1.771 1 N-CA-C 124.784 5.105 . . . . 100.0 124.784 -173.533 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.595 ' CG ' ' HB ' ' A' ' 136' ' ' ILE 0.251 99.3 mt-10 -62.88 -35.56 80.42 Favored 'General case' 0 CA--C 1.48 -1.732 1 CA-C-O 128.621 4.057 . . . . 100.0 107.84 177.889 . . . . . . . . 4 3 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.65 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.49 39.2 m-20 -64.93 -49.03 71.97 Favored 'General case' 1 N--CA 1.354 -5.251 1 CA-C-N 107.796 -4.274 . . . . 100.0 106.297 -178.903 . . . . . . . . 5 3 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.12 -31.23 71.67 Favored 'General case' 0 C--N 1.36 1.033 0 O-C-N 120.535 -1.353 . . . . 100.0 107.682 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.584 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.8 t70 -57.63 -42.77 84.06 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 116.926 -1.512 . . . . 100.0 113.295 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.261 1.701 0 CA-C-O 115.558 -2.163 . . . . 100.0 112.6 -176.913 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -1.017 0 N-CA-C 112.364 0.505 . . . . 100.0 112.364 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.12 93.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.007 1.323 . . . . 100.0 113.135 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.87 147.7 27.01 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.101 0.477 . . . . 100.0 111.594 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -81.5 160.5 23.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.621 0.768 . . . . 100.0 110.004 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.22 2.75 87.71 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.652 -0.527 . . . . 100.0 112.698 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.51 158.92 75.6 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 124.019 0.928 . . . . 100.0 110.329 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.73 158.34 46.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.633 2.889 . . . . 100.0 111.552 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -53.19 132.58 38.82 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 114.843 1.423 . . . . 100.0 114.843 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -93.24 115.36 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 105.682 -1.97 . . . . 100.0 105.682 -178.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -123.58 136.16 54.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.762 -1.563 . . . . 100.0 108.752 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.34 144.32 50.08 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.243 -1.021 . . . . 100.0 108.243 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.28 121.03 35.38 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.433 -1.692 . . . . 100.0 106.433 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -109.52 127.73 54.67 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 113.062 -1.881 . . . . 100.0 106.326 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.402 HG11 ' CE2' ' A' ' 79' ' ' TYR . 49.9 t -102.96 121.09 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 106.572 -1.64 . . . . 100.0 106.572 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD12 ' SD ' ' A' ' 89' ' ' MET . 29.9 tp -109.88 117.08 32.87 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.618 -2.364 . . . . 100.0 104.618 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -127.93 161.98 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 120.718 0.294 . . . . 100.0 111.528 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.22 175.0 26.7 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 108.875 -1.69 . . . . 100.0 108.875 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.03 156.27 39.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 O-C-N 121.832 -0.804 . . . . 100.0 112.092 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.93 141.38 39.77 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 106.984 -2.446 . . . . 100.0 106.984 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.66 -5.96 79.94 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-O 118.773 -1.015 . . . . 100.0 113.404 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -62.68 -39.87 95.29 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 118.804 1.302 . . . . 100.0 111.307 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.87 25.72 4.4 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.743 -1.343 . . . . 100.0 109.743 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.9 mtpt -60.01 -46.79 88.32 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.362 1.465 . . . . 100.0 112.883 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.7 m -63.82 -43.06 97.36 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.408 1.083 . . . . 100.0 109.644 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 m -63.3 -41.4 98.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.483 1.113 . . . . 100.0 109.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.561 ' HA ' HH11 ' A' ' 29' ' ' ARG . 45.1 t80 -60.09 -49.11 78.93 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 123.626 0.77 . . . . 100.0 112.749 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.77 -41.05 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 123.739 0.649 . . . . 100.0 110.958 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.266 99.0 mttt -69.06 -7.57 36.99 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 115.826 1.787 . . . . 100.0 115.826 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.571 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.6 mtm-85 -61.04 -36.91 80.82 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 108.691 -0.855 . . . . 100.0 108.691 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.706 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 55.1 t-80 -80.34 112.23 17.47 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.4 -43.9 97.72 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 115.361 1.615 . . . . 100.0 115.361 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.9 m -63.09 -42.22 99.55 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.888 -0.782 . . . . 100.0 108.888 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.706 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.38 -42.47 99.78 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 111.383 -0.687 . . . . 100.0 111.383 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.64 -44.19 94.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.29 0.636 . . . . 100.0 110.836 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -63.83 -40.58 96.94 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 124.463 1.105 . . . . 100.0 112.295 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -91.14 8.56 35.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -59.18 140.36 55.99 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 114.649 1.352 . . . . 100.0 114.649 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.24 130.6 52.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.169 -1.419 . . . . 100.0 107.169 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -104.47 125.13 50.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 106.766 -1.568 . . . . 100.0 106.766 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.16 113.54 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 102.199 -3.26 . . . . 100.0 102.199 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.51 92.42 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 116.228 1.936 . . . . 100.0 116.228 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.2 p -62.58 -47.42 83.89 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.916 0.486 . . . . 100.0 111.784 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.06 -37.74 75.6 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.899 1.28 . . . . 100.0 112.912 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.36 53.91 Favored Glycine 0 C--N 1.359 1.837 0 N-CA-C 106.71 -2.556 . . . . 100.0 106.71 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 66.9 t -124.43 139.59 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 124.733 1.213 . . . . 100.0 108.754 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.74 117.02 32.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 102.387 -3.19 . . . . 100.0 102.387 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.06 122.1 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.065 -1.458 . . . . 100.0 107.065 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -115.17 121.05 35.66 Favored Pre-proline 0 N--CA 1.432 -1.337 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.105 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -80.13 104.57 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.426 2.084 . . . . 100.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.7 117.07 30.24 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.931 -1.507 . . . . 100.0 106.931 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.52 125.77 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.406 -1.331 . . . . 100.0 107.406 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.45 133.12 55.46 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.851 -1.907 . . . . 100.0 105.851 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -99.67 116.42 31.73 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.0 p -108.49 178.63 4.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.434 -0.803 . . . . 100.0 110.846 -178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -59.87 -43.6 94.62 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.99 1.316 . . . . 100.0 108.427 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -68.99 -38.37 79.26 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 112.839 0.681 . . . . 100.0 112.839 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.96 -172.38 30.61 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.642 -1.783 . . . . 100.0 108.642 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -65.52 136.87 48.26 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.518 2.145 . . . . 100.0 114.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -126.15 130.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 102.111 -3.292 . . . . 100.0 102.111 177.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.85 128.44 55.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.617 -0.883 . . . . 100.0 108.617 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.37 114.79 28.18 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.557 -2.757 . . . . 100.0 103.557 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -87.75 105.7 17.56 Favored 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 99.862 -4.125 . . . . 100.0 99.862 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.76 123.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.448 -1.686 . . . . 100.0 106.448 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -96.84 114.7 26.35 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.878 -1.897 . . . . 100.0 105.878 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.61 137.25 49.72 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.328 -1.731 . . . . 100.0 106.328 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -72.97 161.94 30.09 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.731 0.777 . . . . 100.0 112.487 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.1 19.47 14.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.668 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.47 13.19 52.29 Favored Glycine 0 C--N 1.356 1.681 0 O-C-N 121.818 -0.552 . . . . 100.0 112.277 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.406 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 65.3 mt-30 -60.44 -35.8 76.71 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.52 1.928 . . . . 100.0 111.583 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -58.26 -36.01 72.61 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.13 2.572 . . . . 100.0 111.869 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.84 -42.4 98.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.604 0.762 . . . . 100.0 111.041 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.406 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 26.7 p90 -95.37 -5.85 42.36 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.85 -166.69 38.08 Favored Glycine 0 C--N 1.358 1.756 0 C-N-CA 119.7 -1.238 . . . . 100.0 113.251 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.68 175.27 54.9 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.97 -1.252 . . . . 100.0 109.97 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.7 mt -105.14 140.65 37.99 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 122.18 0.99 . . . . 100.0 110.465 -179.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -68.7 154.64 41.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.676 -1.602 . . . . 100.0 113.602 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.95 -38.31 85.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.531 1.533 . . . . 100.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.04 93.85 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.854 1.216 . . . . 100.0 111.063 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.402 ' CE2' HG11 ' A' ' 14' ' ' VAL . 63.0 t80 -62.23 -46.98 86.45 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.697 0.799 . . . . 100.0 110.866 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 116.298 1.962 . . . . 100.0 116.298 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.3 mt -51.84 136.58 11.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 C-N-CA 125.04 1.336 . . . . 100.0 113.973 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 61.89 31.78 18.13 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.749 2.42 . . . . 100.0 114.706 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.87 128.44 35.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 105.595 -2.002 . . . . 100.0 105.595 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.4 ' O ' HG21 ' A' ' 115' ' ' ILE . 95.9 mm-40 -96.78 -36.82 10.51 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . . . . . . . . . 24.6 p -143.52 159.97 41.45 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.776 0.431 . . . . 100.0 110.842 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.408 ' HB1' HG12 ' A' ' 117' ' ' ILE . . . -146.23 149.17 33.41 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.7 mt -125.65 126.15 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 103.678 -2.712 . . . . 100.0 103.678 176.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.98 124.26 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 101.762 -3.422 . . . . 100.0 101.762 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.525 ' SD ' HD12 ' A' ' 15' ' ' LEU . 95.1 mtp -109.16 131.64 54.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.005 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.4 ' HA ' ' CG2' ' A' ' 97' ' ' THR . 54.5 p90 -129.25 159.43 36.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.155 -1.838 . . . . 100.0 108.434 177.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -106.4 126.95 52.89 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.46 -1.681 . . . . 100.0 106.46 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.65 -21.41 29.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 113.849 1.055 . . . . 100.0 113.849 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.0 p -85.12 -12.19 53.46 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 119.239 -0.41 . . . . 100.0 110.579 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -118.76 117.29 28.5 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.337 1.065 . . . . 100.0 111.427 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -66.51 -38.87 88.16 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.424 -1.262 . . . . 100.0 110.434 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.66 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 126.071 1.749 . . . . 100.0 110.856 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.4 ' CG2' ' HA ' ' A' ' 90' ' ' PHE . 74.8 m -62.71 -42.67 99.77 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.655 -0.498 . . . . 100.0 109.655 -179.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.467 ' CE1' HG21 ' A' ' 136' ' ' ILE . 43.6 t80 -64.15 -40.28 95.81 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 123.452 0.701 . . . . 100.0 110.884 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -60.79 -38.77 86.44 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.546 1.139 . . . . 100.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.38 -9.38 58.6 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 115.182 1.549 . . . . 100.0 115.182 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.3 t -60.06 -42.98 92.99 Favored Pre-proline 0 C--N 1.363 1.194 0 CA-C-O 115.884 -2.007 . . . . 100.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.503 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 82.0 Cg_exo -57.78 -36.83 98.16 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.309 2.006 . . . . 100.0 112.852 177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.44 -46.93 84.05 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 124.355 1.062 . . . . 100.0 110.28 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -64.24 -42.08 96.69 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.162 0.585 . . . . 100.0 111.271 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.58 -44.25 96.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 124.326 1.05 . . . . 100.0 110.39 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -62.76 -44.38 96.35 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.759 -0.639 . . . . 100.0 112.031 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.34 -44.28 96.85 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 123.526 0.516 . . . . 100.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.1 tp -62.45 -46.8 86.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.684 1.193 . . . . 100.0 112.577 179.601 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.32 -38.97 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 125.364 1.465 . . . . 100.0 111.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.37 -46.66 89.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 118.938 -0.553 . . . . 100.0 110.714 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.9 t -72.03 -45.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 120.254 -0.578 . . . . 100.0 111.534 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.81 115.65 18.97 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.249 -0.648 . . . . 100.0 109.249 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -93.29 147.3 23.04 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 115.771 -0.649 . . . . 100.0 112.492 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 54.55 44.55 28.55 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.436 1.895 . . . . 100.0 115.183 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.4 HG21 ' O ' ' A' ' 84' ' ' GLN . 33.9 mm -98.96 132.36 23.77 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 126.116 1.766 . . . . 100.0 107.066 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.49 129.25 25.99 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.536 2.158 . . . . 100.0 109.144 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.413 ' HB ' HD21 ' A' ' 144' ' ' LEU . 71.0 mt -130.71 136.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-O 122.257 1.027 . . . . 100.0 108.689 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.4 130.8 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 105.062 -2.199 . . . . 100.0 105.062 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.515 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 21.9 mt -105.25 127.07 52.76 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.136 -2.912 . . . . 100.0 103.136 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.83 127.21 54.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.642 -1.617 . . . . 100.0 112.061 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . 0.594 ' HA3' ' HH ' ' A' ' 146' ' ' TYR . . . -98.58 105.26 3.06 Favored Glycine 0 CA--C 1.489 -1.558 0 N-CA-C 106.427 -2.669 . . . . 100.0 106.427 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.14 164.25 23.48 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.2 2.6 . . . . 100.0 113.935 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.2 mttp 55.62 45.15 25.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 128.46 2.704 . . . . 100.0 114.367 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.296 32.8 m -71.82 -9.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 120.4 -0.52 . . . . 100.0 111.062 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.65 -39.1 90.15 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.658 1.983 . . . . 100.0 110.287 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.4 130.87 33.75 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.381 -0.97 . . . . 100.0 108.381 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -62.34 -40.54 96.7 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.937 1.458 . . . . 100.0 114.937 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -84.02 96.08 8.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 105.282 -2.118 . . . . 100.0 105.282 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -102.37 120.91 41.29 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 103.621 -2.733 . . . . 100.0 103.621 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.87 -36.51 10.57 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-N 115.612 -0.722 . . . . 100.0 112.528 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.32 104.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 103.534 -2.765 . . . . 100.0 103.534 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.23 179.95 4.13 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.472 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.21 -35.2 71.31 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.336 2.254 . . . . 100.0 109.539 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.712 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.4 mttt -59.29 -37.62 78.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 128.41 2.684 . . . . 100.0 112.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.6 p -104.99 -0.85 26.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 120.091 3.367 . . . . 100.0 120.091 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.599 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 53.8 mt -97.38 94.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 115.583 -2.447 . . . . 100.0 111.431 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.3 p -100.82 -5.32 9.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 115.338 1.606 . . . . 100.0 115.338 -177.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.58 -36.55 74.15 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 115.199 1.555 . . . . 100.0 115.199 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.573 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.5 m-70 -59.54 -39.25 83.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.814 1.646 . . . . 100.0 113.344 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.548 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 57.3 ttp85 -58.69 -48.5 80.88 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 114.031 1.123 . . . . 100.0 114.031 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.52 -40.59 95.91 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.218 0.949 . . . . 100.0 111.812 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.01 -0.1 54.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 116.157 1.91 . . . . 100.0 116.157 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.258 73.2 m-20 54.55 47.13 23.39 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.378 1.471 . . . . 100.0 113.346 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.413 HD21 ' HB ' ' A' ' 117' ' ' ILE . 27.7 mt -103.62 153.39 20.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.115 -1.809 . . . . 100.0 106.115 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -101.53 142.96 32.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.3 -0.63 . . . . 100.0 109.3 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.594 ' HH ' ' HA3' ' A' ' 121' ' ' GLY . 68.2 t80 -105.79 133.63 50.21 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.4 0.889 . . . . 100.0 113.4 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.82 133.4 45.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.575 -1.193 . . . . 100.0 111.491 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.297 37.1 m-20 -85.64 122.97 30.49 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 102.234 -3.247 . . . . 100.0 102.234 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.32 156.89 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 CA-C-O 122.364 1.078 . . . . 100.0 112.237 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.435 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.1 m -138.88 113.19 8.8 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.244 -1.761 . . . . 100.0 106.244 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.571 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.3 -43.06 98.91 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.836 -1.529 . . . . 100.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.22 -42.15 99.04 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.667 1.187 . . . . 100.0 112.375 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.456 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 96.8 p -97.25 2.12 50.45 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 117.3 2.333 . . . . 100.0 117.3 -177.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.49 21.25 11.8 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.583 1.153 . . . . 100.0 110.113 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.435 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 85.8 t80 -73.58 124.48 26.0 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.038 -0.727 . . . . 100.0 109.038 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 53.32 40.1 30.8 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.12 2.568 . . . . 100.0 115.175 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.443 ' CA ' HH21 ' A' ' 29' ' ' ARG . 69.9 t80 -62.25 -44.46 96.51 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 121.638 -0.664 . . . . 100.0 111.529 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.33 -38.49 91.37 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.117 1.895 . . . . 100.0 116.117 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.53 -47.24 99.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 119.999 3.333 . . . . 100.0 119.999 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.07 -41.95 39.95 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.34 2.229 . . . . 100.0 111.334 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.45 -42.29 96.04 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 125.466 1.506 . . . . 100.0 110.884 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -61.14 -46.76 89.21 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 123.885 0.874 . . . . 100.0 112.002 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -63.67 -44.61 93.26 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.082 0.864 . . . . 100.0 110.421 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.8 mt -61.92 -44.85 95.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 123.797 0.686 . . . . 100.0 111.729 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.7 98.26 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.174 0.99 . . . . 100.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.57 -45.71 91.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.564 0.745 . . . . 100.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -68.11 -42.4 80.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.543 0.527 . . . . 100.0 112.354 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.67 -46.96 85.74 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.469 0.708 . . . . 100.0 112.316 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.43 -38.59 74.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 123.546 0.738 . . . . 100.0 110.318 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.46 59.49 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-O 118.781 -1.01 . . . . 100.0 111.053 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -111.5 113.64 53.36 Favored Pre-proline 0 C--N 1.362 1.133 0 N-CA-C 107.492 -1.299 . . . . 100.0 107.492 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.57 -15.19 30.67 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.051 3.167 . . . . 100.0 114.282 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -89.73 2.82 54.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.993 0.917 . . . . 100.0 113.276 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.05 131.44 46.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.51 0.671 . . . . 100.0 109.663 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -133.83 152.94 52.02 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.358 -0.979 . . . . 100.0 108.358 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -90.35 114.29 26.34 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 104.314 -2.476 . . . . 100.0 104.314 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.54 -44.29 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.283 1.033 . . . . 100.0 110.55 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -127.86 148.01 50.46 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.373 0.606 . . . . 100.0 109.697 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 62.5 ttp -90.18 126.23 57.61 Favored Pre-proline 0 N--CA 1.432 -1.339 0 N-CA-C 104.772 -2.307 . . . . 100.0 104.772 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.68 158.1 55.23 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.869 2.379 . . . . 100.0 110.632 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.5 126.04 26.21 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.286 -1.005 . . . . 100.0 108.286 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.51 146.63 46.09 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 114.176 -1.375 . . . . 100.0 110.164 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 137.29 97.08 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 106.832 -1.544 . . . . 100.0 106.832 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -55.98 138.51 82.54 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.534 2.823 . . . . 100.0 112.569 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.68 130.25 32.53 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.738 2.292 . . . . 100.0 113.609 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.83 -44.36 81.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 124.858 1.349 . . . . 100.0 108.579 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.32 159.04 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.498 -1.667 . . . . 100.0 106.498 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.66 131.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.641 -1.985 . . . . 100.0 105.641 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.456 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.0 ttt -86.29 128.12 34.87 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 104.774 -2.306 . . . . 100.0 104.774 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -62.21 128.09 90.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 CA-C-N 114.911 -1.04 . . . . 100.0 109.738 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.53 -36.68 92.44 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.474 2.783 . . . . 100.0 112.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.37 92.22 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.33 1.019 . . . . 100.0 110.766 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.29 -41.89 96.66 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 122.971 0.508 . . . . 100.0 111.493 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.56 96.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 123.63 0.772 . . . . 100.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.8 97.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.293 1.037 . . . . 100.0 110.847 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.09 -43.98 97.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.632 0.773 . . . . 100.0 112.306 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -63.69 -43.7 95.85 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 122.534 0.333 . . . . 100.0 111.712 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -64.2 -39.93 95.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.601 0.36 . . . . 100.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.06 -42.83 99.78 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.625 1.17 . . . . 100.0 110.57 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.95 -42.41 99.09 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.968 0.907 . . . . 100.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.512 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 18.3 tp -59.69 -49.52 77.42 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 124.117 0.886 . . . . 100.0 110.089 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.22 -43.24 98.66 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 115.188 1.551 . . . . 100.0 115.188 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.61 -46.53 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.175 0 CA-C-O 118.425 -0.798 . . . . 100.0 109.984 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.642 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.403 . . -93.59 -0.63 56.13 Favored 'General case' 0 N--CA 1.403 -2.818 1 C-N-CA 109.854 -4.739 . . . . 100.0 114.006 179.76 . . . . . . . . 4 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.484 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.268 57.7 mt-30 -56.9 -35.77 69.36 Favored 'General case' 0 CA--C 1.458 -2.566 0 N-CA-C 107.523 -1.288 . . . . 100.0 107.523 178.418 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -82.74 53.87 2.51 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.403 1.097 . . . . 100.0 108.886 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.312 73.1 p 48.84 38.37 11.88 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 129.477 3.111 . . . . 100.0 116.281 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.457 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -83.13 -178.02 6.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.511 -2.404 . . . . 100.0 104.511 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 83.0 mt -56.31 -41.53 91.56 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-O 115.885 -2.007 . . . . 100.0 114.788 -175.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.712 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.325 32.4 Cg_exo -55.17 137.21 76.25 Favored 'Trans proline' 0 C--N 1.373 1.826 0 CA-C-N 121.406 1.538 . . . . 100.0 112.427 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -63.57 -47.45 81.49 Favored 'General case' 0 N--CA 1.427 -1.614 1 N-CA-C 124.764 5.098 . . . . 100.0 124.764 -173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.599 ' CG ' ' HB ' ' A' ' 136' ' ' ILE . 99.2 mt-10 -63.13 -35.36 80.02 Favored 'General case' 0 CA--C 1.48 -1.746 1 CA-C-O 128.51 4.005 . . . . 100.0 108.045 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.642 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.481 44.0 m-20 -65.74 -48.74 70.89 Favored 'General case' 1 N--CA 1.351 -5.385 2 CA-C-N 107.446 -4.434 . . . . 100.0 106.389 -179.093 . . . . . . . . 5 3 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.46 -29.43 70.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.499 -1.375 . . . . 100.0 107.889 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.566 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.0 OUTLIER -58.51 -43.74 89.24 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-O 117.021 -1.466 . . . . 100.0 113.442 176.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 3.4 mp . . . . . 0 C--O 1.26 1.632 0 CA-C-O 114.514 -2.66 . . . . 100.0 113.227 -176.679 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 113.049 0.759 . . . . 100.0 113.049 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.27 93.92 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.777 1.231 . . . . 100.0 113.655 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.43 151.6 22.09 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.641 0.734 . . . . 100.0 111.894 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -80.97 158.93 25.03 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.763 0.825 . . . . 100.0 109.896 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.19 87.71 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.788 0.709 . . . . 100.0 113.497 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -75.07 156.96 85.78 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 123.961 0.904 . . . . 100.0 112.34 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.58 157.75 49.59 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.566 2.844 . . . . 100.0 111.544 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -54.12 131.94 41.99 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.84 1.256 . . . . 100.0 113.823 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t -94.66 119.64 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -124.4 138.0 54.4 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.884 -1.507 . . . . 100.0 108.261 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.59 144.15 50.31 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.099 -1.075 . . . . 100.0 108.099 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.24 120.34 35.29 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.73 128.36 54.8 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 113.442 -1.708 . . . . 100.0 106.83 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.4 t -104.51 121.05 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 N-CA-C 107.01 -1.478 . . . . 100.0 107.01 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.406 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 31.0 tp -110.48 115.59 29.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.54 161.96 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 115.379 -0.828 . . . . 100.0 111.881 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.68 176.7 30.02 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.008 -2.037 . . . . 100.0 108.008 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -72.1 156.4 39.23 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.831 0.824 . . . . 100.0 111.479 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.96 140.66 38.42 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.1 -5.49 78.57 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-O 118.453 -1.193 . . . . 100.0 113.696 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.1 m -62.2 -39.91 94.32 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 119.064 1.432 . . . . 100.0 111.06 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.69 26.88 4.29 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 109.464 -1.454 . . . . 100.0 109.464 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.511 ' HA ' ' CE ' ' A' ' 89' ' ' MET . 32.7 mtmt -61.49 -44.81 96.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.493 0.717 . . . . 100.0 112.671 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -62.47 -43.08 99.68 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.267 1.027 . . . . 100.0 109.729 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 m -63.07 -41.7 99.49 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.786 1.234 . . . . 100.0 109.218 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.536 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 54.9 t80 -59.99 -48.48 81.52 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 124.141 0.976 . . . . 100.0 112.208 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.46 -41.68 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.691 0.619 . . . . 100.0 110.922 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.252 98.8 mttt -68.06 -8.09 34.89 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.919 1.822 . . . . 100.0 115.919 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.578 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 81.2 mtm-85 -60.91 -37.43 82.21 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 118.941 -0.552 . . . . 100.0 109.724 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.628 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 47.5 t-80 -80.53 113.17 18.53 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.78 -1.563 . . . . 100.0 106.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.52 -43.96 97.54 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 115.604 1.705 . . . . 100.0 115.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.431 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 63.7 m -63.33 -41.89 98.94 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.988 -0.745 . . . . 100.0 108.988 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.628 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.41 -42.45 99.77 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 123.671 0.653 . . . . 100.0 111.565 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.49 -45.36 91.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.368 0.667 . . . . 100.0 111.043 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.16 -40.65 98.16 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 124.685 1.194 . . . . 100.0 112.215 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -93.52 11.24 29.33 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 115.353 1.612 . . . . 100.0 115.353 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.55 140.01 56.66 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 113.875 1.065 . . . . 100.0 113.875 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -118.1 129.47 55.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -103.04 124.63 48.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.2 110.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 101.498 -3.519 . . . . 100.0 101.498 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.03 88.93 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 115.993 1.849 . . . . 100.0 115.993 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.6 p -62.86 -47.25 84.16 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 122.494 0.317 . . . . 100.0 111.568 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.79 -37.14 73.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.892 1.071 . . . . 100.0 113.892 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.77 30.84 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 107.261 -2.335 . . . . 100.0 107.261 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.2 t -126.25 141.99 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 124.246 1.018 . . . . 100.0 109.167 -178.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.55 118.93 37.88 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 102.336 -3.209 . . . . 100.0 102.336 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.68 120.05 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.542 -2.021 . . . . 100.0 105.542 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -114.5 119.79 39.2 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 109.0 -0.741 . . . . 100.0 109.0 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.9 104.67 1.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.863 2.375 . . . . 100.0 110.934 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.33 119.05 34.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.93 126.59 58.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 107.191 -1.411 . . . . 100.0 107.191 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -122.49 133.1 54.6 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.102 -1.814 . . . . 100.0 106.102 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -100.35 118.3 36.32 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 121.73 0.776 . . . . 100.0 108.987 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.424 ' HG1' HD12 ' A' ' 174' ' ' LEU . 22.3 p -110.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.948 -1.023 . . . . 100.0 111.57 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.66 -44.21 93.66 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 125.497 1.519 . . . . 100.0 108.349 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.8 -38.42 76.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.188 0.995 . . . . 100.0 112.395 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.92 -173.05 29.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.889 -1.684 . . . . 100.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.93 138.43 57.43 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.521 2.147 . . . . 100.0 114.199 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 81.1 mt -127.4 129.93 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 102.801 -3.037 . . . . 100.0 102.801 177.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.81 128.99 55.97 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.048 -0.723 . . . . 100.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.85 116.76 31.19 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.653 -2.721 . . . . 100.0 103.653 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -87.81 106.65 18.22 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.616 -4.216 . . . . 100.0 99.616 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.28 122.3 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 106.368 -1.715 . . . . 100.0 106.368 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.25 117.0 30.48 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 106.631 -1.618 . . . . 100.0 106.631 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -116.45 141.28 48.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.005 -2.22 . . . . 100.0 105.005 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 p -75.08 165.88 24.53 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 113.558 0.947 . . . . 100.0 113.558 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.74 12.92 23.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.733 1.213 . . . . 100.0 109.788 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.49 51.14 Favored Glycine 0 C--N 1.358 1.803 0 O-C-N 121.693 -0.629 . . . . 100.0 112.209 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.415 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 85.0 mt-30 -61.96 -27.86 69.14 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.813 1.645 . . . . 100.0 112.166 -179.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -59.05 -36.64 75.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.584 2.353 . . . . 100.0 111.826 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.59 -46.84 88.16 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 117.996 0.362 . . . . 100.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.415 ' CE2' ' HA ' ' A' ' 69' ' ' GLN 0.371 13.9 p90 -71.99 -39.39 69.3 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 114.903 1.445 . . . . 100.0 114.903 178.035 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.5 -156.04 11.45 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 119.903 -1.142 . . . . 100.0 113.431 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.16 171.53 52.52 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.807 0.718 . . . . 100.0 111.731 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -106.3 142.99 35.06 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 121.822 0.82 . . . . 100.0 109.971 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -67.95 155.69 38.89 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.208 -1.36 . . . . 100.0 113.735 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -60.67 -38.36 84.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.776 -1.557 . . . . 100.0 110.372 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.76 -39.33 93.54 Favored Glycine 0 C--N 1.36 1.872 0 C-N-CA 124.38 0.99 . . . . 100.0 111.469 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -62.32 -46.96 86.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.516 0.726 . . . . 100.0 111.293 177.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.92 -37.11 78.73 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.0 mt -52.19 138.22 10.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 125.48 1.512 . . . . 100.0 113.739 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.86 24.65 12.78 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 127.853 2.461 . . . . 100.0 114.378 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.07 129.33 38.68 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.305 -1.368 . . . . 100.0 107.305 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.4 mm-40 -98.71 -34.93 10.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.143 -1.058 . . . . 100.0 108.143 179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.415 ' HB3' HD12 ' A' ' 168' ' ' LEU . 23.5 p -144.37 160.14 41.54 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 122.861 0.465 . . . . 100.0 110.527 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . 0.404 ' HB1' HG12 ' A' ' 117' ' ' ILE . . . -146.17 149.3 33.72 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.404 1.261 . . . . 100.0 114.404 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.47 126.52 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 103.292 -2.855 . . . . 100.0 103.292 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.43 123.81 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 102.353 -3.203 . . . . 100.0 102.353 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.511 ' CE ' ' HA ' ' A' ' 23' ' ' LYS . 41.0 mtm -115.45 140.55 49.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 118.738 -1.185 . . . . 100.0 113.692 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -127.08 159.59 33.73 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 110.423 -3.081 . . . . 100.0 108.751 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -102.87 126.59 50.08 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.802 -1.925 . . . . 100.0 105.802 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.52 -21.58 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.367 0.877 . . . . 100.0 113.367 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -87.59 -8.48 56.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 119.033 -0.508 . . . . 100.0 110.993 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 t -119.42 115.84 24.93 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 122.308 1.051 . . . . 100.0 110.576 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.77 -38.68 87.05 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.622 -1.172 . . . . 100.0 110.55 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.71 -41.86 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.217 1.807 . . . . 100.0 110.391 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.4 m -62.96 -42.06 99.71 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 118.111 0.414 . . . . 100.0 110.306 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.532 ' CE1' HG21 ' A' ' 136' ' ' ILE . 39.5 t80 -63.45 -41.22 98.65 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 123.259 0.624 . . . . 100.0 110.453 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.514 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.7 mttt -61.61 -37.53 84.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.691 0.796 . . . . 100.0 111.652 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.14 -10.3 59.34 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 114.471 1.286 . . . . 100.0 114.471 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.36 -43.04 95.73 Favored Pre-proline 0 C--N 1.363 1.191 0 CA-C-O 115.782 -2.056 . . . . 100.0 111.795 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.514 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 83.2 Cg_exo -57.41 -38.24 95.0 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 122.556 1.949 . . . . 100.0 112.725 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.02 -45.19 90.03 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 123.924 0.89 . . . . 100.0 111.401 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -63.15 -42.79 99.52 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 123.182 0.593 . . . . 100.0 110.347 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -62.15 -45.01 95.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.502 1.121 . . . . 100.0 110.517 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -63.0 -44.01 97.2 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 112.686 0.624 . . . . 100.0 112.686 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.68 -44.03 97.29 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.42 0.45 . . . . 100.0 111.357 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.79 -46.26 88.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.499 1.12 . . . . 100.0 112.247 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.43 -38.58 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 C-N-CA 125.082 1.353 . . . . 100.0 111.143 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -60.5 -46.07 91.45 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.463 0.574 . . . . 100.0 111.197 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.4 -45.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.352 -0.539 . . . . 100.0 111.159 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.1 m -127.39 115.33 18.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.48 0.657 . . . . 100.0 109.558 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.57 147.18 23.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.537 -0.756 . . . . 100.0 112.422 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.07 44.55 27.85 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 126.56 1.944 . . . . 100.0 114.457 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 32.0 mm -100.74 131.29 23.77 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 125.907 1.683 . . . . 100.0 107.193 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.19 130.33 28.45 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.601 2.201 . . . . 100.0 109.181 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.418 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.8 mt -130.82 136.73 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 O-C-N 124.317 1.011 . . . . 100.0 109.147 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 83.9 t -113.6 130.91 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 105.431 -2.062 . . . . 100.0 105.431 178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.405 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 39.7 mt -105.85 125.14 50.64 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.465 -2.791 . . . . 100.0 103.465 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.433 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.4 m -116.82 129.99 56.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.199 -1.364 . . . . 100.0 112.509 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 103.51 2.83 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 105.347 -3.101 . . . . 100.0 105.347 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -84.36 167.44 16.52 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.082 1.353 . . . . 100.0 111.297 -178.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 60.08 42.45 15.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 128.348 2.659 . . . . 100.0 115.199 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.307 20.4 m -73.18 -7.66 10.17 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 116.08 -0.509 . . . . 100.0 111.494 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.96 -38.09 87.21 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.759 2.023 . . . . 100.0 109.801 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.65 130.34 34.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.108 0 N-CA-C 106.694 -1.595 . . . . 100.0 106.694 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.36 -41.11 98.35 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 116.281 1.956 . . . . 100.0 116.281 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -86.23 99.4 11.52 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.201 -2.148 . . . . 100.0 105.201 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -99.01 118.77 36.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.351 -2.833 . . . . 100.0 103.351 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.3 -40.96 13.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.719 -0.673 . . . . 100.0 112.634 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.85 106.36 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 103.667 -2.716 . . . . 100.0 103.667 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -103.64 -179.49 3.97 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.247 -0.888 . . . . 100.0 113.209 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.43 -35.86 72.75 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 127.161 2.184 . . . . 100.0 109.276 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.715 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -59.73 -37.11 78.02 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 128.081 2.552 . . . . 100.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.8 p -103.96 -1.17 27.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 120.114 3.376 . . . . 100.0 120.114 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.591 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 56.2 mt -98.47 95.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.21 0 C-N-CA 115.487 -2.485 . . . . 100.0 111.324 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 5.7 p -100.6 -5.98 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 114.77 1.396 . . . . 100.0 114.77 -178.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.89 -35.7 73.45 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.225 1.565 . . . . 100.0 115.225 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.464 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 87.0 m-70 -59.45 -40.5 87.05 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 125.587 1.555 . . . . 100.0 112.689 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.565 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 55.7 ttp85 -59.09 -47.69 84.33 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 124.567 1.147 . . . . 100.0 113.436 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -63.44 -41.44 98.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.277 0.986 . . . . 100.0 111.728 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.5 3.71 50.64 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 117.277 2.325 . . . . 100.0 117.277 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 57.42 42.84 24.07 Favored 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.526 1.531 . . . . 100.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 117' ' ' ILE . 27.3 mt -106.38 151.33 25.03 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.815 -1.55 . . . . 100.0 106.815 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 86.9 mm-40 -103.91 142.85 33.69 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 113.445 0.905 . . . . 100.0 113.445 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.464 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 79.7 t80 -98.83 132.18 44.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 113.633 0.975 . . . . 100.0 113.633 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.58 132.89 49.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 113.596 -1.638 . . . . 100.0 108.335 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.39 118.28 30.4 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.3 -3.593 . . . . 100.0 101.3 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 43.8 pt -133.57 159.37 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.644 1.212 . . . . 100.0 114.05 -178.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.46 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.1 m -140.02 111.43 7.18 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 106.418 -1.697 . . . . 100.0 106.418 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.578 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.58 -44.35 96.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.337 -1.301 . . . . 100.0 112.92 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.04 -40.12 96.78 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.715 0.806 . . . . 100.0 112.738 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.513 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 99.0 p -96.12 1.66 52.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.139 2.274 . . . . 100.0 117.139 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.42 11.92 Favored 'General case' 0 C--N 1.365 1.244 0 C-N-CA 125.277 1.431 . . . . 100.0 109.964 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.46 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 87.0 t80 -75.33 124.77 27.69 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.012 -0.736 . . . . 100.0 109.012 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 53.59 39.87 30.67 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.121 2.568 . . . . 100.0 115.399 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.565 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 69.8 t80 -62.61 -42.66 99.71 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 121.829 -0.544 . . . . 100.0 111.395 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.13 -39.43 94.67 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 115.746 1.758 . . . . 100.0 115.746 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.16 -48.53 96.87 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 120.932 3.679 . . . . 100.0 120.932 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -61.16 -41.79 40.47 Favored 'Trans proline' 0 C--N 1.373 1.853 0 CA-C-N 123.544 2.301 . . . . 100.0 112.681 178.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.7 -42.49 95.25 Favored 'General case' 0 CA--C 1.491 -1.325 0 O-C-N 124.656 1.223 . . . . 100.0 111.347 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.18 -45.05 93.6 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.457 0.703 . . . . 100.0 111.408 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -63.01 -44.53 95.74 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.523 0.514 . . . . 100.0 110.079 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 80.6 mt -61.78 -44.15 97.44 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.121 0.568 . . . . 100.0 111.469 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.72 98.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.207 1.003 . . . . 100.0 111.315 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -62.22 -45.83 91.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 123.722 0.809 . . . . 100.0 111.022 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -64.56 -45.38 87.36 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.415 HD12 ' HB3' ' A' ' 85' ' ' CYS . 82.0 mt -63.44 -46.74 84.91 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 123.826 0.85 . . . . 100.0 112.929 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 85.9 mt -70.54 -38.51 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 123.06 0.544 . . . . 100.0 109.989 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.98 9.74 59.31 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.477 -1.049 . . . . 100.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -108.97 112.63 59.97 Favored Pre-proline 0 C--N 1.362 1.121 0 N-CA-C 107.332 -1.358 . . . . 100.0 107.332 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.23 -16.7 28.16 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 123.412 2.741 . . . . 100.0 113.832 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.93 -0.12 56.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.827 0.851 . . . . 100.0 113.042 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.424 HD12 ' HG1' ' A' ' 54' ' ' THR . 19.1 tp -63.81 131.61 48.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.286 0.634 . . . . 100.0 110.337 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -136.65 153.77 50.82 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.987 -0.746 . . . . 100.0 108.987 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -88.21 113.21 23.6 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 106.257 -1.757 . . . . 100.0 106.257 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.7 t -67.02 -43.8 88.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.011 0.925 . . . . 100.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.91 150.7 49.19 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.522 0.677 . . . . 100.0 109.634 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 63.5 ttp -96.35 126.63 43.13 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 104.837 -2.283 . . . . 100.0 104.837 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.05 159.49 49.11 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.951 2.434 . . . . 100.0 111.541 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.72 125.06 23.6 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.283 -1.006 . . . . 100.0 108.283 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.1 144.56 46.54 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.335 -1.302 . . . . 100.0 109.972 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.65 137.85 97.27 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -56.08 138.33 82.36 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 123.516 2.811 . . . . 100.0 112.129 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.42 131.74 39.94 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.851 2.367 . . . . 100.0 114.264 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -66.06 -44.85 83.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 124.795 1.309 . . . . 100.0 108.503 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.03 158.42 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.787 -1.56 . . . . 100.0 106.787 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.7 t -99.78 130.64 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 105.651 -1.981 . . . . 100.0 105.651 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.513 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.1 ttt -85.83 126.7 34.24 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.345 -2.465 . . . . 100.0 104.345 178.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 77.6 m-20 -62.74 131.09 94.22 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 115.245 -0.889 . . . . 100.0 110.828 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.7 Cg_exo -58.67 -37.94 91.69 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.948 3.099 . . . . 100.0 112.828 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.05 93.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 124.449 1.093 . . . . 100.0 110.784 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.91 -42.49 97.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.067 0.547 . . . . 100.0 111.483 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 123.731 0.812 . . . . 100.0 110.512 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.88 97.72 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.126 0.97 . . . . 100.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.57 -44.42 96.37 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.614 0.765 . . . . 100.0 112.187 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -63.84 -43.83 95.0 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 112.397 0.518 . . . . 100.0 112.397 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.51 -41.37 98.52 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.55 -0.537 . . . . 100.0 109.55 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.14 -45.32 93.95 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.989 1.316 . . . . 100.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -42.75 99.4 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 123.366 0.667 . . . . 100.0 110.667 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.507 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 17.5 tp -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 124.122 0.889 . . . . 100.0 110.53 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.69 -41.77 95.8 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 115.664 1.727 . . . . 100.0 115.664 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.68 -46.36 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 CA-C-O 118.429 -0.796 . . . . 100.0 109.667 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.639 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.41 . . -93.35 -0.52 56.58 Favored 'General case' 0 N--CA 1.4 -2.931 1 C-N-CA 109.909 -4.717 . . . . 100.0 114.326 -179.886 . . . . . . . . 4 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.464 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.275 59.7 mt-30 -56.63 -36.51 69.56 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 106.535 -1.654 . . . . 100.0 106.535 178.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.7 p -82.44 53.4 2.3 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.211 1.005 . . . . 100.0 108.969 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.291 78.7 p 49.11 37.74 11.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 129.123 2.969 . . . . 100.0 116.402 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.467 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -82.53 -179.32 7.38 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.443 -2.428 . . . . 100.0 104.443 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.6 -39.98 81.7 Favored Pre-proline 0 CA--C 1.499 -0.981 0 CA-C-O 115.851 -2.024 . . . . 100.0 114.904 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.715 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.332 45.4 Cg_exo -55.02 136.7 74.09 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 121.288 1.496 . . . . 100.0 111.991 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -63.55 -47.7 80.5 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 125.132 5.234 . . . . 100.0 125.132 -173.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.591 ' CG ' ' HB ' ' A' ' 136' ' ' ILE . 99.2 mt-10 -63.1 -35.26 79.67 Favored 'General case' 0 CA--C 1.482 -1.673 1 CA-C-O 128.626 4.06 . . . . 100.0 107.782 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.639 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.482 43.2 m-20 -65.49 -49.06 70.43 Favored 'General case' 1 N--CA 1.352 -5.352 1 CA-C-N 107.581 -4.372 . . . . 100.0 106.148 -179.058 . . . . . . . . 5 3 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.15 -27.64 69.21 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 120.412 -1.43 . . . . 100.0 108.217 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.591 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.1 t70 -58.33 -43.59 88.32 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-O 117.178 -1.391 . . . . 100.0 112.507 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.5 mp . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.927 -177.23 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 111.301 0.111 . . . . 100.0 111.301 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.25 97.81 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.704 1.202 . . . . 100.0 112.873 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.87 150.22 20.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.092 0.472 . . . . 100.0 111.268 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.17 160.41 19.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.207 -0.664 . . . . 100.0 109.207 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.97 3.01 88.16 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.599 -0.556 . . . . 100.0 112.834 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -76.98 158.94 79.58 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.854 0.862 . . . . 100.0 109.471 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.64 156.37 53.17 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.485 2.79 . . . . 100.0 111.166 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.87 131.61 35.84 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.664 1.186 . . . . 100.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.1 t -92.64 117.98 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.489 -1.671 . . . . 100.0 106.489 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.76 133.94 52.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.638 -1.619 . . . . 100.0 107.916 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.22 141.91 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.744 -1.206 . . . . 100.0 107.744 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.01 118.49 31.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.9 tp -106.92 125.66 51.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 113.008 -1.905 . . . . 100.0 106.955 -179.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.3 t -102.39 121.86 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 106.23 -1.767 . . . . 100.0 106.23 178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.3 tt -113.68 117.95 33.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.628 -2.36 . . . . 100.0 104.628 -179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -127.58 162.87 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.847 -0.615 . . . . 100.0 112.307 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.78 175.26 28.5 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 108.569 -1.812 . . . . 100.0 108.569 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -71.71 156.1 39.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 121.777 -0.837 . . . . 100.0 111.786 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.0 141.07 40.98 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 107.423 -2.271 . . . . 100.0 107.423 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 -5.43 80.63 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.924 -0.931 . . . . 100.0 113.884 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -62.85 -40.03 96.2 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 118.618 1.209 . . . . 100.0 111.145 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.79 24.64 5.16 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.22 -1.152 . . . . 100.0 110.22 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 52.3 mtpt -60.24 -46.22 90.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.363 1.465 . . . . 100.0 111.98 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.6 m -62.9 -43.76 97.92 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 124.864 1.265 . . . . 100.0 109.622 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.4 m -63.15 -41.64 99.3 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.421 1.088 . . . . 100.0 109.28 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.589 ' HA ' HH11 ' A' ' 29' ' ' ARG . 60.6 t80 -60.62 -48.77 80.32 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 122.868 0.467 . . . . 100.0 111.625 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 98.3 t -64.02 -42.64 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.672 0.789 . . . . 100.0 110.664 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.263 99.5 mttt -70.44 -6.39 35.46 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 115.718 1.747 . . . . 100.0 115.718 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.589 HH11 ' HA ' ' A' ' 26' ' ' PHE . 80.7 mtm-85 -61.32 -36.57 80.49 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 118.884 -0.579 . . . . 100.0 110.069 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.614 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 44.8 t-80 -79.98 113.79 18.41 Favored 'General case' 0 C--N 1.36 1.034 0 N-CA-C 107.128 -1.434 . . . . 100.0 107.128 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.23 -43.91 97.76 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.888 1.44 . . . . 100.0 114.888 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.448 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 79.8 m -64.11 -39.87 94.97 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.694 -0.854 . . . . 100.0 108.694 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.614 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.27 -42.44 99.78 Favored Glycine 0 C--N 1.361 1.938 0 N-CA-C 110.409 -1.076 . . . . 100.0 110.409 179.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.89 -45.33 93.06 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 117.56 0.68 . . . . 100.0 111.536 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.5 -40.92 98.26 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.996 0.919 . . . . 100.0 112.236 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -90.56 6.36 43.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 114.988 1.477 . . . . 100.0 114.988 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -61.06 140.61 57.82 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -121.07 133.59 55.24 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.108 -1.441 . . . . 100.0 107.108 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -103.32 124.63 49.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.331 -1.729 . . . . 100.0 106.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.56 109.73 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 100.641 -3.836 . . . . 100.0 100.641 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.55 92.22 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 116.669 2.1 . . . . 100.0 116.669 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.9 m -63.13 -48.55 78.02 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 123.37 0.419 . . . . 100.0 110.438 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.35 -36.1 74.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 113.957 1.095 . . . . 100.0 113.957 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.24 40.45 33.92 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 107.944 -2.062 . . . . 100.0 107.944 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 41.0 t -127.72 141.81 45.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.077 0.951 . . . . 100.0 109.141 -178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -103.96 119.52 39.1 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 102.839 -3.022 . . . . 100.0 102.839 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.23 120.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.696 -1.964 . . . . 100.0 105.696 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -113.22 119.21 42.73 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.023 -0.732 . . . . 100.0 109.023 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -80.09 106.54 1.93 Allowed 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.093 1.862 . . . . 100.0 109.62 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.32 117.42 32.68 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.196 -1.779 . . . . 100.0 106.196 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.17 125.98 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.41 133.25 54.63 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.782 -1.933 . . . . 100.0 105.782 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -100.66 119.19 38.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.176 -1.046 . . . . 100.0 108.176 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 20.6 p -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.875 -1.057 . . . . 100.0 110.874 -178.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -59.83 -44.44 94.06 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.424 1.489 . . . . 100.0 108.255 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -67.23 -37.96 84.42 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.308 1.443 . . . . 100.0 112.792 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.25 -172.56 28.48 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 108.988 -1.645 . . . . 100.0 108.988 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.97 136.73 49.77 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.674 2.25 . . . . 100.0 113.953 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.58 129.75 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 102.659 -3.089 . . . . 100.0 102.659 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -110.32 129.66 55.7 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.646 -0.872 . . . . 100.0 108.646 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -109.82 116.61 31.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.177 -2.897 . . . . 100.0 103.177 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -87.42 107.7 18.66 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.338 -4.319 . . . . 100.0 99.338 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 26.8 t -93.2 121.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.069 -1.826 . . . . 100.0 106.069 -177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -93.57 109.88 21.49 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.797 -2.298 . . . . 100.0 104.797 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.22 136.6 52.77 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.035 -1.839 . . . . 100.0 106.035 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.2 p -72.95 162.2 29.78 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 113.378 0.881 . . . . 100.0 113.378 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.57 16.22 19.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.325 -0.852 . . . . 100.0 109.789 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.3 51.14 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 121.846 -0.534 . . . . 100.0 112.409 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -60.28 -33.78 72.82 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 126.871 2.069 . . . . 100.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -57.89 -36.68 72.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.566 2.346 . . . . 100.0 112.154 -178.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.36 -43.53 98.6 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.13 0.572 . . . . 100.0 109.792 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -70.6 -41.68 72.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.216 1.406 . . . . 100.0 113.539 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.77 -155.2 13.51 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 121.363 -0.446 . . . . 100.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.0 171.66 52.16 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 123.764 0.697 . . . . 100.0 111.982 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.97 143.12 33.61 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 122.173 0.987 . . . . 100.0 111.128 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -65.16 150.48 48.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.441 -1.708 . . . . 100.0 113.14 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.43 -37.92 85.26 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 114.029 -1.441 . . . . 100.0 109.53 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.35 94.11 Favored Glycine 0 C--N 1.36 1.874 0 C-N-CA 124.728 1.156 . . . . 100.0 111.07 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 64.0 t80 -62.44 -46.83 86.77 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.899 0.88 . . . . 100.0 111.279 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -69.03 -37.21 78.49 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.671 1.73 . . . . 100.0 115.671 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.87 139.29 12.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 125.178 1.391 . . . . 100.0 113.232 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.93 22.17 10.18 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 127.544 2.338 . . . . 100.0 113.182 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.61 128.99 37.61 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.293 -1.373 . . . . 100.0 107.293 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.54 -37.68 10.77 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.471 -1.677 . . . . 100.0 106.471 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.442 ' HB2' HD21 ' A' ' 164' ' ' LEU . 24.3 p -144.6 161.57 38.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.681 0.277 . . . . 100.0 111.271 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.34 150.16 36.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.176 1.547 . . . . 100.0 115.176 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.4 mt -125.54 126.13 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 103.851 -2.648 . . . . 100.0 103.851 176.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.5 mt -111.03 124.17 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 102.944 -2.984 . . . . 100.0 102.944 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.507 ' HE2' ' CG ' ' A' ' 26' ' ' PHE . 38.9 mtt -110.89 135.51 51.32 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.268 -1.333 . . . . 100.0 114.549 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -129.23 159.41 36.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 111.583 -2.553 . . . . 100.0 108.33 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -103.78 126.61 51.03 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.291 -1.744 . . . . 100.0 106.291 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.1 m -64.68 -21.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.857 1.058 . . . . 100.0 113.857 -179.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.6 p -88.33 -10.31 49.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 119.193 -0.432 . . . . 100.0 110.961 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -116.93 114.99 24.63 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.755 1.264 . . . . 100.0 110.193 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -65.93 -39.48 90.56 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.408 1.483 . . . . 100.0 109.815 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.97 -41.84 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.221 1.808 . . . . 100.0 110.777 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.1 m -62.74 -42.46 99.68 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 118.089 0.404 . . . . 100.0 109.93 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.487 ' CE1' HG21 ' A' ' 136' ' ' ILE . 45.7 t80 -63.93 -41.0 97.75 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.691 0.796 . . . . 100.0 110.767 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.501 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -60.83 -38.55 85.87 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.763 0.825 . . . . 100.0 110.515 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.36 -9.78 58.87 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 115.129 1.529 . . . . 100.0 115.129 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.71 -43.4 95.21 Favored Pre-proline 0 C--N 1.364 1.222 0 CA-C-O 115.93 -1.986 . . . . 100.0 111.529 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.501 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.2 Cg_exo -57.4 -36.23 98.84 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.242 1.961 . . . . 100.0 112.93 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.91 -47.08 84.82 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.951 1.3 . . . . 100.0 110.115 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -63.87 -42.64 97.47 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 123.837 0.855 . . . . 100.0 111.161 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . 0.417 ' CE1' HD12 ' A' ' 144' ' ' LEU . 85.7 t60 -62.45 -44.29 96.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.526 1.13 . . . . 100.0 110.265 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -62.62 -45.3 93.49 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 118.697 -0.668 . . . . 100.0 111.661 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -62.41 -43.98 97.53 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 123.481 0.488 . . . . 100.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 46.5 tp -62.71 -46.54 87.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.466 1.106 . . . . 100.0 111.988 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.59 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 C-N-CA 125.376 1.47 . . . . 100.0 111.165 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.08 -46.32 89.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 119.017 -0.516 . . . . 100.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.86 -46.62 59.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.356 -0.538 . . . . 100.0 111.796 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.9 m -127.07 114.03 17.21 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -90.46 146.07 24.42 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.746 -0.661 . . . . 100.0 112.27 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.75 43.3 31.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 126.39 1.876 . . . . 100.0 115.36 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 pt -99.5 139.82 21.17 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 105.953 -1.869 . . . . 100.0 105.953 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.29 129.92 28.57 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.608 2.206 . . . . 100.0 109.525 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.413 ' HB ' HD21 ' A' ' 144' ' ' LEU . 72.3 mt -130.64 135.89 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.235 1.017 . . . . 100.0 108.777 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.67 131.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 105.594 -2.002 . . . . 100.0 105.594 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.507 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 20.5 mt -106.04 126.56 52.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.274 -2.861 . . . . 100.0 103.274 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.468 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 73.8 m -114.57 127.85 56.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.98 -1.464 . . . . 100.0 112.008 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.73 104.02 2.93 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 105.726 -2.95 . . . . 100.0 105.726 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 122' ' ' ASN . 1.1 m-80 -78.95 163.89 24.86 Favored 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 127.823 2.449 . . . . 100.0 112.069 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 55.58 45.48 24.77 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 127.921 2.488 . . . . 100.0 115.556 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.333 33.1 m -72.29 -7.5 9.64 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 120.069 -0.652 . . . . 100.0 111.109 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.46 -38.96 89.13 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.029 2.131 . . . . 100.0 109.932 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.96 130.64 34.05 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 N-CA-C 107.069 -1.456 . . . . 100.0 107.069 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.29 -41.19 98.3 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.323 1.972 . . . . 100.0 116.323 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.5 100.47 12.79 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -96.67 121.35 38.41 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 102.392 -3.188 . . . . 100.0 102.392 178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.19 -36.02 11.09 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.744 -0.662 . . . . 100.0 112.363 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.4 t -104.73 105.23 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 101.707 -3.442 . . . . 100.0 101.707 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -101.87 177.71 4.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.951 1.093 . . . . 100.0 113.951 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.486 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.97 -35.51 73.31 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.082 2.153 . . . . 100.0 108.613 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.716 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.6 mttt -59.58 -37.05 77.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 128.395 2.678 . . . . 100.0 112.327 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.3 p -104.34 -3.13 24.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 120.061 3.356 . . . . 100.0 120.061 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.601 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 55.9 mt -95.75 94.34 4.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 116.394 -2.122 . . . . 100.0 112.317 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 p -99.29 -5.3 9.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 -178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -58.86 -36.73 75.08 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 115.418 1.636 . . . . 100.0 115.418 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.543 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.9 m-70 -59.87 -39.57 85.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.994 1.718 . . . . 100.0 114.371 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.494 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 47.1 ttp180 -58.95 -48.13 82.62 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 124.904 1.282 . . . . 100.0 112.442 -176.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.16 -41.3 99.23 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.039 1.336 . . . . 100.0 111.244 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -98.59 1.54 46.52 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 116.338 1.977 . . . . 100.0 116.338 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 54.9 45.82 25.71 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 125.079 1.351 . . . . 100.0 113.198 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.417 HD12 ' CE1' ' A' ' 105' ' ' HIS . 32.1 mt -106.38 150.05 26.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.863 -1.903 . . . . 100.0 105.863 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.315 89.2 mm-40 -100.97 143.9 30.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.588 -0.845 . . . . 100.0 112.518 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.543 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 69.5 t80 -102.03 132.94 47.58 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.591 0.96 . . . . 100.0 113.591 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.81 132.89 45.51 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -1.268 . . . . 100.0 111.038 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.278 38.0 m-20 -84.58 122.13 28.6 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 103.152 -2.907 . . . . 100.0 103.152 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.28 156.6 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 122.644 1.211 . . . . 100.0 110.999 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 74.5 m -138.6 110.63 7.27 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 105.698 -1.964 . . . . 100.0 105.698 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.554 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.76 -44.06 97.17 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.651 -1.613 . . . . 100.0 112.909 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.87 -41.46 99.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.955 0.902 . . . . 100.0 112.425 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.509 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 87.5 p -96.82 3.42 52.25 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 117.75 2.5 . . . . 100.0 117.75 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.617 HD21 ' HG3' ' A' ' 185' ' ' PRO . 71.6 m-80 65.45 21.17 11.83 Favored 'General case' 0 C--N 1.364 1.239 0 C-N-CA 124.451 1.101 . . . . 100.0 110.806 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.485 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.4 t80 -75.26 124.87 27.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.02 -0.733 . . . . 100.0 109.02 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.84 40.21 30.31 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 128.355 2.662 . . . . 100.0 115.364 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.43 ' HB2' HH21 ' A' ' 29' ' ' ARG . 78.9 t80 -62.65 -43.23 99.32 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.863 -0.523 . . . . 100.0 110.735 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -62.97 -39.19 93.94 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 115.996 1.85 . . . . 100.0 115.996 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.94 -47.45 98.86 Favored Pre-proline 0 C--N 1.356 0.862 0 N-CA-C 119.839 3.274 . . . . 100.0 119.839 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.94 -42.16 39.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 123.31 2.218 . . . . 100.0 111.222 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -64.05 -42.4 97.04 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 125.353 1.461 . . . . 100.0 111.614 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.19 -47.02 88.07 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 123.462 0.705 . . . . 100.0 111.722 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.25 -44.39 95.3 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 124.011 0.819 . . . . 100.0 110.46 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . 0.442 HD21 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.69 -45.42 94.08 Favored 'General case' 0 CA--C 1.495 -1.171 0 O-C-N 123.752 0.657 . . . . 100.0 111.252 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.47 98.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 124.115 0.966 . . . . 100.0 111.555 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.05 -46.05 90.83 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 123.672 0.789 . . . . 100.0 111.402 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -65.52 -44.28 87.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 113.498 0.925 . . . . 100.0 113.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.63 -46.86 83.76 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.427 0.691 . . . . 100.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 87.8 mt -70.4 -38.74 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 123.309 0.644 . . . . 100.0 110.688 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.28 9.53 57.92 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-O 118.899 -0.945 . . . . 100.0 111.139 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -111.03 112.9 55.19 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.692 -1.225 . . . . 100.0 107.692 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.14 -14.93 28.94 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.72 2.946 . . . . 100.0 113.968 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.51 5.18 51.77 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.908 0.707 . . . . 100.0 112.908 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -65.75 131.8 47.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.362 0.665 . . . . 100.0 109.299 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -135.21 152.62 51.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.299 -0.63 . . . . 100.0 109.299 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -88.11 115.07 25.34 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 104.843 -2.281 . . . . 100.0 104.843 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.34 -45.04 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.071 0.948 . . . . 100.0 110.299 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.14 151.4 49.27 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.274 0.559 . . . . 100.0 109.734 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' MET . . . . . 0.403 ' HA ' ' HD3' ' A' ' 180' ' ' PRO . 64.2 ttp -96.63 127.42 39.67 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.322 -2.103 . . . . 100.0 105.322 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 179' ' ' MET . 34.9 Cg_exo -66.14 159.05 51.49 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.127 2.551 . . . . 100.0 111.571 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.56 126.37 27.67 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.02 0.914 . . . . 100.0 108.562 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.78 145.91 47.06 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.163 -1.38 . . . . 100.0 108.979 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.402 ' HA ' ' HD3' ' A' ' 184' ' ' PRO . . . -63.74 138.42 97.38 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.657 -1.238 . . . . 100.0 107.657 179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . 0.44 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 51.7 Cg_exo -56.97 140.4 92.26 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.36 2.707 . . . . 100.0 112.377 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.617 ' HG3' HD21 ' A' ' 154' ' ' ASN . 39.3 Cg_exo -58.5 131.31 41.88 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.413 2.742 . . . . 100.0 114.079 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.94 -44.66 80.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.599 1.187 . . . . 100.0 107.961 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.19 158.4 43.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.458 -1.682 . . . . 100.0 106.458 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.6 130.72 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 105.919 -1.882 . . . . 100.0 105.919 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.509 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 28.1 ttt -87.36 127.4 35.2 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.382 -2.081 . . . . 100.0 105.382 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . 0.424 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 55.4 m-20 -62.91 130.56 94.09 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 115.16 -0.927 . . . . 100.0 111.005 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 54.0 Cg_exo -58.68 -36.74 96.75 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.874 3.049 . . . . 100.0 112.579 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.36 96.35 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.42 1.075 . . . . 100.0 110.447 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.66 -42.78 98.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 123.115 0.566 . . . . 100.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.14 97.67 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 123.512 0.725 . . . . 100.0 110.634 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.5 98.61 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.87 0.868 . . . . 100.0 110.654 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -61.94 -45.83 91.96 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.3 1.04 . . . . 100.0 111.986 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -64.0 -44.63 92.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 112.209 0.448 . . . . 100.0 112.209 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.41 -39.91 94.76 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.353 0.408 . . . . 100.0 111.053 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.69 -43.77 97.96 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.883 1.273 . . . . 100.0 110.829 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.08 -42.53 99.3 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.158 0.983 . . . . 100.0 110.106 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.511 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.4 tp -59.8 -49.43 77.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 124.317 1.01 . . . . 100.0 109.861 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.48 -41.51 96.44 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 115.805 1.78 . . . . 100.0 115.805 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.41 -47.06 91.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 CA-C-O 118.305 -0.855 . . . . 100.0 109.423 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.65 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.409 . . -93.97 0.76 56.22 Favored 'General case' 0 N--CA 1.405 -2.71 1 C-N-CA 109.659 -4.816 . . . . 100.0 114.495 179.694 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 213' ' ' ASP 0.29 61.2 mt-30 -57.27 -35.86 70.28 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 106.94 -1.504 . . . . 100.0 106.94 178.169 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.8 p -82.82 53.88 2.53 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.487 1.137 . . . . 100.0 108.551 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.304 80.4 p 48.66 38.91 12.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 129.507 3.123 . . . . 100.0 115.741 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -83.31 -177.43 6.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.638 -2.356 . . . . 100.0 104.638 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 79.8 mt -56.39 -41.58 91.86 Favored Pre-proline 0 CA--C 1.502 -0.884 0 CA-C-O 116.105 -1.902 . . . . 100.0 114.882 -174.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.307 41.8 Cg_exo -54.52 136.18 69.11 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.112 1.433 . . . . 100.0 112.389 177.191 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 95.3 m-20 -63.63 -47.38 81.57 Favored 'General case' 0 N--CA 1.428 -1.572 1 N-CA-C 124.109 4.855 . . . . 100.0 124.109 -173.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.601 ' CG ' ' HB ' ' A' ' 136' ' ' ILE 0.256 99.5 mt-10 -63.17 -35.17 79.41 Favored 'General case' 0 CA--C 1.477 -1.86 1 CA-C-O 128.562 4.03 . . . . 100.0 108.064 177.753 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.65 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.484 44.7 m-20 -66.57 -48.9 68.13 Favored 'General case' 1 N--CA 1.35 -5.473 1 CA-C-N 107.629 -4.351 . . . . 100.0 105.939 -178.624 . . . . . . . . 5 3 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.74 -25.43 67.93 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.574 -1.329 . . . . 100.0 108.524 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.583 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.84 -42.8 90.18 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-O 117.238 -1.363 . . . . 100.0 112.571 175.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.9 mp . . . . . 0 N--CA 1.425 -1.71 0 CA-C-O 114.335 -2.745 . . . . 100.0 112.039 -176.994 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HG2' HG23 ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 112.142 0.423 . . . . 100.0 112.142 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.46 95.63 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.119 1.367 . . . . 100.0 113.221 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.23 149.65 27.5 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.539 0.685 . . . . 100.0 111.835 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -80.24 160.05 25.7 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.453 -0.794 . . . . 100.0 110.203 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.89 -5.56 79.21 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.458 -0.634 . . . . 100.0 112.097 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.29 154.21 90.23 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 124.32 1.048 . . . . 100.0 110.357 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 161.62 39.63 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.481 2.787 . . . . 100.0 111.707 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.26 132.16 33.56 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 114.492 1.293 . . . . 100.0 114.492 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.455 HG23 ' HG2' ' A' ' 1' ' ' MET . 87.6 t -96.01 116.54 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.532 -2.025 . . . . 100.0 105.532 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -121.29 134.77 55.16 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.238 -1.801 . . . . 100.0 108.155 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.15 143.11 49.28 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.598 -1.26 . . . . 100.0 107.598 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.64 120.81 35.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.793 -1.558 . . . . 100.0 106.793 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -109.21 127.65 54.41 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.913 -1.949 . . . . 100.0 107.107 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 50.8 t -103.02 120.78 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.714 -1.585 . . . . 100.0 106.892 178.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.417 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 48.5 tp -110.69 115.38 29.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.53 161.85 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 CA-C-N 115.741 -0.663 . . . . 100.0 111.992 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.14 176.61 30.38 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 108.341 -1.903 . . . . 100.0 108.341 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -72.67 157.27 37.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.621 0.724 . . . . 100.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.45 141.72 39.42 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 107.109 -2.396 . . . . 100.0 107.109 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.06 -5.62 81.66 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.079 -0.845 . . . . 100.0 113.62 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -63.04 -39.28 94.28 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 118.481 1.141 . . . . 100.0 111.204 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.49 23.9 5.53 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 111.076 -0.81 . . . . 100.0 111.076 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.417 ' HD2' ' HG ' ' A' ' 15' ' ' LEU . 29.3 mtmt -61.71 -43.24 99.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.843 0.857 . . . . 100.0 111.902 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -62.16 -44.19 97.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.681 1.193 . . . . 100.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.2 m -63.08 -41.1 99.34 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.565 1.146 . . . . 100.0 108.826 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.554 ' CD1' ' HE2' ' A' ' 89' ' ' MET . 50.0 t80 -59.75 -49.09 79.07 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.376 0.67 . . . . 100.0 112.676 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -41.95 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 123.869 0.731 . . . . 100.0 110.561 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.49 -8.43 40.93 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 115.757 1.762 . . . . 100.0 115.757 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.582 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.8 mtm-85 -61.36 -37.34 82.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.535 -0.542 . . . . 100.0 109.535 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' HIS . . . . . 0.694 ' HD1' ' H ' ' A' ' 33' ' ' GLY . 53.8 t-80 -80.23 112.35 17.46 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.49 -43.85 97.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 115.222 1.564 . . . . 100.0 115.222 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 85.2 m -63.02 -41.96 99.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.621 0.768 . . . . 100.0 108.934 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.694 ' H ' ' HD1' ' A' ' 30' ' ' HIS . . . -61.66 -42.43 99.75 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 123.855 0.741 . . . . 100.0 111.361 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.82 -43.75 95.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.023 0.529 . . . . 100.0 110.676 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.05 -40.04 95.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.31 1.044 . . . . 100.0 112.349 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -90.42 7.02 40.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 114.422 1.267 . . . . 100.0 114.422 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -58.81 140.23 55.35 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 115.215 1.561 . . . . 100.0 115.215 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.88 130.46 52.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -103.81 123.6 47.38 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.256 -2.127 . . . . 100.0 105.256 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.11 113.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 102.736 -3.061 . . . . 100.0 102.736 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.2 94.01 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.0 p -62.59 -47.41 83.91 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 122.679 0.392 . . . . 100.0 111.723 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.06 -38.22 75.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.718 1.207 . . . . 100.0 112.987 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 35.78 52.42 Favored Glycine 0 C--N 1.359 1.844 0 N-CA-C 106.625 -2.59 . . . . 100.0 106.625 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 84.3 t -125.45 141.45 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.766 1.227 . . . . 100.0 108.622 -177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -106.56 117.36 33.85 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 102.571 -3.122 . . . . 100.0 102.571 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.74 122.25 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 107.039 -1.467 . . . . 100.0 107.039 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -116.63 120.69 34.09 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.265 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -79.97 105.62 1.82 Allowed 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.298 1.999 . . . . 100.0 109.415 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.08 116.75 29.85 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.636 -1.616 . . . . 100.0 106.636 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.65 126.82 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.858 -1.164 . . . . 100.0 107.858 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.41 132.45 53.96 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -99.9 120.03 39.14 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.212 -1.033 . . . . 100.0 108.212 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.413 ' HG1' HD12 ' A' ' 174' ' ' LEU . 23.3 p -109.44 -179.77 3.92 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.817 -1.083 . . . . 100.0 110.754 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.81 -44.11 94.16 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 125.576 1.55 . . . . 100.0 107.837 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.407 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 91.6 mtt-85 -67.32 -39.19 85.83 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.901 1.28 . . . . 100.0 112.846 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.83 -172.54 28.13 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.068 -2.013 . . . . 100.0 108.068 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.27 137.28 50.95 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.628 2.219 . . . . 100.0 114.552 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.9 mt -127.34 130.42 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.325 -3.213 . . . . 100.0 102.325 178.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -110.94 129.65 55.82 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.412 -0.588 . . . . 100.0 109.412 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -111.31 115.27 29.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.174 -2.528 . . . . 100.0 104.174 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -86.82 106.38 17.68 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.653 -3.832 . . . . 100.0 100.653 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 122.4 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -98.04 114.78 27.03 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.116 -1.809 . . . . 100.0 106.116 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -112.63 135.68 53.08 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.531 -1.655 . . . . 100.0 106.531 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -72.25 162.66 29.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.199 0.814 . . . . 100.0 113.199 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.43 14.76 21.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.316 -0.857 . . . . 100.0 110.033 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.21 12.36 42.55 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 121.78 -0.575 . . . . 100.0 112.037 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.46 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 67.8 mt-30 -60.16 -34.43 73.57 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.557 1.943 . . . . 100.0 111.625 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.9 -35.39 70.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 127.624 2.37 . . . . 100.0 112.406 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.08 -40.9 97.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.474 0.71 . . . . 100.0 110.97 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . 0.46 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 p90 -92.05 -14.0 30.01 Favored 'General case' 0 C--N 1.362 1.111 0 N-CA-C 114.908 1.447 . . . . 100.0 114.908 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.93 -163.9 33.04 Favored Glycine 0 C--N 1.357 1.745 0 C-N-CA 119.464 -1.35 . . . . 100.0 113.432 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.51 172.57 54.64 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 110.507 -1.037 . . . . 100.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 93.8 mt -104.25 142.32 34.75 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.836 0.827 . . . . 100.0 110.186 -179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -68.1 155.6 39.24 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.192 -1.367 . . . . 100.0 113.323 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.56 -38.35 84.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 125.421 1.488 . . . . 100.0 110.415 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.91 -39.25 93.78 Favored Glycine 0 C--N 1.36 1.868 0 C-N-CA 124.673 1.13 . . . . 100.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 61.0 t80 -62.24 -46.65 87.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.605 0.762 . . . . 100.0 110.84 177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -68.94 -37.02 78.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 115.86 1.8 . . . . 100.0 115.86 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.9 mt -52.15 137.09 11.79 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 125.396 1.478 . . . . 100.0 113.89 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 64.27 26.26 13.68 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 127.999 2.52 . . . . 100.0 113.753 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.76 36.76 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.993 -1.484 . . . . 100.0 106.993 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . 0.402 ' O ' HG21 ' A' ' 115' ' ' ILE . 96.1 mm-40 -97.25 -37.54 10.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.558 -1.275 . . . . 100.0 107.558 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' CYS . . . . . 0.428 ' HB3' HD12 ' A' ' 168' ' ' LEU . 22.8 p -142.54 160.14 40.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 122.701 0.4 . . . . 100.0 110.988 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -145.61 149.13 33.97 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 114.202 1.186 . . . . 100.0 114.202 179.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.5 mt -126.1 126.72 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.379 -2.823 . . . . 100.0 103.379 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.4 ' HB ' ' CD2' ' A' ' 119' ' ' LEU . 51.5 mt -111.78 124.17 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.947 -2.983 . . . . 100.0 102.947 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.554 ' HE2' ' CD1' ' A' ' 26' ' ' PHE . 42.8 mtt -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.183 -1.371 . . . . 100.0 114.603 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -127.74 158.35 37.87 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.763 -2.471 . . . . 100.0 108.088 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.93 126.56 51.14 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.879 -1.897 . . . . 100.0 105.879 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.54 -21.94 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.332 0.864 . . . . 100.0 113.332 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.8 p -86.99 -8.71 56.93 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 119.266 -0.397 . . . . 100.0 111.167 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.38 115.34 23.32 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.34 1.067 . . . . 100.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -66.84 -38.23 86.01 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 114.895 -1.048 . . . . 100.0 111.383 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.79 -41.0 86.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 125.787 1.635 . . . . 100.0 110.216 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.3 m -62.44 -42.59 99.57 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 118.147 0.43 . . . . 100.0 109.968 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.525 ' CE1' HG21 ' A' ' 136' ' ' ILE . 35.8 t80 -63.12 -41.55 99.36 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.567 0.747 . . . . 100.0 110.801 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.1 mttt -61.25 -37.44 83.11 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 100.0 111.155 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.96 -8.44 57.38 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 115.003 1.483 . . . . 100.0 115.003 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.66 -42.97 94.43 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 116.013 -1.946 . . . . 100.0 111.49 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.1 Cg_exo -57.56 -37.23 97.76 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.074 1.849 . . . . 100.0 112.692 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -63.11 -46.33 87.82 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.366 1.067 . . . . 100.0 110.85 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -64.02 -41.82 97.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 123.25 0.62 . . . . 100.0 111.213 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -61.82 -44.92 95.88 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 124.239 1.016 . . . . 100.0 109.66 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.88 -43.74 97.98 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 118.805 -0.617 . . . . 100.0 112.462 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.15 -45.33 93.92 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 121.251 0.548 . . . . 100.0 110.626 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.4 tp -62.81 -46.46 87.87 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.986 1.314 . . . . 100.0 112.647 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.19 -38.5 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 C-N-CA 125.237 1.415 . . . . 100.0 111.218 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -60.44 -46.38 90.27 Favored 'General case' 0 C--N 1.358 0.973 0 CA-C-O 118.833 -0.603 . . . . 100.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.75 -46.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 120.238 -0.585 . . . . 100.0 111.502 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.31 115.63 19.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -93.0 147.22 23.01 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.89 -0.596 . . . . 100.0 112.41 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 54.37 45.66 26.7 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.394 1.877 . . . . 100.0 114.871 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.402 HG21 ' O ' ' A' ' 84' ' ' GLN . 34.0 mm -99.35 131.45 25.04 Favored Pre-proline 0 N--CA 1.436 -1.139 0 C-N-CA 126.125 1.77 . . . . 100.0 106.802 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.89 130.02 27.94 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.601 2.2 . . . . 100.0 109.008 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.402 ' HB ' HD21 ' A' ' 144' ' ' LEU . 67.6 mt -130.47 137.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 122.369 1.081 . . . . 100.0 108.508 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -114.79 130.75 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.265 -2.124 . . . . 100.0 105.265 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.43 HD13 ' ND1' ' A' ' 139' ' ' HIS . 34.3 mt -104.97 125.24 50.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.079 -2.563 . . . . 100.0 104.079 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' CYS . . . . . 0.427 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.0 m -115.32 128.26 55.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.853 -1.521 . . . . 100.0 112.301 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.26 103.98 2.88 Favored Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.293 -3.123 . . . . 100.0 105.293 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -80.71 166.5 20.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 125.798 1.639 . . . . 100.0 111.725 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 56.58 44.66 23.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 128.29 2.636 . . . . 100.0 115.416 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.29 28.5 m -71.81 -9.33 12.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 120.416 -0.514 . . . . 100.0 110.724 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.91 -38.85 87.16 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 127.186 2.194 . . . . 100.0 110.279 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.55 129.88 34.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 107.414 -1.328 . . . . 100.0 107.414 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.98 -40.07 96.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 116.54 2.052 . . . . 100.0 116.54 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -85.63 98.69 10.81 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 104.426 -2.435 . . . . 100.0 104.426 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -100.72 109.36 21.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 105.384 -2.08 . . . . 100.0 105.384 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.18 -43.49 61.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.79 1.404 . . . . 100.0 114.79 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 48.0 t -108.49 108.54 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 104.73 -2.322 . . . . 100.0 104.73 -176.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.01 179.73 4.19 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.189 -0.914 . . . . 100.0 113.422 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.51 -35.16 71.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.154 2.182 . . . . 100.0 109.318 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LYS . . . . . 0.713 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -59.45 -37.1 77.26 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 128.717 2.807 . . . . 100.0 112.017 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.3 p -105.01 -0.49 26.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 120.624 3.565 . . . . 100.0 120.624 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . 0.597 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 54.3 mt -99.46 96.01 4.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 115.372 -2.531 . . . . 100.0 111.346 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 3.8 p -100.06 -6.77 9.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 115.553 1.686 . . . . 100.0 115.553 -177.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -58.79 -35.87 73.52 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.43 ' ND1' HD13 ' A' ' 119' ' ' LEU . 77.7 m-70 -59.63 -39.55 84.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.588 1.555 . . . . 100.0 112.578 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.48 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 42.3 ttp180 -59.29 -47.08 86.71 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.108 1.363 . . . . 100.0 112.382 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.04 -43.62 98.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.806 1.242 . . . . 100.0 111.469 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 116.213 1.931 . . . . 100.0 116.213 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 54.6 47.42 22.67 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.296 1.438 . . . . 100.0 113.126 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LEU . . . . . 0.402 HD21 ' HB ' ' A' ' 117' ' ' ILE . 30.4 mt -107.22 149.63 27.52 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.245 -1.761 . . . . 100.0 106.245 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -96.38 144.47 26.49 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 120.709 -0.397 . . . . 100.0 111.868 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.407 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 77.5 t80 -106.45 133.59 50.9 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 123.766 0.666 . . . . 100.0 112.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -130.01 132.41 46.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.184 -1.371 . . . . 100.0 110.416 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.314 35.2 m-20 -85.15 122.73 29.77 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 102.054 -3.313 . . . . 100.0 102.054 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 pt -135.88 157.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.574 1.178 . . . . 100.0 112.037 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.438 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 61.9 m -137.34 112.87 9.39 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.26 -43.88 96.71 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.735 -1.575 . . . . 100.0 112.772 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.83 -41.09 99.19 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.352 1.061 . . . . 100.0 112.098 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.627 ' HG ' ' HB2' ' A' ' 189' ' ' MET . 96.1 p -97.48 2.37 50.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 117.563 2.431 . . . . 100.0 117.563 -178.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 66.67 20.03 10.75 Favored 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.638 1.175 . . . . 100.0 110.846 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . 0.438 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.46 -0.571 . . . . 100.0 109.46 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.11 39.79 30.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 128.709 2.804 . . . . 100.0 115.725 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.491 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 76.8 t80 -61.82 -44.89 95.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 121.618 -0.676 . . . . 100.0 112.146 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.14 -37.27 86.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 116.87 2.174 . . . . 100.0 116.87 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.74 -46.82 99.71 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 119.166 3.024 . . . . 100.0 119.166 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -60.7 -42.2 40.92 Favored 'Trans proline' 0 C--N 1.372 1.813 0 CA-C-N 123.204 2.18 . . . . 100.0 111.544 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -64.24 -42.48 96.51 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 124.839 1.256 . . . . 100.0 111.76 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.81 -45.38 92.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 123.775 0.83 . . . . 100.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.18 -43.34 95.42 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 123.549 0.531 . . . . 100.0 110.424 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 82.5 mt -61.6 -44.07 97.69 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 123.509 0.505 . . . . 100.0 111.508 -179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.04 97.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.126 0.97 . . . . 100.0 111.062 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -62.43 -45.67 92.03 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 123.242 0.617 . . . . 100.0 112.075 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -65.71 -44.73 85.21 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.76 0.663 . . . . 100.0 111.764 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' LEU . . . . . 0.428 HD12 ' HB3' ' A' ' 85' ' ' CYS . 85.0 mt -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 124.073 0.949 . . . . 100.0 113.141 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.16 -38.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.436 -0.579 . . . . 100.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.72 10.53 58.9 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 110.138 -1.185 . . . . 100.0 110.138 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.71 111.74 56.66 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 107.812 -1.181 . . . . 100.0 107.812 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.82 -15.85 29.75 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.776 2.984 . . . . 100.0 113.734 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -87.59 0.32 55.8 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.025 0.93 . . . . 100.0 113.133 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.413 HD12 ' HG1' ' A' ' 54' ' ' THR . 18.3 tp -64.78 132.03 48.43 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.178 0.591 . . . . 100.0 109.892 -179.004 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -135.29 152.08 51.16 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 108.679 -0.859 . . . . 100.0 108.679 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -89.11 111.83 22.67 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 104.782 -2.303 . . . . 100.0 104.782 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.08 -43.91 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.243 1.017 . . . . 100.0 110.824 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.51 149.14 49.54 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 121.583 0.706 . . . . 100.0 110.559 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 59.5 ttm -91.39 125.45 57.99 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.433 -2.062 . . . . 100.0 105.433 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.28 157.4 60.23 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 123.039 2.493 . . . . 100.0 111.156 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.35 126.19 27.43 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.1 -1.074 . . . . 100.0 108.1 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.71 145.19 47.74 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 114.36 -1.291 . . . . 100.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.98 138.75 97.49 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.699 -1.223 . . . . 100.0 107.699 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -55.72 138.54 81.59 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.642 2.894 . . . . 100.0 112.3 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.36 129.59 30.42 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.753 2.302 . . . . 100.0 113.726 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -67.08 -43.67 82.03 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 124.774 1.296 . . . . 100.0 108.754 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.77 160.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.322 -1.733 . . . . 100.0 106.322 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.69 130.72 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 107.755 -1.202 . . . . 100.0 107.755 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.627 ' HB2' ' HG ' ' A' ' 153' ' ' SER . 18.1 tpt -80.88 122.72 27.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.789 -2.3 . . . . 100.0 104.789 178.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -65.9 128.2 93.66 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.13 -0.941 . . . . 100.0 109.411 -179.257 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -59.03 -39.06 83.98 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.54 2.827 . . . . 100.0 113.6 -179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.98 92.91 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 124.337 1.023 . . . . 100.0 110.832 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.8 -42.75 97.65 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 122.65 0.38 . . . . 100.0 111.653 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.16 97.4 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 123.546 0.738 . . . . 100.0 110.612 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.77 97.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.031 0.932 . . . . 100.0 110.672 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -63.76 -43.08 97.49 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.186 0.594 . . . . 100.0 112.077 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -63.03 -44.16 96.68 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 122.733 0.413 . . . . 100.0 111.273 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.89 -40.64 96.99 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 122.957 0.503 . . . . 100.0 110.477 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.55 -43.93 97.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.75 1.22 . . . . 100.0 110.78 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.06 -42.5 99.26 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.898 0.879 . . . . 100.0 110.169 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . 0.508 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.6 tp -59.9 -49.04 79.24 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.156 0.91 . . . . 100.0 110.033 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -43.44 98.12 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 115.203 1.557 . . . . 100.0 115.203 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.33 -46.74 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 CA-C-O 118.388 -0.815 . . . . 100.0 109.673 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ALA . . . . . 0.652 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.407 . . -94.61 0.54 55.24 Favored 'General case' 0 N--CA 1.404 -2.752 1 C-N-CA 109.655 -4.818 . . . . 100.0 114.332 179.711 . . . . . . . . 4 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 201' ' ' LEU 0.301 62.4 mt-30 -56.51 -37.01 69.84 Favored 'General case' 0 CA--C 1.465 -2.32 0 N-CA-C 106.354 -1.721 . . . . 100.0 106.354 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.9 p -82.03 52.82 2.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.247 1.022 . . . . 100.0 109.303 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.324 80.5 p 48.83 38.81 12.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.522 3.129 . . . . 100.0 116.111 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' ALA . . . . . 0.459 ' HB1' ' CB ' ' A' ' 204' ' ' ALA . . . -83.12 -177.16 6.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.417 -2.438 . . . . 100.0 104.417 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LEU . . . . . 0.416 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 85.7 mt -56.46 -41.54 91.67 Favored Pre-proline 0 CA--C 1.502 -0.902 0 CA-C-O 116.014 -1.946 . . . . 100.0 114.545 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PRO . . . . . 0.713 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.309 23.3 Cg_exo -55.35 136.67 74.67 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 121.354 1.519 . . . . 100.0 112.382 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -63.71 -47.57 80.61 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 124.493 4.997 . . . . 100.0 124.493 -173.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.597 ' CG ' ' HB ' ' A' ' 136' ' ' ILE . 99.4 mt-10 -62.88 -35.64 80.69 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 128.285 3.898 . . . . 100.0 107.918 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . 0.652 ' HB3' ' C ' ' A' ' 204' ' ' ALA 0.483 44.9 m-20 -65.49 -48.73 71.58 Favored 'General case' 1 N--CA 1.35 -5.426 1 CA-C-N 107.563 -4.381 . . . . 100.0 106.493 -179.017 . . . . . . . . 5 3 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.32 -29.85 71.09 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 120.448 -1.407 . . . . 100.0 108.168 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.559 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.35 -42.99 88.13 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-O 117.297 -1.335 . . . . 100.0 113.41 176.439 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.26 1.645 0 CA-C-O 115.478 -2.201 . . . . 100.0 113.968 -176.288 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.3 t . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.472 -1.677 . . . . 100.0 106.472 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.74 138.89 53.44 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.904 -1.953 . . . . 100.0 108.102 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.66 146.06 50.33 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.753 -0.832 . . . . 100.0 108.753 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -94.67 120.54 35.06 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 104.731 -2.322 . . . . 100.0 104.731 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.542 HD23 HG22 ' A' ' 63' ' ' VAL . 55.3 tp -112.12 126.25 54.99 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.964 -1.926 . . . . 100.0 106.551 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 79' ' ' TYR . 43.0 t -101.82 123.19 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.097 -1.446 . . . . 100.0 107.097 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.5 tp -110.89 116.51 31.36 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.094 -2.558 . . . . 100.0 104.094 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -128.8 163.4 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 120.765 0.317 . . . . 100.0 111.797 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.54 173.47 22.76 Favored Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 107.848 -2.101 . . . . 100.0 107.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -68.12 154.91 40.71 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.964 0.888 . . . . 100.0 112.574 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.85 140.0 41.64 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.606 -2.198 . . . . 100.0 107.606 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 -4.34 82.11 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.469 -1.184 . . . . 100.0 113.868 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.6 p -62.87 -39.01 93.13 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 119.055 1.428 . . . . 100.0 111.372 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 22.82 4.53 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 110.322 -1.111 . . . . 100.0 110.322 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 50.0 mtpt -59.52 -46.56 88.48 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 124.554 1.142 . . . . 100.0 112.889 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -63.23 -44.29 95.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.411 1.084 . . . . 100.0 110.087 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -62.47 -42.01 99.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.294 1.037 . . . . 100.0 109.178 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -60.75 -48.73 80.47 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.06 0.944 . . . . 100.0 113.285 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.9 -40.89 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.064 0.459 . . . . 100.0 110.523 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.27 99.6 mttt -69.35 -6.85 32.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.174 1.916 . . . . 100.0 116.174 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 49.1 mtt180 -60.7 -37.89 83.17 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.03 -1.1 . . . . 100.0 108.03 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 54.0 t-80 -80.87 112.92 18.7 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.48 -43.59 98.44 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.854 1.798 . . . . 100.0 115.854 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 78.8 m -63.75 -40.95 97.96 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.904 -0.776 . . . . 100.0 108.904 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.78 99.5 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.388 -1.085 . . . . 100.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.274 81.0 mt-10 -63.77 -45.15 91.09 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 117.38 0.59 . . . . 100.0 111.649 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.81 -40.32 97.02 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.256 1.022 . . . . 100.0 111.857 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -93.23 8.91 38.34 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 114.841 1.422 . . . . 100.0 114.841 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -60.87 142.57 56.12 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 113.743 1.016 . . . . 100.0 113.743 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -124.01 131.05 53.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.994 -1.003 . . . . 100.0 108.378 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -101.05 123.64 45.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.541 -2.022 . . . . 100.0 105.541 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.64 112.19 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 102.809 -3.034 . . . . 100.0 102.809 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.86 94.98 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 116.471 2.026 . . . . 100.0 116.471 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -61.9 -48.44 80.47 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 122.895 0.478 . . . . 100.0 110.578 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.64 -38.62 70.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.67 1.359 . . . . 100.0 114.67 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.77 44.04 21.26 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 106.312 -2.715 . . . . 100.0 106.312 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 94.5 t -129.86 144.61 37.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.726 1.21 . . . . 100.0 109.271 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -106.1 118.96 37.97 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.077 -3.305 . . . . 100.0 102.077 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.46 120.88 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.267 -1.753 . . . . 100.0 106.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -113.16 119.5 42.23 Favored Pre-proline 0 N--CA 1.434 -1.234 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.55 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -80.32 104.25 1.61 Allowed 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.654 2.236 . . . . 100.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.4 113.97 26.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.31 -0.996 . . . . 100.0 108.31 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.85 127.19 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.272 -1.381 . . . . 100.0 107.272 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.56 135.09 55.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.461 -2.052 . . . . 100.0 105.461 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -102.52 117.6 35.05 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.32 -0.622 . . . . 100.0 109.32 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.5 p -107.09 175.92 5.34 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.816 0.817 . . . . 100.0 110.288 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.26 -35.0 74.52 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.314 1.445 . . . . 100.0 109.502 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.59 -2.33 58.54 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 113.499 0.926 . . . . 100.0 113.499 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.6 -179.72 16.2 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.593 -1.003 . . . . 100.0 110.593 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.74 140.13 54.94 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.869 2.379 . . . . 100.0 115.833 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.13 130.06 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 102.304 -3.221 . . . . 100.0 102.304 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.45 128.35 56.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -110.19 116.31 31.28 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -87.67 106.8 18.28 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.812 -4.144 . . . . 100.0 99.812 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG22 HD23 ' A' ' 13' ' ' LEU . 22.6 t -93.36 123.76 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.396 0 N-CA-C 106.412 -1.699 . . . . 100.0 106.412 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -97.8 114.5 26.55 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 105.838 -1.912 . . . . 100.0 105.838 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -109.33 135.2 50.78 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.5 p -72.28 163.45 27.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.874 0.845 . . . . 100.0 112.559 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.14 20.55 12.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.206 -0.906 . . . . 100.0 108.586 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.85 12.21 58.16 Favored Glycine 0 C--N 1.359 1.847 0 CA-C-O 119.341 -0.699 . . . . 100.0 114.128 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 90.7 mt-30 -60.29 -31.37 70.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.259 1.824 . . . . 100.0 112.591 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -57.54 -32.38 67.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.924 2.49 . . . . 100.0 111.813 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.88 -39.62 95.03 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 123.527 0.731 . . . . 100.0 111.565 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 22.9 p90 -94.87 -14.14 24.83 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.774 1.398 . . . . 100.0 114.774 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.58 -160.36 26.96 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 119.933 -1.127 . . . . 100.0 112.422 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.02 176.95 54.54 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 109.874 -1.29 . . . . 100.0 109.874 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD13 ' CE2' ' A' ' 79' ' ' TYR . 86.9 mt -105.31 143.5 33.4 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.49 -0.929 . . . . 100.0 108.49 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -70.5 160.11 33.04 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.02 -0.991 . . . . 100.0 113.175 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -59.48 -37.99 79.66 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 125.443 1.497 . . . . 100.0 110.237 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.37 91.8 Favored Glycine 0 C--N 1.358 1.797 0 C-N-CA 124.77 1.176 . . . . 100.0 111.29 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.0 t80 -62.98 -47.0 85.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.33 0.565 . . . . 100.0 111.218 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -70.51 -36.73 73.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 116.976 2.213 . . . . 100.0 116.976 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.5 mt -50.86 134.64 11.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-O 123.189 1.471 . . . . 100.0 114.796 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 61.19 29.26 18.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 128.023 2.529 . . . . 100.0 113.877 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 133.12 42.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -96.39 -26.26 15.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 110.103 -0.332 . . . . 100.0 110.103 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' HB2' HD22 ' A' ' 164' ' ' LEU . 18.7 p -153.22 162.61 41.11 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.852 0.358 . . . . 100.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.6 152.84 38.6 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 114.413 1.264 . . . . 100.0 114.413 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.6 mt -126.17 125.89 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 103.41 -2.811 . . . . 100.0 103.41 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' HB ' HD22 ' A' ' 119' ' ' LEU . 48.6 mt -109.74 125.31 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 102.87 -3.011 . . . . 100.0 102.87 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 15' ' ' LEU . 89.3 mtp -110.46 135.91 50.41 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.923 1.083 . . . . 100.0 113.923 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.76 162.43 28.45 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 112.686 -2.052 . . . . 100.0 107.14 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 67.5 t0 -106.53 124.37 49.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.962 -1.496 . . . . 100.0 106.962 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.18 -18.86 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 114.211 1.189 . . . . 100.0 114.211 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.5 p -89.44 -7.5 54.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 118.378 0.535 . . . . 100.0 111.18 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 m -124.98 116.78 22.71 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.596 1.189 . . . . 100.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -63.32 -38.51 91.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.459 1.503 . . . . 100.0 111.872 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.59 -40.88 83.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 125.872 1.669 . . . . 100.0 110.72 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.2 p -62.19 -41.53 98.43 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 118.192 0.451 . . . . 100.0 111.77 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -65.02 -40.95 95.61 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.559 0.743 . . . . 100.0 110.251 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.1 mttt -61.38 -36.45 80.29 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.531 1.132 . . . . 100.0 111.142 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.18 -3.85 53.53 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 115.272 1.582 . . . . 100.0 115.272 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 119' ' ' LEU . 77.2 t -60.55 -41.94 85.73 Favored Pre-proline 0 C--N 1.362 1.128 0 CA-C-O 116.572 -1.68 . . . . 100.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 63.0 Cg_exo -56.86 -38.3 96.17 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.292 1.995 . . . . 100.0 112.864 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.61 -45.25 91.19 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.59 1.156 . . . . 100.0 110.873 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -64.46 -41.36 96.57 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.122 0.264 . . . . 100.0 111.356 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.21 -44.32 96.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.619 0.767 . . . . 100.0 110.14 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -61.99 -45.26 94.42 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 119.015 -0.517 . . . . 100.0 112.179 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.53 -42.43 98.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 O-C-N 123.24 0.337 . . . . 100.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 86' ' ' ALA . 50.6 tp -62.9 -48.16 80.17 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.783 0.833 . . . . 100.0 112.469 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.279 22.9 m -67.2 -29.23 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -60.62 -47.28 86.93 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.778 -0.823 . . . . 100.0 108.778 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.85 -45.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 112.598 0.592 . . . . 100.0 112.598 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.7 m -124.61 107.79 11.39 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.985 0.898 . . . . 100.0 110.077 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.89 140.05 30.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.358 -0.837 . . . . 100.0 111.59 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.13 39.57 31.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.981 2.113 . . . . 100.0 116.701 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.1 144.99 29.24 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 106.635 -1.617 . . . . 100.0 106.635 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -62.59 132.08 36.39 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.21 2.606 . . . . 100.0 109.691 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.801 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.0 mt -134.18 137.57 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.198 0.999 . . . . 100.0 108.364 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.13 132.1 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 105.593 -2.002 . . . . 100.0 105.593 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 101' ' ' VAL 0.294 23.2 mt -105.95 131.04 53.74 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 103.725 -2.694 . . . . 100.0 103.725 175.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.49 131.21 55.54 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.052 -1.431 . . . . 100.0 112.48 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.3 104.97 2.89 Favored Glycine 0 CA--C 1.486 -1.757 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -86.73 173.21 9.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.185 1.179 . . . . 100.0 114.185 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 mttp 60.26 40.39 17.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.141 2.576 . . . . 100.0 113.725 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.339 28.5 m -71.76 -7.79 10.02 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 120.33 -0.548 . . . . 100.0 111.495 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.71 -38.21 89.55 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.464 1.906 . . . . 100.0 110.334 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -69.74 130.18 34.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 N-CA-C 108.514 -0.921 . . . . 100.0 108.514 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.14 -41.82 98.64 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 117.223 2.305 . . . . 100.0 117.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -85.49 94.57 9.04 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.146 -1.798 . . . . 100.0 106.146 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -92.66 123.96 36.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 104.921 -2.251 . . . . 100.0 104.921 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.69 -36.62 10.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 113.301 0.852 . . . . 100.0 113.301 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.93 104.07 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 103.752 -2.684 . . . . 100.0 103.752 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.25 172.77 7.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.905 -1.043 . . . . 100.0 111.513 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.411 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.08 -31.9 65.71 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.267 1.827 . . . . 100.0 109.401 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.028 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -57.11 -39.08 74.39 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 130.092 3.357 . . . . 100.0 111.391 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.2 p -105.06 2.27 29.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 117.047 2.24 . . . . 100.0 117.047 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 60.3 mt -89.43 84.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.361 1.088 0 C-N-CA 118.062 -1.455 . . . . 100.0 110.576 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 2.3 p -100.81 -6.09 9.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HD2' HD11 ' A' ' 119' ' ' LEU . 65.8 t80 -59.37 -37.37 77.73 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 116.09 1.885 . . . . 100.0 116.09 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.275 78.6 m-70 -59.5 -37.97 79.69 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 116.718 2.118 . . . . 100.0 116.718 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.866 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 43.6 ttp85 -59.01 -49.28 78.48 Favored 'General case' 0 CA--C 1.471 -2.092 0 O-C-N 124.178 0.924 . . . . 100.0 112.964 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.63 -41.19 98.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 125.456 1.723 . . . . 100.0 111.074 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.6 mmtt -95.04 0.32 54.4 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.206 2.298 . . . . 100.0 117.206 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 58.32 40.04 24.9 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.155 1.382 . . . . 100.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.801 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.6 mt -101.9 152.52 20.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.754 -1.943 . . . . 100.0 105.754 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.29 143.24 30.71 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.206 -0.665 . . . . 100.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 84.4 t80 -110.32 136.53 49.36 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.299 1.222 . . . . 100.0 114.299 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -134.42 137.61 44.15 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.432 -1.258 . . . . 100.0 111.18 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.276 72.6 m-20 -84.72 128.64 34.7 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 102.688 -3.078 . . . . 100.0 102.688 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.513 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.8 pt -134.22 157.84 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.702 1.239 . . . . 100.0 111.303 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 70.4 m -139.04 108.49 6.15 Favored 'General case' 0 CA--C 1.48 -1.714 0 N-CA-C 104.861 -2.274 . . . . 100.0 104.861 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.8 -44.18 97.38 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.712 -1.131 . . . . 100.0 112.529 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -61.47 -39.24 90.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 124.853 1.261 . . . . 100.0 112.734 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 92.3 p -100.31 2.09 42.23 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 115.868 1.803 . . . . 100.0 115.868 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 68.0 m-80 65.19 20.68 12.0 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.94 1.296 . . . . 100.0 110.99 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 83.4 t80 -72.94 125.7 28.21 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.473 -0.936 . . . . 100.0 108.473 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 54.05 36.68 25.2 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 128.185 2.594 . . . . 100.0 114.584 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 64.3 t80 -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.359 0.99 0 O-C-N 121.881 -0.512 . . . . 100.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -63.67 -38.49 91.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.499 2.037 . . . . 100.0 116.499 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.12 -47.97 98.19 Favored Pre-proline 0 C--N 1.358 0.938 0 N-CA-C 120.097 3.369 . . . . 100.0 120.097 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.15 -41.08 45.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 CA-C-N 123.475 2.277 . . . . 100.0 112.592 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.21 -42.45 96.59 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.712 1.205 . . . . 100.0 110.814 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.23 -44.29 92.32 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 118.795 -0.621 . . . . 100.0 111.628 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -64.88 -42.26 94.96 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 123.499 0.499 . . . . 100.0 110.389 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.8 mt -61.54 -43.82 98.16 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.453 0.47 . . . . 100.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.52 -44.18 97.52 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.076 0.951 . . . . 100.0 110.656 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.58 -45.6 93.42 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 122.672 0.389 . . . . 100.0 111.783 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -66.17 -44.54 83.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.858 0.688 . . . . 100.0 112.858 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.26 -45.19 89.18 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 113.451 0.908 . . . . 100.0 113.451 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 50.9 mm -74.52 -30.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.902 0.881 . . . . 100.0 110.11 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.79 13.82 66.28 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 118.635 -1.091 . . . . 100.0 111.447 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -116.39 112.31 41.55 Favored Pre-proline 0 C--N 1.363 1.168 0 CA-C-N 118.439 1.119 . . . . 100.0 108.044 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.99 -14.1 31.98 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.749 2.966 . . . . 100.0 113.255 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -85.63 -3.18 58.81 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.125 0.97 . . . . 100.0 113.026 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.84 134.21 56.86 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 113.226 0.825 . . . . 100.0 113.226 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.14 149.29 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.525 -1.216 . . . . 100.0 108.235 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -90.03 114.62 26.53 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 103.525 -2.769 . . . . 100.0 103.525 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.24 -40.04 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.53 146.8 52.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.8 mtt -88.27 129.61 48.99 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.336 -1.727 . . . . 100.0 106.336 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.27 158.48 52.14 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.276 1.984 . . . . 100.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.43 124.88 23.98 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.722 -1.214 . . . . 100.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.54 145.85 45.02 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 114.263 -1.335 . . . . 100.0 110.403 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.38 136.28 96.63 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.796 -1.927 . . . . 100.0 105.796 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 138.88 77.58 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 123.55 2.833 . . . . 100.0 112.553 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -57.81 129.09 31.71 Favored 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.23 1.954 . . . . 100.0 113.509 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.86 -43.8 82.65 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 124.701 1.251 . . . . 100.0 108.085 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 158.24 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.58 -1.637 . . . . 100.0 106.58 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.42 131.89 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.47 123.91 32.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.654 -2.721 . . . . 100.0 103.654 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.85 128.65 92.29 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 114.779 -1.101 . . . . 100.0 110.565 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.7 -37.65 93.09 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.725 2.95 . . . . 100.0 113.546 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.06 95.23 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 123.979 0.8 . . . . 100.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.3 -42.22 99.03 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 122.769 0.428 . . . . 100.0 111.147 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.2 97.73 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 123.703 0.801 . . . . 100.0 110.625 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.03 97.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.508 0.723 . . . . 100.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.26 -44.75 95.83 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.758 0.823 . . . . 100.0 112.075 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -63.49 -43.51 97.04 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 122.918 0.487 . . . . 100.0 111.793 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.19 -39.83 94.83 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.707 -0.224 . . . . 100.0 111.19 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.78 -42.67 99.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.158 0.983 . . . . 100.0 110.007 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -61.51 -42.35 98.68 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.838 0.855 . . . . 100.0 110.645 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 81.9 mt -61.03 -48.43 81.84 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.391 -0.822 . . . . 100.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.48 -41.84 98.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.66 -47.14 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.968 0 CA-C-O 118.221 -0.895 . . . . 100.0 109.124 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.959 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.705 . . -88.87 -8.67 53.85 Favored 'General case' 1 N--CA 1.379 -4.008 1 C-N-CA 104.543 -6.863 . . . . 100.0 116.647 179.881 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 1.037 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 55.1 mt-30 -53.48 -34.89 59.7 Favored 'General case' 0 CA--C 1.444 -3.108 0 C-N-CA 128.179 2.591 . . . . 100.0 107.507 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -82.73 41.47 0.73 Allowed 'General case' 0 N--CA 1.416 -2.133 0 O-C-N 124.825 1.328 . . . . 100.0 109.766 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 205' ' ' GLN . 4.6 m 57.96 30.24 18.86 Favored 'General case' 0 CA--C 1.473 -1.988 0 C-N-CA 127.13 2.172 . . . . 100.0 112.578 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.275 . . -73.61 175.51 7.05 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 101.155 -3.646 . . . . 100.0 101.155 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.03 -36.7 49.04 Favored Pre-proline 0 CA--C 1.489 -1.393 0 CA-C-O 116.359 -1.781 . . . . 100.0 114.024 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.028 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.457 0.3 OUTLIER -53.58 137.79 66.35 Favored 'Trans proline' 0 N--CA 1.433 -2.088 0 O-C-N 123.814 1.428 . . . . 100.0 112.634 176.602 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.305 99.3 m-20 -64.01 -43.03 96.86 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 121.499 3.888 . . . . 100.0 121.499 -172.552 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.1 tm-20 -71.42 -16.03 62.37 Favored 'General case' 0 CA--C 1.463 -2.394 1 CA-C-O 130.799 5.095 . . . . 100.0 112.989 177.989 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 1.037 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.785 66.3 m-20 -86.07 -50.04 7.33 Favored 'General case' 1 N--CA 1.257 -10.116 1 CA-C-N 105.781 -5.19 . . . . 100.0 104.025 -172.932 . . . . . . . . 5 3 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 140' ' ' ARG . 37.8 t70 -62.05 -28.96 69.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.255 -2.153 . . . . 100.0 106.528 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.866 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 73.0 m-20 -61.77 -40.29 94.64 Favored 'General case' 0 CA--C 1.476 -1.889 0 C-N-CA 126.925 2.09 . . . . 100.0 112.591 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.283 0.6 OUTLIER . . . . . 0 N--CA 1.428 -1.558 0 CA-C-O 115.334 -2.27 . . . . 100.0 114.301 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.435 -1.194 0 N-CA-C 101.759 -3.422 . . . . 100.0 101.759 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -128.58 138.13 52.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.534 -0.757 . . . . 100.0 109.876 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.75 144.09 51.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.4 122.54 34.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.596 -2.001 . . . . 100.0 105.596 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.21 126.53 55.16 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 79' ' ' TYR . 67.7 t -104.27 124.36 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.773 -1.195 . . . . 100.0 107.773 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.418 HD11 ' SD ' ' A' ' 89' ' ' MET . 38.1 tp -108.7 118.83 37.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.039 -1.837 . . . . 100.0 106.039 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.81 162.36 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.802 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.24 172.78 22.52 Favored Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.015 -2.034 . . . . 100.0 108.015 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -66.74 153.45 43.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.958 0.885 . . . . 100.0 111.973 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.24 140.89 43.89 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.471 -2.252 . . . . 100.0 107.471 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.57 -3.08 85.12 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-O 118.568 -1.129 . . . . 100.0 114.37 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -62.77 -38.53 90.97 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.868 1.334 . . . . 100.0 112.248 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 23.55 3.79 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 110.247 -1.141 . . . . 100.0 110.247 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 51.8 mtpt -59.98 -47.78 84.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.382 1.073 . . . . 100.0 113.163 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -64.17 -42.76 96.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 123.906 0.882 . . . . 100.0 110.42 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -62.53 -42.04 99.26 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.209 1.004 . . . . 100.0 109.309 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -60.29 -49.59 77.01 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.663 1.185 . . . . 100.0 112.646 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.37 -41.63 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 123.547 0.529 . . . . 100.0 111.168 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.302 99.4 mttt -69.45 -6.63 31.61 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 115.775 1.769 . . . . 100.0 115.775 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 154' ' ' ASN . 43.2 mtm180 -60.23 -38.22 82.75 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 109.013 -0.736 . . . . 100.0 109.013 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -81.32 112.22 18.41 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.637 -1.616 . . . . 100.0 106.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.92 -45.12 95.11 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.191 1.923 . . . . 100.0 116.191 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.8 m -63.73 -41.15 98.1 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.252 0.621 . . . . 100.0 109.63 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.66 99.59 Favored Glycine 0 C--N 1.358 1.799 0 N-CA-C 110.841 -0.904 . . . . 100.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.76 -46.52 84.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.824 0.85 . . . . 100.0 111.14 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -63.96 -39.63 94.57 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 113.003 0.742 . . . . 100.0 113.003 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -93.27 11.65 27.32 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 115.4 1.63 . . . . 100.0 115.4 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.85 144.84 51.95 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 113.896 1.073 . . . . 100.0 113.896 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -122.23 130.74 53.47 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.219 -1.03 . . . . 100.0 108.219 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -101.06 125.46 47.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.876 -1.157 . . . . 100.0 107.876 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -99.32 109.18 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.47 98.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 116.649 2.092 . . . . 100.0 116.649 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.4 m -61.92 -44.29 97.08 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.004 0.922 . . . . 100.0 110.925 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.76 -21.39 23.83 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 114.303 1.223 . . . . 100.0 114.303 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.7 45.72 51.01 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 109.296 -1.522 . . . . 100.0 109.296 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.84 144.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 109.147 -0.686 . . . . 100.0 109.147 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -108.26 118.33 36.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 101.598 -3.482 . . . . 100.0 101.598 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.21 120.09 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.71 -1.959 . . . . 100.0 105.71 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -111.52 119.43 45.08 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.825 -0.625 . . . . 100.0 110.076 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.46 103.31 1.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.604 2.203 . . . . 100.0 111.062 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.35 116.03 28.81 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.21 128.46 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.278 -1.378 . . . . 100.0 107.278 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.38 135.6 54.73 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -102.08 117.49 34.9 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -108.56 175.59 5.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.761 0.791 . . . . 100.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.52 -32.97 71.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.39 1.476 . . . . 100.0 109.919 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -92.37 3.81 54.68 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.401 0.889 . . . . 100.0 113.401 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.92 177.93 17.26 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 121.274 -0.891 . . . . 100.0 111.67 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.11 140.45 59.66 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.16 2.573 . . . . 100.0 114.751 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.3 131.12 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 103.057 -2.942 . . . . 100.0 103.057 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -114.4 128.77 56.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.569 -0.53 . . . . 100.0 109.569 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.47 115.7 29.65 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 104.946 -2.242 . . . . 100.0 104.946 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -88.32 105.81 17.81 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 101.051 -3.685 . . . . 100.0 101.051 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.53 123.3 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 107.87 -1.159 . . . . 100.0 107.87 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -95.03 115.73 27.8 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.041 -1.466 . . . . 100.0 107.041 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -111.13 137.62 48.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.625 -1.62 . . . . 100.0 106.625 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -72.77 164.59 26.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.252 1.025 . . . . 100.0 112.38 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.53 22.88 10.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.77 15.63 59.39 Favored Glycine 0 C--N 1.362 1.98 0 O-C-N 121.612 -0.68 . . . . 100.0 113.122 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 60.3 mt-30 -59.64 -35.1 73.73 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 127.077 2.151 . . . . 100.0 112.364 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.47 -33.1 69.38 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 128.064 2.545 . . . . 100.0 112.011 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.42 -39.37 94.31 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.173 0.589 . . . . 100.0 111.569 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 12.6 p90 -94.66 -7.85 39.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.12 -163.38 35.0 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 119.405 1.002 . . . . 100.0 112.382 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.67 -179.59 53.0 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 108.639 -1.784 . . . . 100.0 108.639 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 92.8 mt -107.52 142.22 37.76 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.603 0.716 . . . . 100.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -70.16 157.31 37.85 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.586 -1.188 . . . . 100.0 112.455 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -59.96 -37.57 79.96 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 124.993 1.317 . . . . 100.0 110.623 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.3 -37.45 87.29 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 125.193 1.378 . . . . 100.0 111.102 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 90.0 t80 -62.59 -45.8 91.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.417 0.687 . . . . 100.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -75.58 -28.7 59.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.401 2.0 . . . . 100.0 116.401 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.7 mt -51.31 131.63 12.35 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 123.269 1.509 . . . . 100.0 114.824 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.263 52.9 mt-30 59.87 29.9 19.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 128.899 2.88 . . . . 100.0 114.006 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.36 132.06 45.8 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.015 -1.846 . . . . 100.0 106.015 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.09 -31.53 13.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.473 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.5 p -151.81 163.51 39.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.457 -0.572 . . . . 100.0 109.457 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.67 41.98 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 114.64 1.348 . . . . 100.0 114.64 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.3 mt -127.56 126.38 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 104.072 -2.566 . . . . 100.0 104.072 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.692 ' HB ' HD22 ' A' ' 119' ' ' LEU . 33.3 mt -110.51 124.49 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 102.898 -3.001 . . . . 100.0 102.898 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.5 mtp -111.94 137.08 50.42 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -130.73 163.69 26.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.537 -2.119 . . . . 100.0 107.706 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -106.67 127.25 53.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.076 -1.824 . . . . 100.0 106.076 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.21 -15.93 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.428 0.899 . . . . 100.0 113.428 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.8 p -90.25 -6.85 54.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.072 0.396 . . . . 100.0 110.543 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -125.75 116.04 20.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.449 1.119 . . . . 100.0 110.561 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.0 -37.7 88.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.591 1.156 . . . . 100.0 112.217 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.59 -40.16 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.983 1.713 . . . . 100.0 110.322 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -62.34 -41.68 98.77 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 118.344 0.52 . . . . 100.0 111.28 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.63 -40.92 96.32 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.268 0.627 . . . . 100.0 110.423 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -60.57 -36.95 79.75 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 123.941 0.896 . . . . 100.0 111.091 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -79.11 -5.91 55.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 119' ' ' LEU . 89.8 t -59.94 -42.79 92.46 Favored Pre-proline 0 C--N 1.364 1.215 0 CA-C-O 116.466 -1.73 . . . . 100.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 72.9 Cg_exo -57.8 -37.51 96.18 Favored 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 122.25 1.839 . . . . 100.0 112.69 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -64.14 -44.38 92.35 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.873 1.269 . . . . 100.0 111.076 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -64.64 -40.91 96.28 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 122.877 0.471 . . . . 100.0 110.915 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.73 -44.01 97.73 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 124.09 0.956 . . . . 100.0 109.395 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.46 -45.56 93.77 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 123.71 0.804 . . . . 100.0 111.66 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.0 -45.81 91.95 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.375 0.67 . . . . 100.0 110.699 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.67 -47.27 81.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.665 1.186 . . . . 100.0 113.259 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.321 25.9 m -65.84 -33.8 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 N-CA-C 113.597 0.962 . . . . 100.0 113.597 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 110' ' ' ARG . 55.6 mtt85 -60.14 -46.71 88.75 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 123.813 0.696 . . . . 100.0 109.227 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.07 -44.37 50.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 112.16 0.43 . . . . 100.0 112.16 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.88 107.7 10.74 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.997 0.903 . . . . 100.0 110.715 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.71 138.93 32.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.025 -0.988 . . . . 100.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 53.52 42.02 32.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 117.547 2.425 . . . . 100.0 117.547 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.0 pt -94.99 144.64 28.15 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 106.353 -1.721 . . . . 100.0 106.353 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.61 133.45 42.54 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.36 2.04 . . . . 100.0 110.43 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.775 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.8 mt -133.98 137.45 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.343 -0.984 . . . . 100.0 108.343 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.37 131.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 105.04 -2.207 . . . . 100.0 105.04 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 88' ' ' ILE . 24.6 mt -106.63 128.93 54.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.198 -2.519 . . . . 100.0 104.198 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.6 m -120.23 130.6 54.59 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.465 -1.243 . . . . 100.0 113.363 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.3 107.4 3.23 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 105.4 -3.08 . . . . 100.0 105.4 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.353 0.0 OUTLIER -95.88 177.93 5.6 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 114.501 1.297 . . . . 100.0 114.501 -178.829 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.1 mttt 62.0 40.4 12.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 128.761 2.824 . . . . 100.0 112.863 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.6 m -71.75 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 114.882 -1.054 . . . . 100.0 111.713 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -66.0 -29.14 69.47 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.981 0.912 . . . . 100.0 110.524 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.6 128.43 34.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 107.158 -1.423 . . . . 100.0 107.158 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.23 -41.81 98.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 115.779 1.77 . . . . 100.0 115.779 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.25 97.08 11.0 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.774 -1.935 . . . . 100.0 105.774 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -96.79 125.11 41.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 113.845 -1.525 . . . . 100.0 106.885 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.27 -39.14 12.23 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.585 0.958 . . . . 100.0 113.585 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -103.5 102.93 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.66 -1.607 . . . . 100.0 106.66 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 29.9 mmmt -89.71 168.06 12.41 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.481 1.512 . . . . 100.0 114.022 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.44 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.22 -33.46 67.57 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.989 2.116 . . . . 100.0 108.696 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.08 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 93.8 mttt -57.61 -38.62 75.25 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 129.19 2.996 . . . . 100.0 112.835 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.8 p -105.29 3.04 29.52 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 116.493 2.035 . . . . 100.0 116.493 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 66.8 mt -91.09 89.79 3.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 117.792 -1.563 . . . . 100.0 109.324 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.474 ' CA ' ' HB3' ' A' ' 211' ' ' ASP 0.361 0.0 OUTLIER -101.46 -12.81 8.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 115.636 1.717 . . . . 100.0 115.636 -175.842 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.55 -35.95 73.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 118.235 2.68 . . . . 100.0 118.235 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.597 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.263 60.6 m-70 -59.6 -37.11 77.68 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.396 1.878 . . . . 100.0 113.927 -176.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.774 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.273 55.2 ttp85 -59.15 -50.09 75.38 Favored 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 113.926 1.084 . . . . 100.0 113.926 -175.315 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.68 -41.23 98.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 125.033 1.458 . . . . 100.0 111.769 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.23 2.74 53.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 116.396 1.999 . . . . 100.0 116.396 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 55.69 43.78 27.46 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-O 123.116 1.436 . . . . 100.0 113.37 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' A' ' 117' ' ' ILE . 26.2 mt -101.88 146.48 27.77 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.573 -2.38 . . . . 100.0 104.573 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -94.14 142.39 27.45 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.945 -1.131 . . . . 100.0 107.945 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.475 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 88.3 t80 -113.67 139.04 49.39 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 113.222 0.823 . . . . 100.0 113.222 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.69 139.85 42.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.202 -1.363 . . . . 100.0 111.578 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.26 85.2 m-20 -86.59 128.34 34.98 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 102.743 -3.058 . . . . 100.0 102.743 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 43.3 pt -135.33 157.59 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 122.049 0.928 . . . . 100.0 111.732 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -137.11 109.52 7.38 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 103.376 -2.824 . . . . 100.0 103.376 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.75 -41.38 99.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.885 -1.052 . . . . 100.0 110.825 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.64 -40.85 93.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.208 1.403 . . . . 100.0 112.353 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -100.85 3.57 42.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.305 1.965 . . . . 100.0 116.305 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.634 ' HA ' HH11 ' A' ' 29' ' ' ARG . 72.5 m-80 63.85 22.83 13.18 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.03 1.332 . . . . 100.0 110.677 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -72.61 124.11 24.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.458 -1.312 . . . . 100.0 107.458 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 53.53 37.83 26.71 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.657 2.383 . . . . 100.0 113.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.26 -44.54 95.21 Favored 'General case' 0 C--N 1.362 1.141 0 O-C-N 121.903 -0.498 . . . . 100.0 111.324 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -63.08 -38.69 92.2 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.636 1.974 . . . . 100.0 115.628 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -57.7 -47.4 99.01 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 120.531 3.53 . . . . 100.0 120.531 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.06 -42.39 36.82 Favored 'Trans proline' 0 C--N 1.373 1.834 0 CA-C-N 123.403 2.251 . . . . 100.0 112.066 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -65.08 -42.55 94.01 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 124.852 1.261 . . . . 100.0 111.74 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -44.27 91.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.518 0.727 . . . . 100.0 110.241 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -63.7 -44.51 93.46 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-N 117.949 0.34 . . . . 100.0 110.345 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.7 mt -62.34 -43.25 99.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 119.112 -0.471 . . . . 100.0 111.363 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.62 98.56 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.065 0.946 . . . . 100.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.88 -45.35 94.13 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 119.021 -0.514 . . . . 100.0 112.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.0 -42.53 76.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 112.734 0.642 . . . . 100.0 112.734 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.65 -38.83 74.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.692 1.197 . . . . 100.0 109.937 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.73 10.76 56.29 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-O 118.489 -1.173 . . . . 100.0 111.025 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 48.4 t0 -112.47 111.48 52.2 Favored Pre-proline 0 C--N 1.365 1.258 0 CA-C-N 118.485 1.142 . . . . 100.0 108.262 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -15.99 40.26 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.961 3.108 . . . . 100.0 113.256 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -96.17 8.37 44.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 114.349 1.24 . . . . 100.0 114.349 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 75.5 mt -62.11 136.7 58.06 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-O 121.307 0.575 . . . . 100.0 110.705 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -133.16 150.57 52.01 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.53 -0.915 . . . . 100.0 108.53 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -91.06 113.19 25.39 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 103.65 -2.722 . . . . 100.0 103.65 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.24 -39.51 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 114.061 1.134 . . . . 100.0 114.061 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.0 146.07 51.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.506 -0.924 . . . . 100.0 108.506 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.91 130.48 48.3 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 108.031 -1.1 . . . . 100.0 108.031 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.54 155.62 67.96 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.223 1.949 . . . . 100.0 109.847 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.07 123.73 21.84 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.8 -1.555 . . . . 100.0 106.8 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -119.02 145.85 45.52 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.239 -1.346 . . . . 100.0 109.665 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.64 96.33 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 105.965 -1.865 . . . . 100.0 105.965 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 72.0 Cg_exo -55.65 142.35 82.38 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 123.453 2.769 . . . . 100.0 113.563 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 154' ' ' ASN . 51.0 Cg_exo -56.7 127.63 26.68 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 122.848 2.366 . . . . 100.0 113.281 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -70.14 -42.44 72.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 124.714 1.259 . . . . 100.0 107.867 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.15 158.83 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.411 -1.7 . . . . 100.0 106.411 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.64 128.37 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.408 -2.071 . . . . 100.0 105.408 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -89.58 125.02 35.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.7 -2.333 . . . . 100.0 104.7 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.66 129.27 92.72 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 114.568 -1.196 . . . . 100.0 111.613 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -59.1 -37.53 92.03 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.654 2.903 . . . . 100.0 113.481 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.55 93.73 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.146 0.904 . . . . 100.0 110.179 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.07 -41.84 99.52 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.135 0.574 . . . . 100.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.02 96.35 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.803 0.841 . . . . 100.0 110.672 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.26 99.27 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.699 0.799 . . . . 100.0 110.84 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.32 -45.12 94.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.829 0.851 . . . . 100.0 111.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -63.68 -43.63 96.11 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 112.392 0.515 . . . . 100.0 112.392 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -64.51 -39.86 94.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 123.248 0.343 . . . . 100.0 111.287 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -63.09 -42.45 99.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.952 0.901 . . . . 100.0 110.303 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.4 -42.46 98.77 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.975 0.91 . . . . 100.0 110.609 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.8 mt -61.26 -47.23 86.97 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.431 -0.804 . . . . 100.0 109.262 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.46 -42.04 98.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.3 1.222 . . . . 100.0 114.3 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.34 -47.4 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.047 0 CA-C-O 117.504 -1.236 . . . . 100.0 108.517 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.714 . . -89.72 -8.15 52.93 Favored 'General case' 0 N--CA 1.382 -3.849 1 C-N-CA 103.86 -7.136 . . . . 100.0 117.204 178.721 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 1.044 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 54.3 mt-30 -53.69 -34.07 57.53 Favored 'General case' 0 CA--C 1.447 -2.994 0 C-N-CA 127.813 2.445 . . . . 100.0 106.801 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -80.87 36.57 0.4 Allowed 'General case' 0 N--CA 1.416 -2.142 0 O-C-N 124.933 1.395 . . . . 100.0 109.5 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 58.5 31.9 21.52 Favored 'General case' 0 CA--C 1.472 -2.052 0 C-N-CA 126.871 2.068 . . . . 100.0 112.525 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 204' ' ' ALA . . . -75.63 -178.19 4.04 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 101.642 -3.466 . . . . 100.0 101.642 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 81.3 mt -57.68 -38.24 65.07 Favored Pre-proline 0 CA--C 1.492 -1.263 0 CA-C-O 116.274 -1.822 . . . . 100.0 113.154 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.08 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.422 5.7 Cg_exo -53.1 136.45 61.46 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 CA-C-O 123.64 1.433 . . . . 100.0 112.7 177.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.474 ' HB3' ' CA ' ' A' ' 137' ' ' VAL 0.331 84.8 m-20 -65.18 -42.22 93.85 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 120.956 3.687 . . . . 100.0 120.956 -172.836 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.5 tm-20 -72.44 -14.72 61.76 Favored 'General case' 0 CA--C 1.459 -2.52 1 CA-C-O 130.685 5.04 . . . . 100.0 112.922 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 1.044 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.807 64.0 m-20 -87.55 -48.71 7.7 Favored 'General case' 1 N--CA 1.256 -10.162 1 CA-C-N 106.111 -5.04 . . . . 100.0 103.127 -172.786 . . . . . . . . 5 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.5 -27.57 69.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 118.901 -2.375 . . . . 100.0 106.211 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 51.5 m-20 -62.39 -39.96 94.94 Favored 'General case' 0 CA--C 1.478 -1.825 0 C-N-CA 127.137 2.175 . . . . 100.0 112.604 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.303 3.8 mm? . . . . . 0 N--CA 1.427 -1.624 0 CA-C-O 114.15 -2.833 . . . . 100.0 112.828 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 N--CA 1.439 -1.021 0 N-CA-C 102.844 -3.021 . . . . 100.0 102.844 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -127.89 140.48 51.98 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.839 -1.073 . . . . 100.0 110.431 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -129.07 144.08 51.08 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.074 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.18 120.49 34.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 105.577 -2.009 . . . . 100.0 105.577 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 63' ' ' VAL . 47.7 tp -113.4 127.03 55.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 100.0 107.473 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 79' ' ' TYR . 74.8 t -106.6 124.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 114.844 -1.071 . . . . 100.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD13 HG13 ' A' ' 63' ' ' VAL . 6.4 mp -107.38 119.17 38.66 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-O 121.477 0.656 . . . . 100.0 109.471 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.31 160.56 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.819 -1.082 . . . . 100.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.23 174.31 24.98 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.047 -2.021 . . . . 100.0 108.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.61 155.02 40.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.744 0.783 . . . . 100.0 112.229 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.46 140.76 41.53 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 106.519 -2.632 . . . . 100.0 106.519 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.76 -5.27 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.533 -1.148 . . . . 100.0 114.458 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.0 p -62.28 -37.24 84.77 Favored 'General case' 0 C--N 1.362 1.109 0 CA-C-N 118.929 1.364 . . . . 100.0 112.2 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.25 21.86 6.08 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.179 -0.769 . . . . 100.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 41.5 mtmt -60.95 -44.76 96.81 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 118.112 0.956 . . . . 100.0 112.559 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.2 m -62.25 -44.19 97.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.311 1.044 . . . . 100.0 109.846 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -63.03 -41.82 99.63 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.889 0.876 . . . . 100.0 109.362 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.46 -47.73 84.39 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.028 0.931 . . . . 100.0 112.559 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 63' ' ' VAL . 79.9 t -64.16 -41.03 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 123.284 0.634 . . . . 100.0 110.066 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.38 -7.84 41.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 116.373 1.99 . . . . 100.0 116.373 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.612 HH11 ' HB2' ' A' ' 157' ' ' PHE . 62.0 mtt180 -60.31 -37.97 82.24 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 58.3 t-80 -80.07 112.3 17.25 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 106.977 -1.49 . . . . 100.0 106.977 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.79 -44.93 95.9 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 115.817 1.784 . . . . 100.0 115.817 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 90.4 m -63.77 -42.48 97.79 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.52 0.728 . . . . 100.0 109.7 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.67 99.61 Favored Glycine 0 C--N 1.357 1.732 0 C-N-CA 123.807 0.718 . . . . 100.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.43 -45.55 87.07 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.916 0.886 . . . . 100.0 111.359 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -64.28 -39.77 94.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.501 1.12 . . . . 100.0 111.953 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -93.8 9.67 36.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 115.637 1.717 . . . . 100.0 115.637 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -61.12 141.85 57.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 114.225 1.194 . . . . 100.0 114.225 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -121.74 130.78 53.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.922 -1.035 . . . . 100.0 108.915 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.57 126.87 45.62 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.92 112.28 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 102.166 -3.272 . . . . 100.0 102.166 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.11 90.29 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 118.381 2.734 . . . . 100.0 118.381 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.6 m -63.08 -47.15 84.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 118.381 0.537 . . . . 100.0 110.329 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.88 -37.55 73.04 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 114.054 1.131 . . . . 100.0 114.054 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.01 44.4 30.24 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 106.895 -2.482 . . . . 100.0 106.895 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.9 t -127.57 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.076 0.95 . . . . 100.0 108.622 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -108.57 118.7 37.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.623 -3.473 . . . . 100.0 101.623 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.44 119.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 105.628 -1.99 . . . . 100.0 105.628 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -109.46 120.32 45.64 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.483 -0.781 . . . . 100.0 109.074 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -80.93 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.682 2.254 . . . . 100.0 109.491 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.56 112.83 24.99 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.329 -0.989 . . . . 100.0 108.329 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.35 128.33 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.526 -1.287 . . . . 100.0 107.526 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.24 135.66 54.79 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.437 -2.06 . . . . 100.0 105.437 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -102.59 119.17 38.36 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.55 -0.907 . . . . 100.0 108.55 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 p -108.63 175.87 5.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.99 0.9 . . . . 100.0 110.176 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -61.7 -26.43 68.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.317 1.447 . . . . 100.0 110.356 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -97.88 6.52 47.68 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.868 0.867 . . . . 100.0 112.633 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.65 179.36 20.03 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 121.298 -0.876 . . . . 100.0 111.208 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.72 139.94 59.82 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.182 2.588 . . . . 100.0 116.009 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.52 131.4 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 103.155 -2.905 . . . . 100.0 103.155 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -113.58 128.48 56.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.164 0.507 . . . . 100.0 109.833 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -110.74 114.77 28.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.957 -2.608 . . . . 100.0 103.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -89.74 103.95 16.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 100.87 -3.752 . . . . 100.0 100.87 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.521 HG22 HD23 ' A' ' 13' ' ' LEU . 32.8 t -87.91 124.39 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.404 -1.271 . . . . 100.0 107.95 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -98.36 115.74 29.1 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.024 -2.213 . . . . 100.0 105.024 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.26 137.77 49.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.517 -1.66 . . . . 100.0 106.517 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.1 p -71.56 162.17 29.86 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.845 0.831 . . . . 100.0 112.926 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.3 14.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.939 -1.028 . . . . 100.0 108.538 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.22 57.99 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 121.703 -0.623 . . . . 100.0 113.194 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -59.68 -34.15 72.49 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.544 1.938 . . . . 100.0 112.101 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.22 -30.49 66.54 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.224 2.21 . . . . 100.0 113.131 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.09 -46.54 88.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.41 15.1 p90 -74.22 -40.45 62.43 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 116.912 2.19 . . . . 100.0 116.912 176.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.5 -154.18 9.31 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 120.303 -0.951 . . . . 100.0 111.918 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.46 53.06 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 122.337 0.965 . . . . 100.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.5 mt -105.13 143.16 33.69 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 123.851 0.86 . . . . 100.0 109.993 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -68.18 156.4 37.62 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.417 -1.265 . . . . 100.0 112.949 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.77 -37.69 79.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 125.312 1.445 . . . . 100.0 110.077 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.62 89.27 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 124.867 1.222 . . . . 100.0 111.479 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 85.8 t80 -62.76 -46.82 86.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.057 0.543 . . . . 100.0 111.032 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -70.59 -36.96 73.83 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 115.917 1.821 . . . . 100.0 115.917 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.2 mt -51.96 135.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 114.747 1.388 . . . . 100.0 114.747 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 68.85 14.41 8.91 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.204 2.202 . . . . 100.0 114.694 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 131.02 45.36 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.398 -0.964 . . . . 100.0 108.398 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.81 -31.15 13.87 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.305 -0.861 . . . . 100.0 108.726 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.592 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -151.04 163.8 37.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 120.824 0.345 . . . . 100.0 110.227 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -147.1 154.17 40.82 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG13 HD11 ' A' ' 13' ' ' LEU . 81.7 mt -126.51 125.38 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.231 -2.507 . . . . 100.0 104.231 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.635 ' HB ' HD22 ' A' ' 119' ' ' LEU . 45.4 mt -110.57 124.61 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 102.675 -3.083 . . . . 100.0 102.675 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.8 mtp -112.35 136.54 51.69 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 114.914 1.45 . . . . 100.0 114.914 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -129.47 164.2 24.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 112.501 -2.136 . . . . 100.0 107.976 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -109.69 125.43 52.63 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.041 -1.837 . . . . 100.0 106.041 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 m -64.8 -19.71 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 114.042 1.127 . . . . 100.0 114.042 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -86.75 -9.53 55.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 119.243 -0.408 . . . . 100.0 111.323 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -125.21 117.81 24.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 122.195 0.998 . . . . 100.0 110.547 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.67 -38.1 89.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.915 1.286 . . . . 100.0 111.838 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.92 -40.76 81.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.222 1.809 . . . . 100.0 110.601 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -62.97 -41.28 99.49 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.32 0.509 . . . . 100.0 111.307 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.87 -41.41 95.69 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.863 0.865 . . . . 100.0 110.604 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.6 mttt -60.91 -37.8 83.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.792 1.237 . . . . 100.0 110.777 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.83 -8.43 58.03 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.273 1.583 . . . . 100.0 115.273 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 119' ' ' LEU . 73.0 t -60.11 -42.75 91.59 Favored Pre-proline 0 C--N 1.364 1.224 0 CA-C-O 116.419 -1.753 . . . . 100.0 112.077 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 73.8 Cg_exo -57.49 -37.47 97.16 Favored 'Trans proline' 0 C--N 1.375 1.955 0 CA-C-N 122.153 1.805 . . . . 100.0 112.657 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.93 -45.43 89.27 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.05 1.34 . . . . 100.0 110.894 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -64.16 -41.84 96.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 122.936 0.494 . . . . 100.0 110.917 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -62.65 -43.87 97.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 123.898 0.879 . . . . 100.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -63.0 -43.81 97.76 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 123.042 0.537 . . . . 100.0 111.769 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.5 -44.25 96.84 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.916 0.486 . . . . 100.0 110.425 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.1 tp -63.46 -48.34 78.1 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 124.314 1.046 . . . . 100.0 113.177 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.298 32.7 m -63.86 -35.53 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 C-N-CA 124.16 0.984 . . . . 100.0 113.08 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -59.65 -38.53 81.67 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 118.688 -0.672 . . . . 100.0 111.093 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.14 -43.9 17.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 C-N-CA 119.87 -0.732 . . . . 100.0 110.233 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.1 m -124.75 104.65 8.77 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.454 -0.943 . . . . 100.0 108.454 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.14 145.05 25.0 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.983 0.897 . . . . 100.0 110.389 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 57.79 38.04 27.24 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.447 2.017 . . . . 100.0 116.447 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 pt -96.81 143.59 26.38 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 106.185 -1.783 . . . . 100.0 106.185 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 56.2 Cg_endo -62.59 131.14 32.35 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.782 2.322 . . . . 100.0 110.483 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.747 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.9 mt -132.84 138.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 122.369 1.08 . . . . 100.0 109.421 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.98 131.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.193 -1.78 . . . . 100.0 106.193 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.635 HD22 ' HB ' ' A' ' 88' ' ' ILE . 22.5 mt -105.84 128.96 54.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.852 -2.277 . . . . 100.0 104.852 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.36 130.77 56.19 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.126 -1.397 . . . . 100.0 113.398 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.48 104.36 2.77 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 106.222 -2.751 . . . . 100.0 106.222 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.426 ' HA ' HG13 ' A' ' 149' ' ' ILE . 62.3 t30 -83.24 166.09 18.85 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.555 1.142 . . . . 100.0 112.973 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 61.03 42.97 11.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.57 3.148 . . . . 100.0 114.933 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.327 24.5 m -72.07 -7.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 C-N-CA 120.527 -0.469 . . . . 100.0 111.64 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.93 -36.71 82.17 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.718 2.007 . . . . 100.0 109.958 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.95 128.42 33.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 106.915 -1.513 . . . . 100.0 106.915 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.77 -42.35 99.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 114.919 1.452 . . . . 100.0 114.919 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.21 98.04 11.54 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.843 -1.91 . . . . 100.0 105.843 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -95.57 122.2 38.08 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.771 -1.559 . . . . 100.0 106.911 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.94 -39.91 15.3 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.3 0.852 . . . . 100.0 113.3 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.07 104.86 17.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.552 -2.018 . . . . 100.0 105.552 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.57 174.3 6.51 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.209 -0.905 . . . . 100.0 113.109 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.28 65.69 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 127.045 2.138 . . . . 100.0 109.496 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 0.981 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -57.52 -39.12 75.86 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 129.128 2.971 . . . . 100.0 112.043 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.3 p -104.82 4.18 31.91 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 116.403 2.001 . . . . 100.0 116.403 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 56.5 mt -90.06 80.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 117.197 -1.801 . . . . 100.0 112.035 -176.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.255 58.9 t -71.53 -39.44 70.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 1 C-N-CA 133.757 4.823 . . . . 100.0 118.807 -178.279 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -55.79 -36.34 67.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 121.539 3.903 . . . . 100.0 121.539 -168.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.6 ' HE1' ' HB2' ' A' ' 119' ' ' LEU 0.258 67.8 m-70 -59.73 -38.8 82.69 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 116.924 -1.512 . . . . 100.0 113.493 -176.586 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.97 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.255 0.9 OUTLIER -59.93 -46.83 88.11 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 116.6 2.074 . . . . 100.0 116.6 -176.887 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.93 -40.42 97.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 125.525 1.766 . . . . 100.0 110.2 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.63 3.89 47.94 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 117.279 2.326 . . . . 100.0 117.279 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 55.38 43.47 28.8 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 122.958 1.361 . . . . 100.0 113.311 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.2 mt -103.52 150.4 23.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.643 -1.984 . . . . 100.0 105.643 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -97.28 141.02 30.89 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 109.784 -0.451 . . . . 100.0 109.784 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.491 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.5 t80 -108.27 136.88 47.18 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 113.188 0.81 . . . . 100.0 113.188 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -134.11 136.47 43.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.221 -1.354 . . . . 100.0 110.743 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.322 66.0 m-20 -83.47 130.06 35.01 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 101.996 -3.335 . . . . 100.0 101.996 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' HH22 ' A' ' 29' ' ' ARG . 43.2 pt -134.72 156.73 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.525 1.155 . . . . 100.0 111.674 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 71.3 m -138.2 107.98 6.28 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.941 -2.244 . . . . 100.0 104.941 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.32 -44.63 96.88 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 115.214 -0.903 . . . . 100.0 112.854 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.92 -39.36 91.79 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 125.071 1.348 . . . . 100.0 113.372 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.5 p -99.97 1.57 42.73 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 115.669 1.729 . . . . 100.0 115.669 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.493 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.1 m-80 64.65 21.58 12.44 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.296 1.438 . . . . 100.0 111.263 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 78.1 t80 -70.98 125.61 27.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.906 -1.146 . . . . 100.0 107.906 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 54.45 36.5 25.73 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.102 2.561 . . . . 100.0 114.429 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' HB2' HH11 ' A' ' 29' ' ' ARG . 64.4 t80 -60.99 -45.49 94.62 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 121.644 -0.66 . . . . 100.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -35.63 81.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.799 2.148 . . . . 100.0 116.799 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.26 -46.98 99.73 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.166 3.025 . . . . 100.0 119.166 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -60.98 -42.51 36.45 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.116 2.149 . . . . 100.0 111.815 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -64.53 -42.29 95.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 125.23 1.412 . . . . 100.0 111.496 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.61 -45.01 92.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.839 0.856 . . . . 100.0 111.116 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.82 -43.77 95.24 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 123.372 0.42 . . . . 100.0 110.399 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 85' ' ' CYS . 75.3 mt -61.36 -44.42 97.19 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 123.097 0.559 . . . . 100.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.8 98.18 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.445 1.098 . . . . 100.0 111.1 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.99 -45.04 95.36 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 122.851 0.46 . . . . 100.0 111.565 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 28.1 tptp -65.25 -46.31 81.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 122.893 0.477 . . . . 100.0 111.633 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.41 -46.99 80.85 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.397 1.258 . . . . 100.0 114.397 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.45 -38.23 73.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 C-N-CA 124.917 1.287 . . . . 100.0 109.623 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.71 10.53 57.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-O 118.515 -1.158 . . . . 100.0 111.14 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -114.17 113.1 46.49 Favored Pre-proline 0 C--N 1.364 1.224 0 N-CA-C 107.648 -1.241 . . . . 100.0 107.648 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.68 -14.15 32.95 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 123.894 3.063 . . . . 100.0 113.254 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -91.4 2.4 56.43 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.25 135.01 57.59 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 118.74 0.7 . . . . 100.0 112.108 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -133.99 148.78 51.17 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.029 -1.1 . . . . 100.0 108.029 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -90.25 112.3 23.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.674 -2.713 . . . . 100.0 103.674 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.81 -40.43 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 114.602 1.334 . . . . 100.0 114.602 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.39 145.8 50.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.34 -0.985 . . . . 100.0 108.34 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.4 ttm -85.73 129.58 54.15 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.129 -1.434 . . . . 100.0 107.129 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.95 155.93 65.25 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.366 2.044 . . . . 100.0 109.964 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.12 122.73 18.9 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.632 -1.618 . . . . 100.0 106.632 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.89 148.04 43.34 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-N 114.257 -1.338 . . . . 100.0 109.373 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.14 96.02 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 105.228 -2.138 . . . . 100.0 105.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.4 Cg_exo -56.26 142.04 87.93 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 123.236 2.624 . . . . 100.0 112.866 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.493 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.0 Cg_exo -56.5 125.94 20.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.638 2.226 . . . . 100.0 112.543 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.02 -42.66 72.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 124.938 1.399 . . . . 100.0 108.671 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.62 158.11 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 106.292 -1.744 . . . . 100.0 106.292 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.82 129.77 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.56 -1.644 . . . . 100.0 106.56 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.72 123.64 35.26 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 103.229 -2.878 . . . . 100.0 103.229 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.4 t70 -62.16 129.12 91.86 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.992 -1.004 . . . . 100.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 63.4 Cg_exo -58.9 -38.5 88.0 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.712 2.941 . . . . 100.0 113.552 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.92 94.78 Favored 'General case' 0 C--N 1.36 1.051 0 O-C-N 123.94 0.775 . . . . 100.0 110.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.36 -41.71 98.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 122.979 0.511 . . . . 100.0 111.114 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.14 97.6 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.745 0.818 . . . . 100.0 110.331 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.03 99.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.989 0.916 . . . . 100.0 110.547 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -62.33 -45.61 92.44 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.714 0.806 . . . . 100.0 111.754 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -63.6 -43.38 97.1 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 112.197 0.443 . . . . 100.0 112.197 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.34 -40.54 96.09 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.294 0.371 . . . . 100.0 111.455 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.57 -42.33 98.34 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.866 0.866 . . . . 100.0 110.197 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.33 -42.42 98.65 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 123.68 0.792 . . . . 100.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 85.2 mt -61.12 -48.1 83.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 123.735 0.647 . . . . 100.0 109.453 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.51 -43.64 98.33 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 114.084 1.142 . . . . 100.0 114.084 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.46 -47.02 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.072 0 CA-C-O 117.988 -1.006 . . . . 100.0 108.822 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.97 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.739 . . -88.66 -9.61 51.48 Favored 'General case' 1 N--CA 1.375 -4.202 1 C-N-CA 104.142 -7.023 . . . . 100.0 116.806 179.79 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 1.012 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 60.6 mt-30 -54.57 -36.03 63.93 Favored 'General case' 0 CA--C 1.445 -3.066 0 C-N-CA 128.86 2.864 . . . . 100.0 106.232 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.2 p -81.61 40.18 0.57 Allowed 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 123.07 1.414 . . . . 100.0 110.061 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.289 5.0 m 57.45 29.73 17.49 Favored 'General case' 0 CA--C 1.468 -2.206 0 C-N-CA 128.579 2.752 . . . . 100.0 112.918 175.323 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.257 . . -72.51 172.94 9.59 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 100.989 -3.708 . . . . 100.0 100.989 171.697 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.77 -35.9 34.01 Favored Pre-proline 0 CA--C 1.493 -1.22 0 CA-C-O 116.971 -1.49 . . . . 100.0 114.812 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 0.981 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.414 4.9 Cg_exo -53.97 137.95 69.47 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 CA-C-O 122.948 1.145 . . . . 100.0 113.124 176.569 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.629 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.375 45.8 m-20 -63.87 -43.91 94.66 Favored 'General case' 0 N--CA 1.408 -2.526 1 N-CA-C 122.783 4.364 . . . . 100.0 122.783 -174.245 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 16.0 tm-20 -66.34 -24.54 66.53 Favored 'General case' 0 CA--C 1.468 -2.208 1 CA-C-O 131.487 5.422 . . . . 100.0 111.598 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 1.012 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.749 55.2 m-20 -74.62 -51.47 14.38 Favored 'General case' 1 N--CA 1.267 -9.576 1 CA-C-N 105.454 -5.339 . . . . 100.0 105.406 -176.566 . . . . . . . . 5 3 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -63.66 -26.17 68.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 118.065 -2.897 . . . . 100.0 107.933 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.97 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 48.3 m-20 -62.89 -41.96 99.6 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 126.134 1.774 . . . . 100.0 112.754 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.383 1.0 OUTLIER . . . . . 0 C--O 1.261 1.67 0 CA-C-O 115.082 -2.389 . . . . 100.0 115.74 -178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.432 -1.33 0 CA-C-O 122.114 0.959 . . . . 100.0 109.627 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -127.48 135.75 50.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.399 -1.728 . . . . 100.0 107.73 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -124.43 144.24 50.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.46 -0.791 . . . . 100.0 109.134 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.1 121.64 33.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.32 128.16 56.22 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.419 -1.697 . . . . 100.0 106.419 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.8 t -104.29 125.6 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.621 -1.251 . . . . 100.0 107.621 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 89' ' ' MET . 39.3 tp -110.06 117.47 33.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.86 -1.904 . . . . 100.0 105.86 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.88 160.45 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 112.165 0.432 . . . . 100.0 112.165 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.95 172.71 24.5 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 108.559 -1.816 . . . . 100.0 108.559 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -67.33 154.41 41.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.946 0.879 . . . . 100.0 112.478 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 139.9 42.49 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 107.263 -2.335 . . . . 100.0 107.263 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.0 -4.2 83.03 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 118.634 -1.092 . . . . 100.0 114.258 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 p -62.74 -38.36 90.22 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 118.784 1.292 . . . . 100.0 111.914 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.32 4.78 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.508 -1.037 . . . . 100.0 110.508 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HE3' ' HG ' ' A' ' 15' ' ' LEU . 50.0 mtpt -59.53 -47.11 86.81 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.38 1.072 . . . . 100.0 113.254 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.6 m -64.59 -42.75 95.38 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.254 0.622 . . . . 100.0 110.598 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.6 m -62.24 -42.14 99.05 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 124.126 0.97 . . . . 100.0 108.971 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.75 -48.37 82.11 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.215 1.006 . . . . 100.0 112.968 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.85 -39.94 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 123.133 0.271 . . . . 100.0 110.91 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -65.5 -12.14 49.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 115.249 1.574 . . . . 100.0 115.249 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 41.0 mtt180 -60.02 -38.35 82.43 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.491 -0.929 . . . . 100.0 108.491 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 62.1 t-80 -80.63 111.5 17.12 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 106.799 -1.556 . . . . 100.0 106.799 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.59 -44.37 97.14 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.227 1.566 . . . . 100.0 115.227 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.1 m -62.85 -42.67 99.84 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.333 1.053 . . . . 100.0 109.35 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.07 99.68 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 111.15 -0.78 . . . . 100.0 111.15 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.15 -43.54 91.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 122.783 0.433 . . . . 100.0 111.502 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -62.89 -40.85 98.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.211 1.004 . . . . 100.0 111.85 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -94.07 10.08 35.12 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 115.211 1.56 . . . . 100.0 115.211 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -59.6 142.76 52.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 114.16 1.17 . . . . 100.0 114.16 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.22 132.89 51.65 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.296 -1.002 . . . . 100.0 108.296 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -100.44 127.49 46.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.855 -1.165 . . . . 100.0 107.855 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 109.32 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.352 -3.203 . . . . 100.0 102.352 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.23 99.35 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 p -61.73 -43.67 98.41 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 123.63 0.772 . . . . 100.0 112.718 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.9 mt -93.68 -18.15 22.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 114.393 1.257 . . . . 100.0 114.393 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.96 43.68 64.5 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.268 -1.533 . . . . 100.0 109.268 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.63 143.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.352 -0.981 . . . . 100.0 108.352 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.89 115.4 28.92 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 101.052 -3.685 . . . . 100.0 101.052 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 120.69 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.072 -1.455 . . . . 100.0 107.072 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -113.41 119.15 42.5 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 115.864 -0.607 . . . . 100.0 109.807 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.77 106.22 1.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.3 2.0 . . . . 100.0 111.468 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.79 115.88 29.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.827 -1.175 . . . . 100.0 107.827 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 t -102.39 129.11 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.053 -1.462 . . . . 100.0 107.053 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.91 136.61 53.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.666 -1.975 . . . . 100.0 105.666 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -101.83 119.17 38.36 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.601 -0.888 . . . . 100.0 108.601 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -106.45 -178.46 3.66 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.033 -0.985 . . . . 100.0 111.489 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.0 -37.99 78.16 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.581 1.952 . . . . 100.0 108.583 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -89.98 0.65 56.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 113.741 1.015 . . . . 100.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -175.37 15.86 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.199 -1.16 . . . . 100.0 110.199 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.25 138.95 58.09 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.979 2.452 . . . . 100.0 116.944 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -129.02 130.97 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 102.885 -3.006 . . . . 100.0 102.885 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -114.63 127.58 55.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.422 -0.585 . . . . 100.0 109.422 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -110.96 116.02 30.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -88.11 105.83 17.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 101.465 -3.531 . . . . 100.0 101.465 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.24 122.57 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.708 -1.219 . . . . 100.0 107.708 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -93.6 115.25 27.72 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.886 -1.894 . . . . 100.0 105.886 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -111.37 141.69 44.6 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.642 -1.985 . . . . 100.0 105.642 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -75.04 164.23 26.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.978 0.894 . . . . 100.0 112.882 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.39 16.15 20.95 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.756 -1.111 . . . . 100.0 108.318 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.77 59.2 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 121.728 -0.608 . . . . 100.0 113.422 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -62.24 -23.72 66.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.987 1.715 . . . . 100.0 112.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.31 -33.79 72.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.167 2.187 . . . . 100.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.4 -43.3 99.15 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.044 0.938 . . . . 100.0 109.684 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -70.14 -42.64 72.29 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.919 1.288 . . . . 100.0 113.09 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.93 -149.38 9.17 Favored Glycine 0 C--N 1.358 1.774 0 N-CA-C 110.99 -0.844 . . . . 100.0 110.99 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.87 50.28 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 122.185 0.881 . . . . 100.0 112.664 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.58 142.49 37.42 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 121.939 0.876 . . . . 100.0 109.651 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -64.03 151.75 42.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.403 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.01 -37.22 79.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.428 1.491 . . . . 100.0 110.003 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.76 89.34 Favored Glycine 0 C--N 1.356 1.652 0 C-N-CA 125.237 1.399 . . . . 100.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' A' ' 14' ' ' VAL . 79.9 t80 -62.85 -46.19 89.06 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 123.458 0.703 . . . . 100.0 111.081 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -70.9 -35.59 72.37 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.955 1.835 . . . . 100.0 115.955 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -51.87 134.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 122.987 1.375 . . . . 100.0 114.429 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 65.74 19.27 11.36 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 128.132 2.573 . . . . 100.0 114.635 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 132.32 48.57 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.052 -1.092 . . . . 100.0 108.052 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -95.19 -33.14 12.73 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.544 -0.753 . . . . 100.0 109.075 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.537 ' HB2' HD22 ' A' ' 164' ' ' LEU . 26.0 p -152.38 163.68 39.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.888 -0.412 . . . . 100.0 109.888 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.28 154.36 40.88 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 114.54 1.311 . . . . 100.0 114.54 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.5 mt -125.43 125.93 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.057 -2.571 . . . . 100.0 104.057 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 119' ' ' LEU . 50.8 mt -110.55 123.89 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.941 -2.985 . . . . 100.0 102.941 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.435 ' SD ' HD11 ' A' ' 15' ' ' LEU . 87.3 mtp -111.41 136.82 50.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -129.53 164.23 24.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.295 -2.23 . . . . 100.0 108.187 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -106.39 125.41 50.96 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.476 -2.046 . . . . 100.0 105.476 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.75 -17.15 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -91.69 -4.57 54.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.215 0.462 . . . . 100.0 111.306 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 t -124.38 116.08 22.01 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.472 1.129 . . . . 100.0 109.213 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -65.4 -37.73 87.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.402 1.081 . . . . 100.0 111.087 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.41 -41.22 83.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.258 1.823 . . . . 100.0 110.333 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 p -62.41 -40.97 98.27 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.366 0.53 . . . . 100.0 111.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -64.13 -41.63 97.13 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 123.895 0.878 . . . . 100.0 109.789 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -61.17 -36.85 80.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.095 0.958 . . . . 100.0 111.495 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.27 -6.56 56.95 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.133 1.531 . . . . 100.0 115.133 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.69 -42.4 91.22 Favored Pre-proline 0 C--N 1.364 1.219 0 CA-C-O 116.316 -1.802 . . . . 100.0 111.285 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 75.9 Cg_exo -57.85 -36.82 98.04 Favored 'Trans proline' 0 C--N 1.377 2.071 0 CA-C-N 122.234 1.834 . . . . 100.0 112.597 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.11 -44.41 92.37 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 119.438 1.017 . . . . 100.0 111.385 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -63.98 -42.25 97.28 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 122.817 0.447 . . . . 100.0 110.394 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -62.67 -43.03 99.84 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.082 0.953 . . . . 100.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -62.35 -45.19 94.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 122.892 0.477 . . . . 100.0 112.2 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -63.69 -43.36 96.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.596 0.56 . . . . 100.0 111.397 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 86' ' ' ALA . 51.0 tp -63.11 -48.36 78.89 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.011 0.924 . . . . 100.0 113.093 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 27.5 m -65.69 -36.4 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 123.668 0.787 . . . . 100.0 112.97 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.13 -45.97 91.24 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 118.916 -0.564 . . . . 100.0 109.675 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.03 -45.15 55.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-N 118.154 0.433 . . . . 100.0 111.79 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 24.1 t -130.07 112.68 13.68 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 118.714 -1.195 . . . . 100.0 108.523 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.54 144.56 27.16 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.788 -1.097 . . . . 100.0 113.671 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.08 40.97 32.17 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 117.338 2.347 . . . . 100.0 117.338 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.0 pt -98.36 143.82 26.98 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 107.998 -1.112 . . . . 100.0 107.998 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.4 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 57.9 Cg_endo -62.02 131.75 36.24 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.473 2.115 . . . . 100.0 111.017 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.744 ' HB ' HD22 ' A' ' 144' ' ' LEU . 74.3 mt -133.13 137.32 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 122.406 1.098 . . . . 100.0 108.794 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -115.98 130.88 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 106.767 -1.568 . . . . 100.0 106.767 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 14.4 mt -105.41 128.5 53.55 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.764 -2.31 . . . . 100.0 104.764 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.1 m -118.75 129.69 55.39 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.458 . . . . 100.0 112.399 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.07 3.48 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 105.261 -3.136 . . . . 100.0 105.261 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.378 0.0 OUTLIER -95.57 178.54 5.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -178.844 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 62.41 40.51 10.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 127.816 2.446 . . . . 100.0 112.511 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.3 28.1 m -72.21 -8.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 115.993 -0.549 . . . . 100.0 111.24 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.85 -36.79 84.42 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.47 1.908 . . . . 100.0 109.998 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.42 130.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 108.145 -1.057 . . . . 100.0 108.145 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -43.24 99.22 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.915 1.82 . . . . 100.0 115.915 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -88.68 97.85 11.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.607 -1.998 . . . . 100.0 105.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -96.5 112.79 24.4 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.42 -1.326 . . . . 100.0 107.42 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -75.2 -45.05 42.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.102 1.519 . . . . 100.0 115.102 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.23 106.73 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 105.985 -1.857 . . . . 100.0 105.985 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.07 174.08 6.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.854 -1.066 . . . . 100.0 112.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.63 66.93 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 127.367 2.267 . . . . 100.0 109.09 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.101 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.2 mttt -56.91 -39.33 74.24 Favored 'General case' 0 N--CA 1.42 -1.931 0 C-N-CA 128.723 2.809 . . . . 100.0 112.547 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 89.9 p -104.65 5.1 33.35 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 115.907 1.817 . . . . 100.0 115.907 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 65.6 mt -88.76 77.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.112 0 C-N-CA 117.548 -1.661 . . . . 100.0 111.788 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.253 59.0 t -70.86 -38.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 1 C-N-CA 133.81 4.844 . . . . 100.0 118.869 -178.387 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.04 -35.82 67.32 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 121.427 3.862 . . . . 100.0 121.427 -168.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.704 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.274 72.5 m80 -59.58 -38.58 81.58 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 116.783 -1.579 . . . . 100.0 114.264 -176.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.944 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.254 0.4 OUTLIER -59.42 -46.61 88.23 Favored 'General case' 0 CA--C 1.452 -2.819 0 N-CA-C 116.194 1.924 . . . . 100.0 116.194 -176.661 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.87 -41.08 97.43 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 125.756 1.91 . . . . 100.0 110.832 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -101.49 6.46 42.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 117.15 2.278 . . . . 100.0 117.15 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 56.32 42.36 27.89 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-O 123.026 1.393 . . . . 100.0 113.646 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 117' ' ' ILE . 25.2 mt -99.97 149.17 23.71 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.523 -2.029 . . . . 100.0 105.523 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.77 143.87 28.63 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.482 -0.933 . . . . 100.0 108.482 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.704 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.5 t80 -110.25 137.27 48.21 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.938 0.718 . . . . 100.0 112.938 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -133.78 137.01 44.9 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.543 -1.208 . . . . 100.0 110.575 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.362 69.9 m-20 -85.59 130.09 34.66 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 101.464 -3.532 . . . . 100.0 101.464 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.482 ' HB ' HH22 ' A' ' 29' ' ' ARG . 44.1 pt -137.27 158.29 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 122.248 1.023 . . . . 100.0 111.462 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.8 m -139.06 110.58 7.04 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 106.137 -1.801 . . . . 100.0 106.137 175.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.72 -44.47 96.86 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.625 -1.171 . . . . 100.0 112.71 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.79 -39.7 92.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.324 1.449 . . . . 100.0 113.012 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 115.676 1.732 . . . . 100.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.3 m-80 63.6 24.08 13.83 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 125.158 1.383 . . . . 100.0 110.919 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 80.1 t80 -74.12 125.14 27.69 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.504 -1.295 . . . . 100.0 107.504 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 53.43 36.73 23.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.095 2.558 . . . . 100.0 114.652 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 70.6 t80 -60.82 -43.39 98.3 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.726 -0.609 . . . . 100.0 111.94 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -63.53 -37.28 86.7 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.398 1.999 . . . . 100.0 116.398 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.47 -46.66 99.77 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.897 3.295 . . . . 100.0 119.897 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.62 -41.95 43.52 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.139 2.157 . . . . 100.0 111.919 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.92 -41.43 95.56 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.729 1.212 . . . . 100.0 110.969 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.3 -46.81 87.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.206 1.002 . . . . 100.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -65.63 -42.17 91.81 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 120.28 -0.568 . . . . 100.0 110.494 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.0 mt -61.92 -42.87 99.59 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 119.208 -0.425 . . . . 100.0 111.415 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.73 98.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 124.018 0.927 . . . . 100.0 110.564 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.79 -45.72 92.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 119.188 -0.435 . . . . 100.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 52.6 tptt -65.55 -44.93 85.3 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.518 0.511 . . . . 100.0 112.105 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.46 -46.37 83.37 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 114.279 1.215 . . . . 100.0 114.279 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.7 -37.85 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.225 1.01 . . . . 100.0 109.479 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.43 57.13 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.27 -1.132 . . . . 100.0 110.27 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 54.2 t0 -112.57 110.53 52.58 Favored Pre-proline 0 C--N 1.364 1.218 0 N-CA-C 108.041 -1.096 . . . . 100.0 108.041 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.97 -14.15 32.08 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.748 2.965 . . . . 100.0 113.285 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -90.36 -0.47 57.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.499 1.12 . . . . 100.0 112.987 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 90.3 mt -61.94 136.16 57.85 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.739 1.014 . . . . 100.0 113.739 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -134.89 154.86 51.5 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.908 -1.145 . . . . 100.0 107.908 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -90.49 116.24 28.25 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 103.872 -2.64 . . . . 100.0 103.872 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.7 -44.73 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 123.971 0.908 . . . . 100.0 111.188 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.08 150.5 52.14 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.561 -0.903 . . . . 100.0 108.561 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -95.02 130.86 31.5 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.493 -1.299 . . . . 100.0 107.493 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -64.58 158.27 50.85 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.466 2.11 . . . . 100.0 111.51 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.8 125.43 25.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.37 1.081 . . . . 100.0 108.585 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.35 147.21 45.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.863 -1.517 . . . . 100.0 108.804 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.27 135.84 95.31 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 105.777 -1.934 . . . . 100.0 105.777 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 74.7 Cg_exo -55.97 142.33 85.11 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 123.549 2.833 . . . . 100.0 113.197 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.2 Cg_exo -56.8 128.67 30.91 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.634 2.223 . . . . 100.0 112.94 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.8 -43.37 72.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.892 -1.151 . . . . 100.0 107.892 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 157.78 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 106.538 -1.653 . . . . 100.0 106.538 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.05 130.41 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.87 -1.53 . . . . 100.0 106.87 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.64 125.86 34.62 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 103.664 -2.717 . . . . 100.0 103.664 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.22 126.93 90.26 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.122 -0.945 . . . . 100.0 110.327 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.92 -38.14 89.8 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 123.631 2.887 . . . . 100.0 113.68 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.71 94.07 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.146 0.904 . . . . 100.0 110.049 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -40.81 97.72 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 123.127 0.571 . . . . 100.0 111.251 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.54 98.67 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.659 0.784 . . . . 100.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.45 99.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.935 0.894 . . . . 100.0 110.533 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -61.71 -46.06 91.29 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.349 1.059 . . . . 100.0 111.363 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -63.91 -43.35 96.22 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 112.275 0.472 . . . . 100.0 112.275 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -64.33 -39.66 94.35 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.333 0.396 . . . . 100.0 111.633 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.76 -44.27 96.64 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.223 1.009 . . . . 100.0 110.209 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -61.61 -42.76 99.34 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.459 0.704 . . . . 100.0 110.894 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 79.5 mt -61.15 -48.49 81.37 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 115.784 -0.643 . . . . 100.0 110.271 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.26 -43.95 96.53 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 113.709 1.003 . . . . 100.0 113.709 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -45.81 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.945 0 CA-C-O 118.372 -0.823 . . . . 100.0 109.443 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.746 . . -86.45 -10.78 53.51 Favored 'General case' 1 N--CA 1.376 -4.174 1 C-N-CA 104.526 -6.87 . . . . 100.0 115.747 179.945 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 1.0 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 52.6 mt-30 -54.68 -35.27 63.39 Favored 'General case' 0 CA--C 1.443 -3.158 0 C-N-CA 128.703 2.801 . . . . 100.0 107.148 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.2 p -81.36 40.58 0.57 Allowed 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.857 1.313 . . . . 100.0 109.572 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.266 6.4 m 59.13 27.17 16.07 Favored 'General case' 0 CA--C 1.471 -2.086 0 C-N-CA 127.277 2.231 . . . . 100.0 112.984 175.003 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 204' ' ' ALA 0.266 . . -72.09 170.5 13.78 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.316 -3.587 . . . . 100.0 101.316 171.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.95 -35.4 29.03 Favored Pre-proline 0 CA--C 1.486 -1.515 0 CA-C-O 116.499 -1.715 . . . . 100.0 114.911 -174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.101 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.445 0.0 OUTLIER -54.38 139.48 73.98 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 O-C-N 123.741 1.39 . . . . 100.0 111.898 176.403 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.698 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.453 39.5 m-20 -65.73 -43.21 89.75 Favored 'General case' 0 N--CA 1.408 -2.53 1 N-CA-C 125.03 5.196 . . . . 100.0 125.03 -173.577 . . . . . . . . 4 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.7 tm-20 -62.58 -35.81 80.71 Favored 'General case' 0 CA--C 1.469 -2.16 1 CA-C-O 132.292 5.806 . . . . 100.0 108.734 176.968 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 1.0 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.629 17.5 m-20 -62.34 -51.9 65.8 Favored 'General case' 1 N--CA 1.282 -8.842 2 CA-C-N 104.098 -5.955 . . . . 100.0 107.554 178.719 . . . . . . . . 5 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.28 -25.33 66.0 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 117.261 -3.399 . . . . 100.0 107.579 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.944 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 57.9 m-20 -63.78 -40.4 96.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 126.979 2.112 . . . . 100.0 112.395 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.274 3.2 mm? . . . . . 0 N--CA 1.426 -1.654 0 CA-C-O 114.157 -2.83 . . . . 100.0 112.781 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 102.009 -3.33 . . . . 100.0 102.009 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.41 138.74 52.47 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.813 -0.63 . . . . 100.0 110.828 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.83 144.37 51.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.605 -0.725 . . . . 100.0 110.017 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.64 120.3 32.93 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.217 -1.401 . . . . 100.0 107.217 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 63' ' ' VAL . 57.1 tp -110.6 125.87 53.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.131 -1.849 . . . . 100.0 107.23 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 79' ' ' TYR . 56.0 t -103.05 124.69 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.694 -1.224 . . . . 100.0 107.694 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 89' ' ' MET . 42.5 tp -109.29 117.33 33.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.124 -1.806 . . . . 100.0 106.124 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -128.79 161.47 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 112.129 0.418 . . . . 100.0 112.129 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.69 173.96 24.14 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 108.403 -1.879 . . . . 100.0 108.403 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.4 154.35 41.55 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.061 0.934 . . . . 100.0 112.938 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.84 141.18 43.31 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.07 -2.412 . . . . 100.0 107.07 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.78 -1.53 86.99 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-O 118.084 -1.398 . . . . 100.0 113.288 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 p -63.91 -38.39 90.91 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 119.261 1.531 . . . . 100.0 111.649 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.47 21.78 4.63 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.487 -1.045 . . . . 100.0 110.487 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -59.98 -46.86 88.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.759 1.224 . . . . 100.0 113.237 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -63.68 -43.73 95.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.986 0.914 . . . . 100.0 110.03 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -41.13 99.1 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.939 0.896 . . . . 100.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -60.44 -48.72 80.51 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.945 0.898 . . . . 100.0 112.772 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.89 -40.94 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 123.103 0.252 . . . . 100.0 111.114 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.265 99.3 mttt -69.13 -7.08 32.85 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 116.302 1.964 . . . . 100.0 116.302 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 43.6 mtt180 -61.01 -37.84 83.95 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 107.49 -1.3 . . . . 100.0 107.49 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.71 112.71 18.33 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 106.831 -1.544 . . . . 100.0 106.831 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.92 -44.46 96.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.983 1.845 . . . . 100.0 115.983 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 84.8 m -63.72 -42.12 97.97 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.869 0.868 . . . . 100.0 109.479 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -41.5 99.59 Favored Glycine 0 C--N 1.357 1.744 0 N-CA-C 110.977 -0.849 . . . . 100.0 110.977 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -64.6 -44.25 91.22 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.721 0.808 . . . . 100.0 110.866 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -63.42 -40.32 96.88 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.428 1.091 . . . . 100.0 111.484 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.12 8.6 34.81 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 114.887 1.44 . . . . 100.0 114.887 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -58.84 142.92 49.13 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 114.538 1.311 . . . . 100.0 114.538 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.61 139.98 52.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.354 -1.351 . . . . 100.0 107.354 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -111.89 125.97 54.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.34 -2.467 . . . . 100.0 104.34 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.28 108.15 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.448 -3.167 . . . . 100.0 102.448 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.66 99.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 114.591 1.33 . . . . 100.0 114.591 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -61.47 -42.5 98.86 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 123.699 0.8 . . . . 100.0 112.914 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.58 -20.97 19.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.356 1.243 . . . . 100.0 114.356 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.05 43.24 49.25 Favored Glycine 0 C--N 1.36 1.889 0 N-CA-C 108.504 -1.839 . . . . 100.0 108.504 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 24.1 t -126.7 145.39 34.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.337 -0.986 . . . . 100.0 108.337 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 117.82 34.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 102.44 -3.17 . . . . 100.0 102.44 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.63 123.12 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.094 -1.447 . . . . 100.0 107.094 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -115.15 121.59 34.78 Favored Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 115.365 -0.834 . . . . 100.0 110.519 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -80.45 103.38 1.51 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 122.226 1.951 . . . . 100.0 110.36 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.92 113.0 24.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.595 0.758 . . . . 100.0 109.323 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 t -98.48 130.26 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.689 0.796 . . . . 100.0 108.854 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.92 135.44 51.89 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.529 -2.026 . . . . 100.0 105.529 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -102.12 118.48 36.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.651 -0.819 . . . . 100.0 109.34 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p -103.86 176.12 5.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.077 -0.965 . . . . 100.0 109.768 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -60.13 -35.24 74.83 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.789 1.635 . . . . 100.0 109.582 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -90.5 -0.46 57.67 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 113.767 1.025 . . . . 100.0 113.767 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.07 178.07 15.26 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 119.493 1.042 . . . . 100.0 111.763 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.59 139.84 60.1 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 123.099 2.533 . . . . 100.0 114.323 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 mm -127.42 130.62 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 102.359 -3.2 . . . . 100.0 102.359 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -116.25 130.12 56.62 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 121.681 -0.637 . . . . 100.0 109.978 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.33 115.65 29.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 104.922 -2.251 . . . . 100.0 104.922 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.84 107.33 18.93 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 100.63 -3.841 . . . . 100.0 100.63 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 13' ' ' LEU . 21.5 t -93.56 122.65 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.183 -1.043 . . . . 100.0 108.183 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -94.24 111.77 23.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.155 -2.165 . . . . 100.0 105.155 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -115.02 137.46 51.98 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 106.95 -1.5 . . . . 100.0 106.95 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.5 p -70.85 163.7 26.81 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.04 0.924 . . . . 100.0 113.078 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.88 25.9 7.49 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.229 -1.026 . . . . 100.0 108.229 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.76 13.73 60.59 Favored Glycine 0 C--N 1.361 1.92 0 O-C-N 121.613 -0.679 . . . . 100.0 114.147 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.452 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 73.9 mt-30 -59.55 -35.04 73.47 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.795 2.038 . . . . 100.0 112.296 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.96 -32.84 68.23 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.416 2.686 . . . . 100.0 112.128 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.54 -40.07 95.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.12 0.968 . . . . 100.0 111.159 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 17.3 p90 -94.56 -18.08 21.75 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 115.578 1.696 . . . . 100.0 115.578 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.44 -162.83 27.86 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 119.836 -1.173 . . . . 100.0 112.518 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.25 178.46 53.86 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.601 -1.4 . . . . 100.0 109.601 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.6 mt -102.89 145.48 29.74 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 122.568 1.175 . . . . 100.0 111.09 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.15 150.12 49.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.082 -1.872 . . . . 100.0 111.433 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.39 -36.7 83.14 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.874 1.27 . . . . 100.0 108.859 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.67 -38.02 93.18 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 125.81 1.671 . . . . 100.0 110.587 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' A' ' 75' ' ' LEU . 73.9 t80 -63.66 -46.96 83.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.251 0.526 . . . . 100.0 111.5 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -70.27 -37.01 74.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 116.871 2.174 . . . . 100.0 116.871 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.18 139.89 13.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 CA-C-O 122.375 1.083 . . . . 100.0 113.75 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 70.8 11.5 7.15 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.92 2.088 . . . . 100.0 113.582 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.97 131.55 46.49 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.827 -0.805 . . . . 100.0 108.827 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -98.65 -27.82 13.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.149 -0.932 . . . . 100.0 109.513 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.625 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.4 p -152.21 163.05 40.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 122.284 0.234 . . . . 100.0 110.392 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.74 153.43 38.19 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 13' ' ' LEU . 95.6 mt -126.55 126.5 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 103.856 -2.646 . . . . 100.0 103.856 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.656 ' HB ' HD22 ' A' ' 119' ' ' LEU . 39.8 mt -111.37 125.09 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 102.934 -2.988 . . . . 100.0 102.934 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.8 mtp -112.5 137.1 51.2 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 114.596 1.332 . . . . 100.0 114.596 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -129.94 161.48 30.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.051 -2.34 . . . . 100.0 108.265 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.95 125.77 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.061 -1.829 . . . . 100.0 106.061 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.72 -16.95 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 113.355 0.872 . . . . 100.0 113.355 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -90.21 -7.44 53.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 119.146 -0.454 . . . . 100.0 111.109 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.4 t -123.66 116.9 23.83 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-O 122.214 1.007 . . . . 100.0 110.318 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -65.45 -36.85 85.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.146 0.978 . . . . 100.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.77 -40.22 81.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.571 1.549 . . . . 100.0 110.288 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.9 p -62.36 -41.04 98.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 118.439 0.563 . . . . 100.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -64.3 -41.67 96.74 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 123.734 0.814 . . . . 100.0 110.438 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.6 mttt -60.36 -37.76 81.72 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 124.336 1.054 . . . . 100.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -76.27 -9.79 58.91 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 115.631 1.715 . . . . 100.0 115.631 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -42.19 88.99 Favored Pre-proline 0 C--N 1.362 1.14 0 CA-C-O 116.32 -1.8 . . . . 100.0 112.087 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 76.5 Cg_exo -57.53 -37.91 95.61 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.351 2.034 . . . . 100.0 112.74 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.71 -44.59 89.75 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.631 1.172 . . . . 100.0 110.683 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -63.53 -42.43 98.44 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.267 0.627 . . . . 100.0 110.674 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CE1' HD11 ' A' ' 144' ' ' LEU . 84.4 t60 -62.78 -44.91 94.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 124.339 1.055 . . . . 100.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -63.12 -42.28 99.51 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 112.636 0.606 . . . . 100.0 112.636 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -61.82 -46.11 90.93 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.02 0.528 . . . . 100.0 109.798 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.84 -48.25 79.85 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.588 0.959 . . . . 100.0 113.588 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.32 -38.37 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 125.069 1.348 . . . . 100.0 111.473 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -60.37 -39.38 87.01 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.554 0.616 . . . . 100.0 111.439 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.17 -44.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 118.279 0.49 . . . . 100.0 110.61 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.2 m -127.59 106.78 9.4 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.521 0.601 . . . . 100.0 109.944 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.37 144.96 26.52 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.957 0.884 . . . . 100.0 112.615 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . 0.255 72.2 m-20 54.06 41.18 32.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 116.926 2.195 . . . . 100.0 116.926 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -96.48 144.17 27.37 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.998 -2.223 . . . . 100.0 104.998 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 132.26 36.14 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.354 2.036 . . . . 100.0 110.148 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.8 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.3 mt -132.24 136.59 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 122.309 1.052 . . . . 100.0 108.57 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 160' ' ' PRO . 60.7 t -115.55 131.95 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.989 -1.856 . . . . 100.0 105.989 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.656 HD22 ' HB ' ' A' ' 88' ' ' ILE . 25.9 mt -106.59 127.86 53.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.601 -2.0 . . . . 100.0 105.601 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 70.8 m -119.23 130.16 55.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.398 -1.274 . . . . 100.0 113.406 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.21 107.24 3.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 104.797 -3.321 . . . . 100.0 104.797 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.333 0.6 OUTLIER -95.64 177.9 5.65 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.668 1.358 . . . . 100.0 114.668 -178.266 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 61.82 40.14 13.13 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.742 2.417 . . . . 100.0 112.729 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.303 24.7 m -72.15 -8.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 CA-C-N 116.187 -0.461 . . . . 100.0 111.366 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.09 -37.3 86.64 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.6 1.96 . . . . 100.0 109.977 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.9 129.61 31.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 N-CA-C 107.743 -1.206 . . . . 100.0 107.743 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.54 -44.31 97.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.891 1.441 . . . . 100.0 114.891 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -87.74 95.29 10.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.773 -1.566 . . . . 100.0 106.773 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -94.99 125.31 39.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.229 -1.767 . . . . 100.0 106.229 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.32 -36.28 11.46 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 113.982 1.104 . . . . 100.0 113.982 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.52 106.34 20.35 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 104.395 -2.446 . . . . 100.0 104.395 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -100.8 173.6 6.43 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.115 -0.948 . . . . 100.0 112.045 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -56.84 -34.14 67.46 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.496 1.919 . . . . 100.0 109.477 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.032 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.3 mttt -57.31 -38.91 74.74 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 129.674 3.189 . . . . 100.0 112.094 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.7 p -104.95 2.75 30.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.796 2.147 . . . . 100.0 116.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.468 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 61.9 mt -92.95 89.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 116.589 -2.045 . . . . 100.0 110.624 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.4 p -100.64 -8.61 9.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -60.47 -36.63 78.75 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 117.819 2.525 . . . . 100.0 117.819 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.533 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.262 63.6 m-70 -58.94 -39.14 80.74 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 126.489 1.916 . . . . 100.0 115.265 -176.068 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.831 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.314 24.1 ttp-105 -59.25 -49.6 77.23 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 113.963 1.098 . . . . 100.0 113.963 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.25 -40.81 97.43 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 125.275 1.61 . . . . 100.0 111.318 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.5 mmtt -95.32 -0.65 52.57 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.576 1.695 . . . . 100.0 115.576 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.268 5.5 m120 55.28 44.54 27.29 Favored 'General case' 0 C--N 1.362 1.134 0 CA-C-O 123.367 1.556 . . . . 100.0 114.146 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.5 mt -106.03 143.33 34.32 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.212 -2.514 . . . . 100.0 104.212 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.257 99.8 mm-40 -92.25 145.51 24.44 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 118.625 -1.23 . . . . 100.0 110.247 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.6 t80 -110.6 137.49 48.21 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 113.063 0.764 . . . . 100.0 113.063 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.79 137.21 43.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.35 -1.296 . . . . 100.0 110.652 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.27 78.7 m-20 -83.35 129.22 34.98 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.894 -3.002 . . . . 100.0 102.894 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.484 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.5 pt -135.32 158.5 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-O 122.295 1.045 . . . . 100.0 111.71 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 59.4 m -139.48 110.73 6.97 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 105.42 -2.067 . . . . 100.0 105.42 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -62.28 -44.83 95.62 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.559 -1.201 . . . . 100.0 113.107 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.7 -39.55 94.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 124.735 1.214 . . . . 100.0 112.98 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 91.8 p -97.27 -0.02 47.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 115.314 1.598 . . . . 100.0 115.314 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.464 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.8 m-80 65.45 20.1 11.68 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.918 1.287 . . . . 100.0 111.648 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -69.84 125.88 28.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.404 -0.962 . . . . 100.0 108.404 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 53.1 37.6 25.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 128.103 2.561 . . . . 100.0 114.566 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.505 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 71.1 t80 -60.48 -43.63 96.75 Favored 'General case' 0 C--N 1.362 1.113 0 O-C-N 121.885 -0.509 . . . . 100.0 111.457 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -64.8 -36.81 85.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 118.013 2.597 . . . . 100.0 118.013 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -56.38 -47.97 97.89 Favored Pre-proline 0 C--N 1.358 0.97 0 N-CA-C 118.863 2.912 . . . . 100.0 118.863 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.458 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -60.62 -40.55 54.84 Favored 'Trans proline' 0 C--N 1.373 1.835 0 CA-C-N 122.879 2.064 . . . . 100.0 112.29 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.97 -41.62 95.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 124.5 1.125 . . . . 100.0 111.164 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.45 -46.37 90.34 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 123.726 0.641 . . . . 100.0 112.024 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.78 -43.22 93.95 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.631 0.582 . . . . 100.0 110.646 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.72 -44.83 96.17 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.243 0.617 . . . . 100.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.66 98.46 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 124.306 1.042 . . . . 100.0 110.793 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -61.65 -45.32 94.56 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 119.052 -0.499 . . . . 100.0 111.343 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.03 -43.72 86.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.985 1.106 . . . . 100.0 113.985 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.9 -46.59 84.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.699 0.8 . . . . 100.0 112.998 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 48.7 mm -70.77 -38.05 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.211 1.004 . . . . 100.0 110.469 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.67 10.53 58.95 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.498 -1.041 . . . . 100.0 110.498 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -114.98 114.02 43.93 Favored Pre-proline 0 C--N 1.365 1.242 0 N-CA-C 108.382 -0.97 . . . . 100.0 108.382 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.98 -12.6 30.8 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.931 3.087 . . . . 100.0 113.208 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -90.67 1.2 57.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.396 1.258 . . . . 100.0 114.396 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.95 135.85 57.52 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 118.734 0.697 . . . . 100.0 112.119 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.9 148.25 51.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.166 -0.924 . . . . 100.0 108.625 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -91.09 116.29 28.69 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 103.808 -2.664 . . . . 100.0 103.808 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.97 -44.08 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.776 0.83 . . . . 100.0 111.828 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.52 152.52 51.54 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.57 0.7 . . . . 100.0 110.508 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.06 133.79 47.52 Favored Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.797 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -66.12 156.92 62.32 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.623 2.215 . . . . 100.0 109.437 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.0 121.77 18.8 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.29 -1.745 . . . . 100.0 106.29 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.84 149.01 42.25 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.33 -1.304 . . . . 100.0 109.955 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.4 136.58 95.83 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 105.289 -2.115 . . . . 100.0 105.289 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 56.9 Cg_exo -56.59 142.2 90.53 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.197 2.598 . . . . 100.0 112.602 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -56.13 126.25 21.76 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.834 2.356 . . . . 100.0 112.073 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -70.55 -42.98 70.45 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 124.693 1.245 . . . . 100.0 108.483 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.96 156.59 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 106.074 -1.824 . . . . 100.0 106.074 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.37 131.0 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 106.49 -1.67 . . . . 100.0 106.49 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -86.71 126.15 34.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.986 -2.598 . . . . 100.0 103.986 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.5 t70 -61.17 127.54 88.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 100.0 110.863 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 68.1 Cg_exo -59.31 -38.6 83.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.759 2.973 . . . . 100.0 113.699 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.66 -44.35 90.68 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.186 0.929 . . . . 100.0 110.59 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.69 -42.16 98.04 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.004 0.522 . . . . 100.0 111.419 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.8 96.28 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.321 0.648 . . . . 100.0 110.803 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.73 98.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.796 0.838 . . . . 100.0 110.753 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.0 -42.07 97.28 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.016 0.526 . . . . 100.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -62.94 -43.1 99.7 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 122.82 0.448 . . . . 100.0 111.816 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -62.15 -43.17 99.43 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.529 0.731 . . . . 100.0 109.097 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.03 -44.16 97.29 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.123 1.369 . . . . 100.0 111.976 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.95 -42.14 98.78 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.606 0.762 . . . . 100.0 110.65 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.4 mt -60.93 -48.53 81.38 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.101 0.875 . . . . 100.0 109.308 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.28 -43.64 97.34 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.462 1.282 . . . . 100.0 114.462 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.55 -45.96 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.447 -3.017 0 CA-C-O 117.72 -1.133 . . . . 100.0 109.434 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.749 . . -86.38 -10.89 53.45 Favored 'General case' 0 N--CA 1.381 -3.878 1 C-N-CA 104.503 -6.879 . . . . 100.0 116.547 179.445 . . . . . . . . 4 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 1.043 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 47.3 mt-30 -53.92 -33.83 57.84 Favored 'General case' 0 CA--C 1.445 -3.085 0 C-N-CA 128.534 2.734 . . . . 100.0 107.07 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 38.92 0.51 Allowed 'General case' 0 N--CA 1.415 -2.222 0 O-C-N 124.988 1.43 . . . . 100.0 109.533 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 60.41 25.42 14.98 Favored 'General case' 0 CA--C 1.473 -2.007 0 C-N-CA 126.135 1.774 . . . . 100.0 112.409 175.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.268 . . -71.51 172.98 8.57 Favored 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.776 -3.416 . . . . 100.0 101.776 172.381 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.405 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.1 mt -54.5 -36.65 45.63 Favored Pre-proline 0 CA--C 1.49 -1.337 0 CA-C-O 116.323 -1.799 . . . . 100.0 113.711 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.032 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.448 0.3 OUTLIER -53.42 137.73 65.11 Favored 'Trans proline' 0 N--CA 1.432 -2.143 0 CA-C-O 123.528 1.387 . . . . 100.0 112.991 176.738 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.297 98.1 m-20 -63.65 -43.89 95.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 121.215 3.783 . . . . 100.0 121.215 -172.762 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.9 tm-20 -69.25 -19.0 63.93 Favored 'General case' 0 CA--C 1.465 -2.306 1 CA-C-O 130.946 5.165 . . . . 100.0 112.771 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 1.043 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.777 68.3 m-20 -83.89 -49.73 8.74 Favored 'General case' 1 N--CA 1.262 -9.825 1 CA-C-N 105.623 -5.262 . . . . 100.0 104.915 -173.383 . . . . . . . . 5 3 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.96 -26.86 68.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.038 -2.289 . . . . 100.0 106.56 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.831 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 59.5 m-20 -62.8 -40.0 96.0 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 127.044 2.138 . . . . 100.0 112.952 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.547 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.26 3.9 mm? . . . . . 0 N--CA 1.426 -1.649 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.793 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.431 -1.381 0 N-CA-C 107.19 -1.411 . . . . 100.0 107.19 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -120.26 135.22 55.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.803 -1.999 . . . . 100.0 107.612 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.74 143.67 48.66 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.933 -1.136 . . . . 100.0 107.933 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.33 120.21 34.23 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.382 -1.71 . . . . 100.0 106.382 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.76 127.42 53.99 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.036 -1.893 . . . . 100.0 106.782 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 79' ' ' TYR . 53.6 t -103.52 120.87 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.632 -1.622 . . . . 100.0 106.687 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.6 tp -109.27 117.24 33.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.218 -2.141 . . . . 100.0 105.218 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 m -128.31 161.78 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 120.931 0.396 . . . . 100.0 111.667 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.36 175.45 27.34 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 108.38 -1.888 . . . . 100.0 108.38 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -71.78 155.72 40.12 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.935 -0.744 . . . . 100.0 112.18 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.74 141.7 40.69 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 107.321 -2.311 . . . . 100.0 107.321 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.2 81.46 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-O 118.823 -0.987 . . . . 100.0 113.436 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 80.0 m -62.67 -40.37 96.86 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-N 118.608 1.204 . . . . 100.0 110.777 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.08 25.02 4.61 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.823 -1.311 . . . . 100.0 109.823 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.17 -45.22 93.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.966 1.706 . . . . 100.0 112.554 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -62.89 -44.34 96.38 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.538 1.135 . . . . 100.0 109.486 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.7 m -63.8 -40.21 96.09 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.529 1.132 . . . . 100.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 47.6 t80 -59.4 -49.32 78.25 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 124.935 1.294 . . . . 100.0 111.534 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.19 -41.64 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 123.371 0.419 . . . . 100.0 111.258 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.277 99.2 mttt -69.83 -6.87 35.38 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 115.933 1.827 . . . . 100.0 115.933 -176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.708 HH21 ' HA ' ' A' ' 157' ' ' PHE . 83.7 mtm-85 -60.78 -37.68 82.71 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.129 -1.063 . . . . 100.0 108.129 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.84 112.54 18.32 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 107.054 -1.461 . . . . 100.0 107.054 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.3 -43.78 98.02 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 115.207 1.558 . . . . 100.0 115.207 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.2 m -62.73 -42.48 99.68 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.884 -0.784 . . . . 100.0 108.884 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -42.16 99.71 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 111.061 -0.816 . . . . 100.0 111.061 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.75 -44.95 91.99 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.873 0.869 . . . . 100.0 110.883 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -63.63 -39.72 95.06 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 123.601 0.76 . . . . 100.0 113.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -89.91 5.92 44.25 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -57.32 138.35 54.95 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 114.546 1.313 . . . . 100.0 114.546 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -124.61 130.35 52.28 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.702 -1.222 . . . . 100.0 107.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -100.77 123.27 44.73 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.233 -2.136 . . . . 100.0 105.233 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -102.85 114.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 103.37 -2.826 . . . . 100.0 103.37 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.03 94.94 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 115.393 1.627 . . . . 100.0 115.393 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.1 p -61.93 -48.36 80.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.665 0.386 . . . . 100.0 111.965 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.18 -38.41 75.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.307 1.443 . . . . 100.0 112.982 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.95 32.23 50.26 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 108.112 -1.995 . . . . 100.0 108.112 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 79' ' ' TYR . 22.9 m -129.01 153.17 38.22 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 121.629 0.728 . . . . 100.0 109.672 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.45 120.22 41.84 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 103.074 -2.935 . . . . 100.0 103.074 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.6 123.04 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 106.567 -1.642 . . . . 100.0 106.567 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -117.78 119.43 33.94 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.78 106.51 1.82 Allowed 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.123 1.882 . . . . 100.0 110.229 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.69 117.29 31.65 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.685 -1.598 . . . . 100.0 106.685 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 t -102.86 126.68 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.66 -1.237 . . . . 100.0 107.66 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -121.33 133.49 55.12 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.639 -1.985 . . . . 100.0 105.639 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -101.28 120.28 40.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.715 -1.217 . . . . 100.0 107.715 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.447 HG21 HD12 ' A' ' 59' ' ' ILE . 26.6 p -110.54 -179.26 3.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.05 -0.977 . . . . 100.0 110.894 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.77 -44.25 93.97 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.334 1.454 . . . . 100.0 108.294 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -67.04 -39.26 86.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 124.062 0.945 . . . . 100.0 113.052 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.69 28.83 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 107.381 -2.288 . . . . 100.0 107.381 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.08 137.92 50.1 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.117 1.878 . . . . 100.0 114.647 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -125.05 130.29 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.26 -3.237 . . . . 100.0 102.26 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.01 128.13 55.75 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.749 -0.834 . . . . 100.0 108.749 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.44 116.41 31.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.172 -2.529 . . . . 100.0 104.172 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -87.8 106.05 17.81 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.25 -4.352 . . . . 100.0 99.25 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.29 122.76 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.05 115.89 29.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.339 -2.097 . . . . 100.0 105.339 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -112.46 136.32 52.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.605 -1.998 . . . . 100.0 105.605 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 p -71.96 162.29 29.67 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.76 0.824 . . . . 100.0 112.86 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.74 17.29 16.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.694 -0.684 . . . . 100.0 109.687 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.08 11.64 52.04 Favored Glycine 0 C--N 1.357 1.732 0 O-C-N 121.804 -0.56 . . . . 100.0 112.328 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.27 -29.32 70.34 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.836 1.654 . . . . 100.0 111.385 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.66 -37.23 78.18 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 127.794 2.438 . . . . 100.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.93 -43.12 99.66 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.326 0.65 . . . . 100.0 110.025 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.18 -41.35 77.3 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 125.458 1.503 . . . . 100.0 111.972 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.34 -152.12 12.32 Favored Glycine 0 C--N 1.356 1.665 0 C-N-CA 120.996 -0.621 . . . . 100.0 111.57 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.26 169.58 52.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 122.069 0.816 . . . . 100.0 112.931 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 79' ' ' TYR . 88.6 mt -105.68 143.49 33.76 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.708 -0.746 . . . . 100.0 109.767 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -67.67 155.48 39.12 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.735 -1.12 . . . . 100.0 113.616 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -60.47 -37.68 81.78 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.827 -1.533 . . . . 100.0 110.328 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.78 -39.21 93.43 Favored Glycine 0 C--N 1.358 1.778 0 C-N-CA 124.846 1.213 . . . . 100.0 111.316 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 45' ' ' VAL . 60.8 t80 -62.53 -45.99 90.46 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.422 0.689 . . . . 100.0 110.895 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -68.94 -36.67 78.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.3 mt -50.85 135.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 C-N-CA 125.57 1.548 . . . . 100.0 114.297 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.62 30.29 18.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.104 2.562 . . . . 100.0 114.015 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.66 128.66 36.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.26 -1.756 . . . . 100.0 106.26 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 115' ' ' ILE . 97.3 mm-40 -96.47 -35.35 11.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.3 p -143.76 159.27 42.81 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 120.899 0.381 . . . . 100.0 111.133 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.8 149.57 34.59 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 114.37 1.248 . . . . 100.0 114.37 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.9 mt -125.5 125.75 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.429 ' HB ' HD22 ' A' ' 119' ' ' LEU . 52.0 mt -110.66 123.71 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 102.419 -3.178 . . . . 100.0 102.419 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.417 ' SD ' HD11 ' A' ' 15' ' ' LEU . 81.3 mtp -109.68 134.08 52.39 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 114.144 -1.389 . . . . 100.0 113.602 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -128.18 158.82 37.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 112.555 -2.112 . . . . 100.0 108.433 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.51 125.75 50.97 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.41 -21.6 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 113.797 1.036 . . . . 100.0 113.797 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.7 p -86.65 -10.16 54.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 119.241 -0.409 . . . . 100.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.6 t -118.49 116.39 26.57 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.136 0.969 . . . . 100.0 111.401 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -66.5 -38.38 87.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.892 -1.049 . . . . 100.0 111.079 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.56 -41.75 88.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 125.661 1.584 . . . . 100.0 110.55 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -62.36 -42.8 99.69 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 109.792 -0.448 . . . . 100.0 109.792 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.522 ' CE1' HG23 ' A' ' 136' ' ' ILE . 44.5 t80 -64.11 -41.04 97.41 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 123.714 0.805 . . . . 100.0 110.703 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -61.14 -37.86 84.34 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.958 0.903 . . . . 100.0 111.311 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.65 -9.0 58.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.12 -43.26 93.52 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 115.997 -1.954 . . . . 100.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.4 Cg_exo -57.57 -38.57 93.31 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.158 1.905 . . . . 100.0 112.742 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -64.25 -44.45 91.74 Favored 'General case' 0 C--N 1.358 0.978 0 O-C-N 124.186 0.929 . . . . 100.0 111.443 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -63.88 -41.22 97.79 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 122.744 0.418 . . . . 100.0 110.995 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.5 t60 -62.43 -43.83 97.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.43 1.092 . . . . 100.0 109.932 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.8 -45.34 94.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 123.577 0.751 . . . . 100.0 111.351 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -62.89 -44.82 95.07 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.06 0.544 . . . . 100.0 111.774 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 86' ' ' ALA . 50.8 tp -63.23 -46.03 88.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.548 1.139 . . . . 100.0 112.31 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.36 -37.69 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 125.593 1.557 . . . . 100.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.5 -49.14 78.45 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.649 -0.691 . . . . 100.0 110.183 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.5 t -73.07 -46.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 119.227 -0.989 . . . . 100.0 111.956 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -124.78 113.8 18.41 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 121.641 0.734 . . . . 100.0 110.177 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.64 146.6 23.54 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.466 -0.788 . . . . 100.0 112.142 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 54.72 44.44 28.54 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 126.463 1.905 . . . . 100.0 115.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' GLN . 27.9 mm -98.89 133.21 22.5 Favored Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 126.42 1.888 . . . . 100.0 107.376 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 115' ' ' ILE . 40.5 Cg_exo -62.96 129.02 24.59 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.86 2.373 . . . . 100.0 108.457 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.701 ' HB ' HD22 ' A' ' 144' ' ' LEU . 68.7 mt -131.05 137.58 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 122.292 1.044 . . . . 100.0 108.287 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 160' ' ' PRO . 93.6 t -115.74 131.83 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.145 -2.168 . . . . 100.0 105.145 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 28.8 mt -105.61 125.54 51.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.869 -2.641 . . . . 100.0 103.869 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -113.86 126.74 55.52 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.85 -1.523 . . . . 100.0 112.203 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.01 103.42 2.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 105.162 -3.175 . . . . 100.0 105.162 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.58 165.76 19.8 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.789 1.636 . . . . 100.0 112.53 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 21' ' ' THR . 85.0 mttt 59.42 43.38 16.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 128.541 2.736 . . . . 100.0 114.541 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.313 30.9 m -72.23 -8.8 12.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 C-N-CA 120.526 -0.47 . . . . 100.0 111.231 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.58 -38.3 87.05 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.968 2.107 . . . . 100.0 110.117 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.59 130.79 33.85 Favored 'Isoleucine or valine' 0 C--N 1.363 1.168 0 N-CA-C 107.221 -1.4 . . . . 100.0 107.221 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.14 -40.95 99.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 125.32 1.448 . . . . 100.0 114.357 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.74 91.07 8.2 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.262 -1.385 . . . . 100.0 107.262 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -94.85 120.6 35.34 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.087 -2.561 . . . . 100.0 104.087 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -96.15 -37.22 10.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.324 -0.853 . . . . 100.0 112.876 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 136' ' ' ILE . 45.4 t -104.01 105.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 102.573 -3.121 . . . . 100.0 102.573 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -104.68 178.83 4.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 113.665 0.987 . . . . 100.0 113.665 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.4 -35.33 71.87 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.308 2.243 . . . . 100.0 109.402 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.062 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.7 mttt -59.42 -37.81 79.03 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.989 2.516 . . . . 100.0 112.32 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.5 p -104.73 -1.29 26.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 120.106 3.373 . . . . 100.0 120.106 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.62 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 49.8 mt -96.6 91.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 115.779 -2.368 . . . . 100.0 111.736 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.413 ' N ' ' HB3' ' A' ' 211' ' ' ASP . 4.9 p -97.54 -7.98 9.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 115.767 1.766 . . . . 100.0 115.767 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.91 -36.2 72.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.01 1.485 . . . . 100.0 115.01 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.493 ' HE1' ' HB2' ' A' ' 119' ' ' LEU . 83.9 m-70 -59.87 -40.65 89.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 116.946 -1.502 . . . . 100.0 114.123 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 25.9 ttt180 -61.32 -45.42 94.51 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 119.971 1.259 . . . . 100.0 112.629 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.56 -41.9 98.05 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.387 1.075 . . . . 100.0 110.862 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.23 2.28 48.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 115.875 1.806 . . . . 100.0 115.875 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.67 44.5 26.32 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.777 1.631 . . . . 100.0 113.305 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 117' ' ' ILE . 28.5 mt -106.96 152.19 24.29 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.781 -1.563 . . . . 100.0 106.781 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.336 90.6 mm-40 -101.43 145.71 28.59 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 113.474 0.916 . . . . 100.0 113.474 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.486 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.8 t80 -105.09 133.91 49.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 113.921 1.082 . . . . 100.0 113.921 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.12 133.35 46.58 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.048 -1.433 . . . . 100.0 111.172 173.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.279 36.9 m-20 -84.76 121.54 27.83 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.176 -3.268 . . . . 100.0 102.176 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.42 155.42 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 122.381 1.086 . . . . 100.0 110.613 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.2 m -137.31 111.36 8.35 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 105.908 -1.886 . . . . 100.0 105.908 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.57 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.44 -43.91 97.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.187 -1.369 . . . . 100.0 112.664 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.79 -42.31 98.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.377 1.071 . . . . 100.0 112.508 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 97.4 p -97.04 1.41 50.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.597 2.073 . . . . 100.0 116.597 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.0 m-80 64.03 24.58 13.59 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.223 1.409 . . . . 100.0 110.524 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 75.7 t80 -75.01 125.71 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.133 -1.062 . . . . 100.0 108.133 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 53.55 40.04 30.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.232 2.613 . . . . 100.0 115.404 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HA ' HH21 ' A' ' 29' ' ' ARG . 67.3 t80 -61.77 -44.0 97.75 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.827 -0.546 . . . . 100.0 111.248 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 -39.65 95.04 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 116.374 1.99 . . . . 100.0 116.374 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.57 -47.94 97.83 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 121.035 3.717 . . . . 100.0 121.035 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' HG11 ' A' ' 118' ' ' VAL . 52.9 Cg_endo -61.35 -41.9 38.26 Favored 'Trans proline' 0 C--N 1.371 1.733 0 CA-C-N 123.586 2.316 . . . . 100.0 112.437 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -64.52 -42.52 95.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.922 1.289 . . . . 100.0 110.799 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.8 tp -63.1 -45.19 93.21 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.241 1.017 . . . . 100.0 111.327 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.36 -44.65 94.2 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.684 -0.488 . . . . 100.0 109.684 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.9 mt -61.79 -44.49 96.76 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.062 0.545 . . . . 100.0 111.474 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.67 98.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.966 0.907 . . . . 100.0 111.228 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.13 -45.99 91.02 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 123.341 0.656 . . . . 100.0 111.542 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.38 -42.92 87.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.293 0.849 . . . . 100.0 113.293 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.8 mt -63.72 -45.65 88.96 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.632 0.773 . . . . 100.0 112.032 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.432 HD12 HD22 ' A' ' 174' ' ' LEU . 71.6 mt -69.97 -39.16 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.11 0.564 . . . . 100.0 109.552 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.07 10.64 58.38 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 110.411 -1.076 . . . . 100.0 110.411 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -114.07 112.82 46.92 Favored Pre-proline 0 C--N 1.361 1.107 0 N-CA-C 107.57 -1.27 . . . . 100.0 107.57 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.061 3.174 . . . . 100.0 113.992 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -87.96 2.12 52.44 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 123.979 0.912 . . . . 100.0 113.114 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.432 HD22 HD12 ' A' ' 169' ' ' ILE . 17.0 tp -66.07 132.16 47.88 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.324 0.65 . . . . 100.0 109.355 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -134.44 151.36 51.12 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.15 113.61 23.94 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 104.195 -2.52 . . . . 100.0 104.195 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.02 -43.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 123.594 0.758 . . . . 100.0 110.293 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.48 149.02 51.43 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.451 0.643 . . . . 100.0 109.839 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -92.61 125.95 53.88 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.093 -2.188 . . . . 100.0 105.093 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.17 158.16 53.58 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.076 2.517 . . . . 100.0 111.458 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.77 126.9 29.11 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.146 0.974 . . . . 100.0 108.884 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.25 145.9 46.59 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-N 114.014 -1.448 . . . . 100.0 109.971 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.29 138.02 97.3 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 64.9 Cg_exo -55.95 139.71 84.91 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 123.67 2.913 . . . . 100.0 113.021 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.561 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -57.68 129.44 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 123.206 2.604 . . . . 100.0 113.028 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -68.36 -43.18 77.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 124.742 1.276 . . . . 100.0 108.122 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.9 158.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.351 -1.722 . . . . 100.0 106.351 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.68 130.6 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 106.208 -1.775 . . . . 100.0 106.208 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.24 127.54 35.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.749 -2.315 . . . . 100.0 104.749 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.73 128.14 91.39 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 114.493 -1.231 . . . . 100.0 110.295 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.6 -37.4 88.56 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.772 2.981 . . . . 100.0 113.001 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.18 94.14 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 124.257 0.973 . . . . 100.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.38 -42.28 98.83 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 122.817 0.447 . . . . 100.0 111.633 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.25 97.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.125 0.57 . . . . 100.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.54 98.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.943 0.897 . . . . 100.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -44.27 96.55 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.183 0.993 . . . . 100.0 112.405 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -63.4 -44.1 95.64 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 122.71 0.404 . . . . 100.0 111.073 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -64.5 -39.89 94.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.107 -0.497 . . . . 100.0 110.57 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.31 -43.85 97.88 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.95 1.3 . . . . 100.0 110.524 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.93 -42.89 99.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 123.955 0.902 . . . . 100.0 110.144 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 22.6 tp -59.9 -48.65 80.82 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.222 0.951 . . . . 100.0 109.951 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -43.36 99.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.999 1.481 . . . . 100.0 114.999 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.0 -47.09 91.04 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.217 0 CA-C-O 118.245 -0.883 . . . . 100.0 109.544 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.406 . . -95.66 0.91 53.25 Favored 'General case' 0 N--CA 1.402 -2.847 1 C-N-CA 109.729 -4.789 . . . . 100.0 114.685 179.573 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.329 19.5 mt-30 -56.78 -36.35 69.74 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 106.246 -1.761 . . . . 100.0 106.246 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 64.9 p -82.25 52.04 1.93 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.091 0.948 . . . . 100.0 108.779 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.296 73.9 p 49.25 37.69 11.85 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 129.002 2.921 . . . . 100.0 116.157 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.86 -179.78 7.54 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.286 -2.486 . . . . 100.0 104.286 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' A' ' 210' ' ' PRO 0.439 3.7 pp -57.44 -38.73 70.99 Favored Pre-proline 0 CA--C 1.501 -0.941 0 CA-C-O 115.523 -2.18 . . . . 100.0 115.886 -175.435 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.062 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.312 79.0 Cg_exo -54.88 136.47 72.35 Favored 'Trans proline' 0 C--N 1.375 1.971 0 CA-C-N 121.839 1.692 . . . . 100.0 111.417 176.43 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.413 ' HB3' ' N ' ' A' ' 137' ' ' VAL . 96.0 m-20 -63.46 -47.86 80.1 Favored 'General case' 0 N--CA 1.424 -1.771 1 N-CA-C 124.784 5.105 . . . . 100.0 124.784 -173.533 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.251 99.3 mt-10 -62.88 -35.56 80.42 Favored 'General case' 0 CA--C 1.48 -1.732 1 CA-C-O 128.621 4.057 . . . . 100.0 107.84 177.889 . . . . . . . . 4 3 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.779 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.49 39.2 m-20 -64.93 -49.03 71.97 Favored 'General case' 1 N--CA 1.354 -5.251 1 CA-C-N 107.796 -4.274 . . . . 100.0 106.297 -178.903 . . . . . . . . 5 3 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.12 -31.23 71.67 Favored 'General case' 0 C--N 1.36 1.033 0 O-C-N 120.535 -1.353 . . . . 100.0 107.682 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 1.8 t70 -57.63 -42.77 84.06 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 116.926 -1.512 . . . . 100.0 113.295 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.261 1.701 0 CA-C-O 115.558 -2.163 . . . . 100.0 112.6 -176.913 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 105.682 -1.97 . . . . 100.0 105.682 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -123.58 136.16 54.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.762 -1.563 . . . . 100.0 108.752 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.34 144.32 50.08 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.243 -1.021 . . . . 100.0 108.243 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.28 121.03 35.38 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.433 -1.692 . . . . 100.0 106.433 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -109.52 127.73 54.67 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 113.062 -1.881 . . . . 100.0 106.326 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 79' ' ' TYR . 49.9 t -102.96 121.09 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 106.572 -1.64 . . . . 100.0 106.572 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.619 HD11 ' SD ' ' A' ' 89' ' ' MET . 29.9 tp -109.88 117.08 32.87 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.618 -2.364 . . . . 100.0 104.618 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -127.93 161.98 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 120.718 0.294 . . . . 100.0 111.528 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.22 175.0 26.7 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 108.875 -1.69 . . . . 100.0 108.875 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.03 156.27 39.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 O-C-N 121.832 -0.804 . . . . 100.0 112.092 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.93 141.38 39.77 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 106.984 -2.446 . . . . 100.0 106.984 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.66 -5.96 79.94 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-O 118.773 -1.015 . . . . 100.0 113.404 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -62.68 -39.87 95.29 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 118.804 1.302 . . . . 100.0 111.307 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.87 25.72 4.4 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.743 -1.343 . . . . 100.0 109.743 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 52.9 mtpt -60.01 -46.79 88.32 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.362 1.465 . . . . 100.0 112.883 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.7 m -63.82 -43.06 97.36 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.408 1.083 . . . . 100.0 109.644 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 m -63.3 -41.4 98.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.483 1.113 . . . . 100.0 109.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HA ' HH11 ' A' ' 29' ' ' ARG . 45.1 t80 -60.09 -49.11 78.93 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 123.626 0.77 . . . . 100.0 112.749 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.77 -41.05 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 123.739 0.649 . . . . 100.0 110.958 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.266 99.0 mttt -69.06 -7.57 36.99 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 115.826 1.787 . . . . 100.0 115.826 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.6 mtm-85 -61.04 -36.91 80.82 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 108.691 -0.855 . . . . 100.0 108.691 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 55.1 t-80 -80.34 112.23 17.47 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.4 -43.9 97.72 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 115.361 1.615 . . . . 100.0 115.361 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.442 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.9 m -63.09 -42.22 99.55 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.888 -0.782 . . . . 100.0 108.888 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.47 99.78 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 111.383 -0.687 . . . . 100.0 111.383 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.64 -44.19 94.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.29 0.636 . . . . 100.0 110.836 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -63.83 -40.58 96.94 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 124.463 1.105 . . . . 100.0 112.295 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -91.14 8.56 35.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -59.18 140.36 55.99 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 114.649 1.352 . . . . 100.0 114.649 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.24 130.6 52.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.169 -1.419 . . . . 100.0 107.169 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -104.47 125.13 50.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 106.766 -1.568 . . . . 100.0 106.766 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.16 113.54 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 102.199 -3.26 . . . . 100.0 102.199 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.51 92.42 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 116.228 1.936 . . . . 100.0 116.228 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.2 p -62.58 -47.42 83.89 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.916 0.486 . . . . 100.0 111.784 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.06 -37.74 75.6 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.899 1.28 . . . . 100.0 112.912 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.36 53.91 Favored Glycine 0 C--N 1.359 1.837 0 N-CA-C 106.71 -2.556 . . . . 100.0 106.71 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 ' HD1' ' A' ' 79' ' ' TYR . 66.9 t -124.43 139.59 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 124.733 1.213 . . . . 100.0 108.754 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.74 117.02 32.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 102.387 -3.19 . . . . 100.0 102.387 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.06 122.1 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.065 -1.458 . . . . 100.0 107.065 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -115.17 121.05 35.66 Favored Pre-proline 0 N--CA 1.432 -1.337 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.105 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -80.13 104.57 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.426 2.084 . . . . 100.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.7 117.07 30.24 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.931 -1.507 . . . . 100.0 106.931 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.52 125.77 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.406 -1.331 . . . . 100.0 107.406 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.45 133.12 55.46 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.851 -1.907 . . . . 100.0 105.851 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -99.67 116.42 31.73 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 19.0 p -108.49 178.63 4.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.434 -0.803 . . . . 100.0 110.846 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -59.87 -43.6 94.62 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.99 1.316 . . . . 100.0 108.427 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -68.99 -38.37 79.26 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 112.839 0.681 . . . . 100.0 112.839 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.96 -172.38 30.61 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.642 -1.783 . . . . 100.0 108.642 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -65.52 136.87 48.26 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.518 2.145 . . . . 100.0 114.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 77.7 mt -126.15 130.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 102.111 -3.292 . . . . 100.0 102.111 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.85 128.44 55.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.617 -0.883 . . . . 100.0 108.617 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.37 114.79 28.18 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.557 -2.757 . . . . 100.0 103.557 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -87.75 105.7 17.56 Favored 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 99.862 -4.125 . . . . 100.0 99.862 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.76 123.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.448 -1.686 . . . . 100.0 106.448 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -96.84 114.7 26.35 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.878 -1.897 . . . . 100.0 105.878 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.61 137.25 49.72 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.328 -1.731 . . . . 100.0 106.328 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -72.97 161.94 30.09 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.731 0.777 . . . . 100.0 112.487 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.1 19.47 14.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.668 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.47 13.19 52.29 Favored Glycine 0 C--N 1.356 1.681 0 O-C-N 121.818 -0.552 . . . . 100.0 112.277 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 65.3 mt-30 -60.44 -35.8 76.71 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.52 1.928 . . . . 100.0 111.583 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -58.26 -36.01 72.61 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.13 2.572 . . . . 100.0 111.869 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.84 -42.4 98.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.604 0.762 . . . . 100.0 111.041 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 26.7 p90 -95.37 -5.85 42.36 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.85 -166.69 38.08 Favored Glycine 0 C--N 1.358 1.756 0 C-N-CA 119.7 -1.238 . . . . 100.0 113.251 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.68 175.27 54.9 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.97 -1.252 . . . . 100.0 109.97 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.7 mt -105.14 140.65 37.99 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 122.18 0.99 . . . . 100.0 110.465 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -68.7 154.64 41.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.676 -1.602 . . . . 100.0 113.602 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.95 -38.31 85.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.531 1.533 . . . . 100.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.04 93.85 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.854 1.216 . . . . 100.0 111.063 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HD1' HG21 ' A' ' 45' ' ' VAL . 63.0 t80 -62.23 -46.98 86.45 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.697 0.799 . . . . 100.0 110.866 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 116.298 1.962 . . . . 100.0 116.298 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.3 mt -51.84 136.58 11.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 C-N-CA 125.04 1.336 . . . . 100.0 113.973 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 61.89 31.78 18.13 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.749 2.42 . . . . 100.0 114.706 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.87 128.44 35.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 105.595 -2.002 . . . . 100.0 105.595 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 115' ' ' ILE . 95.9 mm-40 -96.78 -36.82 10.51 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.554 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.6 p -143.52 159.97 41.45 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.776 0.431 . . . . 100.0 110.842 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -146.23 149.17 33.41 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 15' ' ' LEU . 91.7 mt -125.65 126.15 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 103.678 -2.712 . . . . 100.0 103.678 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.98 124.26 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 101.762 -3.422 . . . . 100.0 101.762 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 15' ' ' LEU . 95.1 mtp -109.16 131.64 54.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.005 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -129.25 159.43 36.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.155 -1.838 . . . . 100.0 108.434 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -106.4 126.95 52.89 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.46 -1.681 . . . . 100.0 106.46 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.65 -21.41 29.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 113.849 1.055 . . . . 100.0 113.849 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.0 p -85.12 -12.19 53.46 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 119.239 -0.41 . . . . 100.0 110.579 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -118.76 117.29 28.5 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.337 1.065 . . . . 100.0 111.427 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -66.51 -38.87 88.16 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.424 -1.262 . . . . 100.0 110.434 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.66 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 126.071 1.749 . . . . 100.0 110.856 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.8 m -62.71 -42.67 99.77 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.655 -0.498 . . . . 100.0 109.655 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CE1' HG23 ' A' ' 136' ' ' ILE . 43.6 t80 -64.15 -40.28 95.81 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 123.452 0.701 . . . . 100.0 110.884 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -60.79 -38.77 86.44 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.546 1.139 . . . . 100.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.38 -9.38 58.6 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 115.182 1.549 . . . . 100.0 115.182 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.3 t -60.06 -42.98 92.99 Favored Pre-proline 0 C--N 1.363 1.194 0 CA-C-O 115.884 -2.007 . . . . 100.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 82.0 Cg_exo -57.78 -36.83 98.16 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.309 2.006 . . . . 100.0 112.852 177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.44 -46.93 84.05 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 124.355 1.062 . . . . 100.0 110.28 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -64.24 -42.08 96.69 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.162 0.585 . . . . 100.0 111.271 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.58 -44.25 96.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 124.326 1.05 . . . . 100.0 110.39 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -62.76 -44.38 96.35 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.759 -0.639 . . . . 100.0 112.031 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.34 -44.28 96.85 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 123.526 0.516 . . . . 100.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.1 tp -62.45 -46.8 86.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.684 1.193 . . . . 100.0 112.577 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.32 -38.97 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 125.364 1.465 . . . . 100.0 111.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.37 -46.66 89.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 118.938 -0.553 . . . . 100.0 110.714 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.9 t -72.03 -45.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 120.254 -0.578 . . . . 100.0 111.534 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.81 115.65 18.97 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.249 -0.648 . . . . 100.0 109.249 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -93.29 147.3 23.04 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 115.771 -0.649 . . . . 100.0 112.492 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 54.55 44.55 28.55 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.436 1.895 . . . . 100.0 115.183 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 84' ' ' GLN . 33.9 mm -98.96 132.36 23.77 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 126.116 1.766 . . . . 100.0 107.066 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.49 129.25 25.99 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.536 2.158 . . . . 100.0 109.144 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.717 ' HB ' HD22 ' A' ' 144' ' ' LEU . 71.0 mt -130.71 136.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-O 122.257 1.027 . . . . 100.0 108.689 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.4 130.8 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 105.062 -2.199 . . . . 100.0 105.062 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.9 mt -105.25 127.07 52.76 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.136 -2.912 . . . . 100.0 103.136 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.83 127.21 54.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.642 -1.617 . . . . 100.0 112.061 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.58 105.26 3.06 Favored Glycine 0 CA--C 1.489 -1.558 0 N-CA-C 106.427 -2.669 . . . . 100.0 106.427 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.14 164.25 23.48 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.2 2.6 . . . . 100.0 113.935 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.2 mttp 55.62 45.15 25.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 128.46 2.704 . . . . 100.0 114.367 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.296 32.8 m -71.82 -9.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 120.4 -0.52 . . . . 100.0 111.062 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.65 -39.1 90.15 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.658 1.983 . . . . 100.0 110.287 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.4 130.87 33.75 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.381 -0.97 . . . . 100.0 108.381 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -62.34 -40.54 96.7 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.937 1.458 . . . . 100.0 114.937 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -84.02 96.08 8.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 105.282 -2.118 . . . . 100.0 105.282 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -102.37 120.91 41.29 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 103.621 -2.733 . . . . 100.0 103.621 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.87 -36.51 10.57 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-N 115.612 -0.722 . . . . 100.0 112.528 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.32 104.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 103.534 -2.765 . . . . 100.0 103.534 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.23 179.95 4.13 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.21 -35.2 71.31 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.336 2.254 . . . . 100.0 109.539 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.076 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.4 mttt -59.29 -37.62 78.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 128.41 2.684 . . . . 100.0 112.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.6 p -104.99 -0.85 26.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 120.091 3.367 . . . . 100.0 120.091 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 53.8 mt -97.38 94.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 115.583 -2.447 . . . . 100.0 111.431 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 4.3 p -100.82 -5.32 9.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 115.338 1.606 . . . . 100.0 115.338 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.58 -36.55 74.15 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 115.199 1.555 . . . . 100.0 115.199 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.651 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 70.1 m80 -59.54 -39.25 83.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.814 1.646 . . . . 100.0 113.344 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.648 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 57.3 ttp85 -58.69 -48.5 80.88 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 114.031 1.123 . . . . 100.0 114.031 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.52 -40.59 95.91 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.218 0.949 . . . . 100.0 111.812 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.01 -0.1 54.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 116.157 1.91 . . . . 100.0 116.157 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.258 73.2 m-20 54.55 47.13 23.39 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.378 1.471 . . . . 100.0 113.346 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.7 mt -103.62 153.39 20.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.115 -1.809 . . . . 100.0 106.115 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -101.53 142.96 32.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.3 -0.63 . . . . 100.0 109.3 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.651 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 68.2 t80 -105.79 133.63 50.21 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.4 0.889 . . . . 100.0 113.4 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.82 133.4 45.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.575 -1.193 . . . . 100.0 111.491 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.297 37.1 m-20 -85.64 122.97 30.49 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 102.234 -3.247 . . . . 100.0 102.234 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.32 156.89 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 CA-C-O 122.364 1.078 . . . . 100.0 112.237 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.1 m -138.88 113.19 8.8 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.244 -1.761 . . . . 100.0 106.244 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.3 -43.06 98.91 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.836 -1.529 . . . . 100.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.22 -42.15 99.04 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.667 1.187 . . . . 100.0 112.375 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.8 p -97.25 2.12 50.45 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 117.3 2.333 . . . . 100.0 117.3 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.49 21.25 11.8 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.583 1.153 . . . . 100.0 110.113 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 85.8 t80 -73.58 124.48 26.0 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.038 -0.727 . . . . 100.0 109.038 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 53.32 40.1 30.8 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.12 2.568 . . . . 100.0 115.175 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.9 t80 -62.25 -44.46 96.51 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 121.638 -0.664 . . . . 100.0 111.529 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.33 -38.49 91.37 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.117 1.895 . . . . 100.0 116.117 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.53 -47.24 99.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 119.999 3.333 . . . . 100.0 119.999 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.07 -41.95 39.95 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.34 2.229 . . . . 100.0 111.334 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.45 -42.29 96.04 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 125.466 1.506 . . . . 100.0 110.884 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -61.14 -46.76 89.21 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 123.885 0.874 . . . . 100.0 112.002 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -63.67 -44.61 93.26 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.082 0.864 . . . . 100.0 110.421 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.8 mt -61.92 -44.85 95.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 123.797 0.686 . . . . 100.0 111.729 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.7 98.26 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.174 0.99 . . . . 100.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.57 -45.71 91.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.564 0.745 . . . . 100.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -68.11 -42.4 80.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.543 0.527 . . . . 100.0 112.354 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.67 -46.96 85.74 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.469 0.708 . . . . 100.0 112.316 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.43 -38.59 74.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 123.546 0.738 . . . . 100.0 110.318 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.46 59.49 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-O 118.781 -1.01 . . . . 100.0 111.053 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -111.5 113.64 53.36 Favored Pre-proline 0 C--N 1.362 1.133 0 N-CA-C 107.492 -1.299 . . . . 100.0 107.492 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.57 -15.19 30.67 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.051 3.167 . . . . 100.0 114.282 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -89.73 2.82 54.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.993 0.917 . . . . 100.0 113.276 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.05 131.44 46.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.51 0.671 . . . . 100.0 109.663 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -133.83 152.94 52.02 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.358 -0.979 . . . . 100.0 108.358 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -90.35 114.29 26.34 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 104.314 -2.476 . . . . 100.0 104.314 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.54 -44.29 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.283 1.033 . . . . 100.0 110.55 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -127.86 148.01 50.46 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.373 0.606 . . . . 100.0 109.697 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 62.5 ttp -90.18 126.23 57.61 Favored Pre-proline 0 N--CA 1.432 -1.339 0 N-CA-C 104.772 -2.307 . . . . 100.0 104.772 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.68 158.1 55.23 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.869 2.379 . . . . 100.0 110.632 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.5 126.04 26.21 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.286 -1.005 . . . . 100.0 108.286 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.51 146.63 46.09 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 114.176 -1.375 . . . . 100.0 110.164 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 137.29 97.08 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 106.832 -1.544 . . . . 100.0 106.832 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -55.98 138.51 82.54 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.534 2.823 . . . . 100.0 112.569 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.68 130.25 32.53 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.738 2.292 . . . . 100.0 113.609 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.83 -44.36 81.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 124.858 1.349 . . . . 100.0 108.579 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.32 159.04 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.498 -1.667 . . . . 100.0 106.498 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.66 131.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.641 -1.985 . . . . 100.0 105.641 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -86.29 128.12 34.87 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 104.774 -2.306 . . . . 100.0 104.774 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -62.21 128.09 90.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 CA-C-N 114.911 -1.04 . . . . 100.0 109.738 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.53 -36.68 92.44 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.474 2.783 . . . . 100.0 112.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.37 92.22 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.33 1.019 . . . . 100.0 110.766 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.29 -41.89 96.66 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 122.971 0.508 . . . . 100.0 111.493 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.56 96.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 123.63 0.772 . . . . 100.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.8 97.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.293 1.037 . . . . 100.0 110.847 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.09 -43.98 97.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.632 0.773 . . . . 100.0 112.306 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -63.69 -43.7 95.85 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 122.534 0.333 . . . . 100.0 111.712 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -64.2 -39.93 95.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.601 0.36 . . . . 100.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.06 -42.83 99.78 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.625 1.17 . . . . 100.0 110.57 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.95 -42.41 99.09 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.968 0.907 . . . . 100.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 18.3 tp -59.69 -49.52 77.42 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 124.117 0.886 . . . . 100.0 110.089 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.22 -43.24 98.66 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 115.188 1.551 . . . . 100.0 115.188 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.61 -46.53 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.175 0 CA-C-O 118.425 -0.798 . . . . 100.0 109.984 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.681 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.403 . . -93.59 -0.63 56.13 Favored 'General case' 0 N--CA 1.403 -2.818 1 C-N-CA 109.854 -4.739 . . . . 100.0 114.006 179.76 . . . . . . . . 4 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.823 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.268 57.7 mt-30 -56.9 -35.77 69.36 Favored 'General case' 0 CA--C 1.458 -2.566 0 N-CA-C 107.523 -1.288 . . . . 100.0 107.523 178.418 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -82.74 53.87 2.51 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.403 1.097 . . . . 100.0 108.886 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.312 73.1 p 48.84 38.37 11.88 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 129.477 3.111 . . . . 100.0 116.281 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 204' ' ' ALA . . . -83.13 -178.02 6.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.511 -2.404 . . . . 100.0 104.511 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 83.0 mt -56.31 -41.53 91.56 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-O 115.885 -2.007 . . . . 100.0 114.788 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.076 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.325 32.4 Cg_exo -55.17 137.21 76.25 Favored 'Trans proline' 0 C--N 1.373 1.826 0 CA-C-N 121.406 1.538 . . . . 100.0 112.427 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.6 m-20 -63.57 -47.45 81.49 Favored 'General case' 0 N--CA 1.427 -1.614 1 N-CA-C 124.764 5.098 . . . . 100.0 124.764 -173.805 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.665 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.13 -35.36 80.02 Favored 'General case' 0 CA--C 1.48 -1.746 1 CA-C-O 128.51 4.005 . . . . 100.0 108.045 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.481 44.0 m-20 -65.74 -48.74 70.89 Favored 'General case' 1 N--CA 1.351 -5.385 2 CA-C-N 107.446 -4.434 . . . . 100.0 106.389 -179.093 . . . . . . . . 5 3 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.46 -29.43 70.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.499 -1.375 . . . . 100.0 107.889 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.665 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.0 OUTLIER -58.51 -43.74 89.24 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-O 117.021 -1.466 . . . . 100.0 113.442 176.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.467 HD13 ' HG2' ' A' ' 205' ' ' GLN . 3.4 mp . . . . . 0 C--O 1.26 1.632 0 CA-C-O 114.514 -2.66 . . . . 100.0 113.227 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -124.4 138.0 54.4 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.884 -1.507 . . . . 100.0 108.261 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.59 144.15 50.31 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.099 -1.075 . . . . 100.0 108.099 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.24 120.34 35.29 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.73 128.36 54.8 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 113.442 -1.708 . . . . 100.0 106.83 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.4 t -104.51 121.05 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 N-CA-C 107.01 -1.478 . . . . 100.0 107.01 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 31.0 tp -110.48 115.59 29.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.54 161.96 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 115.379 -0.828 . . . . 100.0 111.881 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.68 176.7 30.02 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.008 -2.037 . . . . 100.0 108.008 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -72.1 156.4 39.23 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.831 0.824 . . . . 100.0 111.479 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.96 140.66 38.42 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.1 -5.49 78.57 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-O 118.453 -1.193 . . . . 100.0 113.696 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.1 m -62.2 -39.91 94.32 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 119.064 1.432 . . . . 100.0 111.06 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.69 26.88 4.29 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 109.464 -1.454 . . . . 100.0 109.464 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' CE ' ' A' ' 89' ' ' MET . 32.7 mtmt -61.49 -44.81 96.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.493 0.717 . . . . 100.0 112.671 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -62.47 -43.08 99.68 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.267 1.027 . . . . 100.0 109.729 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 m -63.07 -41.7 99.49 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.786 1.234 . . . . 100.0 109.218 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.514 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 54.9 t80 -59.99 -48.48 81.52 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 124.141 0.976 . . . . 100.0 112.208 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.46 -41.68 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.691 0.619 . . . . 100.0 110.922 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.252 98.8 mttt -68.06 -8.09 34.89 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.919 1.822 . . . . 100.0 115.919 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.558 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 81.2 mtm-85 -60.91 -37.43 82.21 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 118.941 -0.552 . . . . 100.0 109.724 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 47.5 t-80 -80.53 113.17 18.53 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.78 -1.563 . . . . 100.0 106.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.52 -43.96 97.54 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 115.604 1.705 . . . . 100.0 115.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.435 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 63.7 m -63.33 -41.89 98.94 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.988 -0.745 . . . . 100.0 108.988 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.41 -42.45 99.77 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 123.671 0.653 . . . . 100.0 111.565 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.49 -45.36 91.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.368 0.667 . . . . 100.0 111.043 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.16 -40.65 98.16 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 124.685 1.194 . . . . 100.0 112.215 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -93.52 11.24 29.33 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 115.353 1.612 . . . . 100.0 115.353 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.55 140.01 56.66 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 113.875 1.065 . . . . 100.0 113.875 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -118.1 129.47 55.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -103.04 124.63 48.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.2 110.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 101.498 -3.519 . . . . 100.0 101.498 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.03 88.93 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 115.993 1.849 . . . . 100.0 115.993 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.6 p -62.86 -47.25 84.16 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 122.494 0.317 . . . . 100.0 111.568 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.79 -37.14 73.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.892 1.071 . . . . 100.0 113.892 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.77 30.84 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 107.261 -2.335 . . . . 100.0 107.261 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.2 t -126.25 141.99 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 124.246 1.018 . . . . 100.0 109.167 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.55 118.93 37.88 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 102.336 -3.209 . . . . 100.0 102.336 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.68 120.05 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.542 -2.021 . . . . 100.0 105.542 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -114.5 119.79 39.2 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 109.0 -0.741 . . . . 100.0 109.0 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.9 104.67 1.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.863 2.375 . . . . 100.0 110.934 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.33 119.05 34.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.93 126.59 58.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 107.191 -1.411 . . . . 100.0 107.191 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -122.49 133.1 54.6 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.102 -1.814 . . . . 100.0 106.102 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -100.35 118.3 36.32 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 121.73 0.776 . . . . 100.0 108.987 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.43 HG21 HD12 ' A' ' 59' ' ' ILE . 22.3 p -110.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.948 -1.023 . . . . 100.0 111.57 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.66 -44.21 93.66 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 125.497 1.519 . . . . 100.0 108.349 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.8 -38.42 76.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.188 0.995 . . . . 100.0 112.395 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.92 -173.05 29.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.889 -1.684 . . . . 100.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.93 138.43 57.43 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.521 2.147 . . . . 100.0 114.199 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 54' ' ' THR . 81.1 mt -127.4 129.93 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 102.801 -3.037 . . . . 100.0 102.801 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.81 128.99 55.97 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.048 -0.723 . . . . 100.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.85 116.76 31.19 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.653 -2.721 . . . . 100.0 103.653 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -87.81 106.65 18.22 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.616 -4.216 . . . . 100.0 99.616 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.28 122.3 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 106.368 -1.715 . . . . 100.0 106.368 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.25 117.0 30.48 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 106.631 -1.618 . . . . 100.0 106.631 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -116.45 141.28 48.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.005 -2.22 . . . . 100.0 105.005 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 p -75.08 165.88 24.53 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 113.558 0.947 . . . . 100.0 113.558 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.74 12.92 23.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.733 1.213 . . . . 100.0 109.788 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.49 51.14 Favored Glycine 0 C--N 1.358 1.803 0 O-C-N 121.693 -0.629 . . . . 100.0 112.209 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -61.96 -27.86 69.14 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.813 1.645 . . . . 100.0 112.166 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -59.05 -36.64 75.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.584 2.353 . . . . 100.0 111.826 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.59 -46.84 88.16 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 117.996 0.362 . . . . 100.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.371 13.9 p90 -71.99 -39.39 69.3 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 114.903 1.445 . . . . 100.0 114.903 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.5 -156.04 11.45 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 119.903 -1.142 . . . . 100.0 113.431 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.16 171.53 52.52 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.807 0.718 . . . . 100.0 111.731 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -106.3 142.99 35.06 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 121.822 0.82 . . . . 100.0 109.971 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -67.95 155.69 38.89 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.208 -1.36 . . . . 100.0 113.735 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -60.67 -38.36 84.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.776 -1.557 . . . . 100.0 110.372 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.76 -39.33 93.54 Favored Glycine 0 C--N 1.36 1.872 0 C-N-CA 124.38 0.99 . . . . 100.0 111.469 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HD1' HG21 ' A' ' 45' ' ' VAL . 62.2 t80 -62.32 -46.96 86.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.516 0.726 . . . . 100.0 111.293 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.92 -37.11 78.73 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.0 mt -52.19 138.22 10.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 125.48 1.512 . . . . 100.0 113.739 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.86 24.65 12.78 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 127.853 2.461 . . . . 100.0 114.378 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.07 129.33 38.68 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.305 -1.368 . . . . 100.0 107.305 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.4 mm-40 -98.71 -34.93 10.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.143 -1.058 . . . . 100.0 108.143 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.52 ' HB2' HD22 ' A' ' 164' ' ' LEU . 23.5 p -144.37 160.14 41.54 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 122.861 0.465 . . . . 100.0 110.527 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -146.17 149.3 33.72 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.404 1.261 . . . . 100.0 114.404 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.47 126.52 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 103.292 -2.855 . . . . 100.0 103.292 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.43 123.81 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 102.353 -3.203 . . . . 100.0 102.353 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 23' ' ' LYS . 41.0 mtm -115.45 140.55 49.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 118.738 -1.185 . . . . 100.0 113.692 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -127.08 159.59 33.73 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 110.423 -3.081 . . . . 100.0 108.751 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -102.87 126.59 50.08 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.802 -1.925 . . . . 100.0 105.802 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.52 -21.58 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.367 0.877 . . . . 100.0 113.367 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -87.59 -8.48 56.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 119.033 -0.508 . . . . 100.0 110.993 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 t -119.42 115.84 24.93 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 122.308 1.051 . . . . 100.0 110.576 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.77 -38.68 87.05 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.622 -1.172 . . . . 100.0 110.55 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.71 -41.86 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.217 1.807 . . . . 100.0 110.391 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.4 m -62.96 -42.06 99.71 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 118.111 0.414 . . . . 100.0 110.306 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.555 ' CE1' HG23 ' A' ' 136' ' ' ILE . 39.5 t80 -63.45 -41.22 98.65 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 123.259 0.624 . . . . 100.0 110.453 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.7 mttt -61.61 -37.53 84.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.691 0.796 . . . . 100.0 111.652 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.14 -10.3 59.34 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 114.471 1.286 . . . . 100.0 114.471 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.36 -43.04 95.73 Favored Pre-proline 0 C--N 1.363 1.191 0 CA-C-O 115.782 -2.056 . . . . 100.0 111.795 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 83.2 Cg_exo -57.41 -38.24 95.0 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 122.556 1.949 . . . . 100.0 112.725 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.02 -45.19 90.03 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 123.924 0.89 . . . . 100.0 111.401 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -63.15 -42.79 99.52 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 123.182 0.593 . . . . 100.0 110.347 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -62.15 -45.01 95.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.502 1.121 . . . . 100.0 110.517 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -63.0 -44.01 97.2 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 112.686 0.624 . . . . 100.0 112.686 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.68 -44.03 97.29 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.42 0.45 . . . . 100.0 111.357 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.478 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.7 tp -62.79 -46.26 88.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.499 1.12 . . . . 100.0 112.247 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.43 -38.58 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 C-N-CA 125.082 1.353 . . . . 100.0 111.143 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -60.5 -46.07 91.45 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.463 0.574 . . . . 100.0 111.197 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.4 -45.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.352 -0.539 . . . . 100.0 111.159 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.1 m -127.39 115.33 18.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.48 0.657 . . . . 100.0 109.558 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.57 147.18 23.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.537 -0.756 . . . . 100.0 112.422 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.07 44.55 27.85 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 126.56 1.944 . . . . 100.0 114.457 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' GLN . 32.0 mm -100.74 131.29 23.77 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 125.907 1.683 . . . . 100.0 107.193 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.19 130.33 28.45 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.601 2.201 . . . . 100.0 109.181 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.729 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.8 mt -130.82 136.73 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 O-C-N 124.317 1.011 . . . . 100.0 109.147 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 160' ' ' PRO . 83.9 t -113.6 130.91 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 105.431 -2.062 . . . . 100.0 105.431 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 39.7 mt -105.85 125.14 50.64 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.465 -2.791 . . . . 100.0 103.465 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.4 m -116.82 129.99 56.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.199 -1.364 . . . . 100.0 112.509 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 103.51 2.83 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 105.347 -3.101 . . . . 100.0 105.347 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 149' ' ' ILE . 63.7 t30 -84.36 167.44 16.52 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.082 1.353 . . . . 100.0 111.297 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 60.08 42.45 15.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 128.348 2.659 . . . . 100.0 115.199 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.307 20.4 m -73.18 -7.66 10.17 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 116.08 -0.509 . . . . 100.0 111.494 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.96 -38.09 87.21 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.759 2.023 . . . . 100.0 109.801 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.65 130.34 34.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.108 0 N-CA-C 106.694 -1.595 . . . . 100.0 106.694 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.36 -41.11 98.35 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 116.281 1.956 . . . . 100.0 116.281 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -86.23 99.4 11.52 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.201 -2.148 . . . . 100.0 105.201 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -99.01 118.77 36.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.351 -2.833 . . . . 100.0 103.351 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.3 -40.96 13.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.719 -0.673 . . . . 100.0 112.634 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.85 106.36 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 103.667 -2.716 . . . . 100.0 103.667 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -103.64 -179.49 3.97 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.247 -0.888 . . . . 100.0 113.209 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.481 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.43 -35.86 72.75 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 127.161 2.184 . . . . 100.0 109.276 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.034 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -59.73 -37.11 78.02 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 128.081 2.552 . . . . 100.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.8 p -103.96 -1.17 27.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 120.114 3.376 . . . . 100.0 120.114 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 56.2 mt -98.47 95.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.21 0 C-N-CA 115.487 -2.485 . . . . 100.0 111.324 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 5.7 p -100.6 -5.98 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 114.77 1.396 . . . . 100.0 114.77 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.89 -35.7 73.45 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.225 1.565 . . . . 100.0 115.225 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 87.0 m-70 -59.45 -40.5 87.05 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 125.587 1.555 . . . . 100.0 112.689 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.678 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 55.7 ttp85 -59.09 -47.69 84.33 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 124.567 1.147 . . . . 100.0 113.436 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -63.44 -41.44 98.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.277 0.986 . . . . 100.0 111.728 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.5 3.71 50.64 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 117.277 2.325 . . . . 100.0 117.277 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 57.42 42.84 24.07 Favored 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.526 1.531 . . . . 100.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.729 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.3 mt -106.38 151.33 25.03 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.815 -1.55 . . . . 100.0 106.815 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 86.9 mm-40 -103.91 142.85 33.69 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 113.445 0.905 . . . . 100.0 113.445 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.487 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 79.7 t80 -98.83 132.18 44.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 113.633 0.975 . . . . 100.0 113.633 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.58 132.89 49.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 113.596 -1.638 . . . . 100.0 108.335 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.39 118.28 30.4 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.3 -3.593 . . . . 100.0 101.3 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ILE . . . . . 0.434 HG13 ' HA ' ' A' ' 122' ' ' ASN . 43.8 pt -133.57 159.37 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.644 1.212 . . . . 100.0 114.05 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.1 m -140.02 111.43 7.18 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 106.418 -1.697 . . . . 100.0 106.418 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.558 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.58 -44.35 96.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.337 -1.301 . . . . 100.0 112.92 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.04 -40.12 96.78 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.715 0.806 . . . . 100.0 112.738 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -96.12 1.66 52.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.139 2.274 . . . . 100.0 117.139 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.42 11.92 Favored 'General case' 0 C--N 1.365 1.244 0 C-N-CA 125.277 1.431 . . . . 100.0 109.964 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.504 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 87.0 t80 -75.33 124.77 27.69 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.012 -0.736 . . . . 100.0 109.012 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 53.59 39.87 30.67 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.121 2.568 . . . . 100.0 115.399 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.542 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.8 t80 -62.61 -42.66 99.71 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 121.829 -0.544 . . . . 100.0 111.395 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.13 -39.43 94.67 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 115.746 1.758 . . . . 100.0 115.746 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.16 -48.53 96.87 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 120.932 3.679 . . . . 100.0 120.932 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HB3' HG11 ' A' ' 118' ' ' VAL . 55.4 Cg_endo -61.16 -41.79 40.47 Favored 'Trans proline' 0 C--N 1.373 1.853 0 CA-C-N 123.544 2.301 . . . . 100.0 112.681 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.7 -42.49 95.25 Favored 'General case' 0 CA--C 1.491 -1.325 0 O-C-N 124.656 1.223 . . . . 100.0 111.347 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.18 -45.05 93.6 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.457 0.703 . . . . 100.0 111.408 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -63.01 -44.53 95.74 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.523 0.514 . . . . 100.0 110.079 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.6 mt -61.78 -44.15 97.44 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.121 0.568 . . . . 100.0 111.469 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.72 98.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.207 1.003 . . . . 100.0 111.315 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -62.22 -45.83 91.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 123.722 0.809 . . . . 100.0 111.022 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -64.56 -45.38 87.36 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 85' ' ' CYS . 82.0 mt -63.44 -46.74 84.91 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 123.826 0.85 . . . . 100.0 112.929 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 85.9 mt -70.54 -38.51 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 123.06 0.544 . . . . 100.0 109.989 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.98 9.74 59.31 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.477 -1.049 . . . . 100.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -108.97 112.63 59.97 Favored Pre-proline 0 C--N 1.362 1.121 0 N-CA-C 107.332 -1.358 . . . . 100.0 107.332 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.23 -16.7 28.16 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 123.412 2.741 . . . . 100.0 113.832 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.93 -0.12 56.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.827 0.851 . . . . 100.0 113.042 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.81 131.61 48.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.286 0.634 . . . . 100.0 110.337 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -136.65 153.77 50.82 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.987 -0.746 . . . . 100.0 108.987 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -88.21 113.21 23.6 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 106.257 -1.757 . . . . 100.0 106.257 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.7 t -67.02 -43.8 88.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.011 0.925 . . . . 100.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.91 150.7 49.19 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.522 0.677 . . . . 100.0 109.634 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 63.5 ttp -96.35 126.63 43.13 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 104.837 -2.283 . . . . 100.0 104.837 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.05 159.49 49.11 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.951 2.434 . . . . 100.0 111.541 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.72 125.06 23.6 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.283 -1.006 . . . . 100.0 108.283 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.1 144.56 46.54 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.335 -1.302 . . . . 100.0 109.972 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.65 137.85 97.27 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -56.08 138.33 82.36 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 123.516 2.811 . . . . 100.0 112.129 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.42 131.74 39.94 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.851 2.367 . . . . 100.0 114.264 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -66.06 -44.85 83.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 124.795 1.309 . . . . 100.0 108.503 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.03 158.42 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.787 -1.56 . . . . 100.0 106.787 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.7 t -99.78 130.64 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 105.651 -1.981 . . . . 100.0 105.651 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -85.83 126.7 34.24 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.345 -2.465 . . . . 100.0 104.345 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 77.6 m-20 -62.74 131.09 94.22 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 115.245 -0.889 . . . . 100.0 110.828 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.7 Cg_exo -58.67 -37.94 91.69 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.948 3.099 . . . . 100.0 112.828 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.05 93.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 124.449 1.093 . . . . 100.0 110.784 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.91 -42.49 97.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.067 0.547 . . . . 100.0 111.483 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 123.731 0.812 . . . . 100.0 110.512 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.88 97.72 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.126 0.97 . . . . 100.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.57 -44.42 96.37 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.614 0.765 . . . . 100.0 112.187 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -63.84 -43.83 95.0 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 112.397 0.518 . . . . 100.0 112.397 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.51 -41.37 98.52 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.55 -0.537 . . . . 100.0 109.55 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.14 -45.32 93.95 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.989 1.316 . . . . 100.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -42.75 99.4 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 123.366 0.667 . . . . 100.0 110.667 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.504 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 17.5 tp -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 124.122 0.889 . . . . 100.0 110.53 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.69 -41.77 95.8 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 115.664 1.727 . . . . 100.0 115.664 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.68 -46.36 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 CA-C-O 118.429 -0.796 . . . . 100.0 109.667 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.41 . . -93.35 -0.52 56.58 Favored 'General case' 0 N--CA 1.4 -2.931 1 C-N-CA 109.909 -4.717 . . . . 100.0 114.326 -179.886 . . . . . . . . 4 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.805 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.275 59.7 mt-30 -56.63 -36.51 69.56 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 106.535 -1.654 . . . . 100.0 106.535 178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.7 p -82.44 53.4 2.3 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.211 1.005 . . . . 100.0 108.969 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.291 78.7 p 49.11 37.74 11.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 129.123 2.969 . . . . 100.0 116.402 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.479 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.53 -179.32 7.38 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.443 -2.428 . . . . 100.0 104.443 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.6 -39.98 81.7 Favored Pre-proline 0 CA--C 1.499 -0.981 0 CA-C-O 115.851 -2.024 . . . . 100.0 114.904 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.034 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.332 45.4 Cg_exo -55.02 136.7 74.09 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 121.288 1.496 . . . . 100.0 111.991 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.5 m-20 -63.55 -47.7 80.5 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 125.132 5.234 . . . . 100.0 125.132 -173.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.1 -35.26 79.67 Favored 'General case' 0 CA--C 1.482 -1.673 1 CA-C-O 128.626 4.06 . . . . 100.0 107.782 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.805 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.482 43.2 m-20 -65.49 -49.06 70.43 Favored 'General case' 1 N--CA 1.352 -5.352 1 CA-C-N 107.581 -4.372 . . . . 100.0 106.148 -179.058 . . . . . . . . 5 3 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.15 -27.64 69.21 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 120.412 -1.43 . . . . 100.0 108.217 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.681 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.1 t70 -58.33 -43.59 88.32 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-O 117.178 -1.391 . . . . 100.0 112.507 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.432 HD13 ' HG2' ' A' ' 205' ' ' GLN . 4.5 mp . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.927 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 N--CA 1.434 -1.248 0 N-CA-C 106.489 -1.671 . . . . 100.0 106.489 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.76 133.94 52.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.638 -1.619 . . . . 100.0 107.916 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.22 141.91 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.744 -1.206 . . . . 100.0 107.744 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.01 118.49 31.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD23 HG22 ' A' ' 63' ' ' VAL . 55.9 tp -106.92 125.66 51.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 113.008 -1.905 . . . . 100.0 106.955 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.3 t -102.39 121.86 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 106.23 -1.767 . . . . 100.0 106.23 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 89' ' ' MET . 3.3 tt -113.68 117.95 33.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.628 -2.36 . . . . 100.0 104.628 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -127.58 162.87 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.847 -0.615 . . . . 100.0 112.307 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.78 175.26 28.5 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 108.569 -1.812 . . . . 100.0 108.569 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -71.71 156.1 39.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 121.777 -0.837 . . . . 100.0 111.786 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.0 141.07 40.98 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 107.423 -2.271 . . . . 100.0 107.423 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 -5.43 80.63 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.924 -0.931 . . . . 100.0 113.884 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -62.85 -40.03 96.2 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 118.618 1.209 . . . . 100.0 111.145 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.79 24.64 5.16 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.22 -1.152 . . . . 100.0 110.22 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 52.3 mtpt -60.24 -46.22 90.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.363 1.465 . . . . 100.0 111.98 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.6 m -62.9 -43.76 97.92 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 124.864 1.265 . . . . 100.0 109.622 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.4 m -63.15 -41.64 99.3 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.421 1.088 . . . . 100.0 109.28 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' HA ' HH11 ' A' ' 29' ' ' ARG . 60.6 t80 -60.62 -48.77 80.32 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 122.868 0.467 . . . . 100.0 111.625 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 63' ' ' VAL . 98.3 t -64.02 -42.64 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.672 0.789 . . . . 100.0 110.664 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.263 99.5 mttt -70.44 -6.39 35.46 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 115.718 1.747 . . . . 100.0 115.718 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 80.7 mtm-85 -61.32 -36.57 80.49 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 118.884 -0.579 . . . . 100.0 110.069 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.452 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 44.8 t-80 -79.98 113.79 18.41 Favored 'General case' 0 C--N 1.36 1.034 0 N-CA-C 107.128 -1.434 . . . . 100.0 107.128 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.23 -43.91 97.76 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.888 1.44 . . . . 100.0 114.888 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 79.8 m -64.11 -39.87 94.97 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.694 -0.854 . . . . 100.0 108.694 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.44 99.78 Favored Glycine 0 C--N 1.361 1.938 0 N-CA-C 110.409 -1.076 . . . . 100.0 110.409 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.89 -45.33 93.06 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 117.56 0.68 . . . . 100.0 111.536 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.5 -40.92 98.26 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.996 0.919 . . . . 100.0 112.236 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -90.56 6.36 43.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 114.988 1.477 . . . . 100.0 114.988 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -61.06 140.61 57.82 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -121.07 133.59 55.24 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.108 -1.441 . . . . 100.0 107.108 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -103.32 124.63 49.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.331 -1.729 . . . . 100.0 106.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.56 109.73 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 100.641 -3.836 . . . . 100.0 100.641 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.55 92.22 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 116.669 2.1 . . . . 100.0 116.669 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.9 m -63.13 -48.55 78.02 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 123.37 0.419 . . . . 100.0 110.438 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.35 -36.1 74.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 113.957 1.095 . . . . 100.0 113.957 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.24 40.45 33.92 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 107.944 -2.062 . . . . 100.0 107.944 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG21 ' HD1' ' A' ' 79' ' ' TYR . 41.0 t -127.72 141.81 45.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.077 0.951 . . . . 100.0 109.141 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -103.96 119.52 39.1 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 102.839 -3.022 . . . . 100.0 102.839 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.23 120.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.696 -1.964 . . . . 100.0 105.696 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -113.22 119.21 42.73 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.023 -0.732 . . . . 100.0 109.023 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -80.09 106.54 1.93 Allowed 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.093 1.862 . . . . 100.0 109.62 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.32 117.42 32.68 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.196 -1.779 . . . . 100.0 106.196 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.17 125.98 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.41 133.25 54.63 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.782 -1.933 . . . . 100.0 105.782 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -100.66 119.19 38.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.176 -1.046 . . . . 100.0 108.176 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 59' ' ' ILE . 20.6 p -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.875 -1.057 . . . . 100.0 110.874 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -59.83 -44.44 94.06 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.424 1.489 . . . . 100.0 108.255 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -67.23 -37.96 84.42 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.308 1.443 . . . . 100.0 112.792 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.25 -172.56 28.48 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 108.988 -1.645 . . . . 100.0 108.988 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.97 136.73 49.77 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.674 2.25 . . . . 100.0 113.953 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -127.58 129.75 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 102.659 -3.089 . . . . 100.0 102.659 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -110.32 129.66 55.7 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.646 -0.872 . . . . 100.0 108.646 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -109.82 116.61 31.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.177 -2.897 . . . . 100.0 103.177 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -87.42 107.7 18.66 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.338 -4.319 . . . . 100.0 99.338 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG22 HD23 ' A' ' 13' ' ' LEU . 26.8 t -93.2 121.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.069 -1.826 . . . . 100.0 106.069 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -93.57 109.88 21.49 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.797 -2.298 . . . . 100.0 104.797 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.22 136.6 52.77 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.035 -1.839 . . . . 100.0 106.035 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.2 p -72.95 162.2 29.78 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 113.378 0.881 . . . . 100.0 113.378 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.57 16.22 19.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.325 -0.852 . . . . 100.0 109.789 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.3 51.14 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 121.846 -0.534 . . . . 100.0 112.409 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -60.28 -33.78 72.82 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 126.871 2.069 . . . . 100.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 59.8 mt-10 -57.89 -36.68 72.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.566 2.346 . . . . 100.0 112.154 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.36 -43.53 98.6 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.13 0.572 . . . . 100.0 109.792 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -70.6 -41.68 72.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.216 1.406 . . . . 100.0 113.539 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.77 -155.2 13.51 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 121.363 -0.446 . . . . 100.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.0 171.66 52.16 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 123.764 0.697 . . . . 100.0 111.982 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.97 143.12 33.61 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 122.173 0.987 . . . . 100.0 111.128 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -65.16 150.48 48.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.441 -1.708 . . . . 100.0 113.14 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.43 -37.92 85.26 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 114.029 -1.441 . . . . 100.0 109.53 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.35 94.11 Favored Glycine 0 C--N 1.36 1.874 0 C-N-CA 124.728 1.156 . . . . 100.0 111.07 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HD1' HG21 ' A' ' 45' ' ' VAL . 64.0 t80 -62.44 -46.83 86.77 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.899 0.88 . . . . 100.0 111.279 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -69.03 -37.21 78.49 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.671 1.73 . . . . 100.0 115.671 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.87 139.29 12.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 125.178 1.391 . . . . 100.0 113.232 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.93 22.17 10.18 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 127.544 2.338 . . . . 100.0 113.182 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.61 128.99 37.61 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.293 -1.373 . . . . 100.0 107.293 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.54 -37.68 10.77 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.471 -1.677 . . . . 100.0 106.471 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.681 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.3 p -144.6 161.57 38.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.681 0.277 . . . . 100.0 111.271 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.34 150.16 36.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.176 1.547 . . . . 100.0 115.176 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' A' ' 89' ' ' MET . 97.4 mt -125.54 126.13 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 103.851 -2.648 . . . . 100.0 103.851 176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.5 mt -111.03 124.17 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 102.944 -2.984 . . . . 100.0 102.944 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 87' ' ' ILE . 38.9 mtt -110.89 135.51 51.32 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.268 -1.333 . . . . 100.0 114.549 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -129.23 159.41 36.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 111.583 -2.553 . . . . 100.0 108.33 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -103.78 126.61 51.03 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.291 -1.744 . . . . 100.0 106.291 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 17.1 m -64.68 -21.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.857 1.058 . . . . 100.0 113.857 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.6 p -88.33 -10.31 49.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 119.193 -0.432 . . . . 100.0 110.961 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -116.93 114.99 24.63 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.755 1.264 . . . . 100.0 110.193 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -65.93 -39.48 90.56 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.408 1.483 . . . . 100.0 109.815 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.97 -41.84 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.221 1.808 . . . . 100.0 110.777 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.1 m -62.74 -42.46 99.68 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 118.089 0.404 . . . . 100.0 109.93 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 136' ' ' ILE . 45.7 t80 -63.93 -41.0 97.75 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.691 0.796 . . . . 100.0 110.767 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -60.83 -38.55 85.87 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.763 0.825 . . . . 100.0 110.515 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.36 -9.78 58.87 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 115.129 1.529 . . . . 100.0 115.129 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.71 -43.4 95.21 Favored Pre-proline 0 C--N 1.364 1.222 0 CA-C-O 115.93 -1.986 . . . . 100.0 111.529 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.2 Cg_exo -57.4 -36.23 98.84 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.242 1.961 . . . . 100.0 112.93 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.91 -47.08 84.82 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.951 1.3 . . . . 100.0 110.115 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -63.87 -42.64 97.47 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 123.837 0.855 . . . . 100.0 111.161 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.7 t60 -62.45 -44.29 96.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.526 1.13 . . . . 100.0 110.265 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -62.62 -45.3 93.49 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 118.697 -0.668 . . . . 100.0 111.661 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -62.41 -43.98 97.53 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 123.481 0.488 . . . . 100.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.5 tp -62.71 -46.54 87.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.466 1.106 . . . . 100.0 111.988 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.59 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 C-N-CA 125.376 1.47 . . . . 100.0 111.165 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.08 -46.32 89.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 119.017 -0.516 . . . . 100.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.86 -46.62 59.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.356 -0.538 . . . . 100.0 111.796 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.9 m -127.07 114.03 17.21 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -90.46 146.07 24.42 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.746 -0.661 . . . . 100.0 112.27 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.75 43.3 31.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 126.39 1.876 . . . . 100.0 115.36 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 pt -99.5 139.82 21.17 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 105.953 -1.869 . . . . 100.0 105.953 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.29 129.92 28.57 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.608 2.206 . . . . 100.0 109.525 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 144' ' ' LEU . 72.3 mt -130.64 135.89 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.235 1.017 . . . . 100.0 108.777 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.67 131.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 105.594 -2.002 . . . . 100.0 105.594 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HB2' ' HE2' ' A' ' 139' ' ' HIS . 20.5 mt -106.04 126.56 52.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.274 -2.861 . . . . 100.0 103.274 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 73.8 m -114.57 127.85 56.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.98 -1.464 . . . . 100.0 112.008 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.73 104.02 2.93 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 105.726 -2.95 . . . . 100.0 105.726 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.95 163.89 24.86 Favored 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 127.823 2.449 . . . . 100.0 112.069 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 55.58 45.48 24.77 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 127.921 2.488 . . . . 100.0 115.556 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.333 33.1 m -72.29 -7.5 9.64 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 120.069 -0.652 . . . . 100.0 111.109 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.46 -38.96 89.13 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.029 2.131 . . . . 100.0 109.932 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.96 130.64 34.05 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 N-CA-C 107.069 -1.456 . . . . 100.0 107.069 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.29 -41.19 98.3 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.323 1.972 . . . . 100.0 116.323 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.5 100.47 12.79 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ARG . . . . . 0.402 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 79.1 ttt180 -96.67 121.35 38.41 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 102.392 -3.188 . . . . 100.0 102.392 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.19 -36.02 11.09 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.744 -0.662 . . . . 100.0 112.363 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 136' ' ' ILE . 42.4 t -104.73 105.23 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 101.707 -3.442 . . . . 100.0 101.707 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -101.87 177.71 4.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.951 1.093 . . . . 100.0 113.951 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.97 -35.51 73.31 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.082 2.153 . . . . 100.0 108.613 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.068 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.6 mttt -59.58 -37.05 77.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 128.395 2.678 . . . . 100.0 112.327 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.3 p -104.34 -3.13 24.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 120.061 3.356 . . . . 100.0 120.061 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.634 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 55.9 mt -95.75 94.34 4.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 116.394 -2.122 . . . . 100.0 112.317 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -99.29 -5.3 9.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -58.86 -36.73 75.08 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 115.418 1.636 . . . . 100.0 115.418 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.676 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 70.8 m80 -59.87 -39.57 85.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.994 1.718 . . . . 100.0 114.371 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 47.1 ttp180 -58.95 -48.13 82.62 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 124.904 1.282 . . . . 100.0 112.442 -176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.16 -41.3 99.23 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.039 1.336 . . . . 100.0 111.244 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -98.59 1.54 46.52 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 116.338 1.977 . . . . 100.0 116.338 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 54.9 45.82 25.71 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 125.079 1.351 . . . . 100.0 113.198 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 117' ' ' ILE . 32.1 mt -106.38 150.05 26.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.863 -1.903 . . . . 100.0 105.863 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.315 89.2 mm-40 -100.97 143.9 30.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.588 -0.845 . . . . 100.0 112.518 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.676 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 69.5 t80 -102.03 132.94 47.58 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.591 0.96 . . . . 100.0 113.591 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.81 132.89 45.51 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -1.268 . . . . 100.0 111.038 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.278 38.0 m-20 -84.58 122.13 28.6 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 103.152 -2.907 . . . . 100.0 103.152 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.28 156.6 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 122.644 1.211 . . . . 100.0 110.999 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 74.5 m -138.6 110.63 7.27 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 105.698 -1.964 . . . . 100.0 105.698 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.76 -44.06 97.17 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.651 -1.613 . . . . 100.0 112.909 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.87 -41.46 99.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.955 0.902 . . . . 100.0 112.425 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 185' ' ' PRO . 87.5 p -96.82 3.42 52.25 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 117.75 2.5 . . . . 100.0 117.75 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 m-80 65.45 21.17 11.83 Favored 'General case' 0 C--N 1.364 1.239 0 C-N-CA 124.451 1.101 . . . . 100.0 110.806 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.4 t80 -75.26 124.87 27.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.02 -0.733 . . . . 100.0 109.02 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.84 40.21 30.31 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 128.355 2.662 . . . . 100.0 115.364 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' HH21 ' A' ' 29' ' ' ARG . 78.9 t80 -62.65 -43.23 99.32 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.863 -0.523 . . . . 100.0 110.735 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -62.97 -39.19 93.94 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 115.996 1.85 . . . . 100.0 115.996 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.94 -47.45 98.86 Favored Pre-proline 0 C--N 1.356 0.862 0 N-CA-C 119.839 3.274 . . . . 100.0 119.839 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.94 -42.16 39.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 123.31 2.218 . . . . 100.0 111.222 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -64.05 -42.4 97.04 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 125.353 1.461 . . . . 100.0 111.614 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.19 -47.02 88.07 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 123.462 0.705 . . . . 100.0 111.722 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.25 -44.39 95.3 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 124.011 0.819 . . . . 100.0 110.46 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.69 -45.42 94.08 Favored 'General case' 0 CA--C 1.495 -1.171 0 O-C-N 123.752 0.657 . . . . 100.0 111.252 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.47 98.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 124.115 0.966 . . . . 100.0 111.555 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.05 -46.05 90.83 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 123.672 0.789 . . . . 100.0 111.402 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -65.52 -44.28 87.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 113.498 0.925 . . . . 100.0 113.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.63 -46.86 83.76 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.427 0.691 . . . . 100.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 87.8 mt -70.4 -38.74 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 123.309 0.644 . . . . 100.0 110.688 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.28 9.53 57.92 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-O 118.899 -0.945 . . . . 100.0 111.139 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -111.03 112.9 55.19 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.692 -1.225 . . . . 100.0 107.692 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.14 -14.93 28.94 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.72 2.946 . . . . 100.0 113.968 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.51 5.18 51.77 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.908 0.707 . . . . 100.0 112.908 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -65.75 131.8 47.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.362 0.665 . . . . 100.0 109.299 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -135.21 152.62 51.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.299 -0.63 . . . . 100.0 109.299 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -88.11 115.07 25.34 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 104.843 -2.281 . . . . 100.0 104.843 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.34 -45.04 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.071 0.948 . . . . 100.0 110.299 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.14 151.4 49.27 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.274 0.559 . . . . 100.0 109.734 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.2 ttp -96.63 127.42 39.67 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.322 -2.103 . . . . 100.0 105.322 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.14 159.05 51.49 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.127 2.551 . . . . 100.0 111.571 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.56 126.37 27.67 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.02 0.914 . . . . 100.0 108.562 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.78 145.91 47.06 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.163 -1.38 . . . . 100.0 108.979 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.74 138.42 97.38 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.657 -1.238 . . . . 100.0 107.657 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 51.7 Cg_exo -56.97 140.4 92.26 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.36 2.707 . . . . 100.0 112.377 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 154' ' ' ASN . 39.3 Cg_exo -58.5 131.31 41.88 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.413 2.742 . . . . 100.0 114.079 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.94 -44.66 80.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.599 1.187 . . . . 100.0 107.961 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.19 158.4 43.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.458 -1.682 . . . . 100.0 106.458 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.6 130.72 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 105.919 -1.882 . . . . 100.0 105.919 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -87.36 127.4 35.2 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.382 -2.081 . . . . 100.0 105.382 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 55.4 m-20 -62.91 130.56 94.09 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 115.16 -0.927 . . . . 100.0 111.005 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 54.0 Cg_exo -58.68 -36.74 96.75 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.874 3.049 . . . . 100.0 112.579 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.36 96.35 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.42 1.075 . . . . 100.0 110.447 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.66 -42.78 98.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 123.115 0.566 . . . . 100.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.14 97.67 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 123.512 0.725 . . . . 100.0 110.634 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.5 98.61 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.87 0.868 . . . . 100.0 110.654 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -61.94 -45.83 91.96 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.3 1.04 . . . . 100.0 111.986 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -64.0 -44.63 92.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 112.209 0.448 . . . . 100.0 112.209 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.41 -39.91 94.76 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.353 0.408 . . . . 100.0 111.053 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.69 -43.77 97.96 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.883 1.273 . . . . 100.0 110.829 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.08 -42.53 99.3 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.158 0.983 . . . . 100.0 110.106 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.5 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.4 tp -59.8 -49.43 77.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 124.317 1.01 . . . . 100.0 109.861 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.48 -41.51 96.44 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 115.805 1.78 . . . . 100.0 115.805 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.41 -47.06 91.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 CA-C-O 118.305 -0.855 . . . . 100.0 109.423 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.685 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.409 . . -93.97 0.76 56.22 Favored 'General case' 0 N--CA 1.405 -2.71 1 C-N-CA 109.659 -4.816 . . . . 100.0 114.495 179.694 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.29 61.2 mt-30 -57.27 -35.86 70.28 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 106.94 -1.504 . . . . 100.0 106.94 178.169 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.8 p -82.82 53.88 2.53 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.487 1.137 . . . . 100.0 108.551 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.304 80.4 p 48.66 38.91 12.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 129.507 3.123 . . . . 100.0 115.741 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.31 -177.43 6.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.638 -2.356 . . . . 100.0 104.638 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.8 mt -56.39 -41.58 91.86 Favored Pre-proline 0 CA--C 1.502 -0.884 0 CA-C-O 116.105 -1.902 . . . . 100.0 114.882 -174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.068 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.307 41.8 Cg_exo -54.52 136.18 69.11 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.112 1.433 . . . . 100.0 112.389 177.191 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 95.3 m-20 -63.63 -47.38 81.57 Favored 'General case' 0 N--CA 1.428 -1.572 1 N-CA-C 124.109 4.855 . . . . 100.0 124.109 -173.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.256 99.5 mt-10 -63.17 -35.17 79.41 Favored 'General case' 0 CA--C 1.477 -1.86 1 CA-C-O 128.562 4.03 . . . . 100.0 108.064 177.753 . . . . . . . . 4 3 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.484 44.7 m-20 -66.57 -48.9 68.13 Favored 'General case' 1 N--CA 1.35 -5.473 1 CA-C-N 107.629 -4.351 . . . . 100.0 105.939 -178.624 . . . . . . . . 5 3 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.74 -25.43 67.93 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.574 -1.329 . . . . 100.0 108.524 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.69 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.84 -42.8 90.18 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-O 117.238 -1.363 . . . . 100.0 112.571 175.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' A' ' 205' ' ' GLN . 2.9 mp . . . . . 0 N--CA 1.425 -1.71 0 CA-C-O 114.335 -2.745 . . . . 100.0 112.039 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 105.532 -2.025 . . . . 100.0 105.532 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -121.29 134.77 55.16 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.238 -1.801 . . . . 100.0 108.155 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.15 143.11 49.28 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.598 -1.26 . . . . 100.0 107.598 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.64 120.81 35.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.793 -1.558 . . . . 100.0 106.793 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -109.21 127.65 54.41 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.913 -1.949 . . . . 100.0 107.107 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 79' ' ' TYR . 50.8 t -103.02 120.78 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.714 -1.585 . . . . 100.0 106.892 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 48.5 tp -110.69 115.38 29.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.53 161.85 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 CA-C-N 115.741 -0.663 . . . . 100.0 111.992 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.14 176.61 30.38 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 108.341 -1.903 . . . . 100.0 108.341 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -72.67 157.27 37.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.621 0.724 . . . . 100.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.45 141.72 39.42 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 107.109 -2.396 . . . . 100.0 107.109 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.06 -5.62 81.66 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.079 -0.845 . . . . 100.0 113.62 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -63.04 -39.28 94.28 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 118.481 1.141 . . . . 100.0 111.204 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.49 23.9 5.53 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 111.076 -0.81 . . . . 100.0 111.076 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HD2' ' HG ' ' A' ' 15' ' ' LEU . 29.3 mtmt -61.71 -43.24 99.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.843 0.857 . . . . 100.0 111.902 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -62.16 -44.19 97.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.681 1.193 . . . . 100.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.2 m -63.08 -41.1 99.34 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.565 1.146 . . . . 100.0 108.826 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.527 ' HA ' HH11 ' A' ' 29' ' ' ARG . 50.0 t80 -59.75 -49.09 79.07 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.376 0.67 . . . . 100.0 112.676 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -41.95 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 123.869 0.731 . . . . 100.0 110.561 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.49 -8.43 40.93 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 115.757 1.762 . . . . 100.0 115.757 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 82.8 mtm-85 -61.36 -37.34 82.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.535 -0.542 . . . . 100.0 109.535 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' HIS . . . . . 0.454 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 53.8 t-80 -80.23 112.35 17.46 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.49 -43.85 97.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 115.222 1.564 . . . . 100.0 115.222 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 85.2 m -63.02 -41.96 99.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.621 0.768 . . . . 100.0 108.934 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.43 99.75 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 123.855 0.741 . . . . 100.0 111.361 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.82 -43.75 95.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.023 0.529 . . . . 100.0 110.676 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.05 -40.04 95.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.31 1.044 . . . . 100.0 112.349 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -90.42 7.02 40.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 114.422 1.267 . . . . 100.0 114.422 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -58.81 140.23 55.35 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 115.215 1.561 . . . . 100.0 115.215 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.88 130.46 52.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -103.81 123.6 47.38 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.256 -2.127 . . . . 100.0 105.256 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.11 113.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 102.736 -3.061 . . . . 100.0 102.736 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.2 94.01 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.0 p -62.59 -47.41 83.91 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 122.679 0.392 . . . . 100.0 111.723 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.06 -38.22 75.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.718 1.207 . . . . 100.0 112.987 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 35.78 52.42 Favored Glycine 0 C--N 1.359 1.844 0 N-CA-C 106.625 -2.59 . . . . 100.0 106.625 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.466 HG21 ' HD1' ' A' ' 79' ' ' TYR . 84.3 t -125.45 141.45 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.766 1.227 . . . . 100.0 108.622 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -106.56 117.36 33.85 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 102.571 -3.122 . . . . 100.0 102.571 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.74 122.25 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 107.039 -1.467 . . . . 100.0 107.039 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -116.63 120.69 34.09 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.265 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -79.97 105.62 1.82 Allowed 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.298 1.999 . . . . 100.0 109.415 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.08 116.75 29.85 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.636 -1.616 . . . . 100.0 106.636 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.65 126.82 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.858 -1.164 . . . . 100.0 107.858 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.41 132.45 53.96 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -99.9 120.03 39.14 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.212 -1.033 . . . . 100.0 108.212 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 23.3 p -109.44 -179.77 3.92 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.817 -1.083 . . . . 100.0 110.754 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.81 -44.11 94.16 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 125.576 1.55 . . . . 100.0 107.837 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -67.32 -39.19 85.83 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.901 1.28 . . . . 100.0 112.846 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.83 -172.54 28.13 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.068 -2.013 . . . . 100.0 108.068 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.27 137.28 50.95 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.628 2.219 . . . . 100.0 114.552 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 74.9 mt -127.34 130.42 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.325 -3.213 . . . . 100.0 102.325 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -110.94 129.65 55.82 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.412 -0.588 . . . . 100.0 109.412 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -111.31 115.27 29.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.174 -2.528 . . . . 100.0 104.174 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -86.82 106.38 17.68 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.653 -3.832 . . . . 100.0 100.653 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 122.4 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -98.04 114.78 27.03 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.116 -1.809 . . . . 100.0 106.116 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -112.63 135.68 53.08 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.531 -1.655 . . . . 100.0 106.531 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -72.25 162.66 29.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.199 0.814 . . . . 100.0 113.199 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.43 14.76 21.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.316 -0.857 . . . . 100.0 110.033 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.21 12.36 42.55 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 121.78 -0.575 . . . . 100.0 112.037 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.458 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 67.8 mt-30 -60.16 -34.43 73.57 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.557 1.943 . . . . 100.0 111.625 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.9 -35.39 70.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 127.624 2.37 . . . . 100.0 112.406 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.08 -40.9 97.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.474 0.71 . . . . 100.0 110.97 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 p90 -92.05 -14.0 30.01 Favored 'General case' 0 C--N 1.362 1.111 0 N-CA-C 114.908 1.447 . . . . 100.0 114.908 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.93 -163.9 33.04 Favored Glycine 0 C--N 1.357 1.745 0 C-N-CA 119.464 -1.35 . . . . 100.0 113.432 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.51 172.57 54.64 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 110.507 -1.037 . . . . 100.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.8 mt -104.25 142.32 34.75 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.836 0.827 . . . . 100.0 110.186 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -68.1 155.6 39.24 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.192 -1.367 . . . . 100.0 113.323 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.56 -38.35 84.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 125.421 1.488 . . . . 100.0 110.415 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.91 -39.25 93.78 Favored Glycine 0 C--N 1.36 1.868 0 C-N-CA 124.673 1.13 . . . . 100.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HD1' HG21 ' A' ' 45' ' ' VAL . 61.0 t80 -62.24 -46.65 87.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.605 0.762 . . . . 100.0 110.84 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -68.94 -37.02 78.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 115.86 1.8 . . . . 100.0 115.86 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.9 mt -52.15 137.09 11.79 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 125.396 1.478 . . . . 100.0 113.89 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 64.27 26.26 13.68 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 127.999 2.52 . . . . 100.0 113.753 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.76 36.76 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.993 -1.484 . . . . 100.0 106.993 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.437 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.1 mm-40 -97.25 -37.54 10.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.558 -1.275 . . . . 100.0 107.558 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.8 p -142.54 160.14 40.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 122.701 0.4 . . . . 100.0 110.988 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -145.61 149.13 33.97 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 114.202 1.186 . . . . 100.0 114.202 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.5 mt -126.1 126.72 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.379 -2.823 . . . . 100.0 103.379 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 119' ' ' LEU . 51.5 mt -111.78 124.17 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.947 -2.983 . . . . 100.0 102.947 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 42.8 mtt -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.183 -1.371 . . . . 100.0 114.603 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -127.74 158.35 37.87 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.763 -2.471 . . . . 100.0 108.088 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.93 126.56 51.14 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.879 -1.897 . . . . 100.0 105.879 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.54 -21.94 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.332 0.864 . . . . 100.0 113.332 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.8 p -86.99 -8.71 56.93 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 119.266 -0.397 . . . . 100.0 111.167 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.38 115.34 23.32 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.34 1.067 . . . . 100.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -66.84 -38.23 86.01 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 114.895 -1.048 . . . . 100.0 111.383 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.79 -41.0 86.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 125.787 1.635 . . . . 100.0 110.216 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.3 m -62.44 -42.59 99.57 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 118.147 0.43 . . . . 100.0 109.968 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . 0.547 ' CE1' HG23 ' A' ' 136' ' ' ILE . 35.8 t80 -63.12 -41.55 99.36 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.567 0.747 . . . . 100.0 110.801 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.1 mttt -61.25 -37.44 83.11 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 100.0 111.155 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.96 -8.44 57.38 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 115.003 1.483 . . . . 100.0 115.003 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.66 -42.97 94.43 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 116.013 -1.946 . . . . 100.0 111.49 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.1 Cg_exo -57.56 -37.23 97.76 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.074 1.849 . . . . 100.0 112.692 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -63.11 -46.33 87.82 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.366 1.067 . . . . 100.0 110.85 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -64.02 -41.82 97.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 123.25 0.62 . . . . 100.0 111.213 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -61.82 -44.92 95.88 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 124.239 1.016 . . . . 100.0 109.66 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.88 -43.74 97.98 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 118.805 -0.617 . . . . 100.0 112.462 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.15 -45.33 93.92 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 121.251 0.548 . . . . 100.0 110.626 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.457 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.4 tp -62.81 -46.46 87.87 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.986 1.314 . . . . 100.0 112.647 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.19 -38.5 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 C-N-CA 125.237 1.415 . . . . 100.0 111.218 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -60.44 -46.38 90.27 Favored 'General case' 0 C--N 1.358 0.973 0 CA-C-O 118.833 -0.603 . . . . 100.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.75 -46.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 120.238 -0.585 . . . . 100.0 111.502 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.31 115.63 19.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -93.0 147.22 23.01 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.89 -0.596 . . . . 100.0 112.41 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 54.37 45.66 26.7 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.394 1.877 . . . . 100.0 114.871 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 84' ' ' GLN . 34.0 mm -99.35 131.45 25.04 Favored Pre-proline 0 N--CA 1.436 -1.139 0 C-N-CA 126.125 1.77 . . . . 100.0 106.802 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.89 130.02 27.94 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.601 2.2 . . . . 100.0 109.008 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.6 mt -130.47 137.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 122.369 1.081 . . . . 100.0 108.508 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -114.79 130.75 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.265 -2.124 . . . . 100.0 105.265 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 88' ' ' ILE . 34.3 mt -104.97 125.24 50.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.079 -2.563 . . . . 100.0 104.079 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.0 m -115.32 128.26 55.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.853 -1.521 . . . . 100.0 112.301 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.26 103.98 2.88 Favored Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.293 -3.123 . . . . 100.0 105.293 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -80.71 166.5 20.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 125.798 1.639 . . . . 100.0 111.725 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 56.58 44.66 23.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 128.29 2.636 . . . . 100.0 115.416 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.29 28.5 m -71.81 -9.33 12.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 120.416 -0.514 . . . . 100.0 110.724 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.91 -38.85 87.16 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 127.186 2.194 . . . . 100.0 110.279 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.55 129.88 34.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 107.414 -1.328 . . . . 100.0 107.414 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.98 -40.07 96.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 116.54 2.052 . . . . 100.0 116.54 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -85.63 98.69 10.81 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 104.426 -2.435 . . . . 100.0 104.426 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -100.72 109.36 21.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 105.384 -2.08 . . . . 100.0 105.384 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.18 -43.49 61.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.79 1.404 . . . . 100.0 114.79 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 HD11 ' A' ' 136' ' ' ILE . 48.0 t -108.49 108.54 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 104.73 -2.322 . . . . 100.0 104.73 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.01 179.73 4.19 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.189 -0.914 . . . . 100.0 113.422 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.51 -35.16 71.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.154 2.182 . . . . 100.0 109.318 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LYS . . . . . 1.07 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -59.45 -37.1 77.26 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 128.717 2.807 . . . . 100.0 112.017 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.3 p -105.01 -0.49 26.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 120.624 3.565 . . . . 100.0 120.624 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . 0.622 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 54.3 mt -99.46 96.01 4.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 115.372 -2.531 . . . . 100.0 111.346 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -100.06 -6.77 9.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 115.553 1.686 . . . . 100.0 115.553 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -58.79 -35.87 73.52 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . 0.46 ' ND1' HD12 ' A' ' 119' ' ' LEU . 77.7 m-70 -59.63 -39.55 84.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.588 1.555 . . . . 100.0 112.578 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 42.3 ttp180 -59.29 -47.08 86.71 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.108 1.363 . . . . 100.0 112.382 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.04 -43.62 98.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.806 1.242 . . . . 100.0 111.469 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 116.213 1.931 . . . . 100.0 116.213 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 54.6 47.42 22.67 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.296 1.438 . . . . 100.0 113.126 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 117' ' ' ILE . 30.4 mt -107.22 149.63 27.52 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.245 -1.761 . . . . 100.0 106.245 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -96.38 144.47 26.49 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 120.709 -0.397 . . . . 100.0 111.868 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.426 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 77.5 t80 -106.45 133.59 50.9 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 123.766 0.666 . . . . 100.0 112.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -130.01 132.41 46.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.184 -1.371 . . . . 100.0 110.416 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.314 35.2 m-20 -85.15 122.73 29.77 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 102.054 -3.313 . . . . 100.0 102.054 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 pt -135.88 157.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.574 1.178 . . . . 100.0 112.037 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 61.9 m -137.34 112.87 9.39 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.568 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -63.26 -43.88 96.71 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.735 -1.575 . . . . 100.0 112.772 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.83 -41.09 99.19 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.352 1.061 . . . . 100.0 112.098 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.1 p -97.48 2.37 50.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 117.563 2.431 . . . . 100.0 117.563 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 66.67 20.03 10.75 Favored 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.638 1.175 . . . . 100.0 110.846 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.46 -0.571 . . . . 100.0 109.46 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.11 39.79 30.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 128.709 2.804 . . . . 100.0 115.725 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . 0.488 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 76.8 t80 -61.82 -44.89 95.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 121.618 -0.676 . . . . 100.0 112.146 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.14 -37.27 86.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 116.87 2.174 . . . . 100.0 116.87 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.74 -46.82 99.71 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 119.166 3.024 . . . . 100.0 119.166 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -60.7 -42.2 40.92 Favored 'Trans proline' 0 C--N 1.372 1.813 0 CA-C-N 123.204 2.18 . . . . 100.0 111.544 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -64.24 -42.48 96.51 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 124.839 1.256 . . . . 100.0 111.76 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.81 -45.38 92.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 123.775 0.83 . . . . 100.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.18 -43.34 95.42 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 123.549 0.531 . . . . 100.0 110.424 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.5 mt -61.6 -44.07 97.69 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 123.509 0.505 . . . . 100.0 111.508 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.04 97.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.126 0.97 . . . . 100.0 111.062 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -62.43 -45.67 92.03 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 123.242 0.617 . . . . 100.0 112.075 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -65.71 -44.73 85.21 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.76 0.663 . . . . 100.0 111.764 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.0 mt -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 124.073 0.949 . . . . 100.0 113.141 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.16 -38.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.436 -0.579 . . . . 100.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.72 10.53 58.9 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 110.138 -1.185 . . . . 100.0 110.138 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.71 111.74 56.66 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 107.812 -1.181 . . . . 100.0 107.812 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.82 -15.85 29.75 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.776 2.984 . . . . 100.0 113.734 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -87.59 0.32 55.8 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.025 0.93 . . . . 100.0 113.133 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.78 132.03 48.43 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.178 0.591 . . . . 100.0 109.892 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -135.29 152.08 51.16 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 108.679 -0.859 . . . . 100.0 108.679 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -89.11 111.83 22.67 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 104.782 -2.303 . . . . 100.0 104.782 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.08 -43.91 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.243 1.017 . . . . 100.0 110.824 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.51 149.14 49.54 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 121.583 0.706 . . . . 100.0 110.559 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 59.5 ttm -91.39 125.45 57.99 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.433 -2.062 . . . . 100.0 105.433 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.28 157.4 60.23 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 123.039 2.493 . . . . 100.0 111.156 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.35 126.19 27.43 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.1 -1.074 . . . . 100.0 108.1 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.71 145.19 47.74 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 114.36 -1.291 . . . . 100.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.98 138.75 97.49 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.699 -1.223 . . . . 100.0 107.699 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -55.72 138.54 81.59 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.642 2.894 . . . . 100.0 112.3 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.36 129.59 30.42 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.753 2.302 . . . . 100.0 113.726 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -67.08 -43.67 82.03 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 124.774 1.296 . . . . 100.0 108.754 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.77 160.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.322 -1.733 . . . . 100.0 106.322 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.69 130.72 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 107.755 -1.202 . . . . 100.0 107.755 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 tpt -80.88 122.72 27.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.789 -2.3 . . . . 100.0 104.789 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 35.9 t70 -65.9 128.2 93.66 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.13 -0.941 . . . . 100.0 109.411 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 53.7 Cg_exo -59.03 -39.06 83.98 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.54 2.827 . . . . 100.0 113.6 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.98 92.91 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 124.337 1.023 . . . . 100.0 110.832 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.8 -42.75 97.65 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 122.65 0.38 . . . . 100.0 111.653 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.16 97.4 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 123.546 0.738 . . . . 100.0 110.612 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.77 97.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.031 0.932 . . . . 100.0 110.672 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -63.76 -43.08 97.49 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.186 0.594 . . . . 100.0 112.077 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -63.03 -44.16 96.68 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 122.733 0.413 . . . . 100.0 111.273 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.89 -40.64 96.99 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 122.957 0.503 . . . . 100.0 110.477 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.55 -43.93 97.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.75 1.22 . . . . 100.0 110.78 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.06 -42.5 99.26 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.898 0.879 . . . . 100.0 110.169 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' LEU . . . . . 0.502 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.6 tp -59.9 -49.04 79.24 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.156 0.91 . . . . 100.0 110.033 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -43.44 98.12 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 115.203 1.557 . . . . 100.0 115.203 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.33 -46.74 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 CA-C-O 118.388 -0.815 . . . . 100.0 109.673 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.407 . . -94.61 0.54 55.24 Favored 'General case' 0 N--CA 1.404 -2.752 1 C-N-CA 109.655 -4.818 . . . . 100.0 114.332 179.711 . . . . . . . . 4 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLN . . . . . 0.798 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.301 62.4 mt-30 -56.51 -37.01 69.84 Favored 'General case' 0 CA--C 1.465 -2.32 0 N-CA-C 106.354 -1.721 . . . . 100.0 106.354 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.9 p -82.03 52.82 2.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.247 1.022 . . . . 100.0 109.303 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.324 80.5 p 48.83 38.81 12.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.522 3.129 . . . . 100.0 116.111 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.12 -177.16 6.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.417 -2.438 . . . . 100.0 104.417 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LEU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 85.7 mt -56.46 -41.54 91.67 Favored Pre-proline 0 CA--C 1.502 -0.902 0 CA-C-O 116.014 -1.946 . . . . 100.0 114.545 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PRO . . . . . 1.07 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.309 23.3 Cg_exo -55.35 136.67 74.67 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 121.354 1.519 . . . . 100.0 112.382 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.8 m-20 -63.71 -47.57 80.61 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 124.493 4.997 . . . . 100.0 124.493 -173.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.4 mt-10 -62.88 -35.64 80.69 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 128.285 3.898 . . . . 100.0 107.918 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . 0.798 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.483 44.9 m-20 -65.49 -48.73 71.58 Favored 'General case' 1 N--CA 1.35 -5.426 1 CA-C-N 107.563 -4.381 . . . . 100.0 106.493 -179.017 . . . . . . . . 5 3 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.32 -29.85 71.09 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 120.448 -1.407 . . . . 100.0 108.168 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.664 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.35 -42.99 88.13 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-O 117.297 -1.335 . . . . 100.0 113.41 176.439 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.26 1.645 0 CA-C-O 115.478 -2.201 . . . . 100.0 113.968 -176.288 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.118 0 N-CA-C 113.416 0.895 . . . . 100.0 113.416 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.36 84.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.34 156.15 18.44 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.407 0.892 . . . . 100.0 113.407 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -80.22 160.53 25.57 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 123.843 0.857 . . . . 100.0 110.986 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.48 7.74 87.14 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.068 -0.515 . . . . 100.0 113.719 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -81.94 156.65 69.7 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 117.858 0.829 . . . . 100.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.71 155.23 64.59 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.422 2.748 . . . . 100.0 111.043 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.95 132.58 37.65 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.385 2.735 . . . . 100.0 118.385 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.3 t -92.29 116.07 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.094 -1.866 . . . . 100.0 106.472 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.74 138.89 53.44 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.904 -1.953 . . . . 100.0 108.102 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.66 146.06 50.33 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.753 -0.832 . . . . 100.0 108.753 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -94.67 120.54 35.06 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 104.731 -2.322 . . . . 100.0 104.731 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.542 HD23 HG22 ' A' ' 63' ' ' VAL . 55.3 tp -112.12 126.25 54.99 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.964 -1.926 . . . . 100.0 106.551 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 79' ' ' TYR . 43.0 t -101.82 123.19 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.097 -1.446 . . . . 100.0 107.097 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.5 tp -110.89 116.51 31.36 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.094 -2.558 . . . . 100.0 104.094 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -128.8 163.4 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 120.765 0.317 . . . . 100.0 111.797 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.54 173.47 22.76 Favored Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 107.848 -2.101 . . . . 100.0 107.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -68.12 154.91 40.71 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.964 0.888 . . . . 100.0 112.574 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.85 140.0 41.64 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.606 -2.198 . . . . 100.0 107.606 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 -4.34 82.11 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.469 -1.184 . . . . 100.0 113.868 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.6 p -62.87 -39.01 93.13 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 119.055 1.428 . . . . 100.0 111.372 178.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 22.82 4.53 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 110.322 -1.111 . . . . 100.0 110.322 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 50.0 mtpt -59.52 -46.56 88.48 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 124.554 1.142 . . . . 100.0 112.889 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -63.23 -44.29 95.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.411 1.084 . . . . 100.0 110.087 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -62.47 -42.01 99.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.294 1.037 . . . . 100.0 109.178 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -60.75 -48.73 80.47 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.06 0.944 . . . . 100.0 113.285 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.9 -40.89 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.064 0.459 . . . . 100.0 110.523 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.27 99.6 mttt -69.35 -6.85 32.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.174 1.916 . . . . 100.0 116.174 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 49.1 mtt180 -60.7 -37.89 83.17 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.03 -1.1 . . . . 100.0 108.03 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 54.0 t-80 -80.87 112.92 18.7 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.48 -43.59 98.44 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.854 1.798 . . . . 100.0 115.854 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 78.8 m -63.75 -40.95 97.96 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.904 -0.776 . . . . 100.0 108.904 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.78 99.5 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.388 -1.085 . . . . 100.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.274 81.0 mt-10 -63.77 -45.15 91.09 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 117.38 0.59 . . . . 100.0 111.649 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.81 -40.32 97.02 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.256 1.022 . . . . 100.0 111.857 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -93.23 8.91 38.34 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 114.841 1.422 . . . . 100.0 114.841 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -60.87 142.57 56.12 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 113.743 1.016 . . . . 100.0 113.743 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -124.01 131.05 53.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.994 -1.003 . . . . 100.0 108.378 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -101.05 123.64 45.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.541 -2.022 . . . . 100.0 105.541 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.64 112.19 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 102.809 -3.034 . . . . 100.0 102.809 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.86 94.98 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 116.471 2.026 . . . . 100.0 116.471 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -61.9 -48.44 80.47 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 122.895 0.478 . . . . 100.0 110.578 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.64 -38.62 70.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.67 1.359 . . . . 100.0 114.67 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.77 44.04 21.26 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 106.312 -2.715 . . . . 100.0 106.312 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 94.5 t -129.86 144.61 37.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.726 1.21 . . . . 100.0 109.271 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -106.1 118.96 37.97 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.077 -3.305 . . . . 100.0 102.077 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.46 120.88 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.267 -1.753 . . . . 100.0 106.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -113.16 119.5 42.23 Favored Pre-proline 0 N--CA 1.434 -1.234 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.55 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -80.32 104.25 1.61 Allowed 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.654 2.236 . . . . 100.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.4 113.97 26.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.31 -0.996 . . . . 100.0 108.31 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.85 127.19 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.272 -1.381 . . . . 100.0 107.272 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.56 135.09 55.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.461 -2.052 . . . . 100.0 105.461 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -102.52 117.6 35.05 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.32 -0.622 . . . . 100.0 109.32 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.5 p -107.09 175.92 5.34 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.816 0.817 . . . . 100.0 110.288 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.26 -35.0 74.52 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.314 1.445 . . . . 100.0 109.502 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.59 -2.33 58.54 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 113.499 0.926 . . . . 100.0 113.499 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.6 -179.72 16.2 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.593 -1.003 . . . . 100.0 110.593 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.74 140.13 54.94 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.869 2.379 . . . . 100.0 115.833 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.13 130.06 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 102.304 -3.221 . . . . 100.0 102.304 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.45 128.35 56.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -110.19 116.31 31.28 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -87.67 106.8 18.28 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.812 -4.144 . . . . 100.0 99.812 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG22 HD23 ' A' ' 13' ' ' LEU . 22.6 t -93.36 123.76 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.396 0 N-CA-C 106.412 -1.699 . . . . 100.0 106.412 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -97.8 114.5 26.55 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 105.838 -1.912 . . . . 100.0 105.838 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -109.33 135.2 50.78 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.5 p -72.28 163.45 27.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.874 0.845 . . . . 100.0 112.559 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.14 20.55 12.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.206 -0.906 . . . . 100.0 108.586 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.85 12.21 58.16 Favored Glycine 0 C--N 1.359 1.847 0 CA-C-O 119.341 -0.699 . . . . 100.0 114.128 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 90.7 mt-30 -60.29 -31.37 70.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.259 1.824 . . . . 100.0 112.591 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -57.54 -32.38 67.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.924 2.49 . . . . 100.0 111.813 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.88 -39.62 95.03 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 123.527 0.731 . . . . 100.0 111.565 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 22.9 p90 -94.87 -14.14 24.83 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.774 1.398 . . . . 100.0 114.774 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.58 -160.36 26.96 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 119.933 -1.127 . . . . 100.0 112.422 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.02 176.95 54.54 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 109.874 -1.29 . . . . 100.0 109.874 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD13 ' CE2' ' A' ' 79' ' ' TYR . 86.9 mt -105.31 143.5 33.4 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.49 -0.929 . . . . 100.0 108.49 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -70.5 160.11 33.04 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.02 -0.991 . . . . 100.0 113.175 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -59.48 -37.99 79.66 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 125.443 1.497 . . . . 100.0 110.237 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.37 91.8 Favored Glycine 0 C--N 1.358 1.797 0 C-N-CA 124.77 1.176 . . . . 100.0 111.29 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.0 t80 -62.98 -47.0 85.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.33 0.565 . . . . 100.0 111.218 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -70.51 -36.73 73.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 116.976 2.213 . . . . 100.0 116.976 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.5 mt -50.86 134.64 11.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-O 123.189 1.471 . . . . 100.0 114.796 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 61.19 29.26 18.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 128.023 2.529 . . . . 100.0 113.877 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 133.12 42.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -96.39 -26.26 15.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 110.103 -0.332 . . . . 100.0 110.103 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' HB2' HD22 ' A' ' 164' ' ' LEU . 18.7 p -153.22 162.61 41.11 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.852 0.358 . . . . 100.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.6 152.84 38.6 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 114.413 1.264 . . . . 100.0 114.413 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.6 mt -126.17 125.89 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 103.41 -2.811 . . . . 100.0 103.41 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' HB ' HD22 ' A' ' 119' ' ' LEU . 48.6 mt -109.74 125.31 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 102.87 -3.011 . . . . 100.0 102.87 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 15' ' ' LEU . 89.3 mtp -110.46 135.91 50.41 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.923 1.083 . . . . 100.0 113.923 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.76 162.43 28.45 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 112.686 -2.052 . . . . 100.0 107.14 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . 0.436 ' HA ' ' ND2' ' A' ' 122' ' ' ASN . 67.5 t0 -106.53 124.37 49.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.962 -1.496 . . . . 100.0 106.962 -179.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.18 -18.86 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 114.211 1.189 . . . . 100.0 114.211 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.5 p -89.44 -7.5 54.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 118.378 0.535 . . . . 100.0 111.18 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 m -124.98 116.78 22.71 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.596 1.189 . . . . 100.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -63.32 -38.51 91.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.459 1.503 . . . . 100.0 111.872 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.59 -40.88 83.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 125.872 1.669 . . . . 100.0 110.72 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.2 p -62.19 -41.53 98.43 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 118.192 0.451 . . . . 100.0 111.77 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -65.02 -40.95 95.61 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.559 0.743 . . . . 100.0 110.251 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.1 mttt -61.38 -36.45 80.29 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.531 1.132 . . . . 100.0 111.142 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.18 -3.85 53.53 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 115.272 1.582 . . . . 100.0 115.272 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 119' ' ' LEU . 77.2 t -60.55 -41.94 85.73 Favored Pre-proline 0 C--N 1.362 1.128 0 CA-C-O 116.572 -1.68 . . . . 100.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 63.0 Cg_exo -56.86 -38.3 96.17 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.292 1.995 . . . . 100.0 112.864 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.61 -45.25 91.19 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.59 1.156 . . . . 100.0 110.873 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -64.46 -41.36 96.57 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.122 0.264 . . . . 100.0 111.356 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.21 -44.32 96.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.619 0.767 . . . . 100.0 110.14 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -61.99 -45.26 94.42 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 119.015 -0.517 . . . . 100.0 112.179 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.53 -42.43 98.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 O-C-N 123.24 0.337 . . . . 100.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 86' ' ' ALA . 50.6 tp -62.9 -48.16 80.17 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.783 0.833 . . . . 100.0 112.469 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.279 22.9 m -67.2 -29.23 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -60.62 -47.28 86.93 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.778 -0.823 . . . . 100.0 108.778 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.85 -45.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 112.598 0.592 . . . . 100.0 112.598 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.7 m -124.61 107.79 11.39 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.985 0.898 . . . . 100.0 110.077 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.89 140.05 30.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.358 -0.837 . . . . 100.0 111.59 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.13 39.57 31.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.981 2.113 . . . . 100.0 116.701 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.1 144.99 29.24 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 106.635 -1.617 . . . . 100.0 106.635 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -62.59 132.08 36.39 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.21 2.606 . . . . 100.0 109.691 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.801 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.0 mt -134.18 137.57 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.198 0.999 . . . . 100.0 108.364 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.13 132.1 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 105.593 -2.002 . . . . 100.0 105.593 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 101' ' ' VAL 0.294 23.2 mt -105.95 131.04 53.74 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 103.725 -2.694 . . . . 100.0 103.725 175.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.49 131.21 55.54 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.052 -1.431 . . . . 100.0 112.48 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.3 104.97 2.89 Favored Glycine 0 CA--C 1.486 -1.757 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.436 ' ND2' ' HA ' ' A' ' 91' ' ' ASP . 0.4 OUTLIER -86.73 173.21 9.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.185 1.179 . . . . 100.0 114.185 -178.598 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 mttp 60.26 40.39 17.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.141 2.576 . . . . 100.0 113.725 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.339 28.5 m -71.76 -7.79 10.02 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 120.33 -0.548 . . . . 100.0 111.495 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.71 -38.21 89.55 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.464 1.906 . . . . 100.0 110.334 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -69.74 130.18 34.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 N-CA-C 108.514 -0.921 . . . . 100.0 108.514 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.14 -41.82 98.64 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 117.223 2.305 . . . . 100.0 117.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -85.49 94.57 9.04 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.146 -1.798 . . . . 100.0 106.146 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -92.66 123.96 36.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 104.921 -2.251 . . . . 100.0 104.921 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.69 -36.62 10.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 113.301 0.852 . . . . 100.0 113.301 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.93 104.07 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 103.752 -2.684 . . . . 100.0 103.752 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.25 172.77 7.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.905 -1.043 . . . . 100.0 111.513 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.411 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.08 -31.9 65.71 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.267 1.827 . . . . 100.0 109.401 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.028 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -57.11 -39.08 74.39 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 130.092 3.357 . . . . 100.0 111.391 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.2 p -105.06 2.27 29.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 117.047 2.24 . . . . 100.0 117.047 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 60.3 mt -89.43 84.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.361 1.088 0 C-N-CA 118.062 -1.455 . . . . 100.0 110.576 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 2.3 p -100.81 -6.09 9.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HD2' HD11 ' A' ' 119' ' ' LEU . 65.8 t80 -59.37 -37.37 77.73 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 116.09 1.885 . . . . 100.0 116.09 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.275 78.6 m-70 -59.5 -37.97 79.69 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 116.718 2.118 . . . . 100.0 116.718 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.866 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 43.6 ttp85 -59.01 -49.28 78.48 Favored 'General case' 0 CA--C 1.471 -2.092 0 O-C-N 124.178 0.924 . . . . 100.0 112.964 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.63 -41.19 98.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 125.456 1.723 . . . . 100.0 111.074 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.6 mmtt -95.04 0.32 54.4 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.206 2.298 . . . . 100.0 117.206 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 58.32 40.04 24.9 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.155 1.382 . . . . 100.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.801 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.6 mt -101.9 152.52 20.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.754 -1.943 . . . . 100.0 105.754 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.29 143.24 30.71 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.206 -0.665 . . . . 100.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 84.4 t80 -110.32 136.53 49.36 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.299 1.222 . . . . 100.0 114.299 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -134.42 137.61 44.15 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.432 -1.258 . . . . 100.0 111.18 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.276 72.6 m-20 -84.72 128.64 34.7 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 102.688 -3.078 . . . . 100.0 102.688 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.513 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.8 pt -134.22 157.84 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.702 1.239 . . . . 100.0 111.303 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 70.4 m -139.04 108.49 6.15 Favored 'General case' 0 CA--C 1.48 -1.714 0 N-CA-C 104.861 -2.274 . . . . 100.0 104.861 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.8 -44.18 97.38 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.712 -1.131 . . . . 100.0 112.529 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -61.47 -39.24 90.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 124.853 1.261 . . . . 100.0 112.734 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 92.3 p -100.31 2.09 42.23 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 115.868 1.803 . . . . 100.0 115.868 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 68.0 m-80 65.19 20.68 12.0 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.94 1.296 . . . . 100.0 110.99 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 83.4 t80 -72.94 125.7 28.21 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.473 -0.936 . . . . 100.0 108.473 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 54.05 36.68 25.2 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 128.185 2.594 . . . . 100.0 114.584 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 64.3 t80 -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.359 0.99 0 O-C-N 121.881 -0.512 . . . . 100.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -63.67 -38.49 91.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.499 2.037 . . . . 100.0 116.499 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.12 -47.97 98.19 Favored Pre-proline 0 C--N 1.358 0.938 0 N-CA-C 120.097 3.369 . . . . 100.0 120.097 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.15 -41.08 45.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 CA-C-N 123.475 2.277 . . . . 100.0 112.592 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.21 -42.45 96.59 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.712 1.205 . . . . 100.0 110.814 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.23 -44.29 92.32 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 118.795 -0.621 . . . . 100.0 111.628 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -64.88 -42.26 94.96 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 123.499 0.499 . . . . 100.0 110.389 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.8 mt -61.54 -43.82 98.16 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.453 0.47 . . . . 100.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.52 -44.18 97.52 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.076 0.951 . . . . 100.0 110.656 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.58 -45.6 93.42 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 122.672 0.389 . . . . 100.0 111.783 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -66.17 -44.54 83.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.858 0.688 . . . . 100.0 112.858 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.26 -45.19 89.18 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 113.451 0.908 . . . . 100.0 113.451 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 50.9 mm -74.52 -30.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.902 0.881 . . . . 100.0 110.11 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.79 13.82 66.28 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 118.635 -1.091 . . . . 100.0 111.447 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -116.39 112.31 41.55 Favored Pre-proline 0 C--N 1.363 1.168 0 CA-C-N 118.439 1.119 . . . . 100.0 108.044 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.99 -14.1 31.98 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.749 2.966 . . . . 100.0 113.255 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -85.63 -3.18 58.81 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.125 0.97 . . . . 100.0 113.026 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.84 134.21 56.86 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 113.226 0.825 . . . . 100.0 113.226 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.14 149.29 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.525 -1.216 . . . . 100.0 108.235 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -90.03 114.62 26.53 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 103.525 -2.769 . . . . 100.0 103.525 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.24 -40.04 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.53 146.8 52.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.8 mtt -88.27 129.61 48.99 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.336 -1.727 . . . . 100.0 106.336 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.27 158.48 52.14 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.276 1.984 . . . . 100.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.43 124.88 23.98 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.722 -1.214 . . . . 100.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.54 145.85 45.02 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 114.263 -1.335 . . . . 100.0 110.403 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.38 136.28 96.63 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.796 -1.927 . . . . 100.0 105.796 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 138.88 77.58 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 123.55 2.833 . . . . 100.0 112.553 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -57.81 129.09 31.71 Favored 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.23 1.954 . . . . 100.0 113.509 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.86 -43.8 82.65 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 124.701 1.251 . . . . 100.0 108.085 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 158.24 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.58 -1.637 . . . . 100.0 106.58 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.42 131.89 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.47 123.91 32.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.654 -2.721 . . . . 100.0 103.654 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.85 128.65 92.29 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 114.779 -1.101 . . . . 100.0 110.565 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.7 -37.65 93.09 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.725 2.95 . . . . 100.0 113.546 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.06 95.23 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 123.979 0.8 . . . . 100.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.3 -42.22 99.03 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 122.769 0.428 . . . . 100.0 111.147 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.2 97.73 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 123.703 0.801 . . . . 100.0 110.625 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.03 97.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.508 0.723 . . . . 100.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.26 -44.75 95.83 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.758 0.823 . . . . 100.0 112.075 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -63.49 -43.51 97.04 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 122.918 0.487 . . . . 100.0 111.793 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.19 -39.83 94.83 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.707 -0.224 . . . . 100.0 111.19 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.78 -42.67 99.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.158 0.983 . . . . 100.0 110.007 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -61.51 -42.35 98.68 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.838 0.855 . . . . 100.0 110.645 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 81.9 mt -61.03 -48.43 81.84 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.391 -0.822 . . . . 100.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.48 -41.84 98.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.66 -47.14 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.968 0 CA-C-O 118.221 -0.895 . . . . 100.0 109.124 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.959 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.705 . . -88.87 -8.67 53.85 Favored 'General case' 1 N--CA 1.379 -4.008 1 C-N-CA 104.543 -6.863 . . . . 100.0 116.647 179.881 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 1.037 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 55.1 mt-30 -53.48 -34.89 59.7 Favored 'General case' 0 CA--C 1.444 -3.108 0 C-N-CA 128.179 2.591 . . . . 100.0 107.507 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -82.73 41.47 0.73 Allowed 'General case' 0 N--CA 1.416 -2.133 0 O-C-N 124.825 1.328 . . . . 100.0 109.766 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 205' ' ' GLN . 4.6 m 57.96 30.24 18.86 Favored 'General case' 0 CA--C 1.473 -1.988 0 C-N-CA 127.13 2.172 . . . . 100.0 112.578 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.275 . . -73.61 175.51 7.05 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 101.155 -3.646 . . . . 100.0 101.155 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.03 -36.7 49.04 Favored Pre-proline 0 CA--C 1.489 -1.393 0 CA-C-O 116.359 -1.781 . . . . 100.0 114.024 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.028 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.457 0.3 OUTLIER -53.58 137.79 66.35 Favored 'Trans proline' 0 N--CA 1.433 -2.088 0 O-C-N 123.814 1.428 . . . . 100.0 112.634 176.602 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.305 99.3 m-20 -64.01 -43.03 96.86 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 121.499 3.888 . . . . 100.0 121.499 -172.552 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.1 tm-20 -71.42 -16.03 62.37 Favored 'General case' 0 CA--C 1.463 -2.394 1 CA-C-O 130.799 5.095 . . . . 100.0 112.989 177.989 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 1.037 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.785 66.3 m-20 -86.07 -50.04 7.33 Favored 'General case' 1 N--CA 1.257 -10.116 1 CA-C-N 105.781 -5.19 . . . . 100.0 104.025 -172.932 . . . . . . . . 5 3 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 140' ' ' ARG . 37.8 t70 -62.05 -28.96 69.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.255 -2.153 . . . . 100.0 106.528 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.866 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 73.0 m-20 -61.77 -40.29 94.64 Favored 'General case' 0 CA--C 1.476 -1.889 0 C-N-CA 126.925 2.09 . . . . 100.0 112.591 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.283 0.6 OUTLIER . . . . . 0 N--CA 1.428 -1.558 0 CA-C-O 115.334 -2.27 . . . . 100.0 114.301 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.598 0.237 . . . . 100.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.17 68.51 9.93 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.081 -1.451 . . . . 100.0 107.081 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.13 158.67 43.26 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.468 -1.308 . . . . 100.0 107.468 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.99 156.58 21.08 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.489 -0.778 . . . . 100.0 109.058 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.83 8.26 84.58 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 119.377 -0.68 . . . . 100.0 113.796 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -71.92 138.57 82.43 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 117.911 0.855 . . . . 100.0 110.965 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.05 135.43 54.96 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.607 2.205 . . . . 100.0 109.841 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -76.02 150.89 37.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 124.555 1.16 . . . . 100.0 112.935 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.3 t -93.18 109.67 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 101.759 -3.422 . . . . 100.0 101.759 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -128.58 138.13 52.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.534 -0.757 . . . . 100.0 109.876 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.75 144.09 51.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.4 122.54 34.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.596 -2.001 . . . . 100.0 105.596 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.21 126.53 55.16 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 79' ' ' TYR . 67.7 t -104.27 124.36 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.773 -1.195 . . . . 100.0 107.773 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.418 HD11 ' SD ' ' A' ' 89' ' ' MET . 38.1 tp -108.7 118.83 37.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.039 -1.837 . . . . 100.0 106.039 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.81 162.36 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.802 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.24 172.78 22.52 Favored Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.015 -2.034 . . . . 100.0 108.015 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -66.74 153.45 43.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.958 0.885 . . . . 100.0 111.973 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.24 140.89 43.89 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.471 -2.252 . . . . 100.0 107.471 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.57 -3.08 85.12 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-O 118.568 -1.129 . . . . 100.0 114.37 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -62.77 -38.53 90.97 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.868 1.334 . . . . 100.0 112.248 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 23.55 3.79 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 110.247 -1.141 . . . . 100.0 110.247 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 51.8 mtpt -59.98 -47.78 84.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.382 1.073 . . . . 100.0 113.163 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -64.17 -42.76 96.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 123.906 0.882 . . . . 100.0 110.42 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -62.53 -42.04 99.26 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.209 1.004 . . . . 100.0 109.309 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -60.29 -49.59 77.01 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.663 1.185 . . . . 100.0 112.646 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.37 -41.63 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 123.547 0.529 . . . . 100.0 111.168 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.302 99.4 mttt -69.45 -6.63 31.61 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 115.775 1.769 . . . . 100.0 115.775 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 154' ' ' ASN . 43.2 mtm180 -60.23 -38.22 82.75 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 109.013 -0.736 . . . . 100.0 109.013 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -81.32 112.22 18.41 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.637 -1.616 . . . . 100.0 106.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.92 -45.12 95.11 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.191 1.923 . . . . 100.0 116.191 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.8 m -63.73 -41.15 98.1 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.252 0.621 . . . . 100.0 109.63 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.66 99.59 Favored Glycine 0 C--N 1.358 1.799 0 N-CA-C 110.841 -0.904 . . . . 100.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.76 -46.52 84.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.824 0.85 . . . . 100.0 111.14 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -63.96 -39.63 94.57 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 113.003 0.742 . . . . 100.0 113.003 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -93.27 11.65 27.32 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 115.4 1.63 . . . . 100.0 115.4 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.85 144.84 51.95 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 113.896 1.073 . . . . 100.0 113.896 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -122.23 130.74 53.47 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.219 -1.03 . . . . 100.0 108.219 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -101.06 125.46 47.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.876 -1.157 . . . . 100.0 107.876 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -99.32 109.18 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.47 98.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 116.649 2.092 . . . . 100.0 116.649 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.4 m -61.92 -44.29 97.08 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.004 0.922 . . . . 100.0 110.925 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.76 -21.39 23.83 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 114.303 1.223 . . . . 100.0 114.303 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.7 45.72 51.01 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 109.296 -1.522 . . . . 100.0 109.296 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.84 144.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 109.147 -0.686 . . . . 100.0 109.147 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -108.26 118.33 36.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 101.598 -3.482 . . . . 100.0 101.598 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.21 120.09 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.71 -1.959 . . . . 100.0 105.71 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -111.52 119.43 45.08 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.825 -0.625 . . . . 100.0 110.076 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.46 103.31 1.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.604 2.203 . . . . 100.0 111.062 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.35 116.03 28.81 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.21 128.46 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.278 -1.378 . . . . 100.0 107.278 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.38 135.6 54.73 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -102.08 117.49 34.9 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -108.56 175.59 5.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.761 0.791 . . . . 100.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.52 -32.97 71.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.39 1.476 . . . . 100.0 109.919 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -92.37 3.81 54.68 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.401 0.889 . . . . 100.0 113.401 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.92 177.93 17.26 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 121.274 -0.891 . . . . 100.0 111.67 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.11 140.45 59.66 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.16 2.573 . . . . 100.0 114.751 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.3 131.12 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 103.057 -2.942 . . . . 100.0 103.057 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -114.4 128.77 56.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.569 -0.53 . . . . 100.0 109.569 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.47 115.7 29.65 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 104.946 -2.242 . . . . 100.0 104.946 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -88.32 105.81 17.81 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 101.051 -3.685 . . . . 100.0 101.051 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.53 123.3 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 107.87 -1.159 . . . . 100.0 107.87 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -95.03 115.73 27.8 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.041 -1.466 . . . . 100.0 107.041 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -111.13 137.62 48.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.625 -1.62 . . . . 100.0 106.625 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -72.77 164.59 26.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.252 1.025 . . . . 100.0 112.38 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.53 22.88 10.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.77 15.63 59.39 Favored Glycine 0 C--N 1.362 1.98 0 O-C-N 121.612 -0.68 . . . . 100.0 113.122 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 60.3 mt-30 -59.64 -35.1 73.73 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 127.077 2.151 . . . . 100.0 112.364 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.47 -33.1 69.38 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 128.064 2.545 . . . . 100.0 112.011 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.42 -39.37 94.31 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.173 0.589 . . . . 100.0 111.569 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 12.6 p90 -94.66 -7.85 39.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.12 -163.38 35.0 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 119.405 1.002 . . . . 100.0 112.382 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.67 -179.59 53.0 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 108.639 -1.784 . . . . 100.0 108.639 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 92.8 mt -107.52 142.22 37.76 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.603 0.716 . . . . 100.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -70.16 157.31 37.85 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.586 -1.188 . . . . 100.0 112.455 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -59.96 -37.57 79.96 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 124.993 1.317 . . . . 100.0 110.623 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.3 -37.45 87.29 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 125.193 1.378 . . . . 100.0 111.102 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 90.0 t80 -62.59 -45.8 91.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.417 0.687 . . . . 100.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -75.58 -28.7 59.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.401 2.0 . . . . 100.0 116.401 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.7 mt -51.31 131.63 12.35 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 123.269 1.509 . . . . 100.0 114.824 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.263 52.9 mt-30 59.87 29.9 19.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 128.899 2.88 . . . . 100.0 114.006 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.36 132.06 45.8 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.015 -1.846 . . . . 100.0 106.015 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.09 -31.53 13.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.473 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.5 p -151.81 163.51 39.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.457 -0.572 . . . . 100.0 109.457 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.67 41.98 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 114.64 1.348 . . . . 100.0 114.64 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.3 mt -127.56 126.38 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 104.072 -2.566 . . . . 100.0 104.072 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.692 ' HB ' HD22 ' A' ' 119' ' ' LEU . 33.3 mt -110.51 124.49 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 102.898 -3.001 . . . . 100.0 102.898 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.5 mtp -111.94 137.08 50.42 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -130.73 163.69 26.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.537 -2.119 . . . . 100.0 107.706 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -106.67 127.25 53.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.076 -1.824 . . . . 100.0 106.076 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.21 -15.93 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.428 0.899 . . . . 100.0 113.428 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.8 p -90.25 -6.85 54.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.072 0.396 . . . . 100.0 110.543 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -125.75 116.04 20.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.449 1.119 . . . . 100.0 110.561 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.0 -37.7 88.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.591 1.156 . . . . 100.0 112.217 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.59 -40.16 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.983 1.713 . . . . 100.0 110.322 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -62.34 -41.68 98.77 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 118.344 0.52 . . . . 100.0 111.28 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.63 -40.92 96.32 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.268 0.627 . . . . 100.0 110.423 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -60.57 -36.95 79.75 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 123.941 0.896 . . . . 100.0 111.091 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -79.11 -5.91 55.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 119' ' ' LEU . 89.8 t -59.94 -42.79 92.46 Favored Pre-proline 0 C--N 1.364 1.215 0 CA-C-O 116.466 -1.73 . . . . 100.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 72.9 Cg_exo -57.8 -37.51 96.18 Favored 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 122.25 1.839 . . . . 100.0 112.69 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -64.14 -44.38 92.35 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.873 1.269 . . . . 100.0 111.076 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -64.64 -40.91 96.28 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 122.877 0.471 . . . . 100.0 110.915 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.73 -44.01 97.73 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 124.09 0.956 . . . . 100.0 109.395 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.46 -45.56 93.77 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 123.71 0.804 . . . . 100.0 111.66 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.0 -45.81 91.95 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.375 0.67 . . . . 100.0 110.699 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.67 -47.27 81.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.665 1.186 . . . . 100.0 113.259 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.321 25.9 m -65.84 -33.8 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 N-CA-C 113.597 0.962 . . . . 100.0 113.597 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 110' ' ' ARG . 55.6 mtt85 -60.14 -46.71 88.75 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 123.813 0.696 . . . . 100.0 109.227 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.07 -44.37 50.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 112.16 0.43 . . . . 100.0 112.16 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.88 107.7 10.74 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.997 0.903 . . . . 100.0 110.715 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.71 138.93 32.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.025 -0.988 . . . . 100.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 53.52 42.02 32.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 117.547 2.425 . . . . 100.0 117.547 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.0 pt -94.99 144.64 28.15 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 106.353 -1.721 . . . . 100.0 106.353 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.61 133.45 42.54 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.36 2.04 . . . . 100.0 110.43 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.775 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.8 mt -133.98 137.45 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.343 -0.984 . . . . 100.0 108.343 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.37 131.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 105.04 -2.207 . . . . 100.0 105.04 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 88' ' ' ILE . 24.6 mt -106.63 128.93 54.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.198 -2.519 . . . . 100.0 104.198 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.6 m -120.23 130.6 54.59 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.465 -1.243 . . . . 100.0 113.363 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.3 107.4 3.23 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 105.4 -3.08 . . . . 100.0 105.4 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.353 0.0 OUTLIER -95.88 177.93 5.6 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 114.501 1.297 . . . . 100.0 114.501 -178.829 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.1 mttt 62.0 40.4 12.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 128.761 2.824 . . . . 100.0 112.863 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.6 m -71.75 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 114.882 -1.054 . . . . 100.0 111.713 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -66.0 -29.14 69.47 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.981 0.912 . . . . 100.0 110.524 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.6 128.43 34.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 107.158 -1.423 . . . . 100.0 107.158 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.23 -41.81 98.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 115.779 1.77 . . . . 100.0 115.779 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.25 97.08 11.0 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.774 -1.935 . . . . 100.0 105.774 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -96.79 125.11 41.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 113.845 -1.525 . . . . 100.0 106.885 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.27 -39.14 12.23 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.585 0.958 . . . . 100.0 113.585 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -103.5 102.93 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.66 -1.607 . . . . 100.0 106.66 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 29.9 mmmt -89.71 168.06 12.41 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.481 1.512 . . . . 100.0 114.022 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.44 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.22 -33.46 67.57 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.989 2.116 . . . . 100.0 108.696 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.08 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 93.8 mttt -57.61 -38.62 75.25 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 129.19 2.996 . . . . 100.0 112.835 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.8 p -105.29 3.04 29.52 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 116.493 2.035 . . . . 100.0 116.493 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 66.8 mt -91.09 89.79 3.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 117.792 -1.563 . . . . 100.0 109.324 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.474 ' CA ' ' HB3' ' A' ' 211' ' ' ASP 0.361 0.0 OUTLIER -101.46 -12.81 8.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 115.636 1.717 . . . . 100.0 115.636 -175.842 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.55 -35.95 73.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 118.235 2.68 . . . . 100.0 118.235 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.597 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.263 60.6 m-70 -59.6 -37.11 77.68 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.396 1.878 . . . . 100.0 113.927 -176.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.774 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.273 55.2 ttp85 -59.15 -50.09 75.38 Favored 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 113.926 1.084 . . . . 100.0 113.926 -175.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.68 -41.23 98.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 125.033 1.458 . . . . 100.0 111.769 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.23 2.74 53.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 116.396 1.999 . . . . 100.0 116.396 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 55.69 43.78 27.46 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-O 123.116 1.436 . . . . 100.0 113.37 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' A' ' 117' ' ' ILE . 26.2 mt -101.88 146.48 27.77 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.573 -2.38 . . . . 100.0 104.573 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -94.14 142.39 27.45 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.945 -1.131 . . . . 100.0 107.945 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.475 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 88.3 t80 -113.67 139.04 49.39 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 113.222 0.823 . . . . 100.0 113.222 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.69 139.85 42.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.202 -1.363 . . . . 100.0 111.578 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.26 85.2 m-20 -86.59 128.34 34.98 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 102.743 -3.058 . . . . 100.0 102.743 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 43.3 pt -135.33 157.59 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 122.049 0.928 . . . . 100.0 111.732 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -137.11 109.52 7.38 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 103.376 -2.824 . . . . 100.0 103.376 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.75 -41.38 99.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.885 -1.052 . . . . 100.0 110.825 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.64 -40.85 93.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.208 1.403 . . . . 100.0 112.353 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -100.85 3.57 42.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.305 1.965 . . . . 100.0 116.305 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.634 ' HA ' HH11 ' A' ' 29' ' ' ARG . 72.5 m-80 63.85 22.83 13.18 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.03 1.332 . . . . 100.0 110.677 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -72.61 124.11 24.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.458 -1.312 . . . . 100.0 107.458 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 53.53 37.83 26.71 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.657 2.383 . . . . 100.0 113.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.26 -44.54 95.21 Favored 'General case' 0 C--N 1.362 1.141 0 O-C-N 121.903 -0.498 . . . . 100.0 111.324 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -63.08 -38.69 92.2 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.636 1.974 . . . . 100.0 115.628 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -57.7 -47.4 99.01 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 120.531 3.53 . . . . 100.0 120.531 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.06 -42.39 36.82 Favored 'Trans proline' 0 C--N 1.373 1.834 0 CA-C-N 123.403 2.251 . . . . 100.0 112.066 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -65.08 -42.55 94.01 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 124.852 1.261 . . . . 100.0 111.74 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -44.27 91.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.518 0.727 . . . . 100.0 110.241 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -63.7 -44.51 93.46 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-N 117.949 0.34 . . . . 100.0 110.345 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.7 mt -62.34 -43.25 99.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 119.112 -0.471 . . . . 100.0 111.363 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.62 98.56 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.065 0.946 . . . . 100.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.88 -45.35 94.13 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 119.021 -0.514 . . . . 100.0 112.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.0 -42.53 76.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 112.734 0.642 . . . . 100.0 112.734 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.65 -38.83 74.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.692 1.197 . . . . 100.0 109.937 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.73 10.76 56.29 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-O 118.489 -1.173 . . . . 100.0 111.025 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 48.4 t0 -112.47 111.48 52.2 Favored Pre-proline 0 C--N 1.365 1.258 0 CA-C-N 118.485 1.142 . . . . 100.0 108.262 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -15.99 40.26 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.961 3.108 . . . . 100.0 113.256 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -96.17 8.37 44.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 114.349 1.24 . . . . 100.0 114.349 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 75.5 mt -62.11 136.7 58.06 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-O 121.307 0.575 . . . . 100.0 110.705 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -133.16 150.57 52.01 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.53 -0.915 . . . . 100.0 108.53 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -91.06 113.19 25.39 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 103.65 -2.722 . . . . 100.0 103.65 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.24 -39.51 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 114.061 1.134 . . . . 100.0 114.061 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.0 146.07 51.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.506 -0.924 . . . . 100.0 108.506 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.91 130.48 48.3 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 108.031 -1.1 . . . . 100.0 108.031 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.54 155.62 67.96 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.223 1.949 . . . . 100.0 109.847 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.07 123.73 21.84 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.8 -1.555 . . . . 100.0 106.8 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -119.02 145.85 45.52 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.239 -1.346 . . . . 100.0 109.665 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.64 96.33 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 105.965 -1.865 . . . . 100.0 105.965 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 72.0 Cg_exo -55.65 142.35 82.38 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 123.453 2.769 . . . . 100.0 113.563 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 154' ' ' ASN . 51.0 Cg_exo -56.7 127.63 26.68 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 122.848 2.366 . . . . 100.0 113.281 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -70.14 -42.44 72.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 124.714 1.259 . . . . 100.0 107.867 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.15 158.83 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.411 -1.7 . . . . 100.0 106.411 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.64 128.37 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.408 -2.071 . . . . 100.0 105.408 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -89.58 125.02 35.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.7 -2.333 . . . . 100.0 104.7 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.66 129.27 92.72 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 114.568 -1.196 . . . . 100.0 111.613 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -59.1 -37.53 92.03 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.654 2.903 . . . . 100.0 113.481 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.55 93.73 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.146 0.904 . . . . 100.0 110.179 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.07 -41.84 99.52 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.135 0.574 . . . . 100.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.02 96.35 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.803 0.841 . . . . 100.0 110.672 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.26 99.27 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.699 0.799 . . . . 100.0 110.84 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.32 -45.12 94.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.829 0.851 . . . . 100.0 111.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -63.68 -43.63 96.11 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 112.392 0.515 . . . . 100.0 112.392 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -64.51 -39.86 94.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 123.248 0.343 . . . . 100.0 111.287 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -63.09 -42.45 99.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.952 0.901 . . . . 100.0 110.303 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.4 -42.46 98.77 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.975 0.91 . . . . 100.0 110.609 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.8 mt -61.26 -47.23 86.97 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.431 -0.804 . . . . 100.0 109.262 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.46 -42.04 98.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.3 1.222 . . . . 100.0 114.3 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.34 -47.4 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.047 0 CA-C-O 117.504 -1.236 . . . . 100.0 108.517 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.714 . . -89.72 -8.15 52.93 Favored 'General case' 0 N--CA 1.382 -3.849 1 C-N-CA 103.86 -7.136 . . . . 100.0 117.204 178.721 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 1.044 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 54.3 mt-30 -53.69 -34.07 57.53 Favored 'General case' 0 CA--C 1.447 -2.994 0 C-N-CA 127.813 2.445 . . . . 100.0 106.801 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -80.87 36.57 0.4 Allowed 'General case' 0 N--CA 1.416 -2.142 0 O-C-N 124.933 1.395 . . . . 100.0 109.5 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 58.5 31.9 21.52 Favored 'General case' 0 CA--C 1.472 -2.052 0 C-N-CA 126.871 2.068 . . . . 100.0 112.525 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 204' ' ' ALA . . . -75.63 -178.19 4.04 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 101.642 -3.466 . . . . 100.0 101.642 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 81.3 mt -57.68 -38.24 65.07 Favored Pre-proline 0 CA--C 1.492 -1.263 0 CA-C-O 116.274 -1.822 . . . . 100.0 113.154 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.08 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.422 5.7 Cg_exo -53.1 136.45 61.46 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 CA-C-O 123.64 1.433 . . . . 100.0 112.7 177.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.474 ' HB3' ' CA ' ' A' ' 137' ' ' VAL 0.331 84.8 m-20 -65.18 -42.22 93.85 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 120.956 3.687 . . . . 100.0 120.956 -172.836 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.5 tm-20 -72.44 -14.72 61.76 Favored 'General case' 0 CA--C 1.459 -2.52 1 CA-C-O 130.685 5.04 . . . . 100.0 112.922 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 1.044 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.807 64.0 m-20 -87.55 -48.71 7.7 Favored 'General case' 1 N--CA 1.256 -10.162 1 CA-C-N 106.111 -5.04 . . . . 100.0 103.127 -172.786 . . . . . . . . 5 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.5 -27.57 69.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 118.901 -2.375 . . . . 100.0 106.211 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 51.5 m-20 -62.39 -39.96 94.94 Favored 'General case' 0 CA--C 1.478 -1.825 0 C-N-CA 127.137 2.175 . . . . 100.0 112.604 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.303 3.8 mm? . . . . . 0 N--CA 1.427 -1.624 0 CA-C-O 114.15 -2.833 . . . . 100.0 112.828 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.631 0.253 . . . . 100.0 110.454 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.32 69.94 9.99 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.9 162.64 39.65 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.928 0.891 . . . . 100.0 109.028 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -80.32 157.99 26.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.491 0.716 . . . . 100.0 110.698 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.38 9.73 84.53 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.555 -0.748 . . . . 100.0 113.942 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.75 136.67 73.87 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 118.0 0.9 . . . . 100.0 112.113 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -63.29 136.51 55.85 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.985 2.457 . . . . 100.0 107.807 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.65 150.46 34.57 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 124.286 0.991 . . . . 100.0 111.641 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -88.74 111.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.844 -3.021 . . . . 100.0 102.844 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -127.89 140.48 51.98 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.839 -1.073 . . . . 100.0 110.431 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -129.07 144.08 51.08 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.074 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.18 120.49 34.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 105.577 -2.009 . . . . 100.0 105.577 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 63' ' ' VAL . 47.7 tp -113.4 127.03 55.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 100.0 107.473 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 79' ' ' TYR . 74.8 t -106.6 124.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 114.844 -1.071 . . . . 100.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD13 HG13 ' A' ' 63' ' ' VAL . 6.4 mp -107.38 119.17 38.66 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-O 121.477 0.656 . . . . 100.0 109.471 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.31 160.56 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.819 -1.082 . . . . 100.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.23 174.31 24.98 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.047 -2.021 . . . . 100.0 108.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.61 155.02 40.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.744 0.783 . . . . 100.0 112.229 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.46 140.76 41.53 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 106.519 -2.632 . . . . 100.0 106.519 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.76 -5.27 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.533 -1.148 . . . . 100.0 114.458 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.0 p -62.28 -37.24 84.77 Favored 'General case' 0 C--N 1.362 1.109 0 CA-C-N 118.929 1.364 . . . . 100.0 112.2 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.25 21.86 6.08 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.179 -0.769 . . . . 100.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 41.5 mtmt -60.95 -44.76 96.81 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 118.112 0.956 . . . . 100.0 112.559 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.2 m -62.25 -44.19 97.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.311 1.044 . . . . 100.0 109.846 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -63.03 -41.82 99.63 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.889 0.876 . . . . 100.0 109.362 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.46 -47.73 84.39 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.028 0.931 . . . . 100.0 112.559 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 63' ' ' VAL . 79.9 t -64.16 -41.03 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 123.284 0.634 . . . . 100.0 110.066 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.38 -7.84 41.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 116.373 1.99 . . . . 100.0 116.373 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.612 HH11 ' HB2' ' A' ' 157' ' ' PHE . 62.0 mtt180 -60.31 -37.97 82.24 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 58.3 t-80 -80.07 112.3 17.25 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 106.977 -1.49 . . . . 100.0 106.977 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.79 -44.93 95.9 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 115.817 1.784 . . . . 100.0 115.817 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 90.4 m -63.77 -42.48 97.79 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.52 0.728 . . . . 100.0 109.7 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.67 99.61 Favored Glycine 0 C--N 1.357 1.732 0 C-N-CA 123.807 0.718 . . . . 100.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.43 -45.55 87.07 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.916 0.886 . . . . 100.0 111.359 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -64.28 -39.77 94.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.501 1.12 . . . . 100.0 111.953 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -93.8 9.67 36.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 115.637 1.717 . . . . 100.0 115.637 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -61.12 141.85 57.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 114.225 1.194 . . . . 100.0 114.225 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -121.74 130.78 53.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.922 -1.035 . . . . 100.0 108.915 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.57 126.87 45.62 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.92 112.28 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 102.166 -3.272 . . . . 100.0 102.166 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.11 90.29 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 118.381 2.734 . . . . 100.0 118.381 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.6 m -63.08 -47.15 84.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 118.381 0.537 . . . . 100.0 110.329 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.88 -37.55 73.04 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 114.054 1.131 . . . . 100.0 114.054 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.01 44.4 30.24 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 106.895 -2.482 . . . . 100.0 106.895 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.9 t -127.57 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.076 0.95 . . . . 100.0 108.622 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -108.57 118.7 37.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.623 -3.473 . . . . 100.0 101.623 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.44 119.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 105.628 -1.99 . . . . 100.0 105.628 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -109.46 120.32 45.64 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.483 -0.781 . . . . 100.0 109.074 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -80.93 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.682 2.254 . . . . 100.0 109.491 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.56 112.83 24.99 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.329 -0.989 . . . . 100.0 108.329 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.35 128.33 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.526 -1.287 . . . . 100.0 107.526 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.24 135.66 54.79 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.437 -2.06 . . . . 100.0 105.437 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -102.59 119.17 38.36 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.55 -0.907 . . . . 100.0 108.55 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 p -108.63 175.87 5.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.99 0.9 . . . . 100.0 110.176 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -61.7 -26.43 68.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.317 1.447 . . . . 100.0 110.356 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -97.88 6.52 47.68 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.868 0.867 . . . . 100.0 112.633 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.65 179.36 20.03 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 121.298 -0.876 . . . . 100.0 111.208 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.72 139.94 59.82 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.182 2.588 . . . . 100.0 116.009 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.52 131.4 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 103.155 -2.905 . . . . 100.0 103.155 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -113.58 128.48 56.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.164 0.507 . . . . 100.0 109.833 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -110.74 114.77 28.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.957 -2.608 . . . . 100.0 103.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -89.74 103.95 16.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 100.87 -3.752 . . . . 100.0 100.87 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.521 HG22 HD23 ' A' ' 13' ' ' LEU . 32.8 t -87.91 124.39 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.404 -1.271 . . . . 100.0 107.95 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -98.36 115.74 29.1 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.024 -2.213 . . . . 100.0 105.024 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.26 137.77 49.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.517 -1.66 . . . . 100.0 106.517 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.1 p -71.56 162.17 29.86 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.845 0.831 . . . . 100.0 112.926 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.3 14.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.939 -1.028 . . . . 100.0 108.538 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.22 57.99 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 121.703 -0.623 . . . . 100.0 113.194 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -59.68 -34.15 72.49 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.544 1.938 . . . . 100.0 112.101 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.22 -30.49 66.54 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.224 2.21 . . . . 100.0 113.131 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.09 -46.54 88.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.41 15.1 p90 -74.22 -40.45 62.43 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 116.912 2.19 . . . . 100.0 116.912 176.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.5 -154.18 9.31 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 120.303 -0.951 . . . . 100.0 111.918 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.46 53.06 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 122.337 0.965 . . . . 100.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.5 mt -105.13 143.16 33.69 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 123.851 0.86 . . . . 100.0 109.993 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -68.18 156.4 37.62 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.417 -1.265 . . . . 100.0 112.949 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.77 -37.69 79.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 125.312 1.445 . . . . 100.0 110.077 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.62 89.27 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 124.867 1.222 . . . . 100.0 111.479 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 85.8 t80 -62.76 -46.82 86.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.057 0.543 . . . . 100.0 111.032 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -70.59 -36.96 73.83 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 115.917 1.821 . . . . 100.0 115.917 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.2 mt -51.96 135.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 114.747 1.388 . . . . 100.0 114.747 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 68.85 14.41 8.91 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.204 2.202 . . . . 100.0 114.694 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 131.02 45.36 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.398 -0.964 . . . . 100.0 108.398 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.81 -31.15 13.87 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.305 -0.861 . . . . 100.0 108.726 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.592 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -151.04 163.8 37.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 120.824 0.345 . . . . 100.0 110.227 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -147.1 154.17 40.82 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG13 HD11 ' A' ' 13' ' ' LEU . 81.7 mt -126.51 125.38 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.231 -2.507 . . . . 100.0 104.231 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.635 ' HB ' HD22 ' A' ' 119' ' ' LEU . 45.4 mt -110.57 124.61 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 102.675 -3.083 . . . . 100.0 102.675 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.8 mtp -112.35 136.54 51.69 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 114.914 1.45 . . . . 100.0 114.914 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -129.47 164.2 24.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 112.501 -2.136 . . . . 100.0 107.976 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -109.69 125.43 52.63 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.041 -1.837 . . . . 100.0 106.041 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 m -64.8 -19.71 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 114.042 1.127 . . . . 100.0 114.042 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -86.75 -9.53 55.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 119.243 -0.408 . . . . 100.0 111.323 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -125.21 117.81 24.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 122.195 0.998 . . . . 100.0 110.547 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.67 -38.1 89.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.915 1.286 . . . . 100.0 111.838 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.92 -40.76 81.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.222 1.809 . . . . 100.0 110.601 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -62.97 -41.28 99.49 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.32 0.509 . . . . 100.0 111.307 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.87 -41.41 95.69 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.863 0.865 . . . . 100.0 110.604 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.6 mttt -60.91 -37.8 83.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.792 1.237 . . . . 100.0 110.777 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.83 -8.43 58.03 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.273 1.583 . . . . 100.0 115.273 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 119' ' ' LEU . 73.0 t -60.11 -42.75 91.59 Favored Pre-proline 0 C--N 1.364 1.224 0 CA-C-O 116.419 -1.753 . . . . 100.0 112.077 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 73.8 Cg_exo -57.49 -37.47 97.16 Favored 'Trans proline' 0 C--N 1.375 1.955 0 CA-C-N 122.153 1.805 . . . . 100.0 112.657 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.93 -45.43 89.27 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.05 1.34 . . . . 100.0 110.894 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -64.16 -41.84 96.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 122.936 0.494 . . . . 100.0 110.917 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -62.65 -43.87 97.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 123.898 0.879 . . . . 100.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -63.0 -43.81 97.76 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 123.042 0.537 . . . . 100.0 111.769 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.5 -44.25 96.84 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.916 0.486 . . . . 100.0 110.425 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.1 tp -63.46 -48.34 78.1 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 124.314 1.046 . . . . 100.0 113.177 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.298 32.7 m -63.86 -35.53 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 C-N-CA 124.16 0.984 . . . . 100.0 113.08 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -59.65 -38.53 81.67 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 118.688 -0.672 . . . . 100.0 111.093 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.14 -43.9 17.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 C-N-CA 119.87 -0.732 . . . . 100.0 110.233 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.1 m -124.75 104.65 8.77 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.454 -0.943 . . . . 100.0 108.454 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.14 145.05 25.0 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.983 0.897 . . . . 100.0 110.389 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 57.79 38.04 27.24 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.447 2.017 . . . . 100.0 116.447 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 pt -96.81 143.59 26.38 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 106.185 -1.783 . . . . 100.0 106.185 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 56.2 Cg_endo -62.59 131.14 32.35 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.782 2.322 . . . . 100.0 110.483 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.747 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.9 mt -132.84 138.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 122.369 1.08 . . . . 100.0 109.421 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.98 131.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.193 -1.78 . . . . 100.0 106.193 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.635 HD22 ' HB ' ' A' ' 88' ' ' ILE . 22.5 mt -105.84 128.96 54.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.852 -2.277 . . . . 100.0 104.852 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.36 130.77 56.19 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.126 -1.397 . . . . 100.0 113.398 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.48 104.36 2.77 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 106.222 -2.751 . . . . 100.0 106.222 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.426 ' HA ' HG13 ' A' ' 149' ' ' ILE . 62.3 t30 -83.24 166.09 18.85 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.555 1.142 . . . . 100.0 112.973 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 61.03 42.97 11.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.57 3.148 . . . . 100.0 114.933 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.327 24.5 m -72.07 -7.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 C-N-CA 120.527 -0.469 . . . . 100.0 111.64 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.93 -36.71 82.17 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.718 2.007 . . . . 100.0 109.958 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.95 128.42 33.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 106.915 -1.513 . . . . 100.0 106.915 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.77 -42.35 99.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 114.919 1.452 . . . . 100.0 114.919 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.21 98.04 11.54 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.843 -1.91 . . . . 100.0 105.843 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -95.57 122.2 38.08 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.771 -1.559 . . . . 100.0 106.911 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.94 -39.91 15.3 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.3 0.852 . . . . 100.0 113.3 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.07 104.86 17.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.552 -2.018 . . . . 100.0 105.552 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.57 174.3 6.51 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.209 -0.905 . . . . 100.0 113.109 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.28 65.69 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 127.045 2.138 . . . . 100.0 109.496 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 0.981 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -57.52 -39.12 75.86 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 129.128 2.971 . . . . 100.0 112.043 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.3 p -104.82 4.18 31.91 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 116.403 2.001 . . . . 100.0 116.403 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 56.5 mt -90.06 80.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 117.197 -1.801 . . . . 100.0 112.035 -176.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.255 58.9 t -71.53 -39.44 70.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 1 C-N-CA 133.757 4.823 . . . . 100.0 118.807 -178.279 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -55.79 -36.34 67.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 121.539 3.903 . . . . 100.0 121.539 -168.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.6 ' HE1' ' HB2' ' A' ' 119' ' ' LEU 0.258 67.8 m-70 -59.73 -38.8 82.69 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 116.924 -1.512 . . . . 100.0 113.493 -176.586 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.97 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.255 0.9 OUTLIER -59.93 -46.83 88.11 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 116.6 2.074 . . . . 100.0 116.6 -176.887 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.93 -40.42 97.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 125.525 1.766 . . . . 100.0 110.2 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.63 3.89 47.94 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 117.279 2.326 . . . . 100.0 117.279 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 55.38 43.47 28.8 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 122.958 1.361 . . . . 100.0 113.311 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.2 mt -103.52 150.4 23.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.643 -1.984 . . . . 100.0 105.643 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -97.28 141.02 30.89 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 109.784 -0.451 . . . . 100.0 109.784 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.491 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.5 t80 -108.27 136.88 47.18 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 113.188 0.81 . . . . 100.0 113.188 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -134.11 136.47 43.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.221 -1.354 . . . . 100.0 110.743 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.322 66.0 m-20 -83.47 130.06 35.01 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 101.996 -3.335 . . . . 100.0 101.996 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' HH22 ' A' ' 29' ' ' ARG . 43.2 pt -134.72 156.73 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.525 1.155 . . . . 100.0 111.674 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 71.3 m -138.2 107.98 6.28 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.941 -2.244 . . . . 100.0 104.941 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.32 -44.63 96.88 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 115.214 -0.903 . . . . 100.0 112.854 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.92 -39.36 91.79 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 125.071 1.348 . . . . 100.0 113.372 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.5 p -99.97 1.57 42.73 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 115.669 1.729 . . . . 100.0 115.669 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.493 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.1 m-80 64.65 21.58 12.44 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.296 1.438 . . . . 100.0 111.263 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 78.1 t80 -70.98 125.61 27.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.906 -1.146 . . . . 100.0 107.906 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 54.45 36.5 25.73 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.102 2.561 . . . . 100.0 114.429 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' HB2' HH11 ' A' ' 29' ' ' ARG . 64.4 t80 -60.99 -45.49 94.62 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 121.644 -0.66 . . . . 100.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -35.63 81.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.799 2.148 . . . . 100.0 116.799 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.26 -46.98 99.73 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.166 3.025 . . . . 100.0 119.166 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -60.98 -42.51 36.45 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.116 2.149 . . . . 100.0 111.815 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -64.53 -42.29 95.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 125.23 1.412 . . . . 100.0 111.496 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.61 -45.01 92.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.839 0.856 . . . . 100.0 111.116 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.82 -43.77 95.24 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 123.372 0.42 . . . . 100.0 110.399 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 85' ' ' CYS . 75.3 mt -61.36 -44.42 97.19 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 123.097 0.559 . . . . 100.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.8 98.18 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.445 1.098 . . . . 100.0 111.1 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.99 -45.04 95.36 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 122.851 0.46 . . . . 100.0 111.565 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 28.1 tptp -65.25 -46.31 81.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 122.893 0.477 . . . . 100.0 111.633 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.41 -46.99 80.85 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.397 1.258 . . . . 100.0 114.397 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.45 -38.23 73.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 C-N-CA 124.917 1.287 . . . . 100.0 109.623 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.71 10.53 57.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-O 118.515 -1.158 . . . . 100.0 111.14 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -114.17 113.1 46.49 Favored Pre-proline 0 C--N 1.364 1.224 0 N-CA-C 107.648 -1.241 . . . . 100.0 107.648 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.68 -14.15 32.95 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 123.894 3.063 . . . . 100.0 113.254 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -91.4 2.4 56.43 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.25 135.01 57.59 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 118.74 0.7 . . . . 100.0 112.108 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -133.99 148.78 51.17 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.029 -1.1 . . . . 100.0 108.029 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -90.25 112.3 23.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.674 -2.713 . . . . 100.0 103.674 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.81 -40.43 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 114.602 1.334 . . . . 100.0 114.602 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.39 145.8 50.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.34 -0.985 . . . . 100.0 108.34 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.4 ttm -85.73 129.58 54.15 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.129 -1.434 . . . . 100.0 107.129 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.95 155.93 65.25 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.366 2.044 . . . . 100.0 109.964 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.12 122.73 18.9 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.632 -1.618 . . . . 100.0 106.632 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.89 148.04 43.34 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-N 114.257 -1.338 . . . . 100.0 109.373 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.14 96.02 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 105.228 -2.138 . . . . 100.0 105.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.4 Cg_exo -56.26 142.04 87.93 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 123.236 2.624 . . . . 100.0 112.866 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.493 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.0 Cg_exo -56.5 125.94 20.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.638 2.226 . . . . 100.0 112.543 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.02 -42.66 72.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 124.938 1.399 . . . . 100.0 108.671 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.62 158.11 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 106.292 -1.744 . . . . 100.0 106.292 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.82 129.77 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.56 -1.644 . . . . 100.0 106.56 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.72 123.64 35.26 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 103.229 -2.878 . . . . 100.0 103.229 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.4 t70 -62.16 129.12 91.86 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.992 -1.004 . . . . 100.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 63.4 Cg_exo -58.9 -38.5 88.0 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.712 2.941 . . . . 100.0 113.552 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.92 94.78 Favored 'General case' 0 C--N 1.36 1.051 0 O-C-N 123.94 0.775 . . . . 100.0 110.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.36 -41.71 98.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 122.979 0.511 . . . . 100.0 111.114 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.14 97.6 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.745 0.818 . . . . 100.0 110.331 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.03 99.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.989 0.916 . . . . 100.0 110.547 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -62.33 -45.61 92.44 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.714 0.806 . . . . 100.0 111.754 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -63.6 -43.38 97.1 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 112.197 0.443 . . . . 100.0 112.197 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.34 -40.54 96.09 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.294 0.371 . . . . 100.0 111.455 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.57 -42.33 98.34 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.866 0.866 . . . . 100.0 110.197 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.33 -42.42 98.65 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 123.68 0.792 . . . . 100.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 85.2 mt -61.12 -48.1 83.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 123.735 0.647 . . . . 100.0 109.453 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.51 -43.64 98.33 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 114.084 1.142 . . . . 100.0 114.084 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.46 -47.02 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.072 0 CA-C-O 117.988 -1.006 . . . . 100.0 108.822 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.97 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.739 . . -88.66 -9.61 51.48 Favored 'General case' 1 N--CA 1.375 -4.202 1 C-N-CA 104.142 -7.023 . . . . 100.0 116.806 179.79 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 1.012 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 60.6 mt-30 -54.57 -36.03 63.93 Favored 'General case' 0 CA--C 1.445 -3.066 0 C-N-CA 128.86 2.864 . . . . 100.0 106.232 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.2 p -81.61 40.18 0.57 Allowed 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 123.07 1.414 . . . . 100.0 110.061 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.289 5.0 m 57.45 29.73 17.49 Favored 'General case' 0 CA--C 1.468 -2.206 0 C-N-CA 128.579 2.752 . . . . 100.0 112.918 175.323 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.257 . . -72.51 172.94 9.59 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 100.989 -3.708 . . . . 100.0 100.989 171.697 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.77 -35.9 34.01 Favored Pre-proline 0 CA--C 1.493 -1.22 0 CA-C-O 116.971 -1.49 . . . . 100.0 114.812 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 0.981 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.414 4.9 Cg_exo -53.97 137.95 69.47 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 CA-C-O 122.948 1.145 . . . . 100.0 113.124 176.569 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.629 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.375 45.8 m-20 -63.87 -43.91 94.66 Favored 'General case' 0 N--CA 1.408 -2.526 1 N-CA-C 122.783 4.364 . . . . 100.0 122.783 -174.245 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 16.0 tm-20 -66.34 -24.54 66.53 Favored 'General case' 0 CA--C 1.468 -2.208 1 CA-C-O 131.487 5.422 . . . . 100.0 111.598 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 1.012 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.749 55.2 m-20 -74.62 -51.47 14.38 Favored 'General case' 1 N--CA 1.267 -9.576 1 CA-C-N 105.454 -5.339 . . . . 100.0 105.406 -176.566 . . . . . . . . 5 3 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -63.66 -26.17 68.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 118.065 -2.897 . . . . 100.0 107.933 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.97 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 48.3 m-20 -62.89 -41.96 99.6 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 126.134 1.774 . . . . 100.0 112.754 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.383 1.0 OUTLIER . . . . . 0 C--O 1.261 1.67 0 CA-C-O 115.082 -2.389 . . . . 100.0 115.74 -178.47 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 CA--C 1.494 -1.183 0 CA-C-O 119.384 -0.341 . . . . 100.0 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.61 -41.64 90.83 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.01 158.69 17.92 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 115.291 1.589 . . . . 100.0 115.291 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -85.19 158.83 20.25 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.401 1.08 . . . . 100.0 109.412 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.3 9.63 86.79 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 119.475 -0.625 . . . . 100.0 114.463 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -81.37 150.27 67.04 Favored Pre-proline 0 N--CA 1.437 -1.102 0 CA-C-N 118.443 1.121 . . . . 100.0 109.886 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.8 152.6 81.5 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.98 2.453 . . . . 100.0 109.074 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.7 138.89 58.04 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.228 0.537 . . . . 100.0 111.492 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 115.27 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.585 -1.189 . . . . 100.0 109.627 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -127.48 135.75 50.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.399 -1.728 . . . . 100.0 107.73 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -124.43 144.24 50.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.46 -0.791 . . . . 100.0 109.134 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.1 121.64 33.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.32 128.16 56.22 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.419 -1.697 . . . . 100.0 106.419 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.8 t -104.29 125.6 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.621 -1.251 . . . . 100.0 107.621 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 89' ' ' MET . 39.3 tp -110.06 117.47 33.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.86 -1.904 . . . . 100.0 105.86 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.88 160.45 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 112.165 0.432 . . . . 100.0 112.165 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.95 172.71 24.5 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 108.559 -1.816 . . . . 100.0 108.559 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -67.33 154.41 41.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.946 0.879 . . . . 100.0 112.478 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 139.9 42.49 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 107.263 -2.335 . . . . 100.0 107.263 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.0 -4.2 83.03 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 118.634 -1.092 . . . . 100.0 114.258 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 p -62.74 -38.36 90.22 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 118.784 1.292 . . . . 100.0 111.914 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.32 4.78 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.508 -1.037 . . . . 100.0 110.508 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HE3' ' HG ' ' A' ' 15' ' ' LEU . 50.0 mtpt -59.53 -47.11 86.81 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.38 1.072 . . . . 100.0 113.254 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.6 m -64.59 -42.75 95.38 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.254 0.622 . . . . 100.0 110.598 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.6 m -62.24 -42.14 99.05 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 124.126 0.97 . . . . 100.0 108.971 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.75 -48.37 82.11 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.215 1.006 . . . . 100.0 112.968 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.85 -39.94 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 123.133 0.271 . . . . 100.0 110.91 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -65.5 -12.14 49.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 115.249 1.574 . . . . 100.0 115.249 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 41.0 mtt180 -60.02 -38.35 82.43 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.491 -0.929 . . . . 100.0 108.491 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 62.1 t-80 -80.63 111.5 17.12 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 106.799 -1.556 . . . . 100.0 106.799 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.59 -44.37 97.14 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.227 1.566 . . . . 100.0 115.227 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.1 m -62.85 -42.67 99.84 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.333 1.053 . . . . 100.0 109.35 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.07 99.68 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 111.15 -0.78 . . . . 100.0 111.15 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.15 -43.54 91.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 122.783 0.433 . . . . 100.0 111.502 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -62.89 -40.85 98.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.211 1.004 . . . . 100.0 111.85 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -94.07 10.08 35.12 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 115.211 1.56 . . . . 100.0 115.211 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -59.6 142.76 52.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 114.16 1.17 . . . . 100.0 114.16 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.22 132.89 51.65 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.296 -1.002 . . . . 100.0 108.296 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -100.44 127.49 46.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.855 -1.165 . . . . 100.0 107.855 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 109.32 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.352 -3.203 . . . . 100.0 102.352 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.23 99.35 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 p -61.73 -43.67 98.41 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 123.63 0.772 . . . . 100.0 112.718 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.9 mt -93.68 -18.15 22.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 114.393 1.257 . . . . 100.0 114.393 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.96 43.68 64.5 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.268 -1.533 . . . . 100.0 109.268 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.63 143.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.352 -0.981 . . . . 100.0 108.352 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.89 115.4 28.92 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 101.052 -3.685 . . . . 100.0 101.052 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 120.69 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.072 -1.455 . . . . 100.0 107.072 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -113.41 119.15 42.5 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 115.864 -0.607 . . . . 100.0 109.807 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.77 106.22 1.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.3 2.0 . . . . 100.0 111.468 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.79 115.88 29.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.827 -1.175 . . . . 100.0 107.827 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 t -102.39 129.11 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.053 -1.462 . . . . 100.0 107.053 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.91 136.61 53.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.666 -1.975 . . . . 100.0 105.666 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -101.83 119.17 38.36 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.601 -0.888 . . . . 100.0 108.601 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -106.45 -178.46 3.66 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.033 -0.985 . . . . 100.0 111.489 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.0 -37.99 78.16 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.581 1.952 . . . . 100.0 108.583 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -89.98 0.65 56.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 113.741 1.015 . . . . 100.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -175.37 15.86 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.199 -1.16 . . . . 100.0 110.199 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.25 138.95 58.09 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.979 2.452 . . . . 100.0 116.944 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -129.02 130.97 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 102.885 -3.006 . . . . 100.0 102.885 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -114.63 127.58 55.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.422 -0.585 . . . . 100.0 109.422 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -110.96 116.02 30.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -88.11 105.83 17.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 101.465 -3.531 . . . . 100.0 101.465 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.24 122.57 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.708 -1.219 . . . . 100.0 107.708 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -93.6 115.25 27.72 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.886 -1.894 . . . . 100.0 105.886 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -111.37 141.69 44.6 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.642 -1.985 . . . . 100.0 105.642 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -75.04 164.23 26.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.978 0.894 . . . . 100.0 112.882 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.39 16.15 20.95 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.756 -1.111 . . . . 100.0 108.318 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.77 59.2 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 121.728 -0.608 . . . . 100.0 113.422 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -62.24 -23.72 66.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.987 1.715 . . . . 100.0 112.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.31 -33.79 72.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.167 2.187 . . . . 100.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.4 -43.3 99.15 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.044 0.938 . . . . 100.0 109.684 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -70.14 -42.64 72.29 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.919 1.288 . . . . 100.0 113.09 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.93 -149.38 9.17 Favored Glycine 0 C--N 1.358 1.774 0 N-CA-C 110.99 -0.844 . . . . 100.0 110.99 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.87 50.28 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 122.185 0.881 . . . . 100.0 112.664 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.58 142.49 37.42 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 121.939 0.876 . . . . 100.0 109.651 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -64.03 151.75 42.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.403 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.01 -37.22 79.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.428 1.491 . . . . 100.0 110.003 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.76 89.34 Favored Glycine 0 C--N 1.356 1.652 0 C-N-CA 125.237 1.399 . . . . 100.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' A' ' 14' ' ' VAL . 79.9 t80 -62.85 -46.19 89.06 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 123.458 0.703 . . . . 100.0 111.081 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -70.9 -35.59 72.37 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.955 1.835 . . . . 100.0 115.955 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -51.87 134.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 122.987 1.375 . . . . 100.0 114.429 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 65.74 19.27 11.36 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 128.132 2.573 . . . . 100.0 114.635 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 132.32 48.57 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.052 -1.092 . . . . 100.0 108.052 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -95.19 -33.14 12.73 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.544 -0.753 . . . . 100.0 109.075 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' HB2' HD22 ' A' ' 164' ' ' LEU . 26.0 p -152.38 163.68 39.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.888 -0.412 . . . . 100.0 109.888 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.28 154.36 40.88 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 114.54 1.311 . . . . 100.0 114.54 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.5 mt -125.43 125.93 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.057 -2.571 . . . . 100.0 104.057 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 119' ' ' LEU . 50.8 mt -110.55 123.89 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.941 -2.985 . . . . 100.0 102.941 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.435 ' SD ' HD11 ' A' ' 15' ' ' LEU . 87.3 mtp -111.41 136.82 50.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -129.53 164.23 24.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.295 -2.23 . . . . 100.0 108.187 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -106.39 125.41 50.96 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.476 -2.046 . . . . 100.0 105.476 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.75 -17.15 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -91.69 -4.57 54.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.215 0.462 . . . . 100.0 111.306 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 t -124.38 116.08 22.01 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.472 1.129 . . . . 100.0 109.213 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -65.4 -37.73 87.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.402 1.081 . . . . 100.0 111.087 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.41 -41.22 83.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.258 1.823 . . . . 100.0 110.333 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 p -62.41 -40.97 98.27 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.366 0.53 . . . . 100.0 111.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -64.13 -41.63 97.13 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 123.895 0.878 . . . . 100.0 109.789 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -61.17 -36.85 80.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.095 0.958 . . . . 100.0 111.495 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.27 -6.56 56.95 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.133 1.531 . . . . 100.0 115.133 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.69 -42.4 91.22 Favored Pre-proline 0 C--N 1.364 1.219 0 CA-C-O 116.316 -1.802 . . . . 100.0 111.285 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 75.9 Cg_exo -57.85 -36.82 98.04 Favored 'Trans proline' 0 C--N 1.377 2.071 0 CA-C-N 122.234 1.834 . . . . 100.0 112.597 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.11 -44.41 92.37 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 119.438 1.017 . . . . 100.0 111.385 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -63.98 -42.25 97.28 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 122.817 0.447 . . . . 100.0 110.394 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -62.67 -43.03 99.84 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.082 0.953 . . . . 100.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -62.35 -45.19 94.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 122.892 0.477 . . . . 100.0 112.2 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -63.69 -43.36 96.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.596 0.56 . . . . 100.0 111.397 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 86' ' ' ALA . 51.0 tp -63.11 -48.36 78.89 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.011 0.924 . . . . 100.0 113.093 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 27.5 m -65.69 -36.4 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 123.668 0.787 . . . . 100.0 112.97 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.13 -45.97 91.24 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 118.916 -0.564 . . . . 100.0 109.675 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.03 -45.15 55.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-N 118.154 0.433 . . . . 100.0 111.79 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 24.1 t -130.07 112.68 13.68 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 118.714 -1.195 . . . . 100.0 108.523 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.54 144.56 27.16 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.788 -1.097 . . . . 100.0 113.671 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.08 40.97 32.17 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 117.338 2.347 . . . . 100.0 117.338 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.0 pt -98.36 143.82 26.98 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 107.998 -1.112 . . . . 100.0 107.998 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 57.9 Cg_endo -62.02 131.75 36.24 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.473 2.115 . . . . 100.0 111.017 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.744 ' HB ' HD22 ' A' ' 144' ' ' LEU . 74.3 mt -133.13 137.32 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 122.406 1.098 . . . . 100.0 108.794 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -115.98 130.88 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 106.767 -1.568 . . . . 100.0 106.767 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.483 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 14.4 mt -105.41 128.5 53.55 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.764 -2.31 . . . . 100.0 104.764 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.1 m -118.75 129.69 55.39 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.458 . . . . 100.0 112.399 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.07 3.48 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 105.261 -3.136 . . . . 100.0 105.261 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.378 0.0 OUTLIER -95.57 178.54 5.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -178.844 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 62.41 40.51 10.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 127.816 2.446 . . . . 100.0 112.511 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.3 28.1 m -72.21 -8.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 115.993 -0.549 . . . . 100.0 111.24 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.85 -36.79 84.42 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.47 1.908 . . . . 100.0 109.998 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.42 130.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 108.145 -1.057 . . . . 100.0 108.145 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -43.24 99.22 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.915 1.82 . . . . 100.0 115.915 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -88.68 97.85 11.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.607 -1.998 . . . . 100.0 105.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -96.5 112.79 24.4 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.42 -1.326 . . . . 100.0 107.42 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -75.2 -45.05 42.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.102 1.519 . . . . 100.0 115.102 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.23 106.73 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 105.985 -1.857 . . . . 100.0 105.985 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.07 174.08 6.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.854 -1.066 . . . . 100.0 112.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.63 66.93 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 127.367 2.267 . . . . 100.0 109.09 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.101 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.2 mttt -56.91 -39.33 74.24 Favored 'General case' 0 N--CA 1.42 -1.931 0 C-N-CA 128.723 2.809 . . . . 100.0 112.547 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 89.9 p -104.65 5.1 33.35 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 115.907 1.817 . . . . 100.0 115.907 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 65.6 mt -88.76 77.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.112 0 C-N-CA 117.548 -1.661 . . . . 100.0 111.788 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.253 59.0 t -70.86 -38.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 1 C-N-CA 133.81 4.844 . . . . 100.0 118.869 -178.387 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.04 -35.82 67.32 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 121.427 3.862 . . . . 100.0 121.427 -168.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.704 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.274 72.5 m80 -59.58 -38.58 81.58 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 116.783 -1.579 . . . . 100.0 114.264 -176.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.944 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.254 0.4 OUTLIER -59.42 -46.61 88.23 Favored 'General case' 0 CA--C 1.452 -2.819 0 N-CA-C 116.194 1.924 . . . . 100.0 116.194 -176.661 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.87 -41.08 97.43 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 125.756 1.91 . . . . 100.0 110.832 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -101.49 6.46 42.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 117.15 2.278 . . . . 100.0 117.15 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 56.32 42.36 27.89 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-O 123.026 1.393 . . . . 100.0 113.646 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 117' ' ' ILE . 25.2 mt -99.97 149.17 23.71 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.523 -2.029 . . . . 100.0 105.523 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.77 143.87 28.63 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.482 -0.933 . . . . 100.0 108.482 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.704 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.5 t80 -110.25 137.27 48.21 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.938 0.718 . . . . 100.0 112.938 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -133.78 137.01 44.9 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.543 -1.208 . . . . 100.0 110.575 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.362 69.9 m-20 -85.59 130.09 34.66 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 101.464 -3.532 . . . . 100.0 101.464 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.482 ' HB ' HH22 ' A' ' 29' ' ' ARG . 44.1 pt -137.27 158.29 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 122.248 1.023 . . . . 100.0 111.462 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.8 m -139.06 110.58 7.04 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 106.137 -1.801 . . . . 100.0 106.137 175.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.72 -44.47 96.86 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.625 -1.171 . . . . 100.0 112.71 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.79 -39.7 92.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.324 1.449 . . . . 100.0 113.012 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 115.676 1.732 . . . . 100.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.3 m-80 63.6 24.08 13.83 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 125.158 1.383 . . . . 100.0 110.919 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 80.1 t80 -74.12 125.14 27.69 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.504 -1.295 . . . . 100.0 107.504 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 53.43 36.73 23.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.095 2.558 . . . . 100.0 114.652 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 70.6 t80 -60.82 -43.39 98.3 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.726 -0.609 . . . . 100.0 111.94 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -63.53 -37.28 86.7 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.398 1.999 . . . . 100.0 116.398 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.47 -46.66 99.77 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.897 3.295 . . . . 100.0 119.897 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.62 -41.95 43.52 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.139 2.157 . . . . 100.0 111.919 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.92 -41.43 95.56 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.729 1.212 . . . . 100.0 110.969 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.3 -46.81 87.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.206 1.002 . . . . 100.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -65.63 -42.17 91.81 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 120.28 -0.568 . . . . 100.0 110.494 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.0 mt -61.92 -42.87 99.59 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 119.208 -0.425 . . . . 100.0 111.415 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.73 98.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 124.018 0.927 . . . . 100.0 110.564 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.79 -45.72 92.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 119.188 -0.435 . . . . 100.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 52.6 tptt -65.55 -44.93 85.3 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.518 0.511 . . . . 100.0 112.105 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.46 -46.37 83.37 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 114.279 1.215 . . . . 100.0 114.279 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.7 -37.85 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.225 1.01 . . . . 100.0 109.479 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.43 57.13 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.27 -1.132 . . . . 100.0 110.27 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 54.2 t0 -112.57 110.53 52.58 Favored Pre-proline 0 C--N 1.364 1.218 0 N-CA-C 108.041 -1.096 . . . . 100.0 108.041 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.97 -14.15 32.08 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.748 2.965 . . . . 100.0 113.285 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -90.36 -0.47 57.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.499 1.12 . . . . 100.0 112.987 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 90.3 mt -61.94 136.16 57.85 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.739 1.014 . . . . 100.0 113.739 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -134.89 154.86 51.5 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.908 -1.145 . . . . 100.0 107.908 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -90.49 116.24 28.25 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 103.872 -2.64 . . . . 100.0 103.872 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.7 -44.73 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 123.971 0.908 . . . . 100.0 111.188 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.08 150.5 52.14 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.561 -0.903 . . . . 100.0 108.561 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -95.02 130.86 31.5 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.493 -1.299 . . . . 100.0 107.493 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -64.58 158.27 50.85 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.466 2.11 . . . . 100.0 111.51 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.8 125.43 25.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.37 1.081 . . . . 100.0 108.585 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.35 147.21 45.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.863 -1.517 . . . . 100.0 108.804 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.27 135.84 95.31 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 105.777 -1.934 . . . . 100.0 105.777 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 74.7 Cg_exo -55.97 142.33 85.11 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 123.549 2.833 . . . . 100.0 113.197 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.2 Cg_exo -56.8 128.67 30.91 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.634 2.223 . . . . 100.0 112.94 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.8 -43.37 72.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.892 -1.151 . . . . 100.0 107.892 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 157.78 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 106.538 -1.653 . . . . 100.0 106.538 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.05 130.41 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.87 -1.53 . . . . 100.0 106.87 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.64 125.86 34.62 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 103.664 -2.717 . . . . 100.0 103.664 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.22 126.93 90.26 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.122 -0.945 . . . . 100.0 110.327 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.92 -38.14 89.8 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 123.631 2.887 . . . . 100.0 113.68 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.71 94.07 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.146 0.904 . . . . 100.0 110.049 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -40.81 97.72 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 123.127 0.571 . . . . 100.0 111.251 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.54 98.67 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.659 0.784 . . . . 100.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.45 99.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.935 0.894 . . . . 100.0 110.533 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -61.71 -46.06 91.29 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.349 1.059 . . . . 100.0 111.363 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -63.91 -43.35 96.22 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 112.275 0.472 . . . . 100.0 112.275 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -64.33 -39.66 94.35 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.333 0.396 . . . . 100.0 111.633 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.76 -44.27 96.64 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.223 1.009 . . . . 100.0 110.209 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -61.61 -42.76 99.34 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.459 0.704 . . . . 100.0 110.894 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 79.5 mt -61.15 -48.49 81.37 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 115.784 -0.643 . . . . 100.0 110.271 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.26 -43.95 96.53 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 113.709 1.003 . . . . 100.0 113.709 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -45.81 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.945 0 CA-C-O 118.372 -0.823 . . . . 100.0 109.443 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.746 . . -86.45 -10.78 53.51 Favored 'General case' 1 N--CA 1.376 -4.174 1 C-N-CA 104.526 -6.87 . . . . 100.0 115.747 179.945 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 1.0 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 52.6 mt-30 -54.68 -35.27 63.39 Favored 'General case' 0 CA--C 1.443 -3.158 0 C-N-CA 128.703 2.801 . . . . 100.0 107.148 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.2 p -81.36 40.58 0.57 Allowed 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.857 1.313 . . . . 100.0 109.572 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.266 6.4 m 59.13 27.17 16.07 Favored 'General case' 0 CA--C 1.471 -2.086 0 C-N-CA 127.277 2.231 . . . . 100.0 112.984 175.003 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 204' ' ' ALA 0.266 . . -72.09 170.5 13.78 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.316 -3.587 . . . . 100.0 101.316 171.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.95 -35.4 29.03 Favored Pre-proline 0 CA--C 1.486 -1.515 0 CA-C-O 116.499 -1.715 . . . . 100.0 114.911 -174.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.101 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.445 0.0 OUTLIER -54.38 139.48 73.98 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 O-C-N 123.741 1.39 . . . . 100.0 111.898 176.403 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.698 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.453 39.5 m-20 -65.73 -43.21 89.75 Favored 'General case' 0 N--CA 1.408 -2.53 1 N-CA-C 125.03 5.196 . . . . 100.0 125.03 -173.577 . . . . . . . . 4 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.7 tm-20 -62.58 -35.81 80.71 Favored 'General case' 0 CA--C 1.469 -2.16 1 CA-C-O 132.292 5.806 . . . . 100.0 108.734 176.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 1.0 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.629 17.5 m-20 -62.34 -51.9 65.8 Favored 'General case' 1 N--CA 1.282 -8.842 2 CA-C-N 104.098 -5.955 . . . . 100.0 107.554 178.719 . . . . . . . . 5 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.28 -25.33 66.0 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 117.261 -3.399 . . . . 100.0 107.579 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.944 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 57.9 m-20 -63.78 -40.4 96.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 126.979 2.112 . . . . 100.0 112.395 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.274 3.2 mm? . . . . . 0 N--CA 1.426 -1.654 0 CA-C-O 114.157 -2.83 . . . . 100.0 112.781 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.046 0.45 . . . . 100.0 111.375 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.23 92.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.064 1.346 . . . . 100.0 114.33 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 162.67 27.82 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 116.849 2.166 . . . . 100.0 116.849 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -80.56 164.15 23.15 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.911 1.284 . . . . 100.0 110.126 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.55 -4.27 82.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.688 -0.507 . . . . 100.0 112.381 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 75.5 mm-40 -72.59 141.01 82.15 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 123.811 0.844 . . . . 100.0 111.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 6' ' ' GLU . 39.4 Cg_exo -62.92 137.88 65.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.859 2.373 . . . . 100.0 109.513 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.74 150.05 41.4 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.108 0.88 . . . . 100.0 111.051 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.09 106.92 16.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 102.009 -3.33 . . . . 100.0 102.009 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.41 138.74 52.47 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.813 -0.63 . . . . 100.0 110.828 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.83 144.37 51.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.605 -0.725 . . . . 100.0 110.017 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.64 120.3 32.93 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.217 -1.401 . . . . 100.0 107.217 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 63' ' ' VAL . 57.1 tp -110.6 125.87 53.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.131 -1.849 . . . . 100.0 107.23 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 79' ' ' TYR . 56.0 t -103.05 124.69 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.694 -1.224 . . . . 100.0 107.694 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 89' ' ' MET . 42.5 tp -109.29 117.33 33.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.124 -1.806 . . . . 100.0 106.124 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -128.79 161.47 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 112.129 0.418 . . . . 100.0 112.129 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.69 173.96 24.14 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 108.403 -1.879 . . . . 100.0 108.403 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.4 154.35 41.55 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.061 0.934 . . . . 100.0 112.938 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.84 141.18 43.31 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.07 -2.412 . . . . 100.0 107.07 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.78 -1.53 86.99 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-O 118.084 -1.398 . . . . 100.0 113.288 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 p -63.91 -38.39 90.91 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 119.261 1.531 . . . . 100.0 111.649 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.47 21.78 4.63 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.487 -1.045 . . . . 100.0 110.487 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -59.98 -46.86 88.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.759 1.224 . . . . 100.0 113.237 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -63.68 -43.73 95.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.986 0.914 . . . . 100.0 110.03 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -41.13 99.1 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.939 0.896 . . . . 100.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -60.44 -48.72 80.51 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.945 0.898 . . . . 100.0 112.772 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.89 -40.94 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 123.103 0.252 . . . . 100.0 111.114 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.265 99.3 mttt -69.13 -7.08 32.85 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 116.302 1.964 . . . . 100.0 116.302 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 43.6 mtt180 -61.01 -37.84 83.95 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 107.49 -1.3 . . . . 100.0 107.49 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.71 112.71 18.33 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 106.831 -1.544 . . . . 100.0 106.831 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.92 -44.46 96.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.983 1.845 . . . . 100.0 115.983 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 84.8 m -63.72 -42.12 97.97 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.869 0.868 . . . . 100.0 109.479 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -41.5 99.59 Favored Glycine 0 C--N 1.357 1.744 0 N-CA-C 110.977 -0.849 . . . . 100.0 110.977 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -64.6 -44.25 91.22 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.721 0.808 . . . . 100.0 110.866 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -63.42 -40.32 96.88 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.428 1.091 . . . . 100.0 111.484 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.12 8.6 34.81 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 114.887 1.44 . . . . 100.0 114.887 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -58.84 142.92 49.13 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 114.538 1.311 . . . . 100.0 114.538 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.61 139.98 52.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.354 -1.351 . . . . 100.0 107.354 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -111.89 125.97 54.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.34 -2.467 . . . . 100.0 104.34 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.28 108.15 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.448 -3.167 . . . . 100.0 102.448 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.66 99.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 114.591 1.33 . . . . 100.0 114.591 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -61.47 -42.5 98.86 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 123.699 0.8 . . . . 100.0 112.914 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.58 -20.97 19.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.356 1.243 . . . . 100.0 114.356 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.05 43.24 49.25 Favored Glycine 0 C--N 1.36 1.889 0 N-CA-C 108.504 -1.839 . . . . 100.0 108.504 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 24.1 t -126.7 145.39 34.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.337 -0.986 . . . . 100.0 108.337 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 117.82 34.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 102.44 -3.17 . . . . 100.0 102.44 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.63 123.12 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.094 -1.447 . . . . 100.0 107.094 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -115.15 121.59 34.78 Favored Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 115.365 -0.834 . . . . 100.0 110.519 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -80.45 103.38 1.51 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 122.226 1.951 . . . . 100.0 110.36 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.92 113.0 24.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.595 0.758 . . . . 100.0 109.323 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 t -98.48 130.26 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.689 0.796 . . . . 100.0 108.854 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.92 135.44 51.89 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.529 -2.026 . . . . 100.0 105.529 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -102.12 118.48 36.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.651 -0.819 . . . . 100.0 109.34 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p -103.86 176.12 5.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.077 -0.965 . . . . 100.0 109.768 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -60.13 -35.24 74.83 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.789 1.635 . . . . 100.0 109.582 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -90.5 -0.46 57.67 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 113.767 1.025 . . . . 100.0 113.767 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.07 178.07 15.26 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 119.493 1.042 . . . . 100.0 111.763 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.59 139.84 60.1 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 123.099 2.533 . . . . 100.0 114.323 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 mm -127.42 130.62 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 102.359 -3.2 . . . . 100.0 102.359 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -116.25 130.12 56.62 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 121.681 -0.637 . . . . 100.0 109.978 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.33 115.65 29.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 104.922 -2.251 . . . . 100.0 104.922 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.84 107.33 18.93 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 100.63 -3.841 . . . . 100.0 100.63 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 13' ' ' LEU . 21.5 t -93.56 122.65 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.183 -1.043 . . . . 100.0 108.183 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -94.24 111.77 23.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.155 -2.165 . . . . 100.0 105.155 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -115.02 137.46 51.98 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 106.95 -1.5 . . . . 100.0 106.95 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.5 p -70.85 163.7 26.81 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.04 0.924 . . . . 100.0 113.078 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.88 25.9 7.49 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.229 -1.026 . . . . 100.0 108.229 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.76 13.73 60.59 Favored Glycine 0 C--N 1.361 1.92 0 O-C-N 121.613 -0.679 . . . . 100.0 114.147 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.452 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 73.9 mt-30 -59.55 -35.04 73.47 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.795 2.038 . . . . 100.0 112.296 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.96 -32.84 68.23 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.416 2.686 . . . . 100.0 112.128 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.54 -40.07 95.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.12 0.968 . . . . 100.0 111.159 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 17.3 p90 -94.56 -18.08 21.75 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 115.578 1.696 . . . . 100.0 115.578 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.44 -162.83 27.86 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 119.836 -1.173 . . . . 100.0 112.518 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.25 178.46 53.86 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.601 -1.4 . . . . 100.0 109.601 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.6 mt -102.89 145.48 29.74 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 122.568 1.175 . . . . 100.0 111.09 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.15 150.12 49.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.082 -1.872 . . . . 100.0 111.433 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.39 -36.7 83.14 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.874 1.27 . . . . 100.0 108.859 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.67 -38.02 93.18 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 125.81 1.671 . . . . 100.0 110.587 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' A' ' 75' ' ' LEU . 73.9 t80 -63.66 -46.96 83.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.251 0.526 . . . . 100.0 111.5 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -70.27 -37.01 74.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 116.871 2.174 . . . . 100.0 116.871 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.18 139.89 13.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 CA-C-O 122.375 1.083 . . . . 100.0 113.75 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 70.8 11.5 7.15 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.92 2.088 . . . . 100.0 113.582 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.97 131.55 46.49 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.827 -0.805 . . . . 100.0 108.827 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -98.65 -27.82 13.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.149 -0.932 . . . . 100.0 109.513 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.625 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.4 p -152.21 163.05 40.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 122.284 0.234 . . . . 100.0 110.392 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.74 153.43 38.19 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 13' ' ' LEU . 95.6 mt -126.55 126.5 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 103.856 -2.646 . . . . 100.0 103.856 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.656 ' HB ' HD22 ' A' ' 119' ' ' LEU . 39.8 mt -111.37 125.09 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 102.934 -2.988 . . . . 100.0 102.934 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.8 mtp -112.5 137.1 51.2 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 114.596 1.332 . . . . 100.0 114.596 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -129.94 161.48 30.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.051 -2.34 . . . . 100.0 108.265 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.95 125.77 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.061 -1.829 . . . . 100.0 106.061 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.72 -16.95 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 113.355 0.872 . . . . 100.0 113.355 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -90.21 -7.44 53.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 119.146 -0.454 . . . . 100.0 111.109 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.4 t -123.66 116.9 23.83 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-O 122.214 1.007 . . . . 100.0 110.318 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -65.45 -36.85 85.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.146 0.978 . . . . 100.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.77 -40.22 81.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.571 1.549 . . . . 100.0 110.288 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.9 p -62.36 -41.04 98.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 118.439 0.563 . . . . 100.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -64.3 -41.67 96.74 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 123.734 0.814 . . . . 100.0 110.438 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.6 mttt -60.36 -37.76 81.72 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 124.336 1.054 . . . . 100.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -76.27 -9.79 58.91 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 115.631 1.715 . . . . 100.0 115.631 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -42.19 88.99 Favored Pre-proline 0 C--N 1.362 1.14 0 CA-C-O 116.32 -1.8 . . . . 100.0 112.087 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 76.5 Cg_exo -57.53 -37.91 95.61 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.351 2.034 . . . . 100.0 112.74 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.71 -44.59 89.75 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.631 1.172 . . . . 100.0 110.683 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -63.53 -42.43 98.44 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.267 0.627 . . . . 100.0 110.674 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CE1' HD11 ' A' ' 144' ' ' LEU . 84.4 t60 -62.78 -44.91 94.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 124.339 1.055 . . . . 100.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -63.12 -42.28 99.51 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 112.636 0.606 . . . . 100.0 112.636 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -61.82 -46.11 90.93 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.02 0.528 . . . . 100.0 109.798 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.84 -48.25 79.85 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.588 0.959 . . . . 100.0 113.588 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.32 -38.37 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 125.069 1.348 . . . . 100.0 111.473 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -60.37 -39.38 87.01 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.554 0.616 . . . . 100.0 111.439 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.17 -44.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 118.279 0.49 . . . . 100.0 110.61 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.2 m -127.59 106.78 9.4 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.521 0.601 . . . . 100.0 109.944 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.37 144.96 26.52 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.957 0.884 . . . . 100.0 112.615 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . 0.255 72.2 m-20 54.06 41.18 32.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 116.926 2.195 . . . . 100.0 116.926 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -96.48 144.17 27.37 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.998 -2.223 . . . . 100.0 104.998 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 132.26 36.14 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.354 2.036 . . . . 100.0 110.148 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.8 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.3 mt -132.24 136.59 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 122.309 1.052 . . . . 100.0 108.57 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 160' ' ' PRO . 60.7 t -115.55 131.95 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.989 -1.856 . . . . 100.0 105.989 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.656 HD22 ' HB ' ' A' ' 88' ' ' ILE . 25.9 mt -106.59 127.86 53.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.601 -2.0 . . . . 100.0 105.601 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 70.8 m -119.23 130.16 55.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.398 -1.274 . . . . 100.0 113.406 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.21 107.24 3.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 104.797 -3.321 . . . . 100.0 104.797 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.333 0.6 OUTLIER -95.64 177.9 5.65 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.668 1.358 . . . . 100.0 114.668 -178.266 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 61.82 40.14 13.13 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.742 2.417 . . . . 100.0 112.729 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.303 24.7 m -72.15 -8.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 CA-C-N 116.187 -0.461 . . . . 100.0 111.366 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.09 -37.3 86.64 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.6 1.96 . . . . 100.0 109.977 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.9 129.61 31.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 N-CA-C 107.743 -1.206 . . . . 100.0 107.743 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.54 -44.31 97.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.891 1.441 . . . . 100.0 114.891 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -87.74 95.29 10.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.773 -1.566 . . . . 100.0 106.773 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -94.99 125.31 39.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.229 -1.767 . . . . 100.0 106.229 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.32 -36.28 11.46 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 113.982 1.104 . . . . 100.0 113.982 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.52 106.34 20.35 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 104.395 -2.446 . . . . 100.0 104.395 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -100.8 173.6 6.43 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.115 -0.948 . . . . 100.0 112.045 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -56.84 -34.14 67.46 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.496 1.919 . . . . 100.0 109.477 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.032 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.3 mttt -57.31 -38.91 74.74 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 129.674 3.189 . . . . 100.0 112.094 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.7 p -104.95 2.75 30.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.796 2.147 . . . . 100.0 116.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.468 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 61.9 mt -92.95 89.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 116.589 -2.045 . . . . 100.0 110.624 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.4 p -100.64 -8.61 9.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -60.47 -36.63 78.75 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 117.819 2.525 . . . . 100.0 117.819 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.533 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.262 63.6 m-70 -58.94 -39.14 80.74 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 126.489 1.916 . . . . 100.0 115.265 -176.068 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.831 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.314 24.1 ttp-105 -59.25 -49.6 77.23 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 113.963 1.098 . . . . 100.0 113.963 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.25 -40.81 97.43 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 125.275 1.61 . . . . 100.0 111.318 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.5 mmtt -95.32 -0.65 52.57 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.576 1.695 . . . . 100.0 115.576 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.268 5.5 m120 55.28 44.54 27.29 Favored 'General case' 0 C--N 1.362 1.134 0 CA-C-O 123.367 1.556 . . . . 100.0 114.146 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.5 mt -106.03 143.33 34.32 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.212 -2.514 . . . . 100.0 104.212 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.257 99.8 mm-40 -92.25 145.51 24.44 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 118.625 -1.23 . . . . 100.0 110.247 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.6 t80 -110.6 137.49 48.21 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 113.063 0.764 . . . . 100.0 113.063 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.79 137.21 43.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.35 -1.296 . . . . 100.0 110.652 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.27 78.7 m-20 -83.35 129.22 34.98 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.894 -3.002 . . . . 100.0 102.894 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.484 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.5 pt -135.32 158.5 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-O 122.295 1.045 . . . . 100.0 111.71 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 59.4 m -139.48 110.73 6.97 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 105.42 -2.067 . . . . 100.0 105.42 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -62.28 -44.83 95.62 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.559 -1.201 . . . . 100.0 113.107 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.7 -39.55 94.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 124.735 1.214 . . . . 100.0 112.98 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 91.8 p -97.27 -0.02 47.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 115.314 1.598 . . . . 100.0 115.314 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.464 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.8 m-80 65.45 20.1 11.68 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.918 1.287 . . . . 100.0 111.648 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -69.84 125.88 28.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.404 -0.962 . . . . 100.0 108.404 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 53.1 37.6 25.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 128.103 2.561 . . . . 100.0 114.566 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.505 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 71.1 t80 -60.48 -43.63 96.75 Favored 'General case' 0 C--N 1.362 1.113 0 O-C-N 121.885 -0.509 . . . . 100.0 111.457 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -64.8 -36.81 85.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 118.013 2.597 . . . . 100.0 118.013 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -56.38 -47.97 97.89 Favored Pre-proline 0 C--N 1.358 0.97 0 N-CA-C 118.863 2.912 . . . . 100.0 118.863 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.458 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -60.62 -40.55 54.84 Favored 'Trans proline' 0 C--N 1.373 1.835 0 CA-C-N 122.879 2.064 . . . . 100.0 112.29 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.97 -41.62 95.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 124.5 1.125 . . . . 100.0 111.164 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.45 -46.37 90.34 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 123.726 0.641 . . . . 100.0 112.024 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.78 -43.22 93.95 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.631 0.582 . . . . 100.0 110.646 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.72 -44.83 96.17 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.243 0.617 . . . . 100.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.66 98.46 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 124.306 1.042 . . . . 100.0 110.793 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -61.65 -45.32 94.56 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 119.052 -0.499 . . . . 100.0 111.343 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.03 -43.72 86.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.985 1.106 . . . . 100.0 113.985 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.9 -46.59 84.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.699 0.8 . . . . 100.0 112.998 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 48.7 mm -70.77 -38.05 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.211 1.004 . . . . 100.0 110.469 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.67 10.53 58.95 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.498 -1.041 . . . . 100.0 110.498 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -114.98 114.02 43.93 Favored Pre-proline 0 C--N 1.365 1.242 0 N-CA-C 108.382 -0.97 . . . . 100.0 108.382 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.98 -12.6 30.8 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.931 3.087 . . . . 100.0 113.208 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -90.67 1.2 57.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.396 1.258 . . . . 100.0 114.396 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.95 135.85 57.52 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 118.734 0.697 . . . . 100.0 112.119 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.9 148.25 51.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.166 -0.924 . . . . 100.0 108.625 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -91.09 116.29 28.69 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 103.808 -2.664 . . . . 100.0 103.808 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.97 -44.08 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.776 0.83 . . . . 100.0 111.828 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.52 152.52 51.54 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.57 0.7 . . . . 100.0 110.508 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.06 133.79 47.52 Favored Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.797 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -66.12 156.92 62.32 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.623 2.215 . . . . 100.0 109.437 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.0 121.77 18.8 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.29 -1.745 . . . . 100.0 106.29 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.84 149.01 42.25 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.33 -1.304 . . . . 100.0 109.955 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.4 136.58 95.83 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 105.289 -2.115 . . . . 100.0 105.289 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 56.9 Cg_exo -56.59 142.2 90.53 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.197 2.598 . . . . 100.0 112.602 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -56.13 126.25 21.76 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.834 2.356 . . . . 100.0 112.073 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -70.55 -42.98 70.45 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 124.693 1.245 . . . . 100.0 108.483 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.96 156.59 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 106.074 -1.824 . . . . 100.0 106.074 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.37 131.0 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 106.49 -1.67 . . . . 100.0 106.49 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -86.71 126.15 34.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.986 -2.598 . . . . 100.0 103.986 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.5 t70 -61.17 127.54 88.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 100.0 110.863 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 68.1 Cg_exo -59.31 -38.6 83.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.759 2.973 . . . . 100.0 113.699 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.66 -44.35 90.68 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.186 0.929 . . . . 100.0 110.59 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.69 -42.16 98.04 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.004 0.522 . . . . 100.0 111.419 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.8 96.28 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.321 0.648 . . . . 100.0 110.803 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.73 98.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.796 0.838 . . . . 100.0 110.753 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.0 -42.07 97.28 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.016 0.526 . . . . 100.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -62.94 -43.1 99.7 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 122.82 0.448 . . . . 100.0 111.816 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -62.15 -43.17 99.43 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.529 0.731 . . . . 100.0 109.097 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.03 -44.16 97.29 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.123 1.369 . . . . 100.0 111.976 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.95 -42.14 98.78 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.606 0.762 . . . . 100.0 110.65 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.4 mt -60.93 -48.53 81.38 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.101 0.875 . . . . 100.0 109.308 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.28 -43.64 97.34 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.462 1.282 . . . . 100.0 114.462 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.55 -45.96 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.447 -3.017 0 CA-C-O 117.72 -1.133 . . . . 100.0 109.434 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.749 . . -86.38 -10.89 53.45 Favored 'General case' 0 N--CA 1.381 -3.878 1 C-N-CA 104.503 -6.879 . . . . 100.0 116.547 179.445 . . . . . . . . 4 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 1.043 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 47.3 mt-30 -53.92 -33.83 57.84 Favored 'General case' 0 CA--C 1.445 -3.085 0 C-N-CA 128.534 2.734 . . . . 100.0 107.07 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 38.92 0.51 Allowed 'General case' 0 N--CA 1.415 -2.222 0 O-C-N 124.988 1.43 . . . . 100.0 109.533 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 60.41 25.42 14.98 Favored 'General case' 0 CA--C 1.473 -2.007 0 C-N-CA 126.135 1.774 . . . . 100.0 112.409 175.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.268 . . -71.51 172.98 8.57 Favored 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.776 -3.416 . . . . 100.0 101.776 172.381 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.405 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.1 mt -54.5 -36.65 45.63 Favored Pre-proline 0 CA--C 1.49 -1.337 0 CA-C-O 116.323 -1.799 . . . . 100.0 113.711 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.032 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.448 0.3 OUTLIER -53.42 137.73 65.11 Favored 'Trans proline' 0 N--CA 1.432 -2.143 0 CA-C-O 123.528 1.387 . . . . 100.0 112.991 176.738 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.297 98.1 m-20 -63.65 -43.89 95.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 121.215 3.783 . . . . 100.0 121.215 -172.762 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.9 tm-20 -69.25 -19.0 63.93 Favored 'General case' 0 CA--C 1.465 -2.306 1 CA-C-O 130.946 5.165 . . . . 100.0 112.771 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 1.043 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.777 68.3 m-20 -83.89 -49.73 8.74 Favored 'General case' 1 N--CA 1.262 -9.825 1 CA-C-N 105.623 -5.262 . . . . 100.0 104.915 -173.383 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.96 -26.86 68.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.038 -2.289 . . . . 100.0 106.56 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.831 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 59.5 m-20 -62.8 -40.0 96.0 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 127.044 2.138 . . . . 100.0 112.952 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.547 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.26 3.9 mm? . . . . . 0 N--CA 1.426 -1.649 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.793 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 9' ' ' VAL . 4.3 tpt . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 111.563 0.208 . . . . 100.0 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.691 1.197 . . . . 100.0 112.72 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.54 150.59 23.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 123.689 0.796 . . . . 100.0 111.99 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -89.5 157.9 17.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.514 0.725 . . . . 100.0 109.064 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.4 87.73 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-O 119.619 -0.545 . . . . 100.0 112.836 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -75.28 155.68 85.9 Favored Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.634 1.174 . . . . 100.0 111.349 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.87 154.64 65.11 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.576 2.85 . . . . 100.0 111.394 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -55.22 133.61 49.32 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 114.765 1.394 . . . . 100.0 114.765 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG21 ' SD ' ' A' ' 1' ' ' MET . 94.4 t -96.79 119.43 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 114.009 -1.45 . . . . 100.0 107.19 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -120.26 135.22 55.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.803 -1.999 . . . . 100.0 107.612 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.74 143.67 48.66 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.933 -1.136 . . . . 100.0 107.933 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.33 120.21 34.23 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.382 -1.71 . . . . 100.0 106.382 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.76 127.42 53.99 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.036 -1.893 . . . . 100.0 106.782 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 79' ' ' TYR . 53.6 t -103.52 120.87 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.632 -1.622 . . . . 100.0 106.687 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.6 tp -109.27 117.24 33.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.218 -2.141 . . . . 100.0 105.218 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 m -128.31 161.78 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 120.931 0.396 . . . . 100.0 111.667 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.36 175.45 27.34 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 108.38 -1.888 . . . . 100.0 108.38 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -71.78 155.72 40.12 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.935 -0.744 . . . . 100.0 112.18 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.74 141.7 40.69 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 107.321 -2.311 . . . . 100.0 107.321 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.2 81.46 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-O 118.823 -0.987 . . . . 100.0 113.436 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 80.0 m -62.67 -40.37 96.86 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-N 118.608 1.204 . . . . 100.0 110.777 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.08 25.02 4.61 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.823 -1.311 . . . . 100.0 109.823 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.17 -45.22 93.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.966 1.706 . . . . 100.0 112.554 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -62.89 -44.34 96.38 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.538 1.135 . . . . 100.0 109.486 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.7 m -63.8 -40.21 96.09 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.529 1.132 . . . . 100.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 47.6 t80 -59.4 -49.32 78.25 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 124.935 1.294 . . . . 100.0 111.534 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.19 -41.64 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 123.371 0.419 . . . . 100.0 111.258 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.277 99.2 mttt -69.83 -6.87 35.38 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 115.933 1.827 . . . . 100.0 115.933 -176.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.708 HH21 ' HA ' ' A' ' 157' ' ' PHE . 83.7 mtm-85 -60.78 -37.68 82.71 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.129 -1.063 . . . . 100.0 108.129 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.84 112.54 18.32 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 107.054 -1.461 . . . . 100.0 107.054 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.3 -43.78 98.02 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 115.207 1.558 . . . . 100.0 115.207 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.2 m -62.73 -42.48 99.68 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.884 -0.784 . . . . 100.0 108.884 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -42.16 99.71 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 111.061 -0.816 . . . . 100.0 111.061 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.75 -44.95 91.99 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.873 0.869 . . . . 100.0 110.883 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -63.63 -39.72 95.06 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 123.601 0.76 . . . . 100.0 113.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -89.91 5.92 44.25 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -57.32 138.35 54.95 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 114.546 1.313 . . . . 100.0 114.546 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -124.61 130.35 52.28 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.702 -1.222 . . . . 100.0 107.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -100.77 123.27 44.73 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.233 -2.136 . . . . 100.0 105.233 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -102.85 114.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 103.37 -2.826 . . . . 100.0 103.37 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.03 94.94 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 115.393 1.627 . . . . 100.0 115.393 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.1 p -61.93 -48.36 80.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.665 0.386 . . . . 100.0 111.965 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.18 -38.41 75.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.307 1.443 . . . . 100.0 112.982 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.95 32.23 50.26 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 108.112 -1.995 . . . . 100.0 108.112 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 79' ' ' TYR . 22.9 m -129.01 153.17 38.22 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 121.629 0.728 . . . . 100.0 109.672 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.45 120.22 41.84 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 103.074 -2.935 . . . . 100.0 103.074 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.6 123.04 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 106.567 -1.642 . . . . 100.0 106.567 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -117.78 119.43 33.94 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.78 106.51 1.82 Allowed 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.123 1.882 . . . . 100.0 110.229 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.69 117.29 31.65 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.685 -1.598 . . . . 100.0 106.685 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 t -102.86 126.68 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.66 -1.237 . . . . 100.0 107.66 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -121.33 133.49 55.12 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.639 -1.985 . . . . 100.0 105.639 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -101.28 120.28 40.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.715 -1.217 . . . . 100.0 107.715 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.447 HG21 HD12 ' A' ' 59' ' ' ILE . 26.6 p -110.54 -179.26 3.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.05 -0.977 . . . . 100.0 110.894 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.77 -44.25 93.97 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.334 1.454 . . . . 100.0 108.294 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -67.04 -39.26 86.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 124.062 0.945 . . . . 100.0 113.052 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.69 28.83 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 107.381 -2.288 . . . . 100.0 107.381 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.08 137.92 50.1 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.117 1.878 . . . . 100.0 114.647 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -125.05 130.29 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.26 -3.237 . . . . 100.0 102.26 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.01 128.13 55.75 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.749 -0.834 . . . . 100.0 108.749 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.44 116.41 31.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.172 -2.529 . . . . 100.0 104.172 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 35.0 m120 -87.8 106.05 17.81 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.25 -4.352 . . . . 100.0 99.25 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.29 122.76 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.05 115.89 29.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.339 -2.097 . . . . 100.0 105.339 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -112.46 136.32 52.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.605 -1.998 . . . . 100.0 105.605 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 p -71.96 162.29 29.67 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.76 0.824 . . . . 100.0 112.86 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.74 17.29 16.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.694 -0.684 . . . . 100.0 109.687 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.08 11.64 52.04 Favored Glycine 0 C--N 1.357 1.732 0 O-C-N 121.804 -0.56 . . . . 100.0 112.328 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.27 -29.32 70.34 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.836 1.654 . . . . 100.0 111.385 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.66 -37.23 78.18 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 127.794 2.438 . . . . 100.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.93 -43.12 99.66 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.326 0.65 . . . . 100.0 110.025 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.18 -41.35 77.3 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 125.458 1.503 . . . . 100.0 111.972 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.34 -152.12 12.32 Favored Glycine 0 C--N 1.356 1.665 0 C-N-CA 120.996 -0.621 . . . . 100.0 111.57 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.26 169.58 52.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 122.069 0.816 . . . . 100.0 112.931 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 79' ' ' TYR . 88.6 mt -105.68 143.49 33.76 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.708 -0.746 . . . . 100.0 109.767 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -67.67 155.48 39.12 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.735 -1.12 . . . . 100.0 113.616 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -60.47 -37.68 81.78 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.827 -1.533 . . . . 100.0 110.328 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.78 -39.21 93.43 Favored Glycine 0 C--N 1.358 1.778 0 C-N-CA 124.846 1.213 . . . . 100.0 111.316 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 45' ' ' VAL . 60.8 t80 -62.53 -45.99 90.46 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.422 0.689 . . . . 100.0 110.895 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -68.94 -36.67 78.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.3 mt -50.85 135.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 C-N-CA 125.57 1.548 . . . . 100.0 114.297 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.62 30.29 18.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.104 2.562 . . . . 100.0 114.015 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.66 128.66 36.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.26 -1.756 . . . . 100.0 106.26 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 115' ' ' ILE . 97.3 mm-40 -96.47 -35.35 11.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.3 p -143.76 159.27 42.81 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 120.899 0.381 . . . . 100.0 111.133 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.8 149.57 34.59 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 114.37 1.248 . . . . 100.0 114.37 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.9 mt -125.5 125.75 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.429 ' HB ' HD22 ' A' ' 119' ' ' LEU . 52.0 mt -110.66 123.71 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 102.419 -3.178 . . . . 100.0 102.419 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.417 ' SD ' HD11 ' A' ' 15' ' ' LEU . 81.3 mtp -109.68 134.08 52.39 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 114.144 -1.389 . . . . 100.0 113.602 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -128.18 158.82 37.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 112.555 -2.112 . . . . 100.0 108.433 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.51 125.75 50.97 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.41 -21.6 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 113.797 1.036 . . . . 100.0 113.797 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.7 p -86.65 -10.16 54.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 119.241 -0.409 . . . . 100.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.6 t -118.49 116.39 26.57 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.136 0.969 . . . . 100.0 111.401 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -66.5 -38.38 87.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.892 -1.049 . . . . 100.0 111.079 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.56 -41.75 88.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 125.661 1.584 . . . . 100.0 110.55 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -62.36 -42.8 99.69 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 109.792 -0.448 . . . . 100.0 109.792 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.522 ' CE1' HG23 ' A' ' 136' ' ' ILE . 44.5 t80 -64.11 -41.04 97.41 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 123.714 0.805 . . . . 100.0 110.703 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -61.14 -37.86 84.34 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.958 0.903 . . . . 100.0 111.311 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.65 -9.0 58.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.12 -43.26 93.52 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 115.997 -1.954 . . . . 100.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.4 Cg_exo -57.57 -38.57 93.31 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.158 1.905 . . . . 100.0 112.742 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -64.25 -44.45 91.74 Favored 'General case' 0 C--N 1.358 0.978 0 O-C-N 124.186 0.929 . . . . 100.0 111.443 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -63.88 -41.22 97.79 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 122.744 0.418 . . . . 100.0 110.995 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.5 t60 -62.43 -43.83 97.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.43 1.092 . . . . 100.0 109.932 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.8 -45.34 94.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 123.577 0.751 . . . . 100.0 111.351 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -62.89 -44.82 95.07 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.06 0.544 . . . . 100.0 111.774 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 86' ' ' ALA . 50.8 tp -63.23 -46.03 88.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.548 1.139 . . . . 100.0 112.31 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.36 -37.69 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 125.593 1.557 . . . . 100.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.5 -49.14 78.45 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.649 -0.691 . . . . 100.0 110.183 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.5 t -73.07 -46.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 119.227 -0.989 . . . . 100.0 111.956 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -124.78 113.8 18.41 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 121.641 0.734 . . . . 100.0 110.177 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.64 146.6 23.54 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.466 -0.788 . . . . 100.0 112.142 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 54.72 44.44 28.54 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 126.463 1.905 . . . . 100.0 115.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' GLN . 27.9 mm -98.89 133.21 22.5 Favored Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 126.42 1.888 . . . . 100.0 107.376 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 115' ' ' ILE . 40.5 Cg_exo -62.96 129.02 24.59 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.86 2.373 . . . . 100.0 108.457 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.701 ' HB ' HD22 ' A' ' 144' ' ' LEU . 68.7 mt -131.05 137.58 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 122.292 1.044 . . . . 100.0 108.287 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 160' ' ' PRO . 93.6 t -115.74 131.83 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.145 -2.168 . . . . 100.0 105.145 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 28.8 mt -105.61 125.54 51.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.869 -2.641 . . . . 100.0 103.869 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -113.86 126.74 55.52 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.85 -1.523 . . . . 100.0 112.203 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.01 103.42 2.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 105.162 -3.175 . . . . 100.0 105.162 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.58 165.76 19.8 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.789 1.636 . . . . 100.0 112.53 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 21' ' ' THR . 85.0 mttt 59.42 43.38 16.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 128.541 2.736 . . . . 100.0 114.541 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.313 30.9 m -72.23 -8.8 12.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 C-N-CA 120.526 -0.47 . . . . 100.0 111.231 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.58 -38.3 87.05 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.968 2.107 . . . . 100.0 110.117 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.59 130.79 33.85 Favored 'Isoleucine or valine' 0 C--N 1.363 1.168 0 N-CA-C 107.221 -1.4 . . . . 100.0 107.221 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.14 -40.95 99.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 125.32 1.448 . . . . 100.0 114.357 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.74 91.07 8.2 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.262 -1.385 . . . . 100.0 107.262 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -94.85 120.6 35.34 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.087 -2.561 . . . . 100.0 104.087 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -96.15 -37.22 10.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.324 -0.853 . . . . 100.0 112.876 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 136' ' ' ILE . 45.4 t -104.01 105.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 102.573 -3.121 . . . . 100.0 102.573 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -104.68 178.83 4.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 113.665 0.987 . . . . 100.0 113.665 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.4 -35.33 71.87 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.308 2.243 . . . . 100.0 109.402 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.062 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.7 mttt -59.42 -37.81 79.03 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.989 2.516 . . . . 100.0 112.32 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.5 p -104.73 -1.29 26.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 120.106 3.373 . . . . 100.0 120.106 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.62 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 49.8 mt -96.6 91.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 115.779 -2.368 . . . . 100.0 111.736 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.413 ' N ' ' HB3' ' A' ' 211' ' ' ASP . 4.9 p -97.54 -7.98 9.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 115.767 1.766 . . . . 100.0 115.767 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.91 -36.2 72.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.01 1.485 . . . . 100.0 115.01 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.493 ' HE1' ' HB2' ' A' ' 119' ' ' LEU . 83.9 m-70 -59.87 -40.65 89.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 116.946 -1.502 . . . . 100.0 114.123 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 25.9 ttt180 -61.32 -45.42 94.51 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 119.971 1.259 . . . . 100.0 112.629 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.56 -41.9 98.05 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.387 1.075 . . . . 100.0 110.862 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.23 2.28 48.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 115.875 1.806 . . . . 100.0 115.875 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.67 44.5 26.32 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.777 1.631 . . . . 100.0 113.305 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 117' ' ' ILE . 28.5 mt -106.96 152.19 24.29 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.781 -1.563 . . . . 100.0 106.781 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.336 90.6 mm-40 -101.43 145.71 28.59 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 113.474 0.916 . . . . 100.0 113.474 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.486 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.8 t80 -105.09 133.91 49.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 113.921 1.082 . . . . 100.0 113.921 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.12 133.35 46.58 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.048 -1.433 . . . . 100.0 111.172 173.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.279 36.9 m-20 -84.76 121.54 27.83 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.176 -3.268 . . . . 100.0 102.176 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.42 155.42 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 122.381 1.086 . . . . 100.0 110.613 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.2 m -137.31 111.36 8.35 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 105.908 -1.886 . . . . 100.0 105.908 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.57 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.44 -43.91 97.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.187 -1.369 . . . . 100.0 112.664 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.79 -42.31 98.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.377 1.071 . . . . 100.0 112.508 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 97.4 p -97.04 1.41 50.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.597 2.073 . . . . 100.0 116.597 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.0 m-80 64.03 24.58 13.59 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.223 1.409 . . . . 100.0 110.524 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 75.7 t80 -75.01 125.71 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.133 -1.062 . . . . 100.0 108.133 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 53.55 40.04 30.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.232 2.613 . . . . 100.0 115.404 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HA ' HH21 ' A' ' 29' ' ' ARG . 67.3 t80 -61.77 -44.0 97.75 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.827 -0.546 . . . . 100.0 111.248 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 -39.65 95.04 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 116.374 1.99 . . . . 100.0 116.374 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.57 -47.94 97.83 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 121.035 3.717 . . . . 100.0 121.035 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' HG11 ' A' ' 118' ' ' VAL . 52.9 Cg_endo -61.35 -41.9 38.26 Favored 'Trans proline' 0 C--N 1.371 1.733 0 CA-C-N 123.586 2.316 . . . . 100.0 112.437 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -64.52 -42.52 95.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.922 1.289 . . . . 100.0 110.799 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.8 tp -63.1 -45.19 93.21 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.241 1.017 . . . . 100.0 111.327 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.36 -44.65 94.2 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.684 -0.488 . . . . 100.0 109.684 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.9 mt -61.79 -44.49 96.76 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.062 0.545 . . . . 100.0 111.474 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.67 98.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.966 0.907 . . . . 100.0 111.228 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.13 -45.99 91.02 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 123.341 0.656 . . . . 100.0 111.542 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.38 -42.92 87.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.293 0.849 . . . . 100.0 113.293 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.8 mt -63.72 -45.65 88.96 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.632 0.773 . . . . 100.0 112.032 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.432 HD12 HD22 ' A' ' 174' ' ' LEU . 71.6 mt -69.97 -39.16 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.11 0.564 . . . . 100.0 109.552 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.07 10.64 58.38 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 110.411 -1.076 . . . . 100.0 110.411 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -114.07 112.82 46.92 Favored Pre-proline 0 C--N 1.361 1.107 0 N-CA-C 107.57 -1.27 . . . . 100.0 107.57 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.061 3.174 . . . . 100.0 113.992 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -87.96 2.12 52.44 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 123.979 0.912 . . . . 100.0 113.114 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.432 HD22 HD12 ' A' ' 169' ' ' ILE . 17.0 tp -66.07 132.16 47.88 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.324 0.65 . . . . 100.0 109.355 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -134.44 151.36 51.12 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.15 113.61 23.94 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 104.195 -2.52 . . . . 100.0 104.195 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.02 -43.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 123.594 0.758 . . . . 100.0 110.293 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.48 149.02 51.43 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.451 0.643 . . . . 100.0 109.839 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -92.61 125.95 53.88 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.093 -2.188 . . . . 100.0 105.093 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.17 158.16 53.58 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.076 2.517 . . . . 100.0 111.458 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.77 126.9 29.11 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.146 0.974 . . . . 100.0 108.884 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.25 145.9 46.59 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-N 114.014 -1.448 . . . . 100.0 109.971 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.29 138.02 97.3 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 64.9 Cg_exo -55.95 139.71 84.91 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 123.67 2.913 . . . . 100.0 113.021 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.561 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -57.68 129.44 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 123.206 2.604 . . . . 100.0 113.028 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -68.36 -43.18 77.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 124.742 1.276 . . . . 100.0 108.122 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.9 158.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.351 -1.722 . . . . 100.0 106.351 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.68 130.6 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 106.208 -1.775 . . . . 100.0 106.208 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.24 127.54 35.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.749 -2.315 . . . . 100.0 104.749 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.73 128.14 91.39 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 114.493 -1.231 . . . . 100.0 110.295 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.6 -37.4 88.56 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.772 2.981 . . . . 100.0 113.001 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.18 94.14 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 124.257 0.973 . . . . 100.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.38 -42.28 98.83 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 122.817 0.447 . . . . 100.0 111.633 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.25 97.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.125 0.57 . . . . 100.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.54 98.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.943 0.897 . . . . 100.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -44.27 96.55 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.183 0.993 . . . . 100.0 112.405 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -63.4 -44.1 95.64 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 122.71 0.404 . . . . 100.0 111.073 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -64.5 -39.89 94.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.107 -0.497 . . . . 100.0 110.57 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.31 -43.85 97.88 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.95 1.3 . . . . 100.0 110.524 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.93 -42.89 99.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 123.955 0.902 . . . . 100.0 110.144 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 22.6 tp -59.9 -48.65 80.82 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.222 0.951 . . . . 100.0 109.951 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -43.36 99.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.999 1.481 . . . . 100.0 114.999 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.0 -47.09 91.04 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.217 0 CA-C-O 118.245 -0.883 . . . . 100.0 109.544 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.406 . . -95.66 0.91 53.25 Favored 'General case' 0 N--CA 1.402 -2.847 1 C-N-CA 109.729 -4.789 . . . . 100.0 114.685 179.573 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.329 19.5 mt-30 -56.78 -36.35 69.74 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 106.246 -1.761 . . . . 100.0 106.246 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 64.9 p -82.25 52.04 1.93 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.091 0.948 . . . . 100.0 108.779 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.296 73.9 p 49.25 37.69 11.85 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 129.002 2.921 . . . . 100.0 116.157 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.86 -179.78 7.54 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.286 -2.486 . . . . 100.0 104.286 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' A' ' 210' ' ' PRO 0.439 3.7 pp -57.44 -38.73 70.99 Favored Pre-proline 0 CA--C 1.501 -0.941 0 CA-C-O 115.523 -2.18 . . . . 100.0 115.886 -175.435 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.062 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.312 79.0 Cg_exo -54.88 136.47 72.35 Favored 'Trans proline' 0 C--N 1.375 1.971 0 CA-C-N 121.839 1.692 . . . . 100.0 111.417 176.43 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.413 ' HB3' ' N ' ' A' ' 137' ' ' VAL . 96.0 m-20 -63.46 -47.86 80.1 Favored 'General case' 0 N--CA 1.424 -1.771 1 N-CA-C 124.784 5.105 . . . . 100.0 124.784 -173.533 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.251 99.3 mt-10 -62.88 -35.56 80.42 Favored 'General case' 0 CA--C 1.48 -1.732 1 CA-C-O 128.621 4.057 . . . . 100.0 107.84 177.889 . . . . . . . . 4 3 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.779 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.49 39.2 m-20 -64.93 -49.03 71.97 Favored 'General case' 1 N--CA 1.354 -5.251 1 CA-C-N 107.796 -4.274 . . . . 100.0 106.297 -178.903 . . . . . . . . 5 3 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.12 -31.23 71.67 Favored 'General case' 0 C--N 1.36 1.033 0 O-C-N 120.535 -1.353 . . . . 100.0 107.682 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 1.8 t70 -57.63 -42.77 84.06 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 116.926 -1.512 . . . . 100.0 113.295 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.261 1.701 0 CA-C-O 115.558 -2.163 . . . . 100.0 112.6 -176.913 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -1.017 0 N-CA-C 112.364 0.505 . . . . 100.0 112.364 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.12 93.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.007 1.323 . . . . 100.0 113.135 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.87 147.7 27.01 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.101 0.477 . . . . 100.0 111.594 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -81.5 160.5 23.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.621 0.768 . . . . 100.0 110.004 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.22 2.75 87.71 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.652 -0.527 . . . . 100.0 112.698 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.51 158.92 75.6 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 124.019 0.928 . . . . 100.0 110.329 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.73 158.34 46.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.633 2.889 . . . . 100.0 111.552 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -53.19 132.58 38.82 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 114.843 1.423 . . . . 100.0 114.843 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.443 HG21 ' HG2' ' A' ' 1' ' ' MET . 58.0 t -93.24 115.36 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 105.682 -1.97 . . . . 100.0 105.682 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -123.58 136.16 54.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.762 -1.563 . . . . 100.0 108.752 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.34 144.32 50.08 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.243 -1.021 . . . . 100.0 108.243 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.28 121.03 35.38 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.433 -1.692 . . . . 100.0 106.433 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -109.52 127.73 54.67 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 113.062 -1.881 . . . . 100.0 106.326 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 79' ' ' TYR . 49.9 t -102.96 121.09 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 106.572 -1.64 . . . . 100.0 106.572 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.619 HD11 ' SD ' ' A' ' 89' ' ' MET . 29.9 tp -109.88 117.08 32.87 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.618 -2.364 . . . . 100.0 104.618 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -127.93 161.98 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 120.718 0.294 . . . . 100.0 111.528 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.22 175.0 26.7 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 108.875 -1.69 . . . . 100.0 108.875 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.03 156.27 39.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 O-C-N 121.832 -0.804 . . . . 100.0 112.092 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.93 141.38 39.77 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 106.984 -2.446 . . . . 100.0 106.984 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.66 -5.96 79.94 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-O 118.773 -1.015 . . . . 100.0 113.404 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -62.68 -39.87 95.29 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 118.804 1.302 . . . . 100.0 111.307 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.87 25.72 4.4 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.743 -1.343 . . . . 100.0 109.743 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 52.9 mtpt -60.01 -46.79 88.32 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.362 1.465 . . . . 100.0 112.883 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.7 m -63.82 -43.06 97.36 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.408 1.083 . . . . 100.0 109.644 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 m -63.3 -41.4 98.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.483 1.113 . . . . 100.0 109.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HA ' HH11 ' A' ' 29' ' ' ARG . 45.1 t80 -60.09 -49.11 78.93 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 123.626 0.77 . . . . 100.0 112.749 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.77 -41.05 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 123.739 0.649 . . . . 100.0 110.958 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.266 99.0 mttt -69.06 -7.57 36.99 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 115.826 1.787 . . . . 100.0 115.826 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.6 mtm-85 -61.04 -36.91 80.82 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 108.691 -0.855 . . . . 100.0 108.691 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 55.1 t-80 -80.34 112.23 17.47 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.4 -43.9 97.72 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 115.361 1.615 . . . . 100.0 115.361 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.442 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.9 m -63.09 -42.22 99.55 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.888 -0.782 . . . . 100.0 108.888 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.47 99.78 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 111.383 -0.687 . . . . 100.0 111.383 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.64 -44.19 94.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.29 0.636 . . . . 100.0 110.836 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -63.83 -40.58 96.94 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 124.463 1.105 . . . . 100.0 112.295 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -91.14 8.56 35.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -59.18 140.36 55.99 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 114.649 1.352 . . . . 100.0 114.649 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.24 130.6 52.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.169 -1.419 . . . . 100.0 107.169 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -104.47 125.13 50.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 106.766 -1.568 . . . . 100.0 106.766 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.16 113.54 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 102.199 -3.26 . . . . 100.0 102.199 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.51 92.42 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 116.228 1.936 . . . . 100.0 116.228 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.2 p -62.58 -47.42 83.89 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.916 0.486 . . . . 100.0 111.784 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.06 -37.74 75.6 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.899 1.28 . . . . 100.0 112.912 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.36 53.91 Favored Glycine 0 C--N 1.359 1.837 0 N-CA-C 106.71 -2.556 . . . . 100.0 106.71 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 ' HD1' ' A' ' 79' ' ' TYR . 66.9 t -124.43 139.59 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 124.733 1.213 . . . . 100.0 108.754 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.74 117.02 32.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 102.387 -3.19 . . . . 100.0 102.387 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.06 122.1 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.065 -1.458 . . . . 100.0 107.065 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -115.17 121.05 35.66 Favored Pre-proline 0 N--CA 1.432 -1.337 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.105 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -80.13 104.57 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.426 2.084 . . . . 100.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.7 117.07 30.24 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.931 -1.507 . . . . 100.0 106.931 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.52 125.77 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.406 -1.331 . . . . 100.0 107.406 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.45 133.12 55.46 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.851 -1.907 . . . . 100.0 105.851 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -99.67 116.42 31.73 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 19.0 p -108.49 178.63 4.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.434 -0.803 . . . . 100.0 110.846 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -59.87 -43.6 94.62 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.99 1.316 . . . . 100.0 108.427 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -68.99 -38.37 79.26 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 112.839 0.681 . . . . 100.0 112.839 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.96 -172.38 30.61 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.642 -1.783 . . . . 100.0 108.642 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -65.52 136.87 48.26 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.518 2.145 . . . . 100.0 114.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 77.7 mt -126.15 130.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 102.111 -3.292 . . . . 100.0 102.111 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.85 128.44 55.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.617 -0.883 . . . . 100.0 108.617 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.37 114.79 28.18 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.557 -2.757 . . . . 100.0 103.557 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -87.75 105.7 17.56 Favored 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 99.862 -4.125 . . . . 100.0 99.862 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.76 123.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.448 -1.686 . . . . 100.0 106.448 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -96.84 114.7 26.35 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.878 -1.897 . . . . 100.0 105.878 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.61 137.25 49.72 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.328 -1.731 . . . . 100.0 106.328 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -72.97 161.94 30.09 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.731 0.777 . . . . 100.0 112.487 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.1 19.47 14.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.668 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.47 13.19 52.29 Favored Glycine 0 C--N 1.356 1.681 0 O-C-N 121.818 -0.552 . . . . 100.0 112.277 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 65.3 mt-30 -60.44 -35.8 76.71 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.52 1.928 . . . . 100.0 111.583 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -58.26 -36.01 72.61 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.13 2.572 . . . . 100.0 111.869 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.84 -42.4 98.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.604 0.762 . . . . 100.0 111.041 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 26.7 p90 -95.37 -5.85 42.36 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.85 -166.69 38.08 Favored Glycine 0 C--N 1.358 1.756 0 C-N-CA 119.7 -1.238 . . . . 100.0 113.251 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.68 175.27 54.9 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.97 -1.252 . . . . 100.0 109.97 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.7 mt -105.14 140.65 37.99 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 122.18 0.99 . . . . 100.0 110.465 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -68.7 154.64 41.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.676 -1.602 . . . . 100.0 113.602 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.95 -38.31 85.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.531 1.533 . . . . 100.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.04 93.85 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.854 1.216 . . . . 100.0 111.063 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HD1' HG21 ' A' ' 45' ' ' VAL . 63.0 t80 -62.23 -46.98 86.45 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.697 0.799 . . . . 100.0 110.866 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 116.298 1.962 . . . . 100.0 116.298 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.3 mt -51.84 136.58 11.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 C-N-CA 125.04 1.336 . . . . 100.0 113.973 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 61.89 31.78 18.13 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.749 2.42 . . . . 100.0 114.706 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.87 128.44 35.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 105.595 -2.002 . . . . 100.0 105.595 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 115' ' ' ILE . 95.9 mm-40 -96.78 -36.82 10.51 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.554 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.6 p -143.52 159.97 41.45 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.776 0.431 . . . . 100.0 110.842 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -146.23 149.17 33.41 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 15' ' ' LEU . 91.7 mt -125.65 126.15 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 103.678 -2.712 . . . . 100.0 103.678 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.98 124.26 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 101.762 -3.422 . . . . 100.0 101.762 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 15' ' ' LEU . 95.1 mtp -109.16 131.64 54.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.005 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -129.25 159.43 36.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.155 -1.838 . . . . 100.0 108.434 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -106.4 126.95 52.89 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.46 -1.681 . . . . 100.0 106.46 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.65 -21.41 29.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 113.849 1.055 . . . . 100.0 113.849 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.0 p -85.12 -12.19 53.46 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 119.239 -0.41 . . . . 100.0 110.579 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -118.76 117.29 28.5 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.337 1.065 . . . . 100.0 111.427 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -66.51 -38.87 88.16 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.424 -1.262 . . . . 100.0 110.434 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.66 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 126.071 1.749 . . . . 100.0 110.856 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.8 m -62.71 -42.67 99.77 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.655 -0.498 . . . . 100.0 109.655 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CE1' HG23 ' A' ' 136' ' ' ILE . 43.6 t80 -64.15 -40.28 95.81 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 123.452 0.701 . . . . 100.0 110.884 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -60.79 -38.77 86.44 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.546 1.139 . . . . 100.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.38 -9.38 58.6 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 115.182 1.549 . . . . 100.0 115.182 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.3 t -60.06 -42.98 92.99 Favored Pre-proline 0 C--N 1.363 1.194 0 CA-C-O 115.884 -2.007 . . . . 100.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 82.0 Cg_exo -57.78 -36.83 98.16 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.309 2.006 . . . . 100.0 112.852 177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.44 -46.93 84.05 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 124.355 1.062 . . . . 100.0 110.28 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -64.24 -42.08 96.69 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.162 0.585 . . . . 100.0 111.271 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.58 -44.25 96.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 124.326 1.05 . . . . 100.0 110.39 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -62.76 -44.38 96.35 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.759 -0.639 . . . . 100.0 112.031 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.34 -44.28 96.85 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 123.526 0.516 . . . . 100.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.1 tp -62.45 -46.8 86.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.684 1.193 . . . . 100.0 112.577 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.32 -38.97 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 125.364 1.465 . . . . 100.0 111.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.37 -46.66 89.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 118.938 -0.553 . . . . 100.0 110.714 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.9 t -72.03 -45.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 120.254 -0.578 . . . . 100.0 111.534 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.81 115.65 18.97 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.249 -0.648 . . . . 100.0 109.249 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -93.29 147.3 23.04 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 115.771 -0.649 . . . . 100.0 112.492 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 54.55 44.55 28.55 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.436 1.895 . . . . 100.0 115.183 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 84' ' ' GLN . 33.9 mm -98.96 132.36 23.77 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 126.116 1.766 . . . . 100.0 107.066 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.49 129.25 25.99 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.536 2.158 . . . . 100.0 109.144 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.717 ' HB ' HD22 ' A' ' 144' ' ' LEU . 71.0 mt -130.71 136.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-O 122.257 1.027 . . . . 100.0 108.689 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.4 130.8 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 105.062 -2.199 . . . . 100.0 105.062 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 21.9 mt -105.25 127.07 52.76 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.136 -2.912 . . . . 100.0 103.136 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.83 127.21 54.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.642 -1.617 . . . . 100.0 112.061 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.58 105.26 3.06 Favored Glycine 0 CA--C 1.489 -1.558 0 N-CA-C 106.427 -2.669 . . . . 100.0 106.427 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.14 164.25 23.48 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.2 2.6 . . . . 100.0 113.935 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.2 mttp 55.62 45.15 25.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 128.46 2.704 . . . . 100.0 114.367 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.296 32.8 m -71.82 -9.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 120.4 -0.52 . . . . 100.0 111.062 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.65 -39.1 90.15 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.658 1.983 . . . . 100.0 110.287 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.4 130.87 33.75 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.381 -0.97 . . . . 100.0 108.381 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -62.34 -40.54 96.7 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.937 1.458 . . . . 100.0 114.937 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -84.02 96.08 8.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 105.282 -2.118 . . . . 100.0 105.282 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -102.37 120.91 41.29 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 103.621 -2.733 . . . . 100.0 103.621 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.87 -36.51 10.57 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-N 115.612 -0.722 . . . . 100.0 112.528 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.32 104.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 103.534 -2.765 . . . . 100.0 103.534 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.23 179.95 4.13 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.21 -35.2 71.31 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.336 2.254 . . . . 100.0 109.539 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.076 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.4 mttt -59.29 -37.62 78.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 128.41 2.684 . . . . 100.0 112.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.6 p -104.99 -0.85 26.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 120.091 3.367 . . . . 100.0 120.091 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 53.8 mt -97.38 94.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 115.583 -2.447 . . . . 100.0 111.431 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 4.3 p -100.82 -5.32 9.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 115.338 1.606 . . . . 100.0 115.338 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.58 -36.55 74.15 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 115.199 1.555 . . . . 100.0 115.199 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.651 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 70.1 m80 -59.54 -39.25 83.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.814 1.646 . . . . 100.0 113.344 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.648 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 57.3 ttp85 -58.69 -48.5 80.88 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 114.031 1.123 . . . . 100.0 114.031 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.52 -40.59 95.91 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.218 0.949 . . . . 100.0 111.812 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.01 -0.1 54.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 116.157 1.91 . . . . 100.0 116.157 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.258 73.2 m-20 54.55 47.13 23.39 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.378 1.471 . . . . 100.0 113.346 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.7 mt -103.62 153.39 20.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.115 -1.809 . . . . 100.0 106.115 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -101.53 142.96 32.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.3 -0.63 . . . . 100.0 109.3 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.651 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 68.2 t80 -105.79 133.63 50.21 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.4 0.889 . . . . 100.0 113.4 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.82 133.4 45.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.575 -1.193 . . . . 100.0 111.491 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.297 37.1 m-20 -85.64 122.97 30.49 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 102.234 -3.247 . . . . 100.0 102.234 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.32 156.89 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 CA-C-O 122.364 1.078 . . . . 100.0 112.237 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.1 m -138.88 113.19 8.8 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.244 -1.761 . . . . 100.0 106.244 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.3 -43.06 98.91 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.836 -1.529 . . . . 100.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.22 -42.15 99.04 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.667 1.187 . . . . 100.0 112.375 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.8 p -97.25 2.12 50.45 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 117.3 2.333 . . . . 100.0 117.3 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.49 21.25 11.8 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.583 1.153 . . . . 100.0 110.113 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 85.8 t80 -73.58 124.48 26.0 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.038 -0.727 . . . . 100.0 109.038 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 53.32 40.1 30.8 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.12 2.568 . . . . 100.0 115.175 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.9 t80 -62.25 -44.46 96.51 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 121.638 -0.664 . . . . 100.0 111.529 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.33 -38.49 91.37 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.117 1.895 . . . . 100.0 116.117 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.53 -47.24 99.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 119.999 3.333 . . . . 100.0 119.999 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.07 -41.95 39.95 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.34 2.229 . . . . 100.0 111.334 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.45 -42.29 96.04 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 125.466 1.506 . . . . 100.0 110.884 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -61.14 -46.76 89.21 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 123.885 0.874 . . . . 100.0 112.002 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -63.67 -44.61 93.26 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.082 0.864 . . . . 100.0 110.421 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.8 mt -61.92 -44.85 95.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 123.797 0.686 . . . . 100.0 111.729 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.7 98.26 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.174 0.99 . . . . 100.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.57 -45.71 91.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.564 0.745 . . . . 100.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -68.11 -42.4 80.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.543 0.527 . . . . 100.0 112.354 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.67 -46.96 85.74 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.469 0.708 . . . . 100.0 112.316 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.43 -38.59 74.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 123.546 0.738 . . . . 100.0 110.318 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.46 59.49 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-O 118.781 -1.01 . . . . 100.0 111.053 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -111.5 113.64 53.36 Favored Pre-proline 0 C--N 1.362 1.133 0 N-CA-C 107.492 -1.299 . . . . 100.0 107.492 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.57 -15.19 30.67 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.051 3.167 . . . . 100.0 114.282 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -89.73 2.82 54.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.993 0.917 . . . . 100.0 113.276 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.05 131.44 46.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.51 0.671 . . . . 100.0 109.663 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -133.83 152.94 52.02 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.358 -0.979 . . . . 100.0 108.358 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -90.35 114.29 26.34 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 104.314 -2.476 . . . . 100.0 104.314 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.54 -44.29 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.283 1.033 . . . . 100.0 110.55 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -127.86 148.01 50.46 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.373 0.606 . . . . 100.0 109.697 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 62.5 ttp -90.18 126.23 57.61 Favored Pre-proline 0 N--CA 1.432 -1.339 0 N-CA-C 104.772 -2.307 . . . . 100.0 104.772 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.68 158.1 55.23 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.869 2.379 . . . . 100.0 110.632 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.5 126.04 26.21 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.286 -1.005 . . . . 100.0 108.286 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.51 146.63 46.09 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 114.176 -1.375 . . . . 100.0 110.164 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 137.29 97.08 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 106.832 -1.544 . . . . 100.0 106.832 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -55.98 138.51 82.54 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.534 2.823 . . . . 100.0 112.569 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.68 130.25 32.53 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.738 2.292 . . . . 100.0 113.609 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.83 -44.36 81.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 124.858 1.349 . . . . 100.0 108.579 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.32 159.04 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.498 -1.667 . . . . 100.0 106.498 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.66 131.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.641 -1.985 . . . . 100.0 105.641 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -86.29 128.12 34.87 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 104.774 -2.306 . . . . 100.0 104.774 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -62.21 128.09 90.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 CA-C-N 114.911 -1.04 . . . . 100.0 109.738 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.53 -36.68 92.44 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.474 2.783 . . . . 100.0 112.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.37 92.22 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.33 1.019 . . . . 100.0 110.766 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.29 -41.89 96.66 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 122.971 0.508 . . . . 100.0 111.493 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.56 96.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 123.63 0.772 . . . . 100.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.8 97.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.293 1.037 . . . . 100.0 110.847 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.09 -43.98 97.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.632 0.773 . . . . 100.0 112.306 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -63.69 -43.7 95.85 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 122.534 0.333 . . . . 100.0 111.712 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -64.2 -39.93 95.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.601 0.36 . . . . 100.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.06 -42.83 99.78 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.625 1.17 . . . . 100.0 110.57 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.95 -42.41 99.09 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.968 0.907 . . . . 100.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 18.3 tp -59.69 -49.52 77.42 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 124.117 0.886 . . . . 100.0 110.089 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.22 -43.24 98.66 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 115.188 1.551 . . . . 100.0 115.188 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.61 -46.53 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.175 0 CA-C-O 118.425 -0.798 . . . . 100.0 109.984 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.681 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.403 . . -93.59 -0.63 56.13 Favored 'General case' 0 N--CA 1.403 -2.818 1 C-N-CA 109.854 -4.739 . . . . 100.0 114.006 179.76 . . . . . . . . 4 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.823 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.268 57.7 mt-30 -56.9 -35.77 69.36 Favored 'General case' 0 CA--C 1.458 -2.566 0 N-CA-C 107.523 -1.288 . . . . 100.0 107.523 178.418 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -82.74 53.87 2.51 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.403 1.097 . . . . 100.0 108.886 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.312 73.1 p 48.84 38.37 11.88 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 129.477 3.111 . . . . 100.0 116.281 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 204' ' ' ALA . . . -83.13 -178.02 6.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.511 -2.404 . . . . 100.0 104.511 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 83.0 mt -56.31 -41.53 91.56 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-O 115.885 -2.007 . . . . 100.0 114.788 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.076 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.325 32.4 Cg_exo -55.17 137.21 76.25 Favored 'Trans proline' 0 C--N 1.373 1.826 0 CA-C-N 121.406 1.538 . . . . 100.0 112.427 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.6 m-20 -63.57 -47.45 81.49 Favored 'General case' 0 N--CA 1.427 -1.614 1 N-CA-C 124.764 5.098 . . . . 100.0 124.764 -173.805 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.665 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.13 -35.36 80.02 Favored 'General case' 0 CA--C 1.48 -1.746 1 CA-C-O 128.51 4.005 . . . . 100.0 108.045 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.481 44.0 m-20 -65.74 -48.74 70.89 Favored 'General case' 1 N--CA 1.351 -5.385 2 CA-C-N 107.446 -4.434 . . . . 100.0 106.389 -179.093 . . . . . . . . 5 3 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.46 -29.43 70.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.499 -1.375 . . . . 100.0 107.889 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.665 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.0 OUTLIER -58.51 -43.74 89.24 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-O 117.021 -1.466 . . . . 100.0 113.442 176.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.467 HD13 ' HG2' ' A' ' 205' ' ' GLN . 3.4 mp . . . . . 0 C--O 1.26 1.632 0 CA-C-O 114.514 -2.66 . . . . 100.0 113.227 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 113.049 0.759 . . . . 100.0 113.049 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.27 93.92 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.777 1.231 . . . . 100.0 113.655 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.43 151.6 22.09 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.641 0.734 . . . . 100.0 111.894 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -80.97 158.93 25.03 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.763 0.825 . . . . 100.0 109.896 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.19 87.71 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.788 0.709 . . . . 100.0 113.497 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -75.07 156.96 85.78 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 123.961 0.904 . . . . 100.0 112.34 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.58 157.75 49.59 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.566 2.844 . . . . 100.0 111.544 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -54.12 131.94 41.99 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.84 1.256 . . . . 100.0 113.823 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t -94.66 119.64 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -124.4 138.0 54.4 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.884 -1.507 . . . . 100.0 108.261 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.59 144.15 50.31 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.099 -1.075 . . . . 100.0 108.099 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.24 120.34 35.29 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.73 128.36 54.8 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 113.442 -1.708 . . . . 100.0 106.83 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.4 t -104.51 121.05 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 N-CA-C 107.01 -1.478 . . . . 100.0 107.01 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 31.0 tp -110.48 115.59 29.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.54 161.96 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 115.379 -0.828 . . . . 100.0 111.881 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.68 176.7 30.02 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.008 -2.037 . . . . 100.0 108.008 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -72.1 156.4 39.23 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.831 0.824 . . . . 100.0 111.479 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.96 140.66 38.42 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.1 -5.49 78.57 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-O 118.453 -1.193 . . . . 100.0 113.696 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.1 m -62.2 -39.91 94.32 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 119.064 1.432 . . . . 100.0 111.06 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.69 26.88 4.29 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 109.464 -1.454 . . . . 100.0 109.464 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' CE ' ' A' ' 89' ' ' MET . 32.7 mtmt -61.49 -44.81 96.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.493 0.717 . . . . 100.0 112.671 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -62.47 -43.08 99.68 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.267 1.027 . . . . 100.0 109.729 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 m -63.07 -41.7 99.49 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.786 1.234 . . . . 100.0 109.218 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.514 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 54.9 t80 -59.99 -48.48 81.52 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 124.141 0.976 . . . . 100.0 112.208 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.46 -41.68 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.691 0.619 . . . . 100.0 110.922 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.252 98.8 mttt -68.06 -8.09 34.89 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.919 1.822 . . . . 100.0 115.919 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.558 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 81.2 mtm-85 -60.91 -37.43 82.21 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 118.941 -0.552 . . . . 100.0 109.724 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 47.5 t-80 -80.53 113.17 18.53 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.78 -1.563 . . . . 100.0 106.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.52 -43.96 97.54 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 115.604 1.705 . . . . 100.0 115.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.435 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 63.7 m -63.33 -41.89 98.94 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.988 -0.745 . . . . 100.0 108.988 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.41 -42.45 99.77 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 123.671 0.653 . . . . 100.0 111.565 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.49 -45.36 91.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.368 0.667 . . . . 100.0 111.043 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.16 -40.65 98.16 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 124.685 1.194 . . . . 100.0 112.215 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -93.52 11.24 29.33 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 115.353 1.612 . . . . 100.0 115.353 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.55 140.01 56.66 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 113.875 1.065 . . . . 100.0 113.875 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -118.1 129.47 55.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -103.04 124.63 48.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.2 110.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 101.498 -3.519 . . . . 100.0 101.498 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.03 88.93 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 115.993 1.849 . . . . 100.0 115.993 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.6 p -62.86 -47.25 84.16 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 122.494 0.317 . . . . 100.0 111.568 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.79 -37.14 73.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.892 1.071 . . . . 100.0 113.892 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.77 30.84 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 107.261 -2.335 . . . . 100.0 107.261 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.2 t -126.25 141.99 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 124.246 1.018 . . . . 100.0 109.167 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.55 118.93 37.88 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 102.336 -3.209 . . . . 100.0 102.336 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.68 120.05 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.542 -2.021 . . . . 100.0 105.542 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -114.5 119.79 39.2 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 109.0 -0.741 . . . . 100.0 109.0 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.9 104.67 1.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.863 2.375 . . . . 100.0 110.934 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.33 119.05 34.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.93 126.59 58.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 107.191 -1.411 . . . . 100.0 107.191 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -122.49 133.1 54.6 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.102 -1.814 . . . . 100.0 106.102 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -100.35 118.3 36.32 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 121.73 0.776 . . . . 100.0 108.987 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.43 HG21 HD12 ' A' ' 59' ' ' ILE . 22.3 p -110.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.948 -1.023 . . . . 100.0 111.57 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.66 -44.21 93.66 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 125.497 1.519 . . . . 100.0 108.349 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.8 -38.42 76.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.188 0.995 . . . . 100.0 112.395 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.92 -173.05 29.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.889 -1.684 . . . . 100.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.93 138.43 57.43 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.521 2.147 . . . . 100.0 114.199 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 54' ' ' THR . 81.1 mt -127.4 129.93 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 102.801 -3.037 . . . . 100.0 102.801 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.81 128.99 55.97 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.048 -0.723 . . . . 100.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.85 116.76 31.19 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.653 -2.721 . . . . 100.0 103.653 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -87.81 106.65 18.22 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.616 -4.216 . . . . 100.0 99.616 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.28 122.3 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 106.368 -1.715 . . . . 100.0 106.368 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.25 117.0 30.48 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 106.631 -1.618 . . . . 100.0 106.631 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -116.45 141.28 48.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.005 -2.22 . . . . 100.0 105.005 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 p -75.08 165.88 24.53 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 113.558 0.947 . . . . 100.0 113.558 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.74 12.92 23.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.733 1.213 . . . . 100.0 109.788 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.49 51.14 Favored Glycine 0 C--N 1.358 1.803 0 O-C-N 121.693 -0.629 . . . . 100.0 112.209 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -61.96 -27.86 69.14 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.813 1.645 . . . . 100.0 112.166 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -59.05 -36.64 75.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.584 2.353 . . . . 100.0 111.826 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.59 -46.84 88.16 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 117.996 0.362 . . . . 100.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.371 13.9 p90 -71.99 -39.39 69.3 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 114.903 1.445 . . . . 100.0 114.903 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.5 -156.04 11.45 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 119.903 -1.142 . . . . 100.0 113.431 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.16 171.53 52.52 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.807 0.718 . . . . 100.0 111.731 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -106.3 142.99 35.06 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 121.822 0.82 . . . . 100.0 109.971 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -67.95 155.69 38.89 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.208 -1.36 . . . . 100.0 113.735 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -60.67 -38.36 84.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.776 -1.557 . . . . 100.0 110.372 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.76 -39.33 93.54 Favored Glycine 0 C--N 1.36 1.872 0 C-N-CA 124.38 0.99 . . . . 100.0 111.469 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HD1' HG21 ' A' ' 45' ' ' VAL . 62.2 t80 -62.32 -46.96 86.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.516 0.726 . . . . 100.0 111.293 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.92 -37.11 78.73 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.0 mt -52.19 138.22 10.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 125.48 1.512 . . . . 100.0 113.739 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.86 24.65 12.78 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 127.853 2.461 . . . . 100.0 114.378 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.07 129.33 38.68 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.305 -1.368 . . . . 100.0 107.305 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.4 mm-40 -98.71 -34.93 10.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.143 -1.058 . . . . 100.0 108.143 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.52 ' HB2' HD22 ' A' ' 164' ' ' LEU . 23.5 p -144.37 160.14 41.54 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 122.861 0.465 . . . . 100.0 110.527 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -146.17 149.3 33.72 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.404 1.261 . . . . 100.0 114.404 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.47 126.52 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 103.292 -2.855 . . . . 100.0 103.292 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.43 123.81 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 102.353 -3.203 . . . . 100.0 102.353 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 23' ' ' LYS . 41.0 mtm -115.45 140.55 49.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 118.738 -1.185 . . . . 100.0 113.692 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -127.08 159.59 33.73 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 110.423 -3.081 . . . . 100.0 108.751 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -102.87 126.59 50.08 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.802 -1.925 . . . . 100.0 105.802 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.52 -21.58 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.367 0.877 . . . . 100.0 113.367 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -87.59 -8.48 56.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 119.033 -0.508 . . . . 100.0 110.993 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 t -119.42 115.84 24.93 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 122.308 1.051 . . . . 100.0 110.576 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.77 -38.68 87.05 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.622 -1.172 . . . . 100.0 110.55 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.71 -41.86 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.217 1.807 . . . . 100.0 110.391 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.4 m -62.96 -42.06 99.71 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 118.111 0.414 . . . . 100.0 110.306 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.555 ' CE1' HG23 ' A' ' 136' ' ' ILE . 39.5 t80 -63.45 -41.22 98.65 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 123.259 0.624 . . . . 100.0 110.453 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.7 mttt -61.61 -37.53 84.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.691 0.796 . . . . 100.0 111.652 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.14 -10.3 59.34 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 114.471 1.286 . . . . 100.0 114.471 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.36 -43.04 95.73 Favored Pre-proline 0 C--N 1.363 1.191 0 CA-C-O 115.782 -2.056 . . . . 100.0 111.795 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 83.2 Cg_exo -57.41 -38.24 95.0 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 122.556 1.949 . . . . 100.0 112.725 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.02 -45.19 90.03 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 123.924 0.89 . . . . 100.0 111.401 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -63.15 -42.79 99.52 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 123.182 0.593 . . . . 100.0 110.347 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -62.15 -45.01 95.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.502 1.121 . . . . 100.0 110.517 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -63.0 -44.01 97.2 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 112.686 0.624 . . . . 100.0 112.686 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.68 -44.03 97.29 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.42 0.45 . . . . 100.0 111.357 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.478 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.7 tp -62.79 -46.26 88.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.499 1.12 . . . . 100.0 112.247 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.43 -38.58 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 C-N-CA 125.082 1.353 . . . . 100.0 111.143 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -60.5 -46.07 91.45 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.463 0.574 . . . . 100.0 111.197 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.4 -45.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.352 -0.539 . . . . 100.0 111.159 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.1 m -127.39 115.33 18.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.48 0.657 . . . . 100.0 109.558 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.57 147.18 23.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.537 -0.756 . . . . 100.0 112.422 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.07 44.55 27.85 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 126.56 1.944 . . . . 100.0 114.457 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' GLN . 32.0 mm -100.74 131.29 23.77 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 125.907 1.683 . . . . 100.0 107.193 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.19 130.33 28.45 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.601 2.201 . . . . 100.0 109.181 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.729 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.8 mt -130.82 136.73 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 O-C-N 124.317 1.011 . . . . 100.0 109.147 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 160' ' ' PRO . 83.9 t -113.6 130.91 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 105.431 -2.062 . . . . 100.0 105.431 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 39.7 mt -105.85 125.14 50.64 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.465 -2.791 . . . . 100.0 103.465 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.4 m -116.82 129.99 56.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.199 -1.364 . . . . 100.0 112.509 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 103.51 2.83 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 105.347 -3.101 . . . . 100.0 105.347 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 149' ' ' ILE . 63.7 t30 -84.36 167.44 16.52 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.082 1.353 . . . . 100.0 111.297 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 60.08 42.45 15.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 128.348 2.659 . . . . 100.0 115.199 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.307 20.4 m -73.18 -7.66 10.17 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 116.08 -0.509 . . . . 100.0 111.494 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.96 -38.09 87.21 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.759 2.023 . . . . 100.0 109.801 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.65 130.34 34.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.108 0 N-CA-C 106.694 -1.595 . . . . 100.0 106.694 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.36 -41.11 98.35 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 116.281 1.956 . . . . 100.0 116.281 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -86.23 99.4 11.52 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.201 -2.148 . . . . 100.0 105.201 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -99.01 118.77 36.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.351 -2.833 . . . . 100.0 103.351 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.3 -40.96 13.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.719 -0.673 . . . . 100.0 112.634 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.85 106.36 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 103.667 -2.716 . . . . 100.0 103.667 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -103.64 -179.49 3.97 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.247 -0.888 . . . . 100.0 113.209 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.481 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.43 -35.86 72.75 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 127.161 2.184 . . . . 100.0 109.276 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.034 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -59.73 -37.11 78.02 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 128.081 2.552 . . . . 100.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.8 p -103.96 -1.17 27.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 120.114 3.376 . . . . 100.0 120.114 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 56.2 mt -98.47 95.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.21 0 C-N-CA 115.487 -2.485 . . . . 100.0 111.324 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 5.7 p -100.6 -5.98 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 114.77 1.396 . . . . 100.0 114.77 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.89 -35.7 73.45 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.225 1.565 . . . . 100.0 115.225 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 87.0 m-70 -59.45 -40.5 87.05 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 125.587 1.555 . . . . 100.0 112.689 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.678 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 55.7 ttp85 -59.09 -47.69 84.33 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 124.567 1.147 . . . . 100.0 113.436 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -63.44 -41.44 98.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.277 0.986 . . . . 100.0 111.728 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.5 3.71 50.64 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 117.277 2.325 . . . . 100.0 117.277 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 57.42 42.84 24.07 Favored 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.526 1.531 . . . . 100.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.729 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.3 mt -106.38 151.33 25.03 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.815 -1.55 . . . . 100.0 106.815 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 86.9 mm-40 -103.91 142.85 33.69 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 113.445 0.905 . . . . 100.0 113.445 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.487 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 79.7 t80 -98.83 132.18 44.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 113.633 0.975 . . . . 100.0 113.633 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.58 132.89 49.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 113.596 -1.638 . . . . 100.0 108.335 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.39 118.28 30.4 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.3 -3.593 . . . . 100.0 101.3 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ILE . . . . . 0.434 HG13 ' HA ' ' A' ' 122' ' ' ASN . 43.8 pt -133.57 159.37 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.644 1.212 . . . . 100.0 114.05 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.1 m -140.02 111.43 7.18 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 106.418 -1.697 . . . . 100.0 106.418 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.558 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.58 -44.35 96.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.337 -1.301 . . . . 100.0 112.92 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.04 -40.12 96.78 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.715 0.806 . . . . 100.0 112.738 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -96.12 1.66 52.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.139 2.274 . . . . 100.0 117.139 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.42 11.92 Favored 'General case' 0 C--N 1.365 1.244 0 C-N-CA 125.277 1.431 . . . . 100.0 109.964 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.504 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 87.0 t80 -75.33 124.77 27.69 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.012 -0.736 . . . . 100.0 109.012 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 53.59 39.87 30.67 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.121 2.568 . . . . 100.0 115.399 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.542 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.8 t80 -62.61 -42.66 99.71 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 121.829 -0.544 . . . . 100.0 111.395 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.13 -39.43 94.67 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 115.746 1.758 . . . . 100.0 115.746 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.16 -48.53 96.87 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 120.932 3.679 . . . . 100.0 120.932 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HB3' HG11 ' A' ' 118' ' ' VAL . 55.4 Cg_endo -61.16 -41.79 40.47 Favored 'Trans proline' 0 C--N 1.373 1.853 0 CA-C-N 123.544 2.301 . . . . 100.0 112.681 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.7 -42.49 95.25 Favored 'General case' 0 CA--C 1.491 -1.325 0 O-C-N 124.656 1.223 . . . . 100.0 111.347 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.18 -45.05 93.6 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.457 0.703 . . . . 100.0 111.408 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -63.01 -44.53 95.74 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.523 0.514 . . . . 100.0 110.079 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.6 mt -61.78 -44.15 97.44 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.121 0.568 . . . . 100.0 111.469 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.72 98.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.207 1.003 . . . . 100.0 111.315 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -62.22 -45.83 91.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 123.722 0.809 . . . . 100.0 111.022 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -64.56 -45.38 87.36 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 85' ' ' CYS . 82.0 mt -63.44 -46.74 84.91 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 123.826 0.85 . . . . 100.0 112.929 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 85.9 mt -70.54 -38.51 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 123.06 0.544 . . . . 100.0 109.989 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.98 9.74 59.31 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.477 -1.049 . . . . 100.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -108.97 112.63 59.97 Favored Pre-proline 0 C--N 1.362 1.121 0 N-CA-C 107.332 -1.358 . . . . 100.0 107.332 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.23 -16.7 28.16 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 123.412 2.741 . . . . 100.0 113.832 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.93 -0.12 56.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.827 0.851 . . . . 100.0 113.042 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.81 131.61 48.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.286 0.634 . . . . 100.0 110.337 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -136.65 153.77 50.82 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.987 -0.746 . . . . 100.0 108.987 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -88.21 113.21 23.6 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 106.257 -1.757 . . . . 100.0 106.257 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.7 t -67.02 -43.8 88.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.011 0.925 . . . . 100.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.91 150.7 49.19 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.522 0.677 . . . . 100.0 109.634 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 63.5 ttp -96.35 126.63 43.13 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 104.837 -2.283 . . . . 100.0 104.837 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.05 159.49 49.11 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.951 2.434 . . . . 100.0 111.541 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.72 125.06 23.6 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.283 -1.006 . . . . 100.0 108.283 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.1 144.56 46.54 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.335 -1.302 . . . . 100.0 109.972 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.65 137.85 97.27 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -56.08 138.33 82.36 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 123.516 2.811 . . . . 100.0 112.129 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.42 131.74 39.94 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.851 2.367 . . . . 100.0 114.264 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -66.06 -44.85 83.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 124.795 1.309 . . . . 100.0 108.503 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.03 158.42 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.787 -1.56 . . . . 100.0 106.787 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.7 t -99.78 130.64 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 105.651 -1.981 . . . . 100.0 105.651 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -85.83 126.7 34.24 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.345 -2.465 . . . . 100.0 104.345 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 77.6 m-20 -62.74 131.09 94.22 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 115.245 -0.889 . . . . 100.0 110.828 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.7 Cg_exo -58.67 -37.94 91.69 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.948 3.099 . . . . 100.0 112.828 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.05 93.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 124.449 1.093 . . . . 100.0 110.784 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.91 -42.49 97.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.067 0.547 . . . . 100.0 111.483 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 123.731 0.812 . . . . 100.0 110.512 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.88 97.72 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.126 0.97 . . . . 100.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.57 -44.42 96.37 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.614 0.765 . . . . 100.0 112.187 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -63.84 -43.83 95.0 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 112.397 0.518 . . . . 100.0 112.397 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.51 -41.37 98.52 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.55 -0.537 . . . . 100.0 109.55 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.14 -45.32 93.95 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.989 1.316 . . . . 100.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -42.75 99.4 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 123.366 0.667 . . . . 100.0 110.667 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.504 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 17.5 tp -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 124.122 0.889 . . . . 100.0 110.53 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.69 -41.77 95.8 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 115.664 1.727 . . . . 100.0 115.664 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.68 -46.36 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 CA-C-O 118.429 -0.796 . . . . 100.0 109.667 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.41 . . -93.35 -0.52 56.58 Favored 'General case' 0 N--CA 1.4 -2.931 1 C-N-CA 109.909 -4.717 . . . . 100.0 114.326 -179.886 . . . . . . . . 4 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.805 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.275 59.7 mt-30 -56.63 -36.51 69.56 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 106.535 -1.654 . . . . 100.0 106.535 178.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.7 p -82.44 53.4 2.3 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.211 1.005 . . . . 100.0 108.969 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.291 78.7 p 49.11 37.74 11.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 129.123 2.969 . . . . 100.0 116.402 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.479 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.53 -179.32 7.38 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.443 -2.428 . . . . 100.0 104.443 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.6 -39.98 81.7 Favored Pre-proline 0 CA--C 1.499 -0.981 0 CA-C-O 115.851 -2.024 . . . . 100.0 114.904 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.034 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.332 45.4 Cg_exo -55.02 136.7 74.09 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 121.288 1.496 . . . . 100.0 111.991 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.5 m-20 -63.55 -47.7 80.5 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 125.132 5.234 . . . . 100.0 125.132 -173.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.1 -35.26 79.67 Favored 'General case' 0 CA--C 1.482 -1.673 1 CA-C-O 128.626 4.06 . . . . 100.0 107.782 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.805 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.482 43.2 m-20 -65.49 -49.06 70.43 Favored 'General case' 1 N--CA 1.352 -5.352 1 CA-C-N 107.581 -4.372 . . . . 100.0 106.148 -179.058 . . . . . . . . 5 3 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.15 -27.64 69.21 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 120.412 -1.43 . . . . 100.0 108.217 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.681 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.1 t70 -58.33 -43.59 88.32 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-O 117.178 -1.391 . . . . 100.0 112.507 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.432 HD13 ' HG2' ' A' ' 205' ' ' GLN . 4.5 mp . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.927 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 111.301 0.111 . . . . 100.0 111.301 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.25 97.81 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.704 1.202 . . . . 100.0 112.873 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.87 150.22 20.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.092 0.472 . . . . 100.0 111.268 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.17 160.41 19.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.207 -0.664 . . . . 100.0 109.207 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.97 3.01 88.16 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.599 -0.556 . . . . 100.0 112.834 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -76.98 158.94 79.58 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.854 0.862 . . . . 100.0 109.471 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.64 156.37 53.17 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.485 2.79 . . . . 100.0 111.166 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.87 131.61 35.84 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.664 1.186 . . . . 100.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.1 t -92.64 117.98 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.489 -1.671 . . . . 100.0 106.489 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.76 133.94 52.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.638 -1.619 . . . . 100.0 107.916 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.22 141.91 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.744 -1.206 . . . . 100.0 107.744 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.01 118.49 31.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.548 HD23 HG22 ' A' ' 63' ' ' VAL . 55.9 tp -106.92 125.66 51.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 113.008 -1.905 . . . . 100.0 106.955 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.3 t -102.39 121.86 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 106.23 -1.767 . . . . 100.0 106.23 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 89' ' ' MET . 3.3 tt -113.68 117.95 33.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.628 -2.36 . . . . 100.0 104.628 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -127.58 162.87 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.847 -0.615 . . . . 100.0 112.307 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.78 175.26 28.5 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 108.569 -1.812 . . . . 100.0 108.569 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -71.71 156.1 39.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 121.777 -0.837 . . . . 100.0 111.786 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.0 141.07 40.98 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 107.423 -2.271 . . . . 100.0 107.423 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 -5.43 80.63 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.924 -0.931 . . . . 100.0 113.884 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -62.85 -40.03 96.2 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 118.618 1.209 . . . . 100.0 111.145 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.79 24.64 5.16 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.22 -1.152 . . . . 100.0 110.22 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 52.3 mtpt -60.24 -46.22 90.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.363 1.465 . . . . 100.0 111.98 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.6 m -62.9 -43.76 97.92 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 124.864 1.265 . . . . 100.0 109.622 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.4 m -63.15 -41.64 99.3 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.421 1.088 . . . . 100.0 109.28 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' HA ' HH11 ' A' ' 29' ' ' ARG . 60.6 t80 -60.62 -48.77 80.32 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 122.868 0.467 . . . . 100.0 111.625 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 63' ' ' VAL . 98.3 t -64.02 -42.64 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.672 0.789 . . . . 100.0 110.664 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.263 99.5 mttt -70.44 -6.39 35.46 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 115.718 1.747 . . . . 100.0 115.718 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 80.7 mtm-85 -61.32 -36.57 80.49 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 118.884 -0.579 . . . . 100.0 110.069 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.452 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 44.8 t-80 -79.98 113.79 18.41 Favored 'General case' 0 C--N 1.36 1.034 0 N-CA-C 107.128 -1.434 . . . . 100.0 107.128 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.23 -43.91 97.76 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.888 1.44 . . . . 100.0 114.888 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 79.8 m -64.11 -39.87 94.97 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.694 -0.854 . . . . 100.0 108.694 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.44 99.78 Favored Glycine 0 C--N 1.361 1.938 0 N-CA-C 110.409 -1.076 . . . . 100.0 110.409 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.89 -45.33 93.06 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 117.56 0.68 . . . . 100.0 111.536 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.5 -40.92 98.26 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.996 0.919 . . . . 100.0 112.236 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -90.56 6.36 43.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 114.988 1.477 . . . . 100.0 114.988 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -61.06 140.61 57.82 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -121.07 133.59 55.24 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.108 -1.441 . . . . 100.0 107.108 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -103.32 124.63 49.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.331 -1.729 . . . . 100.0 106.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.56 109.73 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 100.641 -3.836 . . . . 100.0 100.641 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.55 92.22 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 116.669 2.1 . . . . 100.0 116.669 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.9 m -63.13 -48.55 78.02 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 123.37 0.419 . . . . 100.0 110.438 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.35 -36.1 74.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 113.957 1.095 . . . . 100.0 113.957 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.24 40.45 33.92 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 107.944 -2.062 . . . . 100.0 107.944 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG21 ' HD1' ' A' ' 79' ' ' TYR . 41.0 t -127.72 141.81 45.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.077 0.951 . . . . 100.0 109.141 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -103.96 119.52 39.1 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 102.839 -3.022 . . . . 100.0 102.839 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.23 120.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.696 -1.964 . . . . 100.0 105.696 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -113.22 119.21 42.73 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.023 -0.732 . . . . 100.0 109.023 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -80.09 106.54 1.93 Allowed 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.093 1.862 . . . . 100.0 109.62 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.32 117.42 32.68 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.196 -1.779 . . . . 100.0 106.196 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.17 125.98 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.41 133.25 54.63 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.782 -1.933 . . . . 100.0 105.782 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -100.66 119.19 38.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.176 -1.046 . . . . 100.0 108.176 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 59' ' ' ILE . 20.6 p -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.875 -1.057 . . . . 100.0 110.874 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -59.83 -44.44 94.06 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.424 1.489 . . . . 100.0 108.255 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -67.23 -37.96 84.42 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.308 1.443 . . . . 100.0 112.792 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.25 -172.56 28.48 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 108.988 -1.645 . . . . 100.0 108.988 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.97 136.73 49.77 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.674 2.25 . . . . 100.0 113.953 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -127.58 129.75 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 102.659 -3.089 . . . . 100.0 102.659 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -110.32 129.66 55.7 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.646 -0.872 . . . . 100.0 108.646 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -109.82 116.61 31.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.177 -2.897 . . . . 100.0 103.177 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -87.42 107.7 18.66 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.338 -4.319 . . . . 100.0 99.338 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG22 HD23 ' A' ' 13' ' ' LEU . 26.8 t -93.2 121.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.069 -1.826 . . . . 100.0 106.069 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -93.57 109.88 21.49 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.797 -2.298 . . . . 100.0 104.797 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.22 136.6 52.77 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.035 -1.839 . . . . 100.0 106.035 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.2 p -72.95 162.2 29.78 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 113.378 0.881 . . . . 100.0 113.378 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.57 16.22 19.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.325 -0.852 . . . . 100.0 109.789 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.3 51.14 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 121.846 -0.534 . . . . 100.0 112.409 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -60.28 -33.78 72.82 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 126.871 2.069 . . . . 100.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 59.8 mt-10 -57.89 -36.68 72.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.566 2.346 . . . . 100.0 112.154 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.36 -43.53 98.6 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.13 0.572 . . . . 100.0 109.792 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -70.6 -41.68 72.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.216 1.406 . . . . 100.0 113.539 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.77 -155.2 13.51 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 121.363 -0.446 . . . . 100.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.0 171.66 52.16 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 123.764 0.697 . . . . 100.0 111.982 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.97 143.12 33.61 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 122.173 0.987 . . . . 100.0 111.128 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -65.16 150.48 48.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.441 -1.708 . . . . 100.0 113.14 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.43 -37.92 85.26 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 114.029 -1.441 . . . . 100.0 109.53 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.35 94.11 Favored Glycine 0 C--N 1.36 1.874 0 C-N-CA 124.728 1.156 . . . . 100.0 111.07 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HD1' HG21 ' A' ' 45' ' ' VAL . 64.0 t80 -62.44 -46.83 86.77 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.899 0.88 . . . . 100.0 111.279 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -69.03 -37.21 78.49 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.671 1.73 . . . . 100.0 115.671 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.87 139.29 12.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 125.178 1.391 . . . . 100.0 113.232 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.93 22.17 10.18 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 127.544 2.338 . . . . 100.0 113.182 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.61 128.99 37.61 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.293 -1.373 . . . . 100.0 107.293 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.54 -37.68 10.77 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.471 -1.677 . . . . 100.0 106.471 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.681 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.3 p -144.6 161.57 38.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.681 0.277 . . . . 100.0 111.271 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.34 150.16 36.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.176 1.547 . . . . 100.0 115.176 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' A' ' 89' ' ' MET . 97.4 mt -125.54 126.13 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 103.851 -2.648 . . . . 100.0 103.851 176.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.5 mt -111.03 124.17 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 102.944 -2.984 . . . . 100.0 102.944 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 87' ' ' ILE . 38.9 mtt -110.89 135.51 51.32 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.268 -1.333 . . . . 100.0 114.549 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -129.23 159.41 36.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 111.583 -2.553 . . . . 100.0 108.33 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -103.78 126.61 51.03 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.291 -1.744 . . . . 100.0 106.291 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 17.1 m -64.68 -21.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.857 1.058 . . . . 100.0 113.857 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.6 p -88.33 -10.31 49.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 119.193 -0.432 . . . . 100.0 110.961 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -116.93 114.99 24.63 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.755 1.264 . . . . 100.0 110.193 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -65.93 -39.48 90.56 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.408 1.483 . . . . 100.0 109.815 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.97 -41.84 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.221 1.808 . . . . 100.0 110.777 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.1 m -62.74 -42.46 99.68 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 118.089 0.404 . . . . 100.0 109.93 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 136' ' ' ILE . 45.7 t80 -63.93 -41.0 97.75 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.691 0.796 . . . . 100.0 110.767 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -60.83 -38.55 85.87 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.763 0.825 . . . . 100.0 110.515 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.36 -9.78 58.87 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 115.129 1.529 . . . . 100.0 115.129 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.71 -43.4 95.21 Favored Pre-proline 0 C--N 1.364 1.222 0 CA-C-O 115.93 -1.986 . . . . 100.0 111.529 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.2 Cg_exo -57.4 -36.23 98.84 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.242 1.961 . . . . 100.0 112.93 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.91 -47.08 84.82 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.951 1.3 . . . . 100.0 110.115 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -63.87 -42.64 97.47 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 123.837 0.855 . . . . 100.0 111.161 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.7 t60 -62.45 -44.29 96.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.526 1.13 . . . . 100.0 110.265 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -62.62 -45.3 93.49 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 118.697 -0.668 . . . . 100.0 111.661 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -62.41 -43.98 97.53 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 123.481 0.488 . . . . 100.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.5 tp -62.71 -46.54 87.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.466 1.106 . . . . 100.0 111.988 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.59 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 C-N-CA 125.376 1.47 . . . . 100.0 111.165 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.08 -46.32 89.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 119.017 -0.516 . . . . 100.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.86 -46.62 59.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.356 -0.538 . . . . 100.0 111.796 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.9 m -127.07 114.03 17.21 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -90.46 146.07 24.42 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.746 -0.661 . . . . 100.0 112.27 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.75 43.3 31.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 126.39 1.876 . . . . 100.0 115.36 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 pt -99.5 139.82 21.17 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 105.953 -1.869 . . . . 100.0 105.953 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.29 129.92 28.57 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.608 2.206 . . . . 100.0 109.525 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 144' ' ' LEU . 72.3 mt -130.64 135.89 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.235 1.017 . . . . 100.0 108.777 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.67 131.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 105.594 -2.002 . . . . 100.0 105.594 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.418 ' HB2' ' HE2' ' A' ' 139' ' ' HIS . 20.5 mt -106.04 126.56 52.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.274 -2.861 . . . . 100.0 103.274 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 73.8 m -114.57 127.85 56.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.98 -1.464 . . . . 100.0 112.008 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.73 104.02 2.93 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 105.726 -2.95 . . . . 100.0 105.726 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -78.95 163.89 24.86 Favored 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 127.823 2.449 . . . . 100.0 112.069 -178.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 55.58 45.48 24.77 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 127.921 2.488 . . . . 100.0 115.556 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.333 33.1 m -72.29 -7.5 9.64 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 120.069 -0.652 . . . . 100.0 111.109 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.46 -38.96 89.13 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.029 2.131 . . . . 100.0 109.932 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.96 130.64 34.05 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 N-CA-C 107.069 -1.456 . . . . 100.0 107.069 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.29 -41.19 98.3 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.323 1.972 . . . . 100.0 116.323 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.5 100.47 12.79 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.402 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 79.1 ttt180 -96.67 121.35 38.41 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 102.392 -3.188 . . . . 100.0 102.392 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.19 -36.02 11.09 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.744 -0.662 . . . . 100.0 112.363 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 136' ' ' ILE . 42.4 t -104.73 105.23 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 101.707 -3.442 . . . . 100.0 101.707 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -101.87 177.71 4.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.951 1.093 . . . . 100.0 113.951 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.97 -35.51 73.31 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.082 2.153 . . . . 100.0 108.613 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.068 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.6 mttt -59.58 -37.05 77.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 128.395 2.678 . . . . 100.0 112.327 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.3 p -104.34 -3.13 24.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 120.061 3.356 . . . . 100.0 120.061 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.634 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 55.9 mt -95.75 94.34 4.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 116.394 -2.122 . . . . 100.0 112.317 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -99.29 -5.3 9.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -58.86 -36.73 75.08 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 115.418 1.636 . . . . 100.0 115.418 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.676 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 70.8 m80 -59.87 -39.57 85.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.994 1.718 . . . . 100.0 114.371 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 47.1 ttp180 -58.95 -48.13 82.62 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 124.904 1.282 . . . . 100.0 112.442 -176.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.16 -41.3 99.23 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.039 1.336 . . . . 100.0 111.244 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -98.59 1.54 46.52 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 116.338 1.977 . . . . 100.0 116.338 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 54.9 45.82 25.71 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 125.079 1.351 . . . . 100.0 113.198 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 117' ' ' ILE . 32.1 mt -106.38 150.05 26.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.863 -1.903 . . . . 100.0 105.863 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.315 89.2 mm-40 -100.97 143.9 30.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.588 -0.845 . . . . 100.0 112.518 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.676 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 69.5 t80 -102.03 132.94 47.58 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.591 0.96 . . . . 100.0 113.591 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.81 132.89 45.51 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -1.268 . . . . 100.0 111.038 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.278 38.0 m-20 -84.58 122.13 28.6 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 103.152 -2.907 . . . . 100.0 103.152 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.28 156.6 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 122.644 1.211 . . . . 100.0 110.999 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 74.5 m -138.6 110.63 7.27 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 105.698 -1.964 . . . . 100.0 105.698 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.76 -44.06 97.17 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.651 -1.613 . . . . 100.0 112.909 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.87 -41.46 99.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.955 0.902 . . . . 100.0 112.425 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 185' ' ' PRO . 87.5 p -96.82 3.42 52.25 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 117.75 2.5 . . . . 100.0 117.75 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 m-80 65.45 21.17 11.83 Favored 'General case' 0 C--N 1.364 1.239 0 C-N-CA 124.451 1.101 . . . . 100.0 110.806 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.4 t80 -75.26 124.87 27.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.02 -0.733 . . . . 100.0 109.02 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.84 40.21 30.31 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 128.355 2.662 . . . . 100.0 115.364 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' HH21 ' A' ' 29' ' ' ARG . 78.9 t80 -62.65 -43.23 99.32 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.863 -0.523 . . . . 100.0 110.735 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -62.97 -39.19 93.94 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 115.996 1.85 . . . . 100.0 115.996 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.94 -47.45 98.86 Favored Pre-proline 0 C--N 1.356 0.862 0 N-CA-C 119.839 3.274 . . . . 100.0 119.839 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.94 -42.16 39.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 123.31 2.218 . . . . 100.0 111.222 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -64.05 -42.4 97.04 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 125.353 1.461 . . . . 100.0 111.614 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.19 -47.02 88.07 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 123.462 0.705 . . . . 100.0 111.722 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.25 -44.39 95.3 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 124.011 0.819 . . . . 100.0 110.46 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.69 -45.42 94.08 Favored 'General case' 0 CA--C 1.495 -1.171 0 O-C-N 123.752 0.657 . . . . 100.0 111.252 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.47 98.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 124.115 0.966 . . . . 100.0 111.555 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.05 -46.05 90.83 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 123.672 0.789 . . . . 100.0 111.402 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -65.52 -44.28 87.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 113.498 0.925 . . . . 100.0 113.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.63 -46.86 83.76 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.427 0.691 . . . . 100.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 87.8 mt -70.4 -38.74 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 123.309 0.644 . . . . 100.0 110.688 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.28 9.53 57.92 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-O 118.899 -0.945 . . . . 100.0 111.139 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -111.03 112.9 55.19 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.692 -1.225 . . . . 100.0 107.692 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.14 -14.93 28.94 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.72 2.946 . . . . 100.0 113.968 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.51 5.18 51.77 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.908 0.707 . . . . 100.0 112.908 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -65.75 131.8 47.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.362 0.665 . . . . 100.0 109.299 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -135.21 152.62 51.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.299 -0.63 . . . . 100.0 109.299 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -88.11 115.07 25.34 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 104.843 -2.281 . . . . 100.0 104.843 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.34 -45.04 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.071 0.948 . . . . 100.0 110.299 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.14 151.4 49.27 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.274 0.559 . . . . 100.0 109.734 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.2 ttp -96.63 127.42 39.67 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.322 -2.103 . . . . 100.0 105.322 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.14 159.05 51.49 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.127 2.551 . . . . 100.0 111.571 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.56 126.37 27.67 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.02 0.914 . . . . 100.0 108.562 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.78 145.91 47.06 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.163 -1.38 . . . . 100.0 108.979 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.74 138.42 97.38 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.657 -1.238 . . . . 100.0 107.657 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 51.7 Cg_exo -56.97 140.4 92.26 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.36 2.707 . . . . 100.0 112.377 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 154' ' ' ASN . 39.3 Cg_exo -58.5 131.31 41.88 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.413 2.742 . . . . 100.0 114.079 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.94 -44.66 80.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.599 1.187 . . . . 100.0 107.961 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.19 158.4 43.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.458 -1.682 . . . . 100.0 106.458 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.6 130.72 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 105.919 -1.882 . . . . 100.0 105.919 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -87.36 127.4 35.2 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.382 -2.081 . . . . 100.0 105.382 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 55.4 m-20 -62.91 130.56 94.09 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 115.16 -0.927 . . . . 100.0 111.005 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 54.0 Cg_exo -58.68 -36.74 96.75 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.874 3.049 . . . . 100.0 112.579 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.36 96.35 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.42 1.075 . . . . 100.0 110.447 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.66 -42.78 98.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 123.115 0.566 . . . . 100.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.14 97.67 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 123.512 0.725 . . . . 100.0 110.634 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.5 98.61 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.87 0.868 . . . . 100.0 110.654 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -61.94 -45.83 91.96 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.3 1.04 . . . . 100.0 111.986 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -64.0 -44.63 92.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 112.209 0.448 . . . . 100.0 112.209 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.41 -39.91 94.76 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.353 0.408 . . . . 100.0 111.053 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.69 -43.77 97.96 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.883 1.273 . . . . 100.0 110.829 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.08 -42.53 99.3 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.158 0.983 . . . . 100.0 110.106 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.5 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.4 tp -59.8 -49.43 77.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 124.317 1.01 . . . . 100.0 109.861 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.48 -41.51 96.44 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 115.805 1.78 . . . . 100.0 115.805 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.41 -47.06 91.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 CA-C-O 118.305 -0.855 . . . . 100.0 109.423 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.685 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.409 . . -93.97 0.76 56.22 Favored 'General case' 0 N--CA 1.405 -2.71 1 C-N-CA 109.659 -4.816 . . . . 100.0 114.495 179.694 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.29 61.2 mt-30 -57.27 -35.86 70.28 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 106.94 -1.504 . . . . 100.0 106.94 178.169 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.8 p -82.82 53.88 2.53 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.487 1.137 . . . . 100.0 108.551 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.304 80.4 p 48.66 38.91 12.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 129.507 3.123 . . . . 100.0 115.741 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.31 -177.43 6.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.638 -2.356 . . . . 100.0 104.638 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.8 mt -56.39 -41.58 91.86 Favored Pre-proline 0 CA--C 1.502 -0.884 0 CA-C-O 116.105 -1.902 . . . . 100.0 114.882 -174.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.068 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.307 41.8 Cg_exo -54.52 136.18 69.11 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.112 1.433 . . . . 100.0 112.389 177.191 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 95.3 m-20 -63.63 -47.38 81.57 Favored 'General case' 0 N--CA 1.428 -1.572 1 N-CA-C 124.109 4.855 . . . . 100.0 124.109 -173.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.256 99.5 mt-10 -63.17 -35.17 79.41 Favored 'General case' 0 CA--C 1.477 -1.86 1 CA-C-O 128.562 4.03 . . . . 100.0 108.064 177.753 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.484 44.7 m-20 -66.57 -48.9 68.13 Favored 'General case' 1 N--CA 1.35 -5.473 1 CA-C-N 107.629 -4.351 . . . . 100.0 105.939 -178.624 . . . . . . . . 5 3 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.74 -25.43 67.93 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.574 -1.329 . . . . 100.0 108.524 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.69 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.84 -42.8 90.18 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-O 117.238 -1.363 . . . . 100.0 112.571 175.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' A' ' 205' ' ' GLN . 2.9 mp . . . . . 0 N--CA 1.425 -1.71 0 CA-C-O 114.335 -2.745 . . . . 100.0 112.039 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 112.142 0.423 . . . . 100.0 112.142 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.46 95.63 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.119 1.367 . . . . 100.0 113.221 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.23 149.65 27.5 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.539 0.685 . . . . 100.0 111.835 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -80.24 160.05 25.7 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.453 -0.794 . . . . 100.0 110.203 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.89 -5.56 79.21 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.458 -0.634 . . . . 100.0 112.097 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.29 154.21 90.23 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 124.32 1.048 . . . . 100.0 110.357 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 161.62 39.63 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.481 2.787 . . . . 100.0 111.707 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.26 132.16 33.56 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 114.492 1.293 . . . . 100.0 114.492 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 1' ' ' MET . 87.6 t -96.01 116.54 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.532 -2.025 . . . . 100.0 105.532 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -121.29 134.77 55.16 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.238 -1.801 . . . . 100.0 108.155 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.15 143.11 49.28 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.598 -1.26 . . . . 100.0 107.598 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.64 120.81 35.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.793 -1.558 . . . . 100.0 106.793 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -109.21 127.65 54.41 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.913 -1.949 . . . . 100.0 107.107 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 79' ' ' TYR . 50.8 t -103.02 120.78 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.714 -1.585 . . . . 100.0 106.892 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 48.5 tp -110.69 115.38 29.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.53 161.85 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 CA-C-N 115.741 -0.663 . . . . 100.0 111.992 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.14 176.61 30.38 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 108.341 -1.903 . . . . 100.0 108.341 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -72.67 157.27 37.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.621 0.724 . . . . 100.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.45 141.72 39.42 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 107.109 -2.396 . . . . 100.0 107.109 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.06 -5.62 81.66 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.079 -0.845 . . . . 100.0 113.62 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -63.04 -39.28 94.28 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 118.481 1.141 . . . . 100.0 111.204 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.49 23.9 5.53 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 111.076 -0.81 . . . . 100.0 111.076 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HD2' ' HG ' ' A' ' 15' ' ' LEU . 29.3 mtmt -61.71 -43.24 99.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.843 0.857 . . . . 100.0 111.902 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -62.16 -44.19 97.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.681 1.193 . . . . 100.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.2 m -63.08 -41.1 99.34 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.565 1.146 . . . . 100.0 108.826 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.527 ' HA ' HH11 ' A' ' 29' ' ' ARG . 50.0 t80 -59.75 -49.09 79.07 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.376 0.67 . . . . 100.0 112.676 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -41.95 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 123.869 0.731 . . . . 100.0 110.561 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.49 -8.43 40.93 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 115.757 1.762 . . . . 100.0 115.757 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 82.8 mtm-85 -61.36 -37.34 82.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.535 -0.542 . . . . 100.0 109.535 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' HIS . . . . . 0.454 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 53.8 t-80 -80.23 112.35 17.46 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.49 -43.85 97.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 115.222 1.564 . . . . 100.0 115.222 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 85.2 m -63.02 -41.96 99.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.621 0.768 . . . . 100.0 108.934 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.43 99.75 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 123.855 0.741 . . . . 100.0 111.361 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.82 -43.75 95.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.023 0.529 . . . . 100.0 110.676 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.05 -40.04 95.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.31 1.044 . . . . 100.0 112.349 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -90.42 7.02 40.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 114.422 1.267 . . . . 100.0 114.422 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -58.81 140.23 55.35 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 115.215 1.561 . . . . 100.0 115.215 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.88 130.46 52.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -103.81 123.6 47.38 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.256 -2.127 . . . . 100.0 105.256 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.11 113.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 102.736 -3.061 . . . . 100.0 102.736 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.2 94.01 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.0 p -62.59 -47.41 83.91 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 122.679 0.392 . . . . 100.0 111.723 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.06 -38.22 75.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.718 1.207 . . . . 100.0 112.987 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 35.78 52.42 Favored Glycine 0 C--N 1.359 1.844 0 N-CA-C 106.625 -2.59 . . . . 100.0 106.625 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.466 HG21 ' HD1' ' A' ' 79' ' ' TYR . 84.3 t -125.45 141.45 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.766 1.227 . . . . 100.0 108.622 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -106.56 117.36 33.85 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 102.571 -3.122 . . . . 100.0 102.571 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.74 122.25 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 107.039 -1.467 . . . . 100.0 107.039 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -116.63 120.69 34.09 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.265 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -79.97 105.62 1.82 Allowed 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.298 1.999 . . . . 100.0 109.415 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.08 116.75 29.85 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.636 -1.616 . . . . 100.0 106.636 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.65 126.82 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.858 -1.164 . . . . 100.0 107.858 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.41 132.45 53.96 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -99.9 120.03 39.14 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.212 -1.033 . . . . 100.0 108.212 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 23.3 p -109.44 -179.77 3.92 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.817 -1.083 . . . . 100.0 110.754 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.81 -44.11 94.16 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 125.576 1.55 . . . . 100.0 107.837 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.425 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 91.6 mtt-85 -67.32 -39.19 85.83 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.901 1.28 . . . . 100.0 112.846 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.83 -172.54 28.13 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.068 -2.013 . . . . 100.0 108.068 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.27 137.28 50.95 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.628 2.219 . . . . 100.0 114.552 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 74.9 mt -127.34 130.42 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.325 -3.213 . . . . 100.0 102.325 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -110.94 129.65 55.82 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.412 -0.588 . . . . 100.0 109.412 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -111.31 115.27 29.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.174 -2.528 . . . . 100.0 104.174 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -86.82 106.38 17.68 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.653 -3.832 . . . . 100.0 100.653 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 122.4 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -98.04 114.78 27.03 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.116 -1.809 . . . . 100.0 106.116 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -112.63 135.68 53.08 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.531 -1.655 . . . . 100.0 106.531 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -72.25 162.66 29.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.199 0.814 . . . . 100.0 113.199 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.43 14.76 21.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.316 -0.857 . . . . 100.0 110.033 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.21 12.36 42.55 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 121.78 -0.575 . . . . 100.0 112.037 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.458 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 67.8 mt-30 -60.16 -34.43 73.57 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.557 1.943 . . . . 100.0 111.625 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.9 -35.39 70.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 127.624 2.37 . . . . 100.0 112.406 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.08 -40.9 97.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.474 0.71 . . . . 100.0 110.97 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 p90 -92.05 -14.0 30.01 Favored 'General case' 0 C--N 1.362 1.111 0 N-CA-C 114.908 1.447 . . . . 100.0 114.908 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.93 -163.9 33.04 Favored Glycine 0 C--N 1.357 1.745 0 C-N-CA 119.464 -1.35 . . . . 100.0 113.432 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.51 172.57 54.64 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 110.507 -1.037 . . . . 100.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.8 mt -104.25 142.32 34.75 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.836 0.827 . . . . 100.0 110.186 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -68.1 155.6 39.24 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.192 -1.367 . . . . 100.0 113.323 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.56 -38.35 84.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 125.421 1.488 . . . . 100.0 110.415 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.91 -39.25 93.78 Favored Glycine 0 C--N 1.36 1.868 0 C-N-CA 124.673 1.13 . . . . 100.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HD1' HG21 ' A' ' 45' ' ' VAL . 61.0 t80 -62.24 -46.65 87.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.605 0.762 . . . . 100.0 110.84 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -68.94 -37.02 78.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 115.86 1.8 . . . . 100.0 115.86 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.9 mt -52.15 137.09 11.79 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 125.396 1.478 . . . . 100.0 113.89 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 64.27 26.26 13.68 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 127.999 2.52 . . . . 100.0 113.753 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.76 36.76 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.993 -1.484 . . . . 100.0 106.993 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.437 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.1 mm-40 -97.25 -37.54 10.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.558 -1.275 . . . . 100.0 107.558 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.8 p -142.54 160.14 40.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 122.701 0.4 . . . . 100.0 110.988 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -145.61 149.13 33.97 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 114.202 1.186 . . . . 100.0 114.202 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.5 mt -126.1 126.72 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.379 -2.823 . . . . 100.0 103.379 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 119' ' ' LEU . 51.5 mt -111.78 124.17 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.947 -2.983 . . . . 100.0 102.947 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 42.8 mtt -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.183 -1.371 . . . . 100.0 114.603 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -127.74 158.35 37.87 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.763 -2.471 . . . . 100.0 108.088 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.93 126.56 51.14 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.879 -1.897 . . . . 100.0 105.879 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.54 -21.94 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.332 0.864 . . . . 100.0 113.332 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.8 p -86.99 -8.71 56.93 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 119.266 -0.397 . . . . 100.0 111.167 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.38 115.34 23.32 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.34 1.067 . . . . 100.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -66.84 -38.23 86.01 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 114.895 -1.048 . . . . 100.0 111.383 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.79 -41.0 86.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 125.787 1.635 . . . . 100.0 110.216 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.3 m -62.44 -42.59 99.57 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 118.147 0.43 . . . . 100.0 109.968 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.547 ' CE1' HG23 ' A' ' 136' ' ' ILE . 35.8 t80 -63.12 -41.55 99.36 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.567 0.747 . . . . 100.0 110.801 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.1 mttt -61.25 -37.44 83.11 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 100.0 111.155 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.96 -8.44 57.38 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 115.003 1.483 . . . . 100.0 115.003 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.66 -42.97 94.43 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 116.013 -1.946 . . . . 100.0 111.49 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.1 Cg_exo -57.56 -37.23 97.76 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.074 1.849 . . . . 100.0 112.692 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -63.11 -46.33 87.82 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.366 1.067 . . . . 100.0 110.85 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -64.02 -41.82 97.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 123.25 0.62 . . . . 100.0 111.213 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -61.82 -44.92 95.88 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 124.239 1.016 . . . . 100.0 109.66 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.88 -43.74 97.98 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 118.805 -0.617 . . . . 100.0 112.462 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.15 -45.33 93.92 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 121.251 0.548 . . . . 100.0 110.626 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.457 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.4 tp -62.81 -46.46 87.87 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.986 1.314 . . . . 100.0 112.647 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.19 -38.5 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 C-N-CA 125.237 1.415 . . . . 100.0 111.218 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -60.44 -46.38 90.27 Favored 'General case' 0 C--N 1.358 0.973 0 CA-C-O 118.833 -0.603 . . . . 100.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.75 -46.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 120.238 -0.585 . . . . 100.0 111.502 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.31 115.63 19.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -93.0 147.22 23.01 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.89 -0.596 . . . . 100.0 112.41 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 54.37 45.66 26.7 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.394 1.877 . . . . 100.0 114.871 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 84' ' ' GLN . 34.0 mm -99.35 131.45 25.04 Favored Pre-proline 0 N--CA 1.436 -1.139 0 C-N-CA 126.125 1.77 . . . . 100.0 106.802 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.89 130.02 27.94 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.601 2.2 . . . . 100.0 109.008 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.6 mt -130.47 137.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 122.369 1.081 . . . . 100.0 108.508 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -114.79 130.75 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.265 -2.124 . . . . 100.0 105.265 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 88' ' ' ILE . 34.3 mt -104.97 125.24 50.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.079 -2.563 . . . . 100.0 104.079 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.0 m -115.32 128.26 55.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.853 -1.521 . . . . 100.0 112.301 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.26 103.98 2.88 Favored Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.293 -3.123 . . . . 100.0 105.293 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -80.71 166.5 20.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 125.798 1.639 . . . . 100.0 111.725 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 56.58 44.66 23.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 128.29 2.636 . . . . 100.0 115.416 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.29 28.5 m -71.81 -9.33 12.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 120.416 -0.514 . . . . 100.0 110.724 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.91 -38.85 87.16 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 127.186 2.194 . . . . 100.0 110.279 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.55 129.88 34.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 107.414 -1.328 . . . . 100.0 107.414 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.98 -40.07 96.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 116.54 2.052 . . . . 100.0 116.54 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -85.63 98.69 10.81 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 104.426 -2.435 . . . . 100.0 104.426 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -100.72 109.36 21.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 105.384 -2.08 . . . . 100.0 105.384 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.18 -43.49 61.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.79 1.404 . . . . 100.0 114.79 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 HD11 ' A' ' 136' ' ' ILE . 48.0 t -108.49 108.54 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 104.73 -2.322 . . . . 100.0 104.73 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.01 179.73 4.19 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.189 -0.914 . . . . 100.0 113.422 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.51 -35.16 71.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.154 2.182 . . . . 100.0 109.318 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LYS . . . . . 1.07 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -59.45 -37.1 77.26 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 128.717 2.807 . . . . 100.0 112.017 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.3 p -105.01 -0.49 26.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 120.624 3.565 . . . . 100.0 120.624 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . 0.622 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 54.3 mt -99.46 96.01 4.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 115.372 -2.531 . . . . 100.0 111.346 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -100.06 -6.77 9.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 115.553 1.686 . . . . 100.0 115.553 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -58.79 -35.87 73.52 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . 0.46 ' ND1' HD12 ' A' ' 119' ' ' LEU . 77.7 m-70 -59.63 -39.55 84.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.588 1.555 . . . . 100.0 112.578 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 42.3 ttp180 -59.29 -47.08 86.71 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.108 1.363 . . . . 100.0 112.382 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.04 -43.62 98.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.806 1.242 . . . . 100.0 111.469 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 116.213 1.931 . . . . 100.0 116.213 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 54.6 47.42 22.67 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.296 1.438 . . . . 100.0 113.126 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 117' ' ' ILE . 30.4 mt -107.22 149.63 27.52 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.245 -1.761 . . . . 100.0 106.245 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -96.38 144.47 26.49 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 120.709 -0.397 . . . . 100.0 111.868 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.426 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 77.5 t80 -106.45 133.59 50.9 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 123.766 0.666 . . . . 100.0 112.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -130.01 132.41 46.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.184 -1.371 . . . . 100.0 110.416 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.314 35.2 m-20 -85.15 122.73 29.77 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 102.054 -3.313 . . . . 100.0 102.054 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 pt -135.88 157.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.574 1.178 . . . . 100.0 112.037 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 61.9 m -137.34 112.87 9.39 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.568 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -63.26 -43.88 96.71 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.735 -1.575 . . . . 100.0 112.772 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.83 -41.09 99.19 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.352 1.061 . . . . 100.0 112.098 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.1 p -97.48 2.37 50.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 117.563 2.431 . . . . 100.0 117.563 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 66.67 20.03 10.75 Favored 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.638 1.175 . . . . 100.0 110.846 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.46 -0.571 . . . . 100.0 109.46 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.11 39.79 30.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 128.709 2.804 . . . . 100.0 115.725 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.488 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 76.8 t80 -61.82 -44.89 95.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 121.618 -0.676 . . . . 100.0 112.146 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.14 -37.27 86.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 116.87 2.174 . . . . 100.0 116.87 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.74 -46.82 99.71 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 119.166 3.024 . . . . 100.0 119.166 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -60.7 -42.2 40.92 Favored 'Trans proline' 0 C--N 1.372 1.813 0 CA-C-N 123.204 2.18 . . . . 100.0 111.544 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -64.24 -42.48 96.51 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 124.839 1.256 . . . . 100.0 111.76 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.81 -45.38 92.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 123.775 0.83 . . . . 100.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.18 -43.34 95.42 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 123.549 0.531 . . . . 100.0 110.424 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.5 mt -61.6 -44.07 97.69 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 123.509 0.505 . . . . 100.0 111.508 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.04 97.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.126 0.97 . . . . 100.0 111.062 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -62.43 -45.67 92.03 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 123.242 0.617 . . . . 100.0 112.075 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -65.71 -44.73 85.21 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.76 0.663 . . . . 100.0 111.764 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.0 mt -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 124.073 0.949 . . . . 100.0 113.141 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.16 -38.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.436 -0.579 . . . . 100.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.72 10.53 58.9 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 110.138 -1.185 . . . . 100.0 110.138 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.71 111.74 56.66 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 107.812 -1.181 . . . . 100.0 107.812 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.82 -15.85 29.75 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.776 2.984 . . . . 100.0 113.734 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -87.59 0.32 55.8 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.025 0.93 . . . . 100.0 113.133 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.78 132.03 48.43 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.178 0.591 . . . . 100.0 109.892 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -135.29 152.08 51.16 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 108.679 -0.859 . . . . 100.0 108.679 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -89.11 111.83 22.67 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 104.782 -2.303 . . . . 100.0 104.782 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.08 -43.91 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.243 1.017 . . . . 100.0 110.824 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.51 149.14 49.54 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 121.583 0.706 . . . . 100.0 110.559 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 59.5 ttm -91.39 125.45 57.99 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.433 -2.062 . . . . 100.0 105.433 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.28 157.4 60.23 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 123.039 2.493 . . . . 100.0 111.156 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.35 126.19 27.43 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.1 -1.074 . . . . 100.0 108.1 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.71 145.19 47.74 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 114.36 -1.291 . . . . 100.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.98 138.75 97.49 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.699 -1.223 . . . . 100.0 107.699 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -55.72 138.54 81.59 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.642 2.894 . . . . 100.0 112.3 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.36 129.59 30.42 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.753 2.302 . . . . 100.0 113.726 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -67.08 -43.67 82.03 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 124.774 1.296 . . . . 100.0 108.754 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.77 160.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.322 -1.733 . . . . 100.0 106.322 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.69 130.72 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 107.755 -1.202 . . . . 100.0 107.755 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 tpt -80.88 122.72 27.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.789 -2.3 . . . . 100.0 104.789 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 35.9 t70 -65.9 128.2 93.66 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.13 -0.941 . . . . 100.0 109.411 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 53.7 Cg_exo -59.03 -39.06 83.98 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.54 2.827 . . . . 100.0 113.6 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.98 92.91 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 124.337 1.023 . . . . 100.0 110.832 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.8 -42.75 97.65 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 122.65 0.38 . . . . 100.0 111.653 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.16 97.4 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 123.546 0.738 . . . . 100.0 110.612 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.77 97.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.031 0.932 . . . . 100.0 110.672 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -63.76 -43.08 97.49 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.186 0.594 . . . . 100.0 112.077 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -63.03 -44.16 96.68 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 122.733 0.413 . . . . 100.0 111.273 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.89 -40.64 96.99 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 122.957 0.503 . . . . 100.0 110.477 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.55 -43.93 97.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.75 1.22 . . . . 100.0 110.78 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.06 -42.5 99.26 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.898 0.879 . . . . 100.0 110.169 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' LEU . . . . . 0.502 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.6 tp -59.9 -49.04 79.24 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.156 0.91 . . . . 100.0 110.033 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -43.44 98.12 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 115.203 1.557 . . . . 100.0 115.203 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.33 -46.74 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 CA-C-O 118.388 -0.815 . . . . 100.0 109.673 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.407 . . -94.61 0.54 55.24 Favored 'General case' 0 N--CA 1.404 -2.752 1 C-N-CA 109.655 -4.818 . . . . 100.0 114.332 179.711 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLN . . . . . 0.798 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.301 62.4 mt-30 -56.51 -37.01 69.84 Favored 'General case' 0 CA--C 1.465 -2.32 0 N-CA-C 106.354 -1.721 . . . . 100.0 106.354 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.9 p -82.03 52.82 2.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.247 1.022 . . . . 100.0 109.303 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.324 80.5 p 48.83 38.81 12.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.522 3.129 . . . . 100.0 116.111 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.12 -177.16 6.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.417 -2.438 . . . . 100.0 104.417 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LEU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 85.7 mt -56.46 -41.54 91.67 Favored Pre-proline 0 CA--C 1.502 -0.902 0 CA-C-O 116.014 -1.946 . . . . 100.0 114.545 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PRO . . . . . 1.07 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.309 23.3 Cg_exo -55.35 136.67 74.67 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 121.354 1.519 . . . . 100.0 112.382 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.8 m-20 -63.71 -47.57 80.61 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 124.493 4.997 . . . . 100.0 124.493 -173.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.4 mt-10 -62.88 -35.64 80.69 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 128.285 3.898 . . . . 100.0 107.918 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . 0.798 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.483 44.9 m-20 -65.49 -48.73 71.58 Favored 'General case' 1 N--CA 1.35 -5.426 1 CA-C-N 107.563 -4.381 . . . . 100.0 106.493 -179.017 . . . . . . . . 5 3 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.32 -29.85 71.09 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 120.448 -1.407 . . . . 100.0 108.168 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.664 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.35 -42.99 88.13 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-O 117.297 -1.335 . . . . 100.0 113.41 176.439 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.26 1.645 0 CA-C-O 115.478 -2.201 . . . . 100.0 113.968 -176.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.3 t . . . . . 0 N--CA 1.431 -1.414 0 N-CA-C 106.472 -1.677 . . . . 100.0 106.472 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.74 138.89 53.44 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.904 -1.953 . . . . 100.0 108.102 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.66 146.06 50.33 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.753 -0.832 . . . . 100.0 108.753 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -94.67 120.54 35.06 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 104.731 -2.322 . . . . 100.0 104.731 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.542 HD23 HG22 ' A' ' 63' ' ' VAL . 55.3 tp -112.12 126.25 54.99 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.964 -1.926 . . . . 100.0 106.551 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 79' ' ' TYR . 43.0 t -101.82 123.19 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.097 -1.446 . . . . 100.0 107.097 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.5 tp -110.89 116.51 31.36 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.094 -2.558 . . . . 100.0 104.094 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -128.8 163.4 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 120.765 0.317 . . . . 100.0 111.797 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.54 173.47 22.76 Favored Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 107.848 -2.101 . . . . 100.0 107.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -68.12 154.91 40.71 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.964 0.888 . . . . 100.0 112.574 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.85 140.0 41.64 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.606 -2.198 . . . . 100.0 107.606 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 -4.34 82.11 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.469 -1.184 . . . . 100.0 113.868 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.607 ' HB ' HD21 ' A' ' 122' ' ' ASN . 19.6 p -62.87 -39.01 93.13 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 119.055 1.428 . . . . 100.0 111.372 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 22.82 4.53 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 110.322 -1.111 . . . . 100.0 110.322 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 50.0 mtpt -59.52 -46.56 88.48 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 124.554 1.142 . . . . 100.0 112.889 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -63.23 -44.29 95.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.411 1.084 . . . . 100.0 110.087 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -62.47 -42.01 99.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.294 1.037 . . . . 100.0 109.178 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -60.75 -48.73 80.47 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.06 0.944 . . . . 100.0 113.285 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.9 -40.89 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.064 0.459 . . . . 100.0 110.523 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.27 99.6 mttt -69.35 -6.85 32.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.174 1.916 . . . . 100.0 116.174 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 49.1 mtt180 -60.7 -37.89 83.17 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.03 -1.1 . . . . 100.0 108.03 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 54.0 t-80 -80.87 112.92 18.7 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.48 -43.59 98.44 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.854 1.798 . . . . 100.0 115.854 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 78.8 m -63.75 -40.95 97.96 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.904 -0.776 . . . . 100.0 108.904 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.78 99.5 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.388 -1.085 . . . . 100.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.274 81.0 mt-10 -63.77 -45.15 91.09 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 117.38 0.59 . . . . 100.0 111.649 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.81 -40.32 97.02 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.256 1.022 . . . . 100.0 111.857 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -93.23 8.91 38.34 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 114.841 1.422 . . . . 100.0 114.841 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -60.87 142.57 56.12 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 113.743 1.016 . . . . 100.0 113.743 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -124.01 131.05 53.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.994 -1.003 . . . . 100.0 108.378 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -101.05 123.64 45.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.541 -2.022 . . . . 100.0 105.541 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.64 112.19 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 102.809 -3.034 . . . . 100.0 102.809 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.86 94.98 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 116.471 2.026 . . . . 100.0 116.471 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -61.9 -48.44 80.47 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 122.895 0.478 . . . . 100.0 110.578 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.64 -38.62 70.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.67 1.359 . . . . 100.0 114.67 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.77 44.04 21.26 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 106.312 -2.715 . . . . 100.0 106.312 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 94.5 t -129.86 144.61 37.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.726 1.21 . . . . 100.0 109.271 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -106.1 118.96 37.97 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.077 -3.305 . . . . 100.0 102.077 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.46 120.88 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.267 -1.753 . . . . 100.0 106.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -113.16 119.5 42.23 Favored Pre-proline 0 N--CA 1.434 -1.234 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.55 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -80.32 104.25 1.61 Allowed 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.654 2.236 . . . . 100.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.4 113.97 26.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.31 -0.996 . . . . 100.0 108.31 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.85 127.19 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.272 -1.381 . . . . 100.0 107.272 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.56 135.09 55.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.461 -2.052 . . . . 100.0 105.461 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -102.52 117.6 35.05 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.32 -0.622 . . . . 100.0 109.32 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.5 p -107.09 175.92 5.34 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.816 0.817 . . . . 100.0 110.288 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.26 -35.0 74.52 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.314 1.445 . . . . 100.0 109.502 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.59 -2.33 58.54 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 113.499 0.926 . . . . 100.0 113.499 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.6 -179.72 16.2 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.593 -1.003 . . . . 100.0 110.593 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.74 140.13 54.94 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.869 2.379 . . . . 100.0 115.833 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.13 130.06 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 102.304 -3.221 . . . . 100.0 102.304 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.45 128.35 56.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -110.19 116.31 31.28 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -87.67 106.8 18.28 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.812 -4.144 . . . . 100.0 99.812 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.542 HG22 HD23 ' A' ' 13' ' ' LEU . 22.6 t -93.36 123.76 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.396 0 N-CA-C 106.412 -1.699 . . . . 100.0 106.412 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -97.8 114.5 26.55 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 105.838 -1.912 . . . . 100.0 105.838 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -109.33 135.2 50.78 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.5 p -72.28 163.45 27.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.874 0.845 . . . . 100.0 112.559 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.14 20.55 12.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.206 -0.906 . . . . 100.0 108.586 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.85 12.21 58.16 Favored Glycine 0 C--N 1.359 1.847 0 CA-C-O 119.341 -0.699 . . . . 100.0 114.128 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 90.7 mt-30 -60.29 -31.37 70.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.259 1.824 . . . . 100.0 112.591 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -57.54 -32.38 67.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.924 2.49 . . . . 100.0 111.813 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.88 -39.62 95.03 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 123.527 0.731 . . . . 100.0 111.565 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 22.9 p90 -94.87 -14.14 24.83 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.774 1.398 . . . . 100.0 114.774 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.58 -160.36 26.96 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 119.933 -1.127 . . . . 100.0 112.422 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.02 176.95 54.54 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 109.874 -1.29 . . . . 100.0 109.874 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.438 HD13 ' CE2' ' A' ' 79' ' ' TYR . 86.9 mt -105.31 143.5 33.4 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.49 -0.929 . . . . 100.0 108.49 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -70.5 160.11 33.04 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.02 -0.991 . . . . 100.0 113.175 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -59.48 -37.99 79.66 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 125.443 1.497 . . . . 100.0 110.237 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.37 91.8 Favored Glycine 0 C--N 1.358 1.797 0 C-N-CA 124.77 1.176 . . . . 100.0 111.29 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.0 t80 -62.98 -47.0 85.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.33 0.565 . . . . 100.0 111.218 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -70.51 -36.73 73.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 116.976 2.213 . . . . 100.0 116.976 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.5 mt -50.86 134.64 11.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-O 123.189 1.471 . . . . 100.0 114.796 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 61.19 29.26 18.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 128.023 2.529 . . . . 100.0 113.877 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 133.12 42.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -96.39 -26.26 15.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 110.103 -0.332 . . . . 100.0 110.103 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.497 ' HB2' HD22 ' A' ' 164' ' ' LEU . 18.7 p -153.22 162.61 41.11 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.852 0.358 . . . . 100.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.6 152.84 38.6 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 114.413 1.264 . . . . 100.0 114.413 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.6 mt -126.17 125.89 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 103.41 -2.811 . . . . 100.0 103.41 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.554 ' HB ' HD22 ' A' ' 119' ' ' LEU . 48.6 mt -109.74 125.31 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 102.87 -3.011 . . . . 100.0 102.87 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 15' ' ' LEU . 89.3 mtp -110.46 135.91 50.41 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.923 1.083 . . . . 100.0 113.923 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.76 162.43 28.45 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 112.686 -2.052 . . . . 100.0 107.14 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.53 124.37 49.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.962 -1.496 . . . . 100.0 106.962 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.18 -18.86 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 114.211 1.189 . . . . 100.0 114.211 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.5 p -89.44 -7.5 54.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 118.378 0.535 . . . . 100.0 111.18 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 m -124.98 116.78 22.71 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.596 1.189 . . . . 100.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -63.32 -38.51 91.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.459 1.503 . . . . 100.0 111.872 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.59 -40.88 83.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 125.872 1.669 . . . . 100.0 110.72 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.2 p -62.19 -41.53 98.43 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 118.192 0.451 . . . . 100.0 111.77 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -65.02 -40.95 95.61 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.559 0.743 . . . . 100.0 110.251 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.1 mttt -61.38 -36.45 80.29 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.531 1.132 . . . . 100.0 111.142 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.18 -3.85 53.53 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 115.272 1.582 . . . . 100.0 115.272 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 119' ' ' LEU . 77.2 t -60.55 -41.94 85.73 Favored Pre-proline 0 C--N 1.362 1.128 0 CA-C-O 116.572 -1.68 . . . . 100.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 63.0 Cg_exo -56.86 -38.3 96.17 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.292 1.995 . . . . 100.0 112.864 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.61 -45.25 91.19 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.59 1.156 . . . . 100.0 110.873 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -64.46 -41.36 96.57 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.122 0.264 . . . . 100.0 111.356 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.21 -44.32 96.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.619 0.767 . . . . 100.0 110.14 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -61.99 -45.26 94.42 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 119.015 -0.517 . . . . 100.0 112.179 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.53 -42.43 98.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 O-C-N 123.24 0.337 . . . . 100.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 86' ' ' ALA . 50.6 tp -62.9 -48.16 80.17 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.783 0.833 . . . . 100.0 112.469 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.279 22.9 m -67.2 -29.23 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -60.62 -47.28 86.93 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.778 -0.823 . . . . 100.0 108.778 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.85 -45.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 112.598 0.592 . . . . 100.0 112.598 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.7 m -124.61 107.79 11.39 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.985 0.898 . . . . 100.0 110.077 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.89 140.05 30.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.358 -0.837 . . . . 100.0 111.59 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.13 39.57 31.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.981 2.113 . . . . 100.0 116.701 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.1 144.99 29.24 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 106.635 -1.617 . . . . 100.0 106.635 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -62.59 132.08 36.39 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.21 2.606 . . . . 100.0 109.691 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.801 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.0 mt -134.18 137.57 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.198 0.999 . . . . 100.0 108.364 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.13 132.1 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 105.593 -2.002 . . . . 100.0 105.593 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 101' ' ' VAL 0.294 23.2 mt -105.95 131.04 53.74 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 103.725 -2.694 . . . . 100.0 103.725 175.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.49 131.21 55.54 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.052 -1.431 . . . . 100.0 112.48 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.3 104.97 2.89 Favored Glycine 0 CA--C 1.486 -1.757 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.607 HD21 ' HB ' ' A' ' 21' ' ' THR . 24.6 p30 -86.73 173.21 9.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.185 1.179 . . . . 100.0 114.185 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 mttp 60.26 40.39 17.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.141 2.576 . . . . 100.0 113.725 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.339 28.5 m -71.76 -7.79 10.02 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 120.33 -0.548 . . . . 100.0 111.495 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.71 -38.21 89.55 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.464 1.906 . . . . 100.0 110.334 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -69.74 130.18 34.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 N-CA-C 108.514 -0.921 . . . . 100.0 108.514 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.14 -41.82 98.64 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 117.223 2.305 . . . . 100.0 117.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -85.49 94.57 9.04 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.146 -1.798 . . . . 100.0 106.146 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -92.66 123.96 36.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 104.921 -2.251 . . . . 100.0 104.921 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.69 -36.62 10.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 113.301 0.852 . . . . 100.0 113.301 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.93 104.07 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 103.752 -2.684 . . . . 100.0 103.752 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.25 172.77 7.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.905 -1.043 . . . . 100.0 111.513 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.411 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.08 -31.9 65.71 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.267 1.827 . . . . 100.0 109.401 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.028 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -57.11 -39.08 74.39 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 130.092 3.357 . . . . 100.0 111.391 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.2 p -105.06 2.27 29.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 117.047 2.24 . . . . 100.0 117.047 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 60.3 mt -89.43 84.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.361 1.088 0 C-N-CA 118.062 -1.455 . . . . 100.0 110.576 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 2.3 p -100.81 -6.09 9.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HD2' HD11 ' A' ' 119' ' ' LEU . 65.8 t80 -59.37 -37.37 77.73 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 116.09 1.885 . . . . 100.0 116.09 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.275 78.6 m-70 -59.5 -37.97 79.69 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 116.718 2.118 . . . . 100.0 116.718 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.866 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 43.6 ttp85 -59.01 -49.28 78.48 Favored 'General case' 0 CA--C 1.471 -2.092 0 O-C-N 124.178 0.924 . . . . 100.0 112.964 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.63 -41.19 98.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 125.456 1.723 . . . . 100.0 111.074 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.6 mmtt -95.04 0.32 54.4 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.206 2.298 . . . . 100.0 117.206 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 58.32 40.04 24.9 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.155 1.382 . . . . 100.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.801 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.6 mt -101.9 152.52 20.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.754 -1.943 . . . . 100.0 105.754 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.29 143.24 30.71 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.206 -0.665 . . . . 100.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 84.4 t80 -110.32 136.53 49.36 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.299 1.222 . . . . 100.0 114.299 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -134.42 137.61 44.15 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.432 -1.258 . . . . 100.0 111.18 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.276 72.6 m-20 -84.72 128.64 34.7 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 102.688 -3.078 . . . . 100.0 102.688 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.513 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.8 pt -134.22 157.84 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.702 1.239 . . . . 100.0 111.303 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 70.4 m -139.04 108.49 6.15 Favored 'General case' 0 CA--C 1.48 -1.714 0 N-CA-C 104.861 -2.274 . . . . 100.0 104.861 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.8 -44.18 97.38 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.712 -1.131 . . . . 100.0 112.529 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -61.47 -39.24 90.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 124.853 1.261 . . . . 100.0 112.734 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 92.3 p -100.31 2.09 42.23 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 115.868 1.803 . . . . 100.0 115.868 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 68.0 m-80 65.19 20.68 12.0 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.94 1.296 . . . . 100.0 110.99 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 83.4 t80 -72.94 125.7 28.21 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.473 -0.936 . . . . 100.0 108.473 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 54.05 36.68 25.2 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 128.185 2.594 . . . . 100.0 114.584 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 64.3 t80 -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.359 0.99 0 O-C-N 121.881 -0.512 . . . . 100.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -63.67 -38.49 91.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.499 2.037 . . . . 100.0 116.499 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.12 -47.97 98.19 Favored Pre-proline 0 C--N 1.358 0.938 0 N-CA-C 120.097 3.369 . . . . 100.0 120.097 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.15 -41.08 45.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 CA-C-N 123.475 2.277 . . . . 100.0 112.592 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.21 -42.45 96.59 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.712 1.205 . . . . 100.0 110.814 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.23 -44.29 92.32 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 118.795 -0.621 . . . . 100.0 111.628 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -64.88 -42.26 94.96 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 123.499 0.499 . . . . 100.0 110.389 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.8 mt -61.54 -43.82 98.16 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.453 0.47 . . . . 100.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.52 -44.18 97.52 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.076 0.951 . . . . 100.0 110.656 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.58 -45.6 93.42 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 122.672 0.389 . . . . 100.0 111.783 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -66.17 -44.54 83.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.858 0.688 . . . . 100.0 112.858 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.26 -45.19 89.18 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 113.451 0.908 . . . . 100.0 113.451 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 50.9 mm -74.52 -30.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.902 0.881 . . . . 100.0 110.11 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.79 13.82 66.28 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 118.635 -1.091 . . . . 100.0 111.447 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -116.39 112.31 41.55 Favored Pre-proline 0 C--N 1.363 1.168 0 CA-C-N 118.439 1.119 . . . . 100.0 108.044 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.99 -14.1 31.98 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.749 2.966 . . . . 100.0 113.255 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -85.63 -3.18 58.81 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.125 0.97 . . . . 100.0 113.026 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.84 134.21 56.86 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 113.226 0.825 . . . . 100.0 113.226 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.14 149.29 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.525 -1.216 . . . . 100.0 108.235 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -90.03 114.62 26.53 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 103.525 -2.769 . . . . 100.0 103.525 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.24 -40.04 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.53 146.8 52.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.8 mtt -88.27 129.61 48.99 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.336 -1.727 . . . . 100.0 106.336 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.27 158.48 52.14 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.276 1.984 . . . . 100.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.43 124.88 23.98 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.722 -1.214 . . . . 100.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.54 145.85 45.02 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 114.263 -1.335 . . . . 100.0 110.403 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.38 136.28 96.63 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.796 -1.927 . . . . 100.0 105.796 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 138.88 77.58 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 123.55 2.833 . . . . 100.0 112.553 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -57.81 129.09 31.71 Favored 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.23 1.954 . . . . 100.0 113.509 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.86 -43.8 82.65 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 124.701 1.251 . . . . 100.0 108.085 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 158.24 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.58 -1.637 . . . . 100.0 106.58 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.42 131.89 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.47 123.91 32.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.654 -2.721 . . . . 100.0 103.654 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.85 128.65 92.29 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 114.779 -1.101 . . . . 100.0 110.565 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.7 -37.65 93.09 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.725 2.95 . . . . 100.0 113.546 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.06 95.23 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 123.979 0.8 . . . . 100.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.3 -42.22 99.03 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 122.769 0.428 . . . . 100.0 111.147 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.2 97.73 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 123.703 0.801 . . . . 100.0 110.625 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.03 97.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.508 0.723 . . . . 100.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.26 -44.75 95.83 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.758 0.823 . . . . 100.0 112.075 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -63.49 -43.51 97.04 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 122.918 0.487 . . . . 100.0 111.793 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.19 -39.83 94.83 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.707 -0.224 . . . . 100.0 111.19 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.78 -42.67 99.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.158 0.983 . . . . 100.0 110.007 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -61.51 -42.35 98.68 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.838 0.855 . . . . 100.0 110.645 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 81.9 mt -61.03 -48.43 81.84 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.391 -0.822 . . . . 100.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.48 -41.84 98.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.66 -47.14 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.968 0 CA-C-O 118.221 -0.895 . . . . 100.0 109.124 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.959 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.705 . . -88.87 -8.67 53.85 Favored 'General case' 1 N--CA 1.379 -4.008 1 C-N-CA 104.543 -6.863 . . . . 100.0 116.647 179.881 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 1.037 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 55.1 mt-30 -53.48 -34.89 59.7 Favored 'General case' 0 CA--C 1.444 -3.108 0 C-N-CA 128.179 2.591 . . . . 100.0 107.507 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -82.73 41.47 0.73 Allowed 'General case' 0 N--CA 1.416 -2.133 0 O-C-N 124.825 1.328 . . . . 100.0 109.766 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 205' ' ' GLN . 4.6 m 57.96 30.24 18.86 Favored 'General case' 0 CA--C 1.473 -1.988 0 C-N-CA 127.13 2.172 . . . . 100.0 112.578 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.275 . . -73.61 175.51 7.05 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 101.155 -3.646 . . . . 100.0 101.155 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.03 -36.7 49.04 Favored Pre-proline 0 CA--C 1.489 -1.393 0 CA-C-O 116.359 -1.781 . . . . 100.0 114.024 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.028 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.457 0.3 OUTLIER -53.58 137.79 66.35 Favored 'Trans proline' 0 N--CA 1.433 -2.088 0 O-C-N 123.814 1.428 . . . . 100.0 112.634 176.602 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.305 99.3 m-20 -64.01 -43.03 96.86 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 121.499 3.888 . . . . 100.0 121.499 -172.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.1 tm-20 -71.42 -16.03 62.37 Favored 'General case' 0 CA--C 1.463 -2.394 1 CA-C-O 130.799 5.095 . . . . 100.0 112.989 177.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 1.037 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.785 66.3 m-20 -86.07 -50.04 7.33 Favored 'General case' 1 N--CA 1.257 -10.116 1 CA-C-N 105.781 -5.19 . . . . 100.0 104.025 -172.932 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 140' ' ' ARG . 37.8 t70 -62.05 -28.96 69.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.255 -2.153 . . . . 100.0 106.528 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.866 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 73.0 m-20 -61.77 -40.29 94.64 Favored 'General case' 0 CA--C 1.476 -1.889 0 C-N-CA 126.925 2.09 . . . . 100.0 112.591 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.283 0.6 OUTLIER . . . . . 0 N--CA 1.428 -1.558 0 CA-C-O 115.334 -2.27 . . . . 100.0 114.301 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.3 t . . . . . 0 N--CA 1.435 -1.194 0 N-CA-C 101.759 -3.422 . . . . 100.0 101.759 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -128.58 138.13 52.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.534 -0.757 . . . . 100.0 109.876 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.75 144.09 51.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.4 122.54 34.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.596 -2.001 . . . . 100.0 105.596 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.21 126.53 55.16 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 79' ' ' TYR . 67.7 t -104.27 124.36 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.773 -1.195 . . . . 100.0 107.773 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.418 HD11 ' SD ' ' A' ' 89' ' ' MET . 38.1 tp -108.7 118.83 37.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.039 -1.837 . . . . 100.0 106.039 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.81 162.36 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.802 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.24 172.78 22.52 Favored Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.015 -2.034 . . . . 100.0 108.015 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -66.74 153.45 43.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.958 0.885 . . . . 100.0 111.973 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.24 140.89 43.89 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.471 -2.252 . . . . 100.0 107.471 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.57 -3.08 85.12 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-O 118.568 -1.129 . . . . 100.0 114.37 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -62.77 -38.53 90.97 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.868 1.334 . . . . 100.0 112.248 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 23.55 3.79 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 110.247 -1.141 . . . . 100.0 110.247 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 51.8 mtpt -59.98 -47.78 84.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.382 1.073 . . . . 100.0 113.163 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -64.17 -42.76 96.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 123.906 0.882 . . . . 100.0 110.42 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -62.53 -42.04 99.26 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.209 1.004 . . . . 100.0 109.309 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -60.29 -49.59 77.01 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.663 1.185 . . . . 100.0 112.646 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.37 -41.63 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 123.547 0.529 . . . . 100.0 111.168 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.302 99.4 mttt -69.45 -6.63 31.61 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 115.775 1.769 . . . . 100.0 115.775 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 154' ' ' ASN . 43.2 mtm180 -60.23 -38.22 82.75 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 109.013 -0.736 . . . . 100.0 109.013 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -81.32 112.22 18.41 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.637 -1.616 . . . . 100.0 106.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.92 -45.12 95.11 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.191 1.923 . . . . 100.0 116.191 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.8 m -63.73 -41.15 98.1 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.252 0.621 . . . . 100.0 109.63 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.66 99.59 Favored Glycine 0 C--N 1.358 1.799 0 N-CA-C 110.841 -0.904 . . . . 100.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.76 -46.52 84.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.824 0.85 . . . . 100.0 111.14 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -63.96 -39.63 94.57 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 113.003 0.742 . . . . 100.0 113.003 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -93.27 11.65 27.32 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 115.4 1.63 . . . . 100.0 115.4 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.85 144.84 51.95 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 113.896 1.073 . . . . 100.0 113.896 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -122.23 130.74 53.47 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.219 -1.03 . . . . 100.0 108.219 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -101.06 125.46 47.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.876 -1.157 . . . . 100.0 107.876 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -99.32 109.18 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.47 98.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 116.649 2.092 . . . . 100.0 116.649 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.4 m -61.92 -44.29 97.08 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.004 0.922 . . . . 100.0 110.925 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.76 -21.39 23.83 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 114.303 1.223 . . . . 100.0 114.303 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.7 45.72 51.01 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 109.296 -1.522 . . . . 100.0 109.296 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.84 144.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 109.147 -0.686 . . . . 100.0 109.147 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -108.26 118.33 36.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 101.598 -3.482 . . . . 100.0 101.598 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.21 120.09 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.71 -1.959 . . . . 100.0 105.71 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -111.52 119.43 45.08 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.825 -0.625 . . . . 100.0 110.076 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.46 103.31 1.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.604 2.203 . . . . 100.0 111.062 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.35 116.03 28.81 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.21 128.46 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.278 -1.378 . . . . 100.0 107.278 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.38 135.6 54.73 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -102.08 117.49 34.9 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -108.56 175.59 5.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.761 0.791 . . . . 100.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.52 -32.97 71.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.39 1.476 . . . . 100.0 109.919 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -92.37 3.81 54.68 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.401 0.889 . . . . 100.0 113.401 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.92 177.93 17.26 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 121.274 -0.891 . . . . 100.0 111.67 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.11 140.45 59.66 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.16 2.573 . . . . 100.0 114.751 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.3 131.12 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 103.057 -2.942 . . . . 100.0 103.057 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -114.4 128.77 56.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.569 -0.53 . . . . 100.0 109.569 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.47 115.7 29.65 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 104.946 -2.242 . . . . 100.0 104.946 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -88.32 105.81 17.81 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 101.051 -3.685 . . . . 100.0 101.051 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.53 123.3 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 107.87 -1.159 . . . . 100.0 107.87 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -95.03 115.73 27.8 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.041 -1.466 . . . . 100.0 107.041 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -111.13 137.62 48.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.625 -1.62 . . . . 100.0 106.625 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -72.77 164.59 26.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.252 1.025 . . . . 100.0 112.38 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.53 22.88 10.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.77 15.63 59.39 Favored Glycine 0 C--N 1.362 1.98 0 O-C-N 121.612 -0.68 . . . . 100.0 113.122 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 60.3 mt-30 -59.64 -35.1 73.73 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 127.077 2.151 . . . . 100.0 112.364 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.47 -33.1 69.38 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 128.064 2.545 . . . . 100.0 112.011 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.42 -39.37 94.31 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.173 0.589 . . . . 100.0 111.569 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 12.6 p90 -94.66 -7.85 39.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.12 -163.38 35.0 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 119.405 1.002 . . . . 100.0 112.382 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.67 -179.59 53.0 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 108.639 -1.784 . . . . 100.0 108.639 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 92.8 mt -107.52 142.22 37.76 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.603 0.716 . . . . 100.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -70.16 157.31 37.85 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.586 -1.188 . . . . 100.0 112.455 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -59.96 -37.57 79.96 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 124.993 1.317 . . . . 100.0 110.623 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.3 -37.45 87.29 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 125.193 1.378 . . . . 100.0 111.102 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 90.0 t80 -62.59 -45.8 91.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.417 0.687 . . . . 100.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -75.58 -28.7 59.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.401 2.0 . . . . 100.0 116.401 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.7 mt -51.31 131.63 12.35 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 123.269 1.509 . . . . 100.0 114.824 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.263 52.9 mt-30 59.87 29.9 19.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 128.899 2.88 . . . . 100.0 114.006 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.36 132.06 45.8 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.015 -1.846 . . . . 100.0 106.015 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.09 -31.53 13.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.473 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.5 p -151.81 163.51 39.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.457 -0.572 . . . . 100.0 109.457 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.67 41.98 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 114.64 1.348 . . . . 100.0 114.64 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.3 mt -127.56 126.38 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 104.072 -2.566 . . . . 100.0 104.072 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.692 ' HB ' HD22 ' A' ' 119' ' ' LEU . 33.3 mt -110.51 124.49 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 102.898 -3.001 . . . . 100.0 102.898 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.5 mtp -111.94 137.08 50.42 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -130.73 163.69 26.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.537 -2.119 . . . . 100.0 107.706 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -106.67 127.25 53.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.076 -1.824 . . . . 100.0 106.076 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.21 -15.93 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.428 0.899 . . . . 100.0 113.428 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.8 p -90.25 -6.85 54.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.072 0.396 . . . . 100.0 110.543 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -125.75 116.04 20.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.449 1.119 . . . . 100.0 110.561 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.0 -37.7 88.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.591 1.156 . . . . 100.0 112.217 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.59 -40.16 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.983 1.713 . . . . 100.0 110.322 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -62.34 -41.68 98.77 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 118.344 0.52 . . . . 100.0 111.28 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.63 -40.92 96.32 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.268 0.627 . . . . 100.0 110.423 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -60.57 -36.95 79.75 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 123.941 0.896 . . . . 100.0 111.091 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -79.11 -5.91 55.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 119' ' ' LEU . 89.8 t -59.94 -42.79 92.46 Favored Pre-proline 0 C--N 1.364 1.215 0 CA-C-O 116.466 -1.73 . . . . 100.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 72.9 Cg_exo -57.8 -37.51 96.18 Favored 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 122.25 1.839 . . . . 100.0 112.69 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -64.14 -44.38 92.35 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.873 1.269 . . . . 100.0 111.076 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -64.64 -40.91 96.28 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 122.877 0.471 . . . . 100.0 110.915 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.73 -44.01 97.73 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 124.09 0.956 . . . . 100.0 109.395 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.46 -45.56 93.77 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 123.71 0.804 . . . . 100.0 111.66 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.0 -45.81 91.95 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.375 0.67 . . . . 100.0 110.699 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.67 -47.27 81.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.665 1.186 . . . . 100.0 113.259 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.321 25.9 m -65.84 -33.8 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 N-CA-C 113.597 0.962 . . . . 100.0 113.597 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 110' ' ' ARG . 55.6 mtt85 -60.14 -46.71 88.75 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 123.813 0.696 . . . . 100.0 109.227 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.07 -44.37 50.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 112.16 0.43 . . . . 100.0 112.16 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.88 107.7 10.74 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.997 0.903 . . . . 100.0 110.715 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.71 138.93 32.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.025 -0.988 . . . . 100.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 53.52 42.02 32.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 117.547 2.425 . . . . 100.0 117.547 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.0 pt -94.99 144.64 28.15 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 106.353 -1.721 . . . . 100.0 106.353 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.61 133.45 42.54 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.36 2.04 . . . . 100.0 110.43 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.775 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.8 mt -133.98 137.45 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.343 -0.984 . . . . 100.0 108.343 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.37 131.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 105.04 -2.207 . . . . 100.0 105.04 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 88' ' ' ILE . 24.6 mt -106.63 128.93 54.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.198 -2.519 . . . . 100.0 104.198 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.6 m -120.23 130.6 54.59 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.465 -1.243 . . . . 100.0 113.363 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.3 107.4 3.23 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 105.4 -3.08 . . . . 100.0 105.4 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.353 9.0 p-10 -95.88 177.93 5.6 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 114.501 1.297 . . . . 100.0 114.501 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.1 mttt 62.0 40.4 12.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 128.761 2.824 . . . . 100.0 112.863 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.6 m -71.75 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 114.882 -1.054 . . . . 100.0 111.713 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -66.0 -29.14 69.47 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.981 0.912 . . . . 100.0 110.524 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.6 128.43 34.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 107.158 -1.423 . . . . 100.0 107.158 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.23 -41.81 98.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 115.779 1.77 . . . . 100.0 115.779 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.25 97.08 11.0 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.774 -1.935 . . . . 100.0 105.774 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -96.79 125.11 41.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 113.845 -1.525 . . . . 100.0 106.885 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.27 -39.14 12.23 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.585 0.958 . . . . 100.0 113.585 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -103.5 102.93 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.66 -1.607 . . . . 100.0 106.66 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 29.9 mmmt -89.71 168.06 12.41 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.481 1.512 . . . . 100.0 114.022 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.44 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.22 -33.46 67.57 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.989 2.116 . . . . 100.0 108.696 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.08 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 93.8 mttt -57.61 -38.62 75.25 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 129.19 2.996 . . . . 100.0 112.835 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.8 p -105.29 3.04 29.52 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 116.493 2.035 . . . . 100.0 116.493 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 66.8 mt -91.09 89.79 3.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 117.792 -1.563 . . . . 100.0 109.324 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.474 ' CA ' ' HB3' ' A' ' 211' ' ' ASP 0.361 0.0 OUTLIER -101.46 -12.81 8.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 115.636 1.717 . . . . 100.0 115.636 -175.842 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.55 -35.95 73.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 118.235 2.68 . . . . 100.0 118.235 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.597 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.263 60.6 m-70 -59.6 -37.11 77.68 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.396 1.878 . . . . 100.0 113.927 -176.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.774 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.273 55.2 ttp85 -59.15 -50.09 75.38 Favored 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 113.926 1.084 . . . . 100.0 113.926 -175.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.68 -41.23 98.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 125.033 1.458 . . . . 100.0 111.769 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.23 2.74 53.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 116.396 1.999 . . . . 100.0 116.396 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 55.69 43.78 27.46 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-O 123.116 1.436 . . . . 100.0 113.37 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' A' ' 117' ' ' ILE . 26.2 mt -101.88 146.48 27.77 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.573 -2.38 . . . . 100.0 104.573 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -94.14 142.39 27.45 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.945 -1.131 . . . . 100.0 107.945 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.475 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 88.3 t80 -113.67 139.04 49.39 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 113.222 0.823 . . . . 100.0 113.222 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.69 139.85 42.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.202 -1.363 . . . . 100.0 111.578 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.26 85.2 m-20 -86.59 128.34 34.98 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 102.743 -3.058 . . . . 100.0 102.743 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 43.3 pt -135.33 157.59 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 122.049 0.928 . . . . 100.0 111.732 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -137.11 109.52 7.38 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 103.376 -2.824 . . . . 100.0 103.376 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.75 -41.38 99.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.885 -1.052 . . . . 100.0 110.825 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.64 -40.85 93.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.208 1.403 . . . . 100.0 112.353 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -100.85 3.57 42.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.305 1.965 . . . . 100.0 116.305 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.634 ' HA ' HH11 ' A' ' 29' ' ' ARG . 72.5 m-80 63.85 22.83 13.18 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.03 1.332 . . . . 100.0 110.677 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -72.61 124.11 24.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.458 -1.312 . . . . 100.0 107.458 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 53.53 37.83 26.71 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.657 2.383 . . . . 100.0 113.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.26 -44.54 95.21 Favored 'General case' 0 C--N 1.362 1.141 0 O-C-N 121.903 -0.498 . . . . 100.0 111.324 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -63.08 -38.69 92.2 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.636 1.974 . . . . 100.0 115.628 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -57.7 -47.4 99.01 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 120.531 3.53 . . . . 100.0 120.531 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.06 -42.39 36.82 Favored 'Trans proline' 0 C--N 1.373 1.834 0 CA-C-N 123.403 2.251 . . . . 100.0 112.066 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -65.08 -42.55 94.01 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 124.852 1.261 . . . . 100.0 111.74 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -44.27 91.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.518 0.727 . . . . 100.0 110.241 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -63.7 -44.51 93.46 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-N 117.949 0.34 . . . . 100.0 110.345 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.7 mt -62.34 -43.25 99.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 119.112 -0.471 . . . . 100.0 111.363 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.62 98.56 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.065 0.946 . . . . 100.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.88 -45.35 94.13 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 119.021 -0.514 . . . . 100.0 112.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.0 -42.53 76.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 112.734 0.642 . . . . 100.0 112.734 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.65 -38.83 74.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.692 1.197 . . . . 100.0 109.937 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.73 10.76 56.29 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-O 118.489 -1.173 . . . . 100.0 111.025 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 48.4 t0 -112.47 111.48 52.2 Favored Pre-proline 0 C--N 1.365 1.258 0 CA-C-N 118.485 1.142 . . . . 100.0 108.262 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -15.99 40.26 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.961 3.108 . . . . 100.0 113.256 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -96.17 8.37 44.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 114.349 1.24 . . . . 100.0 114.349 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 75.5 mt -62.11 136.7 58.06 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-O 121.307 0.575 . . . . 100.0 110.705 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -133.16 150.57 52.01 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.53 -0.915 . . . . 100.0 108.53 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -91.06 113.19 25.39 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 103.65 -2.722 . . . . 100.0 103.65 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.24 -39.51 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 114.061 1.134 . . . . 100.0 114.061 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.0 146.07 51.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.506 -0.924 . . . . 100.0 108.506 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.91 130.48 48.3 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 108.031 -1.1 . . . . 100.0 108.031 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.54 155.62 67.96 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.223 1.949 . . . . 100.0 109.847 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.07 123.73 21.84 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.8 -1.555 . . . . 100.0 106.8 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -119.02 145.85 45.52 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.239 -1.346 . . . . 100.0 109.665 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.64 96.33 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 105.965 -1.865 . . . . 100.0 105.965 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 72.0 Cg_exo -55.65 142.35 82.38 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 123.453 2.769 . . . . 100.0 113.563 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 154' ' ' ASN . 51.0 Cg_exo -56.7 127.63 26.68 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 122.848 2.366 . . . . 100.0 113.281 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -70.14 -42.44 72.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 124.714 1.259 . . . . 100.0 107.867 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.15 158.83 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.411 -1.7 . . . . 100.0 106.411 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.64 128.37 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.408 -2.071 . . . . 100.0 105.408 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -89.58 125.02 35.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.7 -2.333 . . . . 100.0 104.7 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.66 129.27 92.72 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 114.568 -1.196 . . . . 100.0 111.613 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -59.1 -37.53 92.03 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.654 2.903 . . . . 100.0 113.481 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.55 93.73 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.146 0.904 . . . . 100.0 110.179 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.07 -41.84 99.52 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.135 0.574 . . . . 100.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.02 96.35 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.803 0.841 . . . . 100.0 110.672 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.26 99.27 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.699 0.799 . . . . 100.0 110.84 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.32 -45.12 94.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.829 0.851 . . . . 100.0 111.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -63.68 -43.63 96.11 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 112.392 0.515 . . . . 100.0 112.392 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -64.51 -39.86 94.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 123.248 0.343 . . . . 100.0 111.287 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -63.09 -42.45 99.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.952 0.901 . . . . 100.0 110.303 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.4 -42.46 98.77 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.975 0.91 . . . . 100.0 110.609 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.8 mt -61.26 -47.23 86.97 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.431 -0.804 . . . . 100.0 109.262 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.46 -42.04 98.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.3 1.222 . . . . 100.0 114.3 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.34 -47.4 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.047 0 CA-C-O 117.504 -1.236 . . . . 100.0 108.517 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.714 . . -89.72 -8.15 52.93 Favored 'General case' 0 N--CA 1.382 -3.849 1 C-N-CA 103.86 -7.136 . . . . 100.0 117.204 178.721 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 1.044 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 54.3 mt-30 -53.69 -34.07 57.53 Favored 'General case' 0 CA--C 1.447 -2.994 0 C-N-CA 127.813 2.445 . . . . 100.0 106.801 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -80.87 36.57 0.4 Allowed 'General case' 0 N--CA 1.416 -2.142 0 O-C-N 124.933 1.395 . . . . 100.0 109.5 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 58.5 31.9 21.52 Favored 'General case' 0 CA--C 1.472 -2.052 0 C-N-CA 126.871 2.068 . . . . 100.0 112.525 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 204' ' ' ALA . . . -75.63 -178.19 4.04 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 101.642 -3.466 . . . . 100.0 101.642 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 81.3 mt -57.68 -38.24 65.07 Favored Pre-proline 0 CA--C 1.492 -1.263 0 CA-C-O 116.274 -1.822 . . . . 100.0 113.154 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.08 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.422 5.7 Cg_exo -53.1 136.45 61.46 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 CA-C-O 123.64 1.433 . . . . 100.0 112.7 177.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.474 ' HB3' ' CA ' ' A' ' 137' ' ' VAL 0.331 84.8 m-20 -65.18 -42.22 93.85 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 120.956 3.687 . . . . 100.0 120.956 -172.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.5 tm-20 -72.44 -14.72 61.76 Favored 'General case' 0 CA--C 1.459 -2.52 1 CA-C-O 130.685 5.04 . . . . 100.0 112.922 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 1.044 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.807 64.0 m-20 -87.55 -48.71 7.7 Favored 'General case' 1 N--CA 1.256 -10.162 1 CA-C-N 106.111 -5.04 . . . . 100.0 103.127 -172.786 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.5 -27.57 69.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 118.901 -2.375 . . . . 100.0 106.211 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 51.5 m-20 -62.39 -39.96 94.94 Favored 'General case' 0 CA--C 1.478 -1.825 0 C-N-CA 127.137 2.175 . . . . 100.0 112.604 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.303 3.8 mm? . . . . . 0 N--CA 1.427 -1.624 0 CA-C-O 114.15 -2.833 . . . . 100.0 112.828 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 N--CA 1.439 -1.021 0 N-CA-C 102.844 -3.021 . . . . 100.0 102.844 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -127.89 140.48 51.98 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.839 -1.073 . . . . 100.0 110.431 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -129.07 144.08 51.08 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.074 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.18 120.49 34.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 105.577 -2.009 . . . . 100.0 105.577 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 63' ' ' VAL . 47.7 tp -113.4 127.03 55.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 100.0 107.473 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 79' ' ' TYR . 74.8 t -106.6 124.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 114.844 -1.071 . . . . 100.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.51 HD13 HG13 ' A' ' 63' ' ' VAL . 6.4 mp -107.38 119.17 38.66 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-O 121.477 0.656 . . . . 100.0 109.471 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.31 160.56 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.819 -1.082 . . . . 100.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.23 174.31 24.98 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.047 -2.021 . . . . 100.0 108.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.61 155.02 40.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.744 0.783 . . . . 100.0 112.229 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.46 140.76 41.53 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 106.519 -2.632 . . . . 100.0 106.519 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.76 -5.27 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.533 -1.148 . . . . 100.0 114.458 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.0 p -62.28 -37.24 84.77 Favored 'General case' 0 C--N 1.362 1.109 0 CA-C-N 118.929 1.364 . . . . 100.0 112.2 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.25 21.86 6.08 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.179 -0.769 . . . . 100.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 41.5 mtmt -60.95 -44.76 96.81 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 118.112 0.956 . . . . 100.0 112.559 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.2 m -62.25 -44.19 97.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.311 1.044 . . . . 100.0 109.846 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -63.03 -41.82 99.63 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.889 0.876 . . . . 100.0 109.362 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.46 -47.73 84.39 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.028 0.931 . . . . 100.0 112.559 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 63' ' ' VAL . 79.9 t -64.16 -41.03 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 123.284 0.634 . . . . 100.0 110.066 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.38 -7.84 41.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 116.373 1.99 . . . . 100.0 116.373 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.612 HH11 ' HB2' ' A' ' 157' ' ' PHE . 62.0 mtt180 -60.31 -37.97 82.24 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 58.3 t-80 -80.07 112.3 17.25 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 106.977 -1.49 . . . . 100.0 106.977 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.79 -44.93 95.9 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 115.817 1.784 . . . . 100.0 115.817 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 90.4 m -63.77 -42.48 97.79 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.52 0.728 . . . . 100.0 109.7 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.67 99.61 Favored Glycine 0 C--N 1.357 1.732 0 C-N-CA 123.807 0.718 . . . . 100.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.43 -45.55 87.07 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.916 0.886 . . . . 100.0 111.359 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -64.28 -39.77 94.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.501 1.12 . . . . 100.0 111.953 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -93.8 9.67 36.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 115.637 1.717 . . . . 100.0 115.637 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -61.12 141.85 57.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 114.225 1.194 . . . . 100.0 114.225 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -121.74 130.78 53.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.922 -1.035 . . . . 100.0 108.915 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.57 126.87 45.62 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.92 112.28 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 102.166 -3.272 . . . . 100.0 102.166 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.11 90.29 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 118.381 2.734 . . . . 100.0 118.381 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.6 m -63.08 -47.15 84.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 118.381 0.537 . . . . 100.0 110.329 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.88 -37.55 73.04 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 114.054 1.131 . . . . 100.0 114.054 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.01 44.4 30.24 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 106.895 -2.482 . . . . 100.0 106.895 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.402 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.9 t -127.57 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.076 0.95 . . . . 100.0 108.622 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -108.57 118.7 37.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.623 -3.473 . . . . 100.0 101.623 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.44 119.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 105.628 -1.99 . . . . 100.0 105.628 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -109.46 120.32 45.64 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.483 -0.781 . . . . 100.0 109.074 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -80.93 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.682 2.254 . . . . 100.0 109.491 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.56 112.83 24.99 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.329 -0.989 . . . . 100.0 108.329 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.35 128.33 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.526 -1.287 . . . . 100.0 107.526 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.24 135.66 54.79 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.437 -2.06 . . . . 100.0 105.437 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -102.59 119.17 38.36 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.55 -0.907 . . . . 100.0 108.55 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 p -108.63 175.87 5.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.99 0.9 . . . . 100.0 110.176 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -61.7 -26.43 68.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.317 1.447 . . . . 100.0 110.356 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -97.88 6.52 47.68 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.868 0.867 . . . . 100.0 112.633 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.65 179.36 20.03 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 121.298 -0.876 . . . . 100.0 111.208 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.72 139.94 59.82 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.182 2.588 . . . . 100.0 116.009 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.52 131.4 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 103.155 -2.905 . . . . 100.0 103.155 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -113.58 128.48 56.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.164 0.507 . . . . 100.0 109.833 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -110.74 114.77 28.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.957 -2.608 . . . . 100.0 103.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -89.74 103.95 16.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 100.87 -3.752 . . . . 100.0 100.87 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.521 HG22 HD23 ' A' ' 13' ' ' LEU . 32.8 t -87.91 124.39 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.404 -1.271 . . . . 100.0 107.95 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -98.36 115.74 29.1 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.024 -2.213 . . . . 100.0 105.024 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.26 137.77 49.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.517 -1.66 . . . . 100.0 106.517 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.1 p -71.56 162.17 29.86 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.845 0.831 . . . . 100.0 112.926 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.3 14.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.939 -1.028 . . . . 100.0 108.538 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.22 57.99 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 121.703 -0.623 . . . . 100.0 113.194 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -59.68 -34.15 72.49 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.544 1.938 . . . . 100.0 112.101 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.22 -30.49 66.54 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.224 2.21 . . . . 100.0 113.131 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.09 -46.54 88.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.41 15.1 p90 -74.22 -40.45 62.43 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 116.912 2.19 . . . . 100.0 116.912 176.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.5 -154.18 9.31 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 120.303 -0.951 . . . . 100.0 111.918 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.46 53.06 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 122.337 0.965 . . . . 100.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.5 mt -105.13 143.16 33.69 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 123.851 0.86 . . . . 100.0 109.993 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -68.18 156.4 37.62 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.417 -1.265 . . . . 100.0 112.949 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.77 -37.69 79.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 125.312 1.445 . . . . 100.0 110.077 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.62 89.27 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 124.867 1.222 . . . . 100.0 111.479 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 85.8 t80 -62.76 -46.82 86.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.057 0.543 . . . . 100.0 111.032 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -70.59 -36.96 73.83 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 115.917 1.821 . . . . 100.0 115.917 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.2 mt -51.96 135.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 114.747 1.388 . . . . 100.0 114.747 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 68.85 14.41 8.91 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.204 2.202 . . . . 100.0 114.694 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 131.02 45.36 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.398 -0.964 . . . . 100.0 108.398 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.81 -31.15 13.87 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.305 -0.861 . . . . 100.0 108.726 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.592 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -151.04 163.8 37.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 120.824 0.345 . . . . 100.0 110.227 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -147.1 154.17 40.82 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.421 HG13 HD11 ' A' ' 13' ' ' LEU . 81.7 mt -126.51 125.38 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.231 -2.507 . . . . 100.0 104.231 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.635 ' HB ' HD22 ' A' ' 119' ' ' LEU . 45.4 mt -110.57 124.61 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 102.675 -3.083 . . . . 100.0 102.675 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.8 mtp -112.35 136.54 51.69 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 114.914 1.45 . . . . 100.0 114.914 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -129.47 164.2 24.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 112.501 -2.136 . . . . 100.0 107.976 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -109.69 125.43 52.63 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.041 -1.837 . . . . 100.0 106.041 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 m -64.8 -19.71 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 114.042 1.127 . . . . 100.0 114.042 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -86.75 -9.53 55.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 119.243 -0.408 . . . . 100.0 111.323 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -125.21 117.81 24.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 122.195 0.998 . . . . 100.0 110.547 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.67 -38.1 89.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.915 1.286 . . . . 100.0 111.838 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.92 -40.76 81.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.222 1.809 . . . . 100.0 110.601 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -62.97 -41.28 99.49 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.32 0.509 . . . . 100.0 111.307 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.87 -41.41 95.69 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.863 0.865 . . . . 100.0 110.604 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.6 mttt -60.91 -37.8 83.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.792 1.237 . . . . 100.0 110.777 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.83 -8.43 58.03 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.273 1.583 . . . . 100.0 115.273 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 119' ' ' LEU . 73.0 t -60.11 -42.75 91.59 Favored Pre-proline 0 C--N 1.364 1.224 0 CA-C-O 116.419 -1.753 . . . . 100.0 112.077 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 73.8 Cg_exo -57.49 -37.47 97.16 Favored 'Trans proline' 0 C--N 1.375 1.955 0 CA-C-N 122.153 1.805 . . . . 100.0 112.657 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.93 -45.43 89.27 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.05 1.34 . . . . 100.0 110.894 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -64.16 -41.84 96.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 122.936 0.494 . . . . 100.0 110.917 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -62.65 -43.87 97.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 123.898 0.879 . . . . 100.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -63.0 -43.81 97.76 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 123.042 0.537 . . . . 100.0 111.769 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.5 -44.25 96.84 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.916 0.486 . . . . 100.0 110.425 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.1 tp -63.46 -48.34 78.1 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 124.314 1.046 . . . . 100.0 113.177 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.298 32.7 m -63.86 -35.53 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 C-N-CA 124.16 0.984 . . . . 100.0 113.08 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -59.65 -38.53 81.67 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 118.688 -0.672 . . . . 100.0 111.093 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.14 -43.9 17.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 C-N-CA 119.87 -0.732 . . . . 100.0 110.233 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.1 m -124.75 104.65 8.77 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.454 -0.943 . . . . 100.0 108.454 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.14 145.05 25.0 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.983 0.897 . . . . 100.0 110.389 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 57.79 38.04 27.24 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.447 2.017 . . . . 100.0 116.447 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 pt -96.81 143.59 26.38 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 106.185 -1.783 . . . . 100.0 106.185 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 56.2 Cg_endo -62.59 131.14 32.35 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.782 2.322 . . . . 100.0 110.483 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.747 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.9 mt -132.84 138.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 122.369 1.08 . . . . 100.0 109.421 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.98 131.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.193 -1.78 . . . . 100.0 106.193 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.635 HD22 ' HB ' ' A' ' 88' ' ' ILE . 22.5 mt -105.84 128.96 54.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.852 -2.277 . . . . 100.0 104.852 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.36 130.77 56.19 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.126 -1.397 . . . . 100.0 113.398 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.48 104.36 2.77 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 106.222 -2.751 . . . . 100.0 106.222 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.426 ' HA ' HG13 ' A' ' 149' ' ' ILE . 62.3 t30 -83.24 166.09 18.85 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.555 1.142 . . . . 100.0 112.973 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 61.03 42.97 11.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.57 3.148 . . . . 100.0 114.933 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.327 24.5 m -72.07 -7.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 C-N-CA 120.527 -0.469 . . . . 100.0 111.64 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.93 -36.71 82.17 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.718 2.007 . . . . 100.0 109.958 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.95 128.42 33.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 106.915 -1.513 . . . . 100.0 106.915 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.77 -42.35 99.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 114.919 1.452 . . . . 100.0 114.919 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.21 98.04 11.54 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.843 -1.91 . . . . 100.0 105.843 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -95.57 122.2 38.08 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.771 -1.559 . . . . 100.0 106.911 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.94 -39.91 15.3 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.3 0.852 . . . . 100.0 113.3 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.07 104.86 17.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.552 -2.018 . . . . 100.0 105.552 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.57 174.3 6.51 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.209 -0.905 . . . . 100.0 113.109 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.28 65.69 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 127.045 2.138 . . . . 100.0 109.496 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 0.981 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -57.52 -39.12 75.86 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 129.128 2.971 . . . . 100.0 112.043 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.3 p -104.82 4.18 31.91 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 116.403 2.001 . . . . 100.0 116.403 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 56.5 mt -90.06 80.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 117.197 -1.801 . . . . 100.0 112.035 -176.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.255 58.9 t -71.53 -39.44 70.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 1 C-N-CA 133.757 4.823 . . . . 100.0 118.807 -178.279 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -55.79 -36.34 67.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 121.539 3.903 . . . . 100.0 121.539 -168.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.6 ' HE1' ' HB2' ' A' ' 119' ' ' LEU 0.258 67.8 m-70 -59.73 -38.8 82.69 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 116.924 -1.512 . . . . 100.0 113.493 -176.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.97 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.255 0.9 OUTLIER -59.93 -46.83 88.11 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 116.6 2.074 . . . . 100.0 116.6 -176.887 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.93 -40.42 97.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 125.525 1.766 . . . . 100.0 110.2 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.63 3.89 47.94 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 117.279 2.326 . . . . 100.0 117.279 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 55.38 43.47 28.8 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 122.958 1.361 . . . . 100.0 113.311 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.2 mt -103.52 150.4 23.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.643 -1.984 . . . . 100.0 105.643 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -97.28 141.02 30.89 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 109.784 -0.451 . . . . 100.0 109.784 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.491 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.5 t80 -108.27 136.88 47.18 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 113.188 0.81 . . . . 100.0 113.188 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -134.11 136.47 43.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.221 -1.354 . . . . 100.0 110.743 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.322 66.0 m-20 -83.47 130.06 35.01 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 101.996 -3.335 . . . . 100.0 101.996 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' HH22 ' A' ' 29' ' ' ARG . 43.2 pt -134.72 156.73 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.525 1.155 . . . . 100.0 111.674 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 71.3 m -138.2 107.98 6.28 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.941 -2.244 . . . . 100.0 104.941 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.32 -44.63 96.88 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 115.214 -0.903 . . . . 100.0 112.854 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.92 -39.36 91.79 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 125.071 1.348 . . . . 100.0 113.372 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.5 p -99.97 1.57 42.73 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 115.669 1.729 . . . . 100.0 115.669 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.493 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.1 m-80 64.65 21.58 12.44 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.296 1.438 . . . . 100.0 111.263 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 78.1 t80 -70.98 125.61 27.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.906 -1.146 . . . . 100.0 107.906 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 54.45 36.5 25.73 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.102 2.561 . . . . 100.0 114.429 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.612 ' HB2' HH11 ' A' ' 29' ' ' ARG . 64.4 t80 -60.99 -45.49 94.62 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 121.644 -0.66 . . . . 100.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -35.63 81.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.799 2.148 . . . . 100.0 116.799 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.26 -46.98 99.73 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.166 3.025 . . . . 100.0 119.166 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -60.98 -42.51 36.45 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.116 2.149 . . . . 100.0 111.815 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -64.53 -42.29 95.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 125.23 1.412 . . . . 100.0 111.496 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.61 -45.01 92.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.839 0.856 . . . . 100.0 111.116 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.82 -43.77 95.24 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 123.372 0.42 . . . . 100.0 110.399 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 85' ' ' CYS . 75.3 mt -61.36 -44.42 97.19 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 123.097 0.559 . . . . 100.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.8 98.18 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.445 1.098 . . . . 100.0 111.1 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.99 -45.04 95.36 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 122.851 0.46 . . . . 100.0 111.565 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 28.1 tptp -65.25 -46.31 81.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 122.893 0.477 . . . . 100.0 111.633 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.41 -46.99 80.85 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.397 1.258 . . . . 100.0 114.397 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.45 -38.23 73.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 C-N-CA 124.917 1.287 . . . . 100.0 109.623 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.71 10.53 57.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-O 118.515 -1.158 . . . . 100.0 111.14 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -114.17 113.1 46.49 Favored Pre-proline 0 C--N 1.364 1.224 0 N-CA-C 107.648 -1.241 . . . . 100.0 107.648 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.68 -14.15 32.95 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 123.894 3.063 . . . . 100.0 113.254 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -91.4 2.4 56.43 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.25 135.01 57.59 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 118.74 0.7 . . . . 100.0 112.108 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -133.99 148.78 51.17 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.029 -1.1 . . . . 100.0 108.029 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -90.25 112.3 23.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.674 -2.713 . . . . 100.0 103.674 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.81 -40.43 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 114.602 1.334 . . . . 100.0 114.602 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.39 145.8 50.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.34 -0.985 . . . . 100.0 108.34 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.4 ttm -85.73 129.58 54.15 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.129 -1.434 . . . . 100.0 107.129 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.95 155.93 65.25 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.366 2.044 . . . . 100.0 109.964 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.12 122.73 18.9 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.632 -1.618 . . . . 100.0 106.632 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.89 148.04 43.34 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-N 114.257 -1.338 . . . . 100.0 109.373 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.14 96.02 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 105.228 -2.138 . . . . 100.0 105.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.4 Cg_exo -56.26 142.04 87.93 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 123.236 2.624 . . . . 100.0 112.866 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.493 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.0 Cg_exo -56.5 125.94 20.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.638 2.226 . . . . 100.0 112.543 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.02 -42.66 72.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 124.938 1.399 . . . . 100.0 108.671 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.62 158.11 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 106.292 -1.744 . . . . 100.0 106.292 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.82 129.77 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.56 -1.644 . . . . 100.0 106.56 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.72 123.64 35.26 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 103.229 -2.878 . . . . 100.0 103.229 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.4 t70 -62.16 129.12 91.86 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.992 -1.004 . . . . 100.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 63.4 Cg_exo -58.9 -38.5 88.0 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.712 2.941 . . . . 100.0 113.552 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.92 94.78 Favored 'General case' 0 C--N 1.36 1.051 0 O-C-N 123.94 0.775 . . . . 100.0 110.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.36 -41.71 98.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 122.979 0.511 . . . . 100.0 111.114 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.14 97.6 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.745 0.818 . . . . 100.0 110.331 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.03 99.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.989 0.916 . . . . 100.0 110.547 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -62.33 -45.61 92.44 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.714 0.806 . . . . 100.0 111.754 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -63.6 -43.38 97.1 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 112.197 0.443 . . . . 100.0 112.197 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.34 -40.54 96.09 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.294 0.371 . . . . 100.0 111.455 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.57 -42.33 98.34 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.866 0.866 . . . . 100.0 110.197 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.33 -42.42 98.65 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 123.68 0.792 . . . . 100.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 85.2 mt -61.12 -48.1 83.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 123.735 0.647 . . . . 100.0 109.453 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.51 -43.64 98.33 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 114.084 1.142 . . . . 100.0 114.084 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.46 -47.02 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.072 0 CA-C-O 117.988 -1.006 . . . . 100.0 108.822 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.97 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.739 . . -88.66 -9.61 51.48 Favored 'General case' 1 N--CA 1.375 -4.202 1 C-N-CA 104.142 -7.023 . . . . 100.0 116.806 179.79 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 1.012 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 60.6 mt-30 -54.57 -36.03 63.93 Favored 'General case' 0 CA--C 1.445 -3.066 0 C-N-CA 128.86 2.864 . . . . 100.0 106.232 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.2 p -81.61 40.18 0.57 Allowed 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 123.07 1.414 . . . . 100.0 110.061 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.289 5.0 m 57.45 29.73 17.49 Favored 'General case' 0 CA--C 1.468 -2.206 0 C-N-CA 128.579 2.752 . . . . 100.0 112.918 175.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.257 . . -72.51 172.94 9.59 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 100.989 -3.708 . . . . 100.0 100.989 171.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.77 -35.9 34.01 Favored Pre-proline 0 CA--C 1.493 -1.22 0 CA-C-O 116.971 -1.49 . . . . 100.0 114.812 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 0.981 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.414 4.9 Cg_exo -53.97 137.95 69.47 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 CA-C-O 122.948 1.145 . . . . 100.0 113.124 176.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.629 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.375 45.8 m-20 -63.87 -43.91 94.66 Favored 'General case' 0 N--CA 1.408 -2.526 1 N-CA-C 122.783 4.364 . . . . 100.0 122.783 -174.245 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 16.0 tm-20 -66.34 -24.54 66.53 Favored 'General case' 0 CA--C 1.468 -2.208 1 CA-C-O 131.487 5.422 . . . . 100.0 111.598 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 1.012 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.749 55.2 m-20 -74.62 -51.47 14.38 Favored 'General case' 1 N--CA 1.267 -9.576 1 CA-C-N 105.454 -5.339 . . . . 100.0 105.406 -176.566 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -63.66 -26.17 68.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 118.065 -2.897 . . . . 100.0 107.933 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.97 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 48.3 m-20 -62.89 -41.96 99.6 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 126.134 1.774 . . . . 100.0 112.754 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.383 1.0 OUTLIER . . . . . 0 C--O 1.261 1.67 0 CA-C-O 115.082 -2.389 . . . . 100.0 115.74 -178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t . . . . . 0 N--CA 1.432 -1.33 0 CA-C-O 122.114 0.959 . . . . 100.0 109.627 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -127.48 135.75 50.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.399 -1.728 . . . . 100.0 107.73 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -124.43 144.24 50.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.46 -0.791 . . . . 100.0 109.134 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.1 121.64 33.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.32 128.16 56.22 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.419 -1.697 . . . . 100.0 106.419 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.8 t -104.29 125.6 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.621 -1.251 . . . . 100.0 107.621 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 89' ' ' MET . 39.3 tp -110.06 117.47 33.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.86 -1.904 . . . . 100.0 105.86 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.88 160.45 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 112.165 0.432 . . . . 100.0 112.165 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.95 172.71 24.5 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 108.559 -1.816 . . . . 100.0 108.559 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -67.33 154.41 41.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.946 0.879 . . . . 100.0 112.478 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 139.9 42.49 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 107.263 -2.335 . . . . 100.0 107.263 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.0 -4.2 83.03 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 118.634 -1.092 . . . . 100.0 114.258 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 p -62.74 -38.36 90.22 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 118.784 1.292 . . . . 100.0 111.914 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.32 4.78 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.508 -1.037 . . . . 100.0 110.508 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HE3' ' HG ' ' A' ' 15' ' ' LEU . 50.0 mtpt -59.53 -47.11 86.81 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.38 1.072 . . . . 100.0 113.254 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.6 m -64.59 -42.75 95.38 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.254 0.622 . . . . 100.0 110.598 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.6 m -62.24 -42.14 99.05 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 124.126 0.97 . . . . 100.0 108.971 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.75 -48.37 82.11 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.215 1.006 . . . . 100.0 112.968 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.85 -39.94 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 123.133 0.271 . . . . 100.0 110.91 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -65.5 -12.14 49.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 115.249 1.574 . . . . 100.0 115.249 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 41.0 mtt180 -60.02 -38.35 82.43 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.491 -0.929 . . . . 100.0 108.491 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 62.1 t-80 -80.63 111.5 17.12 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 106.799 -1.556 . . . . 100.0 106.799 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.59 -44.37 97.14 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.227 1.566 . . . . 100.0 115.227 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.1 m -62.85 -42.67 99.84 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.333 1.053 . . . . 100.0 109.35 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.07 99.68 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 111.15 -0.78 . . . . 100.0 111.15 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.15 -43.54 91.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 122.783 0.433 . . . . 100.0 111.502 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -62.89 -40.85 98.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.211 1.004 . . . . 100.0 111.85 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -94.07 10.08 35.12 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 115.211 1.56 . . . . 100.0 115.211 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -59.6 142.76 52.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 114.16 1.17 . . . . 100.0 114.16 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.22 132.89 51.65 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.296 -1.002 . . . . 100.0 108.296 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -100.44 127.49 46.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.855 -1.165 . . . . 100.0 107.855 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 109.32 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.352 -3.203 . . . . 100.0 102.352 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.23 99.35 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 p -61.73 -43.67 98.41 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 123.63 0.772 . . . . 100.0 112.718 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.9 mt -93.68 -18.15 22.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 114.393 1.257 . . . . 100.0 114.393 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.96 43.68 64.5 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.268 -1.533 . . . . 100.0 109.268 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.63 143.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.352 -0.981 . . . . 100.0 108.352 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.89 115.4 28.92 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 101.052 -3.685 . . . . 100.0 101.052 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 120.69 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.072 -1.455 . . . . 100.0 107.072 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -113.41 119.15 42.5 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 115.864 -0.607 . . . . 100.0 109.807 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.77 106.22 1.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.3 2.0 . . . . 100.0 111.468 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.79 115.88 29.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.827 -1.175 . . . . 100.0 107.827 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 t -102.39 129.11 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.053 -1.462 . . . . 100.0 107.053 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.91 136.61 53.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.666 -1.975 . . . . 100.0 105.666 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -101.83 119.17 38.36 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.601 -0.888 . . . . 100.0 108.601 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -106.45 -178.46 3.66 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.033 -0.985 . . . . 100.0 111.489 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.0 -37.99 78.16 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.581 1.952 . . . . 100.0 108.583 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -89.98 0.65 56.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 113.741 1.015 . . . . 100.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -175.37 15.86 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.199 -1.16 . . . . 100.0 110.199 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.25 138.95 58.09 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.979 2.452 . . . . 100.0 116.944 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -129.02 130.97 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 102.885 -3.006 . . . . 100.0 102.885 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -114.63 127.58 55.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.422 -0.585 . . . . 100.0 109.422 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -110.96 116.02 30.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -88.11 105.83 17.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 101.465 -3.531 . . . . 100.0 101.465 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.24 122.57 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.708 -1.219 . . . . 100.0 107.708 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -93.6 115.25 27.72 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.886 -1.894 . . . . 100.0 105.886 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -111.37 141.69 44.6 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.642 -1.985 . . . . 100.0 105.642 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -75.04 164.23 26.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.978 0.894 . . . . 100.0 112.882 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.39 16.15 20.95 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.756 -1.111 . . . . 100.0 108.318 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.77 59.2 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 121.728 -0.608 . . . . 100.0 113.422 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -62.24 -23.72 66.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.987 1.715 . . . . 100.0 112.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.31 -33.79 72.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.167 2.187 . . . . 100.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.4 -43.3 99.15 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.044 0.938 . . . . 100.0 109.684 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -70.14 -42.64 72.29 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.919 1.288 . . . . 100.0 113.09 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.93 -149.38 9.17 Favored Glycine 0 C--N 1.358 1.774 0 N-CA-C 110.99 -0.844 . . . . 100.0 110.99 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.87 50.28 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 122.185 0.881 . . . . 100.0 112.664 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.58 142.49 37.42 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 121.939 0.876 . . . . 100.0 109.651 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -64.03 151.75 42.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.403 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.01 -37.22 79.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.428 1.491 . . . . 100.0 110.003 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.76 89.34 Favored Glycine 0 C--N 1.356 1.652 0 C-N-CA 125.237 1.399 . . . . 100.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' A' ' 14' ' ' VAL . 79.9 t80 -62.85 -46.19 89.06 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 123.458 0.703 . . . . 100.0 111.081 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -70.9 -35.59 72.37 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.955 1.835 . . . . 100.0 115.955 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -51.87 134.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 122.987 1.375 . . . . 100.0 114.429 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 65.74 19.27 11.36 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 128.132 2.573 . . . . 100.0 114.635 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 132.32 48.57 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.052 -1.092 . . . . 100.0 108.052 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -95.19 -33.14 12.73 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.544 -0.753 . . . . 100.0 109.075 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.537 ' HB2' HD22 ' A' ' 164' ' ' LEU . 26.0 p -152.38 163.68 39.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.888 -0.412 . . . . 100.0 109.888 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.28 154.36 40.88 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 114.54 1.311 . . . . 100.0 114.54 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.5 mt -125.43 125.93 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.057 -2.571 . . . . 100.0 104.057 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 119' ' ' LEU . 50.8 mt -110.55 123.89 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.941 -2.985 . . . . 100.0 102.941 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.435 ' SD ' HD11 ' A' ' 15' ' ' LEU . 87.3 mtp -111.41 136.82 50.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -129.53 164.23 24.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.295 -2.23 . . . . 100.0 108.187 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -106.39 125.41 50.96 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.476 -2.046 . . . . 100.0 105.476 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.75 -17.15 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -91.69 -4.57 54.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.215 0.462 . . . . 100.0 111.306 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 t -124.38 116.08 22.01 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.472 1.129 . . . . 100.0 109.213 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -65.4 -37.73 87.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.402 1.081 . . . . 100.0 111.087 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.41 -41.22 83.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.258 1.823 . . . . 100.0 110.333 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 p -62.41 -40.97 98.27 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.366 0.53 . . . . 100.0 111.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -64.13 -41.63 97.13 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 123.895 0.878 . . . . 100.0 109.789 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -61.17 -36.85 80.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.095 0.958 . . . . 100.0 111.495 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.27 -6.56 56.95 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.133 1.531 . . . . 100.0 115.133 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.69 -42.4 91.22 Favored Pre-proline 0 C--N 1.364 1.219 0 CA-C-O 116.316 -1.802 . . . . 100.0 111.285 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 75.9 Cg_exo -57.85 -36.82 98.04 Favored 'Trans proline' 0 C--N 1.377 2.071 0 CA-C-N 122.234 1.834 . . . . 100.0 112.597 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.11 -44.41 92.37 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 119.438 1.017 . . . . 100.0 111.385 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -63.98 -42.25 97.28 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 122.817 0.447 . . . . 100.0 110.394 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -62.67 -43.03 99.84 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.082 0.953 . . . . 100.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -62.35 -45.19 94.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 122.892 0.477 . . . . 100.0 112.2 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -63.69 -43.36 96.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.596 0.56 . . . . 100.0 111.397 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 86' ' ' ALA . 51.0 tp -63.11 -48.36 78.89 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.011 0.924 . . . . 100.0 113.093 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 27.5 m -65.69 -36.4 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 123.668 0.787 . . . . 100.0 112.97 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.13 -45.97 91.24 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 118.916 -0.564 . . . . 100.0 109.675 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.03 -45.15 55.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-N 118.154 0.433 . . . . 100.0 111.79 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 24.1 t -130.07 112.68 13.68 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 118.714 -1.195 . . . . 100.0 108.523 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.54 144.56 27.16 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.788 -1.097 . . . . 100.0 113.671 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.08 40.97 32.17 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 117.338 2.347 . . . . 100.0 117.338 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.0 pt -98.36 143.82 26.98 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 107.998 -1.112 . . . . 100.0 107.998 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.4 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 57.9 Cg_endo -62.02 131.75 36.24 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.473 2.115 . . . . 100.0 111.017 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.744 ' HB ' HD22 ' A' ' 144' ' ' LEU . 74.3 mt -133.13 137.32 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 122.406 1.098 . . . . 100.0 108.794 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -115.98 130.88 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 106.767 -1.568 . . . . 100.0 106.767 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.683 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 14.4 mt -105.41 128.5 53.55 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.764 -2.31 . . . . 100.0 104.764 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.1 m -118.75 129.69 55.39 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.458 . . . . 100.0 112.399 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.07 3.48 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 105.261 -3.136 . . . . 100.0 105.261 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.378 9.4 p-10 -95.57 178.54 5.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 62.41 40.51 10.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 127.816 2.446 . . . . 100.0 112.511 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.3 28.1 m -72.21 -8.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 115.993 -0.549 . . . . 100.0 111.24 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.85 -36.79 84.42 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.47 1.908 . . . . 100.0 109.998 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.42 130.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 108.145 -1.057 . . . . 100.0 108.145 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -43.24 99.22 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.915 1.82 . . . . 100.0 115.915 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -88.68 97.85 11.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.607 -1.998 . . . . 100.0 105.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -96.5 112.79 24.4 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.42 -1.326 . . . . 100.0 107.42 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -75.2 -45.05 42.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.102 1.519 . . . . 100.0 115.102 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.23 106.73 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 105.985 -1.857 . . . . 100.0 105.985 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.07 174.08 6.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.854 -1.066 . . . . 100.0 112.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.63 66.93 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 127.367 2.267 . . . . 100.0 109.09 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.101 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.2 mttt -56.91 -39.33 74.24 Favored 'General case' 0 N--CA 1.42 -1.931 0 C-N-CA 128.723 2.809 . . . . 100.0 112.547 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 89.9 p -104.65 5.1 33.35 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 115.907 1.817 . . . . 100.0 115.907 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 65.6 mt -88.76 77.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.112 0 C-N-CA 117.548 -1.661 . . . . 100.0 111.788 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.253 59.0 t -70.86 -38.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 1 C-N-CA 133.81 4.844 . . . . 100.0 118.869 -178.387 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.04 -35.82 67.32 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 121.427 3.862 . . . . 100.0 121.427 -168.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.859 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.274 81.0 m-70 -59.58 -38.58 81.58 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 116.783 -1.579 . . . . 100.0 114.264 -176.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.944 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.254 0.4 OUTLIER -59.42 -46.61 88.23 Favored 'General case' 0 CA--C 1.452 -2.819 0 N-CA-C 116.194 1.924 . . . . 100.0 116.194 -176.661 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.87 -41.08 97.43 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 125.756 1.91 . . . . 100.0 110.832 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -101.49 6.46 42.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 117.15 2.278 . . . . 100.0 117.15 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 56.32 42.36 27.89 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-O 123.026 1.393 . . . . 100.0 113.646 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 117' ' ' ILE . 25.2 mt -99.97 149.17 23.71 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.523 -2.029 . . . . 100.0 105.523 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.77 143.87 28.63 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.482 -0.933 . . . . 100.0 108.482 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.859 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.5 t80 -110.25 137.27 48.21 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.938 0.718 . . . . 100.0 112.938 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -133.78 137.01 44.9 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.543 -1.208 . . . . 100.0 110.575 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.362 69.9 m-20 -85.59 130.09 34.66 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 101.464 -3.532 . . . . 100.0 101.464 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.482 ' HB ' HH22 ' A' ' 29' ' ' ARG . 44.1 pt -137.27 158.29 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 122.248 1.023 . . . . 100.0 111.462 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.8 m -139.06 110.58 7.04 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 106.137 -1.801 . . . . 100.0 106.137 175.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.72 -44.47 96.86 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.625 -1.171 . . . . 100.0 112.71 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.79 -39.7 92.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.324 1.449 . . . . 100.0 113.012 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 115.676 1.732 . . . . 100.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.3 m-80 63.6 24.08 13.83 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 125.158 1.383 . . . . 100.0 110.919 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 80.1 t80 -74.12 125.14 27.69 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.504 -1.295 . . . . 100.0 107.504 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 53.43 36.73 23.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.095 2.558 . . . . 100.0 114.652 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 70.6 t80 -60.82 -43.39 98.3 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.726 -0.609 . . . . 100.0 111.94 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -63.53 -37.28 86.7 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.398 1.999 . . . . 100.0 116.398 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.47 -46.66 99.77 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.897 3.295 . . . . 100.0 119.897 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.62 -41.95 43.52 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.139 2.157 . . . . 100.0 111.919 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.92 -41.43 95.56 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.729 1.212 . . . . 100.0 110.969 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.3 -46.81 87.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.206 1.002 . . . . 100.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -65.63 -42.17 91.81 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 120.28 -0.568 . . . . 100.0 110.494 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.0 mt -61.92 -42.87 99.59 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 119.208 -0.425 . . . . 100.0 111.415 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.73 98.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 124.018 0.927 . . . . 100.0 110.564 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.79 -45.72 92.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 119.188 -0.435 . . . . 100.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 52.6 tptt -65.55 -44.93 85.3 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.518 0.511 . . . . 100.0 112.105 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.46 -46.37 83.37 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 114.279 1.215 . . . . 100.0 114.279 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.7 -37.85 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.225 1.01 . . . . 100.0 109.479 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.43 57.13 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.27 -1.132 . . . . 100.0 110.27 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 54.2 t0 -112.57 110.53 52.58 Favored Pre-proline 0 C--N 1.364 1.218 0 N-CA-C 108.041 -1.096 . . . . 100.0 108.041 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.97 -14.15 32.08 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.748 2.965 . . . . 100.0 113.285 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -90.36 -0.47 57.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.499 1.12 . . . . 100.0 112.987 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 90.3 mt -61.94 136.16 57.85 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.739 1.014 . . . . 100.0 113.739 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -134.89 154.86 51.5 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.908 -1.145 . . . . 100.0 107.908 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -90.49 116.24 28.25 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 103.872 -2.64 . . . . 100.0 103.872 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.7 -44.73 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 123.971 0.908 . . . . 100.0 111.188 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.08 150.5 52.14 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.561 -0.903 . . . . 100.0 108.561 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -95.02 130.86 31.5 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.493 -1.299 . . . . 100.0 107.493 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -64.58 158.27 50.85 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.466 2.11 . . . . 100.0 111.51 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.8 125.43 25.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.37 1.081 . . . . 100.0 108.585 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.35 147.21 45.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.863 -1.517 . . . . 100.0 108.804 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.27 135.84 95.31 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 105.777 -1.934 . . . . 100.0 105.777 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 74.7 Cg_exo -55.97 142.33 85.11 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 123.549 2.833 . . . . 100.0 113.197 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.2 Cg_exo -56.8 128.67 30.91 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.634 2.223 . . . . 100.0 112.94 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.8 -43.37 72.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.892 -1.151 . . . . 100.0 107.892 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 157.78 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 106.538 -1.653 . . . . 100.0 106.538 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.05 130.41 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.87 -1.53 . . . . 100.0 106.87 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.64 125.86 34.62 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 103.664 -2.717 . . . . 100.0 103.664 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.22 126.93 90.26 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.122 -0.945 . . . . 100.0 110.327 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.92 -38.14 89.8 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 123.631 2.887 . . . . 100.0 113.68 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.71 94.07 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.146 0.904 . . . . 100.0 110.049 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -40.81 97.72 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 123.127 0.571 . . . . 100.0 111.251 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.54 98.67 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.659 0.784 . . . . 100.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.45 99.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.935 0.894 . . . . 100.0 110.533 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -61.71 -46.06 91.29 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.349 1.059 . . . . 100.0 111.363 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -63.91 -43.35 96.22 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 112.275 0.472 . . . . 100.0 112.275 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -64.33 -39.66 94.35 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.333 0.396 . . . . 100.0 111.633 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.76 -44.27 96.64 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.223 1.009 . . . . 100.0 110.209 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -61.61 -42.76 99.34 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.459 0.704 . . . . 100.0 110.894 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 79.5 mt -61.15 -48.49 81.37 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 115.784 -0.643 . . . . 100.0 110.271 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.26 -43.95 96.53 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 113.709 1.003 . . . . 100.0 113.709 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -45.81 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.945 0 CA-C-O 118.372 -0.823 . . . . 100.0 109.443 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.746 . . -86.45 -10.78 53.51 Favored 'General case' 1 N--CA 1.376 -4.174 1 C-N-CA 104.526 -6.87 . . . . 100.0 115.747 179.945 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 1.0 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 52.6 mt-30 -54.68 -35.27 63.39 Favored 'General case' 0 CA--C 1.443 -3.158 0 C-N-CA 128.703 2.801 . . . . 100.0 107.148 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.2 p -81.36 40.58 0.57 Allowed 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.857 1.313 . . . . 100.0 109.572 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.266 6.4 m 59.13 27.17 16.07 Favored 'General case' 0 CA--C 1.471 -2.086 0 C-N-CA 127.277 2.231 . . . . 100.0 112.984 175.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 204' ' ' ALA 0.266 . . -72.09 170.5 13.78 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.316 -3.587 . . . . 100.0 101.316 171.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.95 -35.4 29.03 Favored Pre-proline 0 CA--C 1.486 -1.515 0 CA-C-O 116.499 -1.715 . . . . 100.0 114.911 -174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.101 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.445 0.0 OUTLIER -54.38 139.48 73.98 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 O-C-N 123.741 1.39 . . . . 100.0 111.898 176.403 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.698 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.453 39.5 m-20 -65.73 -43.21 89.75 Favored 'General case' 0 N--CA 1.408 -2.53 1 N-CA-C 125.03 5.196 . . . . 100.0 125.03 -173.577 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.7 tm-20 -62.58 -35.81 80.71 Favored 'General case' 0 CA--C 1.469 -2.16 1 CA-C-O 132.292 5.806 . . . . 100.0 108.734 176.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 1.0 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.629 17.5 m-20 -62.34 -51.9 65.8 Favored 'General case' 1 N--CA 1.282 -8.842 2 CA-C-N 104.098 -5.955 . . . . 100.0 107.554 178.719 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.28 -25.33 66.0 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 117.261 -3.399 . . . . 100.0 107.579 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.944 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 57.9 m-20 -63.78 -40.4 96.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 126.979 2.112 . . . . 100.0 112.395 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.274 3.2 mm? . . . . . 0 N--CA 1.426 -1.654 0 CA-C-O 114.157 -2.83 . . . . 100.0 112.781 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t . . . . . 0 N--CA 1.443 -0.805 0 N-CA-C 102.009 -3.33 . . . . 100.0 102.009 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.41 138.74 52.47 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.813 -0.63 . . . . 100.0 110.828 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.83 144.37 51.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.605 -0.725 . . . . 100.0 110.017 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.64 120.3 32.93 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.217 -1.401 . . . . 100.0 107.217 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 63' ' ' VAL . 57.1 tp -110.6 125.87 53.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.131 -1.849 . . . . 100.0 107.23 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 79' ' ' TYR . 56.0 t -103.05 124.69 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.694 -1.224 . . . . 100.0 107.694 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 89' ' ' MET . 42.5 tp -109.29 117.33 33.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.124 -1.806 . . . . 100.0 106.124 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -128.79 161.47 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 112.129 0.418 . . . . 100.0 112.129 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.69 173.96 24.14 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 108.403 -1.879 . . . . 100.0 108.403 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.4 154.35 41.55 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.061 0.934 . . . . 100.0 112.938 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.84 141.18 43.31 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.07 -2.412 . . . . 100.0 107.07 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.78 -1.53 86.99 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-O 118.084 -1.398 . . . . 100.0 113.288 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 p -63.91 -38.39 90.91 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 119.261 1.531 . . . . 100.0 111.649 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.47 21.78 4.63 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.487 -1.045 . . . . 100.0 110.487 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -59.98 -46.86 88.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.759 1.224 . . . . 100.0 113.237 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -63.68 -43.73 95.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.986 0.914 . . . . 100.0 110.03 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -41.13 99.1 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.939 0.896 . . . . 100.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -60.44 -48.72 80.51 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.945 0.898 . . . . 100.0 112.772 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.89 -40.94 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 123.103 0.252 . . . . 100.0 111.114 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.265 99.3 mttt -69.13 -7.08 32.85 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 116.302 1.964 . . . . 100.0 116.302 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 43.6 mtt180 -61.01 -37.84 83.95 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 107.49 -1.3 . . . . 100.0 107.49 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.71 112.71 18.33 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 106.831 -1.544 . . . . 100.0 106.831 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.92 -44.46 96.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.983 1.845 . . . . 100.0 115.983 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 84.8 m -63.72 -42.12 97.97 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.869 0.868 . . . . 100.0 109.479 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -41.5 99.59 Favored Glycine 0 C--N 1.357 1.744 0 N-CA-C 110.977 -0.849 . . . . 100.0 110.977 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -64.6 -44.25 91.22 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.721 0.808 . . . . 100.0 110.866 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -63.42 -40.32 96.88 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.428 1.091 . . . . 100.0 111.484 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.12 8.6 34.81 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 114.887 1.44 . . . . 100.0 114.887 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -58.84 142.92 49.13 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 114.538 1.311 . . . . 100.0 114.538 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.61 139.98 52.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.354 -1.351 . . . . 100.0 107.354 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -111.89 125.97 54.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.34 -2.467 . . . . 100.0 104.34 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.28 108.15 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.448 -3.167 . . . . 100.0 102.448 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.66 99.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 114.591 1.33 . . . . 100.0 114.591 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -61.47 -42.5 98.86 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 123.699 0.8 . . . . 100.0 112.914 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.58 -20.97 19.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.356 1.243 . . . . 100.0 114.356 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.05 43.24 49.25 Favored Glycine 0 C--N 1.36 1.889 0 N-CA-C 108.504 -1.839 . . . . 100.0 108.504 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 24.1 t -126.7 145.39 34.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.337 -0.986 . . . . 100.0 108.337 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 117.82 34.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 102.44 -3.17 . . . . 100.0 102.44 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.63 123.12 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.094 -1.447 . . . . 100.0 107.094 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -115.15 121.59 34.78 Favored Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 115.365 -0.834 . . . . 100.0 110.519 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -80.45 103.38 1.51 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 122.226 1.951 . . . . 100.0 110.36 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.92 113.0 24.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.595 0.758 . . . . 100.0 109.323 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 t -98.48 130.26 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.689 0.796 . . . . 100.0 108.854 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.92 135.44 51.89 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.529 -2.026 . . . . 100.0 105.529 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -102.12 118.48 36.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.651 -0.819 . . . . 100.0 109.34 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p -103.86 176.12 5.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.077 -0.965 . . . . 100.0 109.768 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -60.13 -35.24 74.83 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.789 1.635 . . . . 100.0 109.582 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -90.5 -0.46 57.67 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 113.767 1.025 . . . . 100.0 113.767 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.07 178.07 15.26 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 119.493 1.042 . . . . 100.0 111.763 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.59 139.84 60.1 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 123.099 2.533 . . . . 100.0 114.323 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 mm -127.42 130.62 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 102.359 -3.2 . . . . 100.0 102.359 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -116.25 130.12 56.62 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 121.681 -0.637 . . . . 100.0 109.978 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.33 115.65 29.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 104.922 -2.251 . . . . 100.0 104.922 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.84 107.33 18.93 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 100.63 -3.841 . . . . 100.0 100.63 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 13' ' ' LEU . 21.5 t -93.56 122.65 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.183 -1.043 . . . . 100.0 108.183 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -94.24 111.77 23.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.155 -2.165 . . . . 100.0 105.155 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -115.02 137.46 51.98 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 106.95 -1.5 . . . . 100.0 106.95 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.5 p -70.85 163.7 26.81 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.04 0.924 . . . . 100.0 113.078 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.88 25.9 7.49 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.229 -1.026 . . . . 100.0 108.229 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.76 13.73 60.59 Favored Glycine 0 C--N 1.361 1.92 0 O-C-N 121.613 -0.679 . . . . 100.0 114.147 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.452 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 73.9 mt-30 -59.55 -35.04 73.47 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.795 2.038 . . . . 100.0 112.296 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.96 -32.84 68.23 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.416 2.686 . . . . 100.0 112.128 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.54 -40.07 95.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.12 0.968 . . . . 100.0 111.159 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 17.3 p90 -94.56 -18.08 21.75 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 115.578 1.696 . . . . 100.0 115.578 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.44 -162.83 27.86 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 119.836 -1.173 . . . . 100.0 112.518 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.25 178.46 53.86 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.601 -1.4 . . . . 100.0 109.601 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.6 mt -102.89 145.48 29.74 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 122.568 1.175 . . . . 100.0 111.09 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.15 150.12 49.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.082 -1.872 . . . . 100.0 111.433 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.39 -36.7 83.14 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.874 1.27 . . . . 100.0 108.859 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.67 -38.02 93.18 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 125.81 1.671 . . . . 100.0 110.587 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' A' ' 75' ' ' LEU . 73.9 t80 -63.66 -46.96 83.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.251 0.526 . . . . 100.0 111.5 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -70.27 -37.01 74.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 116.871 2.174 . . . . 100.0 116.871 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.18 139.89 13.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 CA-C-O 122.375 1.083 . . . . 100.0 113.75 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 70.8 11.5 7.15 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.92 2.088 . . . . 100.0 113.582 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.97 131.55 46.49 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.827 -0.805 . . . . 100.0 108.827 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -98.65 -27.82 13.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.149 -0.932 . . . . 100.0 109.513 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.625 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.4 p -152.21 163.05 40.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 122.284 0.234 . . . . 100.0 110.392 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.74 153.43 38.19 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 13' ' ' LEU . 95.6 mt -126.55 126.5 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 103.856 -2.646 . . . . 100.0 103.856 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.656 ' HB ' HD22 ' A' ' 119' ' ' LEU . 39.8 mt -111.37 125.09 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 102.934 -2.988 . . . . 100.0 102.934 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.8 mtp -112.5 137.1 51.2 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 114.596 1.332 . . . . 100.0 114.596 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -129.94 161.48 30.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.051 -2.34 . . . . 100.0 108.265 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.95 125.77 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.061 -1.829 . . . . 100.0 106.061 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.72 -16.95 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 113.355 0.872 . . . . 100.0 113.355 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -90.21 -7.44 53.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 119.146 -0.454 . . . . 100.0 111.109 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.4 t -123.66 116.9 23.83 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-O 122.214 1.007 . . . . 100.0 110.318 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -65.45 -36.85 85.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.146 0.978 . . . . 100.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.77 -40.22 81.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.571 1.549 . . . . 100.0 110.288 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.9 p -62.36 -41.04 98.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 118.439 0.563 . . . . 100.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -64.3 -41.67 96.74 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 123.734 0.814 . . . . 100.0 110.438 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.6 mttt -60.36 -37.76 81.72 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 124.336 1.054 . . . . 100.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -76.27 -9.79 58.91 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 115.631 1.715 . . . . 100.0 115.631 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -42.19 88.99 Favored Pre-proline 0 C--N 1.362 1.14 0 CA-C-O 116.32 -1.8 . . . . 100.0 112.087 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 76.5 Cg_exo -57.53 -37.91 95.61 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.351 2.034 . . . . 100.0 112.74 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.71 -44.59 89.75 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.631 1.172 . . . . 100.0 110.683 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -63.53 -42.43 98.44 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.267 0.627 . . . . 100.0 110.674 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CE1' HD11 ' A' ' 144' ' ' LEU . 84.4 t60 -62.78 -44.91 94.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 124.339 1.055 . . . . 100.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -63.12 -42.28 99.51 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 112.636 0.606 . . . . 100.0 112.636 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -61.82 -46.11 90.93 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.02 0.528 . . . . 100.0 109.798 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.84 -48.25 79.85 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.588 0.959 . . . . 100.0 113.588 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.32 -38.37 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 125.069 1.348 . . . . 100.0 111.473 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -60.37 -39.38 87.01 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.554 0.616 . . . . 100.0 111.439 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.17 -44.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 118.279 0.49 . . . . 100.0 110.61 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.2 m -127.59 106.78 9.4 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.521 0.601 . . . . 100.0 109.944 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.37 144.96 26.52 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.957 0.884 . . . . 100.0 112.615 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . 0.255 72.2 m-20 54.06 41.18 32.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 116.926 2.195 . . . . 100.0 116.926 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -96.48 144.17 27.37 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.998 -2.223 . . . . 100.0 104.998 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 132.26 36.14 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.354 2.036 . . . . 100.0 110.148 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.8 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.3 mt -132.24 136.59 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 122.309 1.052 . . . . 100.0 108.57 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 160' ' ' PRO . 60.7 t -115.55 131.95 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.989 -1.856 . . . . 100.0 105.989 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.656 HD22 ' HB ' ' A' ' 88' ' ' ILE . 25.9 mt -106.59 127.86 53.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.601 -2.0 . . . . 100.0 105.601 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 70.8 m -119.23 130.16 55.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.398 -1.274 . . . . 100.0 113.406 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.21 107.24 3.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 104.797 -3.321 . . . . 100.0 104.797 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.333 0.6 OUTLIER -95.64 177.9 5.65 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.668 1.358 . . . . 100.0 114.668 -178.266 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 61.82 40.14 13.13 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.742 2.417 . . . . 100.0 112.729 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.303 24.7 m -72.15 -8.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 CA-C-N 116.187 -0.461 . . . . 100.0 111.366 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.09 -37.3 86.64 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.6 1.96 . . . . 100.0 109.977 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.9 129.61 31.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 N-CA-C 107.743 -1.206 . . . . 100.0 107.743 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.54 -44.31 97.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.891 1.441 . . . . 100.0 114.891 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -87.74 95.29 10.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.773 -1.566 . . . . 100.0 106.773 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -94.99 125.31 39.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.229 -1.767 . . . . 100.0 106.229 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.32 -36.28 11.46 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 113.982 1.104 . . . . 100.0 113.982 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.52 106.34 20.35 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 104.395 -2.446 . . . . 100.0 104.395 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -100.8 173.6 6.43 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.115 -0.948 . . . . 100.0 112.045 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -56.84 -34.14 67.46 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.496 1.919 . . . . 100.0 109.477 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.032 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.3 mttt -57.31 -38.91 74.74 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 129.674 3.189 . . . . 100.0 112.094 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.7 p -104.95 2.75 30.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.796 2.147 . . . . 100.0 116.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.468 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 61.9 mt -92.95 89.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 116.589 -2.045 . . . . 100.0 110.624 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.4 p -100.64 -8.61 9.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -60.47 -36.63 78.75 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 117.819 2.525 . . . . 100.0 117.819 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.533 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.262 63.6 m-70 -58.94 -39.14 80.74 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 126.489 1.916 . . . . 100.0 115.265 -176.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.831 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.314 24.1 ttp-105 -59.25 -49.6 77.23 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 113.963 1.098 . . . . 100.0 113.963 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.25 -40.81 97.43 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 125.275 1.61 . . . . 100.0 111.318 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.5 mmtt -95.32 -0.65 52.57 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.576 1.695 . . . . 100.0 115.576 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.268 2.0 m-80 55.28 44.54 27.29 Favored 'General case' 0 C--N 1.362 1.134 0 CA-C-O 123.367 1.556 . . . . 100.0 114.146 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.5 mt -106.03 143.33 34.32 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.212 -2.514 . . . . 100.0 104.212 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.257 99.8 mm-40 -92.25 145.51 24.44 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 118.625 -1.23 . . . . 100.0 110.247 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.6 t80 -110.6 137.49 48.21 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 113.063 0.764 . . . . 100.0 113.063 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.79 137.21 43.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.35 -1.296 . . . . 100.0 110.652 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.27 78.7 m-20 -83.35 129.22 34.98 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.894 -3.002 . . . . 100.0 102.894 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.484 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.5 pt -135.32 158.5 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-O 122.295 1.045 . . . . 100.0 111.71 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 59.4 m -139.48 110.73 6.97 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 105.42 -2.067 . . . . 100.0 105.42 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -62.28 -44.83 95.62 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.559 -1.201 . . . . 100.0 113.107 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.7 -39.55 94.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 124.735 1.214 . . . . 100.0 112.98 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 91.8 p -97.27 -0.02 47.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 115.314 1.598 . . . . 100.0 115.314 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.464 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.8 m-80 65.45 20.1 11.68 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.918 1.287 . . . . 100.0 111.648 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -69.84 125.88 28.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.404 -0.962 . . . . 100.0 108.404 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 53.1 37.6 25.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 128.103 2.561 . . . . 100.0 114.566 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.505 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 71.1 t80 -60.48 -43.63 96.75 Favored 'General case' 0 C--N 1.362 1.113 0 O-C-N 121.885 -0.509 . . . . 100.0 111.457 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -64.8 -36.81 85.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 118.013 2.597 . . . . 100.0 118.013 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -56.38 -47.97 97.89 Favored Pre-proline 0 C--N 1.358 0.97 0 N-CA-C 118.863 2.912 . . . . 100.0 118.863 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.458 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -60.62 -40.55 54.84 Favored 'Trans proline' 0 C--N 1.373 1.835 0 CA-C-N 122.879 2.064 . . . . 100.0 112.29 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.97 -41.62 95.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 124.5 1.125 . . . . 100.0 111.164 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.45 -46.37 90.34 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 123.726 0.641 . . . . 100.0 112.024 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.78 -43.22 93.95 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.631 0.582 . . . . 100.0 110.646 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.72 -44.83 96.17 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.243 0.617 . . . . 100.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.66 98.46 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 124.306 1.042 . . . . 100.0 110.793 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -61.65 -45.32 94.56 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 119.052 -0.499 . . . . 100.0 111.343 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.03 -43.72 86.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.985 1.106 . . . . 100.0 113.985 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.9 -46.59 84.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.699 0.8 . . . . 100.0 112.998 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 48.7 mm -70.77 -38.05 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.211 1.004 . . . . 100.0 110.469 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.67 10.53 58.95 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.498 -1.041 . . . . 100.0 110.498 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -114.98 114.02 43.93 Favored Pre-proline 0 C--N 1.365 1.242 0 N-CA-C 108.382 -0.97 . . . . 100.0 108.382 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.98 -12.6 30.8 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.931 3.087 . . . . 100.0 113.208 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -90.67 1.2 57.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.396 1.258 . . . . 100.0 114.396 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.95 135.85 57.52 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 118.734 0.697 . . . . 100.0 112.119 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.9 148.25 51.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.166 -0.924 . . . . 100.0 108.625 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -91.09 116.29 28.69 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 103.808 -2.664 . . . . 100.0 103.808 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.97 -44.08 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.776 0.83 . . . . 100.0 111.828 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.52 152.52 51.54 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.57 0.7 . . . . 100.0 110.508 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.06 133.79 47.52 Favored Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.797 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -66.12 156.92 62.32 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.623 2.215 . . . . 100.0 109.437 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.0 121.77 18.8 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.29 -1.745 . . . . 100.0 106.29 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.84 149.01 42.25 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.33 -1.304 . . . . 100.0 109.955 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.4 136.58 95.83 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 105.289 -2.115 . . . . 100.0 105.289 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 56.9 Cg_exo -56.59 142.2 90.53 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.197 2.598 . . . . 100.0 112.602 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -56.13 126.25 21.76 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.834 2.356 . . . . 100.0 112.073 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -70.55 -42.98 70.45 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 124.693 1.245 . . . . 100.0 108.483 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.96 156.59 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 106.074 -1.824 . . . . 100.0 106.074 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.37 131.0 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 106.49 -1.67 . . . . 100.0 106.49 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -86.71 126.15 34.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.986 -2.598 . . . . 100.0 103.986 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.5 t70 -61.17 127.54 88.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 100.0 110.863 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 68.1 Cg_exo -59.31 -38.6 83.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.759 2.973 . . . . 100.0 113.699 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.66 -44.35 90.68 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.186 0.929 . . . . 100.0 110.59 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.69 -42.16 98.04 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.004 0.522 . . . . 100.0 111.419 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.8 96.28 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.321 0.648 . . . . 100.0 110.803 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.73 98.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.796 0.838 . . . . 100.0 110.753 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.0 -42.07 97.28 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.016 0.526 . . . . 100.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -62.94 -43.1 99.7 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 122.82 0.448 . . . . 100.0 111.816 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -62.15 -43.17 99.43 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.529 0.731 . . . . 100.0 109.097 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.03 -44.16 97.29 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.123 1.369 . . . . 100.0 111.976 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.95 -42.14 98.78 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.606 0.762 . . . . 100.0 110.65 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.4 mt -60.93 -48.53 81.38 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.101 0.875 . . . . 100.0 109.308 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.28 -43.64 97.34 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.462 1.282 . . . . 100.0 114.462 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.55 -45.96 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.447 -3.017 0 CA-C-O 117.72 -1.133 . . . . 100.0 109.434 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.749 . . -86.38 -10.89 53.45 Favored 'General case' 0 N--CA 1.381 -3.878 1 C-N-CA 104.503 -6.879 . . . . 100.0 116.547 179.445 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 1.043 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 47.3 mt-30 -53.92 -33.83 57.84 Favored 'General case' 0 CA--C 1.445 -3.085 0 C-N-CA 128.534 2.734 . . . . 100.0 107.07 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 38.92 0.51 Allowed 'General case' 0 N--CA 1.415 -2.222 0 O-C-N 124.988 1.43 . . . . 100.0 109.533 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 60.41 25.42 14.98 Favored 'General case' 0 CA--C 1.473 -2.007 0 C-N-CA 126.135 1.774 . . . . 100.0 112.409 175.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.268 . . -71.51 172.98 8.57 Favored 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.776 -3.416 . . . . 100.0 101.776 172.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.405 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.1 mt -54.5 -36.65 45.63 Favored Pre-proline 0 CA--C 1.49 -1.337 0 CA-C-O 116.323 -1.799 . . . . 100.0 113.711 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.032 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.448 0.3 OUTLIER -53.42 137.73 65.11 Favored 'Trans proline' 0 N--CA 1.432 -2.143 0 CA-C-O 123.528 1.387 . . . . 100.0 112.991 176.738 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.297 98.1 m-20 -63.65 -43.89 95.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 121.215 3.783 . . . . 100.0 121.215 -172.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.9 tm-20 -69.25 -19.0 63.93 Favored 'General case' 0 CA--C 1.465 -2.306 1 CA-C-O 130.946 5.165 . . . . 100.0 112.771 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 1.043 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.777 68.3 m-20 -83.89 -49.73 8.74 Favored 'General case' 1 N--CA 1.262 -9.825 1 CA-C-N 105.623 -5.262 . . . . 100.0 104.915 -173.383 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.96 -26.86 68.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.038 -2.289 . . . . 100.0 106.56 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.831 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 59.5 m-20 -62.8 -40.0 96.0 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 127.044 2.138 . . . . 100.0 112.952 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.547 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.26 3.9 mm? . . . . . 0 N--CA 1.426 -1.649 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.793 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 94.4 t . . . . . 0 N--CA 1.431 -1.381 0 N-CA-C 107.19 -1.411 . . . . 100.0 107.19 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -120.26 135.22 55.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.803 -1.999 . . . . 100.0 107.612 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.74 143.67 48.66 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.933 -1.136 . . . . 100.0 107.933 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.33 120.21 34.23 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.382 -1.71 . . . . 100.0 106.382 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.76 127.42 53.99 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.036 -1.893 . . . . 100.0 106.782 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 79' ' ' TYR . 53.6 t -103.52 120.87 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.632 -1.622 . . . . 100.0 106.687 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.417 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.6 tp -109.27 117.24 33.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.218 -2.141 . . . . 100.0 105.218 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 m -128.31 161.78 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 120.931 0.396 . . . . 100.0 111.667 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.36 175.45 27.34 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 108.38 -1.888 . . . . 100.0 108.38 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -71.78 155.72 40.12 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.935 -0.744 . . . . 100.0 112.18 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.74 141.7 40.69 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 107.321 -2.311 . . . . 100.0 107.321 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.2 81.46 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-O 118.823 -0.987 . . . . 100.0 113.436 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 80.0 m -62.67 -40.37 96.86 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-N 118.608 1.204 . . . . 100.0 110.777 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.08 25.02 4.61 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.823 -1.311 . . . . 100.0 109.823 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.17 -45.22 93.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.966 1.706 . . . . 100.0 112.554 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -62.89 -44.34 96.38 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.538 1.135 . . . . 100.0 109.486 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.7 m -63.8 -40.21 96.09 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.529 1.132 . . . . 100.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 47.6 t80 -59.4 -49.32 78.25 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 124.935 1.294 . . . . 100.0 111.534 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.19 -41.64 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 123.371 0.419 . . . . 100.0 111.258 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.277 99.2 mttt -69.83 -6.87 35.38 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 115.933 1.827 . . . . 100.0 115.933 -176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.708 HH21 ' HA ' ' A' ' 157' ' ' PHE . 83.7 mtm-85 -60.78 -37.68 82.71 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.129 -1.063 . . . . 100.0 108.129 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.84 112.54 18.32 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 107.054 -1.461 . . . . 100.0 107.054 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.3 -43.78 98.02 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 115.207 1.558 . . . . 100.0 115.207 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.2 m -62.73 -42.48 99.68 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.884 -0.784 . . . . 100.0 108.884 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -42.16 99.71 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 111.061 -0.816 . . . . 100.0 111.061 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.75 -44.95 91.99 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.873 0.869 . . . . 100.0 110.883 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -63.63 -39.72 95.06 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 123.601 0.76 . . . . 100.0 113.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -89.91 5.92 44.25 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -57.32 138.35 54.95 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 114.546 1.313 . . . . 100.0 114.546 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -124.61 130.35 52.28 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.702 -1.222 . . . . 100.0 107.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -100.77 123.27 44.73 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.233 -2.136 . . . . 100.0 105.233 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -102.85 114.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 103.37 -2.826 . . . . 100.0 103.37 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.03 94.94 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 115.393 1.627 . . . . 100.0 115.393 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.1 p -61.93 -48.36 80.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.665 0.386 . . . . 100.0 111.965 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.18 -38.41 75.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.307 1.443 . . . . 100.0 112.982 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.95 32.23 50.26 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 108.112 -1.995 . . . . 100.0 108.112 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 79' ' ' TYR . 22.9 m -129.01 153.17 38.22 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 121.629 0.728 . . . . 100.0 109.672 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.45 120.22 41.84 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 103.074 -2.935 . . . . 100.0 103.074 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.6 123.04 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 106.567 -1.642 . . . . 100.0 106.567 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -117.78 119.43 33.94 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.78 106.51 1.82 Allowed 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.123 1.882 . . . . 100.0 110.229 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.69 117.29 31.65 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.685 -1.598 . . . . 100.0 106.685 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 t -102.86 126.68 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.66 -1.237 . . . . 100.0 107.66 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -121.33 133.49 55.12 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.639 -1.985 . . . . 100.0 105.639 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -101.28 120.28 40.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.715 -1.217 . . . . 100.0 107.715 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.447 HG21 HD12 ' A' ' 59' ' ' ILE . 26.6 p -110.54 -179.26 3.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.05 -0.977 . . . . 100.0 110.894 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.77 -44.25 93.97 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.334 1.454 . . . . 100.0 108.294 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -67.04 -39.26 86.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 124.062 0.945 . . . . 100.0 113.052 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.69 28.83 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 107.381 -2.288 . . . . 100.0 107.381 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.08 137.92 50.1 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.117 1.878 . . . . 100.0 114.647 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -125.05 130.29 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.26 -3.237 . . . . 100.0 102.26 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.01 128.13 55.75 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.749 -0.834 . . . . 100.0 108.749 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.44 116.41 31.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.172 -2.529 . . . . 100.0 104.172 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -87.8 106.05 17.81 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.25 -4.352 . . . . 100.0 99.25 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.29 122.76 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.05 115.89 29.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.339 -2.097 . . . . 100.0 105.339 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -112.46 136.32 52.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.605 -1.998 . . . . 100.0 105.605 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 p -71.96 162.29 29.67 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.76 0.824 . . . . 100.0 112.86 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.74 17.29 16.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.694 -0.684 . . . . 100.0 109.687 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.08 11.64 52.04 Favored Glycine 0 C--N 1.357 1.732 0 O-C-N 121.804 -0.56 . . . . 100.0 112.328 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.27 -29.32 70.34 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.836 1.654 . . . . 100.0 111.385 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.66 -37.23 78.18 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 127.794 2.438 . . . . 100.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.93 -43.12 99.66 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.326 0.65 . . . . 100.0 110.025 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.18 -41.35 77.3 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 125.458 1.503 . . . . 100.0 111.972 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.34 -152.12 12.32 Favored Glycine 0 C--N 1.356 1.665 0 C-N-CA 120.996 -0.621 . . . . 100.0 111.57 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.26 169.58 52.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 122.069 0.816 . . . . 100.0 112.931 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 79' ' ' TYR . 88.6 mt -105.68 143.49 33.76 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.708 -0.746 . . . . 100.0 109.767 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -67.67 155.48 39.12 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.735 -1.12 . . . . 100.0 113.616 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -60.47 -37.68 81.78 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.827 -1.533 . . . . 100.0 110.328 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.78 -39.21 93.43 Favored Glycine 0 C--N 1.358 1.778 0 C-N-CA 124.846 1.213 . . . . 100.0 111.316 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 45' ' ' VAL . 60.8 t80 -62.53 -45.99 90.46 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.422 0.689 . . . . 100.0 110.895 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -68.94 -36.67 78.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.3 mt -50.85 135.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 C-N-CA 125.57 1.548 . . . . 100.0 114.297 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.62 30.29 18.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.104 2.562 . . . . 100.0 114.015 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.66 128.66 36.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.26 -1.756 . . . . 100.0 106.26 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 115' ' ' ILE . 97.3 mm-40 -96.47 -35.35 11.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.3 p -143.76 159.27 42.81 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 120.899 0.381 . . . . 100.0 111.133 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.8 149.57 34.59 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 114.37 1.248 . . . . 100.0 114.37 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.9 mt -125.5 125.75 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.429 ' HB ' HD22 ' A' ' 119' ' ' LEU . 52.0 mt -110.66 123.71 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 102.419 -3.178 . . . . 100.0 102.419 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.417 ' SD ' HD11 ' A' ' 15' ' ' LEU . 81.3 mtp -109.68 134.08 52.39 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 114.144 -1.389 . . . . 100.0 113.602 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -128.18 158.82 37.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 112.555 -2.112 . . . . 100.0 108.433 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.51 125.75 50.97 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.41 -21.6 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 113.797 1.036 . . . . 100.0 113.797 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.7 p -86.65 -10.16 54.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 119.241 -0.409 . . . . 100.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.6 t -118.49 116.39 26.57 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.136 0.969 . . . . 100.0 111.401 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -66.5 -38.38 87.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.892 -1.049 . . . . 100.0 111.079 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.56 -41.75 88.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 125.661 1.584 . . . . 100.0 110.55 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -62.36 -42.8 99.69 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 109.792 -0.448 . . . . 100.0 109.792 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.522 ' CE1' HG23 ' A' ' 136' ' ' ILE . 44.5 t80 -64.11 -41.04 97.41 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 123.714 0.805 . . . . 100.0 110.703 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -61.14 -37.86 84.34 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.958 0.903 . . . . 100.0 111.311 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.65 -9.0 58.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.12 -43.26 93.52 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 115.997 -1.954 . . . . 100.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.4 Cg_exo -57.57 -38.57 93.31 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.158 1.905 . . . . 100.0 112.742 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -64.25 -44.45 91.74 Favored 'General case' 0 C--N 1.358 0.978 0 O-C-N 124.186 0.929 . . . . 100.0 111.443 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -63.88 -41.22 97.79 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 122.744 0.418 . . . . 100.0 110.995 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.5 t60 -62.43 -43.83 97.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.43 1.092 . . . . 100.0 109.932 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.8 -45.34 94.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 123.577 0.751 . . . . 100.0 111.351 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -62.89 -44.82 95.07 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.06 0.544 . . . . 100.0 111.774 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 86' ' ' ALA . 50.8 tp -63.23 -46.03 88.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.548 1.139 . . . . 100.0 112.31 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.36 -37.69 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 125.593 1.557 . . . . 100.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.5 -49.14 78.45 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.649 -0.691 . . . . 100.0 110.183 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.5 t -73.07 -46.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 119.227 -0.989 . . . . 100.0 111.956 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -124.78 113.8 18.41 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 121.641 0.734 . . . . 100.0 110.177 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.64 146.6 23.54 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.466 -0.788 . . . . 100.0 112.142 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 54.72 44.44 28.54 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 126.463 1.905 . . . . 100.0 115.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' GLN . 27.9 mm -98.89 133.21 22.5 Favored Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 126.42 1.888 . . . . 100.0 107.376 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 115' ' ' ILE . 40.5 Cg_exo -62.96 129.02 24.59 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.86 2.373 . . . . 100.0 108.457 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.701 ' HB ' HD22 ' A' ' 144' ' ' LEU . 68.7 mt -131.05 137.58 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 122.292 1.044 . . . . 100.0 108.287 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 160' ' ' PRO . 93.6 t -115.74 131.83 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.145 -2.168 . . . . 100.0 105.145 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 28.8 mt -105.61 125.54 51.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.869 -2.641 . . . . 100.0 103.869 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -113.86 126.74 55.52 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.85 -1.523 . . . . 100.0 112.203 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.01 103.42 2.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 105.162 -3.175 . . . . 100.0 105.162 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.58 165.76 19.8 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.789 1.636 . . . . 100.0 112.53 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 21' ' ' THR . 85.0 mttt 59.42 43.38 16.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 128.541 2.736 . . . . 100.0 114.541 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.313 30.9 m -72.23 -8.8 12.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 C-N-CA 120.526 -0.47 . . . . 100.0 111.231 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.58 -38.3 87.05 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.968 2.107 . . . . 100.0 110.117 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.59 130.79 33.85 Favored 'Isoleucine or valine' 0 C--N 1.363 1.168 0 N-CA-C 107.221 -1.4 . . . . 100.0 107.221 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.14 -40.95 99.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 125.32 1.448 . . . . 100.0 114.357 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.74 91.07 8.2 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.262 -1.385 . . . . 100.0 107.262 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -94.85 120.6 35.34 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.087 -2.561 . . . . 100.0 104.087 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -96.15 -37.22 10.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.324 -0.853 . . . . 100.0 112.876 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 136' ' ' ILE . 45.4 t -104.01 105.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 102.573 -3.121 . . . . 100.0 102.573 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -104.68 178.83 4.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 113.665 0.987 . . . . 100.0 113.665 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.4 -35.33 71.87 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.308 2.243 . . . . 100.0 109.402 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.062 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.7 mttt -59.42 -37.81 79.03 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.989 2.516 . . . . 100.0 112.32 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.5 p -104.73 -1.29 26.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 120.106 3.373 . . . . 100.0 120.106 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.62 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 49.8 mt -96.6 91.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 115.779 -2.368 . . . . 100.0 111.736 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.413 ' N ' ' HB3' ' A' ' 211' ' ' ASP . 4.9 p -97.54 -7.98 9.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 115.767 1.766 . . . . 100.0 115.767 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.91 -36.2 72.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.01 1.485 . . . . 100.0 115.01 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.493 ' HE1' ' HB2' ' A' ' 119' ' ' LEU . 83.9 m-70 -59.87 -40.65 89.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 116.946 -1.502 . . . . 100.0 114.123 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 25.9 ttt180 -61.32 -45.42 94.51 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 119.971 1.259 . . . . 100.0 112.629 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.56 -41.9 98.05 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.387 1.075 . . . . 100.0 110.862 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.23 2.28 48.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 115.875 1.806 . . . . 100.0 115.875 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.67 44.5 26.32 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.777 1.631 . . . . 100.0 113.305 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 117' ' ' ILE . 28.5 mt -106.96 152.19 24.29 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.781 -1.563 . . . . 100.0 106.781 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.336 90.6 mm-40 -101.43 145.71 28.59 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 113.474 0.916 . . . . 100.0 113.474 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.486 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.8 t80 -105.09 133.91 49.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 113.921 1.082 . . . . 100.0 113.921 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.12 133.35 46.58 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.048 -1.433 . . . . 100.0 111.172 173.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.279 36.9 m-20 -84.76 121.54 27.83 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.176 -3.268 . . . . 100.0 102.176 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.42 155.42 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 122.381 1.086 . . . . 100.0 110.613 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.2 m -137.31 111.36 8.35 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 105.908 -1.886 . . . . 100.0 105.908 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.57 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.44 -43.91 97.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.187 -1.369 . . . . 100.0 112.664 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.79 -42.31 98.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.377 1.071 . . . . 100.0 112.508 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 97.4 p -97.04 1.41 50.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.597 2.073 . . . . 100.0 116.597 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.0 m-80 64.03 24.58 13.59 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.223 1.409 . . . . 100.0 110.524 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 75.7 t80 -75.01 125.71 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.133 -1.062 . . . . 100.0 108.133 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 53.55 40.04 30.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.232 2.613 . . . . 100.0 115.404 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HA ' HH21 ' A' ' 29' ' ' ARG . 67.3 t80 -61.77 -44.0 97.75 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.827 -0.546 . . . . 100.0 111.248 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 -39.65 95.04 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 116.374 1.99 . . . . 100.0 116.374 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.57 -47.94 97.83 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 121.035 3.717 . . . . 100.0 121.035 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' HG11 ' A' ' 118' ' ' VAL . 52.9 Cg_endo -61.35 -41.9 38.26 Favored 'Trans proline' 0 C--N 1.371 1.733 0 CA-C-N 123.586 2.316 . . . . 100.0 112.437 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -64.52 -42.52 95.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.922 1.289 . . . . 100.0 110.799 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.8 tp -63.1 -45.19 93.21 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.241 1.017 . . . . 100.0 111.327 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.36 -44.65 94.2 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.684 -0.488 . . . . 100.0 109.684 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.9 mt -61.79 -44.49 96.76 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.062 0.545 . . . . 100.0 111.474 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.67 98.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.966 0.907 . . . . 100.0 111.228 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.13 -45.99 91.02 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 123.341 0.656 . . . . 100.0 111.542 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.38 -42.92 87.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.293 0.849 . . . . 100.0 113.293 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.8 mt -63.72 -45.65 88.96 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.632 0.773 . . . . 100.0 112.032 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.432 HD12 HD22 ' A' ' 174' ' ' LEU . 71.6 mt -69.97 -39.16 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.11 0.564 . . . . 100.0 109.552 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.07 10.64 58.38 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 110.411 -1.076 . . . . 100.0 110.411 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -114.07 112.82 46.92 Favored Pre-proline 0 C--N 1.361 1.107 0 N-CA-C 107.57 -1.27 . . . . 100.0 107.57 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.061 3.174 . . . . 100.0 113.992 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -87.96 2.12 52.44 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 123.979 0.912 . . . . 100.0 113.114 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.432 HD22 HD12 ' A' ' 169' ' ' ILE . 17.0 tp -66.07 132.16 47.88 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.324 0.65 . . . . 100.0 109.355 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -134.44 151.36 51.12 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.15 113.61 23.94 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 104.195 -2.52 . . . . 100.0 104.195 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.02 -43.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 123.594 0.758 . . . . 100.0 110.293 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.48 149.02 51.43 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.451 0.643 . . . . 100.0 109.839 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -92.61 125.95 53.88 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.093 -2.188 . . . . 100.0 105.093 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.17 158.16 53.58 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.076 2.517 . . . . 100.0 111.458 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.77 126.9 29.11 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.146 0.974 . . . . 100.0 108.884 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.25 145.9 46.59 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-N 114.014 -1.448 . . . . 100.0 109.971 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.29 138.02 97.3 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 64.9 Cg_exo -55.95 139.71 84.91 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 123.67 2.913 . . . . 100.0 113.021 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.561 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -57.68 129.44 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 123.206 2.604 . . . . 100.0 113.028 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -68.36 -43.18 77.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 124.742 1.276 . . . . 100.0 108.122 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.9 158.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.351 -1.722 . . . . 100.0 106.351 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.68 130.6 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 106.208 -1.775 . . . . 100.0 106.208 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.24 127.54 35.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.749 -2.315 . . . . 100.0 104.749 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.73 128.14 91.39 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 114.493 -1.231 . . . . 100.0 110.295 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.6 -37.4 88.56 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.772 2.981 . . . . 100.0 113.001 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.18 94.14 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 124.257 0.973 . . . . 100.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.38 -42.28 98.83 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 122.817 0.447 . . . . 100.0 111.633 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.25 97.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.125 0.57 . . . . 100.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.54 98.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.943 0.897 . . . . 100.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -44.27 96.55 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.183 0.993 . . . . 100.0 112.405 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -63.4 -44.1 95.64 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 122.71 0.404 . . . . 100.0 111.073 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -64.5 -39.89 94.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.107 -0.497 . . . . 100.0 110.57 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.31 -43.85 97.88 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.95 1.3 . . . . 100.0 110.524 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.93 -42.89 99.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 123.955 0.902 . . . . 100.0 110.144 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 22.6 tp -59.9 -48.65 80.82 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.222 0.951 . . . . 100.0 109.951 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -43.36 99.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.999 1.481 . . . . 100.0 114.999 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.0 -47.09 91.04 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.217 0 CA-C-O 118.245 -0.883 . . . . 100.0 109.544 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.406 . . -95.66 0.91 53.25 Favored 'General case' 0 N--CA 1.402 -2.847 1 C-N-CA 109.729 -4.789 . . . . 100.0 114.685 179.573 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.329 67.1 mt-30 -56.78 -36.35 69.74 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 106.246 -1.761 . . . . 100.0 106.246 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 64.9 p -82.25 52.04 1.93 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.091 0.948 . . . . 100.0 108.779 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.296 73.9 p 49.25 37.69 11.85 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 129.002 2.921 . . . . 100.0 116.157 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.86 -179.78 7.54 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.286 -2.486 . . . . 100.0 104.286 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' A' ' 210' ' ' PRO 0.439 3.7 pp -57.44 -38.73 70.99 Favored Pre-proline 0 CA--C 1.501 -0.941 0 CA-C-O 115.523 -2.18 . . . . 100.0 115.886 -175.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.062 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.312 79.0 Cg_exo -54.88 136.47 72.35 Favored 'Trans proline' 0 C--N 1.375 1.971 0 CA-C-N 121.839 1.692 . . . . 100.0 111.417 176.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.413 ' HB3' ' N ' ' A' ' 137' ' ' VAL . 96.0 m-20 -63.46 -47.86 80.1 Favored 'General case' 0 N--CA 1.424 -1.771 1 N-CA-C 124.784 5.105 . . . . 100.0 124.784 -173.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.251 99.3 mt-10 -62.88 -35.56 80.42 Favored 'General case' 0 CA--C 1.48 -1.732 1 CA-C-O 128.621 4.057 . . . . 100.0 107.84 177.889 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.779 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.49 39.2 m-20 -64.93 -49.03 71.97 Favored 'General case' 1 N--CA 1.354 -5.251 1 CA-C-N 107.796 -4.274 . . . . 100.0 106.297 -178.903 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.12 -31.23 71.67 Favored 'General case' 0 C--N 1.36 1.033 0 O-C-N 120.535 -1.353 . . . . 100.0 107.682 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 1.8 t70 -57.63 -42.77 84.06 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 116.926 -1.512 . . . . 100.0 113.295 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.261 1.701 0 CA-C-O 115.558 -2.163 . . . . 100.0 112.6 -176.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t . . . . . 0 N--CA 1.434 -1.269 0 N-CA-C 105.682 -1.97 . . . . 100.0 105.682 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -123.58 136.16 54.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.762 -1.563 . . . . 100.0 108.752 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.34 144.32 50.08 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.243 -1.021 . . . . 100.0 108.243 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.28 121.03 35.38 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.433 -1.692 . . . . 100.0 106.433 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -109.52 127.73 54.67 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 113.062 -1.881 . . . . 100.0 106.326 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 79' ' ' TYR . 49.9 t -102.96 121.09 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 106.572 -1.64 . . . . 100.0 106.572 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.619 HD11 ' SD ' ' A' ' 89' ' ' MET . 29.9 tp -109.88 117.08 32.87 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.618 -2.364 . . . . 100.0 104.618 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -127.93 161.98 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 120.718 0.294 . . . . 100.0 111.528 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.22 175.0 26.7 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 108.875 -1.69 . . . . 100.0 108.875 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.03 156.27 39.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 O-C-N 121.832 -0.804 . . . . 100.0 112.092 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.93 141.38 39.77 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 106.984 -2.446 . . . . 100.0 106.984 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.66 -5.96 79.94 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-O 118.773 -1.015 . . . . 100.0 113.404 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -62.68 -39.87 95.29 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 118.804 1.302 . . . . 100.0 111.307 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.87 25.72 4.4 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.743 -1.343 . . . . 100.0 109.743 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 52.9 mtpt -60.01 -46.79 88.32 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.362 1.465 . . . . 100.0 112.883 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.7 m -63.82 -43.06 97.36 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.408 1.083 . . . . 100.0 109.644 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 m -63.3 -41.4 98.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.483 1.113 . . . . 100.0 109.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HA ' HH11 ' A' ' 29' ' ' ARG . 45.1 t80 -60.09 -49.11 78.93 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 123.626 0.77 . . . . 100.0 112.749 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.77 -41.05 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 123.739 0.649 . . . . 100.0 110.958 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.266 99.0 mttt -69.06 -7.57 36.99 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 115.826 1.787 . . . . 100.0 115.826 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.6 mtm-85 -61.04 -36.91 80.82 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 108.691 -0.855 . . . . 100.0 108.691 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 55.1 t-80 -80.34 112.23 17.47 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.4 -43.9 97.72 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 115.361 1.615 . . . . 100.0 115.361 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.442 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.9 m -63.09 -42.22 99.55 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.888 -0.782 . . . . 100.0 108.888 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.47 99.78 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 111.383 -0.687 . . . . 100.0 111.383 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.64 -44.19 94.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.29 0.636 . . . . 100.0 110.836 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -63.83 -40.58 96.94 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 124.463 1.105 . . . . 100.0 112.295 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -91.14 8.56 35.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -59.18 140.36 55.99 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 114.649 1.352 . . . . 100.0 114.649 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.24 130.6 52.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.169 -1.419 . . . . 100.0 107.169 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -104.47 125.13 50.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 106.766 -1.568 . . . . 100.0 106.766 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.16 113.54 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 102.199 -3.26 . . . . 100.0 102.199 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.51 92.42 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 116.228 1.936 . . . . 100.0 116.228 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.2 p -62.58 -47.42 83.89 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.916 0.486 . . . . 100.0 111.784 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.06 -37.74 75.6 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.899 1.28 . . . . 100.0 112.912 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.36 53.91 Favored Glycine 0 C--N 1.359 1.837 0 N-CA-C 106.71 -2.556 . . . . 100.0 106.71 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 ' HD1' ' A' ' 79' ' ' TYR . 66.9 t -124.43 139.59 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 124.733 1.213 . . . . 100.0 108.754 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.74 117.02 32.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 102.387 -3.19 . . . . 100.0 102.387 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.06 122.1 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.065 -1.458 . . . . 100.0 107.065 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -115.17 121.05 35.66 Favored Pre-proline 0 N--CA 1.432 -1.337 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.105 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -80.13 104.57 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.426 2.084 . . . . 100.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.7 117.07 30.24 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.931 -1.507 . . . . 100.0 106.931 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.52 125.77 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.406 -1.331 . . . . 100.0 107.406 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.45 133.12 55.46 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.851 -1.907 . . . . 100.0 105.851 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -99.67 116.42 31.73 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 19.0 p -108.49 178.63 4.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.434 -0.803 . . . . 100.0 110.846 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -59.87 -43.6 94.62 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.99 1.316 . . . . 100.0 108.427 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -68.99 -38.37 79.26 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 112.839 0.681 . . . . 100.0 112.839 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.96 -172.38 30.61 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.642 -1.783 . . . . 100.0 108.642 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -65.52 136.87 48.26 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.518 2.145 . . . . 100.0 114.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 77.7 mt -126.15 130.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 102.111 -3.292 . . . . 100.0 102.111 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.85 128.44 55.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.617 -0.883 . . . . 100.0 108.617 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.37 114.79 28.18 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.557 -2.757 . . . . 100.0 103.557 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -87.75 105.7 17.56 Favored 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 99.862 -4.125 . . . . 100.0 99.862 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.76 123.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.448 -1.686 . . . . 100.0 106.448 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -96.84 114.7 26.35 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.878 -1.897 . . . . 100.0 105.878 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.61 137.25 49.72 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.328 -1.731 . . . . 100.0 106.328 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -72.97 161.94 30.09 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.731 0.777 . . . . 100.0 112.487 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.1 19.47 14.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.668 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.47 13.19 52.29 Favored Glycine 0 C--N 1.356 1.681 0 O-C-N 121.818 -0.552 . . . . 100.0 112.277 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 65.3 mt-30 -60.44 -35.8 76.71 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.52 1.928 . . . . 100.0 111.583 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -58.26 -36.01 72.61 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.13 2.572 . . . . 100.0 111.869 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.84 -42.4 98.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.604 0.762 . . . . 100.0 111.041 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 26.7 p90 -95.37 -5.85 42.36 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.85 -166.69 38.08 Favored Glycine 0 C--N 1.358 1.756 0 C-N-CA 119.7 -1.238 . . . . 100.0 113.251 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.68 175.27 54.9 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.97 -1.252 . . . . 100.0 109.97 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.7 mt -105.14 140.65 37.99 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 122.18 0.99 . . . . 100.0 110.465 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -68.7 154.64 41.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.676 -1.602 . . . . 100.0 113.602 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.95 -38.31 85.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.531 1.533 . . . . 100.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.04 93.85 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.854 1.216 . . . . 100.0 111.063 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HD1' HG21 ' A' ' 45' ' ' VAL . 63.0 t80 -62.23 -46.98 86.45 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.697 0.799 . . . . 100.0 110.866 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 116.298 1.962 . . . . 100.0 116.298 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.3 mt -51.84 136.58 11.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 C-N-CA 125.04 1.336 . . . . 100.0 113.973 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 61.89 31.78 18.13 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.749 2.42 . . . . 100.0 114.706 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.87 128.44 35.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 105.595 -2.002 . . . . 100.0 105.595 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 115' ' ' ILE . 95.9 mm-40 -96.78 -36.82 10.51 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.554 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.6 p -143.52 159.97 41.45 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.776 0.431 . . . . 100.0 110.842 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -146.23 149.17 33.41 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 15' ' ' LEU . 91.7 mt -125.65 126.15 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 103.678 -2.712 . . . . 100.0 103.678 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.98 124.26 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 101.762 -3.422 . . . . 100.0 101.762 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 15' ' ' LEU . 95.1 mtp -109.16 131.64 54.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.005 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -129.25 159.43 36.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.155 -1.838 . . . . 100.0 108.434 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -106.4 126.95 52.89 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.46 -1.681 . . . . 100.0 106.46 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.65 -21.41 29.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 113.849 1.055 . . . . 100.0 113.849 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.0 p -85.12 -12.19 53.46 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 119.239 -0.41 . . . . 100.0 110.579 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -118.76 117.29 28.5 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.337 1.065 . . . . 100.0 111.427 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -66.51 -38.87 88.16 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.424 -1.262 . . . . 100.0 110.434 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.66 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 126.071 1.749 . . . . 100.0 110.856 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.8 m -62.71 -42.67 99.77 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.655 -0.498 . . . . 100.0 109.655 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CE1' HG23 ' A' ' 136' ' ' ILE . 43.6 t80 -64.15 -40.28 95.81 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 123.452 0.701 . . . . 100.0 110.884 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -60.79 -38.77 86.44 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.546 1.139 . . . . 100.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.38 -9.38 58.6 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 115.182 1.549 . . . . 100.0 115.182 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.3 t -60.06 -42.98 92.99 Favored Pre-proline 0 C--N 1.363 1.194 0 CA-C-O 115.884 -2.007 . . . . 100.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 82.0 Cg_exo -57.78 -36.83 98.16 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.309 2.006 . . . . 100.0 112.852 177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.44 -46.93 84.05 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 124.355 1.062 . . . . 100.0 110.28 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -64.24 -42.08 96.69 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.162 0.585 . . . . 100.0 111.271 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.58 -44.25 96.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 124.326 1.05 . . . . 100.0 110.39 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -62.76 -44.38 96.35 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.759 -0.639 . . . . 100.0 112.031 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.34 -44.28 96.85 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 123.526 0.516 . . . . 100.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.1 tp -62.45 -46.8 86.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.684 1.193 . . . . 100.0 112.577 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.32 -38.97 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 125.364 1.465 . . . . 100.0 111.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.37 -46.66 89.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 118.938 -0.553 . . . . 100.0 110.714 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.9 t -72.03 -45.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 120.254 -0.578 . . . . 100.0 111.534 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.81 115.65 18.97 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.249 -0.648 . . . . 100.0 109.249 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -93.29 147.3 23.04 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 115.771 -0.649 . . . . 100.0 112.492 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 54.55 44.55 28.55 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.436 1.895 . . . . 100.0 115.183 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 84' ' ' GLN . 33.9 mm -98.96 132.36 23.77 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 126.116 1.766 . . . . 100.0 107.066 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.49 129.25 25.99 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.536 2.158 . . . . 100.0 109.144 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.717 ' HB ' HD22 ' A' ' 144' ' ' LEU . 71.0 mt -130.71 136.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-O 122.257 1.027 . . . . 100.0 108.689 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.4 130.8 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 105.062 -2.199 . . . . 100.0 105.062 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 21.9 mt -105.25 127.07 52.76 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.136 -2.912 . . . . 100.0 103.136 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.83 127.21 54.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.642 -1.617 . . . . 100.0 112.061 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.58 105.26 3.06 Favored Glycine 0 CA--C 1.489 -1.558 0 N-CA-C 106.427 -2.669 . . . . 100.0 106.427 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.14 164.25 23.48 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.2 2.6 . . . . 100.0 113.935 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.2 mttp 55.62 45.15 25.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 128.46 2.704 . . . . 100.0 114.367 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.296 32.8 m -71.82 -9.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 120.4 -0.52 . . . . 100.0 111.062 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.65 -39.1 90.15 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.658 1.983 . . . . 100.0 110.287 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.4 130.87 33.75 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.381 -0.97 . . . . 100.0 108.381 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -62.34 -40.54 96.7 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.937 1.458 . . . . 100.0 114.937 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -84.02 96.08 8.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 105.282 -2.118 . . . . 100.0 105.282 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -102.37 120.91 41.29 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 103.621 -2.733 . . . . 100.0 103.621 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.87 -36.51 10.57 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-N 115.612 -0.722 . . . . 100.0 112.528 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.32 104.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 103.534 -2.765 . . . . 100.0 103.534 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.23 179.95 4.13 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.21 -35.2 71.31 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.336 2.254 . . . . 100.0 109.539 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.076 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.4 mttt -59.29 -37.62 78.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 128.41 2.684 . . . . 100.0 112.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.6 p -104.99 -0.85 26.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 120.091 3.367 . . . . 100.0 120.091 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 53.8 mt -97.38 94.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 115.583 -2.447 . . . . 100.0 111.431 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 4.3 p -100.82 -5.32 9.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 115.338 1.606 . . . . 100.0 115.338 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.58 -36.55 74.15 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 115.199 1.555 . . . . 100.0 115.199 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.5 m-70 -59.54 -39.25 83.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.814 1.646 . . . . 100.0 113.344 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.648 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 57.3 ttp85 -58.69 -48.5 80.88 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 114.031 1.123 . . . . 100.0 114.031 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.52 -40.59 95.91 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.218 0.949 . . . . 100.0 111.812 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.01 -0.1 54.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 116.157 1.91 . . . . 100.0 116.157 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.258 73.2 m-20 54.55 47.13 23.39 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.378 1.471 . . . . 100.0 113.346 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.7 mt -103.62 153.39 20.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.115 -1.809 . . . . 100.0 106.115 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -101.53 142.96 32.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.3 -0.63 . . . . 100.0 109.3 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.625 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 68.2 t80 -105.79 133.63 50.21 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.4 0.889 . . . . 100.0 113.4 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.82 133.4 45.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.575 -1.193 . . . . 100.0 111.491 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.297 37.1 m-20 -85.64 122.97 30.49 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 102.234 -3.247 . . . . 100.0 102.234 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.32 156.89 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 CA-C-O 122.364 1.078 . . . . 100.0 112.237 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.1 m -138.88 113.19 8.8 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.244 -1.761 . . . . 100.0 106.244 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.3 -43.06 98.91 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.836 -1.529 . . . . 100.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.22 -42.15 99.04 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.667 1.187 . . . . 100.0 112.375 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.8 p -97.25 2.12 50.45 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 117.3 2.333 . . . . 100.0 117.3 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.49 21.25 11.8 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.583 1.153 . . . . 100.0 110.113 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 85.8 t80 -73.58 124.48 26.0 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.038 -0.727 . . . . 100.0 109.038 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 53.32 40.1 30.8 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.12 2.568 . . . . 100.0 115.175 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.9 t80 -62.25 -44.46 96.51 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 121.638 -0.664 . . . . 100.0 111.529 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.33 -38.49 91.37 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.117 1.895 . . . . 100.0 116.117 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.53 -47.24 99.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 119.999 3.333 . . . . 100.0 119.999 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.07 -41.95 39.95 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.34 2.229 . . . . 100.0 111.334 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.45 -42.29 96.04 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 125.466 1.506 . . . . 100.0 110.884 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -61.14 -46.76 89.21 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 123.885 0.874 . . . . 100.0 112.002 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -63.67 -44.61 93.26 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.082 0.864 . . . . 100.0 110.421 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.8 mt -61.92 -44.85 95.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 123.797 0.686 . . . . 100.0 111.729 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.7 98.26 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.174 0.99 . . . . 100.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.57 -45.71 91.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.564 0.745 . . . . 100.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -68.11 -42.4 80.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.543 0.527 . . . . 100.0 112.354 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.67 -46.96 85.74 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.469 0.708 . . . . 100.0 112.316 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.43 -38.59 74.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 123.546 0.738 . . . . 100.0 110.318 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.46 59.49 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-O 118.781 -1.01 . . . . 100.0 111.053 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -111.5 113.64 53.36 Favored Pre-proline 0 C--N 1.362 1.133 0 N-CA-C 107.492 -1.299 . . . . 100.0 107.492 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.57 -15.19 30.67 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.051 3.167 . . . . 100.0 114.282 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -89.73 2.82 54.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.993 0.917 . . . . 100.0 113.276 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.05 131.44 46.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.51 0.671 . . . . 100.0 109.663 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -133.83 152.94 52.02 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.358 -0.979 . . . . 100.0 108.358 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -90.35 114.29 26.34 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 104.314 -2.476 . . . . 100.0 104.314 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.54 -44.29 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.283 1.033 . . . . 100.0 110.55 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -127.86 148.01 50.46 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.373 0.606 . . . . 100.0 109.697 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 62.5 ttp -90.18 126.23 57.61 Favored Pre-proline 0 N--CA 1.432 -1.339 0 N-CA-C 104.772 -2.307 . . . . 100.0 104.772 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.68 158.1 55.23 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.869 2.379 . . . . 100.0 110.632 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.5 126.04 26.21 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.286 -1.005 . . . . 100.0 108.286 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.51 146.63 46.09 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 114.176 -1.375 . . . . 100.0 110.164 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 137.29 97.08 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 106.832 -1.544 . . . . 100.0 106.832 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -55.98 138.51 82.54 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.534 2.823 . . . . 100.0 112.569 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.68 130.25 32.53 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.738 2.292 . . . . 100.0 113.609 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.83 -44.36 81.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 124.858 1.349 . . . . 100.0 108.579 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.32 159.04 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.498 -1.667 . . . . 100.0 106.498 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.66 131.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.641 -1.985 . . . . 100.0 105.641 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -86.29 128.12 34.87 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 104.774 -2.306 . . . . 100.0 104.774 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -62.21 128.09 90.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 CA-C-N 114.911 -1.04 . . . . 100.0 109.738 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.53 -36.68 92.44 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.474 2.783 . . . . 100.0 112.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.37 92.22 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.33 1.019 . . . . 100.0 110.766 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.29 -41.89 96.66 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 122.971 0.508 . . . . 100.0 111.493 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.56 96.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 123.63 0.772 . . . . 100.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.8 97.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.293 1.037 . . . . 100.0 110.847 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.09 -43.98 97.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.632 0.773 . . . . 100.0 112.306 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -63.69 -43.7 95.85 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 122.534 0.333 . . . . 100.0 111.712 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -64.2 -39.93 95.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.601 0.36 . . . . 100.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.06 -42.83 99.78 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.625 1.17 . . . . 100.0 110.57 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.95 -42.41 99.09 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.968 0.907 . . . . 100.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 18.3 tp -59.69 -49.52 77.42 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 124.117 0.886 . . . . 100.0 110.089 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.22 -43.24 98.66 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 115.188 1.551 . . . . 100.0 115.188 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.61 -46.53 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.175 0 CA-C-O 118.425 -0.798 . . . . 100.0 109.984 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.681 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.403 . . -93.59 -0.63 56.13 Favored 'General case' 0 N--CA 1.403 -2.818 1 C-N-CA 109.854 -4.739 . . . . 100.0 114.006 179.76 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.823 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.268 57.7 mt-30 -56.9 -35.77 69.36 Favored 'General case' 0 CA--C 1.458 -2.566 0 N-CA-C 107.523 -1.288 . . . . 100.0 107.523 178.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -82.74 53.87 2.51 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.403 1.097 . . . . 100.0 108.886 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.312 73.1 p 48.84 38.37 11.88 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 129.477 3.111 . . . . 100.0 116.281 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 204' ' ' ALA . . . -83.13 -178.02 6.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.511 -2.404 . . . . 100.0 104.511 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 83.0 mt -56.31 -41.53 91.56 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-O 115.885 -2.007 . . . . 100.0 114.788 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.076 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.325 32.4 Cg_exo -55.17 137.21 76.25 Favored 'Trans proline' 0 C--N 1.373 1.826 0 CA-C-N 121.406 1.538 . . . . 100.0 112.427 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.6 m-20 -63.57 -47.45 81.49 Favored 'General case' 0 N--CA 1.427 -1.614 1 N-CA-C 124.764 5.098 . . . . 100.0 124.764 -173.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.665 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.13 -35.36 80.02 Favored 'General case' 0 CA--C 1.48 -1.746 1 CA-C-O 128.51 4.005 . . . . 100.0 108.045 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.481 44.0 m-20 -65.74 -48.74 70.89 Favored 'General case' 1 N--CA 1.351 -5.385 2 CA-C-N 107.446 -4.434 . . . . 100.0 106.389 -179.093 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.46 -29.43 70.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.499 -1.375 . . . . 100.0 107.889 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.665 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.0 OUTLIER -58.51 -43.74 89.24 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-O 117.021 -1.466 . . . . 100.0 113.442 176.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.467 HD13 ' HG2' ' A' ' 205' ' ' GLN . 3.4 mp . . . . . 0 C--O 1.26 1.632 0 CA-C-O 114.514 -2.66 . . . . 100.0 113.227 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 N--CA 1.438 -1.072 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -124.4 138.0 54.4 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.884 -1.507 . . . . 100.0 108.261 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.59 144.15 50.31 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.099 -1.075 . . . . 100.0 108.099 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.24 120.34 35.29 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.73 128.36 54.8 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 113.442 -1.708 . . . . 100.0 106.83 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.4 t -104.51 121.05 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 N-CA-C 107.01 -1.478 . . . . 100.0 107.01 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 31.0 tp -110.48 115.59 29.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.54 161.96 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 115.379 -0.828 . . . . 100.0 111.881 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.68 176.7 30.02 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.008 -2.037 . . . . 100.0 108.008 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -72.1 156.4 39.23 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.831 0.824 . . . . 100.0 111.479 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.96 140.66 38.42 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.1 -5.49 78.57 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-O 118.453 -1.193 . . . . 100.0 113.696 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.1 m -62.2 -39.91 94.32 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 119.064 1.432 . . . . 100.0 111.06 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.69 26.88 4.29 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 109.464 -1.454 . . . . 100.0 109.464 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' CE ' ' A' ' 89' ' ' MET . 32.7 mtmt -61.49 -44.81 96.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.493 0.717 . . . . 100.0 112.671 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -62.47 -43.08 99.68 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.267 1.027 . . . . 100.0 109.729 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 m -63.07 -41.7 99.49 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.786 1.234 . . . . 100.0 109.218 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.514 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 54.9 t80 -59.99 -48.48 81.52 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 124.141 0.976 . . . . 100.0 112.208 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.46 -41.68 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.691 0.619 . . . . 100.0 110.922 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.252 98.8 mttt -68.06 -8.09 34.89 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.919 1.822 . . . . 100.0 115.919 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.558 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 81.2 mtm-85 -60.91 -37.43 82.21 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 118.941 -0.552 . . . . 100.0 109.724 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.435 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 47.5 t-80 -80.53 113.17 18.53 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.78 -1.563 . . . . 100.0 106.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.52 -43.96 97.54 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 115.604 1.705 . . . . 100.0 115.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.435 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 63.7 m -63.33 -41.89 98.94 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.988 -0.745 . . . . 100.0 108.988 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.41 -42.45 99.77 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 123.671 0.653 . . . . 100.0 111.565 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.49 -45.36 91.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.368 0.667 . . . . 100.0 111.043 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.16 -40.65 98.16 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 124.685 1.194 . . . . 100.0 112.215 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -93.52 11.24 29.33 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 115.353 1.612 . . . . 100.0 115.353 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.55 140.01 56.66 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 113.875 1.065 . . . . 100.0 113.875 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -118.1 129.47 55.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -103.04 124.63 48.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.2 110.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 101.498 -3.519 . . . . 100.0 101.498 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.03 88.93 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 115.993 1.849 . . . . 100.0 115.993 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.6 p -62.86 -47.25 84.16 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 122.494 0.317 . . . . 100.0 111.568 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.79 -37.14 73.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.892 1.071 . . . . 100.0 113.892 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.77 30.84 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 107.261 -2.335 . . . . 100.0 107.261 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.2 t -126.25 141.99 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 124.246 1.018 . . . . 100.0 109.167 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.55 118.93 37.88 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 102.336 -3.209 . . . . 100.0 102.336 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.68 120.05 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.542 -2.021 . . . . 100.0 105.542 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -114.5 119.79 39.2 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 109.0 -0.741 . . . . 100.0 109.0 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.9 104.67 1.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.863 2.375 . . . . 100.0 110.934 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.33 119.05 34.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.93 126.59 58.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 107.191 -1.411 . . . . 100.0 107.191 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -122.49 133.1 54.6 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.102 -1.814 . . . . 100.0 106.102 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -100.35 118.3 36.32 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 121.73 0.776 . . . . 100.0 108.987 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.43 HG21 HD12 ' A' ' 59' ' ' ILE . 22.3 p -110.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.948 -1.023 . . . . 100.0 111.57 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.66 -44.21 93.66 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 125.497 1.519 . . . . 100.0 108.349 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.8 -38.42 76.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.188 0.995 . . . . 100.0 112.395 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.92 -173.05 29.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.889 -1.684 . . . . 100.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.93 138.43 57.43 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.521 2.147 . . . . 100.0 114.199 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 54' ' ' THR . 81.1 mt -127.4 129.93 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 102.801 -3.037 . . . . 100.0 102.801 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.81 128.99 55.97 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.048 -0.723 . . . . 100.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.85 116.76 31.19 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.653 -2.721 . . . . 100.0 103.653 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -87.81 106.65 18.22 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.616 -4.216 . . . . 100.0 99.616 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.28 122.3 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 106.368 -1.715 . . . . 100.0 106.368 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.25 117.0 30.48 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 106.631 -1.618 . . . . 100.0 106.631 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -116.45 141.28 48.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.005 -2.22 . . . . 100.0 105.005 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 p -75.08 165.88 24.53 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 113.558 0.947 . . . . 100.0 113.558 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.74 12.92 23.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.733 1.213 . . . . 100.0 109.788 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.49 51.14 Favored Glycine 0 C--N 1.358 1.803 0 O-C-N 121.693 -0.629 . . . . 100.0 112.209 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -61.96 -27.86 69.14 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.813 1.645 . . . . 100.0 112.166 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -59.05 -36.64 75.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.584 2.353 . . . . 100.0 111.826 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.59 -46.84 88.16 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 117.996 0.362 . . . . 100.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.371 13.9 p90 -71.99 -39.39 69.3 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 114.903 1.445 . . . . 100.0 114.903 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.5 -156.04 11.45 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 119.903 -1.142 . . . . 100.0 113.431 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.16 171.53 52.52 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.807 0.718 . . . . 100.0 111.731 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -106.3 142.99 35.06 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 121.822 0.82 . . . . 100.0 109.971 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -67.95 155.69 38.89 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.208 -1.36 . . . . 100.0 113.735 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -60.67 -38.36 84.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.776 -1.557 . . . . 100.0 110.372 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.76 -39.33 93.54 Favored Glycine 0 C--N 1.36 1.872 0 C-N-CA 124.38 0.99 . . . . 100.0 111.469 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HD1' HG21 ' A' ' 45' ' ' VAL . 62.2 t80 -62.32 -46.96 86.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.516 0.726 . . . . 100.0 111.293 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.92 -37.11 78.73 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.0 mt -52.19 138.22 10.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 125.48 1.512 . . . . 100.0 113.739 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.86 24.65 12.78 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 127.853 2.461 . . . . 100.0 114.378 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.07 129.33 38.68 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.305 -1.368 . . . . 100.0 107.305 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.4 mm-40 -98.71 -34.93 10.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.143 -1.058 . . . . 100.0 108.143 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.52 ' HB2' HD22 ' A' ' 164' ' ' LEU . 23.5 p -144.37 160.14 41.54 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 122.861 0.465 . . . . 100.0 110.527 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.478 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -146.17 149.3 33.72 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.404 1.261 . . . . 100.0 114.404 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.47 126.52 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 103.292 -2.855 . . . . 100.0 103.292 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.43 123.81 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 102.353 -3.203 . . . . 100.0 102.353 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 23' ' ' LYS . 41.0 mtm -115.45 140.55 49.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 118.738 -1.185 . . . . 100.0 113.692 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -127.08 159.59 33.73 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 110.423 -3.081 . . . . 100.0 108.751 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -102.87 126.59 50.08 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.802 -1.925 . . . . 100.0 105.802 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.52 -21.58 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.367 0.877 . . . . 100.0 113.367 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -87.59 -8.48 56.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 119.033 -0.508 . . . . 100.0 110.993 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 t -119.42 115.84 24.93 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 122.308 1.051 . . . . 100.0 110.576 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.77 -38.68 87.05 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.622 -1.172 . . . . 100.0 110.55 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.71 -41.86 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.217 1.807 . . . . 100.0 110.391 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.4 m -62.96 -42.06 99.71 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 118.111 0.414 . . . . 100.0 110.306 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.555 ' CE1' HG23 ' A' ' 136' ' ' ILE . 39.5 t80 -63.45 -41.22 98.65 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 123.259 0.624 . . . . 100.0 110.453 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.7 mttt -61.61 -37.53 84.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.691 0.796 . . . . 100.0 111.652 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.14 -10.3 59.34 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 114.471 1.286 . . . . 100.0 114.471 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.36 -43.04 95.73 Favored Pre-proline 0 C--N 1.363 1.191 0 CA-C-O 115.782 -2.056 . . . . 100.0 111.795 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 83.2 Cg_exo -57.41 -38.24 95.0 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 122.556 1.949 . . . . 100.0 112.725 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.02 -45.19 90.03 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 123.924 0.89 . . . . 100.0 111.401 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -63.15 -42.79 99.52 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 123.182 0.593 . . . . 100.0 110.347 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -62.15 -45.01 95.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.502 1.121 . . . . 100.0 110.517 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -63.0 -44.01 97.2 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 112.686 0.624 . . . . 100.0 112.686 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.68 -44.03 97.29 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.42 0.45 . . . . 100.0 111.357 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.478 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.7 tp -62.79 -46.26 88.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.499 1.12 . . . . 100.0 112.247 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.43 -38.58 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 C-N-CA 125.082 1.353 . . . . 100.0 111.143 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -60.5 -46.07 91.45 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.463 0.574 . . . . 100.0 111.197 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.4 -45.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.352 -0.539 . . . . 100.0 111.159 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.1 m -127.39 115.33 18.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.48 0.657 . . . . 100.0 109.558 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.57 147.18 23.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.537 -0.756 . . . . 100.0 112.422 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.07 44.55 27.85 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 126.56 1.944 . . . . 100.0 114.457 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' GLN . 32.0 mm -100.74 131.29 23.77 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 125.907 1.683 . . . . 100.0 107.193 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.19 130.33 28.45 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.601 2.201 . . . . 100.0 109.181 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.729 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.8 mt -130.82 136.73 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 O-C-N 124.317 1.011 . . . . 100.0 109.147 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 160' ' ' PRO . 83.9 t -113.6 130.91 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 105.431 -2.062 . . . . 100.0 105.431 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 39.7 mt -105.85 125.14 50.64 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.465 -2.791 . . . . 100.0 103.465 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.4 m -116.82 129.99 56.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.199 -1.364 . . . . 100.0 112.509 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 103.51 2.83 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 105.347 -3.101 . . . . 100.0 105.347 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 149' ' ' ILE . 63.7 t30 -84.36 167.44 16.52 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.082 1.353 . . . . 100.0 111.297 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 60.08 42.45 15.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 128.348 2.659 . . . . 100.0 115.199 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.307 20.4 m -73.18 -7.66 10.17 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 116.08 -0.509 . . . . 100.0 111.494 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.96 -38.09 87.21 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.759 2.023 . . . . 100.0 109.801 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.65 130.34 34.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.108 0 N-CA-C 106.694 -1.595 . . . . 100.0 106.694 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.36 -41.11 98.35 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 116.281 1.956 . . . . 100.0 116.281 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -86.23 99.4 11.52 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.201 -2.148 . . . . 100.0 105.201 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -99.01 118.77 36.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.351 -2.833 . . . . 100.0 103.351 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.3 -40.96 13.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.719 -0.673 . . . . 100.0 112.634 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.85 106.36 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 103.667 -2.716 . . . . 100.0 103.667 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -103.64 -179.49 3.97 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.247 -0.888 . . . . 100.0 113.209 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.481 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.43 -35.86 72.75 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 127.161 2.184 . . . . 100.0 109.276 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.034 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -59.73 -37.11 78.02 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 128.081 2.552 . . . . 100.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.8 p -103.96 -1.17 27.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 120.114 3.376 . . . . 100.0 120.114 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 56.2 mt -98.47 95.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.21 0 C-N-CA 115.487 -2.485 . . . . 100.0 111.324 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 5.7 p -100.6 -5.98 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 114.77 1.396 . . . . 100.0 114.77 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.89 -35.7 73.45 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.225 1.565 . . . . 100.0 115.225 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 87.0 m-70 -59.45 -40.5 87.05 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 125.587 1.555 . . . . 100.0 112.689 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.678 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 55.7 ttp85 -59.09 -47.69 84.33 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 124.567 1.147 . . . . 100.0 113.436 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -63.44 -41.44 98.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.277 0.986 . . . . 100.0 111.728 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.5 3.71 50.64 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 117.277 2.325 . . . . 100.0 117.277 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 57.42 42.84 24.07 Favored 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.526 1.531 . . . . 100.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.729 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.3 mt -106.38 151.33 25.03 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.815 -1.55 . . . . 100.0 106.815 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 86.9 mm-40 -103.91 142.85 33.69 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 113.445 0.905 . . . . 100.0 113.445 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.487 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 79.7 t80 -98.83 132.18 44.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 113.633 0.975 . . . . 100.0 113.633 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.58 132.89 49.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 113.596 -1.638 . . . . 100.0 108.335 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.39 118.28 30.4 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.3 -3.593 . . . . 100.0 101.3 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . 0.434 HG13 ' HA ' ' A' ' 122' ' ' ASN . 43.8 pt -133.57 159.37 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.644 1.212 . . . . 100.0 114.05 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.1 m -140.02 111.43 7.18 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 106.418 -1.697 . . . . 100.0 106.418 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.558 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.58 -44.35 96.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.337 -1.301 . . . . 100.0 112.92 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.04 -40.12 96.78 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.715 0.806 . . . . 100.0 112.738 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -96.12 1.66 52.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.139 2.274 . . . . 100.0 117.139 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.42 11.92 Favored 'General case' 0 C--N 1.365 1.244 0 C-N-CA 125.277 1.431 . . . . 100.0 109.964 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.504 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 87.0 t80 -75.33 124.77 27.69 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.012 -0.736 . . . . 100.0 109.012 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 53.59 39.87 30.67 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.121 2.568 . . . . 100.0 115.399 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.542 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.8 t80 -62.61 -42.66 99.71 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 121.829 -0.544 . . . . 100.0 111.395 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.13 -39.43 94.67 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 115.746 1.758 . . . . 100.0 115.746 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.16 -48.53 96.87 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 120.932 3.679 . . . . 100.0 120.932 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HB3' HG11 ' A' ' 118' ' ' VAL . 55.4 Cg_endo -61.16 -41.79 40.47 Favored 'Trans proline' 0 C--N 1.373 1.853 0 CA-C-N 123.544 2.301 . . . . 100.0 112.681 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.7 -42.49 95.25 Favored 'General case' 0 CA--C 1.491 -1.325 0 O-C-N 124.656 1.223 . . . . 100.0 111.347 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.18 -45.05 93.6 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.457 0.703 . . . . 100.0 111.408 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -63.01 -44.53 95.74 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.523 0.514 . . . . 100.0 110.079 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.6 mt -61.78 -44.15 97.44 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.121 0.568 . . . . 100.0 111.469 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.72 98.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.207 1.003 . . . . 100.0 111.315 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -62.22 -45.83 91.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 123.722 0.809 . . . . 100.0 111.022 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -64.56 -45.38 87.36 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 85' ' ' CYS . 82.0 mt -63.44 -46.74 84.91 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 123.826 0.85 . . . . 100.0 112.929 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 85.9 mt -70.54 -38.51 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 123.06 0.544 . . . . 100.0 109.989 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.98 9.74 59.31 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.477 -1.049 . . . . 100.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -108.97 112.63 59.97 Favored Pre-proline 0 C--N 1.362 1.121 0 N-CA-C 107.332 -1.358 . . . . 100.0 107.332 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.23 -16.7 28.16 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 123.412 2.741 . . . . 100.0 113.832 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.93 -0.12 56.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.827 0.851 . . . . 100.0 113.042 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.81 131.61 48.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.286 0.634 . . . . 100.0 110.337 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -136.65 153.77 50.82 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.987 -0.746 . . . . 100.0 108.987 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -88.21 113.21 23.6 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 106.257 -1.757 . . . . 100.0 106.257 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.7 t -67.02 -43.8 88.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.011 0.925 . . . . 100.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.91 150.7 49.19 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.522 0.677 . . . . 100.0 109.634 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 63.5 ttp -96.35 126.63 43.13 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 104.837 -2.283 . . . . 100.0 104.837 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.05 159.49 49.11 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.951 2.434 . . . . 100.0 111.541 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.72 125.06 23.6 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.283 -1.006 . . . . 100.0 108.283 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.1 144.56 46.54 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.335 -1.302 . . . . 100.0 109.972 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.65 137.85 97.27 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -56.08 138.33 82.36 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 123.516 2.811 . . . . 100.0 112.129 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.42 131.74 39.94 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.851 2.367 . . . . 100.0 114.264 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -66.06 -44.85 83.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 124.795 1.309 . . . . 100.0 108.503 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.03 158.42 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.787 -1.56 . . . . 100.0 106.787 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.7 t -99.78 130.64 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 105.651 -1.981 . . . . 100.0 105.651 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -85.83 126.7 34.24 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.345 -2.465 . . . . 100.0 104.345 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 77.6 m-20 -62.74 131.09 94.22 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 115.245 -0.889 . . . . 100.0 110.828 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.7 Cg_exo -58.67 -37.94 91.69 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.948 3.099 . . . . 100.0 112.828 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.05 93.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 124.449 1.093 . . . . 100.0 110.784 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.91 -42.49 97.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.067 0.547 . . . . 100.0 111.483 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 123.731 0.812 . . . . 100.0 110.512 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.88 97.72 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.126 0.97 . . . . 100.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.57 -44.42 96.37 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.614 0.765 . . . . 100.0 112.187 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -63.84 -43.83 95.0 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 112.397 0.518 . . . . 100.0 112.397 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.51 -41.37 98.52 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.55 -0.537 . . . . 100.0 109.55 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.14 -45.32 93.95 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.989 1.316 . . . . 100.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -42.75 99.4 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 123.366 0.667 . . . . 100.0 110.667 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.504 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 17.5 tp -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 124.122 0.889 . . . . 100.0 110.53 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.69 -41.77 95.8 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 115.664 1.727 . . . . 100.0 115.664 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.68 -46.36 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 CA-C-O 118.429 -0.796 . . . . 100.0 109.667 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.41 . . -93.35 -0.52 56.58 Favored 'General case' 0 N--CA 1.4 -2.931 1 C-N-CA 109.909 -4.717 . . . . 100.0 114.326 -179.886 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.805 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.275 59.7 mt-30 -56.63 -36.51 69.56 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 106.535 -1.654 . . . . 100.0 106.535 178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.7 p -82.44 53.4 2.3 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.211 1.005 . . . . 100.0 108.969 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.291 78.7 p 49.11 37.74 11.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 129.123 2.969 . . . . 100.0 116.402 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.479 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.53 -179.32 7.38 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.443 -2.428 . . . . 100.0 104.443 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.6 -39.98 81.7 Favored Pre-proline 0 CA--C 1.499 -0.981 0 CA-C-O 115.851 -2.024 . . . . 100.0 114.904 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.034 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.332 45.4 Cg_exo -55.02 136.7 74.09 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 121.288 1.496 . . . . 100.0 111.991 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.5 m-20 -63.55 -47.7 80.5 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 125.132 5.234 . . . . 100.0 125.132 -173.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.1 -35.26 79.67 Favored 'General case' 0 CA--C 1.482 -1.673 1 CA-C-O 128.626 4.06 . . . . 100.0 107.782 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.805 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.482 43.2 m-20 -65.49 -49.06 70.43 Favored 'General case' 1 N--CA 1.352 -5.352 1 CA-C-N 107.581 -4.372 . . . . 100.0 106.148 -179.058 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.15 -27.64 69.21 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 120.412 -1.43 . . . . 100.0 108.217 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.681 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.1 t70 -58.33 -43.59 88.32 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-O 117.178 -1.391 . . . . 100.0 112.507 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.432 HD13 ' HG2' ' A' ' 205' ' ' GLN . 4.5 mp . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.927 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.1 t . . . . . 0 N--CA 1.434 -1.248 0 N-CA-C 106.489 -1.671 . . . . 100.0 106.489 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.76 133.94 52.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.638 -1.619 . . . . 100.0 107.916 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.22 141.91 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.744 -1.206 . . . . 100.0 107.744 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.01 118.49 31.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.548 HD23 HG22 ' A' ' 63' ' ' VAL . 55.9 tp -106.92 125.66 51.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 113.008 -1.905 . . . . 100.0 106.955 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.3 t -102.39 121.86 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 106.23 -1.767 . . . . 100.0 106.23 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 89' ' ' MET . 3.3 tt -113.68 117.95 33.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.628 -2.36 . . . . 100.0 104.628 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -127.58 162.87 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.847 -0.615 . . . . 100.0 112.307 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.78 175.26 28.5 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 108.569 -1.812 . . . . 100.0 108.569 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -71.71 156.1 39.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 121.777 -0.837 . . . . 100.0 111.786 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.0 141.07 40.98 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 107.423 -2.271 . . . . 100.0 107.423 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 -5.43 80.63 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.924 -0.931 . . . . 100.0 113.884 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -62.85 -40.03 96.2 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 118.618 1.209 . . . . 100.0 111.145 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.79 24.64 5.16 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.22 -1.152 . . . . 100.0 110.22 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 52.3 mtpt -60.24 -46.22 90.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.363 1.465 . . . . 100.0 111.98 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.6 m -62.9 -43.76 97.92 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 124.864 1.265 . . . . 100.0 109.622 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.4 m -63.15 -41.64 99.3 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.421 1.088 . . . . 100.0 109.28 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' HA ' HH11 ' A' ' 29' ' ' ARG . 60.6 t80 -60.62 -48.77 80.32 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 122.868 0.467 . . . . 100.0 111.625 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 63' ' ' VAL . 98.3 t -64.02 -42.64 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.672 0.789 . . . . 100.0 110.664 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.263 99.5 mttt -70.44 -6.39 35.46 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 115.718 1.747 . . . . 100.0 115.718 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 80.7 mtm-85 -61.32 -36.57 80.49 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 118.884 -0.579 . . . . 100.0 110.069 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.452 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 44.8 t-80 -79.98 113.79 18.41 Favored 'General case' 0 C--N 1.36 1.034 0 N-CA-C 107.128 -1.434 . . . . 100.0 107.128 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.23 -43.91 97.76 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.888 1.44 . . . . 100.0 114.888 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 79.8 m -64.11 -39.87 94.97 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.694 -0.854 . . . . 100.0 108.694 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.44 99.78 Favored Glycine 0 C--N 1.361 1.938 0 N-CA-C 110.409 -1.076 . . . . 100.0 110.409 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.89 -45.33 93.06 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 117.56 0.68 . . . . 100.0 111.536 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.5 -40.92 98.26 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.996 0.919 . . . . 100.0 112.236 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -90.56 6.36 43.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 114.988 1.477 . . . . 100.0 114.988 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -61.06 140.61 57.82 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -121.07 133.59 55.24 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.108 -1.441 . . . . 100.0 107.108 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -103.32 124.63 49.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.331 -1.729 . . . . 100.0 106.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.56 109.73 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 100.641 -3.836 . . . . 100.0 100.641 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.55 92.22 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 116.669 2.1 . . . . 100.0 116.669 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.9 m -63.13 -48.55 78.02 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 123.37 0.419 . . . . 100.0 110.438 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.35 -36.1 74.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 113.957 1.095 . . . . 100.0 113.957 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.24 40.45 33.92 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 107.944 -2.062 . . . . 100.0 107.944 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG21 ' HD1' ' A' ' 79' ' ' TYR . 41.0 t -127.72 141.81 45.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.077 0.951 . . . . 100.0 109.141 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -103.96 119.52 39.1 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 102.839 -3.022 . . . . 100.0 102.839 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.23 120.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.696 -1.964 . . . . 100.0 105.696 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -113.22 119.21 42.73 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.023 -0.732 . . . . 100.0 109.023 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -80.09 106.54 1.93 Allowed 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.093 1.862 . . . . 100.0 109.62 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.32 117.42 32.68 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.196 -1.779 . . . . 100.0 106.196 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.17 125.98 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.41 133.25 54.63 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.782 -1.933 . . . . 100.0 105.782 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -100.66 119.19 38.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.176 -1.046 . . . . 100.0 108.176 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 59' ' ' ILE . 20.6 p -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.875 -1.057 . . . . 100.0 110.874 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -59.83 -44.44 94.06 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.424 1.489 . . . . 100.0 108.255 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -67.23 -37.96 84.42 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.308 1.443 . . . . 100.0 112.792 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.25 -172.56 28.48 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 108.988 -1.645 . . . . 100.0 108.988 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.97 136.73 49.77 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.674 2.25 . . . . 100.0 113.953 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -127.58 129.75 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 102.659 -3.089 . . . . 100.0 102.659 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -110.32 129.66 55.7 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.646 -0.872 . . . . 100.0 108.646 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -109.82 116.61 31.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.177 -2.897 . . . . 100.0 103.177 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -87.42 107.7 18.66 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.338 -4.319 . . . . 100.0 99.338 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.548 HG22 HD23 ' A' ' 13' ' ' LEU . 26.8 t -93.2 121.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.069 -1.826 . . . . 100.0 106.069 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -93.57 109.88 21.49 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.797 -2.298 . . . . 100.0 104.797 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.22 136.6 52.77 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.035 -1.839 . . . . 100.0 106.035 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.2 p -72.95 162.2 29.78 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 113.378 0.881 . . . . 100.0 113.378 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.57 16.22 19.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.325 -0.852 . . . . 100.0 109.789 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.3 51.14 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 121.846 -0.534 . . . . 100.0 112.409 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -60.28 -33.78 72.82 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 126.871 2.069 . . . . 100.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 59.8 mt-10 -57.89 -36.68 72.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.566 2.346 . . . . 100.0 112.154 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.36 -43.53 98.6 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.13 0.572 . . . . 100.0 109.792 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -70.6 -41.68 72.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.216 1.406 . . . . 100.0 113.539 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.77 -155.2 13.51 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 121.363 -0.446 . . . . 100.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.0 171.66 52.16 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 123.764 0.697 . . . . 100.0 111.982 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.97 143.12 33.61 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 122.173 0.987 . . . . 100.0 111.128 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -65.16 150.48 48.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.441 -1.708 . . . . 100.0 113.14 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.43 -37.92 85.26 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 114.029 -1.441 . . . . 100.0 109.53 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.35 94.11 Favored Glycine 0 C--N 1.36 1.874 0 C-N-CA 124.728 1.156 . . . . 100.0 111.07 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HD1' HG21 ' A' ' 45' ' ' VAL . 64.0 t80 -62.44 -46.83 86.77 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.899 0.88 . . . . 100.0 111.279 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -69.03 -37.21 78.49 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.671 1.73 . . . . 100.0 115.671 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.87 139.29 12.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 125.178 1.391 . . . . 100.0 113.232 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.93 22.17 10.18 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 127.544 2.338 . . . . 100.0 113.182 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.61 128.99 37.61 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.293 -1.373 . . . . 100.0 107.293 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.54 -37.68 10.77 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.471 -1.677 . . . . 100.0 106.471 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.681 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.3 p -144.6 161.57 38.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.681 0.277 . . . . 100.0 111.271 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.34 150.16 36.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.176 1.547 . . . . 100.0 115.176 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' A' ' 89' ' ' MET . 97.4 mt -125.54 126.13 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 103.851 -2.648 . . . . 100.0 103.851 176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.5 mt -111.03 124.17 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 102.944 -2.984 . . . . 100.0 102.944 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 87' ' ' ILE . 38.9 mtt -110.89 135.51 51.32 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.268 -1.333 . . . . 100.0 114.549 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -129.23 159.41 36.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 111.583 -2.553 . . . . 100.0 108.33 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -103.78 126.61 51.03 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.291 -1.744 . . . . 100.0 106.291 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 17.1 m -64.68 -21.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.857 1.058 . . . . 100.0 113.857 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.6 p -88.33 -10.31 49.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 119.193 -0.432 . . . . 100.0 110.961 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -116.93 114.99 24.63 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.755 1.264 . . . . 100.0 110.193 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -65.93 -39.48 90.56 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.408 1.483 . . . . 100.0 109.815 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.97 -41.84 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.221 1.808 . . . . 100.0 110.777 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.1 m -62.74 -42.46 99.68 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 118.089 0.404 . . . . 100.0 109.93 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 136' ' ' ILE . 45.7 t80 -63.93 -41.0 97.75 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.691 0.796 . . . . 100.0 110.767 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.523 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -60.83 -38.55 85.87 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.763 0.825 . . . . 100.0 110.515 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.36 -9.78 58.87 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 115.129 1.529 . . . . 100.0 115.129 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.71 -43.4 95.21 Favored Pre-proline 0 C--N 1.364 1.222 0 CA-C-O 115.93 -1.986 . . . . 100.0 111.529 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.2 Cg_exo -57.4 -36.23 98.84 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.242 1.961 . . . . 100.0 112.93 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.91 -47.08 84.82 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.951 1.3 . . . . 100.0 110.115 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -63.87 -42.64 97.47 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 123.837 0.855 . . . . 100.0 111.161 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.7 t60 -62.45 -44.29 96.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.526 1.13 . . . . 100.0 110.265 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -62.62 -45.3 93.49 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 118.697 -0.668 . . . . 100.0 111.661 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -62.41 -43.98 97.53 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 123.481 0.488 . . . . 100.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.465 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.5 tp -62.71 -46.54 87.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.466 1.106 . . . . 100.0 111.988 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.59 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 C-N-CA 125.376 1.47 . . . . 100.0 111.165 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.08 -46.32 89.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 119.017 -0.516 . . . . 100.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.86 -46.62 59.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.356 -0.538 . . . . 100.0 111.796 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.9 m -127.07 114.03 17.21 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -90.46 146.07 24.42 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.746 -0.661 . . . . 100.0 112.27 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.75 43.3 31.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 126.39 1.876 . . . . 100.0 115.36 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 pt -99.5 139.82 21.17 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 105.953 -1.869 . . . . 100.0 105.953 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.29 129.92 28.57 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.608 2.206 . . . . 100.0 109.525 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 144' ' ' LEU . 72.3 mt -130.64 135.89 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.235 1.017 . . . . 100.0 108.777 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.67 131.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 105.594 -2.002 . . . . 100.0 105.594 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 20.5 mt -106.04 126.56 52.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.274 -2.861 . . . . 100.0 103.274 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 73.8 m -114.57 127.85 56.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.98 -1.464 . . . . 100.0 112.008 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.73 104.02 2.93 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 105.726 -2.95 . . . . 100.0 105.726 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 122' ' ' ASN . 1.1 m-80 -78.95 163.89 24.86 Favored 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 127.823 2.449 . . . . 100.0 112.069 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 55.58 45.48 24.77 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 127.921 2.488 . . . . 100.0 115.556 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.333 33.1 m -72.29 -7.5 9.64 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 120.069 -0.652 . . . . 100.0 111.109 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.46 -38.96 89.13 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.029 2.131 . . . . 100.0 109.932 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.96 130.64 34.05 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 N-CA-C 107.069 -1.456 . . . . 100.0 107.069 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.29 -41.19 98.3 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.323 1.972 . . . . 100.0 116.323 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.5 100.47 12.79 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . 0.402 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 79.1 ttt180 -96.67 121.35 38.41 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 102.392 -3.188 . . . . 100.0 102.392 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.19 -36.02 11.09 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.744 -0.662 . . . . 100.0 112.363 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 136' ' ' ILE . 42.4 t -104.73 105.23 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 101.707 -3.442 . . . . 100.0 101.707 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -101.87 177.71 4.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.951 1.093 . . . . 100.0 113.951 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.97 -35.51 73.31 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.082 2.153 . . . . 100.0 108.613 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.068 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.6 mttt -59.58 -37.05 77.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 128.395 2.678 . . . . 100.0 112.327 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.3 p -104.34 -3.13 24.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 120.061 3.356 . . . . 100.0 120.061 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.634 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 55.9 mt -95.75 94.34 4.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 116.394 -2.122 . . . . 100.0 112.317 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -99.29 -5.3 9.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -58.86 -36.73 75.08 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 115.418 1.636 . . . . 100.0 115.418 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.9 m-70 -59.87 -39.57 85.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.994 1.718 . . . . 100.0 114.371 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 47.1 ttp180 -58.95 -48.13 82.62 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 124.904 1.282 . . . . 100.0 112.442 -176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.16 -41.3 99.23 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.039 1.336 . . . . 100.0 111.244 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -98.59 1.54 46.52 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 116.338 1.977 . . . . 100.0 116.338 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 54.9 45.82 25.71 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 125.079 1.351 . . . . 100.0 113.198 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 117' ' ' ILE . 32.1 mt -106.38 150.05 26.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.863 -1.903 . . . . 100.0 105.863 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.315 89.2 mm-40 -100.97 143.9 30.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.588 -0.845 . . . . 100.0 112.518 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 69.5 t80 -102.03 132.94 47.58 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.591 0.96 . . . . 100.0 113.591 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.81 132.89 45.51 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -1.268 . . . . 100.0 111.038 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.278 38.0 m-20 -84.58 122.13 28.6 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 103.152 -2.907 . . . . 100.0 103.152 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.28 156.6 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 122.644 1.211 . . . . 100.0 110.999 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 74.5 m -138.6 110.63 7.27 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 105.698 -1.964 . . . . 100.0 105.698 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.76 -44.06 97.17 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.651 -1.613 . . . . 100.0 112.909 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.87 -41.46 99.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.955 0.902 . . . . 100.0 112.425 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 185' ' ' PRO . 87.5 p -96.82 3.42 52.25 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 117.75 2.5 . . . . 100.0 117.75 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 m-80 65.45 21.17 11.83 Favored 'General case' 0 C--N 1.364 1.239 0 C-N-CA 124.451 1.101 . . . . 100.0 110.806 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.4 t80 -75.26 124.87 27.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.02 -0.733 . . . . 100.0 109.02 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.84 40.21 30.31 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 128.355 2.662 . . . . 100.0 115.364 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' HH21 ' A' ' 29' ' ' ARG . 78.9 t80 -62.65 -43.23 99.32 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.863 -0.523 . . . . 100.0 110.735 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -62.97 -39.19 93.94 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 115.996 1.85 . . . . 100.0 115.996 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.94 -47.45 98.86 Favored Pre-proline 0 C--N 1.356 0.862 0 N-CA-C 119.839 3.274 . . . . 100.0 119.839 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.94 -42.16 39.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 123.31 2.218 . . . . 100.0 111.222 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -64.05 -42.4 97.04 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 125.353 1.461 . . . . 100.0 111.614 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.19 -47.02 88.07 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 123.462 0.705 . . . . 100.0 111.722 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.25 -44.39 95.3 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 124.011 0.819 . . . . 100.0 110.46 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.69 -45.42 94.08 Favored 'General case' 0 CA--C 1.495 -1.171 0 O-C-N 123.752 0.657 . . . . 100.0 111.252 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.47 98.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 124.115 0.966 . . . . 100.0 111.555 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.05 -46.05 90.83 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 123.672 0.789 . . . . 100.0 111.402 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -65.52 -44.28 87.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 113.498 0.925 . . . . 100.0 113.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.63 -46.86 83.76 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.427 0.691 . . . . 100.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 87.8 mt -70.4 -38.74 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 123.309 0.644 . . . . 100.0 110.688 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.28 9.53 57.92 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-O 118.899 -0.945 . . . . 100.0 111.139 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -111.03 112.9 55.19 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.692 -1.225 . . . . 100.0 107.692 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.14 -14.93 28.94 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.72 2.946 . . . . 100.0 113.968 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.51 5.18 51.77 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.908 0.707 . . . . 100.0 112.908 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -65.75 131.8 47.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.362 0.665 . . . . 100.0 109.299 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -135.21 152.62 51.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.299 -0.63 . . . . 100.0 109.299 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -88.11 115.07 25.34 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 104.843 -2.281 . . . . 100.0 104.843 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.34 -45.04 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.071 0.948 . . . . 100.0 110.299 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.14 151.4 49.27 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.274 0.559 . . . . 100.0 109.734 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.2 ttp -96.63 127.42 39.67 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.322 -2.103 . . . . 100.0 105.322 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.14 159.05 51.49 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.127 2.551 . . . . 100.0 111.571 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.56 126.37 27.67 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.02 0.914 . . . . 100.0 108.562 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.78 145.91 47.06 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.163 -1.38 . . . . 100.0 108.979 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.74 138.42 97.38 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.657 -1.238 . . . . 100.0 107.657 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 51.7 Cg_exo -56.97 140.4 92.26 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.36 2.707 . . . . 100.0 112.377 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 154' ' ' ASN . 39.3 Cg_exo -58.5 131.31 41.88 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.413 2.742 . . . . 100.0 114.079 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.94 -44.66 80.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.599 1.187 . . . . 100.0 107.961 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.19 158.4 43.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.458 -1.682 . . . . 100.0 106.458 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.6 130.72 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 105.919 -1.882 . . . . 100.0 105.919 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -87.36 127.4 35.2 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.382 -2.081 . . . . 100.0 105.382 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 55.4 m-20 -62.91 130.56 94.09 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 115.16 -0.927 . . . . 100.0 111.005 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 54.0 Cg_exo -58.68 -36.74 96.75 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.874 3.049 . . . . 100.0 112.579 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.36 96.35 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.42 1.075 . . . . 100.0 110.447 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.66 -42.78 98.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 123.115 0.566 . . . . 100.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.14 97.67 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 123.512 0.725 . . . . 100.0 110.634 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.5 98.61 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.87 0.868 . . . . 100.0 110.654 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -61.94 -45.83 91.96 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.3 1.04 . . . . 100.0 111.986 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -64.0 -44.63 92.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 112.209 0.448 . . . . 100.0 112.209 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.41 -39.91 94.76 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.353 0.408 . . . . 100.0 111.053 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.69 -43.77 97.96 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.883 1.273 . . . . 100.0 110.829 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.08 -42.53 99.3 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.158 0.983 . . . . 100.0 110.106 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.5 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.4 tp -59.8 -49.43 77.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 124.317 1.01 . . . . 100.0 109.861 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.48 -41.51 96.44 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 115.805 1.78 . . . . 100.0 115.805 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.41 -47.06 91.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 CA-C-O 118.305 -0.855 . . . . 100.0 109.423 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.685 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.409 . . -93.97 0.76 56.22 Favored 'General case' 0 N--CA 1.405 -2.71 1 C-N-CA 109.659 -4.816 . . . . 100.0 114.495 179.694 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.29 61.2 mt-30 -57.27 -35.86 70.28 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 106.94 -1.504 . . . . 100.0 106.94 178.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.8 p -82.82 53.88 2.53 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.487 1.137 . . . . 100.0 108.551 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.304 80.4 p 48.66 38.91 12.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 129.507 3.123 . . . . 100.0 115.741 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.31 -177.43 6.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.638 -2.356 . . . . 100.0 104.638 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.8 mt -56.39 -41.58 91.86 Favored Pre-proline 0 CA--C 1.502 -0.884 0 CA-C-O 116.105 -1.902 . . . . 100.0 114.882 -174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.068 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.307 41.8 Cg_exo -54.52 136.18 69.11 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.112 1.433 . . . . 100.0 112.389 177.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 95.3 m-20 -63.63 -47.38 81.57 Favored 'General case' 0 N--CA 1.428 -1.572 1 N-CA-C 124.109 4.855 . . . . 100.0 124.109 -173.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.256 99.5 mt-10 -63.17 -35.17 79.41 Favored 'General case' 0 CA--C 1.477 -1.86 1 CA-C-O 128.562 4.03 . . . . 100.0 108.064 177.753 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.484 44.7 m-20 -66.57 -48.9 68.13 Favored 'General case' 1 N--CA 1.35 -5.473 1 CA-C-N 107.629 -4.351 . . . . 100.0 105.939 -178.624 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.74 -25.43 67.93 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.574 -1.329 . . . . 100.0 108.524 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.69 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.84 -42.8 90.18 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-O 117.238 -1.363 . . . . 100.0 112.571 175.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' A' ' 205' ' ' GLN . 2.9 mp . . . . . 0 N--CA 1.425 -1.71 0 CA-C-O 114.335 -2.745 . . . . 100.0 112.039 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 87.6 t . . . . . 0 N--CA 1.431 -1.389 0 N-CA-C 105.532 -2.025 . . . . 100.0 105.532 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -121.29 134.77 55.16 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.238 -1.801 . . . . 100.0 108.155 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.15 143.11 49.28 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.598 -1.26 . . . . 100.0 107.598 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.64 120.81 35.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.793 -1.558 . . . . 100.0 106.793 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -109.21 127.65 54.41 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.913 -1.949 . . . . 100.0 107.107 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 79' ' ' TYR . 50.8 t -103.02 120.78 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.714 -1.585 . . . . 100.0 106.892 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.415 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 48.5 tp -110.69 115.38 29.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.53 161.85 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 CA-C-N 115.741 -0.663 . . . . 100.0 111.992 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.14 176.61 30.38 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 108.341 -1.903 . . . . 100.0 108.341 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -72.67 157.27 37.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.621 0.724 . . . . 100.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.45 141.72 39.42 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 107.109 -2.396 . . . . 100.0 107.109 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.06 -5.62 81.66 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.079 -0.845 . . . . 100.0 113.62 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -63.04 -39.28 94.28 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 118.481 1.141 . . . . 100.0 111.204 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.49 23.9 5.53 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 111.076 -0.81 . . . . 100.0 111.076 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HD2' ' HG ' ' A' ' 15' ' ' LEU . 29.3 mtmt -61.71 -43.24 99.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.843 0.857 . . . . 100.0 111.902 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -62.16 -44.19 97.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.681 1.193 . . . . 100.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.2 m -63.08 -41.1 99.34 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.565 1.146 . . . . 100.0 108.826 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.527 ' HA ' HH11 ' A' ' 29' ' ' ARG . 50.0 t80 -59.75 -49.09 79.07 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.376 0.67 . . . . 100.0 112.676 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -41.95 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 123.869 0.731 . . . . 100.0 110.561 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.49 -8.43 40.93 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 115.757 1.762 . . . . 100.0 115.757 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 82.8 mtm-85 -61.36 -37.34 82.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.535 -0.542 . . . . 100.0 109.535 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' HIS . . . . . 0.454 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 53.8 t-80 -80.23 112.35 17.46 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.49 -43.85 97.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 115.222 1.564 . . . . 100.0 115.222 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 85.2 m -63.02 -41.96 99.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.621 0.768 . . . . 100.0 108.934 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.43 99.75 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 123.855 0.741 . . . . 100.0 111.361 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.82 -43.75 95.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.023 0.529 . . . . 100.0 110.676 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.05 -40.04 95.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.31 1.044 . . . . 100.0 112.349 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -90.42 7.02 40.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 114.422 1.267 . . . . 100.0 114.422 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -58.81 140.23 55.35 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 115.215 1.561 . . . . 100.0 115.215 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.88 130.46 52.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -103.81 123.6 47.38 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.256 -2.127 . . . . 100.0 105.256 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.11 113.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 102.736 -3.061 . . . . 100.0 102.736 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.2 94.01 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.0 p -62.59 -47.41 83.91 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 122.679 0.392 . . . . 100.0 111.723 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.06 -38.22 75.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.718 1.207 . . . . 100.0 112.987 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 35.78 52.42 Favored Glycine 0 C--N 1.359 1.844 0 N-CA-C 106.625 -2.59 . . . . 100.0 106.625 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.466 HG21 ' HD1' ' A' ' 79' ' ' TYR . 84.3 t -125.45 141.45 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.766 1.227 . . . . 100.0 108.622 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -106.56 117.36 33.85 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 102.571 -3.122 . . . . 100.0 102.571 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.74 122.25 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 107.039 -1.467 . . . . 100.0 107.039 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -116.63 120.69 34.09 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.265 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -79.97 105.62 1.82 Allowed 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.298 1.999 . . . . 100.0 109.415 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.08 116.75 29.85 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.636 -1.616 . . . . 100.0 106.636 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.65 126.82 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.858 -1.164 . . . . 100.0 107.858 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.41 132.45 53.96 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -99.9 120.03 39.14 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.212 -1.033 . . . . 100.0 108.212 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 23.3 p -109.44 -179.77 3.92 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.817 -1.083 . . . . 100.0 110.754 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.81 -44.11 94.16 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 125.576 1.55 . . . . 100.0 107.837 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.6 mtt-85 -67.32 -39.19 85.83 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.901 1.28 . . . . 100.0 112.846 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.83 -172.54 28.13 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.068 -2.013 . . . . 100.0 108.068 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.27 137.28 50.95 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.628 2.219 . . . . 100.0 114.552 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 74.9 mt -127.34 130.42 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.325 -3.213 . . . . 100.0 102.325 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -110.94 129.65 55.82 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.412 -0.588 . . . . 100.0 109.412 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -111.31 115.27 29.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.174 -2.528 . . . . 100.0 104.174 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -86.82 106.38 17.68 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.653 -3.832 . . . . 100.0 100.653 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 122.4 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -98.04 114.78 27.03 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.116 -1.809 . . . . 100.0 106.116 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -112.63 135.68 53.08 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.531 -1.655 . . . . 100.0 106.531 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -72.25 162.66 29.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.199 0.814 . . . . 100.0 113.199 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.43 14.76 21.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.316 -0.857 . . . . 100.0 110.033 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.21 12.36 42.55 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 121.78 -0.575 . . . . 100.0 112.037 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.458 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 67.8 mt-30 -60.16 -34.43 73.57 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.557 1.943 . . . . 100.0 111.625 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.9 -35.39 70.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 127.624 2.37 . . . . 100.0 112.406 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.08 -40.9 97.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.474 0.71 . . . . 100.0 110.97 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 p90 -92.05 -14.0 30.01 Favored 'General case' 0 C--N 1.362 1.111 0 N-CA-C 114.908 1.447 . . . . 100.0 114.908 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.93 -163.9 33.04 Favored Glycine 0 C--N 1.357 1.745 0 C-N-CA 119.464 -1.35 . . . . 100.0 113.432 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.51 172.57 54.64 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 110.507 -1.037 . . . . 100.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.8 mt -104.25 142.32 34.75 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.836 0.827 . . . . 100.0 110.186 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -68.1 155.6 39.24 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.192 -1.367 . . . . 100.0 113.323 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.56 -38.35 84.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 125.421 1.488 . . . . 100.0 110.415 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.91 -39.25 93.78 Favored Glycine 0 C--N 1.36 1.868 0 C-N-CA 124.673 1.13 . . . . 100.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HD1' HG21 ' A' ' 45' ' ' VAL . 61.0 t80 -62.24 -46.65 87.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.605 0.762 . . . . 100.0 110.84 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -68.94 -37.02 78.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 115.86 1.8 . . . . 100.0 115.86 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.9 mt -52.15 137.09 11.79 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 125.396 1.478 . . . . 100.0 113.89 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 64.27 26.26 13.68 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 127.999 2.52 . . . . 100.0 113.753 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.76 36.76 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.993 -1.484 . . . . 100.0 106.993 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.437 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.1 mm-40 -97.25 -37.54 10.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.558 -1.275 . . . . 100.0 107.558 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.8 p -142.54 160.14 40.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 122.701 0.4 . . . . 100.0 110.988 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -145.61 149.13 33.97 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 114.202 1.186 . . . . 100.0 114.202 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.5 mt -126.1 126.72 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.379 -2.823 . . . . 100.0 103.379 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 119' ' ' LEU . 51.5 mt -111.78 124.17 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.947 -2.983 . . . . 100.0 102.947 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 42.8 mtt -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.183 -1.371 . . . . 100.0 114.603 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -127.74 158.35 37.87 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.763 -2.471 . . . . 100.0 108.088 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.93 126.56 51.14 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.879 -1.897 . . . . 100.0 105.879 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.54 -21.94 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.332 0.864 . . . . 100.0 113.332 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.8 p -86.99 -8.71 56.93 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 119.266 -0.397 . . . . 100.0 111.167 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.38 115.34 23.32 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.34 1.067 . . . . 100.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -66.84 -38.23 86.01 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 114.895 -1.048 . . . . 100.0 111.383 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.79 -41.0 86.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 125.787 1.635 . . . . 100.0 110.216 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.3 m -62.44 -42.59 99.57 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 118.147 0.43 . . . . 100.0 109.968 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . 0.547 ' CE1' HG23 ' A' ' 136' ' ' ILE . 35.8 t80 -63.12 -41.55 99.36 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.567 0.747 . . . . 100.0 110.801 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.1 mttt -61.25 -37.44 83.11 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 100.0 111.155 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.96 -8.44 57.38 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 115.003 1.483 . . . . 100.0 115.003 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.66 -42.97 94.43 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 116.013 -1.946 . . . . 100.0 111.49 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.1 Cg_exo -57.56 -37.23 97.76 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.074 1.849 . . . . 100.0 112.692 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -63.11 -46.33 87.82 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.366 1.067 . . . . 100.0 110.85 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -64.02 -41.82 97.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 123.25 0.62 . . . . 100.0 111.213 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -61.82 -44.92 95.88 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 124.239 1.016 . . . . 100.0 109.66 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.88 -43.74 97.98 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 118.805 -0.617 . . . . 100.0 112.462 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.15 -45.33 93.92 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 121.251 0.548 . . . . 100.0 110.626 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.457 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.4 tp -62.81 -46.46 87.87 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.986 1.314 . . . . 100.0 112.647 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.19 -38.5 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 C-N-CA 125.237 1.415 . . . . 100.0 111.218 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -60.44 -46.38 90.27 Favored 'General case' 0 C--N 1.358 0.973 0 CA-C-O 118.833 -0.603 . . . . 100.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.75 -46.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 120.238 -0.585 . . . . 100.0 111.502 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.31 115.63 19.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -93.0 147.22 23.01 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.89 -0.596 . . . . 100.0 112.41 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 54.37 45.66 26.7 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.394 1.877 . . . . 100.0 114.871 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 84' ' ' GLN . 34.0 mm -99.35 131.45 25.04 Favored Pre-proline 0 N--CA 1.436 -1.139 0 C-N-CA 126.125 1.77 . . . . 100.0 106.802 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.89 130.02 27.94 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.601 2.2 . . . . 100.0 109.008 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.6 mt -130.47 137.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 122.369 1.081 . . . . 100.0 108.508 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -114.79 130.75 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.265 -2.124 . . . . 100.0 105.265 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 88' ' ' ILE . 34.3 mt -104.97 125.24 50.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.079 -2.563 . . . . 100.0 104.079 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.0 m -115.32 128.26 55.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.853 -1.521 . . . . 100.0 112.301 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.26 103.98 2.88 Favored Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.293 -3.123 . . . . 100.0 105.293 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -80.71 166.5 20.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 125.798 1.639 . . . . 100.0 111.725 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 56.58 44.66 23.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 128.29 2.636 . . . . 100.0 115.416 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.29 28.5 m -71.81 -9.33 12.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 120.416 -0.514 . . . . 100.0 110.724 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.91 -38.85 87.16 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 127.186 2.194 . . . . 100.0 110.279 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.55 129.88 34.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 107.414 -1.328 . . . . 100.0 107.414 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.98 -40.07 96.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 116.54 2.052 . . . . 100.0 116.54 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -85.63 98.69 10.81 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 104.426 -2.435 . . . . 100.0 104.426 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -100.72 109.36 21.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 105.384 -2.08 . . . . 100.0 105.384 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.18 -43.49 61.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.79 1.404 . . . . 100.0 114.79 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 HD11 ' A' ' 136' ' ' ILE . 48.0 t -108.49 108.54 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 104.73 -2.322 . . . . 100.0 104.73 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.01 179.73 4.19 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.189 -0.914 . . . . 100.0 113.422 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.51 -35.16 71.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.154 2.182 . . . . 100.0 109.318 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LYS . . . . . 1.07 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -59.45 -37.1 77.26 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 128.717 2.807 . . . . 100.0 112.017 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.3 p -105.01 -0.49 26.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 120.624 3.565 . . . . 100.0 120.624 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . 0.622 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 54.3 mt -99.46 96.01 4.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 115.372 -2.531 . . . . 100.0 111.346 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -100.06 -6.77 9.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 115.553 1.686 . . . . 100.0 115.553 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -58.79 -35.87 73.52 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.46 ' ND1' HD12 ' A' ' 119' ' ' LEU . 77.7 m-70 -59.63 -39.55 84.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.588 1.555 . . . . 100.0 112.578 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 42.3 ttp180 -59.29 -47.08 86.71 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.108 1.363 . . . . 100.0 112.382 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.04 -43.62 98.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.806 1.242 . . . . 100.0 111.469 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 116.213 1.931 . . . . 100.0 116.213 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 54.6 47.42 22.67 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.296 1.438 . . . . 100.0 113.126 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 117' ' ' ILE . 30.4 mt -107.22 149.63 27.52 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.245 -1.761 . . . . 100.0 106.245 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -96.38 144.47 26.49 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 120.709 -0.397 . . . . 100.0 111.868 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.426 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 77.5 t80 -106.45 133.59 50.9 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 123.766 0.666 . . . . 100.0 112.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -130.01 132.41 46.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.184 -1.371 . . . . 100.0 110.416 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.314 35.2 m-20 -85.15 122.73 29.77 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 102.054 -3.313 . . . . 100.0 102.054 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 pt -135.88 157.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.574 1.178 . . . . 100.0 112.037 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 61.9 m -137.34 112.87 9.39 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.568 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -63.26 -43.88 96.71 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.735 -1.575 . . . . 100.0 112.772 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.83 -41.09 99.19 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.352 1.061 . . . . 100.0 112.098 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.1 p -97.48 2.37 50.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 117.563 2.431 . . . . 100.0 117.563 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 66.67 20.03 10.75 Favored 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.638 1.175 . . . . 100.0 110.846 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.46 -0.571 . . . . 100.0 109.46 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.11 39.79 30.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 128.709 2.804 . . . . 100.0 115.725 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . 0.488 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 76.8 t80 -61.82 -44.89 95.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 121.618 -0.676 . . . . 100.0 112.146 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.14 -37.27 86.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 116.87 2.174 . . . . 100.0 116.87 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.74 -46.82 99.71 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 119.166 3.024 . . . . 100.0 119.166 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -60.7 -42.2 40.92 Favored 'Trans proline' 0 C--N 1.372 1.813 0 CA-C-N 123.204 2.18 . . . . 100.0 111.544 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -64.24 -42.48 96.51 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 124.839 1.256 . . . . 100.0 111.76 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.81 -45.38 92.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 123.775 0.83 . . . . 100.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.18 -43.34 95.42 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 123.549 0.531 . . . . 100.0 110.424 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.5 mt -61.6 -44.07 97.69 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 123.509 0.505 . . . . 100.0 111.508 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.04 97.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.126 0.97 . . . . 100.0 111.062 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -62.43 -45.67 92.03 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 123.242 0.617 . . . . 100.0 112.075 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -65.71 -44.73 85.21 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.76 0.663 . . . . 100.0 111.764 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.0 mt -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 124.073 0.949 . . . . 100.0 113.141 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.16 -38.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.436 -0.579 . . . . 100.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.72 10.53 58.9 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 110.138 -1.185 . . . . 100.0 110.138 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.71 111.74 56.66 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 107.812 -1.181 . . . . 100.0 107.812 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.82 -15.85 29.75 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.776 2.984 . . . . 100.0 113.734 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -87.59 0.32 55.8 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.025 0.93 . . . . 100.0 113.133 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.78 132.03 48.43 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.178 0.591 . . . . 100.0 109.892 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -135.29 152.08 51.16 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 108.679 -0.859 . . . . 100.0 108.679 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -89.11 111.83 22.67 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 104.782 -2.303 . . . . 100.0 104.782 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.08 -43.91 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.243 1.017 . . . . 100.0 110.824 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.51 149.14 49.54 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 121.583 0.706 . . . . 100.0 110.559 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 59.5 ttm -91.39 125.45 57.99 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.433 -2.062 . . . . 100.0 105.433 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.28 157.4 60.23 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 123.039 2.493 . . . . 100.0 111.156 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.35 126.19 27.43 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.1 -1.074 . . . . 100.0 108.1 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.71 145.19 47.74 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 114.36 -1.291 . . . . 100.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.98 138.75 97.49 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.699 -1.223 . . . . 100.0 107.699 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -55.72 138.54 81.59 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.642 2.894 . . . . 100.0 112.3 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.36 129.59 30.42 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.753 2.302 . . . . 100.0 113.726 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -67.08 -43.67 82.03 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 124.774 1.296 . . . . 100.0 108.754 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.77 160.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.322 -1.733 . . . . 100.0 106.322 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.69 130.72 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 107.755 -1.202 . . . . 100.0 107.755 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 tpt -80.88 122.72 27.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.789 -2.3 . . . . 100.0 104.789 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 35.9 t70 -65.9 128.2 93.66 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.13 -0.941 . . . . 100.0 109.411 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 53.7 Cg_exo -59.03 -39.06 83.98 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.54 2.827 . . . . 100.0 113.6 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.98 92.91 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 124.337 1.023 . . . . 100.0 110.832 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.8 -42.75 97.65 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 122.65 0.38 . . . . 100.0 111.653 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.16 97.4 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 123.546 0.738 . . . . 100.0 110.612 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.77 97.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.031 0.932 . . . . 100.0 110.672 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -63.76 -43.08 97.49 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.186 0.594 . . . . 100.0 112.077 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -63.03 -44.16 96.68 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 122.733 0.413 . . . . 100.0 111.273 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.89 -40.64 96.99 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 122.957 0.503 . . . . 100.0 110.477 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.55 -43.93 97.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.75 1.22 . . . . 100.0 110.78 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.06 -42.5 99.26 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.898 0.879 . . . . 100.0 110.169 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' LEU . . . . . 0.502 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.6 tp -59.9 -49.04 79.24 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.156 0.91 . . . . 100.0 110.033 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -43.44 98.12 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 115.203 1.557 . . . . 100.0 115.203 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.33 -46.74 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 CA-C-O 118.388 -0.815 . . . . 100.0 109.673 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.407 . . -94.61 0.54 55.24 Favored 'General case' 0 N--CA 1.404 -2.752 1 C-N-CA 109.655 -4.818 . . . . 100.0 114.332 179.711 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLN . . . . . 0.798 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.301 62.4 mt-30 -56.51 -37.01 69.84 Favored 'General case' 0 CA--C 1.465 -2.32 0 N-CA-C 106.354 -1.721 . . . . 100.0 106.354 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.9 p -82.03 52.82 2.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.247 1.022 . . . . 100.0 109.303 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.324 80.5 p 48.83 38.81 12.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.522 3.129 . . . . 100.0 116.111 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.12 -177.16 6.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.417 -2.438 . . . . 100.0 104.417 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LEU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 85.7 mt -56.46 -41.54 91.67 Favored Pre-proline 0 CA--C 1.502 -0.902 0 CA-C-O 116.014 -1.946 . . . . 100.0 114.545 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PRO . . . . . 1.07 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.309 23.3 Cg_exo -55.35 136.67 74.67 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 121.354 1.519 . . . . 100.0 112.382 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.8 m-20 -63.71 -47.57 80.61 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 124.493 4.997 . . . . 100.0 124.493 -173.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.4 mt-10 -62.88 -35.64 80.69 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 128.285 3.898 . . . . 100.0 107.918 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . 0.798 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.483 44.9 m-20 -65.49 -48.73 71.58 Favored 'General case' 1 N--CA 1.35 -5.426 1 CA-C-N 107.563 -4.381 . . . . 100.0 106.493 -179.017 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.32 -29.85 71.09 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 120.448 -1.407 . . . . 100.0 108.168 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.664 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.35 -42.99 88.13 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-O 117.297 -1.335 . . . . 100.0 113.41 176.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.26 1.645 0 CA-C-O 115.478 -2.201 . . . . 100.0 113.968 -176.288 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.496 -1.118 0 N-CA-C 113.416 0.895 . . . . 100.0 113.416 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.8 -39.36 84.74 Favored 'General case' 0 N--CA 1.441 -0.901 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 -177.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -105.34 156.15 18.44 Favored 'General case' 0 C--N 1.354 0.788 0 N-CA-C 113.407 0.892 . . . . 100.0 113.407 -178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -80.22 160.53 25.57 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 123.843 0.857 . . . . 100.0 110.986 178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.48 7.74 87.14 Favored Glycine 0 C--N 1.354 1.564 0 CA-C-N 116.068 -0.515 . . . . 100.0 113.719 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -81.94 156.65 69.7 Favored Pre-proline 0 N--CA 1.438 -1.072 0 CA-C-N 117.858 0.829 . . . . 100.0 110.953 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -63.71 155.23 64.59 Favored 'Trans proline' 0 C--N 1.373 1.852 0 C-N-CA 123.422 2.748 . . . . 100.0 111.043 178.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -52.95 132.58 37.65 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 118.385 2.735 . . . . 100.0 118.385 -176.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 91.3 t -92.29 116.07 32.63 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 113.094 -1.866 . . . . 100.0 106.472 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -126.74 138.89 53.44 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.904 -1.953 . . . . 100.0 108.102 -179.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -126.66 146.06 50.33 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 108.753 -0.832 . . . . 100.0 108.753 178.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 69.2 mttm -94.67 120.54 35.06 Favored 'General case' 0 N--CA 1.432 -1.332 0 N-CA-C 104.731 -2.322 . . . . 100.0 104.731 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.542 HD23 HG22 ' A' ' 63' ' ' VAL . 55.3 tp -112.12 126.25 54.99 Favored 'General case' 0 N--CA 1.422 -1.869 0 CA-C-N 112.964 -1.926 . . . . 100.0 106.551 -179.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 HG13 ' CE2' ' A' ' 79' ' ' TYR . 43.0 t -101.82 123.19 54.84 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 107.097 -1.446 . . . . 100.0 107.097 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.473 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.5 tp -110.89 116.51 31.36 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 104.094 -2.558 . . . . 100.0 104.094 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 26.1 m -128.8 163.4 33.68 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.151 0 CA-C-O 120.765 0.317 . . . . 100.0 111.797 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.54 173.47 22.76 Favored Glycine 0 CA--C 1.49 -1.517 0 N-CA-C 107.848 -2.101 . . . . 100.0 107.848 179.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -68.12 154.91 40.71 Favored 'General case' 0 CA--C 1.502 -0.876 0 CA-C-O 121.964 0.888 . . . . 100.0 112.574 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.85 140.0 41.64 Favored Glycine 0 C--N 1.355 1.63 0 N-CA-C 107.606 -2.198 . . . . 100.0 107.606 178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.59 -4.34 82.11 Favored Glycine 0 N--CA 1.437 -1.295 0 CA-C-O 118.469 -1.184 . . . . 100.0 113.868 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.607 ' HB ' HD21 ' A' ' 122' ' ' ASN . 19.6 p -62.87 -39.01 93.13 Favored 'General case' 0 C--N 1.363 1.188 0 CA-C-N 119.055 1.428 . . . . 100.0 111.372 178.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.82 22.82 4.53 Favored Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 110.322 -1.111 . . . . 100.0 110.322 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 50.0 mtpt -59.52 -46.56 88.48 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 124.554 1.142 . . . . 100.0 112.889 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -63.23 -44.29 95.68 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 124.411 1.084 . . . . 100.0 110.087 -179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.6 m -62.47 -42.01 99.18 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.294 1.037 . . . . 100.0 109.178 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 58.3 t80 -60.75 -48.73 80.47 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 124.06 0.944 . . . . 100.0 113.285 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.9 -40.89 90.6 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 CA-C-O 121.064 0.459 . . . . 100.0 110.523 -178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.27 99.6 mttt -69.35 -6.85 32.45 Favored 'General case' 0 N--CA 1.434 -1.231 0 N-CA-C 116.174 1.916 . . . . 100.0 116.174 -177.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 49.1 mtt180 -60.7 -37.89 83.17 Favored 'General case' 0 C--N 1.359 0.99 0 N-CA-C 108.03 -1.1 . . . . 100.0 108.03 178.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.437 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 54.0 t-80 -80.87 112.92 18.7 Favored 'General case' 0 C--N 1.363 1.167 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 -178.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.0 mt -62.48 -43.59 98.44 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 115.854 1.798 . . . . 100.0 115.854 -177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.437 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 78.8 m -63.75 -40.95 97.96 Favored 'General case' 0 C--N 1.354 0.786 0 N-CA-C 108.904 -0.776 . . . . 100.0 108.904 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -60.96 -41.78 99.5 Favored Glycine 0 C--N 1.359 1.838 0 N-CA-C 110.388 -1.085 . . . . 100.0 110.388 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . 0.274 81.0 mt-10 -63.77 -45.15 91.09 Favored 'General case' 0 C--N 1.363 1.161 0 CA-C-N 117.38 0.59 . . . . 100.0 111.649 177.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.8 m-30 -62.81 -40.32 97.02 Favored 'General case' 0 C--N 1.355 0.808 0 C-N-CA 124.256 1.022 . . . . 100.0 111.857 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -93.23 8.91 38.34 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 114.841 1.422 . . . . 100.0 114.841 -178.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.7 pttt -60.87 142.57 56.12 Favored 'General case' 0 C--N 1.365 1.24 0 N-CA-C 113.743 1.016 . . . . 100.0 113.743 -178.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -124.01 131.05 53.51 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-N 114.994 -1.003 . . . . 100.0 108.378 -178.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -101.05 123.64 45.53 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 105.541 -2.022 . . . . 100.0 105.541 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.4 t -99.64 112.19 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.946 0 N-CA-C 102.809 -3.034 . . . . 100.0 102.809 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.88 -44.86 94.98 Favored 'General case' 0 CA--C 1.498 -1.035 0 N-CA-C 116.471 2.026 . . . . 100.0 116.471 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.9 m -61.9 -48.44 80.47 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 122.895 0.478 . . . . 100.0 110.578 -178.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.0 mt -71.64 -38.62 70.7 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 114.67 1.359 . . . . 100.0 114.67 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.77 44.04 21.26 Favored Glycine 0 C--N 1.359 1.807 0 N-CA-C 106.312 -2.715 . . . . 100.0 106.312 -176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 94.5 t -129.86 144.61 37.53 Favored 'Isoleucine or valine' 0 C--N 1.358 0.958 0 C-N-CA 124.726 1.21 . . . . 100.0 109.271 -178.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -106.1 118.96 37.97 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 102.077 -3.305 . . . . 100.0 102.077 176.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -102.46 120.88 52.84 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 N-CA-C 106.267 -1.753 . . . . 100.0 106.267 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.0 m80 -113.16 119.5 42.23 Favored Pre-proline 0 N--CA 1.434 -1.234 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.55 -178.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -80.32 104.25 1.61 Allowed 'Trans proline' 0 C--N 1.364 1.362 0 C-N-CA 122.654 2.236 . . . . 100.0 109.528 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -98.4 113.97 26.15 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 108.31 -0.996 . . . . 100.0 108.31 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.0 t -99.85 127.19 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.837 0 N-CA-C 107.272 -1.381 . . . . 100.0 107.272 -178.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -121.56 135.09 55.03 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 105.461 -2.052 . . . . 100.0 105.461 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.6 m-70 -102.52 117.6 35.05 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 109.32 -0.622 . . . . 100.0 109.32 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 17.5 p -107.09 175.92 5.34 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-O 121.816 0.817 . . . . 100.0 110.288 -179.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.26 -35.0 74.52 Favored 'General case' 0 N--CA 1.442 -0.849 0 C-N-CA 125.314 1.445 . . . . 100.0 109.502 177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.9 mtt180 -87.59 -2.33 58.54 Favored 'General case' 0 C--N 1.359 1.017 0 N-CA-C 113.499 0.926 . . . . 100.0 113.499 177.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 121.6 -179.72 16.2 Favored Glycine 0 C--N 1.354 1.57 0 N-CA-C 110.593 -1.003 . . . . 100.0 110.593 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -66.74 140.13 54.94 Favored 'Trans proline' 0 N--CA 1.44 -1.621 0 C-N-CA 122.869 2.379 . . . . 100.0 115.833 -179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.9 mt -128.13 130.06 69.56 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.959 0 N-CA-C 102.304 -3.221 . . . . 100.0 102.304 177.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.2 mttt -112.45 128.35 56.29 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 109.397 -0.594 . . . . 100.0 109.397 -179.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -110.19 116.31 31.28 Favored 'General case' 0 N--CA 1.434 -1.261 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 176.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.9 m-80 -87.67 106.8 18.28 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.812 -4.144 . . . . 100.0 99.812 178.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.542 HG22 HD23 ' A' ' 13' ' ' LEU . 22.6 t -93.36 123.76 45.56 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.396 0 N-CA-C 106.412 -1.699 . . . . 100.0 106.412 -176.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 21.5 m0 -97.8 114.5 26.55 Favored 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 105.838 -1.912 . . . . 100.0 105.838 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 39.1 t70 -109.33 135.2 50.78 Favored 'General case' 0 CA--C 1.493 -1.22 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 81.5 p -72.28 163.45 27.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.874 0.845 . . . . 100.0 112.559 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.14 20.55 12.2 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.206 -0.906 . . . . 100.0 108.586 178.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.85 12.21 58.16 Favored Glycine 0 C--N 1.359 1.847 0 CA-C-O 119.341 -0.699 . . . . 100.0 114.128 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.41 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 90.7 mt-30 -60.29 -31.37 70.18 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 126.259 1.824 . . . . 100.0 112.591 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -57.54 -32.38 67.02 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 127.924 2.49 . . . . 100.0 111.813 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -62.88 -39.62 95.03 Favored 'General case' 0 N--CA 1.436 -1.164 0 C-N-CA 123.527 0.731 . . . . 100.0 111.565 178.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.41 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 22.9 p90 -94.87 -14.14 24.83 Favored 'General case' 0 C--N 1.365 1.242 0 N-CA-C 114.774 1.398 . . . . 100.0 114.774 -179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.58 -160.36 26.96 Favored Glycine 0 C--N 1.356 1.686 0 C-N-CA 119.933 -1.127 . . . . 100.0 112.422 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.02 176.95 54.54 Favored Glycine 0 C--N 1.355 1.587 0 N-CA-C 109.874 -1.29 . . . . 100.0 109.874 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.438 HD13 ' CE2' ' A' ' 79' ' ' TYR . 86.9 mt -105.31 143.5 33.4 Favored 'General case' 0 CA--C 1.489 -1.387 0 N-CA-C 108.49 -0.929 . . . . 100.0 108.49 -179.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -70.5 160.11 33.04 Favored 'General case' 0 N--CA 1.432 -1.338 0 CA-C-N 115.02 -0.991 . . . . 100.0 113.175 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 63.6 m-20 -59.48 -37.99 79.66 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 125.443 1.497 . . . . 100.0 110.237 -179.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.37 91.8 Favored Glycine 0 C--N 1.358 1.797 0 C-N-CA 124.77 1.176 . . . . 100.0 111.29 -179.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.475 ' CE2' HG13 ' A' ' 14' ' ' VAL . 76.0 t80 -62.98 -47.0 85.01 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 117.33 0.565 . . . . 100.0 111.218 177.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -70.51 -36.73 73.95 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 116.976 2.213 . . . . 100.0 116.976 -179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.5 mt -50.86 134.64 11.41 Favored 'Isoleucine or valine' 0 C--N 1.361 1.069 0 CA-C-O 123.189 1.471 . . . . 100.0 114.796 -175.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 61.19 29.26 18.67 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 128.023 2.529 . . . . 100.0 113.877 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.11 133.12 42.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 106.313 -1.736 . . . . 100.0 106.313 176.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -96.39 -26.26 15.41 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 110.103 -0.332 . . . . 100.0 110.103 178.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.497 ' HB2' HD22 ' A' ' 164' ' ' LEU . 18.7 p -153.22 162.61 41.11 Favored 'General case' 0 N--CA 1.435 -1.22 0 CA-C-O 120.852 0.358 . . . . 100.0 110.839 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.414 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.6 152.84 38.6 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 114.413 1.264 . . . . 100.0 114.413 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 97.6 mt -126.17 125.89 68.55 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.226 0 N-CA-C 103.41 -2.811 . . . . 100.0 103.41 176.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.554 ' HB ' HD22 ' A' ' 119' ' ' LEU . 48.6 mt -109.74 125.31 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.112 0 N-CA-C 102.87 -3.011 . . . . 100.0 102.87 178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.473 ' SD ' HD11 ' A' ' 15' ' ' LEU . 89.3 mtp -110.46 135.91 50.41 Favored 'General case' 0 N--CA 1.428 -1.565 0 N-CA-C 113.923 1.083 . . . . 100.0 113.923 -177.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -129.76 162.43 28.45 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-N 112.686 -2.052 . . . . 100.0 107.14 176.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -106.53 124.37 49.5 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 106.962 -1.496 . . . . 100.0 106.962 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -65.18 -18.86 24.59 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.732 0 N-CA-C 114.211 1.189 . . . . 100.0 114.211 -179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.5 p -89.44 -7.5 54.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 118.378 0.535 . . . . 100.0 111.18 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 m -124.98 116.78 22.71 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-O 122.596 1.189 . . . . 100.0 110.329 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 83.5 mtm-85 -63.32 -38.51 91.43 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 125.459 1.503 . . . . 100.0 111.872 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 63.2 t -59.59 -40.88 83.24 Favored 'Isoleucine or valine' 0 C--N 1.355 0.831 0 C-N-CA 125.872 1.669 . . . . 100.0 110.72 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.2 p -62.19 -41.53 98.43 Favored 'General case' 0 C--N 1.357 0.924 0 CA-C-N 118.192 0.451 . . . . 100.0 111.77 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 69.7 t80 -65.02 -40.95 95.61 Favored 'General case' 0 C--N 1.356 0.877 0 C-N-CA 123.559 0.743 . . . . 100.0 110.251 177.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.497 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.1 mttt -61.38 -36.45 80.29 Favored 'General case' 0 N--CA 1.442 -0.862 0 C-N-CA 124.531 1.132 . . . . 100.0 111.142 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -81.18 -3.85 53.53 Favored 'General case' 0 C--N 1.358 0.94 0 N-CA-C 115.272 1.582 . . . . 100.0 115.272 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.576 HG11 HD13 ' A' ' 119' ' ' LEU . 77.2 t -60.55 -41.94 85.73 Favored Pre-proline 0 C--N 1.362 1.128 0 CA-C-O 116.572 -1.68 . . . . 100.0 111.182 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 63.0 Cg_exo -56.86 -38.3 96.17 Favored 'Trans proline' 0 C--N 1.377 2.033 0 C-N-CA 122.292 1.995 . . . . 100.0 112.864 177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.61 -45.25 91.19 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 124.59 1.156 . . . . 100.0 110.873 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 72.9 m95 -64.46 -41.36 96.57 Favored 'General case' 0 CA--C 1.495 -1.163 0 O-C-N 123.122 0.264 . . . . 100.0 111.356 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.7 t60 -62.21 -44.32 96.84 Favored 'General case' 0 N--CA 1.435 -1.195 0 C-N-CA 123.619 0.767 . . . . 100.0 110.14 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 82.6 mtp180 -61.99 -45.26 94.42 Favored 'General case' 0 CA--C 1.495 -1.152 0 CA-C-O 119.015 -0.517 . . . . 100.0 112.179 -179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 81.7 m-20 -63.53 -42.43 98.44 Favored 'General case' 0 CA--C 1.501 -0.923 0 O-C-N 123.24 0.337 . . . . 100.0 111.85 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD21 ' HB3' ' A' ' 86' ' ' ALA . 50.6 tp -62.9 -48.16 80.17 Favored 'General case' 0 N--CA 1.436 -1.171 0 C-N-CA 123.783 0.833 . . . . 100.0 112.469 179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.279 22.9 m -67.2 -29.23 45.23 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.355 0 N-CA-C 113.544 0.942 . . . . 100.0 113.544 -179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -60.62 -47.28 86.93 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 108.778 -0.823 . . . . 100.0 108.778 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 57.8 t -74.85 -45.04 44.73 Favored 'Isoleucine or valine' 0 C--N 1.357 0.926 0 N-CA-C 112.598 0.592 . . . . 100.0 112.598 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 76.7 m -124.61 107.79 11.39 Favored 'General case' 0 CA--C 1.497 -1.094 0 CA-C-O 121.985 0.898 . . . . 100.0 110.077 -178.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -86.89 140.05 30.03 Favored 'General case' 0 N--CA 1.437 -1.111 0 CA-C-N 115.358 -0.837 . . . . 100.0 111.59 -178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 71.3 m-20 55.13 39.57 31.52 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 126.981 2.113 . . . . 100.0 116.701 178.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.8 pt -93.1 144.99 29.24 Favored Pre-proline 0 N--CA 1.444 -0.768 0 N-CA-C 106.635 -1.617 . . . . 100.0 106.635 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_exo -62.59 132.08 36.39 Favored 'Trans proline' 0 C--N 1.367 1.537 0 C-N-CA 123.21 2.606 . . . . 100.0 109.691 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.801 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.0 mt -134.18 137.57 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 CA-C-O 122.198 0.999 . . . . 100.0 108.364 -178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.6 t -117.13 132.1 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.232 0 N-CA-C 105.593 -2.002 . . . . 100.0 105.593 178.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.576 HD13 HG11 ' A' ' 101' ' ' VAL 0.294 23.2 mt -105.95 131.04 53.74 Favored 'General case' 0 N--CA 1.437 -1.094 0 N-CA-C 103.725 -2.694 . . . . 100.0 103.725 175.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.9 m -119.49 131.21 55.54 Favored 'General case' 0 N--CA 1.424 -1.753 0 CA-C-N 114.052 -1.431 . . . . 100.0 112.48 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.3 104.97 2.89 Favored Glycine 0 CA--C 1.486 -1.757 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.607 HD21 ' HB ' ' A' ' 21' ' ' THR . 24.6 p30 -86.73 173.21 9.61 Favored 'General case' 0 N--CA 1.432 -1.348 0 N-CA-C 114.185 1.179 . . . . 100.0 114.185 -178.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.3 mttp 60.26 40.39 17.91 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 128.141 2.576 . . . . 100.0 113.725 -179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.339 28.5 m -71.76 -7.79 10.02 Favored 'Isoleucine or valine' 0 C--N 1.36 1.042 0 C-N-CA 120.33 -0.548 . . . . 100.0 111.495 178.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -62.71 -38.21 89.55 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 126.464 1.906 . . . . 100.0 110.334 175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 87.4 mt -69.74 130.18 34.27 Favored 'Isoleucine or valine' 0 C--N 1.36 1.051 0 N-CA-C 108.514 -0.921 . . . . 100.0 108.514 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -62.14 -41.82 98.64 Favored 'General case' 0 CA--C 1.497 -1.066 0 N-CA-C 117.223 2.305 . . . . 100.0 117.223 -177.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 61.2 t0 -85.49 94.57 9.04 Favored 'General case' 0 C--N 1.357 0.925 0 N-CA-C 106.146 -1.798 . . . . 100.0 106.146 179.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.9 ttt180 -92.66 123.96 36.33 Favored 'General case' 0 N--CA 1.436 -1.164 0 N-CA-C 104.921 -2.251 . . . . 100.0 104.921 179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -97.69 -36.62 10.19 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 113.301 0.852 . . . . 100.0 113.301 -178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 57.5 t -102.93 104.07 16.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.878 0 N-CA-C 103.752 -2.684 . . . . 100.0 103.752 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -97.25 172.77 7.59 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 114.905 -1.043 . . . . 100.0 111.513 -178.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.411 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.08 -31.9 65.71 Favored 'General case' 0 C--N 1.353 0.755 0 C-N-CA 126.267 1.827 . . . . 100.0 109.401 -179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.028 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -57.11 -39.08 74.39 Favored 'General case' 0 N--CA 1.42 -1.962 0 C-N-CA 130.092 3.357 . . . . 100.0 111.391 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.2 p -105.06 2.27 29.31 Favored 'General case' 0 N--CA 1.435 -1.181 0 N-CA-C 117.047 2.24 . . . . 100.0 117.047 -177.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 60.3 mt -89.43 84.2 2.28 Favored 'Isoleucine or valine' 0 C--N 1.361 1.088 0 C-N-CA 118.062 -1.455 . . . . 100.0 110.576 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 2.3 p -100.81 -6.09 9.14 Favored 'Isoleucine or valine' 0 C--N 1.353 0.756 0 N-CA-C 116.483 2.031 . . . . 100.0 116.483 -177.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.545 ' HD2' HD11 ' A' ' 119' ' ' LEU . 65.8 t80 -59.37 -37.37 77.73 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 116.09 1.885 . . . . 100.0 116.09 -173.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.554 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.275 78.6 m-70 -59.5 -37.97 79.69 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 116.718 2.118 . . . . 100.0 116.718 -177.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.866 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 43.6 ttp85 -59.01 -49.28 78.48 Favored 'General case' 0 CA--C 1.471 -2.092 0 O-C-N 124.178 0.924 . . . . 100.0 112.964 -176.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -62.63 -41.19 98.88 Favored 'General case' 0 N--CA 1.429 -1.482 0 O-C-N 125.456 1.723 . . . . 100.0 111.074 -178.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.409 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.6 mmtt -95.04 0.32 54.4 Favored 'General case' 0 N--CA 1.43 -1.437 0 N-CA-C 117.206 2.298 . . . . 100.0 117.206 -175.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 58.32 40.04 24.9 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 125.155 1.382 . . . . 100.0 112.218 -179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.801 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.6 mt -101.9 152.52 20.82 Favored 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 105.754 -1.943 . . . . 100.0 105.754 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -100.29 143.24 30.71 Favored 'General case' 0 CA--C 1.492 -1.284 0 N-CA-C 109.206 -0.665 . . . . 100.0 109.206 178.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.554 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 84.4 t80 -110.32 136.53 49.36 Favored 'General case' 0 CA--C 1.482 -1.644 0 N-CA-C 114.299 1.222 . . . . 100.0 114.299 -178.173 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -134.42 137.61 44.15 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 114.432 -1.258 . . . . 100.0 111.18 175.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.276 72.6 m-20 -84.72 128.64 34.7 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 102.688 -3.078 . . . . 100.0 102.688 175.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.513 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.8 pt -134.22 157.84 41.82 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.834 0 CA-C-O 122.702 1.239 . . . . 100.0 111.303 179.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.486 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 70.4 m -139.04 108.49 6.15 Favored 'General case' 0 CA--C 1.48 -1.714 0 N-CA-C 104.861 -2.274 . . . . 100.0 104.861 175.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.8 -44.18 97.38 Favored 'General case' 0 CA--C 1.491 -1.31 0 CA-C-N 114.712 -1.131 . . . . 100.0 112.529 -178.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -61.47 -39.24 90.16 Favored 'General case' 0 N--CA 1.432 -1.371 0 C-N-CA 124.853 1.261 . . . . 100.0 112.734 -178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 92.3 p -100.31 2.09 42.23 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 115.868 1.803 . . . . 100.0 115.868 -178.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' ARG . 68.0 m-80 65.19 20.68 12.0 Favored 'General case' 0 C--N 1.361 1.082 0 C-N-CA 124.94 1.296 . . . . 100.0 110.99 -177.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.486 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 83.4 t80 -72.94 125.7 28.21 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 108.473 -0.936 . . . . 100.0 108.473 -178.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 54.05 36.68 25.2 Favored 'General case' 0 N--CA 1.436 -1.154 0 C-N-CA 128.185 2.594 . . . . 100.0 114.584 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 64.3 t80 -60.8 -43.84 97.62 Favored 'General case' 0 C--N 1.359 0.99 0 O-C-N 121.881 -0.512 . . . . 100.0 111.349 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -63.67 -38.49 91.31 Favored 'General case' 0 N--CA 1.433 -1.314 0 N-CA-C 116.499 2.037 . . . . 100.0 116.499 -178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -57.12 -47.97 98.19 Favored Pre-proline 0 C--N 1.358 0.938 0 N-CA-C 120.097 3.369 . . . . 100.0 120.097 -172.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.15 -41.08 45.67 Favored 'Trans proline' 0 C--N 1.37 1.669 0 CA-C-N 123.475 2.277 . . . . 100.0 112.592 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -64.21 -42.45 96.59 Favored 'General case' 0 CA--C 1.49 -1.34 0 C-N-CA 124.712 1.205 . . . . 100.0 110.814 -178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 60.2 tp -64.23 -44.29 92.32 Favored 'General case' 0 N--CA 1.436 -1.149 0 CA-C-O 118.795 -0.621 . . . . 100.0 111.628 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -64.88 -42.26 94.96 Favored 'General case' 0 C--N 1.362 1.131 0 O-C-N 123.499 0.499 . . . . 100.0 110.389 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.497 HD22 ' HB2' ' A' ' 85' ' ' CYS . 77.8 mt -61.54 -43.82 98.16 Favored 'General case' 0 CA--C 1.496 -1.1 0 O-C-N 123.453 0.47 . . . . 100.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.52 -44.18 97.52 Favored 'General case' 0 CA--C 1.495 -1.15 0 C-N-CA 124.076 0.951 . . . . 100.0 110.656 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.7 mtt180 -61.58 -45.6 93.42 Favored 'General case' 0 CA--C 1.494 -1.189 0 C-N-CA 122.672 0.389 . . . . 100.0 111.783 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 60.4 tptt -66.17 -44.54 83.76 Favored 'General case' 0 N--CA 1.435 -1.198 0 N-CA-C 112.858 0.688 . . . . 100.0 112.858 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -64.26 -45.19 89.18 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 113.451 0.908 . . . . 100.0 113.451 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 50.9 mm -74.52 -30.67 25.96 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 C-N-CA 123.902 0.881 . . . . 100.0 110.11 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 86.79 13.82 66.28 Favored Glycine 0 C--N 1.354 1.567 0 CA-C-O 118.635 -1.091 . . . . 100.0 111.447 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -116.39 112.31 41.55 Favored Pre-proline 0 C--N 1.363 1.168 0 CA-C-N 118.439 1.119 . . . . 100.0 108.044 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -70.99 -14.1 31.98 Favored 'Trans proline' 0 C--N 1.367 1.531 0 C-N-CA 123.749 2.966 . . . . 100.0 113.255 179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -85.63 -3.18 58.81 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 124.125 0.97 . . . . 100.0 113.026 -178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 81.7 mt -60.84 134.21 56.86 Favored 'General case' 0 C--N 1.364 1.229 0 N-CA-C 113.226 0.825 . . . . 100.0 113.226 -179.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -135.14 149.29 49.96 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 114.525 -1.216 . . . . 100.0 108.235 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -90.03 114.62 26.53 Favored 'General case' 0 CA--C 1.499 -0.983 0 N-CA-C 103.525 -2.769 . . . . 100.0 103.525 177.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 30.6 m -68.24 -40.04 82.06 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.928 0 N-CA-C 113.933 1.086 . . . . 100.0 113.933 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -131.53 146.8 52.4 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 -179.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.8 mtt -88.27 129.61 48.99 Favored Pre-proline 0 N--CA 1.432 -1.337 0 N-CA-C 106.336 -1.727 . . . . 100.0 106.336 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_exo -65.27 158.48 52.14 Favored 'Trans proline' 0 N--CA 1.443 -1.464 0 C-N-CA 122.276 1.984 . . . . 100.0 110.482 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -66.43 124.88 23.98 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 107.722 -1.214 . . . . 100.0 107.722 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 81.4 mt -118.54 145.85 45.02 Favored 'General case' 0 CA--C 1.485 -1.551 0 CA-C-N 114.263 -1.335 . . . . 100.0 110.403 -177.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.38 136.28 96.63 Favored Pre-proline 0 N--CA 1.439 -1.007 0 N-CA-C 105.796 -1.927 . . . . 100.0 105.796 177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -54.79 138.88 77.58 Favored 'Trans proline' 0 C--N 1.362 1.279 0 C-N-CA 123.55 2.833 . . . . 100.0 112.553 -178.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -57.81 129.09 31.71 Favored 'Trans proline' 0 N--CA 1.442 -1.558 0 C-N-CA 122.23 1.954 . . . . 100.0 113.509 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -66.86 -43.8 82.65 Favored 'General case' 0 CA--C 1.5 -0.974 0 O-C-N 124.701 1.251 . . . . 100.0 108.085 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.6 m -132.12 158.24 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 N-CA-C 106.58 -1.637 . . . . 100.0 106.58 178.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 9.6 p -98.42 131.89 44.62 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.47 123.91 32.88 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 103.654 -2.721 . . . . 100.0 103.654 178.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -62.85 128.65 92.29 Favored Pre-proline 0 N--CA 1.435 -1.19 0 CA-C-N 114.779 -1.101 . . . . 100.0 110.565 -178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_exo -58.7 -37.65 93.09 Favored 'Trans proline' 0 C--N 1.367 1.546 0 C-N-CA 123.725 2.95 . . . . 100.0 113.546 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.52 -43.06 95.23 Favored 'General case' 0 C--N 1.36 1.044 0 O-C-N 123.979 0.8 . . . . 100.0 110.34 179.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.1 mt -63.3 -42.22 99.03 Favored 'General case' 0 CA--C 1.499 -0.984 0 C-N-CA 122.769 0.428 . . . . 100.0 111.147 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.08 -44.2 97.73 Favored 'General case' 0 C--N 1.36 1.06 0 C-N-CA 123.703 0.801 . . . . 100.0 110.625 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.37 -44.03 97.44 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 123.508 0.723 . . . . 100.0 110.91 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -62.26 -44.75 95.83 Favored 'General case' 0 C--N 1.36 1.061 0 C-N-CA 123.758 0.823 . . . . 100.0 112.075 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.4 m-30 -63.49 -43.51 97.04 Favored 'General case' 0 CA--C 1.499 -0.99 0 C-N-CA 122.918 0.487 . . . . 100.0 111.793 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -64.19 -39.83 94.83 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 116.707 -0.224 . . . . 100.0 111.19 178.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.4 t60 -62.78 -42.67 99.8 Favored 'General case' 0 N--CA 1.442 -0.832 0 C-N-CA 124.158 0.983 . . . . 100.0 110.007 178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -61.51 -42.35 98.68 Favored 'General case' 0 C--N 1.359 1.01 0 C-N-CA 123.838 0.855 . . . . 100.0 110.645 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.521 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 81.9 mt -61.03 -48.43 81.84 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 115.391 -0.822 . . . . 100.0 109.387 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -63.48 -41.84 98.57 Favored 'General case' 0 CA--C 1.495 -1.147 0 N-CA-C 114.711 1.374 . . . . 100.0 114.711 -178.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.6 t -59.66 -47.14 92.24 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.968 0 CA-C-O 118.221 -0.895 . . . . 100.0 109.124 -177.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.959 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.705 . . -88.87 -8.67 53.85 Favored 'General case' 1 N--CA 1.379 -4.008 1 C-N-CA 104.543 -6.863 . . . . 100.0 116.647 179.881 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 1.037 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 55.1 mt-30 -53.48 -34.89 59.7 Favored 'General case' 0 CA--C 1.444 -3.108 0 C-N-CA 128.179 2.591 . . . . 100.0 107.507 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -82.73 41.47 0.73 Allowed 'General case' 0 N--CA 1.416 -2.133 0 O-C-N 124.825 1.328 . . . . 100.0 109.766 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 205' ' ' GLN . 4.6 m 57.96 30.24 18.86 Favored 'General case' 0 CA--C 1.473 -1.988 0 C-N-CA 127.13 2.172 . . . . 100.0 112.578 175.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.511 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.275 . . -73.61 175.51 7.05 Favored 'General case' 0 N--CA 1.396 -3.132 0 N-CA-C 101.155 -3.646 . . . . 100.0 101.155 171.91 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 68.1 mt -56.03 -36.7 49.04 Favored Pre-proline 0 CA--C 1.489 -1.393 0 CA-C-O 116.359 -1.781 . . . . 100.0 114.024 -174.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.028 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.457 0.3 OUTLIER -53.58 137.79 66.35 Favored 'Trans proline' 0 N--CA 1.433 -2.088 0 O-C-N 123.814 1.428 . . . . 100.0 112.634 176.602 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.628 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.305 99.3 m-20 -64.01 -43.03 96.86 Favored 'General case' 0 N--CA 1.405 -2.695 0 N-CA-C 121.499 3.888 . . . . 100.0 121.499 -172.552 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.585 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.1 tm-20 -71.42 -16.03 62.37 Favored 'General case' 0 CA--C 1.463 -2.394 1 CA-C-O 130.799 5.095 . . . . 100.0 112.989 177.989 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 1.037 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.785 66.3 m-20 -86.07 -50.04 7.33 Favored 'General case' 1 N--CA 1.257 -10.116 1 CA-C-N 105.781 -5.19 . . . . 100.0 104.025 -172.932 . . . . . . . . 5 3 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 140' ' ' ARG . 37.8 t70 -62.05 -28.96 69.96 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.255 -2.153 . . . . 100.0 106.528 176.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.866 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 73.0 m-20 -61.77 -40.29 94.64 Favored 'General case' 0 CA--C 1.476 -1.889 0 C-N-CA 126.925 2.09 . . . . 100.0 112.591 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.62 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.283 0.6 OUTLIER . . . . . 0 N--CA 1.428 -1.558 0 CA-C-O 115.334 -2.27 . . . . 100.0 114.301 -178.645 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 mtt . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.598 0.237 . . . . 100.0 110.658 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.17 68.51 9.93 Favored 'General case' 0 C--N 1.359 1.011 0 N-CA-C 107.081 -1.451 . . . . 100.0 107.081 179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -152.13 158.67 43.26 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 107.468 -1.308 . . . . 100.0 107.468 -179.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 97.4 mm-40 -84.99 156.58 21.08 Favored 'General case' 0 N--CA 1.435 -1.196 0 CA-C-N 115.489 -0.778 . . . . 100.0 109.058 178.581 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.83 8.26 84.58 Favored Glycine 0 C--N 1.354 1.547 0 CA-C-O 119.377 -0.68 . . . . 100.0 113.796 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 68.5 mm-40 -71.92 138.57 82.43 Favored Pre-proline 0 N--CA 1.439 -0.978 0 CA-C-N 117.911 0.855 . . . . 100.0 110.965 179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -62.05 135.43 54.96 Favored 'Trans proline' 0 C--N 1.369 1.649 0 C-N-CA 122.607 2.205 . . . . 100.0 109.841 179.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -76.02 150.89 37.29 Favored 'General case' 0 CA--C 1.49 -1.341 0 O-C-N 124.555 1.16 . . . . 100.0 112.935 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.3 t -93.18 109.67 22.08 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.194 0 N-CA-C 101.759 -3.422 . . . . 100.0 101.759 178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.6 mt-30 -128.58 138.13 52.06 Favored 'General case' 0 CA--C 1.496 -1.123 0 CA-C-N 115.534 -0.757 . . . . 100.0 109.876 -178.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -128.75 144.09 51.08 Favored 'General case' 0 CA--C 1.497 -1.078 0 N-CA-C 109.561 -0.533 . . . . 100.0 109.561 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.4 122.54 34.09 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 105.596 -2.001 . . . . 100.0 105.596 177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.5 tt -114.21 126.53 55.16 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 105.722 -1.955 . . . . 100.0 105.722 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.428 HG13 ' CE2' ' A' ' 79' ' ' TYR . 67.7 t -104.27 124.36 58.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.107 0 N-CA-C 107.773 -1.195 . . . . 100.0 107.773 179.269 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.418 HD11 ' SD ' ' A' ' 89' ' ' MET . 38.1 tp -108.7 118.83 37.8 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 106.039 -1.837 . . . . 100.0 106.039 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.7 m -129.81 162.36 37.63 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.057 0 CA-C-N 115.974 -0.557 . . . . 100.0 111.802 -178.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.24 172.78 22.52 Favored Glycine 0 CA--C 1.487 -1.685 0 N-CA-C 108.015 -2.034 . . . . 100.0 108.015 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -66.74 153.45 43.22 Favored 'General case' 0 N--CA 1.439 -1.006 0 CA-C-O 121.958 0.885 . . . . 100.0 111.973 -179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.24 140.89 43.89 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.471 -2.252 . . . . 100.0 107.471 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 88.57 -3.08 85.12 Favored Glycine 0 N--CA 1.44 -1.089 0 CA-C-O 118.568 -1.129 . . . . 100.0 114.37 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.0 p -62.77 -38.53 90.97 Favored 'General case' 0 CA--C 1.493 -1.232 0 CA-C-N 118.868 1.334 . . . . 100.0 112.248 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 117.27 23.55 3.79 Favored Glycine 0 C--N 1.353 1.525 0 N-CA-C 110.247 -1.141 . . . . 100.0 110.247 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 51.8 mtpt -59.98 -47.78 84.4 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 124.382 1.073 . . . . 100.0 113.163 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.9 m -64.17 -42.76 96.58 Favored 'General case' 0 N--CA 1.438 -1.062 0 C-N-CA 123.906 0.882 . . . . 100.0 110.42 -179.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.3 m -62.53 -42.04 99.26 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 124.209 1.004 . . . . 100.0 109.309 -179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -60.29 -49.59 77.01 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.663 1.185 . . . . 100.0 112.646 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 99.6 t -65.37 -41.63 91.69 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.725 0 O-C-N 123.547 0.529 . . . . 100.0 111.168 -178.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.302 99.4 mttt -69.45 -6.63 31.61 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 115.775 1.769 . . . . 100.0 115.775 -176.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.634 HH11 ' HA ' ' A' ' 154' ' ' ASN . 43.2 mtm180 -60.23 -38.22 82.75 Favored 'General case' 0 C--N 1.36 1.053 0 N-CA-C 109.013 -0.736 . . . . 100.0 109.013 177.128 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -81.32 112.22 18.41 Favored 'General case' 0 C--N 1.362 1.142 0 N-CA-C 106.637 -1.616 . . . . 100.0 106.637 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -61.92 -45.12 95.11 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 116.191 1.923 . . . . 100.0 116.191 -177.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.8 m -63.73 -41.15 98.1 Favored 'General case' 0 C--N 1.354 0.78 0 C-N-CA 123.252 0.621 . . . . 100.0 109.63 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -41.66 99.59 Favored Glycine 0 C--N 1.358 1.799 0 N-CA-C 110.841 -0.904 . . . . 100.0 110.841 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -63.76 -46.52 84.94 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 123.824 0.85 . . . . 100.0 111.14 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 39.5 m-85 -63.96 -39.63 94.57 Favored 'General case' 0 CA--C 1.503 -0.858 0 N-CA-C 113.003 0.742 . . . . 100.0 113.003 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -93.27 11.65 27.32 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 115.4 1.63 . . . . 100.0 115.4 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.0 pttt -60.85 144.84 51.95 Favored 'General case' 0 C--N 1.359 1.008 0 N-CA-C 113.896 1.073 . . . . 100.0 113.896 -178.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -122.23 130.74 53.47 Favored 'General case' 0 CA--C 1.498 -1.045 0 N-CA-C 108.219 -1.03 . . . . 100.0 108.219 179.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -101.06 125.46 47.68 Favored 'General case' 0 N--CA 1.437 -1.123 0 N-CA-C 107.876 -1.157 . . . . 100.0 107.876 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 89.1 t -99.32 109.18 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.902 0 N-CA-C 102.42 -3.178 . . . . 100.0 102.42 179.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.17 -43.47 98.17 Favored 'General case' 0 CA--C 1.498 -1.036 0 N-CA-C 116.649 2.092 . . . . 100.0 116.649 -177.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.4 m -61.92 -44.29 97.08 Favored 'General case' 0 C--N 1.353 0.746 0 C-N-CA 124.004 0.922 . . . . 100.0 110.925 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.5 mt -88.76 -21.39 23.83 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 114.303 1.223 . . . . 100.0 114.303 -179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 70.7 45.72 51.01 Favored Glycine 0 C--N 1.36 1.898 0 N-CA-C 109.296 -1.522 . . . . 100.0 109.296 -178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.0 t -126.84 144.17 37.9 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 109.147 -0.686 . . . . 100.0 109.147 -178.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 76.7 mt-10 -108.26 118.33 36.49 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 101.598 -3.482 . . . . 100.0 101.598 176.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.21 120.09 52.63 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 105.71 -1.959 . . . . 100.0 105.71 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 40.2 m-70 -111.52 119.43 45.08 Favored Pre-proline 0 N--CA 1.433 -1.301 0 CA-C-N 115.825 -0.625 . . . . 100.0 110.076 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -80.46 103.31 1.5 Allowed 'Trans proline' 0 N--CA 1.444 -1.421 0 C-N-CA 122.604 2.203 . . . . 100.0 111.062 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.7 mp -97.35 116.03 28.81 Favored 'General case' 0 CA--C 1.496 -1.126 0 N-CA-C 108.011 -1.107 . . . . 100.0 108.011 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 46.5 t -100.21 128.46 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 N-CA-C 107.278 -1.378 . . . . 100.0 107.278 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -122.38 135.6 54.73 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 105.344 -2.095 . . . . 100.0 105.344 178.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -102.08 117.49 34.9 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 108.138 -1.06 . . . . 100.0 108.138 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.8 p -108.56 175.59 5.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-O 121.761 0.791 . . . . 100.0 110.361 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.8 p-10 -60.52 -32.97 71.97 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 125.39 1.476 . . . . 100.0 109.919 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -92.37 3.81 54.68 Favored 'General case' 0 C--N 1.358 0.966 0 N-CA-C 113.401 0.889 . . . . 100.0 113.401 178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 117.92 177.93 17.26 Favored Glycine 0 C--N 1.353 1.527 0 O-C-N 121.274 -0.891 . . . . 100.0 111.67 179.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.11 140.45 59.66 Favored 'Trans proline' 0 N--CA 1.444 -1.413 0 C-N-CA 123.16 2.573 . . . . 100.0 114.751 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.3 mt -129.3 131.12 67.79 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.926 0 N-CA-C 103.057 -2.942 . . . . 100.0 103.057 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.2 mttt -114.4 128.77 56.51 Favored 'General case' 0 N--CA 1.436 -1.161 0 N-CA-C 109.569 -0.53 . . . . 100.0 109.569 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -111.47 115.7 29.65 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 104.946 -2.242 . . . . 100.0 104.946 177.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -88.32 105.81 17.81 Favored 'General case' 0 CA--C 1.491 -1.319 0 N-CA-C 101.051 -3.685 . . . . 100.0 101.051 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 61.6 t -93.53 123.3 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.341 0 N-CA-C 107.87 -1.159 . . . . 100.0 107.87 -176.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.6 m0 -95.03 115.73 27.8 Favored 'General case' 0 N--CA 1.424 -1.765 0 N-CA-C 107.041 -1.466 . . . . 100.0 107.041 -179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -111.13 137.62 48.57 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 106.625 -1.62 . . . . 100.0 106.625 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 74.8 p -72.77 164.59 26.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-O 122.252 1.025 . . . . 100.0 112.38 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.53 22.88 10.17 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 107.508 -1.293 . . . . 100.0 107.508 178.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 88.77 15.63 59.39 Favored Glycine 0 C--N 1.362 1.98 0 O-C-N 121.612 -0.68 . . . . 100.0 113.122 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.446 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 60.3 mt-30 -59.64 -35.1 73.73 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 127.077 2.151 . . . . 100.0 112.364 -178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -58.47 -33.1 69.38 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 128.064 2.545 . . . . 100.0 112.011 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -63.42 -39.37 94.31 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 123.173 0.589 . . . . 100.0 111.569 178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.446 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 12.6 p90 -94.66 -7.85 39.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 173.12 -163.38 35.0 Favored Glycine 0 C--N 1.356 1.693 0 CA-C-N 119.405 1.002 . . . . 100.0 112.382 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.67 -179.59 53.0 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 108.639 -1.784 . . . . 100.0 108.639 178.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 92.8 mt -107.52 142.22 37.76 Favored 'General case' 0 CA--C 1.484 -1.566 0 CA-C-O 121.603 0.716 . . . . 100.0 110.165 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -70.16 157.31 37.85 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 114.586 -1.188 . . . . 100.0 112.455 -179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -59.96 -37.57 79.96 Favored 'General case' 0 CA--C 1.494 -1.211 0 C-N-CA 124.993 1.317 . . . . 100.0 110.623 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.3 -37.45 87.29 Favored Glycine 0 C--N 1.356 1.673 0 C-N-CA 125.193 1.378 . . . . 100.0 111.102 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 90.0 t80 -62.59 -45.8 91.24 Favored 'General case' 0 N--CA 1.437 -1.09 0 C-N-CA 123.417 0.687 . . . . 100.0 110.649 178.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -75.58 -28.7 59.06 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 116.401 2.0 . . . . 100.0 116.401 -178.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.7 mt -51.31 131.63 12.35 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 123.269 1.509 . . . . 100.0 114.824 -176.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . 0.263 52.9 mt-30 59.87 29.9 19.45 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 128.899 2.88 . . . . 100.0 114.006 -178.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -69.36 132.06 45.8 Favored 'General case' 0 C--N 1.36 1.03 0 N-CA-C 106.015 -1.846 . . . . 100.0 106.015 177.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.3 mm-40 -95.09 -31.53 13.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.77 -0.65 . . . . 100.0 109.473 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.536 ' HB2' HD22 ' A' ' 164' ' ' LEU . 25.5 p -151.81 163.51 39.04 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 109.457 -0.572 . . . . 100.0 109.457 179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . . . . . . . . . . . -147.7 155.67 41.98 Favored 'General case' 0 CA--C 1.486 -1.507 0 N-CA-C 114.64 1.348 . . . . 100.0 114.64 179.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 86.3 mt -127.56 126.38 67.15 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 104.072 -2.566 . . . . 100.0 104.072 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.692 ' HB ' HD22 ' A' ' 119' ' ' LEU . 33.3 mt -110.51 124.49 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.91 0 N-CA-C 102.898 -3.001 . . . . 100.0 102.898 177.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.418 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.5 mtp -111.94 137.08 50.42 Favored 'General case' 0 N--CA 1.426 -1.629 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.0 p90 -130.73 163.69 26.73 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 112.537 -2.119 . . . . 100.0 107.706 176.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -106.67 127.25 53.21 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 106.076 -1.824 . . . . 100.0 106.076 -179.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.6 m -68.21 -15.93 20.34 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.633 0 N-CA-C 113.428 0.899 . . . . 100.0 113.428 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.8 p -90.25 -6.85 54.72 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 118.072 0.396 . . . . 100.0 110.543 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 69.3 m -125.75 116.04 20.99 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-O 122.449 1.119 . . . . 100.0 110.561 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.5 mtm180 -64.0 -37.7 88.38 Favored 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.591 1.156 . . . . 100.0 112.217 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 88.8 t -59.59 -40.16 81.35 Favored 'Isoleucine or valine' 0 C--N 1.354 0.784 0 C-N-CA 125.983 1.713 . . . . 100.0 110.322 -178.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.5 p -62.34 -41.68 98.77 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-N 118.344 0.52 . . . . 100.0 111.28 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -64.63 -40.92 96.32 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.268 0.627 . . . . 100.0 110.423 177.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -60.57 -36.95 79.75 Favored 'General case' 0 CA--C 1.504 -0.789 0 C-N-CA 123.941 0.896 . . . . 100.0 111.091 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 78.1 m-20 -79.11 -5.91 55.23 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.459 HG11 HD13 ' A' ' 119' ' ' LEU . 89.8 t -59.94 -42.79 92.46 Favored Pre-proline 0 C--N 1.364 1.215 0 CA-C-O 116.466 -1.73 . . . . 100.0 111.368 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 72.9 Cg_exo -57.8 -37.51 96.18 Favored 'Trans proline' 0 C--N 1.377 2.029 0 CA-C-N 122.25 1.839 . . . . 100.0 112.69 177.786 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -64.14 -44.38 92.35 Favored 'General case' 0 C--N 1.356 0.887 0 C-N-CA 124.873 1.269 . . . . 100.0 111.076 179.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 74.7 m95 -64.64 -40.91 96.28 Favored 'General case' 0 CA--C 1.499 -1.018 0 C-N-CA 122.877 0.471 . . . . 100.0 110.915 178.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.7 t60 -61.73 -44.01 97.73 Favored 'General case' 0 CA--C 1.499 -1.01 0 C-N-CA 124.09 0.956 . . . . 100.0 109.395 179.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -61.46 -45.56 93.77 Favored 'General case' 0 CA--C 1.498 -1.024 0 C-N-CA 123.71 0.804 . . . . 100.0 111.66 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -62.0 -45.81 91.95 Favored 'General case' 0 CA--C 1.504 -0.82 0 C-N-CA 123.375 0.67 . . . . 100.0 110.699 -178.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.0 tp -63.67 -47.27 81.92 Favored 'General case' 0 N--CA 1.432 -1.345 0 C-N-CA 124.665 1.186 . . . . 100.0 113.259 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.321 25.9 m -65.84 -33.8 66.0 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.677 0 N-CA-C 113.597 0.962 . . . . 100.0 113.597 -179.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 110' ' ' ARG . 55.6 mtt85 -60.14 -46.71 88.75 Favored 'General case' 0 C--N 1.361 1.072 0 O-C-N 123.813 0.696 . . . . 100.0 109.227 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.7 t -74.07 -44.37 50.35 Favored 'Isoleucine or valine' 0 C--N 1.356 0.868 0 N-CA-C 112.16 0.43 . . . . 100.0 112.16 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 74.2 m -125.88 107.7 10.74 Favored 'General case' 0 CA--C 1.495 -1.143 0 CA-C-O 121.997 0.903 . . . . 100.0 110.715 -178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -84.71 138.93 32.36 Favored 'General case' 0 N--CA 1.434 -1.256 0 CA-C-N 115.025 -0.988 . . . . 100.0 112.566 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 53.52 42.02 32.0 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 117.547 2.425 . . . . 100.0 117.547 177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 46.0 pt -94.99 144.64 28.15 Favored Pre-proline 0 N--CA 1.444 -0.731 0 N-CA-C 106.353 -1.721 . . . . 100.0 106.353 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -62.61 133.45 42.54 Favored 'Trans proline' 0 C--N 1.371 1.73 0 C-N-CA 122.36 2.04 . . . . 100.0 110.43 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.775 ' HB ' HD22 ' A' ' 144' ' ' LEU . 70.8 mt -133.98 137.45 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.983 0 N-CA-C 108.343 -0.984 . . . . 100.0 108.343 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 67.9 t -114.37 131.3 66.82 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.049 0 N-CA-C 105.04 -2.207 . . . . 100.0 105.04 177.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.692 HD22 ' HB ' ' A' ' 88' ' ' ILE . 24.6 mt -106.63 128.93 54.56 Favored 'General case' 0 N--CA 1.43 -1.474 0 N-CA-C 104.198 -2.519 . . . . 100.0 104.198 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 72.6 m -120.23 130.6 54.59 Favored 'General case' 0 N--CA 1.427 -1.597 0 CA-C-N 114.465 -1.243 . . . . 100.0 113.363 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.3 107.4 3.23 Favored Glycine 0 CA--C 1.488 -1.598 0 N-CA-C 105.4 -3.08 . . . . 100.0 105.4 178.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.435 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.353 9.0 p-10 -95.88 177.93 5.6 Favored 'General case' 0 N--CA 1.427 -1.599 0 N-CA-C 114.501 1.297 . . . . 100.0 114.501 -178.829 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 83.1 mttt 62.0 40.4 12.29 Favored 'General case' 0 N--CA 1.437 -1.114 0 C-N-CA 128.761 2.824 . . . . 100.0 112.863 -177.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 30.6 m -71.75 -10.57 14.11 Favored 'Isoleucine or valine' 0 C--N 1.358 0.974 0 CA-C-N 114.882 -1.054 . . . . 100.0 111.713 178.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -66.0 -29.14 69.47 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 123.981 0.912 . . . . 100.0 110.524 176.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -71.6 128.43 34.66 Favored 'Isoleucine or valine' 0 C--N 1.361 1.085 0 N-CA-C 107.158 -1.423 . . . . 100.0 107.158 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.23 -41.81 98.75 Favored 'General case' 0 N--CA 1.436 -1.138 0 N-CA-C 115.779 1.77 . . . . 100.0 115.779 -177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.9 t0 -89.25 97.08 11.0 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 105.774 -1.935 . . . . 100.0 105.774 179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -96.79 125.11 41.0 Favored 'General case' 0 N--CA 1.434 -1.248 0 CA-C-N 113.845 -1.525 . . . . 100.0 106.885 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -91.27 -39.14 12.23 Favored 'General case' 0 CA--C 1.495 -1.143 0 N-CA-C 113.585 0.958 . . . . 100.0 113.585 -178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 51.7 t -103.5 102.93 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 106.66 -1.607 . . . . 100.0 106.66 -177.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.405 ' HE3' ' HB3' ' A' ' 132' ' ' LYS . 29.9 mmmt -89.71 168.06 12.41 Favored 'General case' 0 CA--C 1.493 -1.224 0 C-N-CA 125.481 1.512 . . . . 100.0 114.022 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.44 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -57.22 -33.46 67.57 Favored 'General case' 0 C--N 1.354 0.792 0 C-N-CA 126.989 2.116 . . . . 100.0 108.696 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.08 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 93.8 mttt -57.61 -38.62 75.25 Favored 'General case' 0 N--CA 1.418 -2.046 0 C-N-CA 129.19 2.996 . . . . 100.0 112.835 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.8 p -105.29 3.04 29.52 Favored 'General case' 0 N--CA 1.435 -1.207 0 N-CA-C 116.493 2.035 . . . . 100.0 116.493 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.478 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 66.8 mt -91.09 89.79 3.12 Favored 'Isoleucine or valine' 0 C--O 1.21 -1.016 0 C-N-CA 117.792 -1.563 . . . . 100.0 109.324 -176.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.474 ' CA ' ' HB3' ' A' ' 211' ' ' ASP 0.361 0.0 OUTLIER -101.46 -12.81 8.53 Favored 'Isoleucine or valine' 0 C--N 1.354 0.762 0 N-CA-C 115.636 1.717 . . . . 100.0 115.636 -175.842 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 70.6 t80 -58.55 -35.95 73.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 118.235 2.68 . . . . 100.0 118.235 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.597 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.263 60.6 m-70 -59.6 -37.11 77.68 Favored 'General case' 0 CA--C 1.507 -0.695 0 C-N-CA 126.396 1.878 . . . . 100.0 113.927 -176.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.774 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.273 55.2 ttp85 -59.15 -50.09 75.38 Favored 'General case' 0 CA--C 1.47 -2.097 0 N-CA-C 113.926 1.084 . . . . 100.0 113.926 -175.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -63.68 -41.23 98.19 Favored 'General case' 0 N--CA 1.427 -1.579 0 O-C-N 125.033 1.458 . . . . 100.0 111.769 -177.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.23 2.74 53.22 Favored 'General case' 0 N--CA 1.432 -1.353 0 N-CA-C 116.396 1.999 . . . . 100.0 116.396 -176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 55.69 43.78 27.46 Favored 'General case' 0 C--N 1.358 0.959 0 CA-C-O 123.116 1.436 . . . . 100.0 113.37 -179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' A' ' 117' ' ' ILE . 26.2 mt -101.88 146.48 27.77 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.573 -2.38 . . . . 100.0 104.573 179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -94.14 142.39 27.45 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 107.945 -1.131 . . . . 100.0 107.945 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.475 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 88.3 t80 -113.67 139.04 49.39 Favored 'General case' 0 CA--C 1.495 -1.148 0 N-CA-C 113.222 0.823 . . . . 100.0 113.222 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -136.69 139.85 42.26 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 114.202 -1.363 . . . . 100.0 111.578 175.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.26 85.2 m-20 -86.59 128.34 34.98 Favored 'General case' 0 CA--C 1.5 -0.964 0 N-CA-C 102.743 -3.058 . . . . 100.0 102.743 175.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 122' ' ' ASN . 43.3 pt -135.33 157.59 40.03 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 CA-C-O 122.049 0.928 . . . . 100.0 111.732 179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 32.6 t -137.11 109.52 7.38 Favored 'General case' 0 CA--C 1.485 -1.519 0 N-CA-C 103.376 -2.824 . . . . 100.0 103.376 174.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.438 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.75 -41.38 99.18 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 114.885 -1.052 . . . . 100.0 110.825 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 92.9 mttt -60.64 -40.85 93.5 Favored 'General case' 0 N--CA 1.437 -1.112 0 C-N-CA 125.208 1.403 . . . . 100.0 112.353 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 95.8 p -100.85 3.57 42.06 Favored 'General case' 0 N--CA 1.44 -0.969 0 N-CA-C 116.305 1.965 . . . . 100.0 116.305 -178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.634 ' HA ' HH11 ' A' ' 29' ' ' ARG . 72.5 m-80 63.85 22.83 13.18 Favored 'General case' 0 C--N 1.361 1.098 0 C-N-CA 125.03 1.332 . . . . 100.0 110.677 -177.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 81.9 t80 -72.61 124.11 24.59 Favored 'General case' 0 CA--C 1.492 -1.257 0 N-CA-C 107.458 -1.312 . . . . 100.0 107.458 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 53.53 37.83 26.71 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 127.657 2.383 . . . . 100.0 113.987 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 63.1 t80 -60.26 -44.54 95.21 Favored 'General case' 0 C--N 1.362 1.141 0 O-C-N 121.903 -0.498 . . . . 100.0 111.324 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 81.7 mt-10 -63.08 -38.69 92.2 Favored 'General case' 0 N--CA 1.433 -1.322 0 C-N-CA 126.636 1.974 . . . . 100.0 115.628 -177.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -57.7 -47.4 99.01 Favored Pre-proline 0 C--N 1.358 0.943 0 N-CA-C 120.531 3.53 . . . . 100.0 120.531 -173.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -61.06 -42.39 36.82 Favored 'Trans proline' 0 C--N 1.373 1.834 0 CA-C-N 123.403 2.251 . . . . 100.0 112.066 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.5 m-85 -65.08 -42.55 94.01 Favored 'General case' 0 CA--C 1.489 -1.373 0 C-N-CA 124.852 1.261 . . . . 100.0 111.74 -179.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.52 -44.27 91.41 Favored 'General case' 0 N--CA 1.438 -1.061 0 C-N-CA 123.518 0.727 . . . . 100.0 110.241 -179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 90.4 t90 -63.7 -44.51 93.46 Favored 'General case' 0 C--N 1.364 1.196 0 CA-C-N 117.949 0.34 . . . . 100.0 110.345 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.536 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.7 mt -62.34 -43.25 99.26 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 119.112 -0.471 . . . . 100.0 111.363 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.4 -43.62 98.56 Favored 'General case' 0 CA--C 1.492 -1.271 0 C-N-CA 124.065 0.946 . . . . 100.0 110.493 -179.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -61.88 -45.35 94.13 Favored 'General case' 0 CA--C 1.492 -1.275 0 CA-C-O 119.021 -0.514 . . . . 100.0 112.079 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.7 tttt -69.0 -42.53 76.33 Favored 'General case' 0 N--CA 1.435 -1.186 0 N-CA-C 112.734 0.642 . . . . 100.0 112.734 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.2 mt -63.78 -46.61 84.46 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 47.0 mm -70.65 -38.83 74.7 Favored 'Isoleucine or valine' 0 C--N 1.35 0.615 0 C-N-CA 124.692 1.197 . . . . 100.0 109.937 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.73 10.76 56.29 Favored Glycine 0 C--N 1.351 1.409 0 CA-C-O 118.489 -1.173 . . . . 100.0 111.025 -178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.443 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 48.4 t0 -112.47 111.48 52.2 Favored Pre-proline 0 C--N 1.365 1.258 0 CA-C-N 118.485 1.142 . . . . 100.0 108.262 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -69.03 -15.99 40.26 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.961 3.108 . . . . 100.0 113.256 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -96.17 8.37 44.0 Favored 'General case' 0 N--CA 1.435 -1.193 0 N-CA-C 114.349 1.24 . . . . 100.0 114.349 -178.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.443 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 75.5 mt -62.11 136.7 58.06 Favored 'General case' 0 C--N 1.365 1.242 0 CA-C-O 121.307 0.575 . . . . 100.0 110.705 178.627 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 66.3 mt-10 -133.16 150.57 52.01 Favored 'General case' 0 N--CA 1.435 -1.18 0 N-CA-C 108.53 -0.915 . . . . 100.0 108.53 179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -91.06 113.19 25.39 Favored 'General case' 0 C--N 1.357 0.911 0 N-CA-C 103.65 -2.722 . . . . 100.0 103.65 177.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 31.2 m -69.24 -39.51 79.24 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.895 0 N-CA-C 114.061 1.134 . . . . 100.0 114.061 -179.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.0 146.07 51.07 Favored 'General case' 0 CA--C 1.494 -1.183 0 N-CA-C 108.506 -0.924 . . . . 100.0 108.506 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.1 mtp -86.91 130.48 48.3 Favored Pre-proline 0 N--CA 1.437 -1.109 0 N-CA-C 108.031 -1.1 . . . . 100.0 108.031 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.54 155.62 67.96 Favored 'Trans proline' 0 N--CA 1.443 -1.495 0 C-N-CA 122.223 1.949 . . . . 100.0 109.847 177.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -69.07 123.73 21.84 Favored 'General case' 0 CA--C 1.498 -1.043 0 N-CA-C 106.8 -1.555 . . . . 100.0 106.8 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.0 mt -119.02 145.85 45.52 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 114.239 -1.346 . . . . 100.0 109.665 -177.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.26 135.64 96.33 Favored Pre-proline 0 N--CA 1.439 -1.023 0 N-CA-C 105.965 -1.865 . . . . 100.0 105.965 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.455 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 72.0 Cg_exo -55.65 142.35 82.38 Favored 'Trans proline' 0 C--N 1.363 1.341 0 C-N-CA 123.453 2.769 . . . . 100.0 113.563 -178.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.5 ' HG3' HD22 ' A' ' 154' ' ' ASN . 51.0 Cg_exo -56.7 127.63 26.68 Favored 'Trans proline' 0 N--CA 1.443 -1.461 0 C-N-CA 122.848 2.366 . . . . 100.0 113.281 -178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -70.14 -42.44 72.55 Favored 'General case' 0 N--CA 1.438 -1.032 0 O-C-N 124.714 1.259 . . . . 100.0 107.867 178.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.15 158.83 42.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 106.411 -1.7 . . . . 100.0 106.411 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.3 t -101.64 128.37 54.13 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.94 0 N-CA-C 105.408 -2.071 . . . . 100.0 105.408 179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -89.58 125.02 35.06 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 104.7 -2.333 . . . . 100.0 104.7 178.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -62.66 129.27 92.72 Favored Pre-proline 0 N--CA 1.432 -1.358 0 CA-C-N 114.568 -1.196 . . . . 100.0 111.613 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_exo -59.1 -37.53 92.03 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.654 2.903 . . . . 100.0 113.481 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.51 -43.55 93.73 Favored 'General case' 0 C--N 1.36 1.028 0 O-C-N 124.146 0.904 . . . . 100.0 110.179 179.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.5 mt -63.07 -41.84 99.52 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.135 0.574 . . . . 100.0 110.967 178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.15 -45.02 96.35 Favored 'General case' 0 CA--C 1.498 -1.049 0 C-N-CA 123.803 0.841 . . . . 100.0 110.672 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.67 -43.26 99.27 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 123.699 0.799 . . . . 100.0 110.84 179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -62.32 -45.12 94.65 Favored 'General case' 0 C--N 1.359 0.996 0 C-N-CA 123.829 0.851 . . . . 100.0 111.896 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -63.68 -43.63 96.11 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 112.392 0.515 . . . . 100.0 112.392 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -64.51 -39.86 94.56 Favored 'General case' 0 N--CA 1.439 -1.024 0 O-C-N 123.248 0.343 . . . . 100.0 111.287 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 84.1 t60 -63.09 -42.45 99.61 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.952 0.901 . . . . 100.0 110.303 178.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -61.4 -42.46 98.77 Favored 'General case' 0 C--N 1.359 0.994 0 C-N-CA 123.975 0.91 . . . . 100.0 110.609 -179.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.8 mt -61.26 -47.23 86.97 Favored 'General case' 0 N--CA 1.437 -1.093 0 CA-C-N 115.431 -0.804 . . . . 100.0 109.262 178.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.46 -42.04 98.61 Favored 'General case' 0 CA--C 1.497 -1.091 0 N-CA-C 114.3 1.222 . . . . 100.0 114.3 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.6 t -59.34 -47.4 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.446 -3.047 0 CA-C-O 117.504 -1.236 . . . . 100.0 108.517 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.963 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.714 . . -89.72 -8.15 52.93 Favored 'General case' 0 N--CA 1.382 -3.849 1 C-N-CA 103.86 -7.136 . . . . 100.0 117.204 178.721 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 1.044 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 54.3 mt-30 -53.69 -34.07 57.53 Favored 'General case' 0 CA--C 1.447 -2.994 0 C-N-CA 127.813 2.445 . . . . 100.0 106.801 -179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.5 p -80.87 36.57 0.4 Allowed 'General case' 0 N--CA 1.416 -2.142 0 O-C-N 124.933 1.395 . . . . 100.0 109.5 177.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 58.5 31.9 21.52 Favored 'General case' 0 CA--C 1.472 -2.052 0 C-N-CA 126.871 2.068 . . . . 100.0 112.525 175.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.593 ' HB3' ' HB2' ' A' ' 204' ' ' ALA . . . -75.63 -178.19 4.04 Favored 'General case' 0 N--CA 1.396 -3.16 0 N-CA-C 101.642 -3.466 . . . . 100.0 101.642 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.439 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 81.3 mt -57.68 -38.24 65.07 Favored Pre-proline 0 CA--C 1.492 -1.263 0 CA-C-O 116.274 -1.822 . . . . 100.0 113.154 -175.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.08 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.422 5.7 Cg_exo -53.1 136.45 61.46 Favored 'Trans proline' 0 N--CA 1.435 -1.917 0 CA-C-O 123.64 1.433 . . . . 100.0 112.7 177.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.474 ' HB3' ' CA ' ' A' ' 137' ' ' VAL 0.331 84.8 m-20 -65.18 -42.22 93.85 Favored 'General case' 0 N--CA 1.407 -2.602 0 N-CA-C 120.956 3.687 . . . . 100.0 120.956 -172.836 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.593 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.5 tm-20 -72.44 -14.72 61.76 Favored 'General case' 0 CA--C 1.459 -2.52 1 CA-C-O 130.685 5.04 . . . . 100.0 112.922 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 1.044 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.807 64.0 m-20 -87.55 -48.71 7.7 Favored 'General case' 1 N--CA 1.256 -10.162 1 CA-C-N 106.111 -5.04 . . . . 100.0 103.127 -172.786 . . . . . . . . 5 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -62.5 -27.57 69.23 Favored 'General case' 0 N--CA 1.452 -0.364 0 O-C-N 118.901 -2.375 . . . . 100.0 106.211 176.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.774 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 51.5 m-20 -62.39 -39.96 94.94 Favored 'General case' 0 CA--C 1.478 -1.825 0 C-N-CA 127.137 2.175 . . . . 100.0 112.604 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.526 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.303 3.8 mm? . . . . . 0 N--CA 1.427 -1.624 0 CA-C-O 114.15 -2.833 . . . . 100.0 112.828 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.6 mtt . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 120.631 0.253 . . . . 100.0 110.454 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -87.32 69.94 9.99 Favored 'General case' 0 N--CA 1.441 -0.909 0 N-CA-C 107.433 -1.321 . . . . 100.0 107.433 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.9 162.64 39.65 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 123.928 0.891 . . . . 100.0 109.028 -179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -80.32 157.99 26.23 Favored 'General case' 0 N--CA 1.439 -0.977 0 C-N-CA 123.491 0.716 . . . . 100.0 110.698 178.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 82.38 9.73 84.53 Favored Glycine 0 C--N 1.353 1.522 0 CA-C-N 115.555 -0.748 . . . . 100.0 113.942 179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -74.75 136.67 73.87 Favored Pre-proline 0 N--CA 1.437 -1.098 0 CA-C-N 118.0 0.9 . . . . 100.0 112.113 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -63.29 136.51 55.85 Favored 'Trans proline' 0 C--N 1.371 1.755 0 C-N-CA 122.985 2.457 . . . . 100.0 107.807 178.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -77.65 150.46 34.57 Favored 'General case' 0 N--CA 1.433 -1.307 0 O-C-N 124.286 0.991 . . . . 100.0 111.641 -179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 97.9 t -88.74 111.75 23.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 N-CA-C 102.844 -3.021 . . . . 100.0 102.844 179.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -127.89 140.48 51.98 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-N 114.839 -1.073 . . . . 100.0 110.431 -177.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -129.07 144.08 51.08 Favored 'General case' 0 CA--C 1.496 -1.134 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.074 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -94.18 120.49 34.51 Favored 'General case' 0 N--CA 1.436 -1.166 0 N-CA-C 105.577 -2.009 . . . . 100.0 105.577 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD23 HG22 ' A' ' 63' ' ' VAL . 47.7 tp -113.4 127.03 55.98 Favored 'General case' 0 N--CA 1.422 -1.854 0 CA-C-N 113.005 -1.907 . . . . 100.0 107.473 -179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.42 HG13 ' CE2' ' A' ' 79' ' ' TYR . 74.8 t -106.6 124.09 61.91 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 CA-C-N 114.844 -1.071 . . . . 100.0 110.317 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.51 HD13 HG13 ' A' ' 63' ' ' VAL . 6.4 mp -107.38 119.17 38.66 Favored 'General case' 0 CA--C 1.476 -1.875 0 CA-C-O 121.477 0.656 . . . . 100.0 109.471 177.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.31 160.56 38.25 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.013 0 CA-C-N 114.819 -1.082 . . . . 100.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.23 174.31 24.98 Favored Glycine 0 CA--C 1.488 -1.606 0 N-CA-C 108.047 -2.021 . . . . 100.0 108.047 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -67.61 155.02 40.13 Favored 'General case' 0 CA--C 1.499 -1.017 0 CA-C-O 121.744 0.783 . . . . 100.0 112.229 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -65.46 140.76 41.53 Favored Glycine 0 C--N 1.354 1.554 0 N-CA-C 106.519 -2.632 . . . . 100.0 106.519 178.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.76 -5.27 82.22 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 118.533 -1.148 . . . . 100.0 114.458 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 22.0 p -62.28 -37.24 84.77 Favored 'General case' 0 C--N 1.362 1.109 0 CA-C-N 118.929 1.364 . . . . 100.0 112.2 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.25 21.86 6.08 Favored Glycine 0 C--N 1.354 1.539 0 N-CA-C 111.179 -0.769 . . . . 100.0 111.179 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . 41.5 mtmt -60.95 -44.76 96.81 Favored 'General case' 0 CA--C 1.497 -1.073 0 CA-C-N 118.112 0.956 . . . . 100.0 112.559 -178.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.2 m -62.25 -44.19 97.11 Favored 'General case' 0 N--CA 1.438 -1.049 0 C-N-CA 124.311 1.044 . . . . 100.0 109.846 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 53.2 m -63.03 -41.82 99.63 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 123.889 0.876 . . . . 100.0 109.362 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -61.46 -47.73 84.39 Favored 'General case' 0 C--N 1.359 1.009 0 C-N-CA 124.028 0.931 . . . . 100.0 112.559 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.434 HG22 HG11 ' A' ' 63' ' ' VAL . 79.9 t -64.16 -41.03 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 123.284 0.634 . . . . 100.0 110.066 -178.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -69.38 -7.84 41.11 Favored 'General case' 0 CA--C 1.496 -1.102 0 N-CA-C 116.373 1.99 . . . . 100.0 116.373 -177.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.612 HH11 ' HB2' ' A' ' 157' ' ' PHE . 62.0 mtt180 -60.31 -37.97 82.24 Favored 'General case' 0 C--N 1.361 1.079 0 N-CA-C 107.452 -1.314 . . . . 100.0 107.452 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.429 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 58.3 t-80 -80.07 112.3 17.25 Favored 'General case' 0 C--N 1.365 1.265 0 N-CA-C 106.977 -1.49 . . . . 100.0 106.977 -179.304 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -61.79 -44.93 95.9 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 115.817 1.784 . . . . 100.0 115.817 -176.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.429 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 90.4 m -63.77 -42.48 97.79 Favored 'General case' 0 C--N 1.353 0.725 0 C-N-CA 123.52 0.728 . . . . 100.0 109.7 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.57 -41.67 99.61 Favored Glycine 0 C--N 1.357 1.732 0 C-N-CA 123.807 0.718 . . . . 100.0 111.437 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -64.43 -45.55 87.07 Favored 'General case' 0 N--CA 1.441 -0.919 0 C-N-CA 123.916 0.886 . . . . 100.0 111.359 178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -64.28 -39.77 94.6 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 124.501 1.12 . . . . 100.0 111.953 -178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -93.8 9.67 36.23 Favored 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 115.637 1.717 . . . . 100.0 115.637 -177.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -61.12 141.85 57.14 Favored 'General case' 0 C--N 1.359 0.993 0 N-CA-C 114.225 1.194 . . . . 100.0 114.225 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 27.1 ttpp -121.74 130.78 53.68 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 114.922 -1.035 . . . . 100.0 108.915 -179.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -99.57 126.87 45.62 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.323 -0.991 . . . . 100.0 108.323 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 95.5 t -101.92 112.28 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 102.166 -3.272 . . . . 100.0 102.166 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.26 -46.11 90.29 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 118.381 2.734 . . . . 100.0 118.381 -176.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 87.6 m -63.08 -47.15 84.12 Favored 'General case' 0 C--N 1.356 0.885 0 CA-C-N 118.381 0.537 . . . . 100.0 110.329 -178.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.88 -37.55 73.04 Favored 'General case' 0 N--CA 1.432 -1.325 0 N-CA-C 114.054 1.131 . . . . 100.0 114.054 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.01 44.4 30.24 Favored Glycine 0 C--N 1.358 1.785 0 N-CA-C 106.895 -2.482 . . . . 100.0 106.895 -177.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.402 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.9 t -127.57 143.7 39.84 Favored 'Isoleucine or valine' 0 C--N 1.357 0.925 0 C-N-CA 124.076 0.95 . . . . 100.0 108.622 -178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 60.2 mt-10 -108.57 118.7 37.47 Favored 'General case' 0 N--CA 1.432 -1.371 0 N-CA-C 101.623 -3.473 . . . . 100.0 101.623 176.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.7 t -102.44 119.89 51.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.089 0 N-CA-C 105.628 -1.99 . . . . 100.0 105.628 -179.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 32.9 m80 -109.46 120.32 45.64 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.483 -0.781 . . . . 100.0 109.074 -178.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -80.93 104.38 1.55 Allowed 'Trans proline' 0 C--N 1.366 1.473 0 C-N-CA 122.682 2.254 . . . . 100.0 109.491 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -99.56 112.83 24.99 Favored 'General case' 0 CA--C 1.494 -1.191 0 N-CA-C 108.329 -0.989 . . . . 100.0 108.329 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 41.7 t -99.35 128.33 51.18 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.942 0 N-CA-C 107.526 -1.287 . . . . 100.0 107.526 -178.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -122.24 135.66 54.79 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 105.437 -2.06 . . . . 100.0 105.437 178.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -102.59 119.17 38.36 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 108.55 -0.907 . . . . 100.0 108.55 -179.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.1 p -108.63 175.87 5.31 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.99 0.9 . . . . 100.0 110.176 -179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.2 p-10 -61.7 -26.43 68.04 Favored 'General case' 0 N--CA 1.443 -0.822 0 C-N-CA 125.317 1.447 . . . . 100.0 110.356 177.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 94.3 mtt-85 -97.88 6.52 47.68 Favored 'General case' 0 C--N 1.36 1.047 0 C-N-CA 123.868 0.867 . . . . 100.0 112.633 178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 111.65 179.36 20.03 Favored Glycine 0 C--N 1.354 1.544 0 O-C-N 121.298 -0.876 . . . . 100.0 111.208 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -65.72 139.94 59.82 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 123.182 2.588 . . . . 100.0 116.009 -179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 77.7 mt -128.52 131.4 68.84 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 N-CA-C 103.155 -2.905 . . . . 100.0 103.155 177.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -113.58 128.48 56.45 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.164 0.507 . . . . 100.0 109.833 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -110.74 114.77 28.39 Favored 'General case' 0 N--CA 1.43 -1.445 0 N-CA-C 103.957 -2.608 . . . . 100.0 103.957 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -89.74 103.95 16.55 Favored 'General case' 0 CA--C 1.491 -1.312 0 N-CA-C 100.87 -3.752 . . . . 100.0 100.87 179.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.521 HG22 HD23 ' A' ' 13' ' ' LEU . 32.8 t -87.91 124.39 41.06 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.3 0 CA-C-N 114.404 -1.271 . . . . 100.0 107.95 -176.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.2 m0 -98.36 115.74 29.1 Favored 'General case' 0 N--CA 1.426 -1.651 0 N-CA-C 105.024 -2.213 . . . . 100.0 105.024 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -112.26 137.77 49.9 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 106.517 -1.66 . . . . 100.0 106.517 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 77.1 p -71.56 162.17 29.86 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-O 121.845 0.831 . . . . 100.0 112.926 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.41 19.3 14.66 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-N 114.939 -1.028 . . . . 100.0 108.538 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 92.03 13.22 57.99 Favored Glycine 0 C--N 1.36 1.888 0 O-C-N 121.703 -0.623 . . . . 100.0 113.194 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -59.68 -34.15 72.49 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 126.544 1.938 . . . . 100.0 112.101 -179.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -58.22 -30.49 66.54 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 127.224 2.21 . . . . 100.0 113.131 -179.408 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.09 -46.54 88.63 Favored 'General case' 0 C--N 1.357 0.91 0 N-CA-C 109.555 -0.535 . . . . 100.0 109.555 179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.41 15.1 p90 -74.22 -40.45 62.43 Favored 'General case' 0 C--N 1.36 1.06 0 N-CA-C 116.912 2.19 . . . . 100.0 116.912 176.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.5 -154.18 9.31 Favored Glycine 0 C--N 1.355 1.629 0 C-N-CA 120.303 -0.951 . . . . 100.0 111.918 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.49 175.46 53.06 Favored Glycine 0 C--N 1.353 1.519 0 CA-C-O 122.337 0.965 . . . . 100.0 111.276 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.463 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.5 mt -105.13 143.16 33.69 Favored 'General case' 0 CA--C 1.486 -1.482 0 C-N-CA 123.851 0.86 . . . . 100.0 109.993 -179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 81.8 mtm180 -68.18 156.4 37.62 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 114.417 -1.265 . . . . 100.0 112.949 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -59.77 -37.69 79.77 Favored 'General case' 0 CA--C 1.494 -1.205 0 C-N-CA 125.312 1.445 . . . . 100.0 110.077 -179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.56 -37.62 89.27 Favored Glycine 0 C--N 1.355 1.623 0 C-N-CA 124.867 1.222 . . . . 100.0 111.479 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' CE2' HD13 ' A' ' 75' ' ' LEU . 85.8 t80 -62.76 -46.82 86.24 Favored 'General case' 0 N--CA 1.439 -1.004 0 C-N-CA 123.057 0.543 . . . . 100.0 111.032 178.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -70.59 -36.96 73.83 Favored 'General case' 0 N--CA 1.437 -1.09 0 N-CA-C 115.917 1.821 . . . . 100.0 115.917 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.2 mt -51.96 135.08 13.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.065 0 N-CA-C 114.747 1.388 . . . . 100.0 114.747 -175.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 59.7 mt-30 68.85 14.41 8.91 Favored 'General case' 0 C--N 1.359 0.991 0 C-N-CA 127.204 2.202 . . . . 100.0 114.694 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.47 131.02 45.36 Favored 'General case' 0 C--N 1.364 1.196 0 N-CA-C 108.398 -0.964 . . . . 100.0 108.398 178.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.4 mm-40 -94.81 -31.15 13.87 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.305 -0.861 . . . . 100.0 108.726 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.592 ' HB2' HD22 ' A' ' 164' ' ' LEU . 20.6 p -151.04 163.8 37.93 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 120.824 0.345 . . . . 100.0 110.227 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.49 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -147.1 154.17 40.82 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 179.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.421 HG13 HD11 ' A' ' 13' ' ' LEU . 81.7 mt -126.51 125.38 67.16 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 N-CA-C 104.231 -2.507 . . . . 100.0 104.231 176.374 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.635 ' HB ' HD22 ' A' ' 119' ' ' LEU . 45.4 mt -110.57 124.61 67.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 N-CA-C 102.675 -3.083 . . . . 100.0 102.675 178.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . . . . . . . . . 79.8 mtp -112.35 136.54 51.69 Favored 'General case' 0 N--CA 1.425 -1.697 0 N-CA-C 114.914 1.45 . . . . 100.0 114.914 -176.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -129.47 164.2 24.23 Favored 'General case' 0 N--CA 1.434 -1.259 0 CA-C-N 112.501 -2.136 . . . . 100.0 107.976 177.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -109.69 125.43 52.63 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.041 -1.837 . . . . 100.0 106.041 -179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 14.7 m -64.8 -19.71 25.98 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 N-CA-C 114.042 1.127 . . . . 100.0 114.042 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.3 p -86.75 -9.53 55.69 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-O 119.243 -0.408 . . . . 100.0 111.323 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 70.1 m -125.21 117.81 24.67 Favored 'General case' 0 N--CA 1.436 -1.154 0 CA-C-O 122.195 0.998 . . . . 100.0 110.547 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -63.67 -38.1 89.83 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 124.915 1.286 . . . . 100.0 111.838 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.8 t -58.92 -40.76 81.13 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.222 1.809 . . . . 100.0 110.601 -177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.5 p -62.97 -41.28 99.49 Favored 'General case' 0 C--N 1.356 0.864 0 CA-C-N 118.32 0.509 . . . . 100.0 111.307 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 59.9 t80 -64.87 -41.41 95.69 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.863 0.865 . . . . 100.0 110.604 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.6 mttt -60.91 -37.8 83.51 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.792 1.237 . . . . 100.0 110.777 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.83 -8.43 58.03 Favored 'General case' 0 C--N 1.353 0.759 0 N-CA-C 115.273 1.583 . . . . 100.0 115.273 179.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.44 HG11 HD13 ' A' ' 119' ' ' LEU . 73.0 t -60.11 -42.75 91.59 Favored Pre-proline 0 C--N 1.364 1.224 0 CA-C-O 116.419 -1.753 . . . . 100.0 112.077 -179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 73.8 Cg_exo -57.49 -37.47 97.16 Favored 'Trans proline' 0 C--N 1.375 1.955 0 CA-C-N 122.153 1.805 . . . . 100.0 112.657 177.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -63.93 -45.43 89.27 Favored 'General case' 0 C--N 1.355 0.847 0 C-N-CA 125.05 1.34 . . . . 100.0 110.894 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -64.16 -41.84 96.98 Favored 'General case' 0 CA--C 1.496 -1.099 0 C-N-CA 122.936 0.494 . . . . 100.0 110.917 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -62.65 -43.87 97.7 Favored 'General case' 0 N--CA 1.434 -1.237 0 C-N-CA 123.898 0.879 . . . . 100.0 110.384 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 77.0 mtt-85 -63.0 -43.81 97.76 Favored 'General case' 0 CA--C 1.499 -0.996 0 C-N-CA 123.042 0.537 . . . . 100.0 111.769 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -62.5 -44.25 96.84 Favored 'General case' 0 C--N 1.356 0.864 0 C-N-CA 122.916 0.486 . . . . 100.0 110.425 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.1 tp -63.46 -48.34 78.1 Favored 'General case' 0 N--CA 1.436 -1.158 0 C-N-CA 124.314 1.046 . . . . 100.0 113.177 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.298 32.7 m -63.86 -35.53 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.627 0 C-N-CA 124.16 0.984 . . . . 100.0 113.08 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 89.4 mtt-85 -59.65 -38.53 81.67 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 118.688 -0.672 . . . . 100.0 111.093 178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 58.3 t -85.14 -43.9 17.07 Favored 'Isoleucine or valine' 0 C--N 1.357 0.894 0 C-N-CA 119.87 -0.732 . . . . 100.0 110.233 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 78.1 m -124.75 104.65 8.77 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 108.454 -0.943 . . . . 100.0 108.454 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -91.14 145.05 25.0 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-O 121.983 0.897 . . . . 100.0 110.389 -178.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 57.79 38.04 27.24 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 116.447 2.017 . . . . 100.0 116.447 178.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.4 pt -96.81 143.59 26.38 Favored Pre-proline 0 N--CA 1.442 -0.843 0 N-CA-C 106.185 -1.783 . . . . 100.0 106.185 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 56.2 Cg_endo -62.59 131.14 32.35 Favored 'Trans proline' 0 C--N 1.369 1.613 0 C-N-CA 122.782 2.322 . . . . 100.0 110.483 178.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.747 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.9 mt -132.84 138.34 52.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-O 122.369 1.08 . . . . 100.0 109.421 -178.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 78.1 t -115.98 131.2 69.16 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 N-CA-C 106.193 -1.78 . . . . 100.0 106.193 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.635 HD22 ' HB ' ' A' ' 88' ' ' ILE . 22.5 mt -105.84 128.96 54.07 Favored 'General case' 0 N--CA 1.432 -1.352 0 N-CA-C 104.852 -2.277 . . . . 100.0 104.852 175.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.9 m -118.36 130.77 56.19 Favored 'General case' 0 N--CA 1.428 -1.539 0 CA-C-N 114.126 -1.397 . . . . 100.0 113.398 -177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -100.48 104.36 2.77 Favored Glycine 0 C--N 1.35 1.343 0 N-CA-C 106.222 -2.751 . . . . 100.0 106.222 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.426 ' HA ' HG13 ' A' ' 149' ' ' ILE . 62.3 t30 -83.24 166.09 18.85 Favored 'General case' 0 N--CA 1.436 -1.13 0 C-N-CA 124.555 1.142 . . . . 100.0 112.973 -178.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 55.2 mttp 61.03 42.97 11.91 Favored 'General case' 0 N--CA 1.437 -1.108 0 C-N-CA 129.57 3.148 . . . . 100.0 114.933 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.327 24.5 m -72.07 -7.53 9.61 Favored 'Isoleucine or valine' 0 C--N 1.361 1.1 0 C-N-CA 120.527 -0.469 . . . . 100.0 111.64 178.225 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -61.93 -36.71 82.17 Favored 'General case' 0 C--N 1.361 1.106 0 C-N-CA 126.718 2.007 . . . . 100.0 109.958 175.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.0 mt -69.95 128.42 33.27 Favored 'Isoleucine or valine' 0 C--N 1.362 1.139 0 N-CA-C 106.915 -1.513 . . . . 100.0 106.915 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -62.77 -42.35 99.65 Favored 'General case' 0 N--CA 1.436 -1.135 0 N-CA-C 114.919 1.452 . . . . 100.0 114.919 -176.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -89.21 98.04 11.54 Favored 'General case' 0 C--N 1.359 0.979 0 N-CA-C 105.843 -1.91 . . . . 100.0 105.843 -179.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -95.57 122.2 38.08 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-N 113.771 -1.559 . . . . 100.0 106.911 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.94 -39.91 15.3 Favored 'General case' 0 CA--C 1.497 -1.067 0 N-CA-C 113.3 0.852 . . . . 100.0 113.3 -178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.5 t -105.07 104.86 17.6 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 N-CA-C 105.552 -2.018 . . . . 100.0 105.552 -178.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -98.57 174.3 6.51 Favored 'General case' 0 CA--C 1.494 -1.187 0 CA-C-N 115.209 -0.905 . . . . 100.0 113.109 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.02 -34.28 65.69 Favored 'General case' 0 C--N 1.353 0.76 0 C-N-CA 127.045 2.138 . . . . 100.0 109.496 -179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 0.981 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -57.52 -39.12 75.86 Favored 'General case' 0 N--CA 1.416 -2.127 0 C-N-CA 129.128 2.971 . . . . 100.0 112.043 179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.3 p -104.82 4.18 31.91 Favored 'General case' 0 N--CA 1.432 -1.349 0 N-CA-C 116.403 2.001 . . . . 100.0 116.403 -178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.511 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 56.5 mt -90.06 80.88 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.363 1.164 0 C-N-CA 117.197 -1.801 . . . . 100.0 112.035 -176.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.629 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.255 58.9 t -71.53 -39.44 70.45 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 1 C-N-CA 133.757 4.823 . . . . 100.0 118.807 -178.279 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -55.79 -36.34 67.29 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 121.539 3.903 . . . . 100.0 121.539 -168.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.6 ' HE1' ' HB2' ' A' ' 119' ' ' LEU 0.258 67.8 m-70 -59.73 -38.8 82.69 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 116.924 -1.512 . . . . 100.0 113.493 -176.586 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.97 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.255 0.9 OUTLIER -59.93 -46.83 88.11 Favored 'General case' 0 CA--C 1.457 -2.614 0 N-CA-C 116.6 2.074 . . . . 100.0 116.6 -176.887 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -62.93 -40.42 97.59 Favored 'General case' 0 N--CA 1.426 -1.636 0 O-C-N 125.525 1.766 . . . . 100.0 110.2 -177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.63 3.89 47.94 Favored 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 117.279 2.326 . . . . 100.0 117.279 -177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 55.38 43.47 28.8 Favored 'General case' 0 C--N 1.358 0.975 0 CA-C-O 122.958 1.361 . . . . 100.0 113.311 -179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.747 HD22 ' HB ' ' A' ' 117' ' ' ILE . 24.2 mt -103.52 150.4 23.95 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 105.643 -1.984 . . . . 100.0 105.643 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 81.8 mm-40 -97.28 141.02 30.89 Favored 'General case' 0 CA--C 1.485 -1.537 0 N-CA-C 109.784 -0.451 . . . . 100.0 109.784 178.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.491 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.5 t80 -108.27 136.88 47.18 Favored 'General case' 0 CA--C 1.487 -1.479 0 N-CA-C 113.188 0.81 . . . . 100.0 113.188 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -134.11 136.47 43.9 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 114.221 -1.354 . . . . 100.0 110.743 175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.322 66.0 m-20 -83.47 130.06 35.01 Favored 'General case' 0 C--N 1.357 0.896 0 N-CA-C 101.996 -3.335 . . . . 100.0 101.996 176.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.534 ' HB ' HH22 ' A' ' 29' ' ' ARG . 43.2 pt -134.72 156.73 40.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.937 0 CA-C-O 122.525 1.155 . . . . 100.0 111.674 178.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.53 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 71.3 m -138.2 107.98 6.28 Favored 'General case' 0 CA--C 1.484 -1.574 0 N-CA-C 104.941 -2.244 . . . . 100.0 104.941 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.54 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.32 -44.63 96.88 Favored 'General case' 0 CA--C 1.494 -1.208 0 CA-C-N 115.214 -0.903 . . . . 100.0 112.854 -178.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -61.92 -39.36 91.79 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 125.071 1.348 . . . . 100.0 113.372 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 93.5 p -99.97 1.57 42.73 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 115.669 1.729 . . . . 100.0 115.669 -178.56 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.493 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.1 m-80 64.65 21.58 12.44 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 125.296 1.438 . . . . 100.0 111.263 -177.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.53 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 78.1 t80 -70.98 125.61 27.33 Favored 'General case' 0 N--CA 1.434 -1.243 0 N-CA-C 107.906 -1.146 . . . . 100.0 107.906 -179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 54.45 36.5 25.73 Favored 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 128.102 2.561 . . . . 100.0 114.429 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.612 ' HB2' HH11 ' A' ' 29' ' ' ARG . 64.4 t80 -60.99 -45.49 94.62 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 121.644 -0.66 . . . . 100.0 112.32 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -65.01 -35.63 81.81 Favored 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 116.799 2.148 . . . . 100.0 116.799 -178.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -56.26 -46.98 99.73 Favored Pre-proline 0 C--N 1.355 0.81 0 N-CA-C 119.166 3.025 . . . . 100.0 119.166 -173.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_exo -60.98 -42.51 36.45 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.116 2.149 . . . . 100.0 111.815 178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -64.53 -42.29 95.85 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 125.23 1.412 . . . . 100.0 111.496 -178.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 63.8 tp -63.61 -45.01 92.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.839 0.856 . . . . 100.0 111.116 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.82 -43.77 95.24 Favored 'General case' 0 C--N 1.361 1.086 0 O-C-N 123.372 0.42 . . . . 100.0 110.399 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.592 HD22 ' HB2' ' A' ' 85' ' ' CYS . 75.3 mt -61.36 -44.42 97.19 Favored 'General case' 0 CA--C 1.496 -1.12 0 C-N-CA 123.097 0.559 . . . . 100.0 110.91 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.8 98.18 Favored 'General case' 0 CA--C 1.491 -1.296 0 C-N-CA 124.445 1.098 . . . . 100.0 111.1 -179.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -61.99 -45.04 95.36 Favored 'General case' 0 CA--C 1.495 -1.154 0 C-N-CA 122.851 0.46 . . . . 100.0 111.565 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.451 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 28.1 tptp -65.25 -46.31 81.05 Favored 'General case' 0 N--CA 1.436 -1.131 0 C-N-CA 122.893 0.477 . . . . 100.0 111.633 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.9 mt -64.41 -46.99 80.85 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 114.397 1.258 . . . . 100.0 114.397 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 45.3 mm -70.45 -38.23 73.13 Favored 'Isoleucine or valine' 0 C--N 1.35 0.589 0 C-N-CA 124.917 1.287 . . . . 100.0 109.623 178.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.71 10.53 57.73 Favored Glycine 0 N--CA 1.434 -1.45 0 CA-C-O 118.515 -1.158 . . . . 100.0 111.14 -178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 49.4 t0 -114.17 113.1 46.49 Favored Pre-proline 0 C--N 1.364 1.224 0 N-CA-C 107.648 -1.241 . . . . 100.0 107.648 179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -70.68 -14.15 32.95 Favored 'Trans proline' 0 C--N 1.365 1.416 0 C-N-CA 123.894 3.063 . . . . 100.0 113.254 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.7 m-80 -91.4 2.4 56.43 Favored 'General case' 0 N--CA 1.435 -1.206 0 N-CA-C 113.448 0.907 . . . . 100.0 113.448 -178.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.9 mt -61.25 135.01 57.59 Favored 'General case' 0 C--N 1.364 1.227 0 CA-C-N 118.74 0.7 . . . . 100.0 112.108 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -133.99 148.78 51.17 Favored 'General case' 0 N--CA 1.435 -1.222 0 N-CA-C 108.029 -1.1 . . . . 100.0 108.029 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.0 m-30 -90.25 112.3 23.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 N-CA-C 103.674 -2.713 . . . . 100.0 103.674 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 32.6 m -67.81 -40.43 83.66 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 114.602 1.334 . . . . 100.0 114.602 -179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.39 145.8 50.97 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 108.34 -0.985 . . . . 100.0 108.34 -179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 56.4 ttm -85.73 129.58 54.15 Favored Pre-proline 0 N--CA 1.432 -1.344 0 N-CA-C 107.129 -1.434 . . . . 100.0 107.129 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -64.95 155.93 65.25 Favored 'Trans proline' 0 N--CA 1.442 -1.536 0 C-N-CA 122.366 2.044 . . . . 100.0 109.964 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -68.12 122.73 18.9 Favored 'General case' 0 CA--C 1.499 -0.984 0 N-CA-C 106.632 -1.618 . . . . 100.0 106.632 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 84.4 mt -118.89 148.04 43.34 Favored 'General case' 0 CA--C 1.484 -1.573 0 CA-C-N 114.257 -1.338 . . . . 100.0 109.373 -178.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.96 135.14 96.02 Favored Pre-proline 0 N--CA 1.44 -0.952 0 N-CA-C 105.228 -2.138 . . . . 100.0 105.228 177.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.436 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 66.4 Cg_exo -56.26 142.04 87.93 Favored 'Trans proline' 0 C--N 1.364 1.359 0 C-N-CA 123.236 2.624 . . . . 100.0 112.866 -178.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.493 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.0 Cg_exo -56.5 125.94 20.68 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.638 2.226 . . . . 100.0 112.543 -178.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 67.9 mt-10 -70.02 -42.66 72.67 Favored 'General case' 0 N--CA 1.438 -1.057 0 O-C-N 124.938 1.399 . . . . 100.0 108.671 179.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 29.9 m -129.62 158.11 42.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 106.292 -1.744 . . . . 100.0 106.292 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 92.0 t -97.82 129.77 47.5 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 106.56 -1.644 . . . . 100.0 106.56 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -91.72 123.64 35.26 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 103.229 -2.878 . . . . 100.0 103.229 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.4 t70 -62.16 129.12 91.86 Favored Pre-proline 0 N--CA 1.434 -1.263 0 CA-C-N 114.992 -1.004 . . . . 100.0 111.505 -178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 63.4 Cg_exo -58.9 -38.5 88.0 Favored 'Trans proline' 0 C--N 1.369 1.614 0 C-N-CA 123.712 2.941 . . . . 100.0 113.552 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.75 -42.92 94.78 Favored 'General case' 0 C--N 1.36 1.051 0 O-C-N 123.94 0.775 . . . . 100.0 110.263 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 92.6 mt -63.36 -41.71 98.84 Favored 'General case' 0 CA--C 1.498 -1.025 0 C-N-CA 122.979 0.511 . . . . 100.0 111.114 178.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.5 -44.14 97.6 Favored 'General case' 0 C--N 1.36 1.05 0 C-N-CA 123.745 0.818 . . . . 100.0 110.331 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.03 99.81 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 123.989 0.916 . . . . 100.0 110.547 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -62.33 -45.61 92.44 Favored 'General case' 0 C--N 1.359 1.004 0 C-N-CA 123.714 0.806 . . . . 100.0 111.754 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -63.6 -43.38 97.1 Favored 'General case' 0 CA--C 1.493 -1.235 0 N-CA-C 112.197 0.443 . . . . 100.0 112.197 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -64.34 -40.54 96.09 Favored 'General case' 0 N--CA 1.439 -1.001 0 O-C-N 123.294 0.371 . . . . 100.0 111.455 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -63.57 -42.33 98.34 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.866 0.866 . . . . 100.0 110.197 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -61.33 -42.42 98.65 Favored 'General case' 0 C--N 1.362 1.116 0 C-N-CA 123.68 0.792 . . . . 100.0 110.647 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.579 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 85.2 mt -61.12 -48.1 83.2 Favored 'General case' 0 N--CA 1.435 -1.186 0 O-C-N 123.735 0.647 . . . . 100.0 109.453 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -62.51 -43.64 98.33 Favored 'General case' 0 CA--C 1.494 -1.186 0 N-CA-C 114.084 1.142 . . . . 100.0 114.084 -178.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 52.2 t -59.46 -47.02 92.26 Favored 'Isoleucine or valine' 0 CA--C 1.445 -3.072 0 CA-C-O 117.988 -1.006 . . . . 100.0 108.822 -177.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.97 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.739 . . -88.66 -9.61 51.48 Favored 'General case' 1 N--CA 1.375 -4.202 1 C-N-CA 104.142 -7.023 . . . . 100.0 116.806 179.79 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 1.012 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 60.6 mt-30 -54.57 -36.03 63.93 Favored 'General case' 0 CA--C 1.445 -3.066 0 C-N-CA 128.86 2.864 . . . . 100.0 106.232 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 69.2 p -81.61 40.18 0.57 Allowed 'General case' 0 N--CA 1.417 -2.107 0 CA-C-O 123.07 1.414 . . . . 100.0 110.061 177.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.448 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.289 5.0 m 57.45 29.73 17.49 Favored 'General case' 0 CA--C 1.468 -2.206 0 C-N-CA 128.579 2.752 . . . . 100.0 112.918 175.323 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.561 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.257 . . -72.51 172.94 9.59 Favored 'General case' 0 N--CA 1.398 -3.026 0 N-CA-C 100.989 -3.708 . . . . 100.0 100.989 171.697 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 67.1 mt -53.77 -35.9 34.01 Favored Pre-proline 0 CA--C 1.493 -1.22 0 CA-C-O 116.971 -1.49 . . . . 100.0 114.812 -174.085 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 0.981 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.414 4.9 Cg_exo -53.97 137.95 69.47 Favored 'Trans proline' 0 N--CA 1.432 -2.124 0 CA-C-O 122.948 1.145 . . . . 100.0 113.124 176.569 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.629 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.375 45.8 m-20 -63.87 -43.91 94.66 Favored 'General case' 0 N--CA 1.408 -2.526 1 N-CA-C 122.783 4.364 . . . . 100.0 122.783 -174.245 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.631 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 16.0 tm-20 -66.34 -24.54 66.53 Favored 'General case' 0 CA--C 1.468 -2.208 1 CA-C-O 131.487 5.422 . . . . 100.0 111.598 176.644 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 1.012 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.749 55.2 m-20 -74.62 -51.47 14.38 Favored 'General case' 1 N--CA 1.267 -9.576 1 CA-C-N 105.454 -5.339 . . . . 100.0 105.406 -176.566 . . . . . . . . 5 3 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 70.5 m-20 -63.66 -26.17 68.55 Favored 'General case' 0 CA--C 1.513 -0.456 0 O-C-N 118.065 -2.897 . . . . 100.0 107.933 176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.97 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 48.3 m-20 -62.89 -41.96 99.6 Favored 'General case' 0 N--CA 1.419 -2.017 0 C-N-CA 126.134 1.774 . . . . 100.0 112.754 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.666 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.383 1.0 OUTLIER . . . . . 0 C--O 1.261 1.67 0 CA-C-O 115.082 -2.389 . . . . 100.0 115.74 -178.47 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.7 ttt . . . . . 0 CA--C 1.494 -1.183 0 CA-C-O 119.384 -0.341 . . . . 100.0 111.084 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -59.61 -41.64 90.83 Favored 'General case' 0 N--CA 1.437 -1.116 0 N-CA-C 114.434 1.272 . . . . 100.0 114.434 -177.618 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -89.01 158.69 17.92 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 115.291 1.589 . . . . 100.0 115.291 -178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -85.19 158.83 20.25 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.401 1.08 . . . . 100.0 109.412 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.3 9.63 86.79 Favored Glycine 0 C--N 1.356 1.645 0 CA-C-O 119.475 -0.625 . . . . 100.0 114.463 178.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 77.5 mt-10 -81.37 150.27 67.04 Favored Pre-proline 0 N--CA 1.437 -1.102 0 CA-C-N 118.443 1.121 . . . . 100.0 109.886 -179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -64.8 152.6 81.5 Favored 'Trans proline' 0 C--N 1.37 1.704 0 C-N-CA 122.98 2.453 . . . . 100.0 109.074 178.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.7 138.89 58.04 Favored 'General case' 0 CA--C 1.497 -1.078 0 CA-C-O 121.228 0.537 . . . . 100.0 111.492 -178.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 57.3 t -82.79 115.27 25.0 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.33 0 CA-C-N 114.585 -1.189 . . . . 100.0 109.627 -176.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.1 mt-30 -127.48 135.75 50.81 Favored 'General case' 0 N--CA 1.433 -1.278 0 CA-C-N 113.399 -1.728 . . . . 100.0 107.73 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -124.43 144.24 50.18 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 115.46 -0.791 . . . . 100.0 109.134 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -92.1 121.64 33.84 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 178.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.4 tt -114.32 128.16 56.22 Favored 'General case' 0 N--CA 1.425 -1.704 0 N-CA-C 106.419 -1.697 . . . . 100.0 106.419 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.406 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.8 t -104.29 125.6 59.06 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.621 -1.251 . . . . 100.0 107.621 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.435 HD11 ' SD ' ' A' ' 89' ' ' MET . 39.3 tp -110.06 117.47 33.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 105.86 -1.904 . . . . 100.0 105.86 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 21.9 m -129.88 160.45 40.9 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 N-CA-C 112.165 0.432 . . . . 100.0 112.165 -178.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.95 172.71 24.5 Favored Glycine 0 CA--C 1.487 -1.688 0 N-CA-C 108.559 -1.816 . . . . 100.0 108.559 179.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -67.33 154.41 41.4 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-O 121.946 0.879 . . . . 100.0 112.478 -179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.35 139.9 42.49 Favored Glycine 0 C--N 1.354 1.545 0 N-CA-C 107.263 -2.335 . . . . 100.0 107.263 178.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 90.0 -4.2 83.03 Favored Glycine 0 N--CA 1.439 -1.153 0 CA-C-O 118.634 -1.092 . . . . 100.0 114.258 -179.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 21.1 p -62.74 -38.36 90.22 Favored 'General case' 0 CA--C 1.494 -1.197 0 CA-C-N 118.784 1.292 . . . . 100.0 111.914 178.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 115.57 22.32 4.78 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.508 -1.037 . . . . 100.0 110.508 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.428 ' HE3' ' HG ' ' A' ' 15' ' ' LEU . 50.0 mtpt -59.53 -47.11 86.81 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 124.38 1.072 . . . . 100.0 113.254 -179.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.6 m -64.59 -42.75 95.38 Favored 'General case' 0 N--CA 1.439 -1.017 0 C-N-CA 123.254 0.622 . . . . 100.0 110.598 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 48.6 m -62.24 -42.14 99.05 Favored 'General case' 0 C--N 1.356 0.849 0 C-N-CA 124.126 0.97 . . . . 100.0 108.971 -179.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -60.75 -48.37 82.11 Favored 'General case' 0 CA--C 1.497 -1.077 0 C-N-CA 124.215 1.006 . . . . 100.0 112.968 178.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.1 t -65.85 -39.94 86.16 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 O-C-N 123.133 0.271 . . . . 100.0 110.91 -178.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -65.5 -12.14 49.89 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 115.249 1.574 . . . . 100.0 115.249 -177.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.597 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 41.0 mtt180 -60.02 -38.35 82.43 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.491 -0.929 . . . . 100.0 108.491 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.46 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 62.1 t-80 -80.63 111.5 17.12 Favored 'General case' 0 C--N 1.362 1.138 0 N-CA-C 106.799 -1.556 . . . . 100.0 106.799 -178.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.0 mt -61.59 -44.37 97.14 Favored 'General case' 0 CA--C 1.495 -1.156 0 N-CA-C 115.227 1.566 . . . . 100.0 115.227 -177.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.46 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.1 m -62.85 -42.67 99.84 Favored 'General case' 0 C--N 1.352 0.703 0 C-N-CA 124.333 1.053 . . . . 100.0 109.35 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.07 99.68 Favored Glycine 0 C--N 1.359 1.861 0 N-CA-C 111.15 -0.78 . . . . 100.0 111.15 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -65.15 -43.54 91.48 Favored 'General case' 0 N--CA 1.442 -0.844 0 C-N-CA 122.783 0.433 . . . . 100.0 111.502 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.3 m-30 -62.89 -40.85 98.82 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 124.211 1.004 . . . . 100.0 111.85 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.9 mt-10 -94.07 10.08 35.12 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 115.211 1.56 . . . . 100.0 115.211 -177.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 59.4 pttt -59.6 142.76 52.14 Favored 'General case' 0 C--N 1.359 0.984 0 N-CA-C 114.16 1.17 . . . . 100.0 114.16 -178.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -126.22 132.89 51.65 Favored 'General case' 0 CA--C 1.499 -0.996 0 N-CA-C 108.296 -1.002 . . . . 100.0 108.296 -178.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 82.4 t80 -100.44 127.49 46.76 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 107.855 -1.165 . . . . 100.0 107.855 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.8 t -101.6 109.32 25.6 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.352 -3.203 . . . . 100.0 102.352 179.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.84 -43.23 99.35 Favored 'General case' 0 CA--C 1.498 -1.04 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 72.4 p -61.73 -43.67 98.41 Favored 'General case' 0 CA--C 1.502 -0.904 0 C-N-CA 123.63 0.772 . . . . 100.0 112.718 -178.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.9 mt -93.68 -18.15 22.45 Favored 'General case' 0 N--CA 1.429 -1.517 0 N-CA-C 114.393 1.257 . . . . 100.0 114.393 -178.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 69.96 43.68 64.5 Favored Glycine 0 C--N 1.36 1.887 0 N-CA-C 109.268 -1.533 . . . . 100.0 109.268 -178.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 53.4 t -123.63 143.81 35.5 Favored 'Isoleucine or valine' 0 C--N 1.354 0.774 0 N-CA-C 108.352 -0.981 . . . . 100.0 108.352 -178.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -111.89 115.4 28.92 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 101.052 -3.685 . . . . 100.0 101.052 177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.5 t -100.59 120.69 50.42 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.072 -1.455 . . . . 100.0 107.072 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 58.2 m-70 -113.41 119.15 42.5 Favored Pre-proline 0 N--CA 1.432 -1.334 0 CA-C-N 115.864 -0.607 . . . . 100.0 109.807 -179.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -80.77 106.22 1.79 Allowed 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.3 2.0 . . . . 100.0 111.468 178.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 10.9 mp -98.79 115.88 29.77 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 107.827 -1.175 . . . . 100.0 107.827 -179.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 34.1 t -102.39 129.11 54.38 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.837 0 N-CA-C 107.053 -1.462 . . . . 100.0 107.053 -177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -124.91 136.61 53.93 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 105.666 -1.975 . . . . 100.0 105.666 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 60.2 t-80 -101.83 119.17 38.36 Favored 'General case' 0 N--CA 1.44 -0.956 0 N-CA-C 108.601 -0.888 . . . . 100.0 108.601 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 26.7 p -106.45 -178.46 3.66 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-N 115.033 -0.985 . . . . 100.0 111.489 -178.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -59.0 -37.99 78.16 Favored 'General case' 0 C--N 1.358 0.935 0 C-N-CA 126.581 1.952 . . . . 100.0 108.583 178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -89.98 0.65 56.98 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 113.741 1.015 . . . . 100.0 113.741 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 115.6 -175.37 15.86 Favored Glycine 0 C--N 1.352 1.45 0 N-CA-C 110.199 -1.16 . . . . 100.0 110.199 -179.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -65.25 138.95 58.09 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 122.979 2.452 . . . . 100.0 116.944 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 74.4 mt -129.02 130.97 68.46 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 102.885 -3.006 . . . . 100.0 102.885 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 88.7 mttt -114.63 127.58 55.85 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 109.422 -0.585 . . . . 100.0 109.422 -179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -110.96 116.02 30.49 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 104.999 -2.223 . . . . 100.0 104.999 177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 73.7 m-80 -88.11 105.83 17.76 Favored 'General case' 0 CA--C 1.492 -1.278 0 N-CA-C 101.465 -3.531 . . . . 100.0 101.465 178.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.7 t -93.24 122.57 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 N-CA-C 107.708 -1.219 . . . . 100.0 107.708 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 14.8 m0 -93.6 115.25 27.72 Favored 'General case' 0 N--CA 1.425 -1.722 0 N-CA-C 105.886 -1.894 . . . . 100.0 105.886 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -111.37 141.69 44.6 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 105.642 -1.985 . . . . 100.0 105.642 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 69.2 p -75.04 164.23 26.76 Favored 'General case' 0 N--CA 1.435 -1.176 0 CA-C-O 121.978 0.894 . . . . 100.0 112.882 -179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -97.39 16.15 20.95 Favored 'General case' 0 N--CA 1.435 -1.183 0 CA-C-N 114.756 -1.111 . . . . 100.0 108.318 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 93.26 10.77 59.2 Favored Glycine 0 C--N 1.362 1.982 0 O-C-N 121.728 -0.608 . . . . 100.0 113.422 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -62.24 -23.72 66.83 Favored 'General case' 0 C--N 1.356 0.879 0 C-N-CA 125.987 1.715 . . . . 100.0 112.624 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -60.31 -33.79 72.88 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 127.167 2.187 . . . . 100.0 111.398 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.4 -43.3 99.15 Favored 'General case' 0 C--N 1.355 0.818 0 C-N-CA 124.044 0.938 . . . . 100.0 109.684 179.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -70.14 -42.64 72.29 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.919 1.288 . . . . 100.0 113.09 178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 177.93 -149.38 9.17 Favored Glycine 0 C--N 1.358 1.774 0 N-CA-C 110.99 -0.844 . . . . 100.0 110.99 -178.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.18 173.87 50.28 Favored Glycine 0 C--N 1.355 1.596 0 CA-C-O 122.185 0.881 . . . . 100.0 112.664 -179.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 91.1 mt -107.58 142.49 37.42 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 121.939 0.876 . . . . 100.0 109.651 -178.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 83.9 mtm180 -64.03 151.75 42.1 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.403 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -60.01 -37.22 79.08 Favored 'General case' 0 CA--C 1.496 -1.111 0 C-N-CA 125.428 1.491 . . . . 100.0 110.003 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.51 -37.76 89.34 Favored Glycine 0 C--N 1.356 1.652 0 C-N-CA 125.237 1.399 . . . . 100.0 111.143 -179.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.406 ' CE2' HG13 ' A' ' 14' ' ' VAL . 79.9 t80 -62.85 -46.19 89.06 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 123.458 0.703 . . . . 100.0 111.081 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 67.1 m-85 -70.9 -35.59 72.37 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 115.955 1.835 . . . . 100.0 115.955 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 64.8 mt -51.87 134.82 13.19 Favored 'Isoleucine or valine' 0 C--N 1.359 1.007 0 CA-C-O 122.987 1.375 . . . . 100.0 114.429 -176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 65.74 19.27 11.36 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 128.132 2.573 . . . . 100.0 114.635 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.56 132.32 48.57 Favored 'General case' 0 C--N 1.36 1.057 0 N-CA-C 108.052 -1.092 . . . . 100.0 108.052 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 97.3 mm-40 -95.19 -33.14 12.73 Favored 'General case' 0 N--CA 1.437 -1.087 0 CA-C-N 115.544 -0.753 . . . . 100.0 109.075 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.537 ' HB2' HD22 ' A' ' 164' ' ' LEU . 26.0 p -152.38 163.68 39.01 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 109.888 -0.412 . . . . 100.0 109.888 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.433 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -147.28 154.36 40.88 Favored 'General case' 0 CA--C 1.487 -1.462 0 N-CA-C 114.54 1.311 . . . . 100.0 114.54 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 91.5 mt -125.43 125.93 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.196 0 N-CA-C 104.057 -2.571 . . . . 100.0 104.057 176.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.402 ' HB ' HD22 ' A' ' 119' ' ' LEU . 50.8 mt -110.55 123.89 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.994 0 N-CA-C 102.941 -2.985 . . . . 100.0 102.941 178.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.435 ' SD ' HD11 ' A' ' 15' ' ' LEU . 87.3 mtp -111.41 136.82 50.01 Favored 'General case' 0 N--CA 1.426 -1.636 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -177.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.5 p90 -129.53 164.23 24.22 Favored 'General case' 0 N--CA 1.433 -1.306 0 CA-C-N 112.295 -2.23 . . . . 100.0 108.187 177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -106.39 125.41 50.96 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.476 -2.046 . . . . 100.0 105.476 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 16.1 m -66.75 -17.15 22.16 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.66 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -91.69 -4.57 54.97 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 118.215 0.462 . . . . 100.0 111.306 178.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 45.1 t -124.38 116.08 22.01 Favored 'General case' 0 N--CA 1.435 -1.212 0 CA-C-O 122.472 1.129 . . . . 100.0 109.213 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -65.4 -37.73 87.85 Favored 'General case' 0 N--CA 1.44 -0.937 0 C-N-CA 124.402 1.081 . . . . 100.0 111.087 179.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.2 t -59.41 -41.22 83.75 Favored 'Isoleucine or valine' 0 C--N 1.355 0.819 0 C-N-CA 126.258 1.823 . . . . 100.0 110.333 -178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.9 p -62.41 -40.97 98.27 Favored 'General case' 0 C--N 1.356 0.876 0 CA-C-N 118.366 0.53 . . . . 100.0 111.719 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -64.13 -41.63 97.13 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 123.895 0.878 . . . . 100.0 109.789 177.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.485 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 99.1 mttt -61.17 -36.85 80.95 Favored 'General case' 0 N--CA 1.443 -0.792 0 C-N-CA 124.095 0.958 . . . . 100.0 111.495 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 74.7 m-80 -79.27 -6.56 56.95 Favored 'General case' 0 C--N 1.354 0.787 0 N-CA-C 115.133 1.531 . . . . 100.0 115.133 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 72.2 t -59.69 -42.4 91.22 Favored Pre-proline 0 C--N 1.364 1.219 0 CA-C-O 116.316 -1.802 . . . . 100.0 111.285 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.485 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 75.9 Cg_exo -57.85 -36.82 98.04 Favored 'Trans proline' 0 C--N 1.377 2.071 0 CA-C-N 122.234 1.834 . . . . 100.0 112.597 177.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -64.11 -44.41 92.37 Favored 'General case' 0 C--N 1.361 1.076 0 CA-C-N 119.438 1.017 . . . . 100.0 111.385 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 85.4 m95 -63.98 -42.25 97.28 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 122.817 0.447 . . . . 100.0 110.394 179.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 82.8 t60 -62.67 -43.03 99.84 Favored 'General case' 0 N--CA 1.435 -1.197 0 C-N-CA 124.082 0.953 . . . . 100.0 110.095 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 71.7 mtt85 -62.35 -45.19 94.29 Favored 'General case' 0 CA--C 1.493 -1.213 0 C-N-CA 122.892 0.477 . . . . 100.0 112.2 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -63.69 -43.36 96.88 Favored 'General case' 0 CA--C 1.499 -0.994 0 O-C-N 123.596 0.56 . . . . 100.0 111.397 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 86' ' ' ALA . 51.0 tp -63.11 -48.36 78.89 Favored 'General case' 0 N--CA 1.435 -1.217 0 C-N-CA 124.011 0.924 . . . . 100.0 113.093 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . 0.28 27.5 m -65.69 -36.4 77.5 Favored 'Isoleucine or valine' 0 CA--C 1.483 -1.625 0 C-N-CA 123.668 0.787 . . . . 100.0 112.97 -179.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.8 ttp85 -60.13 -45.97 91.24 Favored 'General case' 0 N--CA 1.438 -1.041 0 CA-C-O 118.916 -0.564 . . . . 100.0 109.675 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 94.3 t -73.03 -45.15 55.34 Favored 'Isoleucine or valine' 0 C--N 1.359 0.988 0 CA-C-N 118.154 0.433 . . . . 100.0 111.79 178.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 24.1 t -130.07 112.68 13.68 Favored 'General case' 0 C--N 1.363 1.192 0 C-N-CA 118.714 -1.195 . . . . 100.0 108.523 -179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -86.54 144.56 27.16 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-N 114.788 -1.097 . . . . 100.0 113.671 -177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 54.08 40.97 32.17 Favored 'General case' 0 N--CA 1.44 -0.935 0 N-CA-C 117.338 2.347 . . . . 100.0 117.338 178.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 26.0 pt -98.36 143.82 26.98 Favored Pre-proline 0 N--CA 1.441 -0.906 0 N-CA-C 107.998 -1.112 . . . . 100.0 107.998 177.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' HB3' ' HG2' ' A' ' 167' ' ' LYS . 57.9 Cg_endo -62.02 131.75 36.24 Favored 'Trans proline' 0 C--N 1.369 1.657 0 C-N-CA 122.473 2.115 . . . . 100.0 111.017 178.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.744 ' HB ' HD22 ' A' ' 144' ' ' LEU . 74.3 mt -133.13 137.32 53.79 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.042 0 CA-C-O 122.406 1.098 . . . . 100.0 108.794 -178.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.4 t -115.98 130.88 69.94 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.231 0 N-CA-C 106.767 -1.568 . . . . 100.0 106.767 178.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.683 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 14.4 mt -105.41 128.5 53.55 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 104.764 -2.31 . . . . 100.0 104.764 176.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 71.1 m -118.75 129.69 55.39 Favored 'General case' 0 N--CA 1.426 -1.636 0 CA-C-N 113.991 -1.458 . . . . 100.0 112.399 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -102.09 109.07 3.48 Favored Glycine 0 CA--C 1.487 -1.671 0 N-CA-C 105.261 -3.136 . . . . 100.0 105.261 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.419 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.378 9.4 p-10 -95.57 178.54 5.44 Favored 'General case' 0 N--CA 1.428 -1.551 0 N-CA-C 114.732 1.382 . . . . 100.0 114.732 -178.844 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.1 mttt 62.41 40.51 10.94 Favored 'General case' 0 N--CA 1.435 -1.185 0 C-N-CA 127.816 2.446 . . . . 100.0 112.511 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.3 28.1 m -72.21 -8.74 11.95 Favored 'Isoleucine or valine' 0 C--N 1.364 1.225 0 CA-C-N 115.993 -0.549 . . . . 100.0 111.24 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -62.85 -36.79 84.42 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 126.47 1.908 . . . . 100.0 109.998 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 82.2 mt -67.42 130.25 32.59 Favored 'Isoleucine or valine' 0 C--N 1.361 1.068 0 N-CA-C 108.145 -1.057 . . . . 100.0 108.145 -179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -61.67 -43.24 99.22 Favored 'General case' 0 CA--C 1.498 -1.051 0 N-CA-C 115.915 1.82 . . . . 100.0 115.915 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 64.5 t0 -88.68 97.85 11.35 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 105.607 -1.998 . . . . 100.0 105.607 -179.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -96.5 112.79 24.4 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 107.42 -1.326 . . . . 100.0 107.42 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -75.2 -45.05 42.97 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 115.102 1.519 . . . . 100.0 115.102 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 60.9 t -103.23 106.73 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.921 0 N-CA-C 105.985 -1.857 . . . . 100.0 105.985 -176.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.07 174.08 6.72 Favored 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 114.854 -1.066 . . . . 100.0 112.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.4 -34.63 66.93 Favored 'General case' 0 C--N 1.355 0.807 0 C-N-CA 127.367 2.267 . . . . 100.0 109.09 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.101 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.2 mttt -56.91 -39.33 74.24 Favored 'General case' 0 N--CA 1.42 -1.931 0 C-N-CA 128.723 2.809 . . . . 100.0 112.547 179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 89.9 p -104.65 5.1 33.35 Favored 'General case' 0 N--CA 1.433 -1.286 0 N-CA-C 115.907 1.817 . . . . 100.0 115.907 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.505 ' HB ' ' HB2' ' A' ' 212' ' ' GLU . 65.6 mt -88.76 77.01 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.362 1.112 0 C-N-CA 117.548 -1.661 . . . . 100.0 111.788 -176.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.698 ' HA ' ' HB3' ' A' ' 211' ' ' ASP 0.253 59.0 t -70.86 -38.94 74.62 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 1 C-N-CA 133.81 4.844 . . . . 100.0 118.869 -178.387 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 45.6 t80 -56.04 -35.82 67.32 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 121.427 3.862 . . . . 100.0 121.427 -168.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.859 ' CE1' ' HB2' ' A' ' 146' ' ' TYR 0.274 81.0 m-70 -59.58 -38.58 81.58 Favored 'General case' 0 CA--C 1.506 -0.73 0 CA-C-O 116.783 -1.579 . . . . 100.0 114.264 -176.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.944 ' HB3' ' HA ' ' A' ' 215' ' ' ASP 0.254 0.4 OUTLIER -59.42 -46.61 88.23 Favored 'General case' 0 CA--C 1.452 -2.819 0 N-CA-C 116.194 1.924 . . . . 100.0 116.194 -176.661 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -61.87 -41.08 97.43 Favored 'General case' 0 N--CA 1.424 -1.766 0 O-C-N 125.756 1.91 . . . . 100.0 110.832 -177.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 49.3 mmtm -101.49 6.46 42.36 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 117.15 2.278 . . . . 100.0 117.15 -176.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 66.6 m-20 56.32 42.36 27.89 Favored 'General case' 0 C--N 1.358 0.951 0 CA-C-O 123.026 1.393 . . . . 100.0 113.646 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.744 HD22 ' HB ' ' A' ' 117' ' ' ILE . 25.2 mt -99.97 149.17 23.71 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 105.523 -2.029 . . . . 100.0 105.523 179.683 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -98.77 143.87 28.63 Favored 'General case' 0 CA--C 1.493 -1.234 0 N-CA-C 108.482 -0.933 . . . . 100.0 108.482 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.859 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.5 t80 -110.25 137.27 48.21 Favored 'General case' 0 CA--C 1.488 -1.429 0 N-CA-C 112.938 0.718 . . . . 100.0 112.938 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -133.78 137.01 44.9 Favored 'General case' 0 N--CA 1.44 -0.972 0 CA-C-N 114.543 -1.208 . . . . 100.0 110.575 175.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.362 69.9 m-20 -85.59 130.09 34.66 Favored 'General case' 0 C--N 1.363 1.169 0 N-CA-C 101.464 -3.532 . . . . 100.0 101.464 176.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.482 ' HB ' HH22 ' A' ' 29' ' ' ARG . 44.1 pt -137.27 158.29 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.801 0 CA-C-O 122.248 1.023 . . . . 100.0 111.462 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.42 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.8 m -139.06 110.58 7.04 Favored 'General case' 0 CA--C 1.477 -1.851 0 N-CA-C 106.137 -1.801 . . . . 100.0 106.137 175.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.597 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -61.72 -44.47 96.86 Favored 'General case' 0 N--CA 1.434 -1.244 0 CA-C-N 114.625 -1.171 . . . . 100.0 112.71 -178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -61.79 -39.7 92.64 Favored 'General case' 0 N--CA 1.435 -1.204 0 C-N-CA 125.324 1.449 . . . . 100.0 113.012 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -99.98 1.83 42.95 Favored 'General case' 0 N--CA 1.441 -0.925 0 N-CA-C 115.676 1.732 . . . . 100.0 115.676 -178.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.491 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.3 m-80 63.6 24.08 13.83 Favored 'General case' 0 C--N 1.362 1.126 0 C-N-CA 125.158 1.383 . . . . 100.0 110.919 -177.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.42 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 80.1 t80 -74.12 125.14 27.69 Favored 'General case' 0 N--CA 1.435 -1.211 0 N-CA-C 107.504 -1.295 . . . . 100.0 107.504 -178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 53.43 36.73 23.86 Favored 'General case' 0 N--CA 1.439 -0.978 0 C-N-CA 128.095 2.558 . . . . 100.0 114.652 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.485 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 70.6 t80 -60.82 -43.39 98.3 Favored 'General case' 0 C--N 1.358 0.974 0 O-C-N 121.726 -0.609 . . . . 100.0 111.94 -179.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -63.53 -37.28 86.7 Favored 'General case' 0 N--CA 1.432 -1.33 0 N-CA-C 116.398 1.999 . . . . 100.0 116.398 -178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -57.47 -46.66 99.77 Favored Pre-proline 0 C--N 1.356 0.85 0 N-CA-C 119.897 3.295 . . . . 100.0 119.897 -173.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -60.62 -41.95 43.52 Favored 'Trans proline' 0 C--N 1.373 1.817 0 CA-C-N 123.139 2.157 . . . . 100.0 111.919 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.1 m-85 -64.92 -41.43 95.56 Favored 'General case' 0 CA--C 1.491 -1.318 0 C-N-CA 124.729 1.212 . . . . 100.0 110.969 -179.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 64.4 tp -62.3 -46.81 87.07 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 124.206 1.002 . . . . 100.0 111.203 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 86.4 t90 -65.63 -42.17 91.81 Favored 'General case' 0 C--N 1.364 1.214 0 C-N-CA 120.28 -0.568 . . . . 100.0 110.494 -179.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 85' ' ' CYS . 85.0 mt -61.92 -42.87 99.59 Favored 'General case' 0 CA--C 1.497 -1.088 0 CA-C-O 119.208 -0.425 . . . . 100.0 111.415 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.66 -43.73 98.3 Favored 'General case' 0 CA--C 1.493 -1.234 0 C-N-CA 124.018 0.927 . . . . 100.0 110.564 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -61.79 -45.72 92.66 Favored 'General case' 0 CA--C 1.496 -1.114 0 CA-C-O 119.188 -0.435 . . . . 100.0 111.751 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.4 ' HG2' ' HB3' ' A' ' 116' ' ' PRO . 52.6 tptt -65.55 -44.93 85.3 Favored 'General case' 0 N--CA 1.437 -1.121 0 O-C-N 123.518 0.511 . . . . 100.0 112.105 -178.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 84.3 mt -64.46 -46.37 83.37 Favored 'General case' 0 N--CA 1.441 -0.898 0 N-CA-C 114.279 1.215 . . . . 100.0 114.279 -179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.7 -37.85 70.77 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 C-N-CA 124.225 1.01 . . . . 100.0 109.479 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.44 11.43 57.13 Favored Glycine 0 C--N 1.352 1.446 0 N-CA-C 110.27 -1.132 . . . . 100.0 110.27 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 174' ' ' LEU . 54.2 t0 -112.57 110.53 52.58 Favored Pre-proline 0 C--N 1.364 1.218 0 N-CA-C 108.041 -1.096 . . . . 100.0 108.041 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -70.97 -14.15 32.08 Favored 'Trans proline' 0 C--N 1.363 1.293 0 C-N-CA 123.748 2.965 . . . . 100.0 113.285 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -90.36 -0.47 57.66 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 124.499 1.12 . . . . 100.0 112.987 -178.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 171' ' ' ASP . 90.3 mt -61.94 136.16 57.85 Favored 'General case' 0 CA--C 1.492 -1.266 0 N-CA-C 113.739 1.014 . . . . 100.0 113.739 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -134.89 154.86 51.5 Favored 'General case' 0 CA--C 1.496 -1.107 0 N-CA-C 107.908 -1.145 . . . . 100.0 107.908 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.0 m-30 -90.49 116.24 28.25 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 103.872 -2.64 . . . . 100.0 103.872 178.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 64.1 t -65.7 -44.73 93.25 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 C-N-CA 123.971 0.908 . . . . 100.0 111.188 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.08 150.5 52.14 Favored 'General case' 0 CA--C 1.494 -1.199 0 N-CA-C 108.561 -0.903 . . . . 100.0 108.561 -178.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -95.02 130.86 31.5 Favored Pre-proline 0 N--CA 1.434 -1.232 0 N-CA-C 107.493 -1.299 . . . . 100.0 107.493 179.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -64.58 158.27 50.85 Favored 'Trans proline' 0 N--CA 1.443 -1.448 0 C-N-CA 122.466 2.11 . . . . 100.0 111.51 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.8 125.43 25.32 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-O 122.37 1.081 . . . . 100.0 108.585 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 83.0 mt -120.35 147.21 45.33 Favored 'General case' 0 N--CA 1.427 -1.6 0 CA-C-N 113.863 -1.517 . . . . 100.0 108.804 -178.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.27 135.84 95.31 Favored Pre-proline 0 N--CA 1.44 -0.959 0 N-CA-C 105.777 -1.934 . . . . 100.0 105.777 178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.434 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 74.7 Cg_exo -55.97 142.33 85.11 Favored 'Trans proline' 0 C--N 1.365 1.411 0 C-N-CA 123.549 2.833 . . . . 100.0 113.197 -177.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.491 ' HG3' HD22 ' A' ' 154' ' ' ASN . 50.2 Cg_exo -56.8 128.67 30.91 Favored 'Trans proline' 0 C--N 1.367 1.536 0 C-N-CA 122.634 2.223 . . . . 100.0 112.94 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -69.8 -43.37 72.23 Favored 'General case' 0 N--CA 1.439 -0.982 0 N-CA-C 107.892 -1.151 . . . . 100.0 107.892 178.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 33.1 m -131.06 157.78 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.866 0 N-CA-C 106.538 -1.653 . . . . 100.0 106.538 178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 96.2 t -98.05 130.41 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.897 0 N-CA-C 106.87 -1.53 . . . . 100.0 106.87 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.64 125.86 34.62 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 103.664 -2.717 . . . . 100.0 103.664 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -63.22 126.93 90.26 Favored Pre-proline 0 N--CA 1.433 -1.311 0 CA-C-N 115.122 -0.945 . . . . 100.0 110.327 -178.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -58.92 -38.14 89.8 Favored 'Trans proline' 0 N--CA 1.44 -1.619 0 C-N-CA 123.631 2.887 . . . . 100.0 113.68 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.25 -43.71 94.07 Favored 'General case' 0 C--N 1.359 1.006 0 O-C-N 124.146 0.904 . . . . 100.0 110.049 179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.5 mt -63.7 -40.81 97.72 Favored 'General case' 0 C--N 1.359 0.988 0 C-N-CA 123.127 0.571 . . . . 100.0 111.251 179.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -43.54 98.67 Favored 'General case' 0 CA--C 1.499 -1.007 0 C-N-CA 123.659 0.784 . . . . 100.0 110.284 179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -63.01 -42.45 99.82 Favored 'General case' 0 N--CA 1.438 -1.026 0 C-N-CA 123.935 0.894 . . . . 100.0 110.533 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -61.71 -46.06 91.29 Favored 'General case' 0 C--N 1.36 1.033 0 C-N-CA 124.349 1.059 . . . . 100.0 111.363 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -63.91 -43.35 96.22 Favored 'General case' 0 CA--C 1.491 -1.299 0 N-CA-C 112.275 0.472 . . . . 100.0 112.275 179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -64.33 -39.66 94.35 Favored 'General case' 0 CA--C 1.499 -0.999 0 O-C-N 123.333 0.396 . . . . 100.0 111.633 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.76 -44.27 96.64 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.223 1.009 . . . . 100.0 110.209 179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -61.61 -42.76 99.34 Favored 'General case' 0 C--N 1.358 0.978 0 C-N-CA 123.459 0.704 . . . . 100.0 110.894 -179.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.5 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 79.5 mt -61.15 -48.49 81.37 Favored 'General case' 0 C--N 1.361 1.104 0 CA-C-N 115.784 -0.643 . . . . 100.0 110.271 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 29.7 tp10 -63.26 -43.95 96.53 Favored 'General case' 0 CA--C 1.499 -1.017 0 N-CA-C 113.709 1.003 . . . . 100.0 113.709 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.53 -45.81 96.48 Favored 'Isoleucine or valine' 0 CA--C 1.448 -2.945 0 CA-C-O 118.372 -0.823 . . . . 100.0 109.443 -177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.962 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.746 . . -86.45 -10.78 53.51 Favored 'General case' 1 N--CA 1.376 -4.174 1 C-N-CA 104.526 -6.87 . . . . 100.0 115.747 179.945 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 1.0 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 52.6 mt-30 -54.68 -35.27 63.39 Favored 'General case' 0 CA--C 1.443 -3.158 0 C-N-CA 128.703 2.801 . . . . 100.0 107.148 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 75.2 p -81.36 40.58 0.57 Allowed 'General case' 0 N--CA 1.415 -2.201 0 CA-C-O 122.857 1.313 . . . . 100.0 109.572 177.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.447 ' H ' ' C ' ' A' ' 205' ' ' GLN 0.266 6.4 m 59.13 27.17 16.07 Favored 'General case' 0 CA--C 1.471 -2.086 0 C-N-CA 127.277 2.231 . . . . 100.0 112.984 175.003 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.527 ' HB3' ' HA ' ' A' ' 204' ' ' ALA 0.266 . . -72.09 170.5 13.78 Favored 'General case' 0 N--CA 1.398 -3.047 0 N-CA-C 101.316 -3.587 . . . . 100.0 101.316 171.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -53.95 -35.4 29.03 Favored Pre-proline 0 CA--C 1.486 -1.515 0 CA-C-O 116.499 -1.715 . . . . 100.0 114.911 -174.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.101 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.445 0.0 OUTLIER -54.38 139.48 73.98 Favored 'Trans proline' 0 N--CA 1.432 -2.119 0 O-C-N 123.741 1.39 . . . . 100.0 111.898 176.403 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.698 ' HB3' ' HA ' ' A' ' 137' ' ' VAL 0.453 39.5 m-20 -65.73 -43.21 89.75 Favored 'General case' 0 N--CA 1.408 -2.53 1 N-CA-C 125.03 5.196 . . . . 100.0 125.03 -173.577 . . . . . . . . 4 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.658 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 15.7 tm-20 -62.58 -35.81 80.71 Favored 'General case' 0 CA--C 1.469 -2.16 1 CA-C-O 132.292 5.806 . . . . 100.0 108.734 176.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 1.0 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.629 17.5 m-20 -62.34 -51.9 65.8 Favored 'General case' 1 N--CA 1.282 -8.842 2 CA-C-N 104.098 -5.955 . . . . 100.0 107.554 178.719 . . . . . . . . 5 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -67.28 -25.33 66.0 Favored 'General case' 0 C--O 1.233 0.233 0 O-C-N 117.261 -3.399 . . . . 100.0 107.579 178.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.944 ' HA ' ' HB3' ' A' ' 140' ' ' ARG . 57.9 m-20 -63.78 -40.4 96.56 Favored 'General case' 0 N--CA 1.419 -1.986 0 C-N-CA 126.979 2.112 . . . . 100.0 112.395 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.493 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.274 3.2 mm? . . . . . 0 N--CA 1.426 -1.654 0 CA-C-O 114.157 -2.83 . . . . 100.0 112.781 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mpp? . . . . . 0 N--CA 1.481 1.11 0 CA-C-O 121.046 0.45 . . . . 100.0 111.375 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.48 -39.23 92.79 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 125.064 1.346 . . . . 100.0 114.33 -178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -76.1 162.67 27.82 Favored 'General case' 0 C--N 1.355 0.843 0 N-CA-C 116.849 2.166 . . . . 100.0 116.849 -178.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -80.56 164.15 23.15 Favored 'General case' 0 C--N 1.359 1.014 0 C-N-CA 124.911 1.284 . . . . 100.0 110.126 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.55 -4.27 82.13 Favored Glycine 0 C--N 1.355 1.626 0 CA-C-O 119.688 -0.507 . . . . 100.0 112.381 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 75.5 mm-40 -72.59 141.01 82.15 Favored Pre-proline 0 N--CA 1.436 -1.164 0 C-N-CA 123.811 0.844 . . . . 100.0 111.221 179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 6' ' ' GLU . 39.4 Cg_exo -62.92 137.88 65.12 Favored 'Trans proline' 0 C--N 1.369 1.644 0 C-N-CA 122.859 2.373 . . . . 100.0 109.513 179.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.8 mm-40 -73.74 150.05 41.4 Favored 'General case' 0 N--CA 1.436 -1.148 0 O-C-N 124.108 0.88 . . . . 100.0 111.051 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 95.8 t -87.09 106.92 16.49 Favored 'Isoleucine or valine' 0 C--N 1.355 0.844 0 N-CA-C 102.009 -3.33 . . . . 100.0 102.009 179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.0 mt-30 -128.41 138.74 52.47 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.813 -0.63 . . . . 100.0 110.828 -177.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -128.83 144.37 51.15 Favored 'General case' 0 N--CA 1.437 -1.082 0 CA-C-N 115.605 -0.725 . . . . 100.0 110.017 179.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.64 120.3 32.93 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 107.217 -1.401 . . . . 100.0 107.217 178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.577 HD23 HG22 ' A' ' 63' ' ' VAL . 57.1 tp -110.6 125.87 53.85 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 113.131 -1.849 . . . . 100.0 107.23 -179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.405 HG13 ' CE2' ' A' ' 79' ' ' TYR . 56.0 t -103.05 124.69 57.32 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 107.694 -1.224 . . . . 100.0 107.694 179.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.456 HD11 ' SD ' ' A' ' 89' ' ' MET . 42.5 tp -109.29 117.33 33.8 Favored 'General case' 0 N--CA 1.432 -1.328 0 N-CA-C 106.124 -1.806 . . . . 100.0 106.124 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 22.1 m -128.79 161.47 37.81 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.078 0 N-CA-C 112.129 0.418 . . . . 100.0 112.129 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.69 173.96 24.14 Favored Glycine 0 CA--C 1.489 -1.59 0 N-CA-C 108.403 -1.879 . . . . 100.0 108.403 178.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 84.5 m-20 -67.4 154.35 41.55 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-O 122.061 0.934 . . . . 100.0 112.938 -179.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -64.84 141.18 43.31 Favored Glycine 0 C--N 1.353 1.51 0 N-CA-C 107.07 -2.412 . . . . 100.0 107.07 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 86.78 -1.53 86.99 Favored Glycine 0 N--CA 1.435 -1.397 0 CA-C-O 118.084 -1.398 . . . . 100.0 113.288 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 20.2 p -63.91 -38.39 90.91 Favored 'General case' 0 CA--C 1.493 -1.216 0 CA-C-N 119.261 1.531 . . . . 100.0 111.649 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 116.47 21.78 4.63 Favored Glycine 0 C--N 1.353 1.49 0 N-CA-C 110.487 -1.045 . . . . 100.0 110.487 -179.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.7 mtpm? -59.98 -46.86 88.06 Favored 'General case' 0 N--CA 1.438 -1.074 0 C-N-CA 124.759 1.224 . . . . 100.0 113.237 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.9 m -63.68 -43.73 95.8 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 123.986 0.914 . . . . 100.0 110.03 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 56.2 m -63.21 -41.13 99.1 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 123.939 0.896 . . . . 100.0 109.581 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 41.8 t80 -60.44 -48.72 80.51 Favored 'General case' 0 CA--C 1.497 -1.076 0 C-N-CA 123.945 0.898 . . . . 100.0 112.772 178.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 86.7 t -65.89 -40.94 88.94 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.795 0 O-C-N 123.103 0.252 . . . . 100.0 111.114 -178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.265 99.3 mttt -69.13 -7.08 32.85 Favored 'General case' 0 CA--C 1.498 -1.03 0 N-CA-C 116.302 1.964 . . . . 100.0 116.302 -177.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 151' ' ' ALA . 43.6 mtt180 -61.01 -37.84 83.95 Favored 'General case' 0 C--N 1.362 1.118 0 N-CA-C 107.49 -1.3 . . . . 100.0 107.49 178.14 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.44 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.71 112.71 18.33 Favored 'General case' 0 C--N 1.365 1.262 0 N-CA-C 106.831 -1.544 . . . . 100.0 106.831 -178.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 94.9 mt -61.92 -44.46 96.73 Favored 'General case' 0 CA--C 1.492 -1.268 0 N-CA-C 115.983 1.845 . . . . 100.0 115.983 -176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 84.8 m -63.72 -42.12 97.97 Favored 'General case' 0 C--N 1.353 0.719 0 C-N-CA 123.869 0.868 . . . . 100.0 109.479 -179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.63 -41.5 99.59 Favored Glycine 0 C--N 1.357 1.744 0 N-CA-C 110.977 -0.849 . . . . 100.0 110.977 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -64.6 -44.25 91.22 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.721 0.808 . . . . 100.0 110.866 178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -63.42 -40.32 96.88 Favored 'General case' 0 C--N 1.354 0.766 0 C-N-CA 124.428 1.091 . . . . 100.0 111.484 -179.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -91.12 8.6 34.81 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 114.887 1.44 . . . . 100.0 114.887 -177.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.1 pttt -58.84 142.92 49.13 Favored 'General case' 0 C--N 1.361 1.083 0 N-CA-C 114.538 1.311 . . . . 100.0 114.538 -177.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -121.61 139.98 52.84 Favored 'General case' 0 N--CA 1.44 -0.95 0 N-CA-C 107.354 -1.351 . . . . 100.0 107.354 -178.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.6 t80 -111.89 125.97 54.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 104.34 -2.467 . . . . 100.0 104.34 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 85.0 t -100.28 108.15 22.37 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 102.448 -3.167 . . . . 100.0 102.448 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.05 -42.66 99.76 Favored 'General case' 0 CA--C 1.499 -1.002 0 N-CA-C 114.591 1.33 . . . . 100.0 114.591 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 67.1 p -61.47 -42.5 98.86 Favored 'General case' 0 CA--C 1.5 -0.972 0 C-N-CA 123.699 0.8 . . . . 100.0 112.914 -178.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.3 mt -93.58 -20.97 19.72 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 114.356 1.243 . . . . 100.0 114.356 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 72.05 43.24 49.25 Favored Glycine 0 C--N 1.36 1.889 0 N-CA-C 108.504 -1.839 . . . . 100.0 108.504 -177.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG21 ' HD1' ' A' ' 79' ' ' TYR . 24.1 t -126.7 145.39 34.34 Favored 'Isoleucine or valine' 0 C--N 1.358 0.939 0 N-CA-C 108.337 -0.986 . . . . 100.0 108.337 -178.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -109.72 117.82 34.9 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 102.44 -3.17 . . . . 100.0 102.44 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 58.0 t -103.63 123.12 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 N-CA-C 107.094 -1.447 . . . . 100.0 107.094 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 45.3 m-70 -115.15 121.59 34.78 Favored Pre-proline 0 N--CA 1.436 -1.169 0 CA-C-N 115.365 -0.834 . . . . 100.0 110.519 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -80.45 103.38 1.51 Allowed 'Trans proline' 0 C--N 1.367 1.529 0 C-N-CA 122.226 1.951 . . . . 100.0 110.36 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -97.92 113.0 24.71 Favored 'General case' 0 CA--C 1.501 -0.925 0 C-N-CA 123.595 0.758 . . . . 100.0 109.323 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.6 t -98.48 130.26 47.56 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.757 0 C-N-CA 123.689 0.796 . . . . 100.0 108.854 -177.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -125.92 135.44 51.89 Favored 'General case' 0 CA--C 1.496 -1.13 0 N-CA-C 105.529 -2.026 . . . . 100.0 105.529 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -102.12 118.48 36.99 Favored 'General case' 0 N--CA 1.438 -1.029 0 C-N-CA 119.651 -0.819 . . . . 100.0 109.34 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 19.6 p -103.86 176.12 5.26 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.077 -0.965 . . . . 100.0 109.768 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 17.3 p-10 -60.13 -35.24 74.83 Favored 'General case' 0 N--CA 1.44 -0.967 0 C-N-CA 125.789 1.635 . . . . 100.0 109.582 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 92.2 mtt-85 -90.5 -0.46 57.67 Favored 'General case' 0 C--N 1.358 0.971 0 N-CA-C 113.767 1.025 . . . . 100.0 113.767 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 124.07 178.07 15.26 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 119.493 1.042 . . . . 100.0 111.763 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -65.59 139.84 60.1 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 123.099 2.533 . . . . 100.0 114.323 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.2 mm -127.42 130.62 70.71 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 N-CA-C 102.359 -3.2 . . . . 100.0 102.359 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -116.25 130.12 56.62 Favored 'General case' 0 CA--C 1.498 -1.053 0 O-C-N 121.681 -0.637 . . . . 100.0 109.978 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -112.33 115.65 29.09 Favored 'General case' 0 N--CA 1.432 -1.364 0 N-CA-C 104.922 -2.251 . . . . 100.0 104.922 177.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 -88.84 107.33 18.93 Favored 'General case' 0 CA--C 1.494 -1.2 0 N-CA-C 100.63 -3.841 . . . . 100.0 100.63 178.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.577 HG22 HD23 ' A' ' 13' ' ' LEU . 21.5 t -93.56 122.65 45.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 108.183 -1.043 . . . . 100.0 108.183 -175.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 53.2 m95 -94.24 111.77 23.53 Favored 'General case' 0 N--CA 1.43 -1.461 0 N-CA-C 105.155 -2.165 . . . . 100.0 105.155 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -115.02 137.46 51.98 Favored 'General case' 0 CA--C 1.494 -1.175 0 N-CA-C 106.95 -1.5 . . . . 100.0 106.95 179.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.5 p -70.85 163.7 26.81 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-O 122.04 0.924 . . . . 100.0 113.078 -178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -100.88 25.9 7.49 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 108.229 -1.026 . . . . 100.0 108.229 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 89.76 13.73 60.59 Favored Glycine 0 C--N 1.361 1.92 0 O-C-N 121.613 -0.679 . . . . 100.0 114.147 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.452 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 73.9 mt-30 -59.55 -35.04 73.47 Favored 'General case' 0 C--N 1.351 0.663 0 C-N-CA 126.795 2.038 . . . . 100.0 112.296 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -57.96 -32.84 68.23 Favored 'General case' 0 N--CA 1.441 -0.885 0 C-N-CA 128.416 2.686 . . . . 100.0 112.128 -178.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.54 -40.07 95.62 Favored 'General case' 0 N--CA 1.441 -0.89 0 C-N-CA 124.12 0.968 . . . . 100.0 111.159 179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.452 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 17.3 p90 -94.56 -18.08 21.75 Favored 'General case' 0 C--N 1.36 1.032 0 N-CA-C 115.578 1.696 . . . . 100.0 115.578 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -176.44 -162.83 27.86 Favored Glycine 0 C--N 1.354 1.582 0 C-N-CA 119.836 -1.173 . . . . 100.0 112.518 -179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.25 178.46 53.86 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.601 -1.4 . . . . 100.0 109.601 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.6 mt -102.89 145.48 29.74 Favored 'General case' 0 CA--C 1.485 -1.556 0 CA-C-O 122.568 1.175 . . . . 100.0 111.09 -178.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -67.15 150.12 49.58 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 113.082 -1.872 . . . . 100.0 111.433 -177.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -62.39 -36.7 83.14 Favored 'General case' 0 CA--C 1.501 -0.906 0 C-N-CA 124.874 1.27 . . . . 100.0 108.859 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.67 -38.02 93.18 Favored Glycine 0 C--N 1.358 1.79 0 C-N-CA 125.81 1.671 . . . . 100.0 110.587 179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.485 ' CE2' HD13 ' A' ' 75' ' ' LEU . 73.9 t80 -63.66 -46.96 83.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 117.251 0.526 . . . . 100.0 111.5 177.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.6 m-85 -70.27 -37.01 74.78 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 116.871 2.174 . . . . 100.0 116.871 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 14.4 tt -55.18 139.89 13.71 Favored 'Isoleucine or valine' 0 C--N 1.357 0.892 0 CA-C-O 122.375 1.083 . . . . 100.0 113.75 -174.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 70.8 11.5 7.15 Favored 'General case' 0 C--N 1.359 1.02 0 C-N-CA 126.92 2.088 . . . . 100.0 113.582 -179.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -65.97 131.55 46.49 Favored 'General case' 0 C--N 1.362 1.121 0 N-CA-C 108.827 -0.805 . . . . 100.0 108.827 178.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 98.3 mm-40 -98.65 -27.82 13.82 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.149 -0.932 . . . . 100.0 109.513 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.625 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.4 p -152.21 163.05 40.2 Favored 'General case' 0 CA--C 1.498 -1.057 0 C-N-CA 122.284 0.234 . . . . 100.0 110.392 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.4 ' HA ' HD12 ' A' ' 13' ' ' LEU . . . -148.74 153.43 38.19 Favored 'General case' 0 CA--C 1.489 -1.372 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.424 HG13 HD11 ' A' ' 13' ' ' LEU . 95.6 mt -126.55 126.5 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.183 0 N-CA-C 103.856 -2.646 . . . . 100.0 103.856 176.403 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.656 ' HB ' HD22 ' A' ' 119' ' ' LEU . 39.8 mt -111.37 125.09 68.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 102.934 -2.988 . . . . 100.0 102.934 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.456 ' SD ' HD11 ' A' ' 15' ' ' LEU . 88.8 mtp -112.5 137.1 51.2 Favored 'General case' 0 N--CA 1.424 -1.769 0 N-CA-C 114.596 1.332 . . . . 100.0 114.596 -177.214 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -129.94 161.48 30.8 Favored 'General case' 0 N--CA 1.43 -1.465 0 CA-C-N 112.051 -2.34 . . . . 100.0 108.265 177.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -104.95 125.77 51.3 Favored 'General case' 0 N--CA 1.434 -1.269 0 N-CA-C 106.061 -1.829 . . . . 100.0 106.061 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.2 m -66.72 -16.95 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.676 0 N-CA-C 113.355 0.872 . . . . 100.0 113.355 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 67.5 p -90.21 -7.44 53.56 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 119.146 -0.454 . . . . 100.0 111.109 178.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 42.4 t -123.66 116.9 23.83 Favored 'General case' 0 C--N 1.363 1.191 0 CA-C-O 122.214 1.007 . . . . 100.0 110.318 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 79.7 mtt180 -65.45 -36.85 85.14 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 124.146 0.978 . . . . 100.0 111.898 178.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 93.3 t -59.77 -40.22 81.94 Favored 'Isoleucine or valine' 0 C--N 1.355 0.816 0 C-N-CA 125.571 1.549 . . . . 100.0 110.288 -178.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 78.9 p -62.36 -41.04 98.3 Favored 'General case' 0 C--N 1.36 1.027 0 CA-C-N 118.439 0.563 . . . . 100.0 111.028 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.9 t80 -64.3 -41.67 96.74 Favored 'General case' 0 C--N 1.36 1.024 0 C-N-CA 123.734 0.814 . . . . 100.0 110.438 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.529 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.6 mttt -60.36 -37.76 81.72 Favored 'General case' 0 CA--C 1.505 -0.782 0 C-N-CA 124.336 1.054 . . . . 100.0 110.615 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -76.27 -9.79 58.91 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 115.631 1.715 . . . . 100.0 115.631 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 82.4 t -60.0 -42.19 88.99 Favored Pre-proline 0 C--N 1.362 1.14 0 CA-C-O 116.32 -1.8 . . . . 100.0 112.087 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.529 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 76.5 Cg_exo -57.53 -37.91 95.61 Favored 'Trans proline' 0 C--N 1.377 2.028 0 C-N-CA 122.351 2.034 . . . . 100.0 112.74 177.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 -64.71 -44.59 89.75 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 124.631 1.172 . . . . 100.0 110.683 179.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 77.5 m95 -63.53 -42.43 98.44 Favored 'General case' 0 C--N 1.359 0.99 0 C-N-CA 123.267 0.627 . . . . 100.0 110.674 179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.413 ' CE1' HD11 ' A' ' 144' ' ' LEU . 84.4 t60 -62.78 -44.91 94.92 Favored 'General case' 0 N--CA 1.433 -1.28 0 C-N-CA 124.339 1.055 . . . . 100.0 110.231 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.1 mtm-85 -63.12 -42.28 99.51 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 112.636 0.606 . . . . 100.0 112.636 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 -61.82 -46.11 90.93 Favored 'General case' 0 C--N 1.357 0.91 0 C-N-CA 123.02 0.528 . . . . 100.0 109.798 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 52.6 tp -62.84 -48.25 79.85 Favored 'General case' 0 N--CA 1.436 -1.148 0 N-CA-C 113.588 0.959 . . . . 100.0 113.588 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.5 t -63.32 -38.37 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.409 0 C-N-CA 125.069 1.348 . . . . 100.0 111.473 -178.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -60.37 -39.38 87.01 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-N 118.554 0.616 . . . . 100.0 111.439 179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 62.5 t -80.17 -44.12 22.37 Favored 'Isoleucine or valine' 0 C--N 1.356 0.853 0 CA-C-N 118.279 0.49 . . . . 100.0 110.61 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 77.2 m -127.59 106.78 9.4 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.521 0.601 . . . . 100.0 109.944 -179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -87.37 144.96 26.52 Favored 'General case' 0 CA--C 1.492 -1.263 0 CA-C-O 121.957 0.884 . . . . 100.0 112.615 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . 0.255 72.2 m-20 54.06 41.18 32.13 Favored 'General case' 0 N--CA 1.439 -0.991 0 N-CA-C 116.926 2.195 . . . . 100.0 116.926 179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 47.9 pt -96.48 144.17 27.37 Favored Pre-proline 0 N--CA 1.442 -0.866 0 N-CA-C 104.998 -2.223 . . . . 100.0 104.998 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -62.98 132.26 36.14 Favored 'Trans proline' 0 C--N 1.372 1.792 0 C-N-CA 122.354 2.036 . . . . 100.0 110.148 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.8 ' HB ' HD22 ' A' ' 144' ' ' LEU . 73.3 mt -132.24 136.59 56.17 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 122.309 1.052 . . . . 100.0 108.57 -178.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.458 HG11 ' HB3' ' A' ' 160' ' ' PRO . 60.7 t -115.55 131.95 66.37 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 N-CA-C 105.989 -1.856 . . . . 100.0 105.989 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.656 HD22 ' HB ' ' A' ' 88' ' ' ILE . 25.9 mt -106.59 127.86 53.67 Favored 'General case' 0 N--CA 1.43 -1.429 0 N-CA-C 105.601 -2.0 . . . . 100.0 105.601 176.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 70.8 m -119.23 130.16 55.32 Favored 'General case' 0 N--CA 1.429 -1.518 0 CA-C-N 114.398 -1.274 . . . . 100.0 113.406 -178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -101.21 107.24 3.21 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 104.797 -3.321 . . . . 100.0 104.797 179.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.437 ' HA ' ' O ' ' A' ' 149' ' ' ILE 0.333 0.6 OUTLIER -95.64 177.9 5.65 Favored 'General case' 0 N--CA 1.427 -1.582 0 N-CA-C 114.668 1.358 . . . . 100.0 114.668 -178.266 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.6 mttt 61.82 40.14 13.13 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 127.742 2.417 . . . . 100.0 112.729 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.303 24.7 m -72.15 -8.38 11.26 Favored 'Isoleucine or valine' 0 C--N 1.363 1.171 0 CA-C-N 116.187 -0.461 . . . . 100.0 111.366 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -63.09 -37.3 86.64 Favored 'General case' 0 C--N 1.359 1.019 0 C-N-CA 126.6 1.96 . . . . 100.0 109.977 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.9 129.61 31.57 Favored 'Isoleucine or valine' 0 C--N 1.359 0.994 0 N-CA-C 107.743 -1.206 . . . . 100.0 107.743 -179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.54 -44.31 97.29 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 114.891 1.441 . . . . 100.0 114.891 -177.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -87.74 95.29 10.02 Favored 'General case' 0 N--CA 1.439 -1.024 0 N-CA-C 106.773 -1.566 . . . . 100.0 106.773 -178.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -94.99 125.31 39.57 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 106.229 -1.767 . . . . 100.0 106.229 -179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -95.32 -36.28 11.46 Favored 'General case' 0 CA--C 1.495 -1.161 0 N-CA-C 113.982 1.104 . . . . 100.0 113.982 -178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 59.4 t -105.52 106.34 20.35 Favored 'Isoleucine or valine' 0 C--N 1.358 0.969 0 N-CA-C 104.395 -2.446 . . . . 100.0 104.395 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -100.8 173.6 6.43 Favored 'General case' 0 N--CA 1.435 -1.192 0 CA-C-N 115.115 -0.948 . . . . 100.0 112.045 -178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.402 ' HB1' ' OD2' ' A' ' 213' ' ' ASP . . . -56.84 -34.14 67.46 Favored 'General case' 0 C--N 1.353 0.747 0 C-N-CA 126.496 1.919 . . . . 100.0 109.477 -179.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.032 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.3 mttt -57.31 -38.91 74.74 Favored 'General case' 0 N--CA 1.418 -2.065 0 C-N-CA 129.674 3.189 . . . . 100.0 112.094 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 91.7 p -104.95 2.75 30.03 Favored 'General case' 0 N--CA 1.43 -1.462 0 N-CA-C 116.796 2.147 . . . . 100.0 116.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.468 ' CG2' ' NE2' ' A' ' 139' ' ' HIS . 61.9 mt -92.95 89.62 2.82 Favored 'Isoleucine or valine' 0 C--N 1.36 1.038 0 C-N-CA 116.589 -2.045 . . . . 100.0 110.624 -176.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.603 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.4 p -100.64 -8.61 9.05 Favored 'Isoleucine or valine' 0 C--N 1.351 0.636 0 N-CA-C 117.51 2.411 . . . . 100.0 117.51 -176.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -60.47 -36.63 78.75 Favored 'General case' 0 C--O 1.243 0.735 0 N-CA-C 117.819 2.525 . . . . 100.0 117.819 -173.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.533 ' CE1' ' HB2' ' A' ' 119' ' ' LEU 0.262 63.6 m-70 -58.94 -39.14 80.74 Favored 'General case' 0 CA--C 1.506 -0.75 0 C-N-CA 126.489 1.916 . . . . 100.0 115.265 -176.068 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.831 ' HB2' ' HA ' ' A' ' 215' ' ' ASP 0.314 24.1 ttp-105 -59.25 -49.6 77.23 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 113.963 1.098 . . . . 100.0 113.963 -174.84 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -62.25 -40.81 97.43 Favored 'General case' 0 N--CA 1.427 -1.613 0 O-C-N 125.275 1.61 . . . . 100.0 111.318 -176.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.405 ' HB2' ' HG ' ' A' ' 144' ' ' LEU . 74.5 mmtt -95.32 -0.65 52.57 Favored 'General case' 0 N--CA 1.431 -1.403 0 N-CA-C 115.576 1.695 . . . . 100.0 115.576 -176.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.268 2.0 m-80 55.28 44.54 27.29 Favored 'General case' 0 C--N 1.362 1.134 0 CA-C-O 123.367 1.556 . . . . 100.0 114.146 -178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.8 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.5 mt -106.03 143.33 34.32 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 104.212 -2.514 . . . . 100.0 104.212 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.257 99.8 mm-40 -92.25 145.51 24.44 Favored 'General case' 0 CA--C 1.487 -1.465 0 C-N-CA 118.625 -1.23 . . . . 100.0 110.247 178.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 139' ' ' HIS . 81.6 t80 -110.6 137.49 48.21 Favored 'General case' 0 CA--C 1.488 -1.404 0 N-CA-C 113.063 0.764 . . . . 100.0 113.063 -178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -134.79 137.21 43.16 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.35 -1.296 . . . . 100.0 110.652 175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.27 78.7 m-20 -83.35 129.22 34.98 Favored 'General case' 0 C--N 1.36 1.049 0 N-CA-C 102.894 -3.002 . . . . 100.0 102.894 175.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.484 ' HB ' HH22 ' A' ' 29' ' ' ARG . 41.5 pt -135.32 158.5 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.853 0 CA-C-O 122.295 1.045 . . . . 100.0 111.71 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.456 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 59.4 m -139.48 110.73 6.97 Favored 'General case' 0 CA--C 1.478 -1.796 0 N-CA-C 105.42 -2.067 . . . . 100.0 105.42 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 29' ' ' ARG . . . -62.28 -44.83 95.62 Favored 'General case' 0 N--CA 1.433 -1.313 0 CA-C-N 114.559 -1.201 . . . . 100.0 113.107 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -62.7 -39.55 94.37 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 124.735 1.214 . . . . 100.0 112.98 -178.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 91.8 p -97.27 -0.02 47.35 Favored 'General case' 0 N--CA 1.442 -0.867 0 N-CA-C 115.314 1.598 . . . . 100.0 115.314 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.464 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.8 m-80 65.45 20.1 11.68 Favored 'General case' 0 C--N 1.364 1.197 0 C-N-CA 124.918 1.287 . . . . 100.0 111.648 -177.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.456 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -69.84 125.88 28.07 Favored 'General case' 0 N--CA 1.438 -1.034 0 N-CA-C 108.404 -0.962 . . . . 100.0 108.404 -179.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 53.1 37.6 25.29 Favored 'General case' 0 N--CA 1.439 -1.013 0 C-N-CA 128.103 2.561 . . . . 100.0 114.566 179.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.505 ' CD1' ' HD2' ' A' ' 29' ' ' ARG . 71.1 t80 -60.48 -43.63 96.75 Favored 'General case' 0 C--N 1.362 1.113 0 O-C-N 121.885 -0.509 . . . . 100.0 111.457 -179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -64.8 -36.81 85.52 Favored 'General case' 0 CA--C 1.491 -1.321 0 N-CA-C 118.013 2.597 . . . . 100.0 118.013 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -56.38 -47.97 97.89 Favored Pre-proline 0 C--N 1.358 0.97 0 N-CA-C 118.863 2.912 . . . . 100.0 118.863 -173.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.458 ' HB3' HG11 ' A' ' 118' ' ' VAL . 50.5 Cg_endo -60.62 -40.55 54.84 Favored 'Trans proline' 0 C--N 1.373 1.835 0 CA-C-N 122.879 2.064 . . . . 100.0 112.29 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -64.97 -41.62 95.29 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 124.5 1.125 . . . . 100.0 111.164 -179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 41.6 mt -61.45 -46.37 90.34 Favored 'General case' 0 CA--C 1.488 -1.416 0 O-C-N 123.726 0.641 . . . . 100.0 112.024 178.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.78 -43.22 93.95 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 123.631 0.582 . . . . 100.0 110.646 -178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.625 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.72 -44.83 96.17 Favored 'General case' 0 CA--C 1.497 -1.078 0 C-N-CA 123.243 0.617 . . . . 100.0 110.885 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.54 -43.66 98.46 Favored 'General case' 0 CA--C 1.491 -1.316 0 C-N-CA 124.306 1.042 . . . . 100.0 110.793 -178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 75.3 mtt85 -61.65 -45.32 94.56 Favored 'General case' 0 CA--C 1.492 -1.269 0 CA-C-O 119.052 -0.499 . . . . 100.0 111.343 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.03 -43.72 86.75 Favored 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 113.985 1.106 . . . . 100.0 113.985 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 82.0 mt -63.9 -46.59 84.15 Favored 'General case' 0 CA--C 1.5 -0.95 0 C-N-CA 123.699 0.8 . . . . 100.0 112.998 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 48.7 mm -70.77 -38.05 71.3 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 C-N-CA 124.211 1.004 . . . . 100.0 110.469 178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.67 10.53 58.95 Favored Glycine 0 C--N 1.351 1.373 0 N-CA-C 110.498 -1.041 . . . . 100.0 110.498 -178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -114.98 114.02 43.93 Favored Pre-proline 0 C--N 1.365 1.242 0 N-CA-C 108.382 -0.97 . . . . 100.0 108.382 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -70.98 -12.6 30.8 Favored 'Trans proline' 0 C--N 1.365 1.435 0 C-N-CA 123.931 3.087 . . . . 100.0 113.208 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 70.3 m-80 -90.67 1.2 57.03 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 114.396 1.258 . . . . 100.0 114.396 -178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 85.6 mt -62.95 135.85 57.52 Favored 'General case' 0 C--N 1.364 1.236 0 CA-C-N 118.734 0.697 . . . . 100.0 112.119 179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -133.9 148.25 51.21 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.166 -0.924 . . . . 100.0 108.625 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.9 m-30 -91.09 116.29 28.69 Favored 'General case' 0 C--N 1.363 1.156 0 N-CA-C 103.808 -2.664 . . . . 100.0 103.808 177.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.2 t -65.97 -44.08 92.46 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 C-N-CA 123.776 0.83 . . . . 100.0 111.828 -179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -132.52 152.52 51.54 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-O 121.57 0.7 . . . . 100.0 110.508 -178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 81.0 mtp -83.06 133.79 47.52 Favored Pre-proline 0 N--CA 1.432 -1.331 0 CA-C-N 114.786 -1.097 . . . . 100.0 108.797 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -66.12 156.92 62.32 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 122.623 2.215 . . . . 100.0 109.437 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -71.0 121.77 18.8 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 106.29 -1.745 . . . . 100.0 106.29 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 86.5 mt -118.84 149.01 42.25 Favored 'General case' 0 CA--C 1.482 -1.666 0 CA-C-N 114.33 -1.304 . . . . 100.0 109.955 -178.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -62.4 136.58 95.83 Favored Pre-proline 0 N--CA 1.44 -0.973 0 N-CA-C 105.289 -2.115 . . . . 100.0 105.289 177.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.43 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 56.9 Cg_exo -56.59 142.2 90.53 Favored 'Trans proline' 0 C--N 1.364 1.352 0 C-N-CA 123.197 2.598 . . . . 100.0 112.602 -178.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.464 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -56.13 126.25 21.76 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.834 2.356 . . . . 100.0 112.073 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 82.4 mt-10 -70.55 -42.98 70.45 Favored 'General case' 0 N--CA 1.438 -1.054 0 O-C-N 124.693 1.245 . . . . 100.0 108.483 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 32.2 m -130.96 156.59 42.86 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.941 0 N-CA-C 106.074 -1.824 . . . . 100.0 106.074 178.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.4 t -98.37 131.0 46.35 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.009 0 N-CA-C 106.49 -1.67 . . . . 100.0 106.49 -179.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -86.71 126.15 34.37 Favored 'General case' 0 N--CA 1.436 -1.137 0 N-CA-C 103.986 -2.598 . . . . 100.0 103.986 178.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.441 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 36.5 t70 -61.17 127.54 88.16 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 115.066 -0.97 . . . . 100.0 110.863 -178.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 68.1 Cg_exo -59.31 -38.6 83.95 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 123.759 2.973 . . . . 100.0 113.699 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.66 -44.35 90.68 Favored 'General case' 0 C--N 1.36 1.045 0 O-C-N 124.186 0.929 . . . . 100.0 110.59 179.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 90.6 mt -63.69 -42.16 98.04 Favored 'General case' 0 CA--C 1.493 -1.221 0 C-N-CA 123.004 0.522 . . . . 100.0 111.419 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.8 96.28 Favored 'General case' 0 CA--C 1.498 -1.033 0 C-N-CA 123.321 0.648 . . . . 100.0 110.803 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.73 98.08 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 123.796 0.838 . . . . 100.0 110.753 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -64.0 -42.07 97.28 Favored 'General case' 0 C--N 1.358 0.96 0 C-N-CA 123.016 0.526 . . . . 100.0 111.667 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.3 m-30 -62.94 -43.1 99.7 Favored 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 122.82 0.448 . . . . 100.0 111.816 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -62.15 -43.17 99.43 Favored 'General case' 0 C--N 1.358 0.977 0 C-N-CA 123.529 0.731 . . . . 100.0 109.097 179.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 47.4 t-80 -62.03 -44.16 97.29 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 125.123 1.369 . . . . 100.0 111.976 179.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -61.95 -42.14 98.78 Favored 'General case' 0 CA--C 1.501 -0.933 0 C-N-CA 123.606 0.762 . . . . 100.0 110.65 -179.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.493 ' O ' ' HG3' ' A' ' 205' ' ' GLN . 80.4 mt -60.93 -48.53 81.38 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.101 0.875 . . . . 100.0 109.308 179.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -63.28 -43.64 97.34 Favored 'General case' 0 CA--C 1.496 -1.106 0 N-CA-C 114.462 1.282 . . . . 100.0 114.462 -178.527 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 54.0 t -60.55 -45.96 96.31 Favored 'Isoleucine or valine' 0 CA--C 1.447 -3.017 0 CA-C-O 117.72 -1.133 . . . . 100.0 109.434 -177.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 1.016 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.749 . . -86.38 -10.89 53.45 Favored 'General case' 0 N--CA 1.381 -3.878 1 C-N-CA 104.503 -6.879 . . . . 100.0 116.547 179.445 . . . . . . . . 4 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 1.043 ' HA ' ' HA ' ' A' ' 213' ' ' ASP . 47.3 mt-30 -53.92 -33.83 57.84 Favored 'General case' 0 CA--C 1.445 -3.085 0 C-N-CA 128.534 2.734 . . . . 100.0 107.07 -179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 71.8 p -81.45 38.92 0.51 Allowed 'General case' 0 N--CA 1.415 -2.222 0 O-C-N 124.988 1.43 . . . . 100.0 109.533 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . 0.418 ' H ' ' C ' ' A' ' 205' ' ' GLN . 5.8 m 60.41 25.42 14.98 Favored 'General case' 0 CA--C 1.473 -2.007 0 C-N-CA 126.135 1.774 . . . . 100.0 112.409 175.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.521 ' HB3' ' HB2' ' A' ' 204' ' ' ALA 0.268 . . -71.51 172.98 8.57 Favored 'General case' 0 N--CA 1.4 -2.938 0 N-CA-C 101.776 -3.416 . . . . 100.0 101.776 172.381 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.405 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.1 mt -54.5 -36.65 45.63 Favored Pre-proline 0 CA--C 1.49 -1.337 0 CA-C-O 116.323 -1.799 . . . . 100.0 113.711 -174.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.032 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.448 0.3 OUTLIER -53.42 137.73 65.11 Favored 'Trans proline' 0 N--CA 1.432 -2.143 0 CA-C-O 123.528 1.387 . . . . 100.0 112.991 176.738 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.603 ' HB3' ' HB ' ' A' ' 137' ' ' VAL 0.297 98.1 m-20 -63.65 -43.89 95.41 Favored 'General case' 0 N--CA 1.405 -2.681 0 N-CA-C 121.215 3.783 . . . . 100.0 121.215 -172.762 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.575 ' O ' ' HB2' ' A' ' 215' ' ' ASP . 13.9 tm-20 -69.25 -19.0 63.93 Favored 'General case' 0 CA--C 1.465 -2.306 1 CA-C-O 130.946 5.165 . . . . 100.0 112.771 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 1.043 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.777 68.3 m-20 -83.89 -49.73 8.74 Favored 'General case' 1 N--CA 1.262 -9.825 1 CA-C-N 105.623 -5.262 . . . . 100.0 104.915 -173.383 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -63.96 -26.86 68.77 Favored 'General case' 0 N--CA 1.451 -0.412 0 O-C-N 119.038 -2.289 . . . . 100.0 106.56 177.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.831 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 59.5 m-20 -62.8 -40.0 96.0 Favored 'General case' 0 N--CA 1.418 -2.047 0 C-N-CA 127.044 2.138 . . . . 100.0 112.952 178.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.547 ' HB2' ' HG2' ' A' ' 205' ' ' GLN 0.26 3.9 mm? . . . . . 0 N--CA 1.426 -1.649 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.793 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' SD ' HG21 ' A' ' 9' ' ' VAL . 4.3 tpt . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 111.563 0.208 . . . . 100.0 111.563 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -62.23 -42.18 99.08 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 124.691 1.197 . . . . 100.0 112.72 -179.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -88.54 150.59 23.01 Favored 'General case' 0 N--CA 1.44 -0.968 0 C-N-CA 123.689 0.796 . . . . 100.0 111.99 -179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -89.5 157.9 17.9 Favored 'General case' 0 N--CA 1.44 -0.938 0 C-N-CA 123.514 0.725 . . . . 100.0 109.064 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.03 3.4 87.73 Favored Glycine 0 C--N 1.353 1.499 0 CA-C-O 119.619 -0.545 . . . . 100.0 112.836 -179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -75.28 155.68 85.9 Favored Pre-proline 0 N--CA 1.439 -1.013 0 C-N-CA 124.634 1.174 . . . . 100.0 111.349 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -62.87 154.64 65.11 Favored 'Trans proline' 0 C--N 1.371 1.76 0 C-N-CA 123.576 2.85 . . . . 100.0 111.394 178.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.5 mm-40 -55.22 133.61 49.32 Favored 'General case' 0 CA--C 1.493 -1.242 0 N-CA-C 114.765 1.394 . . . . 100.0 114.765 -177.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.421 HG21 ' SD ' ' A' ' 1' ' ' MET . 94.4 t -96.79 119.43 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.381 0 CA-C-N 114.009 -1.45 . . . . 100.0 107.19 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -120.26 135.22 55.07 Favored 'General case' 0 N--CA 1.428 -1.569 0 CA-C-N 112.803 -1.999 . . . . 100.0 107.612 -179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.74 143.67 48.66 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.933 -1.136 . . . . 100.0 107.933 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.33 120.21 34.23 Favored 'General case' 0 N--CA 1.432 -1.336 0 N-CA-C 106.382 -1.71 . . . . 100.0 106.382 178.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 tt -108.76 127.42 53.99 Favored 'General case' 0 N--CA 1.421 -1.896 0 CA-C-N 113.036 -1.893 . . . . 100.0 106.782 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.425 HG13 ' CE2' ' A' ' 79' ' ' TYR . 53.6 t -103.52 120.87 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.243 0 CA-C-N 113.632 -1.622 . . . . 100.0 106.687 179.124 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.417 HD11 ' SD ' ' A' ' 89' ' ' MET . 36.6 tp -109.27 117.24 33.57 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 105.218 -2.141 . . . . 100.0 105.218 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.4 m -128.31 161.78 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.047 0 CA-C-O 120.931 0.396 . . . . 100.0 111.667 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.36 175.45 27.34 Favored Glycine 0 CA--C 1.492 -1.372 0 N-CA-C 108.38 -1.888 . . . . 100.0 108.38 178.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 -71.78 155.72 40.12 Favored 'General case' 0 CA--C 1.495 -1.138 0 O-C-N 121.935 -0.744 . . . . 100.0 112.18 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.74 141.7 40.69 Favored Glycine 0 C--N 1.354 1.552 0 N-CA-C 107.321 -2.311 . . . . 100.0 107.321 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.14 -5.2 81.46 Favored Glycine 0 N--CA 1.436 -1.339 0 CA-C-O 118.823 -0.987 . . . . 100.0 113.436 -179.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.425 ' O ' ' HE3' ' A' ' 123' ' ' LYS . 80.0 m -62.67 -40.37 96.86 Favored 'General case' 0 C--N 1.361 1.078 0 CA-C-N 118.608 1.204 . . . . 100.0 110.777 178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 113.08 25.02 4.61 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 109.823 -1.311 . . . . 100.0 109.823 -178.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -60.17 -45.22 93.84 Favored 'General case' 0 N--CA 1.438 -1.069 0 C-N-CA 125.966 1.706 . . . . 100.0 112.554 -179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 92.3 m -62.89 -44.34 96.38 Favored 'General case' 0 N--CA 1.437 -1.092 0 C-N-CA 124.538 1.135 . . . . 100.0 109.486 -179.452 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.7 m -63.8 -40.21 96.09 Favored 'General case' 0 C--N 1.357 0.894 0 C-N-CA 124.529 1.132 . . . . 100.0 109.407 -179.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.466 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 47.6 t80 -59.4 -49.32 78.25 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 124.935 1.294 . . . . 100.0 111.534 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 90.4 t -67.19 -41.64 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 O-C-N 123.371 0.419 . . . . 100.0 111.258 -179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.277 99.2 mttt -69.83 -6.87 35.38 Favored 'General case' 0 CA--C 1.49 -1.35 0 N-CA-C 115.933 1.827 . . . . 100.0 115.933 -176.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.708 HH21 ' HA ' ' A' ' 157' ' ' PHE . 83.7 mtm-85 -60.78 -37.68 82.71 Favored 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 108.129 -1.063 . . . . 100.0 108.129 177.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.465 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 60.8 t-80 -80.84 112.54 18.32 Favored 'General case' 0 C--N 1.362 1.131 0 N-CA-C 107.054 -1.461 . . . . 100.0 107.054 -179.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.9 mt -62.3 -43.78 98.02 Favored 'General case' 0 CA--C 1.493 -1.225 0 N-CA-C 115.207 1.558 . . . . 100.0 115.207 -177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.465 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.2 m -62.73 -42.48 99.68 Favored 'General case' 0 C--N 1.354 0.782 0 N-CA-C 108.884 -0.784 . . . . 100.0 108.884 -179.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.46 -42.16 99.71 Favored Glycine 0 C--N 1.359 1.84 0 N-CA-C 111.061 -0.816 . . . . 100.0 111.061 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -63.75 -44.95 91.99 Favored 'General case' 0 C--N 1.355 0.843 0 C-N-CA 123.873 0.869 . . . . 100.0 110.883 178.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -63.63 -39.72 95.06 Favored 'General case' 0 CA--C 1.503 -0.859 0 C-N-CA 123.601 0.76 . . . . 100.0 113.025 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 70.7 mm-40 -89.91 5.92 44.25 Favored 'General case' 0 N--CA 1.44 -0.933 0 N-CA-C 115.028 1.492 . . . . 100.0 115.028 -178.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 56.4 pttt -57.32 138.35 54.95 Favored 'General case' 0 C--N 1.358 0.974 0 N-CA-C 114.546 1.313 . . . . 100.0 114.546 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 50.4 mmtm -124.61 130.35 52.28 Favored 'General case' 0 CA--C 1.493 -1.216 0 N-CA-C 107.702 -1.222 . . . . 100.0 107.702 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 67.7 t80 -100.77 123.27 44.73 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 105.233 -2.136 . . . . 100.0 105.233 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 91.8 t -102.85 114.74 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.109 0 N-CA-C 103.37 -2.826 . . . . 100.0 103.37 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.43 -45.03 94.94 Favored 'General case' 0 N--CA 1.435 -1.19 0 N-CA-C 115.393 1.627 . . . . 100.0 115.393 -178.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 70.1 p -61.93 -48.36 80.79 Favored 'General case' 0 C--N 1.358 0.97 0 C-N-CA 122.665 0.386 . . . . 100.0 111.965 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.3 mt -70.18 -38.41 75.36 Favored 'General case' 0 N--CA 1.437 -1.091 0 C-N-CA 125.307 1.443 . . . . 100.0 112.982 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 76.95 32.23 50.26 Favored Glycine 0 C--N 1.355 1.609 0 N-CA-C 108.112 -1.995 . . . . 100.0 108.112 -177.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.536 HG11 ' CD1' ' A' ' 79' ' ' TYR . 22.9 m -129.01 153.17 38.22 Favored 'Isoleucine or valine' 0 C--N 1.361 1.102 0 CA-C-O 121.629 0.728 . . . . 100.0 109.672 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -109.45 120.22 41.84 Favored 'General case' 0 N--CA 1.423 -1.802 0 N-CA-C 103.074 -2.935 . . . . 100.0 103.074 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -99.6 123.04 52.11 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 106.567 -1.642 . . . . 100.0 106.567 -177.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -117.78 119.43 33.94 Favored Pre-proline 0 N--CA 1.429 -1.522 0 N-CA-C 108.083 -1.08 . . . . 100.0 108.083 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -80.78 106.51 1.82 Allowed 'Trans proline' 0 N--CA 1.439 -1.707 0 C-N-CA 122.123 1.882 . . . . 100.0 110.229 178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.69 117.29 31.65 Favored 'General case' 0 CA--C 1.493 -1.224 0 N-CA-C 106.685 -1.598 . . . . 100.0 106.685 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 33.8 t -102.86 126.68 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 107.66 -1.237 . . . . 100.0 107.66 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -121.33 133.49 55.12 Favored 'General case' 0 CA--C 1.495 -1.164 0 N-CA-C 105.639 -1.985 . . . . 100.0 105.639 178.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -101.28 120.28 40.01 Favored 'General case' 0 CA--C 1.498 -1.054 0 N-CA-C 107.715 -1.217 . . . . 100.0 107.715 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.447 HG21 HD12 ' A' ' 59' ' ' ILE . 26.6 p -110.54 -179.26 3.71 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 115.05 -0.977 . . . . 100.0 110.894 -178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 -59.77 -44.25 93.97 Favored 'General case' 0 C--N 1.361 1.089 0 C-N-CA 125.334 1.454 . . . . 100.0 108.294 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 93.8 mtt-85 -67.04 -39.26 86.92 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 124.062 0.945 . . . . 100.0 113.052 178.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.7 -172.69 28.83 Favored Glycine 0 N--CA 1.436 -1.341 0 N-CA-C 107.381 -2.288 . . . . 100.0 107.381 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.08 137.92 50.1 Favored 'Trans proline' 0 N--CA 1.442 -1.507 0 C-N-CA 122.117 1.878 . . . . 100.0 114.647 179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.447 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -125.05 130.29 73.2 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.26 -3.237 . . . . 100.0 102.26 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 92.5 mttt -111.01 128.13 55.75 Favored 'General case' 0 N--CA 1.433 -1.287 0 N-CA-C 108.749 -0.834 . . . . 100.0 108.749 -179.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -110.44 116.41 31.36 Favored 'General case' 0 N--CA 1.43 -1.449 0 N-CA-C 104.172 -2.529 . . . . 100.0 104.172 176.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -87.8 106.05 17.81 Favored 'General case' 0 CA--C 1.493 -1.23 1 N-CA-C 99.25 -4.352 . . . . 100.0 99.25 179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.29 122.76 46.03 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.492 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -177.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 26.5 m0 -98.05 115.89 29.14 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 105.339 -2.097 . . . . 100.0 105.339 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -112.46 136.32 52.1 Favored 'General case' 0 N--CA 1.432 -1.362 0 N-CA-C 105.605 -1.998 . . . . 100.0 105.605 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 80.8 p -71.96 162.29 29.67 Favored 'General case' 0 N--CA 1.437 -1.081 0 C-N-CA 123.76 0.824 . . . . 100.0 112.86 -178.139 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.74 17.29 16.88 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 115.694 -0.684 . . . . 100.0 109.687 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.08 11.64 52.04 Favored Glycine 0 C--N 1.357 1.732 0 O-C-N 121.804 -0.56 . . . . 100.0 112.328 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -62.27 -29.32 70.34 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 125.836 1.654 . . . . 100.0 111.385 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.66 -37.23 78.18 Favored 'General case' 0 CA--C 1.499 -0.981 0 C-N-CA 127.794 2.438 . . . . 100.0 112.009 -179.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.93 -43.12 99.66 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.326 0.65 . . . . 100.0 110.025 179.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 85.9 t80 -69.18 -41.35 77.3 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 125.458 1.503 . . . . 100.0 111.972 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.34 -152.12 12.32 Favored Glycine 0 C--N 1.356 1.665 0 C-N-CA 120.996 -0.621 . . . . 100.0 111.57 -178.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.26 169.58 52.99 Favored Glycine 0 C--N 1.353 1.509 0 CA-C-O 122.069 0.816 . . . . 100.0 112.931 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 HD13 ' CE2' ' A' ' 79' ' ' TYR . 88.6 mt -105.68 143.49 33.76 Favored 'General case' 0 CA--C 1.49 -1.361 0 CA-C-N 114.708 -0.746 . . . . 100.0 109.767 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 88.1 mtm180 -67.67 155.48 39.12 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 114.735 -1.12 . . . . 100.0 113.616 -179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -60.47 -37.68 81.78 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-N 113.827 -1.533 . . . . 100.0 110.328 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.78 -39.21 93.43 Favored Glycine 0 C--N 1.358 1.778 0 C-N-CA 124.846 1.213 . . . . 100.0 111.316 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.536 ' CD1' HG11 ' A' ' 45' ' ' VAL . 60.8 t80 -62.53 -45.99 90.46 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.422 0.689 . . . . 100.0 110.895 177.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -68.94 -36.67 78.23 Favored 'General case' 0 N--CA 1.437 -1.102 0 N-CA-C 115.333 1.605 . . . . 100.0 115.333 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 57.3 mt -50.85 135.96 10.24 Favored 'Isoleucine or valine' 0 C--N 1.361 1.09 0 C-N-CA 125.57 1.548 . . . . 100.0 114.297 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 95.6 mt-30 61.62 30.29 18.54 Favored 'General case' 0 C--N 1.359 1.006 0 C-N-CA 128.104 2.562 . . . . 100.0 114.015 -178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.66 128.66 36.09 Favored 'General case' 0 CA--C 1.49 -1.348 0 N-CA-C 106.26 -1.756 . . . . 100.0 106.26 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.477 ' O ' HG23 ' A' ' 115' ' ' ILE . 97.3 mm-40 -96.47 -35.35 11.17 Favored 'General case' 0 N--CA 1.434 -1.274 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.502 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.3 p -143.76 159.27 42.81 Favored 'General case' 0 CA--C 1.494 -1.2 0 CA-C-O 120.899 0.381 . . . . 100.0 111.133 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.482 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.8 149.57 34.59 Favored 'General case' 0 CA--C 1.486 -1.511 0 N-CA-C 114.37 1.248 . . . . 100.0 114.37 179.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.9 mt -125.5 125.75 69.33 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.255 0 N-CA-C 103.917 -2.623 . . . . 100.0 103.917 176.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.429 ' HB ' HD22 ' A' ' 119' ' ' LEU . 52.0 mt -110.66 123.71 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 102.419 -3.178 . . . . 100.0 102.419 178.577 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.417 ' SD ' HD11 ' A' ' 15' ' ' LEU . 81.3 mtp -109.68 134.08 52.39 Favored 'General case' 0 N--CA 1.417 -2.102 0 CA-C-N 114.144 -1.389 . . . . 100.0 113.602 -177.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -128.18 158.82 37.03 Favored 'General case' 0 N--CA 1.428 -1.56 0 CA-C-N 112.555 -2.112 . . . . 100.0 108.433 177.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -104.51 125.75 50.97 Favored 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 105.895 -1.891 . . . . 100.0 105.895 -178.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.7 m -64.41 -21.6 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.762 0 N-CA-C 113.797 1.036 . . . . 100.0 113.797 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 65.7 p -86.65 -10.16 54.44 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-O 119.241 -0.409 . . . . 100.0 111.126 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.6 t -118.49 116.39 26.57 Favored 'General case' 0 N--CA 1.436 -1.136 0 CA-C-O 122.136 0.969 . . . . 100.0 111.401 -179.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 80.9 mtt85 -66.5 -38.38 87.12 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.892 -1.049 . . . . 100.0 111.079 177.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 94.5 t -60.56 -41.75 88.99 Favored 'Isoleucine or valine' 0 C--N 1.357 0.907 0 C-N-CA 125.661 1.584 . . . . 100.0 110.55 -178.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 62.3 m -62.36 -42.8 99.69 Favored 'General case' 0 C--N 1.356 0.887 0 N-CA-C 109.792 -0.448 . . . . 100.0 109.792 -179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.522 ' CE1' HG23 ' A' ' 136' ' ' ILE . 44.5 t80 -64.11 -41.04 97.41 Favored 'General case' 0 C--N 1.362 1.136 0 C-N-CA 123.714 0.805 . . . . 100.0 110.703 177.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.52 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.3 mttt -61.14 -37.86 84.34 Favored 'General case' 0 CA--C 1.504 -0.818 0 C-N-CA 123.958 0.903 . . . . 100.0 111.311 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -76.65 -9.0 58.35 Favored 'General case' 0 C--N 1.354 0.803 0 N-CA-C 114.769 1.396 . . . . 100.0 114.769 179.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.8 t -60.12 -43.26 93.52 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 115.997 -1.954 . . . . 100.0 111.186 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.4 Cg_exo -57.57 -38.57 93.31 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.158 1.905 . . . . 100.0 112.742 177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -64.25 -44.45 91.74 Favored 'General case' 0 C--N 1.358 0.978 0 O-C-N 124.186 0.929 . . . . 100.0 111.443 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 64.8 m95 -63.88 -41.22 97.79 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 122.744 0.418 . . . . 100.0 110.995 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.41 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.5 t60 -62.43 -43.83 97.88 Favored 'General case' 0 N--CA 1.435 -1.177 0 C-N-CA 124.43 1.092 . . . . 100.0 109.932 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -61.8 -45.34 94.28 Favored 'General case' 0 CA--C 1.501 -0.932 0 C-N-CA 123.577 0.751 . . . . 100.0 111.351 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 85.6 m-20 -62.89 -44.82 95.07 Favored 'General case' 0 C--N 1.358 0.952 0 C-N-CA 123.06 0.544 . . . . 100.0 111.774 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' CB ' ' A' ' 86' ' ' ALA . 50.8 tp -63.23 -46.03 88.87 Favored 'General case' 0 N--CA 1.438 -1.042 0 C-N-CA 124.548 1.139 . . . . 100.0 112.31 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.7 t -64.36 -37.69 80.61 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.03 0 C-N-CA 125.593 1.557 . . . . 100.0 110.865 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 63.9 ttp85 -58.5 -49.14 78.45 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 118.649 -0.691 . . . . 100.0 110.183 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 65.5 t -73.07 -46.38 51.41 Favored 'Isoleucine or valine' 0 C--N 1.355 0.83 0 C-N-CA 119.227 -0.989 . . . . 100.0 111.956 178.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 64.6 m -124.78 113.8 18.41 Favored 'General case' 0 C--N 1.361 1.07 0 CA-C-O 121.641 0.734 . . . . 100.0 110.177 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 93.7 mt-10 -92.64 146.6 23.54 Favored 'General case' 0 CA--C 1.497 -1.067 0 CA-C-N 115.466 -0.788 . . . . 100.0 112.142 -178.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 54.72 44.44 28.54 Favored 'General case' 0 C--N 1.355 0.823 0 C-N-CA 126.463 1.905 . . . . 100.0 115.491 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.477 HG23 ' O ' ' A' ' 84' ' ' GLN . 27.9 mm -98.89 133.21 22.5 Favored Pre-proline 0 N--CA 1.438 -1.065 0 C-N-CA 126.42 1.888 . . . . 100.0 107.376 178.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 115' ' ' ILE . 40.5 Cg_exo -62.96 129.02 24.59 Favored 'Trans proline' 0 C--N 1.373 1.823 0 C-N-CA 122.86 2.373 . . . . 100.0 108.457 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.701 ' HB ' HD22 ' A' ' 144' ' ' LEU . 68.7 mt -131.05 137.58 55.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.189 0 CA-C-O 122.292 1.044 . . . . 100.0 108.287 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.443 HG11 ' HB3' ' A' ' 160' ' ' PRO . 93.6 t -115.74 131.83 66.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 N-CA-C 105.145 -2.168 . . . . 100.0 105.145 178.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.493 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 28.8 mt -105.61 125.54 51.1 Favored 'General case' 0 N--CA 1.429 -1.492 0 N-CA-C 103.869 -2.641 . . . . 100.0 103.869 176.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 76.0 m -113.86 126.74 55.52 Favored 'General case' 0 N--CA 1.431 -1.376 0 CA-C-N 113.85 -1.523 . . . . 100.0 112.203 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.01 103.42 2.81 Favored Glycine 0 C--N 1.352 1.468 0 N-CA-C 105.162 -3.175 . . . . 100.0 105.162 178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -82.58 165.76 19.8 Favored 'General case' 0 N--CA 1.435 -1.188 0 C-N-CA 125.789 1.636 . . . . 100.0 112.53 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.425 ' HE3' ' O ' ' A' ' 21' ' ' THR . 85.0 mttt 59.42 43.38 16.49 Favored 'General case' 0 N--CA 1.434 -1.26 0 C-N-CA 128.541 2.736 . . . . 100.0 114.541 179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.313 30.9 m -72.23 -8.8 12.07 Favored 'Isoleucine or valine' 0 C--N 1.36 1.049 0 C-N-CA 120.526 -0.47 . . . . 100.0 111.231 178.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.58 -38.3 87.05 Favored 'General case' 0 C--N 1.361 1.076 0 C-N-CA 126.968 2.107 . . . . 100.0 110.117 176.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 84.4 mt -68.59 130.79 33.85 Favored 'Isoleucine or valine' 0 C--N 1.363 1.168 0 N-CA-C 107.221 -1.4 . . . . 100.0 107.221 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 13.3 mptt -63.14 -40.95 99.07 Favored 'General case' 0 CA--C 1.494 -1.199 0 C-N-CA 125.32 1.448 . . . . 100.0 114.357 -177.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -85.74 91.07 8.2 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 107.262 -1.385 . . . . 100.0 107.262 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.1 ttt180 -94.85 120.6 35.34 Favored 'General case' 0 CA--C 1.493 -1.228 0 N-CA-C 104.087 -2.561 . . . . 100.0 104.087 179.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -96.15 -37.22 10.67 Favored 'General case' 0 N--CA 1.433 -1.319 0 CA-C-N 115.324 -0.853 . . . . 100.0 112.876 -177.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.415 HG12 HD11 ' A' ' 136' ' ' ILE . 45.4 t -104.01 105.96 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.054 0 N-CA-C 102.573 -3.121 . . . . 100.0 102.573 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -104.68 178.83 4.45 Favored 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 113.665 0.987 . . . . 100.0 113.665 -177.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.483 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.4 -35.33 71.87 Favored 'General case' 0 C--N 1.359 0.983 0 C-N-CA 127.308 2.243 . . . . 100.0 109.402 179.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.062 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.7 mttt -59.42 -37.81 79.03 Favored 'General case' 0 N--CA 1.424 -1.738 0 C-N-CA 127.989 2.516 . . . . 100.0 112.32 179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.5 p -104.73 -1.29 26.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 120.106 3.373 . . . . 100.0 120.106 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.62 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 49.8 mt -96.6 91.87 2.88 Favored 'Isoleucine or valine' 0 C--N 1.361 1.096 0 C-N-CA 115.779 -2.368 . . . . 100.0 111.736 -176.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.413 ' N ' ' HB3' ' A' ' 211' ' ' ASP . 4.9 p -97.54 -7.98 9.26 Favored 'Isoleucine or valine' 0 C--N 1.352 0.696 0 N-CA-C 115.767 1.766 . . . . 100.0 115.767 -178.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -57.91 -36.2 72.13 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 115.01 1.485 . . . . 100.0 115.01 -174.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.493 ' HE1' ' HB2' ' A' ' 119' ' ' LEU . 83.9 m-70 -59.87 -40.65 89.38 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-O 116.946 -1.502 . . . . 100.0 114.123 -177.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.699 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 25.9 ttt180 -61.32 -45.42 94.51 Favored 'General case' 0 CA--C 1.486 -1.505 0 CA-C-N 119.971 1.259 . . . . 100.0 112.629 -176.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -61.56 -41.9 98.05 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 124.387 1.075 . . . . 100.0 110.862 -178.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -98.23 2.28 48.14 Favored 'General case' 0 N--CA 1.433 -1.309 0 N-CA-C 115.875 1.806 . . . . 100.0 115.875 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 55.67 44.5 26.32 Favored 'General case' 0 C--N 1.362 1.122 0 C-N-CA 125.777 1.631 . . . . 100.0 113.305 -179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.701 HD22 ' HB ' ' A' ' 117' ' ' ILE . 28.5 mt -106.96 152.19 24.29 Favored 'General case' 0 CA--C 1.498 -1.037 0 N-CA-C 106.781 -1.563 . . . . 100.0 106.781 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.336 90.6 mm-40 -101.43 145.71 28.59 Favored 'General case' 0 CA--C 1.481 -1.681 0 N-CA-C 113.474 0.916 . . . . 100.0 113.474 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.486 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 75.8 t80 -105.09 133.91 49.08 Favored 'General case' 0 CA--C 1.487 -1.443 0 N-CA-C 113.921 1.082 . . . . 100.0 113.921 -177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -130.12 133.35 46.58 Favored 'General case' 0 N--CA 1.441 -0.916 0 CA-C-N 114.048 -1.433 . . . . 100.0 111.172 173.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.279 36.9 m-20 -84.76 121.54 27.83 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 102.176 -3.268 . . . . 100.0 102.176 177.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.7 pp -133.42 155.42 40.52 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.077 0 CA-C-O 122.381 1.086 . . . . 100.0 110.613 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.498 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.2 m -137.31 111.36 8.35 Favored 'General case' 0 CA--C 1.475 -1.915 0 N-CA-C 105.908 -1.886 . . . . 100.0 105.908 176.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.57 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.44 -43.91 97.69 Favored 'General case' 0 N--CA 1.43 -1.459 0 CA-C-N 114.187 -1.369 . . . . 100.0 112.664 -179.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -61.79 -42.31 98.84 Favored 'General case' 0 N--CA 1.432 -1.33 0 C-N-CA 124.377 1.071 . . . . 100.0 112.508 -178.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 97.4 p -97.04 1.41 50.1 Favored 'General case' 0 N--CA 1.438 -1.042 0 N-CA-C 116.597 2.073 . . . . 100.0 116.597 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.561 HD22 ' HG3' ' A' ' 185' ' ' PRO . 68.0 m-80 64.03 24.58 13.59 Favored 'General case' 0 C--N 1.362 1.117 0 C-N-CA 125.223 1.409 . . . . 100.0 110.524 -177.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.498 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 75.7 t80 -75.01 125.71 29.48 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 108.133 -1.062 . . . . 100.0 108.133 -178.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 53.55 40.04 30.87 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 128.232 2.613 . . . . 100.0 115.404 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.708 ' HA ' HH21 ' A' ' 29' ' ' ARG . 67.3 t80 -61.77 -44.0 97.75 Favored 'General case' 0 C--N 1.356 0.871 0 O-C-N 121.827 -0.546 . . . . 100.0 111.248 178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 90.5 mt-10 -63.45 -39.65 95.04 Favored 'General case' 0 CA--C 1.489 -1.397 0 N-CA-C 116.374 1.99 . . . . 100.0 116.374 -177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -58.57 -47.94 97.83 Favored Pre-proline 0 N--CA 1.436 -1.131 0 N-CA-C 121.035 3.717 . . . . 100.0 121.035 -172.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.443 ' HB3' HG11 ' A' ' 118' ' ' VAL . 52.9 Cg_endo -61.35 -41.9 38.26 Favored 'Trans proline' 0 C--N 1.371 1.733 0 CA-C-N 123.586 2.316 . . . . 100.0 112.437 178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -64.52 -42.52 95.74 Favored 'General case' 0 N--CA 1.437 -1.118 0 C-N-CA 124.922 1.289 . . . . 100.0 110.799 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 67.8 tp -63.1 -45.19 93.21 Favored 'General case' 0 N--CA 1.439 -0.986 0 C-N-CA 124.241 1.017 . . . . 100.0 111.327 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 91.0 t90 -63.36 -44.65 94.2 Favored 'General case' 0 C--N 1.361 1.09 0 N-CA-C 109.684 -0.488 . . . . 100.0 109.684 -179.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.502 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.9 mt -61.79 -44.49 96.76 Favored 'General case' 0 CA--C 1.489 -1.381 0 C-N-CA 123.062 0.545 . . . . 100.0 111.474 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.07 -43.67 98.33 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.966 0.907 . . . . 100.0 111.228 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -62.13 -45.99 91.02 Favored 'General case' 0 CA--C 1.491 -1.307 0 C-N-CA 123.341 0.656 . . . . 100.0 111.542 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 75.9 mmtt -66.38 -42.92 87.24 Favored 'General case' 0 N--CA 1.437 -1.12 0 N-CA-C 113.293 0.849 . . . . 100.0 113.293 -179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.455 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.8 mt -63.72 -45.65 88.96 Favored 'General case' 0 CA--C 1.5 -0.963 0 C-N-CA 123.632 0.773 . . . . 100.0 112.032 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.432 HD12 HD22 ' A' ' 174' ' ' LEU . 71.6 mt -69.97 -39.16 77.12 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 C-N-CA 123.11 0.564 . . . . 100.0 109.552 178.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.07 10.64 58.38 Favored Glycine 0 C--N 1.352 1.469 0 N-CA-C 110.411 -1.076 . . . . 100.0 110.411 -178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -114.07 112.82 46.92 Favored Pre-proline 0 C--N 1.361 1.107 0 N-CA-C 107.57 -1.27 . . . . 100.0 107.57 -179.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -71.65 -14.03 30.07 Favored 'Trans proline' 0 C--N 1.367 1.501 0 C-N-CA 124.061 3.174 . . . . 100.0 113.992 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -87.96 2.12 52.44 Favored 'General case' 0 N--CA 1.441 -0.918 0 C-N-CA 123.979 0.912 . . . . 100.0 113.114 -178.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.432 HD22 HD12 ' A' ' 169' ' ' ILE . 17.0 tp -66.07 132.16 47.88 Favored 'General case' 0 N--CA 1.436 -1.147 0 C-N-CA 123.324 0.65 . . . . 100.0 109.355 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -134.44 151.36 51.12 Favored 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 108.732 -0.84 . . . . 100.0 108.732 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -88.15 113.61 23.94 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 104.195 -2.52 . . . . 100.0 104.195 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 97.9 t -66.02 -43.88 92.37 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 123.594 0.758 . . . . 100.0 110.293 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -129.48 149.02 51.43 Favored 'General case' 0 CA--C 1.489 -1.399 0 CA-C-O 121.451 0.643 . . . . 100.0 109.839 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.7 ttp -92.61 125.95 53.88 Favored Pre-proline 0 N--CA 1.43 -1.448 0 N-CA-C 105.093 -2.188 . . . . 100.0 105.093 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -65.17 158.16 53.58 Favored 'Trans proline' 0 N--CA 1.443 -1.471 0 C-N-CA 123.076 2.517 . . . . 100.0 111.458 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.77 126.9 29.11 Favored 'General case' 0 CA--C 1.496 -1.12 0 CA-C-O 122.146 0.974 . . . . 100.0 108.884 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.7 mt -120.25 145.9 46.59 Favored 'General case' 0 CA--C 1.484 -1.578 0 CA-C-N 114.014 -1.448 . . . . 100.0 109.971 -178.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.29 138.02 97.3 Favored Pre-proline 0 N--CA 1.439 -0.989 0 N-CA-C 106.812 -1.551 . . . . 100.0 106.812 178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.466 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 64.9 Cg_exo -55.95 139.71 84.91 Favored 'Trans proline' 0 C--N 1.366 1.482 0 C-N-CA 123.67 2.913 . . . . 100.0 113.021 -178.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.561 ' HG3' HD22 ' A' ' 154' ' ' ASN . 52.5 Cg_exo -57.68 129.44 33.62 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 123.206 2.604 . . . . 100.0 113.028 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -68.36 -43.18 77.95 Favored 'General case' 0 N--CA 1.438 -1.04 0 O-C-N 124.742 1.276 . . . . 100.0 108.122 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.9 158.43 43.27 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.855 0 N-CA-C 106.351 -1.722 . . . . 100.0 106.351 178.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 95.2 t -99.68 130.6 48.49 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.923 0 N-CA-C 106.208 -1.775 . . . . 100.0 106.208 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.2 ttt -87.24 127.54 35.16 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 104.749 -2.315 . . . . 100.0 104.749 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -62.73 128.14 91.39 Favored Pre-proline 0 N--CA 1.431 -1.387 0 CA-C-N 114.493 -1.231 . . . . 100.0 110.295 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -59.6 -37.4 88.56 Favored 'Trans proline' 0 C--N 1.368 1.574 0 C-N-CA 123.772 2.981 . . . . 100.0 113.001 179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.76 -43.18 94.14 Favored 'General case' 0 C--N 1.36 1.041 0 O-C-N 124.257 0.973 . . . . 100.0 110.231 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 87.6 mt -63.38 -42.28 98.83 Favored 'General case' 0 CA--C 1.494 -1.191 0 C-N-CA 122.817 0.447 . . . . 100.0 111.633 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.55 -44.25 97.39 Favored 'General case' 0 CA--C 1.498 -1.031 0 C-N-CA 123.125 0.57 . . . . 100.0 110.383 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.55 -43.54 98.56 Favored 'General case' 0 N--CA 1.438 -1.064 0 C-N-CA 123.943 0.897 . . . . 100.0 110.693 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 72.8 tp60 -62.9 -44.27 96.55 Favored 'General case' 0 C--N 1.358 0.944 0 C-N-CA 124.183 0.993 . . . . 100.0 112.405 179.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -63.4 -44.1 95.64 Favored 'General case' 0 CA--C 1.499 -1.015 0 C-N-CA 122.71 0.404 . . . . 100.0 111.073 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -64.5 -39.89 94.63 Favored 'General case' 0 N--CA 1.44 -0.96 0 CA-C-N 116.107 -0.497 . . . . 100.0 110.57 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -62.31 -43.85 97.88 Favored 'General case' 0 C--N 1.357 0.934 0 C-N-CA 124.95 1.3 . . . . 100.0 110.524 179.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.2 m-20 -61.93 -42.89 99.63 Favored 'General case' 0 CA--C 1.499 -0.997 0 C-N-CA 123.955 0.902 . . . . 100.0 110.144 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.517 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 22.6 tp -59.9 -48.65 80.82 Favored 'General case' 0 C--N 1.362 1.127 0 O-C-N 124.222 0.951 . . . . 100.0 109.951 178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -62.58 -43.36 99.01 Favored 'General case' 0 CA--C 1.492 -1.259 0 N-CA-C 114.999 1.481 . . . . 100.0 114.999 -178.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 46.2 t -59.0 -47.09 91.04 Favored 'Isoleucine or valine' 0 CA--C 1.467 -2.217 0 CA-C-O 118.245 -0.883 . . . . 100.0 109.544 -176.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.406 . . -95.66 0.91 53.25 Favored 'General case' 0 N--CA 1.402 -2.847 1 C-N-CA 109.729 -4.789 . . . . 100.0 114.685 179.573 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.779 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.329 67.1 mt-30 -56.78 -36.35 69.74 Favored 'General case' 0 CA--C 1.461 -2.474 0 N-CA-C 106.246 -1.761 . . . . 100.0 106.246 178.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 64.9 p -82.25 52.04 1.93 Allowed 'General case' 0 N--CA 1.429 -1.484 0 CA-C-O 122.091 0.948 . . . . 100.0 108.779 178.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.296 73.9 p 49.25 37.69 11.85 Favored 'General case' 0 N--CA 1.433 -1.295 0 C-N-CA 129.002 2.921 . . . . 100.0 116.157 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.86 -179.78 7.54 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 104.286 -2.486 . . . . 100.0 104.286 176.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.516 ' HG ' ' HD3' ' A' ' 210' ' ' PRO 0.439 3.7 pp -57.44 -38.73 70.99 Favored Pre-proline 0 CA--C 1.501 -0.941 0 CA-C-O 115.523 -2.18 . . . . 100.0 115.886 -175.435 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.062 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.312 79.0 Cg_exo -54.88 136.47 72.35 Favored 'Trans proline' 0 C--N 1.375 1.971 0 CA-C-N 121.839 1.692 . . . . 100.0 111.417 176.43 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.413 ' HB3' ' N ' ' A' ' 137' ' ' VAL . 96.0 m-20 -63.46 -47.86 80.1 Favored 'General case' 0 N--CA 1.424 -1.771 1 N-CA-C 124.784 5.105 . . . . 100.0 124.784 -173.533 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.66 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.251 99.3 mt-10 -62.88 -35.56 80.42 Favored 'General case' 0 CA--C 1.48 -1.732 1 CA-C-O 128.621 4.057 . . . . 100.0 107.84 177.889 . . . . . . . . 4 3 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.779 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.49 39.2 m-20 -64.93 -49.03 71.97 Favored 'General case' 1 N--CA 1.354 -5.251 1 CA-C-N 107.796 -4.274 . . . . 100.0 106.297 -178.903 . . . . . . . . 5 3 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -62.12 -31.23 71.67 Favored 'General case' 0 C--N 1.36 1.033 0 O-C-N 120.535 -1.353 . . . . 100.0 107.682 177.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.699 ' HA ' ' HB2' ' A' ' 140' ' ' ARG . 1.8 t70 -57.63 -42.77 84.06 Favored 'General case' 0 CA--C 1.474 -1.946 0 CA-C-O 116.926 -1.512 . . . . 100.0 113.295 176.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 4.0 mp . . . . . 0 C--O 1.261 1.701 0 CA-C-O 115.558 -2.163 . . . . 100.0 112.6 -176.913 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.443 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -1.017 0 N-CA-C 112.364 0.505 . . . . 100.0 112.364 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.62 -40.12 93.73 Favored 'General case' 0 N--CA 1.44 -0.929 0 C-N-CA 125.007 1.323 . . . . 100.0 113.135 -179.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -103.87 147.7 27.01 Favored 'General case' 0 CA--C 1.499 -1.019 0 CA-C-O 121.101 0.477 . . . . 100.0 111.594 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.1 mm-40 -81.5 160.5 23.92 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.621 0.768 . . . . 100.0 110.004 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.22 2.75 87.71 Favored Glycine 0 C--N 1.354 1.555 0 CA-C-O 119.652 -0.527 . . . . 100.0 112.698 -179.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -78.51 158.92 75.6 Favored Pre-proline 0 N--CA 1.44 -0.928 0 C-N-CA 124.019 0.928 . . . . 100.0 110.329 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -63.73 158.34 46.99 Favored 'Trans proline' 0 C--N 1.373 1.854 0 C-N-CA 123.633 2.889 . . . . 100.0 111.552 179.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -53.19 132.58 38.82 Favored 'General case' 0 CA--C 1.495 -1.165 0 N-CA-C 114.843 1.423 . . . . 100.0 114.843 -177.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.443 HG21 ' HG2' ' A' ' 1' ' ' MET . 58.0 t -93.24 115.36 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.269 0 N-CA-C 105.682 -1.97 . . . . 100.0 105.682 -178.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -123.58 136.16 54.37 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 113.762 -1.563 . . . . 100.0 108.752 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 95.2 m-85 -124.34 144.32 50.08 Favored 'General case' 0 N--CA 1.436 -1.143 0 N-CA-C 108.243 -1.021 . . . . 100.0 108.243 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.28 121.03 35.38 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 106.433 -1.692 . . . . 100.0 106.433 178.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 tt -109.52 127.73 54.67 Favored 'General case' 0 N--CA 1.421 -1.907 0 CA-C-N 113.062 -1.881 . . . . 100.0 106.326 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.441 HG13 ' CE2' ' A' ' 79' ' ' TYR . 49.9 t -102.96 121.09 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.307 0 N-CA-C 106.572 -1.64 . . . . 100.0 106.572 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.619 HD11 ' SD ' ' A' ' 89' ' ' MET . 29.9 tp -109.88 117.08 32.87 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 104.618 -2.364 . . . . 100.0 104.618 -179.217 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.3 m -127.93 161.98 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 CA-C-O 120.718 0.294 . . . . 100.0 111.528 -179.158 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.22 175.0 26.7 Favored Glycine 0 CA--C 1.492 -1.394 0 N-CA-C 108.875 -1.69 . . . . 100.0 108.875 178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -72.03 156.27 39.41 Favored 'General case' 0 CA--C 1.494 -1.208 0 O-C-N 121.832 -0.804 . . . . 100.0 112.092 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.93 141.38 39.77 Favored Glycine 0 C--N 1.353 1.482 0 N-CA-C 106.984 -2.446 . . . . 100.0 106.984 178.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.66 -5.96 79.94 Favored Glycine 0 N--CA 1.437 -1.246 0 CA-C-O 118.773 -1.015 . . . . 100.0 113.404 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 77.7 m -62.68 -39.87 95.29 Favored 'General case' 0 C--N 1.36 1.048 0 CA-C-N 118.804 1.302 . . . . 100.0 111.307 178.601 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 112.87 25.72 4.4 Favored Glycine 0 C--N 1.352 1.422 0 N-CA-C 109.743 -1.343 . . . . 100.0 109.743 -178.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' HB3' ' HE2' ' A' ' 23' ' ' LYS . 52.9 mtpt -60.01 -46.79 88.32 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 125.362 1.465 . . . . 100.0 112.883 -179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.7 m -63.82 -43.06 97.36 Favored 'General case' 0 N--CA 1.437 -1.121 0 C-N-CA 124.408 1.083 . . . . 100.0 109.644 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 40.6 m -63.3 -41.4 98.95 Favored 'General case' 0 C--N 1.358 0.964 0 C-N-CA 124.483 1.113 . . . . 100.0 109.057 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.555 ' HA ' HH11 ' A' ' 29' ' ' ARG . 45.1 t80 -60.09 -49.11 78.93 Favored 'General case' 0 CA--C 1.498 -1.053 0 C-N-CA 123.626 0.77 . . . . 100.0 112.749 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.5 t -66.77 -41.05 87.34 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.784 0 O-C-N 123.739 0.649 . . . . 100.0 110.958 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.266 99.0 mttt -69.06 -7.57 36.99 Favored 'General case' 0 CA--C 1.491 -1.323 0 N-CA-C 115.826 1.787 . . . . 100.0 115.826 -177.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.56 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 82.6 mtm-85 -61.04 -36.91 80.82 Favored 'General case' 0 C--N 1.362 1.134 0 N-CA-C 108.691 -0.855 . . . . 100.0 108.691 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.442 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 55.1 t-80 -80.34 112.23 17.47 Favored 'General case' 0 C--N 1.362 1.116 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 -179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.8 mt -62.4 -43.9 97.72 Favored 'General case' 0 CA--C 1.495 -1.163 0 N-CA-C 115.361 1.615 . . . . 100.0 115.361 -177.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.442 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 87.9 m -63.09 -42.22 99.55 Favored 'General case' 0 C--N 1.355 0.81 0 N-CA-C 108.888 -0.782 . . . . 100.0 108.888 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.38 -42.47 99.78 Favored Glycine 0 C--N 1.359 1.814 0 N-CA-C 111.383 -0.687 . . . . 100.0 111.383 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -63.64 -44.19 94.58 Favored 'General case' 0 N--CA 1.441 -0.917 0 C-N-CA 123.29 0.636 . . . . 100.0 110.836 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -63.83 -40.58 96.94 Favored 'General case' 0 CA--C 1.505 -0.763 0 C-N-CA 124.463 1.105 . . . . 100.0 112.295 -178.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -91.14 8.56 35.02 Favored 'General case' 0 N--CA 1.441 -0.878 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -59.18 140.36 55.99 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 114.649 1.352 . . . . 100.0 114.649 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -123.24 130.6 52.96 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 107.169 -1.419 . . . . 100.0 107.169 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.2 t80 -104.47 125.13 50.37 Favored 'General case' 0 N--CA 1.435 -1.219 0 N-CA-C 106.766 -1.568 . . . . 100.0 106.766 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.9 t -101.16 113.54 37.58 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.992 0 N-CA-C 102.199 -3.26 . . . . 100.0 102.199 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.69 -45.51 92.42 Favored 'General case' 0 CA--C 1.498 -1.057 0 N-CA-C 116.228 1.936 . . . . 100.0 116.228 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.2 p -62.58 -47.42 83.89 Favored 'General case' 0 C--N 1.356 0.865 0 C-N-CA 122.916 0.486 . . . . 100.0 111.784 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.4 mt -70.06 -37.74 75.6 Favored 'General case' 0 N--CA 1.433 -1.311 0 C-N-CA 124.899 1.28 . . . . 100.0 112.912 178.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 73.64 36.36 53.91 Favored Glycine 0 C--N 1.359 1.837 0 N-CA-C 106.71 -2.556 . . . . 100.0 106.71 -177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.47 HG21 ' HD1' ' A' ' 79' ' ' TYR . 66.9 t -124.43 139.59 50.27 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 C-N-CA 124.733 1.213 . . . . 100.0 108.754 -177.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -106.74 117.02 32.95 Favored 'General case' 0 N--CA 1.427 -1.613 0 N-CA-C 102.387 -3.19 . . . . 100.0 102.387 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.4 t -102.06 122.1 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.138 0 N-CA-C 107.065 -1.458 . . . . 100.0 107.065 -177.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.0 m-70 -115.17 121.05 35.66 Favored Pre-proline 0 N--CA 1.432 -1.337 0 CA-C-N 115.495 -0.775 . . . . 100.0 109.105 -179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -80.13 104.57 1.67 Allowed 'Trans proline' 0 N--CA 1.443 -1.452 0 C-N-CA 122.426 2.084 . . . . 100.0 109.529 178.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.1 mp -96.7 117.07 30.24 Favored 'General case' 0 CA--C 1.493 -1.243 0 N-CA-C 106.931 -1.507 . . . . 100.0 106.931 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 40.7 t -102.52 125.77 56.75 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.001 0 N-CA-C 107.406 -1.331 . . . . 100.0 107.406 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -120.45 133.12 55.46 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 105.851 -1.907 . . . . 100.0 105.851 178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -99.67 116.42 31.73 Favored 'General case' 0 CA--C 1.491 -1.291 0 N-CA-C 108.148 -1.056 . . . . 100.0 108.148 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 19.0 p -108.49 178.63 4.43 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-N 115.434 -0.803 . . . . 100.0 110.846 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -59.87 -43.6 94.62 Favored 'General case' 0 C--N 1.359 1.005 0 C-N-CA 124.99 1.316 . . . . 100.0 108.427 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 82.7 mtt180 -68.99 -38.37 79.26 Favored 'General case' 0 C--N 1.359 0.992 0 N-CA-C 112.839 0.681 . . . . 100.0 112.839 177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 150.96 -172.38 30.61 Favored Glycine 0 C--N 1.35 1.355 0 N-CA-C 108.642 -1.783 . . . . 100.0 108.642 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -65.52 136.87 48.26 Favored 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 122.518 2.145 . . . . 100.0 114.457 179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 77.7 mt -126.15 130.05 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 N-CA-C 102.111 -3.292 . . . . 100.0 102.111 177.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 90.2 mttt -109.85 128.44 55.34 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 108.617 -0.883 . . . . 100.0 108.617 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 79.4 m-85 -111.37 114.79 28.18 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 103.557 -2.757 . . . . 100.0 103.557 177.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.0 m-80 -87.75 105.7 17.56 Favored 'General case' 0 CA--C 1.49 -1.331 1 N-CA-C 99.862 -4.125 . . . . 100.0 99.862 179.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 63.0 t -92.76 123.69 44.94 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.395 0 N-CA-C 106.448 -1.686 . . . . 100.0 106.448 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.1 m0 -96.84 114.7 26.35 Favored 'General case' 0 N--CA 1.421 -1.888 0 N-CA-C 105.878 -1.897 . . . . 100.0 105.878 -179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -111.61 137.25 49.72 Favored 'General case' 0 N--CA 1.432 -1.345 0 N-CA-C 106.328 -1.731 . . . . 100.0 106.328 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.6 p -72.97 161.94 30.09 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-O 121.731 0.777 . . . . 100.0 112.487 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -98.1 19.47 14.02 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.668 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 95.47 13.19 52.29 Favored Glycine 0 C--N 1.356 1.681 0 O-C-N 121.818 -0.552 . . . . 100.0 112.277 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.407 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 65.3 mt-30 -60.44 -35.8 76.71 Favored 'General case' 0 C--N 1.355 0.83 0 C-N-CA 126.52 1.928 . . . . 100.0 111.583 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -58.26 -36.01 72.61 Favored 'General case' 0 CA--C 1.5 -0.946 0 C-N-CA 128.13 2.572 . . . . 100.0 111.869 -178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -61.84 -42.4 98.99 Favored 'General case' 0 N--CA 1.441 -0.892 0 C-N-CA 123.604 0.762 . . . . 100.0 111.041 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.407 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 26.7 p90 -95.37 -5.85 42.36 Favored 'General case' 0 C--N 1.36 1.022 0 N-CA-C 116.208 1.929 . . . . 100.0 116.208 -179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 175.85 -166.69 38.08 Favored Glycine 0 C--N 1.358 1.756 0 C-N-CA 119.7 -1.238 . . . . 100.0 113.251 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.68 175.27 54.9 Favored Glycine 0 C--N 1.354 1.557 0 N-CA-C 109.97 -1.252 . . . . 100.0 109.97 179.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD13 ' CE2' ' A' ' 79' ' ' TYR . 95.7 mt -105.14 140.65 37.99 Favored 'General case' 0 CA--C 1.484 -1.595 0 CA-C-O 122.18 0.99 . . . . 100.0 110.465 -179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 89.6 mtm180 -68.7 154.64 41.57 Favored 'General case' 0 N--CA 1.429 -1.495 0 CA-C-N 113.676 -1.602 . . . . 100.0 113.602 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 72.0 m-20 -60.95 -38.31 85.42 Favored 'General case' 0 N--CA 1.436 -1.157 0 C-N-CA 125.531 1.533 . . . . 100.0 110.421 -179.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -59.08 -39.04 93.85 Favored Glycine 0 C--N 1.361 1.934 0 C-N-CA 124.854 1.216 . . . . 100.0 111.063 -179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HD1' HG21 ' A' ' 45' ' ' VAL . 63.0 t80 -62.23 -46.98 86.45 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 123.697 0.799 . . . . 100.0 110.866 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.3 m-85 -68.01 -37.17 81.11 Favored 'General case' 0 N--CA 1.436 -1.127 0 N-CA-C 116.298 1.962 . . . . 100.0 116.298 -179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 66.3 mt -51.84 136.58 11.63 Favored 'Isoleucine or valine' 0 C--N 1.358 0.942 0 C-N-CA 125.04 1.336 . . . . 100.0 113.973 -176.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 61.89 31.78 18.13 Favored 'General case' 0 N--CA 1.438 -1.032 0 C-N-CA 127.749 2.42 . . . . 100.0 114.706 -178.004 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -74.87 128.44 35.58 Favored 'General case' 0 CA--C 1.495 -1.149 0 N-CA-C 105.595 -2.002 . . . . 100.0 105.595 177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.421 ' O ' HG23 ' A' ' 115' ' ' ILE . 95.9 mm-40 -96.78 -36.82 10.51 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 107.357 -1.349 . . . . 100.0 107.357 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.554 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.6 p -143.52 159.97 41.45 Favored 'General case' 0 N--CA 1.438 -1.033 0 C-N-CA 122.776 0.431 . . . . 100.0 110.842 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.481 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -146.23 149.17 33.41 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 114.594 1.331 . . . . 100.0 114.594 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.423 ' HB ' HD12 ' A' ' 15' ' ' LEU . 91.7 mt -125.65 126.15 69.77 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.208 0 N-CA-C 103.678 -2.712 . . . . 100.0 103.678 176.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.2 mt -109.98 124.26 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 101.762 -3.422 . . . . 100.0 101.762 178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.619 ' SD ' HD11 ' A' ' 15' ' ' LEU . 95.1 mtp -109.16 131.64 54.88 Favored 'General case' 0 N--CA 1.417 -2.084 0 CA-C-N 113.915 -1.493 . . . . 100.0 113.005 -176.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.5 p90 -129.25 159.43 36.13 Favored 'General case' 0 N--CA 1.43 -1.462 0 CA-C-N 113.155 -1.838 . . . . 100.0 108.434 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -106.4 126.95 52.89 Favored 'General case' 0 N--CA 1.432 -1.326 0 N-CA-C 106.46 -1.681 . . . . 100.0 106.46 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 15.5 m -64.65 -21.41 29.21 Favored 'Isoleucine or valine' 0 C--N 1.352 0.702 0 N-CA-C 113.849 1.055 . . . . 100.0 113.849 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.0 p -85.12 -12.19 53.46 Favored 'General case' 0 N--CA 1.44 -0.953 0 CA-C-O 119.239 -0.41 . . . . 100.0 110.579 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 40.9 t -118.76 117.29 28.5 Favored 'General case' 0 C--N 1.363 1.18 0 CA-C-O 122.337 1.065 . . . . 100.0 111.427 -179.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 94.0 mtt-85 -66.51 -38.87 88.16 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 114.424 -1.262 . . . . 100.0 110.434 177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 90.3 t -60.66 -41.28 87.57 Favored 'Isoleucine or valine' 0 C--N 1.357 0.904 0 C-N-CA 126.071 1.749 . . . . 100.0 110.856 -178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.8 m -62.71 -42.67 99.77 Favored 'General case' 0 C--N 1.358 0.942 0 N-CA-C 109.655 -0.498 . . . . 100.0 109.655 -179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.459 ' CE1' HG23 ' A' ' 136' ' ' ILE . 43.6 t80 -64.15 -40.28 95.81 Favored 'General case' 0 C--N 1.361 1.107 0 C-N-CA 123.452 0.701 . . . . 100.0 110.884 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.517 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.5 mttt -60.79 -38.77 86.44 Favored 'General case' 0 C--N 1.353 0.756 0 C-N-CA 124.546 1.139 . . . . 100.0 110.485 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -76.38 -9.38 58.6 Favored 'General case' 0 C--N 1.354 0.781 0 N-CA-C 115.182 1.549 . . . . 100.0 115.182 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 66.3 t -60.06 -42.98 92.99 Favored Pre-proline 0 C--N 1.363 1.194 0 CA-C-O 115.884 -2.007 . . . . 100.0 111.176 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.517 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 82.0 Cg_exo -57.78 -36.83 98.16 Favored 'Trans proline' 0 C--N 1.377 2.062 0 C-N-CA 122.309 2.006 . . . . 100.0 112.852 177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 -63.44 -46.93 84.05 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 124.355 1.062 . . . . 100.0 110.28 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 73.6 m95 -64.24 -42.08 96.69 Favored 'General case' 0 CA--C 1.495 -1.135 0 C-N-CA 123.162 0.585 . . . . 100.0 111.271 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -62.58 -44.25 96.79 Favored 'General case' 0 N--CA 1.433 -1.306 0 C-N-CA 124.326 1.05 . . . . 100.0 110.39 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 95.2 mtm-85 -62.76 -44.38 96.35 Favored 'General case' 0 CA--C 1.492 -1.283 0 CA-C-O 118.759 -0.639 . . . . 100.0 112.031 -179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 79.9 m-20 -62.34 -44.28 96.85 Favored 'General case' 0 C--N 1.355 0.844 0 O-C-N 123.526 0.516 . . . . 100.0 111.112 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.406 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.1 tp -62.45 -46.8 86.9 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.684 1.193 . . . . 100.0 112.577 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 75.6 t -64.32 -38.97 83.92 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.026 0 C-N-CA 125.364 1.465 . . . . 100.0 111.289 -179.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 90.3 mtt180 -60.37 -46.66 89.17 Favored 'General case' 0 CA--C 1.501 -0.928 0 CA-C-O 118.938 -0.553 . . . . 100.0 110.714 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.9 t -72.03 -45.84 61.8 Favored 'Isoleucine or valine' 0 C--N 1.359 1.001 0 C-N-CA 120.254 -0.578 . . . . 100.0 111.534 179.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.81 115.65 18.97 Favored 'General case' 0 CA--C 1.498 -1.044 0 N-CA-C 109.249 -0.648 . . . . 100.0 109.249 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -93.29 147.3 23.04 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-N 115.771 -0.649 . . . . 100.0 112.492 -178.049 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.1 m-20 54.55 44.55 28.55 Favored 'General case' 0 C--N 1.356 0.89 0 C-N-CA 126.436 1.895 . . . . 100.0 115.183 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.421 HG23 ' O ' ' A' ' 84' ' ' GLN . 33.9 mm -98.96 132.36 23.77 Favored Pre-proline 0 N--CA 1.437 -1.113 0 C-N-CA 126.116 1.766 . . . . 100.0 107.066 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -62.49 129.25 25.99 Favored 'Trans proline' 0 C--N 1.373 1.825 0 C-N-CA 122.536 2.158 . . . . 100.0 109.144 178.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.717 ' HB ' HD22 ' A' ' 144' ' ' LEU . 71.0 mt -130.71 136.69 57.72 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 CA-C-O 122.257 1.027 . . . . 100.0 108.689 -178.115 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.4 130.8 69.38 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 N-CA-C 105.062 -2.199 . . . . 100.0 105.062 178.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.541 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 21.9 mt -105.25 127.07 52.76 Favored 'General case' 0 N--CA 1.433 -1.317 0 N-CA-C 103.136 -2.912 . . . . 100.0 103.136 175.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . . . . . . . . . 73.1 m -115.83 127.21 54.88 Favored 'General case' 0 N--CA 1.424 -1.755 0 CA-C-N 113.642 -1.617 . . . . 100.0 112.061 -178.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.58 105.26 3.06 Favored Glycine 0 CA--C 1.489 -1.558 0 N-CA-C 106.427 -2.669 . . . . 100.0 106.427 179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -80.14 164.25 23.48 Favored 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 128.2 2.6 . . . . 100.0 113.935 -178.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 54.2 mttp 55.62 45.15 25.32 Favored 'General case' 0 N--CA 1.434 -1.251 0 C-N-CA 128.46 2.704 . . . . 100.0 114.367 178.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.296 32.8 m -71.82 -9.53 12.97 Favored 'Isoleucine or valine' 0 C--N 1.361 1.091 0 C-N-CA 120.4 -0.52 . . . . 100.0 111.062 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.65 -39.1 90.15 Favored 'General case' 0 C--N 1.361 1.077 0 C-N-CA 126.658 1.983 . . . . 100.0 110.287 176.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.7 mt -68.4 130.87 33.75 Favored 'Isoleucine or valine' 0 C--N 1.359 1.021 0 N-CA-C 108.381 -0.97 . . . . 100.0 108.381 -179.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 65.0 mttp -62.34 -40.54 96.7 Favored 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.937 1.458 . . . . 100.0 114.937 -178.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -84.02 96.08 8.76 Favored 'General case' 0 N--CA 1.441 -0.914 0 N-CA-C 105.282 -2.118 . . . . 100.0 105.282 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -102.37 120.91 41.29 Favored 'General case' 0 CA--C 1.491 -1.325 0 N-CA-C 103.621 -2.733 . . . . 100.0 103.621 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -96.87 -36.51 10.57 Favored 'General case' 0 CA--C 1.491 -1.314 0 CA-C-N 115.612 -0.722 . . . . 100.0 112.528 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 42.7 t -104.32 104.81 17.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.136 0 N-CA-C 103.534 -2.765 . . . . 100.0 103.534 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -103.23 179.95 4.13 Favored 'General case' 0 N--CA 1.437 -1.109 0 N-CA-C 113.788 1.033 . . . . 100.0 113.788 -178.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.469 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.21 -35.2 71.31 Favored 'General case' 0 C--N 1.359 0.993 0 C-N-CA 127.336 2.254 . . . . 100.0 109.539 179.437 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.076 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.4 mttt -59.29 -37.62 78.14 Favored 'General case' 0 N--CA 1.422 -1.858 0 C-N-CA 128.41 2.684 . . . . 100.0 112.189 179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 98.6 p -104.99 -0.85 26.46 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 120.091 3.367 . . . . 100.0 120.091 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.627 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 53.8 mt -97.38 94.39 3.91 Favored 'Isoleucine or valine' 0 C--N 1.362 1.145 0 C-N-CA 115.583 -2.447 . . . . 100.0 111.431 -176.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.434 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 4.3 p -100.82 -5.32 9.17 Favored 'Isoleucine or valine' 0 C--N 1.353 0.729 0 N-CA-C 115.338 1.606 . . . . 100.0 115.338 -177.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -58.58 -36.55 74.15 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 115.199 1.555 . . . . 100.0 115.199 -174.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.625 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.5 m-70 -59.54 -39.25 83.33 Favored 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.814 1.646 . . . . 100.0 113.344 -177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.648 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 57.3 ttp85 -58.69 -48.5 80.88 Favored 'General case' 0 CA--C 1.479 -1.781 0 N-CA-C 114.031 1.123 . . . . 100.0 114.031 -177.094 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.52 -40.59 95.91 Favored 'General case' 0 N--CA 1.432 -1.371 0 O-C-N 124.218 0.949 . . . . 100.0 111.812 -179.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -95.01 -0.1 54.1 Favored 'General case' 0 N--CA 1.431 -1.392 0 N-CA-C 116.157 1.91 . . . . 100.0 116.157 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . 0.258 73.2 m-20 54.55 47.13 23.39 Favored 'General case' 0 C--N 1.36 1.037 0 C-N-CA 125.378 1.471 . . . . 100.0 113.346 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.7 mt -103.62 153.39 20.66 Favored 'General case' 0 CA--C 1.502 -0.896 0 N-CA-C 106.115 -1.809 . . . . 100.0 106.115 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -101.53 142.96 32.12 Favored 'General case' 0 CA--C 1.503 -0.844 0 N-CA-C 109.3 -0.63 . . . . 100.0 109.3 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.625 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 68.2 t80 -105.79 133.63 50.21 Favored 'General case' 0 CA--C 1.494 -1.182 0 N-CA-C 113.4 0.889 . . . . 100.0 113.4 -178.581 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -130.82 133.4 45.92 Favored 'General case' 0 C--N 1.356 0.85 0 CA-C-N 114.575 -1.193 . . . . 100.0 111.491 174.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.297 37.1 m-20 -85.64 122.97 30.49 Favored 'General case' 0 C--N 1.36 1.028 0 N-CA-C 102.234 -3.247 . . . . 100.0 102.234 177.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 45.6 pt -135.32 156.89 39.54 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.056 0 CA-C-O 122.364 1.078 . . . . 100.0 112.237 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.472 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 68.1 m -138.88 113.19 8.8 Favored 'General case' 0 CA--C 1.476 -1.886 0 N-CA-C 106.244 -1.761 . . . . 100.0 106.244 176.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.56 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -63.3 -43.06 98.91 Favored 'General case' 0 N--CA 1.429 -1.509 0 CA-C-N 113.836 -1.529 . . . . 100.0 112.664 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -62.22 -42.15 99.04 Favored 'General case' 0 N--CA 1.434 -1.272 0 C-N-CA 124.667 1.187 . . . . 100.0 112.375 -178.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.8 p -97.25 2.12 50.45 Favored 'General case' 0 N--CA 1.436 -1.153 0 N-CA-C 117.3 2.333 . . . . 100.0 117.3 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 65.49 21.25 11.8 Favored 'General case' 0 C--N 1.365 1.269 0 C-N-CA 124.583 1.153 . . . . 100.0 110.113 -177.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.472 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 85.8 t80 -73.58 124.48 26.0 Favored 'General case' 0 CA--C 1.49 -1.328 0 N-CA-C 109.038 -0.727 . . . . 100.0 109.038 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 87.7 m-20 53.32 40.1 30.8 Favored 'General case' 0 N--CA 1.437 -1.105 0 C-N-CA 128.12 2.568 . . . . 100.0 115.175 179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.454 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.9 t80 -62.25 -44.46 96.51 Favored 'General case' 0 C--N 1.357 0.93 0 O-C-N 121.638 -0.664 . . . . 100.0 111.529 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.33 -38.49 91.37 Favored 'General case' 0 N--CA 1.432 -1.354 0 N-CA-C 116.117 1.895 . . . . 100.0 116.117 -178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -57.53 -47.24 99.33 Favored Pre-proline 0 N--CA 1.442 -0.868 0 N-CA-C 119.999 3.333 . . . . 100.0 119.999 -173.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -61.07 -41.95 39.95 Favored 'Trans proline' 0 C--N 1.374 1.904 0 CA-C-N 123.34 2.229 . . . . 100.0 111.334 178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.2 m-85 -64.45 -42.29 96.04 Favored 'General case' 0 CA--C 1.492 -1.267 0 C-N-CA 125.466 1.506 . . . . 100.0 110.884 -179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 27.0 mt -61.14 -46.76 89.21 Favored 'General case' 0 CA--C 1.485 -1.526 0 C-N-CA 123.885 0.874 . . . . 100.0 112.002 178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 89.5 t90 -63.67 -44.61 93.26 Favored 'General case' 0 C--N 1.359 0.979 0 O-C-N 124.082 0.864 . . . . 100.0 110.421 -178.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.554 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.8 mt -61.92 -44.85 95.93 Favored 'General case' 0 CA--C 1.49 -1.343 0 O-C-N 123.797 0.686 . . . . 100.0 111.729 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.14 -43.7 98.26 Favored 'General case' 0 CA--C 1.496 -1.097 0 C-N-CA 124.174 0.99 . . . . 100.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -62.57 -45.71 91.69 Favored 'General case' 0 CA--C 1.491 -1.319 0 C-N-CA 123.564 0.745 . . . . 100.0 111.785 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -68.11 -42.4 80.34 Favored 'General case' 0 N--CA 1.436 -1.173 0 O-C-N 123.543 0.527 . . . . 100.0 112.354 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 80.6 mt -62.67 -46.96 85.74 Favored 'General case' 0 CA--C 1.5 -0.964 0 C-N-CA 123.469 0.708 . . . . 100.0 112.316 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 89.4 mt -70.43 -38.59 74.45 Favored 'Isoleucine or valine' 0 C--N 1.353 0.744 0 C-N-CA 123.546 0.738 . . . . 100.0 110.318 178.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 94.04 9.46 59.49 Favored Glycine 0 N--CA 1.435 -1.39 0 CA-C-O 118.781 -1.01 . . . . 100.0 111.053 -178.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -111.5 113.64 53.36 Favored Pre-proline 0 C--N 1.362 1.133 0 N-CA-C 107.492 -1.299 . . . . 100.0 107.492 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -71.57 -15.19 30.67 Favored 'Trans proline' 0 C--N 1.365 1.423 0 C-N-CA 124.051 3.167 . . . . 100.0 114.282 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 71.5 m-80 -89.73 2.82 54.37 Favored 'General case' 0 N--CA 1.442 -0.87 0 C-N-CA 123.993 0.917 . . . . 100.0 113.276 -177.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.0 tp -65.05 131.44 46.57 Favored 'General case' 0 N--CA 1.435 -1.193 0 CA-C-O 121.51 0.671 . . . . 100.0 109.663 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -133.83 152.94 52.02 Favored 'General case' 0 CA--C 1.5 -0.966 0 N-CA-C 108.358 -0.979 . . . . 100.0 108.358 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.5 m-30 -90.35 114.29 26.34 Favored 'General case' 0 C--N 1.361 1.089 0 N-CA-C 104.314 -2.476 . . . . 100.0 104.314 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 67.9 t -65.54 -44.29 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.283 1.033 . . . . 100.0 110.55 -179.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -127.86 148.01 50.46 Favored 'General case' 0 CA--C 1.488 -1.441 0 CA-C-O 121.373 0.606 . . . . 100.0 109.697 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 62.5 ttp -90.18 126.23 57.61 Favored Pre-proline 0 N--CA 1.432 -1.339 0 N-CA-C 104.772 -2.307 . . . . 100.0 104.772 178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.68 158.1 55.23 Favored 'Trans proline' 0 N--CA 1.442 -1.509 0 C-N-CA 122.869 2.379 . . . . 100.0 110.632 178.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -63.5 126.04 26.21 Favored 'General case' 0 CA--C 1.498 -1.039 0 N-CA-C 108.286 -1.005 . . . . 100.0 108.286 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.51 146.63 46.09 Favored 'General case' 0 CA--C 1.482 -1.646 0 CA-C-N 114.176 -1.375 . . . . 100.0 110.164 -178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.49 137.29 97.08 Favored Pre-proline 0 N--CA 1.436 -1.143 0 N-CA-C 106.832 -1.544 . . . . 100.0 106.832 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_exo -55.98 138.51 82.54 Favored 'Trans proline' 0 C--N 1.368 1.566 0 C-N-CA 123.534 2.823 . . . . 100.0 112.569 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -60.68 130.25 32.53 Favored 'Trans proline' 0 N--CA 1.437 -1.799 0 C-N-CA 122.738 2.292 . . . . 100.0 113.609 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -66.83 -44.36 81.3 Favored 'General case' 0 N--CA 1.438 -1.051 0 O-C-N 124.858 1.349 . . . . 100.0 108.579 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 30.4 m -132.32 159.04 43.38 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.907 0 N-CA-C 106.498 -1.667 . . . . 100.0 106.498 178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.66 131.06 50.29 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 N-CA-C 105.641 -1.985 . . . . 100.0 105.641 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.0 ttt -86.29 128.12 34.87 Favored 'General case' 0 N--CA 1.435 -1.225 0 N-CA-C 104.774 -2.306 . . . . 100.0 104.774 179.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . . . . . . . . . 64.4 t0 -62.21 128.09 90.52 Favored Pre-proline 0 N--CA 1.437 -1.086 0 CA-C-N 114.911 -1.04 . . . . 100.0 109.738 -179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_exo -59.53 -36.68 92.44 Favored 'Trans proline' 0 C--N 1.37 1.659 0 C-N-CA 123.474 2.783 . . . . 100.0 112.28 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.15 -45.37 92.22 Favored 'General case' 0 C--N 1.36 1.053 0 O-C-N 124.33 1.019 . . . . 100.0 110.766 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 95.5 mt -64.29 -41.89 96.66 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 122.971 0.508 . . . . 100.0 111.493 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.56 -44.56 96.81 Favored 'General case' 0 CA--C 1.496 -1.11 0 C-N-CA 123.63 0.772 . . . . 100.0 110.646 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.8 97.89 Favored 'General case' 0 N--CA 1.437 -1.124 0 C-N-CA 124.293 1.037 . . . . 100.0 110.847 179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -63.09 -43.98 97.01 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.632 0.773 . . . . 100.0 112.306 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.5 m-85 -63.69 -43.7 95.85 Favored 'General case' 0 CA--C 1.498 -1.052 0 C-N-CA 122.534 0.333 . . . . 100.0 111.712 179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -64.2 -39.93 95.01 Favored 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 122.601 0.36 . . . . 100.0 110.811 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -63.06 -42.83 99.78 Favored 'General case' 0 C--N 1.356 0.873 0 C-N-CA 124.625 1.17 . . . . 100.0 110.57 178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.95 -42.41 99.09 Favored 'General case' 0 C--N 1.36 1.052 0 C-N-CA 123.968 0.907 . . . . 100.0 109.775 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.506 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 18.3 tp -59.69 -49.52 77.42 Favored 'General case' 0 C--N 1.363 1.187 0 O-C-N 124.117 0.886 . . . . 100.0 110.089 178.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -63.22 -43.24 98.66 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 115.188 1.551 . . . . 100.0 115.188 -178.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 55.9 t -59.61 -46.53 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.175 0 CA-C-O 118.425 -0.798 . . . . 100.0 109.984 -176.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.681 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.403 . . -93.59 -0.63 56.13 Favored 'General case' 0 N--CA 1.403 -2.818 1 C-N-CA 109.854 -4.739 . . . . 100.0 114.006 179.76 . . . . . . . . 4 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.823 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.268 57.7 mt-30 -56.9 -35.77 69.36 Favored 'General case' 0 CA--C 1.458 -2.566 0 N-CA-C 107.523 -1.288 . . . . 100.0 107.523 178.418 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 63.6 p -82.74 53.87 2.51 Favored 'General case' 0 N--CA 1.429 -1.513 0 CA-C-O 122.403 1.097 . . . . 100.0 108.886 177.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.312 73.1 p 48.84 38.37 11.88 Favored 'General case' 0 N--CA 1.432 -1.327 0 C-N-CA 129.477 3.111 . . . . 100.0 116.281 177.044 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.478 ' HB3' ' HA ' ' A' ' 204' ' ' ALA . . . -83.13 -178.02 6.96 Favored 'General case' 0 N--CA 1.433 -1.296 0 N-CA-C 104.511 -2.404 . . . . 100.0 104.511 176.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.411 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 83.0 mt -56.31 -41.53 91.56 Favored Pre-proline 0 CA--C 1.503 -0.854 0 CA-C-O 115.885 -2.007 . . . . 100.0 114.788 -175.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.076 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.325 32.4 Cg_exo -55.17 137.21 76.25 Favored 'Trans proline' 0 C--N 1.373 1.826 0 CA-C-N 121.406 1.538 . . . . 100.0 112.427 177.238 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.434 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.6 m-20 -63.57 -47.45 81.49 Favored 'General case' 0 N--CA 1.427 -1.614 1 N-CA-C 124.764 5.098 . . . . 100.0 124.764 -173.805 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.665 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.13 -35.36 80.02 Favored 'General case' 0 CA--C 1.48 -1.746 1 CA-C-O 128.51 4.005 . . . . 100.0 108.045 177.946 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.823 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.481 44.0 m-20 -65.74 -48.74 70.89 Favored 'General case' 1 N--CA 1.351 -5.385 2 CA-C-N 107.446 -4.434 . . . . 100.0 106.389 -179.093 . . . . . . . . 5 3 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -63.46 -29.43 70.72 Favored 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.499 -1.375 . . . . 100.0 107.889 178.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.665 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.0 OUTLIER -58.51 -43.74 89.24 Favored 'General case' 0 CA--C 1.475 -1.917 0 CA-C-O 117.021 -1.466 . . . . 100.0 113.442 176.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.467 HD13 ' HG2' ' A' ' 205' ' ' GLN . 3.4 mp . . . . . 0 C--O 1.26 1.632 0 CA-C-O 114.514 -2.66 . . . . 100.0 113.227 -176.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.9 tpt . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 113.049 0.759 . . . . 100.0 113.049 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.27 93.92 Favored 'General case' 0 N--CA 1.44 -0.948 0 C-N-CA 124.777 1.231 . . . . 100.0 113.655 -178.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -102.43 151.6 22.09 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-O 121.641 0.734 . . . . 100.0 111.894 -179.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.9 mm-40 -80.97 158.93 25.03 Favored 'General case' 0 N--CA 1.44 -0.97 0 C-N-CA 123.763 0.825 . . . . 100.0 109.896 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.35 2.19 87.71 Favored Glycine 0 C--N 1.353 1.505 0 C-N-CA 123.788 0.709 . . . . 100.0 113.497 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -75.07 156.96 85.78 Favored Pre-proline 0 N--CA 1.439 -1.003 0 C-N-CA 123.961 0.904 . . . . 100.0 112.34 179.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -63.58 157.75 49.59 Favored 'Trans proline' 0 C--N 1.373 1.845 0 C-N-CA 123.566 2.844 . . . . 100.0 111.544 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -54.12 131.94 41.99 Favored 'General case' 0 N--CA 1.442 -0.85 0 C-N-CA 124.84 1.256 . . . . 100.0 113.823 -177.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.9 t -94.66 119.64 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.072 0 N-CA-C 106.723 -1.584 . . . . 100.0 106.723 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.1 mt-30 -124.4 138.0 54.4 Favored 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 113.884 -1.507 . . . . 100.0 108.261 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -124.59 144.15 50.31 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 108.099 -1.075 . . . . 100.0 108.099 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -95.24 120.34 35.29 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 106.646 -1.613 . . . . 100.0 106.646 178.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.9 tt -108.73 128.36 54.8 Favored 'General case' 0 N--CA 1.424 -1.762 0 CA-C-N 113.442 -1.708 . . . . 100.0 106.83 -179.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 55.4 t -104.51 121.05 55.8 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.129 0 N-CA-C 107.01 -1.478 . . . . 100.0 107.01 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 31.0 tp -110.48 115.59 29.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 N-CA-C 106.48 -1.674 . . . . 100.0 106.48 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 24.2 m -126.54 161.96 31.73 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.029 0 CA-C-N 115.379 -0.828 . . . . 100.0 111.881 -178.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.68 176.7 30.02 Favored Glycine 0 CA--C 1.492 -1.363 0 N-CA-C 108.008 -2.037 . . . . 100.0 108.008 179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -72.1 156.4 39.23 Favored 'General case' 0 CA--C 1.496 -1.098 0 CA-C-O 121.831 0.824 . . . . 100.0 111.479 179.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.96 140.66 38.42 Favored Glycine 0 C--N 1.352 1.427 0 N-CA-C 106.242 -2.743 . . . . 100.0 106.242 178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 92.1 -5.49 78.57 Favored Glycine 0 N--CA 1.437 -1.257 0 CA-C-O 118.453 -1.193 . . . . 100.0 113.696 -179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 79.1 m -62.2 -39.91 94.32 Favored 'General case' 0 C--N 1.362 1.116 0 CA-C-N 119.064 1.432 . . . . 100.0 111.06 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.69 26.88 4.29 Favored Glycine 0 C--N 1.351 1.416 0 N-CA-C 109.464 -1.454 . . . . 100.0 109.464 -178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.534 ' HA ' ' CE ' ' A' ' 89' ' ' MET . 32.7 mtmt -61.49 -44.81 96.41 Favored 'General case' 0 N--CA 1.436 -1.17 0 C-N-CA 123.493 0.717 . . . . 100.0 112.671 -179.034 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 87.2 m -62.47 -43.08 99.68 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 124.267 1.027 . . . . 100.0 109.729 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 41.4 m -63.07 -41.7 99.49 Favored 'General case' 0 C--N 1.356 0.871 0 C-N-CA 124.786 1.234 . . . . 100.0 109.218 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.514 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . 54.9 t80 -59.99 -48.48 81.52 Favored 'General case' 0 CA--C 1.499 -1.014 0 C-N-CA 124.141 0.976 . . . . 100.0 112.208 179.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 85.5 t -66.46 -41.68 89.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 O-C-N 123.691 0.619 . . . . 100.0 110.922 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.252 98.8 mttt -68.06 -8.09 34.89 Favored 'General case' 0 CA--C 1.49 -1.337 0 N-CA-C 115.919 1.822 . . . . 100.0 115.919 -177.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.558 ' NH1' ' HA ' ' A' ' 151' ' ' ALA . 81.2 mtm-85 -60.91 -37.43 82.21 Favored 'General case' 0 C--N 1.361 1.081 0 CA-C-O 118.941 -0.552 . . . . 100.0 109.724 177.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.435 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 47.5 t-80 -80.53 113.17 18.53 Favored 'General case' 0 C--N 1.36 1.038 0 N-CA-C 106.78 -1.563 . . . . 100.0 106.78 -179.643 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.3 mt -62.52 -43.96 97.54 Favored 'General case' 0 CA--C 1.494 -1.21 0 N-CA-C 115.604 1.705 . . . . 100.0 115.604 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.435 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 63.7 m -63.33 -41.89 98.94 Favored 'General case' 0 C--N 1.356 0.889 0 N-CA-C 108.988 -0.745 . . . . 100.0 108.988 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.41 -42.45 99.77 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 123.671 0.653 . . . . 100.0 111.565 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -63.49 -45.36 91.07 Favored 'General case' 0 N--CA 1.44 -0.971 0 C-N-CA 123.368 0.667 . . . . 100.0 111.043 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.7 m-30 -63.16 -40.65 98.16 Favored 'General case' 0 CA--C 1.501 -0.942 0 C-N-CA 124.685 1.194 . . . . 100.0 112.215 -178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -93.52 11.24 29.33 Favored 'General case' 0 N--CA 1.437 -1.11 0 N-CA-C 115.353 1.612 . . . . 100.0 115.353 -177.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -59.55 140.01 56.66 Favored 'General case' 0 C--N 1.362 1.126 0 N-CA-C 113.875 1.065 . . . . 100.0 113.875 -178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -118.1 129.47 55.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 105.962 -1.866 . . . . 100.0 105.962 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -103.04 124.63 48.9 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 106.575 -1.639 . . . . 100.0 106.575 -179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 96.9 t -99.2 110.31 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.008 0 N-CA-C 101.498 -3.519 . . . . 100.0 101.498 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -63.21 -46.03 88.93 Favored 'General case' 0 CA--C 1.495 -1.135 0 N-CA-C 115.993 1.849 . . . . 100.0 115.993 -177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 76.6 p -62.86 -47.25 84.16 Favored 'General case' 0 C--N 1.358 0.961 0 C-N-CA 122.494 0.317 . . . . 100.0 111.568 -179.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 96.6 mt -70.79 -37.14 73.28 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 113.892 1.071 . . . . 100.0 113.892 178.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.69 40.77 30.84 Favored Glycine 0 C--N 1.36 1.895 0 N-CA-C 107.261 -2.335 . . . . 100.0 107.261 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.431 HG21 ' HD1' ' A' ' 79' ' ' TYR . 58.2 t -126.25 141.99 44.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 C-N-CA 124.246 1.018 . . . . 100.0 109.167 -178.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 54.8 mt-10 -103.55 118.93 37.88 Favored 'General case' 0 N--CA 1.436 -1.154 0 N-CA-C 102.336 -3.209 . . . . 100.0 102.336 177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.0 t -104.68 120.05 54.55 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.12 0 N-CA-C 105.542 -2.021 . . . . 100.0 105.542 -179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -114.5 119.79 39.2 Favored Pre-proline 0 N--CA 1.433 -1.304 0 N-CA-C 109.0 -0.741 . . . . 100.0 109.0 -179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -79.9 104.67 1.71 Allowed 'Trans proline' 0 N--CA 1.443 -1.49 0 C-N-CA 122.863 2.375 . . . . 100.0 110.934 178.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.33 119.05 34.1 Favored 'General case' 0 N--CA 1.434 -1.247 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.93 126.59 58.49 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.887 0 N-CA-C 107.191 -1.411 . . . . 100.0 107.191 -177.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -122.49 133.1 54.6 Favored 'General case' 0 CA--C 1.494 -1.201 0 N-CA-C 106.102 -1.814 . . . . 100.0 106.102 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 99.1 m-70 -100.35 118.3 36.32 Favored 'General case' 0 CA--C 1.488 -1.404 0 CA-C-O 121.73 0.776 . . . . 100.0 108.987 -179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.43 HG21 HD12 ' A' ' 59' ' ' ILE . 22.3 p -110.23 -179.97 3.93 Favored 'General case' 0 N--CA 1.434 -1.243 0 CA-C-N 114.948 -1.023 . . . . 100.0 111.57 -178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -59.66 -44.21 93.66 Favored 'General case' 0 C--N 1.359 0.978 0 C-N-CA 125.497 1.519 . . . . 100.0 108.349 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.4 mtt-85 -69.8 -38.42 76.64 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 124.188 0.995 . . . . 100.0 112.395 178.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 149.92 -173.05 29.74 Favored Glycine 0 C--N 1.35 1.338 0 N-CA-C 108.889 -1.684 . . . . 100.0 108.889 -179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -64.93 138.43 57.43 Favored 'Trans proline' 0 N--CA 1.44 -1.652 0 C-N-CA 122.521 2.147 . . . . 100.0 114.199 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.43 HD12 HG21 ' A' ' 54' ' ' THR . 81.1 mt -127.4 129.93 70.66 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.184 0 N-CA-C 102.801 -3.037 . . . . 100.0 102.801 177.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -110.81 128.99 55.97 Favored 'General case' 0 CA--C 1.493 -1.226 0 N-CA-C 109.048 -0.723 . . . . 100.0 109.048 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -111.85 116.76 31.19 Favored 'General case' 0 N--CA 1.43 -1.467 0 N-CA-C 103.653 -2.721 . . . . 100.0 103.653 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 76.0 m-80 -87.81 106.65 18.22 Favored 'General case' 0 CA--C 1.493 -1.222 1 N-CA-C 99.616 -4.216 . . . . 100.0 99.616 179.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 68.5 t -93.28 122.3 44.67 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.371 0 N-CA-C 106.368 -1.715 . . . . 100.0 106.368 -177.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 18.4 m0 -97.25 117.0 30.48 Favored 'General case' 0 N--CA 1.423 -1.822 0 N-CA-C 106.631 -1.618 . . . . 100.0 106.631 -179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -116.45 141.28 48.38 Favored 'General case' 0 N--CA 1.432 -1.333 0 N-CA-C 105.005 -2.22 . . . . 100.0 105.005 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 72.9 p -75.08 165.88 24.53 Favored 'General case' 0 N--CA 1.438 -1.073 0 N-CA-C 113.558 0.947 . . . . 100.0 113.558 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.74 12.92 23.95 Favored 'General case' 0 N--CA 1.44 -0.96 0 C-N-CA 124.733 1.213 . . . . 100.0 109.788 179.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.49 11.49 51.14 Favored Glycine 0 C--N 1.358 1.803 0 O-C-N 121.693 -0.629 . . . . 100.0 112.209 -179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -61.96 -27.86 69.14 Favored 'General case' 0 C--N 1.355 0.827 0 C-N-CA 125.813 1.645 . . . . 100.0 112.166 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -59.05 -36.64 75.35 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 127.584 2.353 . . . . 100.0 111.826 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -61.59 -46.84 88.16 Favored 'General case' 0 C--N 1.358 0.978 0 CA-C-N 117.996 0.362 . . . . 100.0 111.046 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . 0.371 13.9 p90 -71.99 -39.39 69.3 Favored 'General case' 0 C--N 1.362 1.11 0 N-CA-C 114.903 1.445 . . . . 100.0 114.903 178.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.5 -156.04 11.45 Favored Glycine 0 C--N 1.358 1.776 0 C-N-CA 119.903 -1.142 . . . . 100.0 113.431 -178.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.16 171.53 52.52 Favored Glycine 0 C--N 1.354 1.583 0 C-N-CA 123.807 0.718 . . . . 100.0 111.731 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 89.0 mt -106.3 142.99 35.06 Favored 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 121.822 0.82 . . . . 100.0 109.971 -178.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.4 mtm180 -67.95 155.69 38.89 Favored 'General case' 0 N--CA 1.432 -1.356 0 CA-C-N 114.208 -1.36 . . . . 100.0 113.735 -178.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -60.67 -38.36 84.63 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-N 113.776 -1.557 . . . . 100.0 110.372 -179.472 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.76 -39.33 93.54 Favored Glycine 0 C--N 1.36 1.872 0 C-N-CA 124.38 0.99 . . . . 100.0 111.469 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.431 ' HD1' HG21 ' A' ' 45' ' ' VAL . 62.2 t80 -62.32 -46.96 86.4 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 123.516 0.726 . . . . 100.0 111.293 177.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -68.92 -37.11 78.73 Favored 'General case' 0 N--CA 1.437 -1.088 0 N-CA-C 115.502 1.668 . . . . 100.0 115.502 -179.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.0 mt -52.19 138.22 10.56 Favored 'Isoleucine or valine' 0 C--N 1.36 1.061 0 C-N-CA 125.48 1.512 . . . . 100.0 113.739 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 64.86 24.65 12.78 Favored 'General case' 0 C--N 1.36 1.032 0 C-N-CA 127.853 2.461 . . . . 100.0 114.378 -178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.07 129.33 38.68 Favored 'General case' 0 CA--C 1.493 -1.227 0 N-CA-C 107.305 -1.368 . . . . 100.0 107.305 178.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.4 mm-40 -98.71 -34.93 10.34 Favored 'General case' 0 N--CA 1.434 -1.236 0 N-CA-C 108.143 -1.058 . . . . 100.0 108.143 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.52 ' HB2' HD22 ' A' ' 164' ' ' LEU . 23.5 p -144.37 160.14 41.54 Favored 'General case' 0 N--CA 1.432 -1.332 0 C-N-CA 122.861 0.465 . . . . 100.0 110.527 179.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.478 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -146.17 149.3 33.72 Favored 'General case' 0 CA--C 1.488 -1.414 0 N-CA-C 114.404 1.261 . . . . 100.0 114.404 179.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 84.8 mt -126.47 126.52 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 103.292 -2.855 . . . . 100.0 103.292 176.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 55.7 mt -112.43 123.81 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 N-CA-C 102.353 -3.203 . . . . 100.0 102.353 178.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 23' ' ' LYS . 41.0 mtm -115.45 140.55 49.04 Favored 'General case' 0 N--CA 1.416 -2.145 0 C-N-CA 118.738 -1.185 . . . . 100.0 113.692 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -127.08 159.59 33.73 Favored 'General case' 0 N--CA 1.421 -1.887 0 CA-C-N 110.423 -3.081 . . . . 100.0 108.751 178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -102.87 126.59 50.08 Favored 'General case' 0 N--CA 1.429 -1.516 0 N-CA-C 105.802 -1.925 . . . . 100.0 105.802 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 19.5 m -64.52 -21.58 29.47 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.367 0.877 . . . . 100.0 113.367 -179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 73.3 p -87.59 -8.48 56.22 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-O 119.033 -0.508 . . . . 100.0 110.993 179.044 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.4 t -119.42 115.84 24.93 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 122.308 1.051 . . . . 100.0 110.576 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -66.77 -38.68 87.05 Favored 'General case' 0 CA--C 1.499 -0.996 0 CA-C-N 114.622 -1.172 . . . . 100.0 110.55 178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.0 t -60.71 -41.86 89.86 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 126.217 1.807 . . . . 100.0 110.391 -178.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 90.4 m -62.96 -42.06 99.71 Favored 'General case' 0 C--N 1.357 0.9 0 CA-C-N 118.111 0.414 . . . . 100.0 110.306 -179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.555 ' CE1' HG23 ' A' ' 136' ' ' ILE . 39.5 t80 -63.45 -41.22 98.65 Favored 'General case' 0 C--N 1.36 1.035 0 C-N-CA 123.259 0.624 . . . . 100.0 110.453 177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.541 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 98.7 mttt -61.61 -37.53 84.28 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 123.691 0.796 . . . . 100.0 111.652 179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -75.14 -10.3 59.34 Favored 'General case' 0 C--N 1.356 0.85 0 N-CA-C 114.471 1.286 . . . . 100.0 114.471 178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.36 -43.04 95.73 Favored Pre-proline 0 C--N 1.363 1.191 0 CA-C-O 115.782 -2.056 . . . . 100.0 111.795 -179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 83.2 Cg_exo -57.41 -38.24 95.0 Favored 'Trans proline' 0 C--N 1.378 2.102 0 CA-C-N 122.556 1.949 . . . . 100.0 112.725 177.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -64.02 -45.19 90.03 Favored 'General case' 0 C--N 1.358 0.973 0 C-N-CA 123.924 0.89 . . . . 100.0 111.401 179.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -63.15 -42.79 99.52 Favored 'General case' 0 C--N 1.363 1.17 0 C-N-CA 123.182 0.593 . . . . 100.0 110.347 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -62.15 -45.01 95.34 Favored 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 124.502 1.121 . . . . 100.0 110.517 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 87.1 mtt-85 -63.0 -44.01 97.2 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 112.686 0.624 . . . . 100.0 112.686 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 77.3 m-20 -62.68 -44.03 97.29 Favored 'General case' 0 C--N 1.356 0.86 0 O-C-N 123.42 0.45 . . . . 100.0 111.357 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.478 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.7 tp -62.79 -46.26 88.82 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 124.499 1.12 . . . . 100.0 112.247 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 77.5 t -64.43 -38.58 82.95 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.008 0 C-N-CA 125.082 1.353 . . . . 100.0 111.143 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 74.5 mtt85 -60.5 -46.07 91.45 Favored 'General case' 0 CA--C 1.5 -0.969 0 CA-C-N 118.463 0.574 . . . . 100.0 111.197 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 64.8 t -71.4 -45.58 68.54 Favored 'Isoleucine or valine' 0 C--N 1.357 0.933 0 C-N-CA 120.352 -0.539 . . . . 100.0 111.159 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 63.1 m -127.39 115.33 18.78 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.48 0.657 . . . . 100.0 109.558 -179.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -93.57 147.18 23.23 Favored 'General case' 0 CA--C 1.496 -1.124 0 CA-C-N 115.537 -0.756 . . . . 100.0 112.422 -178.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 77.5 m-20 55.07 44.55 27.85 Favored 'General case' 0 C--N 1.358 0.962 0 C-N-CA 126.56 1.944 . . . . 100.0 114.457 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.412 HG23 ' O ' ' A' ' 84' ' ' GLN . 32.0 mm -100.74 131.29 23.77 Favored Pre-proline 0 N--CA 1.436 -1.155 0 C-N-CA 125.907 1.683 . . . . 100.0 107.193 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -63.19 130.33 28.45 Favored 'Trans proline' 0 C--N 1.373 1.838 0 C-N-CA 122.601 2.201 . . . . 100.0 109.181 178.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.729 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.8 mt -130.82 136.73 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.16 0 O-C-N 124.317 1.011 . . . . 100.0 109.147 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . 0.432 HG11 ' HB3' ' A' ' 160' ' ' PRO . 83.9 t -113.6 130.91 66.8 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.15 0 N-CA-C 105.431 -2.062 . . . . 100.0 105.431 178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.479 ' HB2' ' HE1' ' A' ' 139' ' ' HIS . 39.7 mt -105.85 125.14 50.64 Favored 'General case' 0 N--CA 1.431 -1.383 0 N-CA-C 103.465 -2.791 . . . . 100.0 103.465 175.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.438 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 72.4 m -116.82 129.99 56.43 Favored 'General case' 0 N--CA 1.428 -1.537 0 CA-C-N 114.199 -1.364 . . . . 100.0 112.509 -179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.99 103.51 2.83 Favored Glycine 0 CA--C 1.486 -1.753 0 N-CA-C 105.347 -3.101 . . . . 100.0 105.347 179.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.434 ' HA ' HG13 ' A' ' 149' ' ' ILE . 63.7 t30 -84.36 167.44 16.52 Favored 'General case' 0 N--CA 1.432 -1.331 0 C-N-CA 125.082 1.353 . . . . 100.0 111.297 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.0 mttt 60.08 42.45 15.69 Favored 'General case' 0 N--CA 1.435 -1.201 0 C-N-CA 128.348 2.659 . . . . 100.0 115.199 179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.307 20.4 m -73.18 -7.66 10.17 Favored 'Isoleucine or valine' 0 C--N 1.359 0.982 0 CA-C-N 116.08 -0.509 . . . . 100.0 111.494 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -61.96 -38.09 87.21 Favored 'General case' 0 C--N 1.36 1.053 0 C-N-CA 126.759 2.023 . . . . 100.0 109.801 176.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.5 mt -69.65 130.34 34.27 Favored 'Isoleucine or valine' 0 C--N 1.361 1.108 0 N-CA-C 106.694 -1.595 . . . . 100.0 106.694 -179.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -62.36 -41.11 98.35 Favored 'General case' 0 CA--C 1.492 -1.255 0 N-CA-C 116.281 1.956 . . . . 100.0 116.281 -177.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -86.23 99.4 11.52 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 105.201 -2.148 . . . . 100.0 105.201 -179.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -99.01 118.77 36.55 Favored 'General case' 0 N--CA 1.431 -1.422 0 N-CA-C 103.351 -2.833 . . . . 100.0 103.351 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -88.3 -40.96 13.2 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 115.719 -0.673 . . . . 100.0 112.634 -178.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 44.5 t -104.85 106.36 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.08 0 N-CA-C 103.667 -2.716 . . . . 100.0 103.667 -177.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -103.64 -179.49 3.97 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 115.247 -0.888 . . . . 100.0 113.209 -177.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.481 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.43 -35.86 72.75 Favored 'General case' 0 C--N 1.359 1.015 0 C-N-CA 127.161 2.184 . . . . 100.0 109.276 179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.034 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.5 mttt -59.73 -37.11 78.02 Favored 'General case' 0 N--CA 1.421 -1.904 0 C-N-CA 128.081 2.552 . . . . 100.0 112.716 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.8 p -103.96 -1.17 27.98 Favored 'General case' 0 N--CA 1.436 -1.15 0 N-CA-C 120.114 3.376 . . . . 100.0 120.114 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.614 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 56.2 mt -98.47 95.07 4.09 Favored 'Isoleucine or valine' 0 C--N 1.364 1.21 0 C-N-CA 115.487 -2.485 . . . . 100.0 111.324 -176.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.419 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 5.7 p -100.6 -5.98 9.15 Favored 'Isoleucine or valine' 0 C--N 1.352 0.677 0 N-CA-C 114.77 1.396 . . . . 100.0 114.77 -178.024 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -58.89 -35.7 73.45 Favored 'General case' 0 C--N 1.35 0.618 0 N-CA-C 115.225 1.565 . . . . 100.0 115.225 -175.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.487 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 87.0 m-70 -59.45 -40.5 87.05 Favored 'General case' 0 N--CA 1.432 -1.369 0 C-N-CA 125.587 1.555 . . . . 100.0 112.689 -176.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.678 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 55.7 ttp85 -59.09 -47.69 84.33 Favored 'General case' 0 CA--C 1.484 -1.583 0 C-N-CA 124.567 1.147 . . . . 100.0 113.436 -177.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 57.5 mtmt -63.44 -41.44 98.67 Favored 'General case' 0 N--CA 1.431 -1.392 0 O-C-N 124.277 0.986 . . . . 100.0 111.728 -178.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -97.5 3.71 50.64 Favored 'General case' 0 N--CA 1.433 -1.297 0 N-CA-C 117.277 2.325 . . . . 100.0 117.277 -177.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 68.4 m-20 57.42 42.84 24.07 Favored 'General case' 0 C--N 1.363 1.187 0 C-N-CA 125.526 1.531 . . . . 100.0 112.275 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.729 HD22 ' HB ' ' A' ' 117' ' ' ILE . 27.3 mt -106.38 151.33 25.03 Favored 'General case' 0 CA--C 1.497 -1.059 0 N-CA-C 106.815 -1.55 . . . . 100.0 106.815 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.348 86.9 mm-40 -103.91 142.85 33.69 Favored 'General case' 0 CA--C 1.484 -1.588 0 N-CA-C 113.445 0.905 . . . . 100.0 113.445 178.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.487 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 79.7 t80 -98.83 132.18 44.38 Favored 'General case' 0 CA--C 1.483 -1.6 0 N-CA-C 113.633 0.975 . . . . 100.0 113.633 -178.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -127.58 132.89 49.78 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 113.596 -1.638 . . . . 100.0 108.335 174.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -91.39 118.28 30.4 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 101.3 -3.593 . . . . 100.0 101.3 -178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . 0.434 HG13 ' HA ' ' A' ' 122' ' ' ASN . 43.8 pt -133.57 159.37 42.73 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.988 0 CA-C-O 122.644 1.212 . . . . 100.0 114.05 -178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.504 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 58.1 m -140.02 111.43 7.18 Favored 'General case' 0 CA--C 1.479 -1.771 0 N-CA-C 106.418 -1.697 . . . . 100.0 106.418 175.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.558 ' HA ' ' NH1' ' A' ' 29' ' ' ARG . . . -62.58 -44.35 96.55 Favored 'General case' 0 N--CA 1.43 -1.436 0 CA-C-N 114.337 -1.301 . . . . 100.0 112.92 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -63.04 -40.12 96.78 Favored 'General case' 0 N--CA 1.432 -1.35 0 C-N-CA 123.715 0.806 . . . . 100.0 112.738 -178.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 99.0 p -96.12 1.66 52.6 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 117.139 2.274 . . . . 100.0 117.139 -178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 60.0 m-20 65.43 22.42 11.92 Favored 'General case' 0 C--N 1.365 1.244 0 C-N-CA 125.277 1.431 . . . . 100.0 109.964 -177.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.504 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 87.0 t80 -75.33 124.77 27.69 Favored 'General case' 0 N--CA 1.433 -1.279 0 N-CA-C 109.012 -0.736 . . . . 100.0 109.012 -177.706 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 53.59 39.87 30.67 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 128.121 2.568 . . . . 100.0 115.399 179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.542 ' HA ' HH21 ' A' ' 29' ' ' ARG . 69.8 t80 -62.61 -42.66 99.71 Favored 'General case' 0 C--N 1.356 0.888 0 O-C-N 121.829 -0.544 . . . . 100.0 111.395 179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.13 -39.43 94.67 Favored 'General case' 0 N--CA 1.434 -1.241 0 N-CA-C 115.746 1.758 . . . . 100.0 115.746 -178.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -58.16 -48.53 96.87 Favored Pre-proline 0 N--CA 1.44 -0.929 0 N-CA-C 120.932 3.679 . . . . 100.0 120.932 -173.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.432 ' HB3' HG11 ' A' ' 118' ' ' VAL . 55.4 Cg_endo -61.16 -41.79 40.47 Favored 'Trans proline' 0 C--N 1.373 1.853 0 CA-C-N 123.544 2.301 . . . . 100.0 112.681 178.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -64.7 -42.49 95.25 Favored 'General case' 0 CA--C 1.491 -1.325 0 O-C-N 124.656 1.223 . . . . 100.0 111.347 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 62.7 tp -63.18 -45.05 93.6 Favored 'General case' 0 N--CA 1.438 -1.068 0 C-N-CA 123.457 0.703 . . . . 100.0 111.408 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 92.1 t90 -63.01 -44.53 95.74 Favored 'General case' 0 C--N 1.359 1.005 0 O-C-N 123.523 0.514 . . . . 100.0 110.079 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.52 HD22 ' HB2' ' A' ' 85' ' ' CYS . 80.6 mt -61.78 -44.15 97.44 Favored 'General case' 0 CA--C 1.492 -1.277 0 C-N-CA 123.121 0.568 . . . . 100.0 111.469 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -62.0 -43.72 98.24 Favored 'General case' 0 CA--C 1.497 -1.07 0 C-N-CA 124.207 1.003 . . . . 100.0 111.315 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 65.0 mtp180 -62.22 -45.83 91.61 Favored 'General case' 0 CA--C 1.497 -1.096 0 C-N-CA 123.722 0.809 . . . . 100.0 111.022 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt -64.56 -45.38 87.36 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 113.116 0.784 . . . . 100.0 113.116 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.434 HD11 ' HB3' ' A' ' 85' ' ' CYS . 82.0 mt -63.44 -46.74 84.91 Favored 'General case' 0 CA--C 1.495 -1.155 0 C-N-CA 123.826 0.85 . . . . 100.0 112.929 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 85.9 mt -70.54 -38.51 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 C-N-CA 123.06 0.544 . . . . 100.0 109.989 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.98 9.74 59.31 Favored Glycine 0 N--CA 1.434 -1.441 0 N-CA-C 110.477 -1.049 . . . . 100.0 110.477 -178.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -108.97 112.63 59.97 Favored Pre-proline 0 C--N 1.362 1.121 0 N-CA-C 107.332 -1.358 . . . . 100.0 107.332 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -72.23 -16.7 28.16 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 123.412 2.741 . . . . 100.0 113.832 179.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -87.93 -0.12 56.59 Favored 'General case' 0 CA--C 1.503 -0.835 0 C-N-CA 123.827 0.851 . . . . 100.0 113.042 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 19.1 tp -63.81 131.61 48.35 Favored 'General case' 0 N--CA 1.436 -1.143 0 C-N-CA 123.286 0.634 . . . . 100.0 110.337 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -136.65 153.77 50.82 Favored 'General case' 0 CA--C 1.499 -0.986 0 N-CA-C 108.987 -0.746 . . . . 100.0 108.987 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 16.1 m-30 -88.21 113.21 23.6 Favored 'General case' 0 C--N 1.359 0.998 0 N-CA-C 106.257 -1.757 . . . . 100.0 106.257 179.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 62.7 t -67.02 -43.8 88.78 Favored 'Isoleucine or valine' 0 C--N 1.352 0.683 0 C-N-CA 124.011 0.925 . . . . 100.0 110.884 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.91 150.7 49.19 Favored 'General case' 0 CA--C 1.489 -1.368 0 CA-C-O 121.522 0.677 . . . . 100.0 109.634 -178.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 63.5 ttp -96.35 126.63 43.13 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 104.837 -2.283 . . . . 100.0 104.837 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.05 159.49 49.11 Favored 'Trans proline' 0 N--CA 1.443 -1.456 0 C-N-CA 122.951 2.434 . . . . 100.0 111.541 179.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.72 125.06 23.6 Favored 'General case' 0 CA--C 1.497 -1.074 0 N-CA-C 108.283 -1.006 . . . . 100.0 108.283 -179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.5 mt -119.1 144.56 46.54 Favored 'General case' 0 CA--C 1.486 -1.503 0 CA-C-N 114.335 -1.302 . . . . 100.0 109.972 -178.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -64.65 137.85 97.27 Favored Pre-proline 0 N--CA 1.437 -1.107 0 N-CA-C 107.156 -1.424 . . . . 100.0 107.156 178.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_exo -56.08 138.33 82.36 Favored 'Trans proline' 0 C--N 1.368 1.592 0 C-N-CA 123.516 2.811 . . . . 100.0 112.129 -178.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.42 131.74 39.94 Favored 'Trans proline' 0 N--CA 1.438 -1.748 0 C-N-CA 122.851 2.367 . . . . 100.0 114.264 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -66.06 -44.85 83.33 Favored 'General case' 0 N--CA 1.44 -0.957 0 O-C-N 124.795 1.309 . . . . 100.0 108.503 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.0 m -132.03 158.42 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.99 0 N-CA-C 106.787 -1.56 . . . . 100.0 106.787 179.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 86.7 t -99.78 130.64 48.56 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.917 0 N-CA-C 105.651 -1.981 . . . . 100.0 105.651 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -85.83 126.7 34.24 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 104.345 -2.465 . . . . 100.0 104.345 178.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.42 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 77.6 m-20 -62.74 131.09 94.22 Favored Pre-proline 0 N--CA 1.437 -1.103 0 CA-C-N 115.245 -0.889 . . . . 100.0 110.828 -178.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 58.7 Cg_exo -58.67 -37.94 91.69 Favored 'Trans proline' 0 C--N 1.368 1.555 0 C-N-CA 123.948 3.099 . . . . 100.0 112.828 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -63.22 -45.05 93.47 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 124.449 1.093 . . . . 100.0 110.784 179.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 93.8 mt -63.91 -42.49 97.41 Favored 'General case' 0 CA--C 1.494 -1.185 0 C-N-CA 123.067 0.547 . . . . 100.0 111.483 179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.4 -44.41 97.19 Favored 'General case' 0 CA--C 1.498 -1.048 0 C-N-CA 123.731 0.812 . . . . 100.0 110.512 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.57 -43.88 97.72 Favored 'General case' 0 N--CA 1.438 -1.063 0 C-N-CA 124.126 0.97 . . . . 100.0 110.768 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -62.57 -44.42 96.37 Favored 'General case' 0 CA--C 1.499 -1.006 0 C-N-CA 123.614 0.765 . . . . 100.0 112.187 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -63.84 -43.83 95.0 Favored 'General case' 0 CA--C 1.496 -1.111 0 N-CA-C 112.397 0.518 . . . . 100.0 112.397 179.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 65.8 mm-40 -63.51 -41.37 98.52 Favored 'General case' 0 C--N 1.357 0.922 0 N-CA-C 109.55 -0.537 . . . . 100.0 109.55 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -62.14 -45.32 93.95 Favored 'General case' 0 C--N 1.358 0.976 0 C-N-CA 124.989 1.316 . . . . 100.0 111.194 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.8 -42.75 99.4 Favored 'General case' 0 C--N 1.36 1.042 0 C-N-CA 123.366 0.667 . . . . 100.0 110.667 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.504 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 17.5 tp -60.01 -49.56 77.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 O-C-N 124.122 0.889 . . . . 100.0 110.53 178.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -64.69 -41.77 95.8 Favored 'General case' 0 CA--C 1.492 -1.283 0 N-CA-C 115.664 1.727 . . . . 100.0 115.664 -178.378 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.5 t -59.68 -46.36 93.43 Favored 'Isoleucine or valine' 0 CA--C 1.47 -2.121 0 CA-C-O 118.429 -0.796 . . . . 100.0 109.667 -177.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.68 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.41 . . -93.35 -0.52 56.58 Favored 'General case' 0 N--CA 1.4 -2.931 1 C-N-CA 109.909 -4.717 . . . . 100.0 114.326 -179.886 . . . . . . . . 4 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.805 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.275 59.7 mt-30 -56.63 -36.51 69.56 Favored 'General case' 0 CA--C 1.467 -2.215 0 N-CA-C 106.535 -1.654 . . . . 100.0 106.535 178.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 59.7 p -82.44 53.4 2.3 Favored 'General case' 0 N--CA 1.431 -1.395 0 CA-C-O 122.211 1.005 . . . . 100.0 108.969 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.291 78.7 p 49.11 37.74 11.42 Favored 'General case' 0 N--CA 1.432 -1.358 0 C-N-CA 129.123 2.969 . . . . 100.0 116.402 177.32 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.479 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -82.53 -179.32 7.38 Favored 'General case' 0 N--CA 1.435 -1.22 0 N-CA-C 104.443 -2.428 . . . . 100.0 104.443 176.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . . . . . . . . . 72.7 mt -56.6 -39.98 81.7 Favored Pre-proline 0 CA--C 1.499 -0.981 0 CA-C-O 115.851 -2.024 . . . . 100.0 114.904 -175.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.034 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.332 45.4 Cg_exo -55.02 136.7 74.09 Favored 'Trans proline' 0 C--N 1.371 1.756 0 CA-C-N 121.288 1.496 . . . . 100.0 111.991 177.326 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.419 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.5 m-20 -63.55 -47.7 80.5 Favored 'General case' 0 N--CA 1.427 -1.616 1 N-CA-C 125.132 5.234 . . . . 100.0 125.132 -173.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.681 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.2 mt-10 -63.1 -35.26 79.67 Favored 'General case' 0 CA--C 1.482 -1.673 1 CA-C-O 128.626 4.06 . . . . 100.0 107.782 177.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.805 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.482 43.2 m-20 -65.49 -49.06 70.43 Favored 'General case' 1 N--CA 1.352 -5.352 1 CA-C-N 107.581 -4.372 . . . . 100.0 106.148 -179.058 . . . . . . . . 5 3 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -64.15 -27.64 69.21 Favored 'General case' 0 C--N 1.358 0.945 0 O-C-N 120.412 -1.43 . . . . 100.0 108.217 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.681 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 1.1 t70 -58.33 -43.59 88.32 Favored 'General case' 0 CA--C 1.473 -1.984 0 CA-C-O 117.178 -1.391 . . . . 100.0 112.507 176.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.432 HD13 ' HG2' ' A' ' 205' ' ' GLN . 4.5 mp . . . . . 0 N--CA 1.426 -1.666 0 CA-C-O 114.292 -2.766 . . . . 100.0 111.927 -177.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -1.012 0 N-CA-C 111.301 0.111 . . . . 100.0 111.301 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.98 -41.25 97.81 Favored 'General case' 0 N--CA 1.441 -0.922 0 C-N-CA 124.704 1.202 . . . . 100.0 112.873 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -96.87 150.22 20.98 Favored 'General case' 0 CA--C 1.498 -1.049 0 CA-C-O 121.092 0.472 . . . . 100.0 111.268 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -86.17 160.41 19.22 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 109.207 -0.664 . . . . 100.0 109.207 178.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.97 3.01 88.16 Favored Glycine 0 C--N 1.353 1.523 0 CA-C-O 119.599 -0.556 . . . . 100.0 112.834 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -76.98 158.94 79.58 Favored Pre-proline 0 N--CA 1.441 -0.901 0 C-N-CA 123.854 0.862 . . . . 100.0 109.471 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.64 156.37 53.17 Favored 'Trans proline' 0 C--N 1.375 1.935 0 C-N-CA 123.485 2.79 . . . . 100.0 111.166 179.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -52.87 131.61 35.84 Favored 'General case' 0 C--N 1.357 0.925 0 C-N-CA 124.664 1.186 . . . . 100.0 113.442 -177.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 73.1 t -92.64 117.98 37.21 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.248 0 N-CA-C 106.489 -1.671 . . . . 100.0 106.489 -178.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -124.76 133.94 52.97 Favored 'General case' 0 N--CA 1.43 -1.428 0 CA-C-N 113.638 -1.619 . . . . 100.0 107.916 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -121.22 141.91 50.41 Favored 'General case' 0 CA--C 1.493 -1.244 0 N-CA-C 107.744 -1.206 . . . . 100.0 107.744 179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -93.01 118.49 31.24 Favored 'General case' 0 N--CA 1.429 -1.48 0 N-CA-C 107.349 -1.352 . . . . 100.0 107.349 179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.548 HD23 HG22 ' A' ' 63' ' ' VAL . 55.9 tp -106.92 125.66 51.3 Favored 'General case' 0 N--CA 1.425 -1.725 0 CA-C-N 113.008 -1.905 . . . . 100.0 106.955 -179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.422 HG13 ' CE2' ' A' ' 79' ' ' TYR . 55.3 t -102.39 121.86 53.98 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.193 0 N-CA-C 106.23 -1.767 . . . . 100.0 106.23 178.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.414 HD11 ' HE3' ' A' ' 89' ' ' MET . 3.3 tt -113.68 117.95 33.0 Favored 'General case' 0 N--CA 1.429 -1.501 0 N-CA-C 104.628 -2.36 . . . . 100.0 104.628 -179.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.6 m -127.58 162.87 32.22 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.092 0 CA-C-N 115.847 -0.615 . . . . 100.0 112.307 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.78 175.26 28.5 Favored Glycine 0 CA--C 1.493 -1.312 0 N-CA-C 108.569 -1.812 . . . . 100.0 108.569 178.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 88.5 m-20 -71.71 156.1 39.73 Favored 'General case' 0 CA--C 1.499 -0.987 0 O-C-N 121.777 -0.837 . . . . 100.0 111.786 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -66.0 141.07 40.98 Favored Glycine 0 C--N 1.354 1.551 0 N-CA-C 107.423 -2.271 . . . . 100.0 107.423 178.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.41 -5.43 80.63 Favored Glycine 0 C--N 1.349 1.288 0 CA-C-O 118.924 -0.931 . . . . 100.0 113.884 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 74.8 m -62.85 -40.03 96.2 Favored 'General case' 0 C--N 1.358 0.95 0 CA-C-N 118.618 1.209 . . . . 100.0 111.145 179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.79 24.64 5.16 Favored Glycine 0 C--N 1.353 1.516 0 N-CA-C 110.22 -1.152 . . . . 100.0 110.22 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' HE2' ' HB3' ' A' ' 23' ' ' LYS . 52.3 mtpt -60.24 -46.22 90.53 Favored 'General case' 0 N--CA 1.44 -0.942 0 C-N-CA 125.363 1.465 . . . . 100.0 111.98 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.6 m -62.9 -43.76 97.92 Favored 'General case' 0 N--CA 1.436 -1.167 0 C-N-CA 124.864 1.265 . . . . 100.0 109.622 -178.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 39.4 m -63.15 -41.64 99.3 Favored 'General case' 0 C--N 1.356 0.863 0 C-N-CA 124.421 1.088 . . . . 100.0 109.28 -179.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' HA ' HH11 ' A' ' 29' ' ' ARG . 60.6 t80 -60.62 -48.77 80.32 Favored 'General case' 0 C--N 1.362 1.144 0 C-N-CA 122.868 0.467 . . . . 100.0 111.625 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.438 HG22 HG11 ' A' ' 63' ' ' VAL . 98.3 t -64.02 -42.64 96.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.702 0 C-N-CA 123.672 0.789 . . . . 100.0 110.664 -177.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . 0.263 99.5 mttt -70.44 -6.39 35.46 Favored 'General case' 0 N--CA 1.435 -1.176 0 N-CA-C 115.718 1.747 . . . . 100.0 115.718 -177.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.591 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 80.7 mtm-85 -61.32 -36.57 80.49 Favored 'General case' 0 C--N 1.362 1.118 0 CA-C-O 118.884 -0.579 . . . . 100.0 110.069 177.4 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.452 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 44.8 t-80 -79.98 113.79 18.41 Favored 'General case' 0 C--N 1.36 1.034 0 N-CA-C 107.128 -1.434 . . . . 100.0 107.128 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.2 mt -62.23 -43.91 97.76 Favored 'General case' 0 CA--C 1.499 -1.005 0 N-CA-C 114.888 1.44 . . . . 100.0 114.888 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.452 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 79.8 m -64.11 -39.87 94.97 Favored 'General case' 0 C--N 1.355 0.811 0 N-CA-C 108.694 -0.854 . . . . 100.0 108.694 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.27 -42.44 99.78 Favored Glycine 0 C--N 1.361 1.938 0 N-CA-C 110.409 -1.076 . . . . 100.0 110.409 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -62.89 -45.33 93.06 Favored 'General case' 0 C--N 1.361 1.106 0 CA-C-N 117.56 0.68 . . . . 100.0 111.536 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 20.0 m-30 -62.5 -40.92 98.26 Favored 'General case' 0 CA--C 1.5 -0.977 0 C-N-CA 123.996 0.919 . . . . 100.0 112.236 -178.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -90.56 6.36 43.97 Favored 'General case' 0 N--CA 1.434 -1.227 0 N-CA-C 114.988 1.477 . . . . 100.0 114.988 -177.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -61.06 140.61 57.82 Favored 'General case' 0 C--N 1.364 1.209 0 N-CA-C 115.352 1.612 . . . . 100.0 115.352 -178.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -121.07 133.59 55.24 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 107.108 -1.441 . . . . 100.0 107.108 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -103.32 124.63 49.03 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 106.331 -1.729 . . . . 100.0 106.331 179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 88.4 t -97.56 109.73 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 100.641 -3.836 . . . . 100.0 100.641 179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.73 -45.55 92.22 Favored 'General case' 0 CA--C 1.494 -1.202 0 N-CA-C 116.669 2.1 . . . . 100.0 116.669 -177.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 96.9 m -63.13 -48.55 78.02 Favored 'General case' 0 C--N 1.355 0.843 0 O-C-N 123.37 0.419 . . . . 100.0 110.438 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.3 mt -70.35 -36.1 74.0 Favored 'General case' 0 N--CA 1.434 -1.257 0 N-CA-C 113.957 1.095 . . . . 100.0 113.957 179.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 75.24 40.45 33.92 Favored Glycine 0 C--N 1.358 1.777 0 N-CA-C 107.944 -2.062 . . . . 100.0 107.944 -177.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG21 ' HD1' ' A' ' 79' ' ' TYR . 41.0 t -127.72 141.81 45.37 Favored 'Isoleucine or valine' 0 C--N 1.357 0.918 0 C-N-CA 124.077 0.951 . . . . 100.0 109.141 -178.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -103.96 119.52 39.1 Favored 'General case' 0 N--CA 1.433 -1.324 0 N-CA-C 102.839 -3.022 . . . . 100.0 102.839 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.5 t -103.23 120.58 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.113 0 N-CA-C 105.696 -1.964 . . . . 100.0 105.696 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.1 m80 -113.22 119.21 42.73 Favored Pre-proline 0 N--CA 1.434 -1.245 0 N-CA-C 109.023 -0.732 . . . . 100.0 109.023 -178.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_exo -80.09 106.54 1.93 Allowed 'Trans proline' 0 N--CA 1.441 -1.572 0 C-N-CA 122.093 1.862 . . . . 100.0 109.62 179.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.0 mp -98.32 117.42 32.68 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 106.196 -1.779 . . . . 100.0 106.196 179.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 19.8 t -101.17 125.98 55.03 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.917 0 N-CA-C 106.876 -1.527 . . . . 100.0 106.876 -177.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -122.41 133.25 54.63 Favored 'General case' 0 CA--C 1.494 -1.181 0 N-CA-C 105.782 -1.933 . . . . 100.0 105.782 178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 68.7 t60 -100.66 119.19 38.21 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 108.176 -1.046 . . . . 100.0 108.176 -179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.461 HG21 HD12 ' A' ' 59' ' ' ILE . 20.6 p -108.48 178.69 4.41 Favored 'General case' 0 N--CA 1.436 -1.152 0 CA-C-N 114.875 -1.057 . . . . 100.0 110.874 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -59.83 -44.44 94.06 Favored 'General case' 0 C--N 1.359 1.012 0 C-N-CA 125.424 1.489 . . . . 100.0 108.255 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.2 mtt-85 -67.23 -37.96 84.42 Favored 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 125.308 1.443 . . . . 100.0 112.792 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 148.25 -172.56 28.48 Favored Glycine 0 C--N 1.351 1.396 0 N-CA-C 108.988 -1.645 . . . . 100.0 108.988 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -64.97 136.73 49.77 Favored 'Trans proline' 0 N--CA 1.445 -1.361 0 C-N-CA 122.674 2.25 . . . . 100.0 113.953 179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.461 HD12 HG21 ' A' ' 54' ' ' THR . 79.8 mt -127.58 129.75 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.988 0 N-CA-C 102.659 -3.089 . . . . 100.0 102.659 177.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -110.32 129.66 55.7 Favored 'General case' 0 N--CA 1.433 -1.298 0 N-CA-C 108.646 -0.872 . . . . 100.0 108.646 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -109.82 116.61 31.97 Favored 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 103.177 -2.897 . . . . 100.0 103.177 176.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.9 m120 -87.42 107.7 18.66 Favored 'General case' 0 CA--C 1.491 -1.315 1 N-CA-C 99.338 -4.319 . . . . 100.0 99.338 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.548 HG22 HD23 ' A' ' 13' ' ' LEU . 26.8 t -93.2 121.28 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.458 0 N-CA-C 106.069 -1.826 . . . . 100.0 106.069 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -93.57 109.88 21.49 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 104.797 -2.298 . . . . 100.0 104.797 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -114.22 136.6 52.77 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 106.035 -1.839 . . . . 100.0 106.035 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 82.2 p -72.95 162.2 29.78 Favored 'General case' 0 N--CA 1.437 -1.108 0 N-CA-C 113.378 0.881 . . . . 100.0 113.378 -178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.57 16.22 19.44 Favored 'General case' 0 N--CA 1.438 -1.034 0 CA-C-N 115.325 -0.852 . . . . 100.0 109.789 179.38 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 97.67 11.3 51.14 Favored Glycine 0 C--N 1.357 1.74 0 O-C-N 121.846 -0.534 . . . . 100.0 112.409 -179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -60.28 -33.78 72.82 Favored 'General case' 0 C--N 1.354 0.801 0 C-N-CA 126.871 2.069 . . . . 100.0 111.152 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.405 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 59.8 mt-10 -57.89 -36.68 72.74 Favored 'General case' 0 N--CA 1.44 -0.934 0 C-N-CA 127.566 2.346 . . . . 100.0 112.154 -178.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -62.36 -43.53 98.6 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 123.13 0.572 . . . . 100.0 109.792 178.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -70.6 -41.68 72.0 Favored 'General case' 0 N--CA 1.439 -0.987 0 C-N-CA 125.216 1.406 . . . . 100.0 113.539 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.77 -155.2 13.51 Favored Glycine 0 C--N 1.358 1.793 0 C-N-CA 121.363 -0.446 . . . . 100.0 112.071 -178.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.0 171.66 52.16 Favored Glycine 0 C--N 1.356 1.68 0 C-N-CA 123.764 0.697 . . . . 100.0 111.982 -179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 95.8 mt -104.97 143.12 33.61 Favored 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 122.173 0.987 . . . . 100.0 111.128 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -65.16 150.48 48.1 Favored 'General case' 0 N--CA 1.43 -1.45 0 CA-C-N 113.441 -1.708 . . . . 100.0 113.14 -178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -61.43 -37.92 85.26 Favored 'General case' 0 CA--C 1.496 -1.128 0 CA-C-N 114.029 -1.441 . . . . 100.0 109.53 178.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.99 -39.35 94.11 Favored Glycine 0 C--N 1.36 1.874 0 C-N-CA 124.728 1.156 . . . . 100.0 111.07 -179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.437 ' HD1' HG21 ' A' ' 45' ' ' VAL . 64.0 t80 -62.44 -46.83 86.77 Favored 'General case' 0 N--CA 1.439 -0.984 0 C-N-CA 123.899 0.88 . . . . 100.0 111.279 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -69.03 -37.21 78.49 Favored 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 115.671 1.73 . . . . 100.0 115.671 -179.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 62.8 mt -53.87 139.29 12.43 Favored 'Isoleucine or valine' 0 C--N 1.358 0.938 0 C-N-CA 125.178 1.391 . . . . 100.0 113.232 -176.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 78.0 mt-30 66.93 22.17 10.18 Favored 'General case' 0 C--N 1.362 1.119 0 C-N-CA 127.544 2.338 . . . . 100.0 113.182 -178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.61 128.99 37.61 Favored 'General case' 0 CA--C 1.493 -1.23 0 N-CA-C 107.293 -1.373 . . . . 100.0 107.293 178.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 95.7 mm-40 -95.54 -37.68 10.77 Favored 'General case' 0 N--CA 1.434 -1.268 0 N-CA-C 106.471 -1.677 . . . . 100.0 106.471 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.681 ' HB2' HD22 ' A' ' 164' ' ' LEU . 24.3 p -144.6 161.57 38.8 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-O 120.681 0.277 . . . . 100.0 111.271 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' CB ' HD21 ' A' ' 108' ' ' LEU . . . -145.34 150.16 36.09 Favored 'General case' 0 CA--C 1.489 -1.375 0 N-CA-C 115.176 1.547 . . . . 100.0 115.176 179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.535 HG21 ' HE2' ' A' ' 89' ' ' MET . 97.4 mt -125.54 126.13 69.9 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.241 0 N-CA-C 103.851 -2.648 . . . . 100.0 103.851 176.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 57.5 mt -111.03 124.17 67.6 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.251 0 N-CA-C 102.944 -2.984 . . . . 100.0 102.944 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.535 ' HE2' HG21 ' A' ' 87' ' ' ILE . 38.9 mtt -110.89 135.51 51.32 Favored 'General case' 0 N--CA 1.417 -2.095 0 CA-C-N 114.268 -1.333 . . . . 100.0 114.549 -178.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 53.8 p90 -129.23 159.41 36.17 Favored 'General case' 0 N--CA 1.429 -1.515 0 CA-C-N 111.583 -2.553 . . . . 100.0 108.33 177.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.6 t0 -103.78 126.61 51.03 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.291 -1.744 . . . . 100.0 106.291 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.402 ' HB ' ' HG3' ' A' ' 129' ' ' ARG . 17.1 m -64.68 -21.28 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 N-CA-C 113.857 1.058 . . . . 100.0 113.857 -179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.6 p -88.33 -10.31 49.88 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 119.193 -0.432 . . . . 100.0 110.961 178.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.3 t -116.93 114.99 24.63 Favored 'General case' 0 N--CA 1.436 -1.147 0 CA-C-O 122.755 1.264 . . . . 100.0 110.193 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 88.8 mtm-85 -65.93 -39.48 90.56 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.408 1.483 . . . . 100.0 109.815 178.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 87.7 t -60.97 -41.84 90.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 C-N-CA 126.221 1.808 . . . . 100.0 110.777 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 80.1 m -62.74 -42.46 99.68 Favored 'General case' 0 C--N 1.356 0.891 0 CA-C-N 118.089 0.404 . . . . 100.0 109.93 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.456 ' CE1' HG23 ' A' ' 136' ' ' ILE . 45.7 t80 -63.93 -41.0 97.75 Favored 'General case' 0 C--N 1.363 1.162 0 C-N-CA 123.691 0.796 . . . . 100.0 110.767 177.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.523 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 96.9 mttt -60.83 -38.55 85.87 Favored 'General case' 0 C--N 1.353 0.74 0 C-N-CA 123.763 0.825 . . . . 100.0 110.515 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 76.4 m-20 -75.36 -9.78 58.87 Favored 'General case' 0 C--N 1.355 0.845 0 N-CA-C 115.129 1.529 . . . . 100.0 115.129 179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.9 t -59.71 -43.4 95.21 Favored Pre-proline 0 C--N 1.364 1.222 0 CA-C-O 115.93 -1.986 . . . . 100.0 111.529 -179.594 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.2 Cg_exo -57.4 -36.23 98.84 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 122.242 1.961 . . . . 100.0 112.93 177.656 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -62.91 -47.08 84.82 Favored 'General case' 0 C--N 1.357 0.935 0 C-N-CA 124.951 1.3 . . . . 100.0 110.115 179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -63.87 -42.64 97.47 Favored 'General case' 0 CA--C 1.492 -1.258 0 C-N-CA 123.837 0.855 . . . . 100.0 111.161 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . 0.451 ' CE1' HD11 ' A' ' 144' ' ' LEU . 85.7 t60 -62.45 -44.29 96.76 Favored 'General case' 0 N--CA 1.431 -1.397 0 C-N-CA 124.526 1.13 . . . . 100.0 110.265 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 94.0 mtm-85 -62.62 -45.3 93.49 Favored 'General case' 0 CA--C 1.491 -1.313 0 CA-C-O 118.697 -0.668 . . . . 100.0 111.661 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -62.41 -43.98 97.53 Favored 'General case' 0 C--N 1.357 0.924 0 O-C-N 123.481 0.488 . . . . 100.0 111.959 -179.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.465 HD21 ' CB ' ' A' ' 86' ' ' ALA . 46.5 tp -62.71 -46.54 87.67 Favored 'General case' 0 N--CA 1.435 -1.189 0 C-N-CA 124.466 1.106 . . . . 100.0 111.988 179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 79.7 t -64.59 -38.45 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.889 0 C-N-CA 125.376 1.47 . . . . 100.0 111.165 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -60.08 -46.32 89.96 Favored 'General case' 0 CA--C 1.502 -0.899 0 CA-C-O 119.017 -0.516 . . . . 100.0 110.286 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 75.0 t -71.86 -46.62 59.87 Favored 'Isoleucine or valine' 0 C--N 1.358 0.943 0 C-N-CA 120.356 -0.538 . . . . 100.0 111.796 179.045 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 73.9 m -127.07 114.03 17.21 Favored 'General case' 0 CA--C 1.494 -1.207 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 63.8 mt-10 -90.46 146.07 24.42 Favored 'General case' 0 CA--C 1.495 -1.166 0 CA-C-N 115.746 -0.661 . . . . 100.0 112.27 -178.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 75.2 m-20 53.75 43.3 31.23 Favored 'General case' 0 CA--C 1.502 -0.873 0 C-N-CA 126.39 1.876 . . . . 100.0 115.36 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . . . . . . . . . 45.5 pt -99.5 139.82 21.17 Favored Pre-proline 0 N--CA 1.438 -1.053 0 N-CA-C 105.953 -1.869 . . . . 100.0 105.953 178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.29 129.92 28.57 Favored 'Trans proline' 0 C--N 1.367 1.514 0 C-N-CA 122.608 2.206 . . . . 100.0 109.525 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.723 ' HB ' HD22 ' A' ' 144' ' ' LEU . 72.3 mt -130.64 135.89 59.43 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.097 0 CA-C-O 122.235 1.017 . . . . 100.0 108.777 -178.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 98.1 t -114.67 131.49 66.65 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 N-CA-C 105.594 -2.002 . . . . 100.0 105.594 178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.533 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 20.5 mt -106.04 126.56 52.35 Favored 'General case' 0 N--CA 1.433 -1.289 0 N-CA-C 103.274 -2.861 . . . . 100.0 103.274 175.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.47 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 73.8 m -114.57 127.85 56.01 Favored 'General case' 0 N--CA 1.428 -1.549 0 CA-C-N 113.98 -1.464 . . . . 100.0 112.008 -178.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -97.73 104.02 2.93 Favored Glycine 0 CA--C 1.49 -1.492 0 N-CA-C 105.726 -2.95 . . . . 100.0 105.726 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . 0.471 HD22 ' N ' ' A' ' 122' ' ' ASN . 1.1 m-80 -78.95 163.89 24.86 Favored 'General case' 0 CA--C 1.491 -1.314 0 C-N-CA 127.823 2.449 . . . . 100.0 112.069 -178.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 55.58 45.48 24.77 Favored 'General case' 0 N--CA 1.434 -1.269 0 C-N-CA 127.921 2.488 . . . . 100.0 115.556 177.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.333 33.1 m -72.29 -7.5 9.64 Favored 'Isoleucine or valine' 0 C--N 1.363 1.157 0 C-N-CA 120.069 -0.652 . . . . 100.0 111.109 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -61.46 -38.96 89.13 Favored 'General case' 0 C--N 1.362 1.135 0 C-N-CA 127.029 2.131 . . . . 100.0 109.932 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 86.3 mt -68.96 130.64 34.05 Favored 'Isoleucine or valine' 0 C--N 1.362 1.144 0 N-CA-C 107.069 -1.456 . . . . 100.0 107.069 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -62.29 -41.19 98.3 Favored 'General case' 0 CA--C 1.493 -1.248 0 N-CA-C 116.323 1.972 . . . . 100.0 116.323 -177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -87.5 100.47 12.79 Favored 'General case' 0 N--CA 1.439 -1.002 0 N-CA-C 105.109 -2.182 . . . . 100.0 105.109 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.402 ' HG3' ' HB ' ' A' ' 92' ' ' VAL . 79.1 ttt180 -96.67 121.35 38.41 Favored 'General case' 0 N--CA 1.434 -1.256 0 N-CA-C 102.392 -3.188 . . . . 100.0 102.392 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -96.19 -36.02 11.09 Favored 'General case' 0 N--CA 1.435 -1.188 0 CA-C-N 115.744 -0.662 . . . . 100.0 112.363 -177.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.432 HG12 HD11 ' A' ' 136' ' ' ILE . 42.4 t -104.73 105.23 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.019 0 N-CA-C 101.707 -3.442 . . . . 100.0 101.707 -179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -101.87 177.71 4.82 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 113.951 1.093 . . . . 100.0 113.951 -177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.484 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.97 -35.51 73.31 Favored 'General case' 0 C--N 1.36 1.048 0 C-N-CA 127.082 2.153 . . . . 100.0 108.613 178.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.068 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 95.6 mttt -59.58 -37.05 77.48 Favored 'General case' 0 N--CA 1.421 -1.896 0 C-N-CA 128.395 2.678 . . . . 100.0 112.327 179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 97.3 p -104.34 -3.13 24.56 Favored 'General case' 0 N--CA 1.435 -1.218 0 N-CA-C 120.061 3.356 . . . . 100.0 120.061 -177.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.634 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 55.9 mt -95.75 94.34 4.2 Favored 'Isoleucine or valine' 0 C--N 1.361 1.072 0 C-N-CA 116.394 -2.122 . . . . 100.0 112.317 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.437 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -99.29 -5.3 9.3 Favored 'Isoleucine or valine' 0 C--N 1.351 0.631 0 N-CA-C 114.991 1.478 . . . . 100.0 114.991 -178.11 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -58.86 -36.73 75.08 Favored 'General case' 0 C--N 1.351 0.667 0 N-CA-C 115.418 1.636 . . . . 100.0 115.418 -174.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.591 ' CE1' ' HB2' ' A' ' 146' ' ' TYR . 93.9 m-70 -59.87 -39.57 85.72 Favored 'General case' 0 N--CA 1.431 -1.413 0 C-N-CA 125.994 1.718 . . . . 100.0 114.371 -177.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.567 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 47.1 ttp180 -58.95 -48.13 82.62 Favored 'General case' 0 CA--C 1.487 -1.471 0 C-N-CA 124.904 1.282 . . . . 100.0 112.442 -176.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -63.16 -41.3 99.23 Favored 'General case' 0 N--CA 1.429 -1.503 0 C-N-CA 125.039 1.336 . . . . 100.0 111.244 -178.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -98.59 1.54 46.52 Favored 'General case' 0 N--CA 1.434 -1.255 0 N-CA-C 116.338 1.977 . . . . 100.0 116.338 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 54.9 45.82 25.71 Favored 'General case' 0 C--N 1.362 1.131 0 C-N-CA 125.079 1.351 . . . . 100.0 113.198 -178.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' A' ' 117' ' ' ILE . 32.1 mt -106.38 150.05 26.39 Favored 'General case' 0 CA--C 1.497 -1.081 0 N-CA-C 105.863 -1.903 . . . . 100.0 105.863 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . 0.315 89.2 mm-40 -100.97 143.9 30.56 Favored 'General case' 0 CA--C 1.486 -1.486 0 C-N-CA 119.588 -0.845 . . . . 100.0 112.518 178.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.591 ' HB2' ' CE1' ' A' ' 139' ' ' HIS . 69.5 t80 -102.03 132.94 47.58 Favored 'General case' 0 CA--C 1.486 -1.501 0 N-CA-C 113.591 0.96 . . . . 100.0 113.591 -178.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -130.81 132.89 45.51 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-N 114.41 -1.268 . . . . 100.0 111.038 174.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.278 38.0 m-20 -84.58 122.13 28.6 Favored 'General case' 0 CA--C 1.497 -1.086 0 N-CA-C 103.152 -2.907 . . . . 100.0 103.152 177.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 2.4 pp -132.28 156.6 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 CA-C-O 122.644 1.211 . . . . 100.0 110.999 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.547 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 74.5 m -138.6 110.63 7.27 Favored 'General case' 0 CA--C 1.476 -1.882 0 N-CA-C 105.698 -1.964 . . . . 100.0 105.698 176.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.591 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -62.76 -44.06 97.17 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.651 -1.613 . . . . 100.0 112.909 -179.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.87 -41.46 99.39 Favored 'General case' 0 N--CA 1.432 -1.373 0 C-N-CA 123.955 0.902 . . . . 100.0 112.425 -178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.465 ' HA ' ' HB3' ' A' ' 185' ' ' PRO . 87.5 p -96.82 3.42 52.25 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 117.75 2.5 . . . . 100.0 117.75 -177.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.602 HD22 ' HG3' ' A' ' 185' ' ' PRO . 71.6 m-80 65.45 21.17 11.83 Favored 'General case' 0 C--N 1.364 1.239 0 C-N-CA 124.451 1.101 . . . . 100.0 110.806 -177.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.4 t80 -75.26 124.87 27.84 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 109.02 -0.733 . . . . 100.0 109.02 -177.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 52.84 40.21 30.31 Favored 'General case' 0 N--CA 1.437 -1.103 0 C-N-CA 128.355 2.662 . . . . 100.0 115.364 179.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.442 ' HB2' HH21 ' A' ' 29' ' ' ARG . 78.9 t80 -62.65 -43.23 99.32 Favored 'General case' 0 C--N 1.356 0.875 0 O-C-N 121.863 -0.523 . . . . 100.0 110.735 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -62.97 -39.19 93.94 Favored 'General case' 0 N--CA 1.435 -1.217 0 N-CA-C 115.996 1.85 . . . . 100.0 115.996 -178.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -57.94 -47.45 98.86 Favored Pre-proline 0 C--N 1.356 0.862 0 N-CA-C 119.839 3.274 . . . . 100.0 119.839 -173.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.94 -42.16 39.36 Favored 'Trans proline' 0 C--N 1.375 1.94 0 CA-C-N 123.31 2.218 . . . . 100.0 111.222 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -64.05 -42.4 97.04 Favored 'General case' 0 CA--C 1.49 -1.334 0 C-N-CA 125.353 1.461 . . . . 100.0 111.614 -179.335 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 29.4 mt -61.19 -47.02 88.07 Favored 'General case' 0 CA--C 1.485 -1.538 0 C-N-CA 123.462 0.705 . . . . 100.0 111.722 178.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.1 t90 -63.25 -44.39 95.3 Favored 'General case' 0 C--N 1.359 0.998 0 O-C-N 124.011 0.819 . . . . 100.0 110.46 -178.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.681 HD22 ' HB2' ' A' ' 85' ' ' CYS . 72.8 mt -61.69 -45.42 94.08 Favored 'General case' 0 CA--C 1.495 -1.171 0 O-C-N 123.752 0.657 . . . . 100.0 111.252 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.97 -43.47 98.77 Favored 'General case' 0 CA--C 1.495 -1.157 0 C-N-CA 124.115 0.966 . . . . 100.0 111.555 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 93.7 mtt180 -62.05 -46.05 90.83 Favored 'General case' 0 CA--C 1.491 -1.32 0 C-N-CA 123.672 0.789 . . . . 100.0 111.402 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -65.52 -44.28 87.43 Favored 'General case' 0 CA--C 1.494 -1.19 0 N-CA-C 113.498 0.925 . . . . 100.0 113.498 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . . . . . . . . . 86.2 mt -63.63 -46.86 83.76 Favored 'General case' 0 CA--C 1.498 -1.034 0 C-N-CA 123.427 0.691 . . . . 100.0 112.351 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 87.8 mt -70.4 -38.74 75.05 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 123.309 0.644 . . . . 100.0 110.688 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 95.28 9.53 57.92 Favored Glycine 0 N--CA 1.434 -1.481 0 CA-C-O 118.899 -0.945 . . . . 100.0 111.139 -178.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 53.5 t0 -111.03 112.9 55.19 Favored Pre-proline 0 C--N 1.361 1.076 0 N-CA-C 107.692 -1.225 . . . . 100.0 107.692 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -72.14 -14.93 28.94 Favored 'Trans proline' 0 C--N 1.364 1.356 0 C-N-CA 123.72 2.946 . . . . 100.0 113.968 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -92.51 5.18 51.77 Favored 'General case' 0 CA--C 1.504 -0.822 0 N-CA-C 112.908 0.707 . . . . 100.0 112.908 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 22.0 tp -65.75 131.8 47.19 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 123.362 0.665 . . . . 100.0 109.299 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -135.21 152.62 51.73 Favored 'General case' 0 CA--C 1.496 -1.12 0 N-CA-C 109.299 -0.63 . . . . 100.0 109.299 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 17.2 m-30 -88.11 115.07 25.34 Favored 'General case' 0 C--N 1.36 1.061 0 N-CA-C 104.843 -2.281 . . . . 100.0 104.843 178.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 87.3 t -65.34 -45.04 94.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 C-N-CA 124.071 0.948 . . . . 100.0 110.299 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -128.14 151.4 49.27 Favored 'General case' 0 CA--C 1.488 -1.423 0 CA-C-O 121.274 0.559 . . . . 100.0 109.734 -178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 64.2 ttp -96.63 127.42 39.67 Favored Pre-proline 0 N--CA 1.43 -1.447 0 N-CA-C 105.322 -2.103 . . . . 100.0 105.322 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -66.14 159.05 51.49 Favored 'Trans proline' 0 N--CA 1.444 -1.403 0 C-N-CA 123.127 2.551 . . . . 100.0 111.571 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -64.56 126.37 27.67 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-O 122.02 0.914 . . . . 100.0 108.562 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 89.3 mt -120.78 145.91 47.06 Favored 'General case' 0 N--CA 1.427 -1.588 0 CA-C-N 114.163 -1.38 . . . . 100.0 108.979 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.74 138.42 97.38 Favored Pre-proline 0 N--CA 1.438 -1.034 0 N-CA-C 107.657 -1.238 . . . . 100.0 107.657 179.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . 0.498 ' HA ' ' HD3' ' A' ' 185' ' ' PRO . 51.7 Cg_exo -56.97 140.4 92.26 Favored 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 123.36 2.707 . . . . 100.0 112.377 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.602 ' HG3' HD22 ' A' ' 154' ' ' ASN . 39.3 Cg_exo -58.5 131.31 41.88 Favored 'Trans proline' 0 N--CA 1.441 -1.581 0 C-N-CA 123.413 2.742 . . . . 100.0 114.079 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -66.94 -44.66 80.06 Favored 'General case' 0 N--CA 1.442 -0.874 0 O-C-N 124.599 1.187 . . . . 100.0 107.961 177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 31.2 m -133.19 158.4 43.08 Favored 'Isoleucine or valine' 0 C--N 1.356 0.855 0 N-CA-C 106.458 -1.682 . . . . 100.0 106.458 178.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.5 t -100.6 130.72 49.44 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.93 0 N-CA-C 105.919 -1.882 . . . . 100.0 105.919 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 28.1 ttt -87.36 127.4 35.2 Favored 'General case' 0 N--CA 1.435 -1.223 0 N-CA-C 105.382 -2.081 . . . . 100.0 105.382 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.435 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 55.4 m-20 -62.91 130.56 94.09 Favored Pre-proline 0 N--CA 1.435 -1.175 0 CA-C-N 115.16 -0.927 . . . . 100.0 111.005 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 54.0 Cg_exo -58.68 -36.74 96.75 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 123.874 3.049 . . . . 100.0 112.579 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.36 96.35 Favored 'General case' 0 C--N 1.358 0.946 0 O-C-N 124.42 1.075 . . . . 100.0 110.447 179.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.9 mt -63.66 -42.78 98.04 Favored 'General case' 0 CA--C 1.495 -1.138 0 C-N-CA 123.115 0.566 . . . . 100.0 111.288 179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.38 -44.14 97.67 Favored 'General case' 0 CA--C 1.499 -0.995 0 C-N-CA 123.512 0.725 . . . . 100.0 110.634 -179.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.95 -43.5 98.61 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 123.87 0.868 . . . . 100.0 110.654 179.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 73.2 tp60 -61.94 -45.83 91.96 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 124.3 1.04 . . . . 100.0 111.986 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -64.0 -44.63 92.05 Favored 'General case' 0 CA--C 1.499 -0.981 0 N-CA-C 112.209 0.448 . . . . 100.0 112.209 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.41 -39.91 94.76 Favored 'General case' 0 C--N 1.357 0.92 0 O-C-N 123.353 0.408 . . . . 100.0 111.053 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 85.2 t60 -62.69 -43.77 97.96 Favored 'General case' 0 C--N 1.355 0.837 0 C-N-CA 124.883 1.273 . . . . 100.0 110.829 178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -62.08 -42.53 99.3 Favored 'General case' 0 C--N 1.36 1.026 0 C-N-CA 124.158 0.983 . . . . 100.0 110.106 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.5 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.4 tp -59.8 -49.43 77.75 Favored 'General case' 0 C--N 1.361 1.09 0 O-C-N 124.317 1.01 . . . . 100.0 109.861 178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -64.48 -41.51 96.44 Favored 'General case' 0 CA--C 1.491 -1.304 0 N-CA-C 115.805 1.78 . . . . 100.0 115.805 -178.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 48.7 t -59.41 -47.06 91.99 Favored 'Isoleucine or valine' 0 CA--C 1.468 -2.178 0 CA-C-O 118.305 -0.855 . . . . 100.0 109.423 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.685 ' C ' ' HB3' ' A' ' 213' ' ' ASP 0.409 . . -93.97 0.76 56.22 Favored 'General case' 0 N--CA 1.405 -2.71 1 C-N-CA 109.659 -4.816 . . . . 100.0 114.495 179.694 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.783 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.29 61.2 mt-30 -57.27 -35.86 70.28 Favored 'General case' 0 CA--C 1.462 -2.42 0 N-CA-C 106.94 -1.504 . . . . 100.0 106.94 178.169 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.8 p -82.82 53.88 2.53 Favored 'General case' 0 N--CA 1.434 -1.24 0 CA-C-O 122.487 1.137 . . . . 100.0 108.551 178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.304 80.4 p 48.66 38.91 12.43 Favored 'General case' 0 N--CA 1.429 -1.489 0 C-N-CA 129.507 3.123 . . . . 100.0 115.741 177.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.473 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.31 -177.43 6.74 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 104.638 -2.356 . . . . 100.0 104.638 176.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.414 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 79.8 mt -56.39 -41.58 91.86 Favored Pre-proline 0 CA--C 1.502 -0.884 0 CA-C-O 116.105 -1.902 . . . . 100.0 114.882 -174.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.068 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.307 41.8 Cg_exo -54.52 136.18 69.11 Favored 'Trans proline' 0 C--N 1.372 1.794 0 CA-C-N 121.112 1.433 . . . . 100.0 112.389 177.191 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.437 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 95.3 m-20 -63.63 -47.38 81.57 Favored 'General case' 0 N--CA 1.428 -1.572 1 N-CA-C 124.109 4.855 . . . . 100.0 124.109 -173.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.69 ' O ' ' HB3' ' A' ' 215' ' ' ASP 0.256 99.5 mt-10 -63.17 -35.17 79.41 Favored 'General case' 0 CA--C 1.477 -1.86 1 CA-C-O 128.562 4.03 . . . . 100.0 108.064 177.753 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.783 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.484 44.7 m-20 -66.57 -48.9 68.13 Favored 'General case' 1 N--CA 1.35 -5.473 1 CA-C-N 107.629 -4.351 . . . . 100.0 105.939 -178.624 . . . . . . . . 5 3 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.74 -25.43 67.93 Favored 'General case' 0 C--N 1.36 1.027 0 O-C-N 120.574 -1.329 . . . . 100.0 108.524 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.69 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.84 -42.8 90.18 Favored 'General case' 0 CA--C 1.473 -2.019 0 CA-C-O 117.238 -1.363 . . . . 100.0 112.571 175.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.479 HD13 ' HG2' ' A' ' 205' ' ' GLN . 2.9 mp . . . . . 0 N--CA 1.425 -1.71 0 CA-C-O 114.335 -2.745 . . . . 100.0 112.039 -176.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' HG2' HG21 ' A' ' 9' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.499 -0.989 0 N-CA-C 112.142 0.423 . . . . 100.0 112.142 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -61.95 -40.46 95.63 Favored 'General case' 0 N--CA 1.439 -1.0 0 C-N-CA 125.119 1.367 . . . . 100.0 113.221 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -107.23 149.65 27.5 Favored 'General case' 0 CA--C 1.496 -1.133 0 CA-C-O 121.539 0.685 . . . . 100.0 111.835 -178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 99.8 mm-40 -80.24 160.05 25.7 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 115.453 -0.794 . . . . 100.0 110.203 178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.89 -5.56 79.21 Favored Glycine 0 C--N 1.353 1.503 0 CA-C-O 119.458 -0.634 . . . . 100.0 112.097 -179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -73.29 154.21 90.23 Favored Pre-proline 0 N--CA 1.441 -0.898 0 C-N-CA 124.32 1.048 . . . . 100.0 110.357 179.075 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -66.24 161.62 39.63 Favored 'Trans proline' 0 C--N 1.37 1.702 0 C-N-CA 123.481 2.787 . . . . 100.0 111.707 178.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 98.6 mm-40 -52.26 132.16 33.56 Favored 'General case' 0 CA--C 1.494 -1.206 0 N-CA-C 114.492 1.293 . . . . 100.0 114.492 -177.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.478 HG21 ' HG2' ' A' ' 1' ' ' MET . 87.6 t -96.01 116.54 38.09 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.389 0 N-CA-C 105.532 -2.025 . . . . 100.0 105.532 -179.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -121.29 134.77 55.16 Favored 'General case' 0 N--CA 1.428 -1.565 0 CA-C-N 113.238 -1.801 . . . . 100.0 108.155 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -121.15 143.11 49.28 Favored 'General case' 0 N--CA 1.434 -1.242 0 N-CA-C 107.598 -1.26 . . . . 100.0 107.598 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.64 120.81 35.45 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 106.793 -1.558 . . . . 100.0 106.793 179.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.3 tt -109.21 127.65 54.41 Favored 'General case' 0 N--CA 1.42 -1.935 0 CA-C-N 112.913 -1.949 . . . . 100.0 107.107 -179.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.437 HG13 ' CE2' ' A' ' 79' ' ' TYR . 50.8 t -103.02 120.78 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.284 0 CA-C-N 113.714 -1.585 . . . . 100.0 106.892 178.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' HG ' ' HD2' ' A' ' 23' ' ' LYS . 48.5 tp -110.69 115.38 29.47 Favored 'General case' 0 N--CA 1.429 -1.493 0 N-CA-C 105.795 -1.928 . . . . 100.0 105.795 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 23.3 m -126.53 161.85 31.91 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.084 0 CA-C-N 115.741 -0.663 . . . . 100.0 111.992 -178.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.14 176.61 30.38 Favored Glycine 0 CA--C 1.492 -1.362 0 N-CA-C 108.341 -1.903 . . . . 100.0 108.341 178.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -72.67 157.27 37.85 Favored 'General case' 0 CA--C 1.498 -1.037 0 CA-C-O 121.621 0.724 . . . . 100.0 111.287 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -67.45 141.72 39.42 Favored Glycine 0 C--N 1.353 1.507 0 N-CA-C 107.109 -2.396 . . . . 100.0 107.109 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 91.06 -5.62 81.66 Favored Glycine 0 C--N 1.35 1.36 0 CA-C-O 119.079 -0.845 . . . . 100.0 113.62 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 93.5 m -63.04 -39.28 94.28 Favored 'General case' 0 C--N 1.358 0.96 0 CA-C-N 118.481 1.141 . . . . 100.0 111.204 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 111.49 23.9 5.53 Favored Glycine 0 C--N 1.353 1.485 0 N-CA-C 111.076 -0.81 . . . . 100.0 111.076 -179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.415 ' HD2' ' HG ' ' A' ' 15' ' ' LEU . 29.3 mtmt -61.71 -43.24 99.23 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 123.843 0.857 . . . . 100.0 111.902 -179.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.8 m -62.16 -44.19 97.17 Favored 'General case' 0 C--N 1.355 0.824 0 C-N-CA 124.681 1.193 . . . . 100.0 109.87 -179.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 51.2 m -63.08 -41.1 99.34 Favored 'General case' 0 C--N 1.358 0.943 0 C-N-CA 124.565 1.146 . . . . 100.0 108.826 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.527 ' HA ' HH11 ' A' ' 29' ' ' ARG . 50.0 t80 -59.75 -49.09 79.07 Favored 'General case' 0 CA--C 1.497 -1.084 0 C-N-CA 123.376 0.67 . . . . 100.0 112.676 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.03 -41.95 93.36 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 O-C-N 123.869 0.731 . . . . 100.0 110.561 -177.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -68.49 -8.43 40.93 Favored 'General case' 0 CA--C 1.491 -1.289 0 N-CA-C 115.757 1.762 . . . . 100.0 115.757 -177.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.568 ' HD3' ' O ' ' A' ' 151' ' ' ALA . 82.8 mtm-85 -61.36 -37.34 82.99 Favored 'General case' 0 N--CA 1.438 -1.047 0 N-CA-C 109.535 -0.542 . . . . 100.0 109.535 177.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' HIS . . . . . 0.454 ' CE1' ' HB ' ' A' ' 32' ' ' THR . 53.8 t-80 -80.23 112.35 17.46 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 106.516 -1.661 . . . . 100.0 106.516 -179.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.5 mt -62.49 -43.85 97.81 Favored 'General case' 0 CA--C 1.494 -1.176 0 N-CA-C 115.222 1.564 . . . . 100.0 115.222 -177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' HB ' ' CE1' ' A' ' 30' ' ' HIS . 85.2 m -63.02 -41.96 99.67 Favored 'General case' 0 C--N 1.355 0.815 0 C-N-CA 123.621 0.768 . . . . 100.0 108.934 -179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -61.66 -42.43 99.75 Favored Glycine 0 C--N 1.359 1.851 0 C-N-CA 123.855 0.741 . . . . 100.0 111.361 179.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -63.82 -43.75 95.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.023 0.529 . . . . 100.0 110.676 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.0 m-30 -64.05 -40.04 95.42 Favored 'General case' 0 N--CA 1.444 -0.73 0 C-N-CA 124.31 1.044 . . . . 100.0 112.349 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -90.42 7.02 40.82 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 114.422 1.267 . . . . 100.0 114.422 -178.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 60.1 pttt -58.81 140.23 55.35 Favored 'General case' 0 C--N 1.359 0.991 0 N-CA-C 115.215 1.561 . . . . 100.0 115.215 -177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -123.88 130.46 52.63 Favored 'General case' 0 N--CA 1.435 -1.203 0 N-CA-C 106.576 -1.639 . . . . 100.0 106.576 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -103.81 123.6 47.38 Favored 'General case' 0 N--CA 1.437 -1.124 0 N-CA-C 105.256 -2.127 . . . . 100.0 105.256 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 90.7 t -100.11 113.77 36.63 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 102.736 -3.061 . . . . 100.0 102.736 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -62.56 -45.2 94.01 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 115.842 1.793 . . . . 100.0 115.842 -178.183 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 65.0 p -62.59 -47.41 83.91 Favored 'General case' 0 C--N 1.357 0.915 0 C-N-CA 122.679 0.392 . . . . 100.0 111.723 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.06 -38.22 75.73 Favored 'General case' 0 N--CA 1.433 -1.285 0 C-N-CA 124.718 1.207 . . . . 100.0 112.987 178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.17 35.78 52.42 Favored Glycine 0 C--N 1.359 1.844 0 N-CA-C 106.625 -2.59 . . . . 100.0 106.625 -176.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.466 HG21 ' HD1' ' A' ' 79' ' ' TYR . 84.3 t -125.45 141.45 45.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.997 0 C-N-CA 124.766 1.227 . . . . 100.0 108.622 -177.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -106.56 117.36 33.85 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 102.571 -3.122 . . . . 100.0 102.571 179.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.3 t -101.74 122.25 53.7 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.191 0 N-CA-C 107.039 -1.467 . . . . 100.0 107.039 -177.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -116.63 120.69 34.09 Favored Pre-proline 0 N--CA 1.431 -1.412 0 CA-C-N 115.651 -0.704 . . . . 100.0 109.265 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_exo -79.97 105.62 1.82 Allowed 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.298 1.999 . . . . 100.0 109.415 178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.2 mp -97.08 116.75 29.85 Favored 'General case' 0 N--CA 1.436 -1.165 0 N-CA-C 106.636 -1.616 . . . . 100.0 106.636 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 21.9 t -100.65 126.82 54.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.949 0 N-CA-C 107.858 -1.164 . . . . 100.0 107.858 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -123.41 132.45 53.96 Favored 'General case' 0 CA--C 1.493 -1.238 0 N-CA-C 105.781 -1.933 . . . . 100.0 105.781 178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' HIS . . . . . . . . . . . . . 74.2 t60 -99.9 120.03 39.14 Favored 'General case' 0 CA--C 1.496 -1.105 0 N-CA-C 108.212 -1.033 . . . . 100.0 108.212 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 59' ' ' ILE . 23.3 p -109.44 -179.77 3.92 Favored 'General case' 0 N--CA 1.434 -1.267 0 CA-C-N 114.817 -1.083 . . . . 100.0 110.754 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -59.81 -44.11 94.16 Favored 'General case' 0 C--N 1.359 0.981 0 C-N-CA 125.576 1.55 . . . . 100.0 107.837 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.425 ' HD3' ' SD ' ' A' ' 1' ' ' MET . 91.6 mtt-85 -67.32 -39.19 85.83 Favored 'General case' 0 CA--C 1.502 -0.892 0 C-N-CA 124.901 1.28 . . . . 100.0 112.846 177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 147.83 -172.54 28.13 Favored Glycine 0 C--N 1.349 1.268 0 N-CA-C 108.068 -2.013 . . . . 100.0 108.068 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -65.27 137.28 50.95 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.628 2.219 . . . . 100.0 114.552 179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 HD12 HG21 ' A' ' 54' ' ' THR . 74.9 mt -127.34 130.42 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.068 0 N-CA-C 102.325 -3.213 . . . . 100.0 102.325 178.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 91.1 mttt -110.94 129.65 55.82 Favored 'General case' 0 CA--C 1.491 -1.297 0 N-CA-C 109.412 -0.588 . . . . 100.0 109.412 179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -111.31 115.27 29.04 Favored 'General case' 0 N--CA 1.43 -1.46 0 N-CA-C 104.174 -2.528 . . . . 100.0 104.174 177.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 74.6 m-80 -86.82 106.38 17.68 Favored 'General case' 0 CA--C 1.488 -1.411 0 N-CA-C 100.653 -3.832 . . . . 100.0 100.653 178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 78.7 t -92.77 122.4 44.22 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.5 0 N-CA-C 106.218 -1.771 . . . . 100.0 106.218 -177.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TRP . . . . . . . . . . . . . 22.5 m0 -98.04 114.78 27.03 Favored 'General case' 0 N--CA 1.421 -1.909 0 N-CA-C 106.116 -1.809 . . . . 100.0 106.116 -179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -112.63 135.68 53.08 Favored 'General case' 0 N--CA 1.433 -1.308 0 N-CA-C 106.531 -1.655 . . . . 100.0 106.531 -179.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.4 p -72.25 162.66 29.15 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 113.199 0.814 . . . . 100.0 113.199 -178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -95.43 14.76 21.53 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 115.316 -0.857 . . . . 100.0 110.033 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 99.21 12.36 42.55 Favored Glycine 0 C--N 1.358 1.769 0 O-C-N 121.78 -0.575 . . . . 100.0 112.037 -179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.458 ' HA ' ' CE2' ' A' ' 72' ' ' PHE . 67.8 mt-30 -60.16 -34.43 73.57 Favored 'General case' 0 C--N 1.356 0.869 0 C-N-CA 126.557 1.943 . . . . 100.0 111.625 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -57.9 -35.39 70.96 Favored 'General case' 0 CA--C 1.498 -1.038 0 C-N-CA 127.624 2.37 . . . . 100.0 112.406 -179.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -62.08 -40.9 97.4 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.474 0.71 . . . . 100.0 110.97 179.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . 0.458 ' CE2' ' HA ' ' A' ' 69' ' ' GLN . 15.0 p90 -92.05 -14.0 30.01 Favored 'General case' 0 C--N 1.362 1.111 0 N-CA-C 114.908 1.447 . . . . 100.0 114.908 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 176.93 -163.9 33.04 Favored Glycine 0 C--N 1.357 1.745 0 C-N-CA 119.464 -1.35 . . . . 100.0 113.432 -179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.51 172.57 54.64 Favored Glycine 0 C--N 1.353 1.484 0 N-CA-C 110.507 -1.037 . . . . 100.0 110.507 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.431 HD13 ' CE2' ' A' ' 79' ' ' TYR . 93.8 mt -104.25 142.32 34.75 Favored 'General case' 0 CA--C 1.485 -1.53 0 CA-C-O 121.836 0.827 . . . . 100.0 110.186 -179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 90.0 mtm180 -68.1 155.6 39.24 Favored 'General case' 0 N--CA 1.432 -1.326 0 CA-C-N 114.192 -1.367 . . . . 100.0 113.323 -178.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -60.56 -38.35 84.23 Favored 'General case' 0 CA--C 1.493 -1.244 0 C-N-CA 125.421 1.488 . . . . 100.0 110.415 -179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -58.91 -39.25 93.78 Favored Glycine 0 C--N 1.36 1.868 0 C-N-CA 124.673 1.13 . . . . 100.0 111.398 -179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.466 ' HD1' HG21 ' A' ' 45' ' ' VAL . 61.0 t80 -62.24 -46.65 87.87 Favored 'General case' 0 N--CA 1.439 -0.992 0 C-N-CA 123.605 0.762 . . . . 100.0 110.84 177.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 53.9 m-85 -68.94 -37.02 78.62 Favored 'General case' 0 N--CA 1.437 -1.118 0 N-CA-C 115.86 1.8 . . . . 100.0 115.86 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 61.9 mt -52.15 137.09 11.79 Favored 'Isoleucine or valine' 0 C--N 1.359 1.008 0 C-N-CA 125.396 1.478 . . . . 100.0 113.89 -176.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 64.27 26.26 13.68 Favored 'General case' 0 C--N 1.361 1.096 0 C-N-CA 127.999 2.52 . . . . 100.0 113.753 -178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . . . . . . . . . . . -71.91 128.76 36.76 Favored 'General case' 0 CA--C 1.494 -1.195 0 N-CA-C 106.993 -1.484 . . . . 100.0 106.993 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.437 ' O ' HG23 ' A' ' 115' ' ' ILE . 96.1 mm-40 -97.25 -37.54 10.03 Favored 'General case' 0 N--CA 1.433 -1.281 0 N-CA-C 107.558 -1.275 . . . . 100.0 107.558 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' CYS . . . . . 0.514 ' HB2' HD22 ' A' ' 164' ' ' LEU . 22.8 p -142.54 160.14 40.86 Favored 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 122.701 0.4 . . . . 100.0 110.988 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ALA . . . . . 0.465 ' HB3' HG12 ' A' ' 117' ' ' ILE . . . -145.61 149.13 33.97 Favored 'General case' 0 CA--C 1.487 -1.464 0 N-CA-C 114.202 1.186 . . . . 100.0 114.202 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . . . . . . . . . 81.5 mt -126.1 126.72 70.08 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.314 0 N-CA-C 103.379 -2.823 . . . . 100.0 103.379 176.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.464 ' HB ' HD22 ' A' ' 119' ' ' LEU . 51.5 mt -111.78 124.17 68.27 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.209 0 N-CA-C 102.947 -2.983 . . . . 100.0 102.947 178.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.426 ' HG2' ' HB2' ' A' ' 120' ' ' CYS . 42.8 mtt -109.47 135.28 50.74 Favored 'General case' 0 N--CA 1.417 -2.098 0 CA-C-N 114.183 -1.371 . . . . 100.0 114.603 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.2 p90 -127.74 158.35 37.87 Favored 'General case' 0 N--CA 1.424 -1.746 0 CA-C-N 111.763 -2.471 . . . . 100.0 108.088 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -103.93 126.56 51.14 Favored 'General case' 0 N--CA 1.432 -1.342 0 N-CA-C 105.879 -1.897 . . . . 100.0 105.879 -178.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 17.9 m -64.54 -21.94 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 N-CA-C 113.332 0.864 . . . . 100.0 113.332 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 59.8 p -86.99 -8.71 56.93 Favored 'General case' 0 N--CA 1.439 -1.025 0 CA-C-O 119.266 -0.397 . . . . 100.0 111.167 178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.5 t -120.38 115.34 23.32 Favored 'General case' 0 C--N 1.362 1.117 0 CA-C-O 122.34 1.067 . . . . 100.0 110.849 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -66.84 -38.23 86.01 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 114.895 -1.048 . . . . 100.0 111.383 178.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 91.6 t -60.79 -41.0 86.87 Favored 'Isoleucine or valine' 0 C--N 1.354 0.769 0 C-N-CA 125.787 1.635 . . . . 100.0 110.216 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 79.3 m -62.44 -42.59 99.57 Favored 'General case' 0 C--N 1.357 0.921 0 CA-C-N 118.147 0.43 . . . . 100.0 109.968 -179.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.547 ' CE1' HG23 ' A' ' 136' ' ' ILE . 35.8 t80 -63.12 -41.55 99.36 Favored 'General case' 0 C--N 1.362 1.129 0 C-N-CA 123.567 0.747 . . . . 100.0 110.801 177.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.521 ' O ' ' HD2' ' A' ' 102' ' ' PRO . 97.1 mttt -61.25 -37.44 83.11 Favored 'General case' 0 N--CA 1.444 -0.767 0 C-N-CA 124.259 1.024 . . . . 100.0 111.155 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 77.3 m-20 -76.96 -8.44 57.38 Favored 'General case' 0 C--N 1.355 0.822 0 N-CA-C 115.003 1.483 . . . . 100.0 115.003 178.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 69.9 t -59.66 -42.97 94.43 Favored Pre-proline 0 C--N 1.364 1.234 0 CA-C-O 116.013 -1.946 . . . . 100.0 111.49 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PRO . . . . . 0.521 ' HD2' ' O ' ' A' ' 99' ' ' LYS . 84.1 Cg_exo -57.56 -37.23 97.76 Favored 'Trans proline' 0 C--N 1.377 2.046 0 C-N-CA 122.074 1.849 . . . . 100.0 112.692 177.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -63.11 -46.33 87.82 Favored 'General case' 0 C--N 1.359 1.017 0 C-N-CA 124.366 1.067 . . . . 100.0 110.85 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -64.02 -41.82 97.33 Favored 'General case' 0 CA--C 1.495 -1.159 0 C-N-CA 123.25 0.62 . . . . 100.0 111.213 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 84.0 t60 -61.82 -44.92 95.88 Favored 'General case' 0 N--CA 1.434 -1.225 0 C-N-CA 124.239 1.016 . . . . 100.0 109.66 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -62.88 -43.74 97.98 Favored 'General case' 0 CA--C 1.497 -1.09 0 CA-C-O 118.805 -0.617 . . . . 100.0 112.462 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 82.6 m-20 -62.15 -45.33 93.92 Favored 'General case' 0 C--N 1.356 0.875 0 CA-C-O 121.251 0.548 . . . . 100.0 110.626 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.457 HD21 ' CB ' ' A' ' 86' ' ' ALA . 47.4 tp -62.81 -46.46 87.87 Favored 'General case' 0 N--CA 1.438 -1.047 0 C-N-CA 124.986 1.314 . . . . 100.0 112.647 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' VAL . . . . . . . . . . . . . 69.7 t -64.19 -38.5 82.63 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.121 0 C-N-CA 125.237 1.415 . . . . 100.0 111.218 -179.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 68.4 mtt85 -60.44 -46.38 90.27 Favored 'General case' 0 C--N 1.358 0.973 0 CA-C-O 118.833 -0.603 . . . . 100.0 110.797 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 63.2 t -71.75 -46.05 63.33 Favored 'Isoleucine or valine' 0 C--N 1.357 0.934 0 C-N-CA 120.238 -0.585 . . . . 100.0 111.502 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . . . . . . . . . 66.1 m -127.31 115.63 19.3 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 109.123 -0.695 . . . . 100.0 109.123 -179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 94.0 mt-10 -93.0 147.22 23.01 Favored 'General case' 0 CA--C 1.497 -1.075 0 CA-C-N 115.89 -0.596 . . . . 100.0 112.41 -177.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 66.7 m-20 54.37 45.66 26.7 Favored 'General case' 0 C--N 1.358 0.974 0 C-N-CA 126.394 1.877 . . . . 100.0 114.871 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.437 HG23 ' O ' ' A' ' 84' ' ' GLN . 34.0 mm -99.35 131.45 25.04 Favored Pre-proline 0 N--CA 1.436 -1.139 0 C-N-CA 126.125 1.77 . . . . 100.0 106.802 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -62.89 130.02 27.94 Favored 'Trans proline' 0 C--N 1.372 1.77 0 C-N-CA 122.601 2.2 . . . . 100.0 109.008 178.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 144' ' ' LEU . 67.6 mt -130.47 137.59 55.85 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 CA-C-O 122.369 1.081 . . . . 100.0 108.508 -178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' VAL . . . . . . . . . . . . . 95.5 t -114.79 130.75 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 105.265 -2.124 . . . . 100.0 105.265 178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.464 HD22 ' HB ' ' A' ' 88' ' ' ILE . 34.3 mt -104.97 125.24 50.75 Favored 'General case' 0 N--CA 1.428 -1.539 0 N-CA-C 104.079 -2.563 . . . . 100.0 104.079 176.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' CYS . . . . . 0.426 ' HB2' ' HG2' ' A' ' 89' ' ' MET . 71.0 m -115.32 128.26 55.98 Favored 'General case' 0 N--CA 1.427 -1.591 0 CA-C-N 113.853 -1.521 . . . . 100.0 112.301 -178.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLY . . . . . . . . . . . . . . . -98.26 103.98 2.88 Favored Glycine 0 CA--C 1.489 -1.571 0 N-CA-C 105.293 -3.123 . . . . 100.0 105.293 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 38.0 m-20 -80.71 166.5 20.97 Favored 'General case' 0 N--CA 1.436 -1.162 0 C-N-CA 125.798 1.639 . . . . 100.0 111.725 -179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 88.2 mttt 56.58 44.66 23.61 Favored 'General case' 0 N--CA 1.436 -1.159 0 C-N-CA 128.29 2.636 . . . . 100.0 115.416 178.406 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . 0.29 28.5 m -71.81 -9.33 12.76 Favored 'Isoleucine or valine' 0 C--N 1.36 1.05 0 C-N-CA 120.416 -0.514 . . . . 100.0 110.724 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -60.91 -38.85 87.16 Favored 'General case' 0 C--N 1.361 1.104 0 C-N-CA 127.186 2.194 . . . . 100.0 110.279 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 85.9 mt -69.55 129.88 34.08 Favored 'Isoleucine or valine' 0 C--N 1.359 1.013 0 N-CA-C 107.414 -1.328 . . . . 100.0 107.414 -179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -62.98 -40.07 96.61 Favored 'General case' 0 CA--C 1.492 -1.28 0 N-CA-C 116.54 2.052 . . . . 100.0 116.54 -178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -85.63 98.69 10.81 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 104.426 -2.435 . . . . 100.0 104.426 179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 79.5 ttt180 -100.72 109.36 21.38 Favored 'General case' 0 N--CA 1.432 -1.346 0 N-CA-C 105.384 -2.08 . . . . 100.0 105.384 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -73.18 -43.49 61.36 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 114.79 1.404 . . . . 100.0 114.79 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 HD11 ' A' ' 136' ' ' ILE . 48.0 t -108.49 108.54 25.55 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.05 0 N-CA-C 104.73 -2.322 . . . . 100.0 104.73 -176.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -104.01 179.73 4.19 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.189 -0.914 . . . . 100.0 113.422 -178.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.482 ' HA ' ' CD ' ' A' ' 212' ' ' GLU . . . -58.51 -35.16 71.82 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 127.154 2.182 . . . . 100.0 109.318 179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LYS . . . . . 1.07 ' HA ' ' HB3' ' A' ' 210' ' ' PRO . 96.2 mttt -59.45 -37.1 77.26 Favored 'General case' 0 N--CA 1.421 -1.889 0 C-N-CA 128.717 2.807 . . . . 100.0 112.017 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.3 p -105.01 -0.49 26.76 Favored 'General case' 0 N--CA 1.433 -1.288 0 N-CA-C 120.624 3.565 . . . . 100.0 120.624 -177.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . 0.622 ' HB ' ' CG ' ' A' ' 212' ' ' GLU . 54.3 mt -99.46 96.01 4.65 Favored 'Isoleucine or valine' 0 C--N 1.365 1.262 0 C-N-CA 115.372 -2.531 . . . . 100.0 111.346 -176.416 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.403 ' HB ' ' HB3' ' A' ' 211' ' ' ASP . 3.8 p -100.06 -6.77 9.14 Favored 'Isoleucine or valine' 0 C--N 1.352 0.693 0 N-CA-C 115.553 1.686 . . . . 100.0 115.553 -177.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . . . . . . . . . 66.4 t80 -58.79 -35.87 73.52 Favored 'General case' 0 CA--C 1.507 -0.703 0 N-CA-C 115.629 1.714 . . . . 100.0 115.629 -175.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.46 ' ND1' HD12 ' A' ' 119' ' ' LEU . 77.7 m-70 -59.63 -39.55 84.67 Favored 'General case' 0 N--CA 1.431 -1.381 0 C-N-CA 125.588 1.555 . . . . 100.0 112.578 -176.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.537 ' HB2' ' HA ' ' A' ' 215' ' ' ASP . 42.3 ttp180 -59.29 -47.08 86.71 Favored 'General case' 0 CA--C 1.488 -1.434 0 C-N-CA 125.108 1.363 . . . . 100.0 112.382 -177.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -62.04 -43.62 98.44 Favored 'General case' 0 N--CA 1.431 -1.404 0 C-N-CA 124.806 1.242 . . . . 100.0 111.469 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -97.64 2.32 49.71 Favored 'General case' 0 N--CA 1.433 -1.299 0 N-CA-C 116.213 1.931 . . . . 100.0 116.213 -177.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 54.6 47.42 22.67 Favored 'General case' 0 C--N 1.36 1.041 0 C-N-CA 125.296 1.438 . . . . 100.0 113.126 -179.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 117' ' ' ILE . 30.4 mt -107.22 149.63 27.52 Favored 'General case' 0 CA--C 1.501 -0.941 0 N-CA-C 106.245 -1.761 . . . . 100.0 106.245 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLN . . . . . . . . . . . . . 97.7 mm-40 -96.38 144.47 26.49 Favored 'General case' 0 CA--C 1.486 -1.489 0 C-N-CA 120.709 -0.397 . . . . 100.0 111.868 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.426 ' HB2' ' NE2' ' A' ' 139' ' ' HIS . 77.5 t80 -106.45 133.59 50.9 Favored 'General case' 0 CA--C 1.49 -1.356 0 O-C-N 123.766 0.666 . . . . 100.0 112.694 -178.756 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -130.01 132.41 46.24 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 114.184 -1.371 . . . . 100.0 110.416 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . 0.314 35.2 m-20 -85.15 122.73 29.77 Favored 'General case' 0 C--N 1.363 1.157 0 N-CA-C 102.054 -3.313 . . . . 100.0 102.054 177.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ILE . . . . . . . . . . . . . 37.7 pt -135.88 157.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 122.574 1.178 . . . . 100.0 112.037 179.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.474 ' HB2' ' HB3' ' A' ' 155' ' ' TYR . 61.9 m -137.34 112.87 9.39 Favored 'General case' 0 CA--C 1.476 -1.895 0 N-CA-C 106.168 -1.79 . . . . 100.0 106.168 176.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.568 ' O ' ' HD3' ' A' ' 29' ' ' ARG . . . -63.26 -43.88 96.71 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 113.735 -1.575 . . . . 100.0 112.772 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -62.83 -41.09 99.19 Favored 'General case' 0 N--CA 1.431 -1.378 0 C-N-CA 124.352 1.061 . . . . 100.0 112.098 -178.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.1 p -97.48 2.37 50.18 Favored 'General case' 0 N--CA 1.438 -1.043 0 N-CA-C 117.563 2.431 . . . . 100.0 117.563 -178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . . . . . . . . . 61.5 m-80 66.67 20.03 10.75 Favored 'General case' 0 C--N 1.365 1.259 0 C-N-CA 124.638 1.175 . . . . 100.0 110.846 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.474 ' HB3' ' HB2' ' A' ' 150' ' ' SER . 81.2 t80 -74.3 124.02 25.66 Favored 'General case' 0 N--CA 1.434 -1.266 0 N-CA-C 109.46 -0.571 . . . . 100.0 109.46 -178.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 53.11 39.79 30.16 Favored 'General case' 0 N--CA 1.441 -0.914 0 C-N-CA 128.709 2.804 . . . . 100.0 115.725 179.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.488 ' HB2' ' HE ' ' A' ' 29' ' ' ARG . 76.8 t80 -61.82 -44.89 95.94 Favored 'General case' 0 C--N 1.355 0.84 0 O-C-N 121.618 -0.676 . . . . 100.0 112.146 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -64.14 -37.27 86.86 Favored 'General case' 0 N--CA 1.432 -1.355 0 N-CA-C 116.87 2.174 . . . . 100.0 116.87 -178.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -57.74 -46.82 99.71 Favored Pre-proline 0 N--CA 1.442 -0.872 0 N-CA-C 119.166 3.024 . . . . 100.0 119.166 -174.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -60.7 -42.2 40.92 Favored 'Trans proline' 0 C--N 1.372 1.813 0 CA-C-N 123.204 2.18 . . . . 100.0 111.544 178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -64.24 -42.48 96.51 Favored 'General case' 0 CA--C 1.488 -1.421 0 C-N-CA 124.839 1.256 . . . . 100.0 111.76 -179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 66.6 tp -62.81 -45.38 92.89 Favored 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 123.775 0.83 . . . . 100.0 111.081 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' TRP . . . . . . . . . . . . . 87.6 t90 -64.18 -43.34 95.42 Favored 'General case' 0 C--N 1.363 1.171 0 O-C-N 123.549 0.531 . . . . 100.0 110.424 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . 0.514 HD22 ' HB2' ' A' ' 85' ' ' CYS . 82.5 mt -61.6 -44.07 97.69 Favored 'General case' 0 CA--C 1.492 -1.269 0 O-C-N 123.509 0.505 . . . . 100.0 111.508 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -61.93 -44.04 97.59 Favored 'General case' 0 CA--C 1.497 -1.091 0 C-N-CA 124.126 0.97 . . . . 100.0 111.062 -179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -62.43 -45.67 92.03 Favored 'General case' 0 CA--C 1.492 -1.278 0 C-N-CA 123.242 0.617 . . . . 100.0 112.075 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . . . . . . . . . 50.4 tptt -65.71 -44.73 85.21 Favored 'General case' 0 N--CA 1.436 -1.159 0 O-C-N 123.76 0.663 . . . . 100.0 111.764 -178.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' LEU . . . . . 0.451 HD11 ' HB3' ' A' ' 85' ' ' CYS . 85.0 mt -63.51 -46.61 85.28 Favored 'General case' 0 CA--C 1.494 -1.175 0 C-N-CA 124.073 0.949 . . . . 100.0 113.141 -179.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.16 -38.47 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 109.436 -0.579 . . . . 100.0 109.436 178.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLY . . . . . . . . . . . . . . . 93.72 10.53 58.9 Favored Glycine 0 C--N 1.353 1.496 0 N-CA-C 110.138 -1.185 . . . . 100.0 110.138 -178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -110.71 111.74 56.66 Favored Pre-proline 0 C--N 1.361 1.103 0 N-CA-C 107.812 -1.181 . . . . 100.0 107.812 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -71.82 -15.85 29.75 Favored 'Trans proline' 0 C--N 1.364 1.39 0 C-N-CA 123.776 2.984 . . . . 100.0 113.734 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 72.5 m-20 -87.59 0.32 55.8 Favored 'General case' 0 CA--C 1.501 -0.913 0 C-N-CA 124.025 0.93 . . . . 100.0 113.133 -177.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 18.3 tp -64.78 132.03 48.43 Favored 'General case' 0 N--CA 1.436 -1.127 0 C-N-CA 123.178 0.591 . . . . 100.0 109.892 -179.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -135.29 152.08 51.16 Favored 'General case' 0 CA--C 1.498 -1.058 0 N-CA-C 108.679 -0.859 . . . . 100.0 108.679 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -89.11 111.83 22.67 Favored 'General case' 0 C--N 1.36 1.042 0 N-CA-C 104.782 -2.303 . . . . 100.0 104.782 178.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' VAL . . . . . . . . . . . . . 99.1 t -66.08 -43.91 92.15 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.713 0 C-N-CA 124.243 1.017 . . . . 100.0 110.824 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -126.51 149.14 49.54 Favored 'General case' 0 CA--C 1.488 -1.408 0 CA-C-O 121.583 0.706 . . . . 100.0 110.559 -178.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' MET . . . . . . . . . . . . . 59.5 ttm -91.39 125.45 57.99 Favored Pre-proline 0 N--CA 1.433 -1.306 0 N-CA-C 105.433 -2.062 . . . . 100.0 105.433 178.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -66.28 157.4 60.23 Favored 'Trans proline' 0 N--CA 1.444 -1.393 0 C-N-CA 123.039 2.493 . . . . 100.0 111.156 179.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' ALA . . . . . . . . . . . . . . . -65.35 126.19 27.43 Favored 'General case' 0 CA--C 1.498 -1.028 0 N-CA-C 108.1 -1.074 . . . . 100.0 108.1 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 87.6 mt -120.71 145.19 47.74 Favored 'General case' 0 CA--C 1.487 -1.46 0 CA-C-N 114.36 -1.291 . . . . 100.0 110.145 -178.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . . . . . . . . . . . -63.98 138.75 97.49 Favored Pre-proline 0 N--CA 1.439 -1.024 0 N-CA-C 107.699 -1.223 . . . . 100.0 107.699 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_exo -55.72 138.54 81.59 Favored 'Trans proline' 0 C--N 1.368 1.562 0 C-N-CA 123.642 2.894 . . . . 100.0 112.3 -178.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -60.36 129.59 30.42 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 122.753 2.302 . . . . 100.0 113.726 -178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLU . . . . . . . . . . . . . 90.1 mt-10 -67.08 -43.67 82.03 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 124.774 1.296 . . . . 100.0 108.754 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . . . . . . . . . 23.9 m -131.77 160.06 42.66 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.797 0 N-CA-C 106.322 -1.733 . . . . 100.0 106.322 178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' VAL . . . . . . . . . . . . . 93.7 t -101.69 130.72 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.906 0 N-CA-C 107.755 -1.202 . . . . 100.0 107.755 -179.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 tpt -80.88 122.72 27.58 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 104.789 -2.3 . . . . 100.0 104.789 178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ASP . . . . . 0.409 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . 35.9 t70 -65.9 128.2 93.66 Favored Pre-proline 0 N--CA 1.436 -1.151 0 CA-C-N 115.13 -0.941 . . . . 100.0 109.411 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 190' ' ' ASP . 53.7 Cg_exo -59.03 -39.06 83.98 Favored 'Trans proline' 0 C--N 1.368 1.583 0 C-N-CA 123.54 2.827 . . . . 100.0 113.6 -179.588 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ALA . . . . . . . . . . . . . . . -64.34 -43.98 92.91 Favored 'General case' 0 CA--C 1.499 -1.019 0 O-C-N 124.337 1.023 . . . . 100.0 110.832 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 94.5 mt -63.8 -42.75 97.65 Favored 'General case' 0 CA--C 1.498 -1.047 0 C-N-CA 122.65 0.38 . . . . 100.0 111.653 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ALA . . . . . . . . . . . . . . . -61.83 -44.16 97.4 Favored 'General case' 0 CA--C 1.496 -1.134 0 C-N-CA 123.546 0.738 . . . . 100.0 110.612 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . . . . . . . . . . . -62.88 -43.77 97.91 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 124.031 0.932 . . . . 100.0 110.672 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -63.76 -43.08 97.49 Favored 'General case' 0 C--N 1.359 0.985 0 C-N-CA 123.186 0.594 . . . . 100.0 112.077 -179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -63.03 -44.16 96.68 Favored 'General case' 0 CA--C 1.5 -0.957 0 C-N-CA 122.733 0.413 . . . . 100.0 111.273 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -63.89 -40.64 96.99 Favored 'General case' 0 N--CA 1.441 -0.894 0 C-N-CA 122.957 0.503 . . . . 100.0 110.477 179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' HIS . . . . . . . . . . . . . 86.6 t60 -62.55 -43.93 97.6 Favored 'General case' 0 C--N 1.356 0.857 0 C-N-CA 124.75 1.22 . . . . 100.0 110.78 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . . . . . . . . . 94.1 m-20 -62.06 -42.5 99.26 Favored 'General case' 0 CA--C 1.499 -1.0 0 C-N-CA 123.898 0.879 . . . . 100.0 110.169 -179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . 0.502 ' HA ' ' OD1' ' A' ' 213' ' ' ASP . 20.6 tp -59.9 -49.04 79.24 Favored 'General case' 0 N--CA 1.436 -1.164 0 O-C-N 124.156 0.91 . . . . 100.0 110.033 178.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -63.22 -43.44 98.12 Favored 'General case' 0 CA--C 1.491 -1.317 0 N-CA-C 115.203 1.557 . . . . 100.0 115.203 -178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' VAL . . . . . . . . . . . . . 50.3 t -59.33 -46.74 92.23 Favored 'Isoleucine or valine' 0 CA--C 1.469 -2.151 0 CA-C-O 118.388 -0.815 . . . . 100.0 109.673 -176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ALA . . . . . 0.689 ' HB3' ' HB2' ' A' ' 210' ' ' PRO 0.407 . . -94.61 0.54 55.24 Favored 'General case' 0 N--CA 1.404 -2.752 1 C-N-CA 109.655 -4.818 . . . . 100.0 114.332 179.711 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLN . . . . . 0.798 ' HA ' ' HA ' ' A' ' 213' ' ' ASP 0.301 62.4 mt-30 -56.51 -37.01 69.84 Favored 'General case' 0 CA--C 1.465 -2.32 0 N-CA-C 106.354 -1.721 . . . . 100.0 106.354 178.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 67.9 p -82.03 52.82 2.06 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-O 122.247 1.022 . . . . 100.0 109.303 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' THR . . . . . . . . . . . . 0.324 80.5 p 48.83 38.81 12.78 Favored 'General case' 0 N--CA 1.429 -1.484 0 C-N-CA 129.522 3.129 . . . . 100.0 116.111 176.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' ALA . . . . . 0.472 ' HB3' ' CB ' ' A' ' 204' ' ' ALA . . . -83.12 -177.16 6.66 Favored 'General case' 0 N--CA 1.432 -1.331 0 N-CA-C 104.417 -2.438 . . . . 100.0 104.417 176.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LEU . . . . . 0.445 ' HB2' ' HD3' ' A' ' 210' ' ' PRO . 85.7 mt -56.46 -41.54 91.67 Favored Pre-proline 0 CA--C 1.502 -0.902 0 CA-C-O 116.014 -1.946 . . . . 100.0 114.545 -175.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PRO . . . . . 1.07 ' HB3' ' HA ' ' A' ' 134' ' ' LYS 0.309 23.3 Cg_exo -55.35 136.67 74.67 Favored 'Trans proline' 0 C--N 1.374 1.892 0 CA-C-N 121.354 1.519 . . . . 100.0 112.382 177.482 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASP . . . . . 0.403 ' HB3' ' HB ' ' A' ' 137' ' ' VAL . 96.8 m-20 -63.71 -47.57 80.61 Favored 'General case' 0 N--CA 1.426 -1.64 1 N-CA-C 124.493 4.997 . . . . 100.0 124.493 -173.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.664 ' O ' ' HB3' ' A' ' 215' ' ' ASP . 99.4 mt-10 -62.88 -35.64 80.69 Favored 'General case' 0 CA--C 1.481 -1.696 0 CA-C-O 128.285 3.898 . . . . 100.0 107.918 177.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . 0.798 ' HA ' ' HA ' ' A' ' 205' ' ' GLN 0.483 44.9 m-20 -65.49 -48.73 71.58 Favored 'General case' 1 N--CA 1.35 -5.426 1 CA-C-N 107.563 -4.381 . . . . 100.0 106.493 -179.017 . . . . . . . . 5 3 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -63.32 -29.85 71.09 Favored 'General case' 0 C--N 1.359 0.996 0 O-C-N 120.448 -1.407 . . . . 100.0 108.168 178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.664 ' HB3' ' O ' ' A' ' 212' ' ' GLU . 0.8 OUTLIER -58.35 -42.99 88.13 Favored 'General case' 0 CA--C 1.478 -1.797 0 CA-C-O 117.297 -1.335 . . . . 100.0 113.41 176.439 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 C--O 1.26 1.645 0 CA-C-O 115.478 -2.201 . . . . 100.0 113.968 -176.288 . . . . . . . . 0 0 . 1 stop_ save_